data_2kpk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kpk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.448 -1.181 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -83.24 105.45 14.21 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.582 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 3.1 t80 -103.03 124.61 48.85 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -130.78 11.18 5.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.926 0.869 . . . . 0.0 111.577 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.582 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 40.2 mtt180 55.21 6.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.774 1.63 . . . . 0.0 114.955 173.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -133.91 121.76 16.05 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -59.27 -27.16 84.26 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 123.611 2.874 . . . . 0.0 112.307 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 m -80.02 -24.4 40.82 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.521 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.53 -28.03 15.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 44.2 tp -70.24 155.16 41.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.053 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.473 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 24.4 mtmm -90.02 -175.71 4.66 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.561 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 109.02 178.16 21.49 Favored Glycine 0 C--N 1.278 -2.662 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.729 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 1.6 tmpt? -91.07 134.19 34.71 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 91.8 m-85 -122.84 128.26 50.14 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 119.061 0.846 . . . . 0.0 109.867 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.548 HG13 ' HE3' ' A' ' 14' ' ' LYS . 73.8 mt -137.73 127.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -104.49 104.73 14.63 Favored 'General case' 0 N--CA 1.396 -3.144 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -124.07 143.86 50.2 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.799 0.809 . . . . 0.0 110.853 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.801 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.4 ttmp? -88.35 126.38 35.17 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.14 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.18 117.33 33.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 42.3 ttt-85 -77.07 113.89 15.28 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.405 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 70.9 tttt -69.64 97.52 1.06 Allowed 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.41 ' O ' HG21 ' A' ' 89' ' ' ILE . 32.2 t -83.59 -155.21 0.17 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.675 1.19 . . . . 0.0 108.514 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -59.4 -40.93 88.21 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.501 0.667 . . . . 0.0 109.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.02 -20.85 34.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.804 0.812 . . . . 0.0 109.521 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 98.18 -120.53 6.83 Favored Glycine 1 N--CA 1.378 -5.232 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.7 m-85 -91.57 141.72 28.42 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.565 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.21 1.27 87.59 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.107 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -110.81 163.34 13.88 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.817 0.818 . . . . 0.0 112.161 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 63.0 p -123.2 152.87 40.81 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -127.11 154.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.123 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.83 150.63 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.071 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.75 -138.74 13.89 Favored Glycine 1 N--CA 1.393 -4.175 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.61 28.9 31.03 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.1 -29.39 68.3 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt-20 -154.49 163.09 25.4 Favored Pre-proline 0 CA--C 1.456 -2.64 0 C-N-CA 118.025 -1.47 . . . . 0.0 109.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.0 Cg_endo -68.3 52.83 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.215 0 C-N-CA 123.076 2.517 . . . . 0.0 109.896 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 171.19 3.28 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.368 -168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.449 ' HG3' ' CG ' ' A' ' 36' ' ' GLU . 25.7 mt-10 -132.88 130.21 39.41 Favored 'General case' 0 C--O 1.275 2.44 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 163.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.646 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.256 5.2 m-30 -76.8 158.8 30.61 Favored 'General case' 0 N--CA 1.525 3.305 0 O-C-N 128.898 3.874 . . . . 0.0 114.008 -167.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 4.8 mp -93.09 141.69 28.12 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.21 151.44 47.69 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.1 mm -68.37 109.93 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 41.4 ttmt -58.36 -38.1 76.57 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.408 ' HA ' HG23 ' A' ' 60' ' ' THR . 40.9 t 161.77 173.13 0.01 OUTLIER 'General case' 0 C--N 1.362 1.148 0 O-C-N 125.659 1.849 . . . . 0.0 109.825 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 pp -141.16 149.2 41.18 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.784 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.414 HG13 ' H ' ' A' ' 49' ' ' ASP . 16.9 t -80.1 127.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.81 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.72 -3.69 1.66 Allowed 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 127.423 2.289 . . . . 0.0 113.567 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.414 ' H ' HG13 ' A' ' 47' ' ' VAL . 18.5 t70 -102.61 -25.56 13.53 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.492 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.42 ' O ' HD11 ' A' ' 54' ' ' LEU . . . -85.69 162.93 36.41 Favored Glycine 0 N--CA 1.399 -3.822 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.908 -171.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.12 -33.51 35.57 Favored 'Trans proline' 0 C--O 1.188 -2.003 0 C-N-CA 125.006 3.804 . . . . 0.0 113.486 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.7 78.98 Favored 'General case' 0 C--O 1.28 2.702 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.33 -34.54 55.27 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.389 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.42 HD11 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -68.7 -42.5 77.67 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.977 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.704 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 34.7 t70 -64.16 -38.73 92.12 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.903 1.335 . . . . 0.0 107.483 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 -15.75 44.4 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 112.522 -2.126 . . . . 0.0 114.098 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.704 ' HB2' ' OD2' ' A' ' 55' ' ' ASP . 45.8 mtmt -79.14 -17.25 55.37 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.6 ttm -106.93 135.07 49.11 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.111 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.26 164.57 27.78 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.34 0.591 . . . . 0.0 109.903 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 45' ' ' SER . 77.7 p -63.08 118.26 7.62 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.354 1.062 . . . . 0.0 110.083 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 104.67 -5.76 44.0 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.125 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.638 ' OD2' ' HB2' ' A' ' 99' ' ' ARG . 3.0 m-20 -63.19 127.27 30.48 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -77.46 114.93 18.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 175.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 mm -67.8 122.11 18.33 Favored 'Isoleucine or valine' 1 C--O 1.331 5.369 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 73' ' ' LEU . 61.9 t -114.11 -38.4 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 110.759 -2.928 . . . . 0.0 110.73 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.1 m -151.27 160.57 43.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.163 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.402 HG11 ' HB ' ' A' ' 72' ' ' VAL . 3.6 p -140.59 127.92 22.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.44 31.98 18.01 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 t70 71.31 1.8 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.179 1.392 . . . . 0.0 111.956 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.2 m -88.84 123.92 33.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.58 104.76 1.67 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.675 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.402 ' HB ' HG11 ' A' ' 67' ' ' VAL . 3.2 p -113.76 17.14 7.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.646 HD11 ' CE1' ' A' ' 40' ' ' PHE . 28.5 tp -59.69 112.95 2.0 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 29.72 45.85 0.09 OUTLIER Glycine 0 N--CA 1.499 2.859 0 O-C-N 125.269 1.606 . . . . 0.0 112.917 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.506 ' O ' HG21 ' A' ' 76' ' ' THR . 5.0 t60 -47.98 -68.39 0.19 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.599 ' OG1' ' HG2' ' A' ' 79' ' ' GLN . 22.1 p -166.16 143.98 5.48 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 151.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.609 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.61 -31.7 26.02 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 119.948 1.249 . . . . 0.0 110.519 172.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.01 83.12 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 121.971 -0.456 . . . . 0.0 110.72 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.599 ' HG2' ' OG1' ' A' ' 76' ' ' THR . 55.3 mm-40 -64.91 -43.2 93.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 77' ' ' HIS . 15.8 m -60.16 -43.13 92.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.115 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 71.2 t -64.73 -41.98 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.666 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -57.24 -41.93 80.5 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.518 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.666 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 34.1 mt -67.18 -36.15 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 122.038 0.923 . . . . 0.0 111.686 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.87 -25.84 61.24 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.354 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 25.8 mt-30 -76.32 -24.33 54.31 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 67.6 m -73.75 -28.61 61.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.957 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.7 mt -92.78 133.84 28.57 Favored Pre-proline 0 N--CA 1.411 -2.407 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.556 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 16.3 Cg_endo -92.38 162.13 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.844 3.029 . . . . 0.0 113.393 -174.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.499 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.0 mm -62.72 131.86 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 CA-C-O 121.302 0.573 . . . . 0.0 111.072 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.64 12.17 51.45 Favored Glycine 0 C--N 1.294 -1.79 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.806 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.05 -171.24 2.01 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 14.8 m -151.27 157.48 42.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.801 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.4 125.54 6.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 C-N-CA 118.393 -1.323 . . . . 0.0 112.972 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.7 107.38 11.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.1 mt -107.75 144.53 34.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.592 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -97.49 115.75 28.39 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 75.0 mt -113.07 123.76 51.02 Favored 'General case' 0 C--O 1.25 1.119 0 C-N-CA 124.82 1.248 . . . . 0.0 110.55 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -101.68 122.11 43.28 Favored 'General case' 0 C--O 1.154 -3.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.638 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 43.8 ttp180 -116.97 144.07 44.99 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 120.072 -1.642 . . . . 0.0 110.713 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.42 -19.27 3.4 Favored Glycine 0 C--N 1.287 -2.151 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -90.66 132.47 34.91 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 C-N-CA 123.265 2.643 . . . . 0.0 112.396 -176.239 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.433 -2.072 0 CA-C-O 121.332 0.472 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -83.88 104.76 14.23 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -116.67 124.96 51.01 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 t -134.42 19.58 3.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.48 0.657 . . . . 0.0 110.616 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.509 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 30.8 mtm180 54.32 5.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.431 1.892 . . . . 0.0 115.167 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 9' ' ' SER . 23.8 t-20 -133.35 123.77 17.84 Favored Pre-proline 0 C--N 1.298 -1.649 0 CA-C-O 120.963 0.411 . . . . 0.0 111.136 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' HD3' ' SG ' ' A' ' 71' ' ' CYS . 14.8 Cg_endo -64.13 -12.59 33.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.887 3.725 . . . . 0.0 114.425 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 33.2 t -90.67 -36.75 14.18 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -74.39 -39.07 62.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.569 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.477 HD23 ' CZ ' ' A' ' 40' ' ' PHE . 52.5 tp -73.03 158.77 34.77 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.406 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 61.3 mttm -119.31 -174.26 2.68 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.01 -131.55 7.29 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.263 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 3.2 tmpt? -140.53 127.96 21.33 Favored 'General case' 0 C--N 1.257 -3.432 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 98' ' ' CYS . 98.4 m-85 -122.63 123.31 40.87 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 118.666 0.666 . . . . 0.0 110.198 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.64 HD12 ' CE ' ' A' ' 14' ' ' LYS . 70.0 mt -132.05 131.66 61.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.899 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 94' ' ' ASP . 3.7 t60 -103.29 113.31 26.7 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -138.67 142.5 39.01 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.748 0.785 . . . . 0.0 110.55 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.826 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -87.58 133.44 33.8 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.053 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -108.47 117.57 34.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 21.2 ttt180 -77.43 110.54 12.28 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 66.2 tttt -65.76 96.78 0.3 Allowed 'General case' 0 C--O 1.19 -2.059 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 170.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -90.0 -154.79 0.34 Allowed 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.674 1.19 . . . . 0.0 108.927 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -57.06 -38.76 73.72 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.782 0.833 . . . . 0.0 110.495 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.424 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 mmp_? -90.45 -14.85 32.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 109.785 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.581 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 93.7 -115.47 4.97 Favored Glycine 1 N--CA 1.395 -4.058 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 38.6 m-85 -99.88 138.59 36.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 117.907 0.853 . . . . 0.0 109.095 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.08 80.73 Favored Glycine 0 C--O 1.207 -1.591 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.892 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -106.49 163.35 12.94 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.438 0.637 . . . . 0.0 111.162 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 73.6 p -125.96 146.12 50.0 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 m -123.03 148.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.933 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.96 154.59 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.689 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.95 -138.3 14.19 Favored Glycine 1 N--CA 1.386 -4.674 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.84 32.18 25.55 Favored Glycine 0 CA--C 1.47 -2.765 0 C-N-CA 123.559 0.6 . . . . 0.0 112.242 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -35.74 81.95 Favored 'General case' 0 CA--C 1.451 -2.855 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.17 165.47 18.51 Favored Pre-proline 0 CA--C 1.462 -2.441 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.293 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.3 Cg_endo -67.27 58.96 0.66 Allowed 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.766 2.311 . . . . 0.0 109.349 170.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 37.2 t70 174.4 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.393 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.1 mt-10 -128.91 127.42 41.74 Favored 'General case' 0 C--O 1.279 2.631 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.595 ' CE1' HD11 ' A' ' 73' ' ' LEU . 7.0 m-30 -77.22 158.82 30.09 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 129.023 3.952 . . . . 0.0 113.694 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.48 HD23 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -92.22 143.0 26.87 Favored 'General case' 0 CA--C 1.46 -2.516 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.724 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.4 mt-30 -136.46 152.78 50.94 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 62' ' ' ASP . 30.2 mm -71.83 108.93 3.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 39.5 ttpt -60.66 -36.99 80.08 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.42 ' HA ' HG23 ' A' ' 60' ' ' THR . 39.9 t 161.14 173.41 0.01 OUTLIER 'General case' 0 C--N 1.372 1.573 0 O-C-N 125.711 1.882 . . . . 0.0 109.53 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.63 152.11 51.54 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.63 113.43 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . 0.9 OUTLIER -69.35 -6.96 33.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.306 1.05 . . . . 0.0 113.101 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.72 -3.86 48.48 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.914 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.425 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -97.79 174.81 29.51 Favored Glycine 0 N--CA 1.423 -2.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.595 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.54 -29.2 84.11 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 123.973 3.115 . . . . 0.0 113.404 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.0 -46.93 86.94 Favored 'General case' 0 C--O 1.268 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 111.95 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . . . -77.14 -35.66 55.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.043 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 50' ' ' GLY . 9.3 mp -71.54 -34.62 70.17 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.23 -19.97 60.33 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.776 1.275 . . . . 0.0 107.637 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.36 31.74 81.78 Favored Glycine 0 CA--C 1.491 -1.459 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.922 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.28 -29.65 4.78 Favored 'General case' 0 N--CA 1.394 -3.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.3 ttm -101.19 139.76 36.43 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.539 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.14 156.58 46.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.91 0.862 . . . . 0.0 109.477 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.42 HG23 ' HA ' ' A' ' 45' ' ' SER . 51.6 p -64.25 115.76 5.34 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 124.861 1.265 . . . . 0.0 109.601 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 117.61 -20.06 11.17 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.577 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.2 m-20 -58.96 135.85 57.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -87.32 117.89 32.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 C-N-CA 122.79 0.436 . . . . 0.0 111.392 175.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 mm -68.46 123.2 21.32 Favored 'Isoleucine or valine' 1 C--O 1.332 5.432 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 73' ' ' LEU . 46.4 t -115.6 -41.11 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 127.441 2.963 . . . . 0.0 111.793 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 66.4 m -147.04 161.84 40.01 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.17 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.49 134.58 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 m120 65.68 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.718 0.636 . . . . 0.0 110.054 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -163.96 33.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.813 1.768 . . . . 0.0 108.008 169.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.8 m -123.74 128.94 50.3 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.787 -1.551 . . . . 0.0 107.762 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.55 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 t -71.29 121.44 18.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.402 ' H ' ' HA ' ' A' ' 66' ' ' SER . 4.7 p -121.23 20.15 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.595 HD11 ' CE1' ' A' ' 40' ' ' PHE . 34.0 tp -60.24 113.09 2.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.45 44.81 0.09 OUTLIER Glycine 0 N--CA 1.503 3.119 0 O-C-N 125.632 1.832 . . . . 0.0 111.729 -171.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t60 -49.44 -65.62 0.53 Allowed 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.7 p -166.75 143.81 4.82 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 152.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -50.8 -34.21 26.67 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 119.904 1.229 . . . . 0.0 110.902 172.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.94 96.49 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 122.192 -0.317 . . . . 0.0 110.929 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.517 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 8.2 mm-40 -67.51 -41.39 84.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 77' ' ' HIS . 20.2 m -63.45 -45.88 96.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.96 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.96 -39.51 85.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -56.22 -43.14 78.28 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 123.445 0.465 . . . . 0.0 110.975 175.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.665 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.7 mm -65.16 -36.8 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.432 0.634 . . . . 0.0 112.265 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -75.45 -32.83 60.79 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.192 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -73.05 -21.75 60.74 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.337 1.055 . . . . 0.0 111.305 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.3 m -77.9 -35.19 51.01 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.34 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.6 mt -77.88 133.25 66.08 Favored Pre-proline 0 N--CA 1.417 -2.098 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.238 177.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 13.6 Cg_endo -90.18 161.74 4.73 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.114 2.543 . . . . 0.0 112.972 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.505 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.4 mm -62.76 133.17 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.128 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.98 54.13 Favored Glycine 0 C--N 1.296 -1.649 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.672 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' C ' ' HG ' ' A' ' 92' ' ' SER . . . -99.44 -172.41 2.25 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.7 m -151.1 153.63 35.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.826 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.5 125.53 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.127 0 C-N-CA 117.343 -1.743 . . . . 0.0 113.353 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 8.5 m-20 -78.85 105.2 10.0 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.44 146.61 34.22 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 124.279 1.031 . . . . 0.0 109.672 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -107.93 117.01 33.0 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.539 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 68.9 mt -107.48 134.36 50.63 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 125.626 1.57 . . . . 0.0 110.697 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.712 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 31.1 t -106.97 123.99 48.98 Favored 'General case' 0 C--O 1.164 -3.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.484 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.595 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 2.9 mtm180 -103.73 123.93 47.95 Favored 'General case' 0 C--N 1.259 -3.331 0 O-C-N 120.641 -1.287 . . . . 0.0 109.525 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.1 -23.5 0.17 Allowed Glycine 0 C--N 1.271 -3.039 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.609 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.412 ' HH ' HD13 ' A' ' 11' ' ' LEU . 38.6 m-85 -96.94 139.21 21.42 Favored Pre-proline 0 N--CA 1.431 -1.382 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.637 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 101' ' ' TYR . 20.6 Cg_exo . . . . . 0 C--O 1.247 0.937 0 C-N-CA 123.341 2.694 . . . . 0.0 112.587 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.451 -1.002 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.01 103.81 4.63 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.595 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.5 t80 -111.29 128.98 56.11 Favored 'General case' 0 C--N 1.268 -2.94 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -139.46 13.45 2.56 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.226 0.536 . . . . 0.0 110.846 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.471 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtm180 55.25 6.47 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.139 1.776 . . . . 0.0 114.937 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -133.03 120.41 16.25 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD3' ' SG ' ' A' ' 71' ' ' CYS . 23.8 Cg_exo -54.2 -32.49 70.82 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 124.472 3.448 . . . . 0.0 112.535 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -72.81 -21.93 60.89 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.59 0.709 . . . . 0.0 111.15 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -94.44 -25.94 16.69 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.571 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 HD23 ' CZ ' ' A' ' 40' ' ' PHE . 42.4 tp -81.31 152.39 27.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.741 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -121.16 146.67 46.52 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.608 0.718 . . . . 0.0 110.151 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.747 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 158.35 -169.2 34.85 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -173.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.555 ' CE ' HG12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -103.76 108.66 20.07 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 118.401 1.1 . . . . 0.0 109.052 171.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 52.2 m-85 -90.04 120.22 31.05 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.941 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.555 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.7 mt -118.15 138.57 48.43 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.075 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -110.0 118.44 36.44 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -140.73 127.86 20.88 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.457 0.646 . . . . 0.0 112.678 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.827 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -88.51 126.41 35.24 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.428 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.64 119.75 40.3 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 13.3 ttp180 -79.29 106.35 11.26 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.723 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.586 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.8 tttt -62.71 97.52 0.1 Allowed 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 89' ' ' ILE . 37.3 t -81.69 -157.24 0.18 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 124.335 1.054 . . . . 0.0 108.798 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -63.35 -34.68 78.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.6 tmt_? -81.94 -20.71 38.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 87.58 -118.4 4.99 Favored Glycine 1 N--CA 1.391 -4.325 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.452 ' CE2' ' HD2' ' A' ' 22' ' ' LYS . 44.9 m-85 -94.56 144.14 25.83 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.888 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.23 3.28 63.99 Favored Glycine 0 C--O 1.203 -1.803 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.479 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -114.58 163.14 15.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.333 0.587 . . . . 0.0 110.358 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 55.9 p -122.71 148.65 45.06 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.7 m -121.87 143.76 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 CA-C-O 121.608 0.718 . . . . 0.0 111.113 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.66 148.5 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.083 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 118.4 -137.57 13.07 Favored Glycine 2 N--CA 1.381 -5.012 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.8 31.7 16.85 Favored Glycine 0 CA--C 1.467 -2.943 0 O-C-N 124.358 0.681 . . . . 0.0 111.528 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -70.14 -22.98 62.94 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.14 166.03 8.66 Favored Pre-proline 0 CA--C 1.463 -2.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 18.0 Cg_endo -66.56 58.18 0.5 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.389 2.06 . . . . 0.0 109.831 171.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 23.5 t70 177.08 -11.92 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.454 -171.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 17.7 mt-10 -124.63 124.98 43.38 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 169.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.609 ' CE1' HD12 ' A' ' 73' ' ' LEU 0.252 4.9 m-30 -76.78 159.26 30.27 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 131.044 3.738 . . . . 0.0 113.932 -169.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 80' ' ' VAL . 8.0 mp -92.56 144.33 25.45 Favored 'General case' 0 C--O 1.183 -2.432 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.3 mt-30 -139.23 156.93 46.74 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 62' ' ' ASP . 26.3 mm -72.42 111.45 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.261 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 36.8 ttpt -63.06 -40.97 99.29 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 37.8 t 165.15 174.4 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 125.148 1.53 . . . . 0.0 109.81 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.425 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 pp -142.64 147.61 36.05 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.94 0.876 . . . . 0.0 112.712 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.0 116.39 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.984 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.724 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.89 -24.59 62.47 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.403 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -94.46 -2.51 51.69 Favored 'General case' 0 C--N 1.258 -3.373 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.656 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -99.65 170.46 23.12 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.505 -174.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.77 -29.25 79.99 Favored 'Trans proline' 0 C--O 1.196 -1.586 0 C-N-CA 124.203 3.269 . . . . 0.0 113.312 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.49 98.73 Favored 'General case' 0 C--O 1.269 2.112 0 CA-C-O 121.459 0.647 . . . . 0.0 111.479 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.46 47.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.77 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 50' ' ' GLY . 9.4 mp -70.48 -38.96 74.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.581 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.74 -24.91 62.71 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.85 74.03 Favored Glycine 0 CA--C 1.483 -1.923 0 CA-C-N 112.304 -2.225 . . . . 0.0 113.164 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -118.04 -2.04 11.32 Favored 'General case' 0 N--CA 1.385 -3.696 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.98 134.82 52.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.447 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.35 151.83 45.56 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 45' ' ' SER . 76.2 p -64.91 110.22 2.37 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.378 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.31 -19.65 7.16 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-O 119.254 -0.748 . . . . 0.0 113.237 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 43' ' ' ILE . 13.5 m-20 -61.33 132.23 52.89 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.005 0.902 . . . . 0.0 109.461 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.257 0.1 OUTLIER -82.38 120.54 34.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 177.528 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mm -71.86 123.09 25.53 Favored 'Isoleucine or valine' 1 C--O 1.333 5.488 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.51 HG12 HD13 ' A' ' 73' ' ' LEU . 52.8 t -115.56 -40.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 127.442 2.964 . . . . 0.0 111.28 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -146.25 162.14 38.73 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.319 -0.863 . . . . 0.0 112.906 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.412 HG12 ' CG2' ' A' ' 83' ' ' ILE . 52.7 t -139.82 126.54 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 C-N-CA 125.443 1.497 . . . . 0.0 107.197 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 m120 57.55 30.71 19.17 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.67 0.606 . . . . 0.0 110.947 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.9 t70 77.93 -8.12 1.72 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.043 1.337 . . . . 0.0 111.882 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.1 m -86.51 121.16 28.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 49.7 t -60.89 112.88 2.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.492 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG23 HG13 ' A' ' 80' ' ' VAL . 3.2 p -119.98 18.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 40' ' ' PHE . 38.5 tp -60.52 112.42 1.97 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.17 39.05 0.06 OUTLIER Glycine 0 N--CA 1.504 3.233 0 O-C-N 125.007 1.442 . . . . 0.0 112.107 -171.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 76' ' ' THR . 5.8 t60 -42.85 -64.34 0.64 Allowed 'General case' 0 C--N 1.373 1.604 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 75' ' ' HIS . 5.3 p -166.99 142.99 4.34 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 150.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.634 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -51.57 -32.15 27.25 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 120.951 1.705 . . . . 0.0 110.889 173.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.33 77.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.811 0.338 . . . . 0.0 110.619 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 12.6 mm-40 -65.23 -40.79 94.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.634 HG21 ' O ' ' A' ' 77' ' ' HIS . 11.0 m -63.65 -44.47 98.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.94 -40.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -56.73 -41.64 77.85 Favored 'General case' 0 C--O 1.196 -1.74 0 O-C-N 123.465 0.478 . . . . 0.0 110.835 175.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.665 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.5 mm -65.91 -36.05 76.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 0.0 112.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.39 -26.94 56.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.92 -30.05 61.15 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.179 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -66.29 -42.98 87.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.101 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.4 mt -76.22 131.88 74.46 Favored Pre-proline 0 N--CA 1.404 -2.769 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.683 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 91' ' ' ALA . 37.0 Cg_endo -92.42 161.91 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.175 2.584 . . . . 0.0 112.92 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 26.8 mm -58.68 132.35 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.36 11.41 54.18 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.98 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.409 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . . . -101.77 -169.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.4 m -151.62 157.44 42.16 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -147.3 124.94 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.601 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.5 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.45 103.79 8.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.2 mt -100.01 148.95 23.97 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 125.092 1.357 . . . . 0.0 109.045 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 29.0 tt0 -111.18 119.13 37.91 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.75 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 96.1 mt -106.18 164.6 11.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.646 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.747 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 7.9 t -142.09 117.28 10.08 Favored 'General case' 0 C--O 1.18 -2.577 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -100.99 145.25 28.93 Favored 'General case' 0 C--N 1.261 -3.267 0 O-C-N 120.472 -1.393 . . . . 0.0 109.734 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.15 -27.93 1.55 Allowed Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -84.88 130.82 51.13 Favored Pre-proline 0 N--CA 1.427 -1.619 0 CA-C-O 121.051 0.453 . . . . 0.0 110.51 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 123.459 2.772 . . . . 0.0 114.208 -173.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.443 -1.468 0 CA-C-O 121.036 0.348 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.76 103.74 14.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.59 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.2 t80 -115.94 126.68 54.19 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.451 ' CG2' HD23 ' A' ' 11' ' ' LEU . 5.8 t -139.4 23.67 2.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.887 0.851 . . . . 0.0 110.884 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 60.0 mtt180 53.03 4.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 127.381 2.272 . . . . 0.0 116.136 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.7 t-20 -134.4 122.98 16.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.56 -31.58 70.45 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 123.753 2.969 . . . . 0.0 112.602 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -71.2 -26.81 63.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.397 0.618 . . . . 0.0 110.221 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -93.22 -15.26 26.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.344 0.592 . . . . 0.0 110.85 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.451 HD23 ' CG2' ' A' ' 5' ' ' THR . 33.3 mt -76.43 -173.68 2.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.51 1.147 . . . . 0.0 111.767 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -120.5 178.52 4.64 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.567 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.98 164.57 35.27 Favored Glycine 0 C--N 1.281 -2.476 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.204 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 34.0 tptt -88.25 126.83 35.37 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.654 0.782 . . . . 0.0 109.678 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 93.4 m-85 -104.79 119.63 39.47 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.016 0.912 . . . . 0.0 110.583 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.53 HD12 ' NH2' ' A' ' 99' ' ' ARG . 8.5 mt -121.67 146.56 26.57 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.116 -172.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -117.29 127.34 53.98 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -139.05 156.86 46.86 Favored 'General case' 0 C--O 1.184 -2.369 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.803 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 38.2 ttpt -127.26 123.57 36.79 Favored 'General case' 0 C--N 1.258 -3.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -106.81 116.4 31.86 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.75 -170.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 32.8 ttp-105 -79.01 102.38 8.31 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.268 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.6 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 70.6 tttt -59.54 97.79 0.04 OUTLIER 'General case' 0 C--O 1.179 -2.649 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 t -84.82 -155.3 0.2 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.792 1.237 . . . . 0.0 109.173 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -61.13 -36.36 79.53 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.396 0.617 . . . . 0.0 109.468 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -86.69 -16.78 35.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.736 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.6 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 88.38 -112.17 3.87 Favored Glycine 1 N--CA 1.391 -4.308 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 44.1 m-85 -97.09 135.12 39.53 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.172 0.51 . . . . 0.0 109.919 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.93 -3.42 90.6 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.896 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 27' ' ' PHE . 9.7 p90 -113.58 163.68 14.64 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.604 0.716 . . . . 0.0 111.903 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.2 p -124.08 148.06 47.4 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.369 1.468 . . . . 0.0 107.281 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' CE1' ' A' ' 77' ' ' HIS . 15.4 m -121.66 148.23 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.75 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.41 153.48 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.434 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.43 -131.79 9.59 Favored Glycine 0 N--CA 1.398 -3.877 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.65 36.33 24.87 Favored Glycine 0 CA--C 1.466 -2.97 0 O-C-N 124.593 0.82 . . . . 0.0 111.902 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.08 -31.05 70.42 Favored 'General case' 0 CA--C 1.449 -2.932 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -161.4 166.87 14.16 Favored Pre-proline 0 CA--C 1.45 -2.869 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.216 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -66.72 64.04 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.126 1.884 . . . . 0.0 108.468 168.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 12.9 t70 170.69 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.376 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 21.3 mt-10 -127.58 127.4 43.82 Favored 'General case' 0 C--O 1.276 2.457 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 73' ' ' LEU . 9.7 m-85 -76.92 159.25 30.15 Favored 'General case' 0 N--CA 1.532 3.639 0 O-C-N 128.836 3.835 . . . . 0.0 113.319 -167.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.48 HD23 HG21 ' A' ' 80' ' ' VAL . 5.1 mp -92.34 143.2 26.63 Favored 'General case' 0 CA--C 1.469 -2.161 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.8 mt-30 -135.5 154.28 51.46 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.9 mm -75.35 111.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.39 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 45' ' ' SER . 47.6 tptt -60.83 -47.29 87.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.521 ' HA ' HG21 ' A' ' 60' ' ' THR . 39.9 t 173.2 172.71 0.13 Allowed 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.871 1.357 . . . . 0.0 111.183 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pp -143.1 145.74 33.13 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 123.764 0.826 . . . . 0.0 111.128 -175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.18 121.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.494 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 1.8 pt? -69.42 -5.24 22.45 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.965 0.888 . . . . 0.0 112.585 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -85.4 -26.65 26.29 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.903 -1.499 . . . . 0.0 108.917 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.424 ' O ' HD11 ' A' ' 54' ' ' LEU . . . -90.44 172.08 37.34 Favored Glycine 0 N--CA 1.402 -3.586 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.676 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.87 -26.37 48.06 Favored 'Trans proline' 0 C--O 1.201 -1.375 0 C-N-CA 124.911 3.741 . . . . 0.0 113.325 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.26 -52.66 64.64 Favored 'General case' 0 C--O 1.291 3.244 0 C-N-CA 123.377 0.671 . . . . 0.0 112.789 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.36 -33.53 55.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.456 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 50' ' ' GLY . 7.3 mp -70.31 -35.59 73.76 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.097 -176.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.34 -21.84 65.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.59 11.83 84.86 Favored Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 112.61 -2.087 . . . . 0.0 113.47 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -107.62 -43.02 4.6 Favored 'General case' 1 N--CA 1.376 -4.132 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.0 ptp -95.92 154.7 17.1 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 116.631 -2.028 . . . . 0.0 112.296 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.42 161.19 38.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.749 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.521 HG21 ' HA ' ' A' ' 45' ' ' SER . 75.0 p -65.86 113.7 4.56 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.25 -14.18 10.24 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.716 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 99' ' ' ARG . 2.4 m-20 -65.95 152.69 43.99 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.44 125.18 55.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.989 -0.444 . . . . 0.0 111.571 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 mm -75.52 124.09 32.77 Favored 'Isoleucine or valine' 1 C--O 1.323 4.938 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 73' ' ' LEU . 57.7 t -115.11 -36.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 111.037 -2.801 . . . . 0.0 111.247 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 70.3 m -150.8 160.24 44.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.001 -1.062 . . . . 0.0 113.081 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 95' ' ' LEU . 55.0 t -142.18 129.59 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.5 m120 55.12 41.61 31.47 Favored 'General case' 0 C--O 1.256 1.437 0 O-C-N 123.776 0.673 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 25.26 5.69 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.47 1.108 . . . . 0.0 113.215 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 m -114.72 125.95 54.31 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.435 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 27.4 t -67.08 110.82 3.57 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 67' ' ' VAL . 2.2 p -117.35 16.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.59 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 32.6 tp -57.95 112.85 1.63 Allowed 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.03 40.3 0.05 OUTLIER Glycine 0 N--CA 1.497 2.701 0 O-C-N 125.511 1.757 . . . . 0.0 112.934 -170.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 76' ' ' THR . 4.7 t60 -43.71 -66.48 0.38 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.8 p -166.35 143.51 5.13 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 150.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -51.47 -31.37 23.2 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 119.699 1.136 . . . . 0.0 110.775 172.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.65 85.51 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.942 -0.474 . . . . 0.0 110.946 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.476 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 21.9 mm-40 -65.34 -42.18 93.13 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 77' ' ' HIS . 18.4 m -62.11 -43.71 98.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.26 -39.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -61.0 -41.62 96.88 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.02 176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' SER . 37.1 mt -62.01 -40.96 89.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.34 0.59 . . . . 0.0 111.635 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -70.89 -34.97 72.11 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.804 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -72.77 -19.64 61.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.06 0.944 . . . . 0.0 111.676 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 53.4 m -79.79 -27.81 40.35 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.132 0.973 . . . . 0.0 109.372 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.2 mt -85.17 134.65 40.47 Favored Pre-proline 0 N--CA 1.416 -2.141 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.607 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.5 Cg_endo -92.66 161.68 2.85 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 123.347 2.698 . . . . 0.0 113.039 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.512 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.65 133.55 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.63 12.49 53.43 Favored Glycine 0 C--N 1.289 -2.042 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.955 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.431 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -100.3 -170.26 1.85 Allowed 'General case' 0 C--O 1.199 -1.6 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.594 ' OG ' ' HG2' ' A' ' 19' ' ' LYS . 3.3 t -151.36 159.72 44.13 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.0 t -147.68 126.15 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.507 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.04 112.93 17.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 67' ' ' VAL . 45.2 mt -109.89 144.55 38.21 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 126.387 1.875 . . . . 0.0 109.962 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 66' ' ' SER . 8.9 tp10 -103.45 118.61 37.14 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 23.7 mt -105.6 165.07 11.41 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.903 1.281 . . . . 0.0 108.784 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -142.94 111.05 6.03 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.781 0.801 . . . . 0.0 110.96 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.53 ' NH2' HD12 ' A' ' 16' ' ' ILE . 13.1 mtm180 -97.0 129.69 44.43 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.211 -0.931 . . . . 0.0 112.213 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.07 -17.78 0.82 Allowed Glycine 0 C--N 1.277 -2.702 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.512 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.12 148.85 40.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.862 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.352 0.755 0 C-N-CA 122.889 2.392 . . . . 0.0 111.538 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.554 1.523 0 CA-C-O 121.29 0.454 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.12 107.26 18.95 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.593 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.1 t80 -99.11 129.8 45.39 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 7' ' ' ASN . 14.6 t -138.1 10.82 2.82 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.873 0.845 . . . . 0.0 110.628 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 31.3 mtt180 58.25 -22.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.557 2.343 . . . . 0.0 115.738 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 5' ' ' THR . 56.1 t-20 -104.6 117.74 58.25 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HB3' HG11 ' A' ' 65' ' ' VAL . 9.3 Cg_endo -57.39 -26.05 68.99 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.965 3.11 . . . . 0.0 112.956 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -74.11 -30.29 62.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.124 0.487 . . . . 0.0 110.002 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -89.36 -29.61 18.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 41.2 tp -72.07 155.85 39.84 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.548 0.689 . . . . 0.0 111.619 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 9.2 mtmp? -90.18 -167.17 1.77 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.614 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.622 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 91.13 173.58 43.65 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.183 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -97.44 129.6 44.63 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.5 m-85 -103.16 113.74 27.47 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-O 122.538 1.161 . . . . 0.0 110.04 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -116.55 143.7 26.06 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.908 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.51 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.7 t60 -110.62 131.02 55.41 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 8.8 t -139.29 156.76 46.82 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.2 ttmp? -125.24 122.83 38.08 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -108.35 116.68 32.43 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.393 -174.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.0 ttp180 -75.09 107.77 7.38 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.021 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.554 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.7 tttt -66.71 95.68 0.36 Allowed 'General case' 0 C--O 1.171 -3.07 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 167.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t -89.55 -155.26 0.35 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 m -60.95 -32.81 72.33 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 122.56 0.344 . . . . 0.0 110.397 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -83.11 -21.02 33.78 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.368 0.604 . . . . 0.0 109.55 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.554 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 73.12 80.16 0.45 Allowed Glycine 0 N--CA 1.417 -2.584 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' N ' ' HA ' ' A' ' 22' ' ' LYS . 24.3 m-85 80.49 168.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.736 2.014 . . . . 0.0 110.07 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.18 10.99 5.6 Favored Glycine 0 CA--C 1.497 -1.077 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.018 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -119.49 162.93 18.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.235 0.54 . . . . 0.0 109.758 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.4 p -119.41 153.83 34.61 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -144.85 141.41 23.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.117 -174.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.505 HG21 ' N ' ' A' ' 33' ' ' GLY . 14.6 p -151.83 166.12 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.353 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.505 ' N ' HG21 ' A' ' 32' ' ' VAL . . . 109.6 3.06 30.74 Favored Glycine 0 CA--C 1.454 -3.766 0 N-CA-C 116.521 1.368 . . . . 0.0 116.521 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.725 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -117.06 48.89 0.9 Allowed Glycine 1 CA--C 1.41 -6.516 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -168.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 39' ' ' GLU . 3.2 t70 -56.26 -29.16 60.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 112.841 -1.679 . . . . 0.0 110.239 -173.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.442 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.6 pt-20 -163.81 171.96 5.46 Favored Pre-proline 0 CA--C 1.465 -2.293 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.093 -172.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 21.9 Cg_endo -64.73 54.9 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.011 2.474 . . . . 0.0 110.898 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -177.53 -19.62 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.305 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.725 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 2.8 mt-10 -119.53 122.73 42.31 Favored 'General case' 0 C--O 1.265 1.885 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 171.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.296 5.4 m-30 -78.92 155.99 28.78 Favored 'General case' 0 N--CA 1.533 3.703 0 O-C-N 127.78 3.175 . . . . 0.0 112.722 -176.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD12 ' HA3' ' A' ' 34' ' ' GLY . 7.4 mp -85.75 143.08 28.54 Favored 'General case' 0 C--O 1.179 -2.607 0 C-N-CA 117.153 -1.819 . . . . 0.0 108.112 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.0 mt-30 -139.31 151.24 46.25 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.9 mm -72.38 110.95 5.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 58.3 tttm -59.39 -38.99 81.96 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.443 ' HA ' HG23 ' A' ' 60' ' ' THR . 30.7 t 163.78 172.34 0.02 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.637 1.836 . . . . 0.0 110.646 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -141.58 152.14 43.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.866 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.9 t -81.61 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . 1.6 pt? -68.63 -11.12 59.67 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -95.15 -7.29 39.69 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.073 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.26 163.0 37.18 Favored Glycine 0 N--CA 1.404 -3.461 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.765 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.83 -30.37 38.14 Favored 'Trans proline' 0 C--O 1.211 -0.873 0 C-N-CA 124.718 3.612 . . . . 0.0 112.897 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -57.87 -45.82 85.78 Favored 'General case' 0 C--O 1.271 2.223 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.798 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 48' ' ' LEU . . . -76.9 -31.94 57.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.645 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.32 -40.62 64.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.069 0.547 . . . . 0.0 112.419 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.76 -25.62 67.35 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.02 5.33 65.08 Favored Glycine 0 CA--C 1.483 -1.935 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.939 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.89 -28.78 14.53 Favored 'General case' 1 N--CA 1.378 -4.061 0 C-N-CA 122.782 0.433 . . . . 0.0 111.551 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.8 ttm -97.04 140.49 31.48 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.064 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -137.97 161.9 35.5 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -71.01 107.53 4.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.825 0.85 . . . . 0.0 111.264 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.83 -16.6 9.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.207 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.532 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 2.9 m-20 -61.9 134.45 56.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -84.62 124.89 40.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.276 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.75 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.4 mm -73.8 124.58 31.36 Favored 'Isoleucine or valine' 1 C--O 1.32 4.78 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 170.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 73' ' ' LEU . 47.9 t -115.09 -40.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 111.481 -2.6 . . . . 0.0 110.939 -176.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.2 m -146.27 166.29 26.71 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.193 -1.003 . . . . 0.0 113.345 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.412 HG22 ' CD2' ' A' ' 95' ' ' LEU . 39.8 t -139.7 120.69 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 125.313 1.445 . . . . 0.0 107.493 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.7 m120 67.53 -75.75 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.471 1.107 . . . . 0.0 109.809 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.07 4.14 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.322 0.649 . . . . 0.0 110.862 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -96.94 121.82 39.23 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.489 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 72.1 m -70.71 88.2 0.71 Allowed 'General case' 0 N--CA 1.398 -3.045 0 O-C-N 124.639 1.212 . . . . 0.0 108.366 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 HG23 ' CD2' ' A' ' 75' ' ' HIS . 3.8 p -97.73 19.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.43 -171.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.593 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.3 tp -58.82 113.19 1.94 Allowed 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.84 44.92 0.1 OUTLIER Glycine 0 C--N 1.384 3.246 0 O-C-N 125.996 2.06 . . . . 0.0 111.661 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.576 ' O ' HG21 ' A' ' 76' ' ' THR . 3.5 t60 -48.42 -64.26 0.85 Allowed 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.576 HG21 ' O ' ' A' ' 75' ' ' HIS . 12.0 p -166.42 142.79 4.83 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 151.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.635 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.35 -31.58 22.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 120.498 1.499 . . . . 0.0 111.373 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.56 77.0 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 122.029 -0.419 . . . . 0.0 110.438 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 11.9 mm-40 -64.46 -39.01 93.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 77' ' ' HIS . 11.6 m -64.16 -43.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.2 -37.8 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.1 tmtm? -57.78 -42.84 84.94 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.298 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.645 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.3 mm -66.21 -33.72 65.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.642 0.734 . . . . 0.0 112.628 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -76.09 -28.92 57.74 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.297 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -72.89 -28.26 62.38 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.373 1.069 . . . . 0.0 110.663 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.59 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.8 m -65.57 -38.66 90.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.455 175.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 22.1 mt -82.89 133.76 48.08 Favored Pre-proline 0 N--CA 1.405 -2.681 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.03 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.1 Cg_endo -90.71 161.98 4.2 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.086 2.524 . . . . 0.0 113.234 -173.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.523 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.1 mm -60.77 133.84 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.457 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 11.62 56.63 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.133 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.92 -169.72 1.72 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -151.34 165.73 33.16 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.2 t -150.35 126.21 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.887 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.51 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -78.65 107.02 11.03 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.194 -1.002 . . . . 0.0 108.743 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.412 ' CD2' HG22 ' A' ' 67' ' ' VAL . 56.7 mt -103.84 152.45 21.9 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.801 1.64 . . . . 0.0 108.391 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 30.1 tt0 -111.11 123.42 50.17 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 76.6 mt -105.65 153.87 21.23 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.759 1.223 . . . . 0.0 110.247 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.644 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 9.6 t -124.26 107.12 10.85 Favored 'General case' 0 C--O 1.186 -2.241 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.476 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.532 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 40.4 ttp180 -101.39 138.62 38.15 Favored 'General case' 1 C--N 1.243 -4.052 0 O-C-N 120.59 -1.319 . . . . 0.0 110.494 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.51 -32.84 0.84 Allowed Glycine 0 CA--C 1.464 -3.123 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.45 137.59 45.03 Favored Pre-proline 0 N--CA 1.412 -2.34 0 CA-C-N 113.871 -1.165 . . . . 0.0 108.434 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 C--N 1.317 -1.106 0 C-N-CA 122.964 2.443 . . . . 0.0 112.242 -177.256 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.438 -1.774 0 CA-C-O 121.35 0.479 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -94.5 111.15 22.9 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.598 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -107.81 123.17 48.17 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 7' ' ' ASN . 12.4 t -133.3 12.41 4.19 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.339 0.59 . . . . 0.0 110.279 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtp180 60.47 -29.7 0.05 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.446 2.298 . . . . 0.0 115.381 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 5' ' ' THR . 55.6 t-20 -95.92 117.38 66.39 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HB3' HG12 ' A' ' 65' ' ' VAL . 6.4 Cg_endo -59.36 -22.79 67.27 Favored 'Trans proline' 0 C--O 1.21 -0.924 0 C-N-CA 123.772 2.982 . . . . 0.0 113.134 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -76.92 -25.37 52.85 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.804 -0.56 . . . . 0.0 109.562 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -93.82 -19.32 21.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.574 0.702 . . . . 0.0 110.22 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 12' ' ' LYS . 3.4 tm? -88.14 145.78 25.74 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.369 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' N ' HD11 ' A' ' 11' ' ' LEU . 57.3 mttm -103.32 137.74 41.03 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-O 121.873 0.844 . . . . 0.0 110.581 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.665 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 152.82 169.52 18.15 Favored Glycine 1 C--N 1.246 -4.417 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.237 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.47 122.3 40.37 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.908 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.2 m-85 -96.53 111.34 23.5 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.784 1.278 . . . . 0.0 112.157 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.48 HD12 ' HG3' ' A' ' 99' ' ' ARG . 5.9 mm -92.55 152.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 CA-C-N 112.779 -2.009 . . . . 0.0 108.436 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 113.05 14.47 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 t -139.37 132.88 30.3 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.918 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.813 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.9 ttpt -92.95 125.92 37.78 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -106.28 117.3 33.69 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -175.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.437 ' HD3' ' OG ' ' A' ' 92' ' ' SER . 18.6 tpp180 -74.59 103.83 5.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.954 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 69.9 tttt -62.17 97.29 0.08 Allowed 'General case' 0 C--O 1.177 -2.733 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.0 t -129.71 125.87 36.94 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t 62.18 -77.73 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.127 1.371 . . . . 0.0 110.534 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -85.48 -20.63 29.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.614 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 107.83 -110.43 3.16 Favored Glycine 1 N--CA 1.385 -4.73 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 44.1 m-85 -92.45 135.7 33.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.268 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.56 3.55 84.71 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.812 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CE2' HG22 ' A' ' 31' ' ' VAL . 10.0 p90 -119.07 162.92 17.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.194 0.521 . . . . 0.0 110.434 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 21.5 p -113.15 145.81 40.3 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 29' ' ' PHE . 1.6 t -119.19 143.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.505 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.33 149.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.785 0 CA-C-O 121.336 0.588 . . . . 0.0 109.428 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.25 -138.52 11.02 Favored Glycine 1 N--CA 1.391 -4.317 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.63 36.97 19.46 Favored Glycine 0 CA--C 1.456 -3.598 0 O-C-N 124.517 0.775 . . . . 0.0 111.346 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -69.93 -27.71 65.0 Favored 'General case' 0 CA--C 1.463 -2.394 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -164.28 167.69 10.19 Favored Pre-proline 0 CA--C 1.464 -2.354 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.057 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.707 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.4 Cg_endo -67.21 56.03 0.55 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.394 2.063 . . . . 0.0 110.277 172.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.416 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 21.5 t70 177.97 -7.86 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.338 -169.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 22.9 mm-40 -129.29 125.34 36.58 Favored 'General case' 0 C--O 1.276 2.493 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' CE1' HD12 ' A' ' 73' ' ' LEU 0.253 6.0 m-30 -76.44 158.93 30.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 129.871 3.268 . . . . 0.0 112.514 -169.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 6.7 mp -88.97 147.77 24.13 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.5 mt-30 -144.18 155.6 43.97 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 62' ' ' ASP . 20.4 mm -72.98 115.91 14.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 38.4 ttmt -58.95 -44.65 91.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.477 ' HA ' HG23 ' A' ' 60' ' ' THR . 21.0 t 169.62 173.65 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 125.144 1.527 . . . . 0.0 110.453 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -144.27 144.91 31.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-O 121.647 0.737 . . . . 0.0 111.899 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 t -73.26 122.92 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.769 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.2 mt -61.31 -15.01 31.19 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 112.489 -2.141 . . . . 0.0 113.121 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -92.72 -13.66 29.04 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.767 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -91.53 163.62 28.74 Favored Glycine 0 N--CA 1.415 -2.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.425 -172.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.44 -28.73 45.71 Favored 'Trans proline' 0 C--O 1.205 -1.136 0 C-N-CA 124.72 3.613 . . . . 0.0 112.798 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -57.85 -50.77 72.17 Favored 'General case' 0 C--O 1.264 1.853 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.052 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.26 -33.49 55.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 50' ' ' GLY . 7.8 mp -72.57 -33.72 66.96 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.049 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.43 -27.79 66.5 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.416 ' C ' ' HE3' ' A' ' 57' ' ' LYS . . . 78.61 3.59 86.91 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 112.51 -2.132 . . . . 0.0 113.352 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HE3' ' C ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -96.18 -31.8 12.79 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.0 ttm -97.97 142.0 30.24 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.616 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -139.25 159.16 42.8 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 122.226 1.012 . . . . 0.0 110.061 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 45' ' ' SER . 65.7 p -63.85 115.65 5.03 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.564 1.146 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 111.74 -15.96 26.28 Favored Glycine 0 N--CA 1.435 -1.425 0 O-C-N 121.767 -0.583 . . . . 0.0 112.799 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 43' ' ' ILE . 17.4 m-20 -61.08 134.28 56.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -83.38 126.47 40.13 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 CA-C-N 118.905 0.775 . . . . 0.0 113.035 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 12.7 mm -76.78 125.27 36.43 Favored 'Isoleucine or valine' 1 C--O 1.321 4.866 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG13 HD13 ' A' ' 73' ' ' LEU . 25.9 t -115.68 -37.6 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 111.435 -2.62 . . . . 0.0 111.035 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.468 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.9 m -144.51 149.75 36.43 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.227 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 ' OD1' ' A' ' 68' ' ' ASN . 12.4 p -134.58 133.43 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' OD1' HG21 ' A' ' 67' ' ' VAL . 21.7 m120 60.13 27.84 17.35 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.02 0.914 . . . . 0.0 110.398 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 72.97 2.48 4.39 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.668 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.7 m -90.56 126.88 36.08 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 31.7 t -66.49 108.0 2.25 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 66' ' ' SER . 29.6 m -123.18 27.87 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.841 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.598 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.0 tp -59.88 113.54 2.34 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.7 41.57 0.26 Allowed Glycine 0 C--N 1.376 2.767 0 O-C-N 125.191 1.557 . . . . 0.0 112.205 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.568 ' O ' HG21 ' A' ' 76' ' ' THR . 8.8 t60 -44.01 -67.86 0.24 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.568 HG21 ' O ' ' A' ' 75' ' ' HIS . 18.2 p -166.1 143.46 5.36 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 149.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -50.77 -37.15 40.49 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 120.098 1.317 . . . . 0.0 110.711 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.409 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.532 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 9.0 mm-40 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.453 HG23 HD21 ' A' ' 41' ' ' LEU . 34.0 m -69.17 -39.88 79.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.591 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.511 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 71.1 t -65.45 -37.43 80.04 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.28 -38.55 83.93 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 122.887 0.117 . . . . 0.0 111.277 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 86' ' ' SER . 63.1 mt -65.58 -35.73 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.612 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.6 -31.52 65.25 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.356 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 71.1 mm-40 -72.82 -26.56 61.53 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 122.084 0.945 . . . . 0.0 109.901 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.2 m -73.66 -47.06 42.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.602 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 20.9 mt -66.68 136.58 94.74 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.302 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 30.5 Cg_endo -91.64 162.49 3.49 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.185 3.257 . . . . 0.0 113.125 -174.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.504 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 28.8 mm -62.29 135.25 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 121.07 0.462 . . . . 0.0 110.63 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.85 57.14 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.554 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.14 -172.42 2.16 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -149.01 158.87 44.52 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -142.49 125.27 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.211 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -79.33 104.17 9.77 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.44 143.84 32.47 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 125.357 1.463 . . . . 0.0 111.514 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 38.0 tt0 -104.41 127.04 52.01 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.336 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 67.1 mt -115.11 157.83 23.03 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.573 1.171 . . . . 0.0 110.027 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.665 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.6 t -129.83 111.17 12.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.548 1.166 . . . . 0.0 110.157 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.48 ' HG3' HD12 ' A' ' 16' ' ' ILE . 3.7 mmm180 -88.54 120.9 30.35 Favored 'General case' 0 C--N 1.245 -3.958 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 157.32 -22.06 0.43 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.7 138.56 21.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 C--N 1.365 1.421 0 C-N-CA 124.756 3.638 . . . . 0.0 112.936 -179.318 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.55 1.283 0 CA-C-O 121.153 0.397 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -84.53 104.22 14.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.613 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -111.27 130.04 55.79 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 7' ' ' ASN . 10.7 t -143.43 16.39 1.85 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.628 0.728 . . . . 0.0 110.063 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 16.0 mtm180 58.06 -21.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 127.993 2.517 . . . . 0.0 115.683 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.464 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -99.89 113.37 65.11 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-O 120.894 0.378 . . . . 0.0 111.5 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 1.3 Cg_endo -48.14 -36.1 27.91 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.582 3.522 . . . . 0.0 112.705 174.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -73.97 -17.04 61.05 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.063 0.459 . . . . 0.0 111.61 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 20.8 mm-40 -94.93 -17.28 22.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.228 0.537 . . . . 0.0 110.201 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.5 mt -80.15 178.36 8.31 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 122.109 0.957 . . . . 0.0 109.697 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -114.48 -161.33 0.77 Allowed 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.665 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.87 176.69 38.14 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.081 -1.533 . . . . 0.0 112.799 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.1 OUTLIER -103.29 132.09 49.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.633 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.4 m-85 -108.07 111.77 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.486 1.136 . . . . 0.0 111.535 -175.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.504 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 21.3 mt -112.46 149.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.03 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.896 -174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -130.45 104.64 7.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -123.58 129.48 51.24 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 122.318 1.056 . . . . 0.0 111.581 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.813 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.4 ttmt -88.77 122.07 31.8 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.572 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' CD2' ' HA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -106.01 117.35 33.81 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 27.3 ttp-105 -79.27 107.36 11.97 Favored 'General case' 0 N--CA 1.394 -3.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.754 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.586 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 64.6 tttt -64.08 97.88 0.19 Allowed 'General case' 0 C--O 1.176 -2.781 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 169.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 89' ' ' ILE . 22.9 t -80.46 -155.81 0.12 Allowed 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 124.54 1.136 . . . . 0.0 109.16 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 m -58.55 -41.47 85.66 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -85.86 -21.46 28.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.586 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 102.27 -124.8 8.31 Favored Glycine 1 N--CA 1.392 -4.266 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 35.9 m-85 -86.74 145.7 26.55 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.729 0.764 . . . . 0.0 110.48 -176.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.63 1.63 64.03 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.908 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE2' HG23 ' A' ' 31' ' ' VAL . 6.7 p90 -114.27 163.06 15.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.453 0.644 . . . . 0.0 111.813 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -116.13 148.53 40.22 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 29' ' ' PHE . 4.0 t -127.23 143.68 39.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.125 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 33' ' ' GLY . 9.0 p -152.23 163.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.956 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 32' ' ' VAL . . . 124.76 -65.04 0.55 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 172.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -76.11 58.81 3.16 Favored Glycine 2 CA--C 1.408 -6.64 0 C-N-CA 125.621 1.581 . . . . 0.0 116.971 -166.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -66.21 -9.07 28.51 Favored 'General case' 0 C--N 1.253 -3.629 0 O-C-N 124.32 0.659 . . . . 0.0 111.75 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt-20 -160.62 166.36 15.69 Favored Pre-proline 0 CA--C 1.452 -2.799 0 C-N-CA 116.078 -2.249 . . . . 0.0 111.849 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.4 Cg_endo -67.62 53.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.807 2.338 . . . . 0.0 110.287 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -177.61 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.498 1.519 . . . . 0.0 109.872 -171.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.647 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 34.3 mt-10 -117.72 129.75 55.9 Favored 'General case' 0 C--O 1.272 2.256 0 CA-C-O 116.649 -1.643 . . . . 0.0 106.75 169.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.263 6.8 m-30 -79.33 156.4 28.03 Favored 'General case' 0 N--CA 1.523 3.18 0 O-C-N 128.675 3.735 . . . . 0.0 111.927 -177.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD12 ' HA3' ' A' ' 34' ' ' GLY . 6.3 mp -91.68 143.17 26.83 Favored 'General case' 0 CA--C 1.455 -2.689 0 C-N-CA 117.153 -1.819 . . . . 0.0 107.437 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.54 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 14.1 mt-30 -139.36 154.74 47.92 Favored 'General case' 0 C--N 1.266 -3.04 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.7 mm -75.11 109.48 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.431 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.22 -37.01 79.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.5 t 161.87 173.66 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 125.388 1.68 . . . . 0.0 109.344 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.3 pp -137.33 151.87 49.09 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 123.257 0.623 . . . . 0.0 111.469 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.08 116.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HA ' ' HB1' ' A' ' 53' ' ' ALA 0.264 0.8 OUTLIER -69.38 -4.17 17.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -174.389 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.49 -2.67 54.14 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.406 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.42 167.11 24.56 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.818 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.32 -31.78 58.3 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 124.624 3.549 . . . . 0.0 113.411 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -57.84 -44.55 86.57 Favored 'General case' 0 C--O 1.273 2.293 0 CA-C-O 121.753 0.787 . . . . 0.0 111.522 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 48' ' ' LEU . . . -76.74 -35.21 57.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.328 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.21 -28.21 53.75 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.36 -20.86 62.11 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.27 63.58 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.962 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -29.76 7.39 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.637 -172.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 51.2 ttm -96.96 132.84 42.35 Favored 'General case' 0 N--CA 1.407 -2.593 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.187 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -124.29 156.94 36.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 122.193 0.997 . . . . 0.0 109.336 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -71.48 107.76 4.55 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.297 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.08 -11.96 9.24 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.755 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 8.6 m-20 -64.44 151.46 44.16 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.401 1.101 . . . . 0.0 108.654 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -99.94 123.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 175.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 10.8 mm -71.29 122.31 23.1 Favored 'Isoleucine or valine' 1 C--O 1.322 4.883 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 171.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG12 HD12 ' A' ' 73' ' ' LEU . 44.4 t -114.69 -34.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 O-C-N 127.122 2.764 . . . . 0.0 109.905 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 39.4 m -147.66 148.84 31.49 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.457 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 ' CG1' ' A' ' 72' ' ' VAL . 8.4 p -125.28 133.11 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.57 27.24 16.39 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.519 0.676 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.35 26.13 14.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 123.484 1.612 . . . . 0.0 111.466 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.9 m -109.16 124.54 50.99 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.24 105.57 0.93 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.101 0.876 . . . . 0.0 109.927 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG1' HG12 ' A' ' 67' ' ' VAL . 35.7 m -121.18 27.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.406 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.613 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 43.8 tp -60.9 113.28 2.43 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.18 45.88 0.3 Allowed Glycine 0 N--CA 1.492 2.397 0 O-C-N 125.557 1.786 . . . . 0.0 111.606 -170.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.591 ' O ' HG21 ' A' ' 76' ' ' THR . 5.9 t60 -46.83 -69.14 0.14 Allowed 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 175.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.591 HG21 ' O ' ' A' ' 75' ' ' HIS . 21.5 p -164.86 144.0 6.89 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 148.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -49.84 -36.14 25.69 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 119.718 1.145 . . . . 0.0 110.437 173.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.01 91.89 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.481 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.564 ' NE2' ' HG1' ' A' ' 76' ' ' THR . 2.1 mp0 -64.05 -44.08 93.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.45 HG21 HD21 ' A' ' 41' ' ' LEU . 28.8 m -70.34 -43.5 78.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.808 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.1 -36.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.657 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.58 -43.27 99.17 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.328 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.657 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.7 -36.54 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.24 0.543 . . . . 0.0 112.435 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.33 -32.64 68.81 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.316 0.579 . . . . 0.0 110.173 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.576 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 7.8 mm-40 -75.55 -26.3 57.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.749 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.8 m -72.02 -40.36 68.5 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.765 1.226 . . . . 0.0 109.275 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.439 HG23 ' HD3' ' A' ' 22' ' ' LYS . 23.5 mt -69.81 135.45 87.8 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.994 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 16.3 Cg_endo -90.39 162.53 4.51 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 123.679 2.919 . . . . 0.0 113.208 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.479 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.7 mm -59.92 135.1 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.031 175.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.71 10.26 63.42 Favored Glycine 0 C--N 1.291 -1.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.843 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.53 133.57 49.16 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 6.7 m -100.79 159.42 15.2 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.538 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -144.74 125.5 8.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.648 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.623 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.42 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 23.4 m-20 -79.11 109.42 13.4 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.5 mt -104.63 136.91 43.28 Favored 'General case' 0 C--N 1.277 -2.557 0 C-N-CA 124.842 1.257 . . . . 0.0 109.836 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 40.8 tt0 -97.6 122.99 41.32 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 95.9 mt -112.65 148.84 33.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 125.154 1.382 . . . . 0.0 109.713 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.665 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 8.1 t -124.56 115.18 20.43 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.915 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 18.9 ttm180 -102.01 141.98 34.0 Favored 'General case' 0 C--N 1.256 -3.489 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.067 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.71 -17.06 3.98 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.354 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -92.01 139.97 24.59 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 C--N 1.361 1.204 0 C-N-CA 124.712 3.608 . . . . 0.0 113.935 -175.145 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.448 -1.184 0 N-CA-C 111.094 -0.387 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.19 104.83 3.2 Favored 'General case' 0 N--CA 1.411 -2.377 0 C-N-CA 124.349 1.06 . . . . 0.0 108.562 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.612 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.7 t80 -98.94 139.12 35.07 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -147.51 10.28 0.96 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.963 0.887 . . . . 0.0 110.79 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.514 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 14.1 mtp180 52.9 6.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.803 2.041 . . . . 0.0 115.092 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -134.09 122.1 16.05 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -54.98 -34.93 88.6 Favored 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 124.135 3.223 . . . . 0.0 112.345 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -71.81 -21.99 61.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.563 0.697 . . . . 0.0 111.21 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -92.45 -24.27 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.435 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 42.5 tp -85.91 159.2 19.73 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.829 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 53.4 mttp -99.13 -171.23 2.05 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.96 177.93 27.94 Favored Glycine 0 C--N 1.292 -1.865 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.911 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -99.81 122.67 43.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 98' ' ' CYS . 98.5 m-85 -103.87 117.97 35.59 Favored 'General case' 0 C--N 1.253 -3.628 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.25 126.74 68.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.463 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -99.95 111.95 24.24 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 57' ' ' LYS . 14.8 t -133.1 147.59 52.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.018 0.913 . . . . 0.0 110.73 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.852 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 22.0 ttpp -90.17 132.31 35.54 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.608 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -109.68 119.27 38.88 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 72.5 ttt180 -81.48 109.47 15.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.965 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.596 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.5 tttt -63.95 96.51 0.14 Allowed 'General case' 0 C--O 1.184 -2.377 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -90.03 -154.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 124.457 1.103 . . . . 0.0 109.061 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 m -52.35 -40.63 62.2 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.878 0.871 . . . . 0.0 111.695 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -95.6 -9.41 32.27 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.012 0.434 . . . . 0.0 110.065 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.596 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.01 -119.08 6.25 Favored Glycine 1 N--CA 1.392 -4.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.428 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 46.2 m-85 -91.46 139.88 30.29 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 117.763 0.782 . . . . 0.0 108.935 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.94 3.01 87.28 Favored Glycine 0 C--N 1.315 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.897 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HB2' HG21 ' A' ' 43' ' ' ILE . 12.1 p90 -116.33 162.69 17.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.353 0.597 . . . . 0.0 111.324 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 26.3 p -116.19 152.91 32.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.53 143.86 38.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.464 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 33' ' ' GLY . 10.6 p -152.66 155.61 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 171.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 136.25 -72.94 0.45 Allowed Glycine 0 CA--C 1.459 -3.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.0 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.833 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -62.11 58.51 0.03 OUTLIER Glycine 1 CA--C 1.442 -4.505 0 C-N-CA 127.454 2.454 . . . . 0.0 117.459 -169.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.49 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 17.3 t70 -63.09 -27.98 69.77 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -154.82 166.31 16.32 Favored Pre-proline 0 CA--C 1.454 -2.727 0 C-N-CA 116.192 -2.203 . . . . 0.0 110.941 -170.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.7 Cg_endo -68.42 55.79 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.308 2.005 . . . . 0.0 109.718 171.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -178.63 -17.15 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.008 1.723 . . . . 0.0 110.06 -171.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.833 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 19.1 mm-40 -115.89 127.03 54.68 Favored 'General case' 0 C--O 1.273 2.301 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.269 6.0 m-30 -79.02 157.68 28.04 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 128.77 3.794 . . . . 0.0 111.628 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.499 HD12 ' HA3' ' A' ' 34' ' ' GLY . 5.3 mp -88.25 143.53 26.98 Favored 'General case' 0 C--O 1.185 -2.319 0 C-N-CA 117.149 -1.821 . . . . 0.0 107.105 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.2 mt-30 -140.25 154.68 46.94 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 HG21 ' HB2' ' A' ' 29' ' ' PHE . 18.9 mm -73.96 113.24 11.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 19.2 ttmm -57.14 -38.04 72.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 125.13 1.519 . . . . 0.0 107.16 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 60' ' ' THR . 34.8 t 159.86 173.35 0.01 OUTLIER 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.428 1.891 . . . . 0.0 109.114 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.4 147.82 41.98 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.414 0.626 . . . . 0.0 111.671 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -76.53 128.06 37.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -64.53 -15.45 60.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.12 6.83 46.32 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.957 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.25 158.81 21.79 Favored Glycine 0 N--CA 1.398 -3.847 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.21 -30.52 42.12 Favored 'Trans proline' 0 C--O 1.202 -1.318 0 C-N-CA 124.429 3.42 . . . . 0.0 112.884 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -60.1 -44.59 94.73 Favored 'General case' 0 C--O 1.278 2.565 0 CA-C-O 121.551 0.691 . . . . 0.0 111.982 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.55 -35.02 53.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.811 -1.541 . . . . 0.0 111.022 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.1 -46.02 72.1 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.313 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 38.3 t70 -63.67 -34.58 78.17 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -8.77 58.25 Favored Glycine 0 CA--C 1.492 -1.393 0 CA-C-N 112.484 -2.144 . . . . 0.0 114.082 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HB2' ' OD2' ' A' ' 55' ' ' ASP . 46.1 mttp -86.7 -14.53 42.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 123.117 0.567 . . . . 0.0 112.081 -176.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 ttm -104.02 144.96 30.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -143.67 155.52 44.25 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 121.447 0.642 . . . . 0.0 110.103 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 ' HA ' ' A' ' 45' ' ' SER . 77.8 p -63.21 108.45 1.28 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.86 -0.31 31.92 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.121 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.54 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.0 p30 -73.43 146.94 44.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.425 -1.71 . . . . 0.0 107.292 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -94.65 120.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 26.6 mm -71.08 125.16 28.93 Favored 'Isoleucine or valine' 1 C--O 1.319 4.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG12 HD11 ' A' ' 73' ' ' LEU . 48.6 t -115.27 -41.36 3.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.614 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.436 ' HA ' HG22 ' A' ' 72' ' ' VAL . 66.5 m -145.34 147.42 32.29 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.281 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.1 132.0 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.03 29.57 14.67 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.452 0.644 . . . . 0.0 111.101 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 67.58 11.51 8.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.7 m -93.47 122.85 36.33 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.2 t -66.04 103.6 0.98 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.455 ' CA ' ' HB2' ' A' ' 75' ' ' HIS . 33.6 m -117.84 25.67 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.884 0.849 . . . . 0.0 110.501 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.612 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.2 tp -61.43 113.28 2.57 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 35.46 40.72 0.3 Allowed Glycine 0 N--CA 1.497 2.725 0 O-C-N 125.188 1.555 . . . . 0.0 111.785 -170.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.55 ' O ' HG21 ' A' ' 76' ' ' THR . 7.0 t60 -43.98 -67.22 0.3 Allowed 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.55 HG21 ' O ' ' A' ' 75' ' ' HIS . 2.4 p -167.35 143.57 4.25 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 150.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 -36.55 26.7 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 120.194 1.361 . . . . 0.0 110.119 172.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.2 81.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.448 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.562 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 7.3 mm-40 -66.8 -44.26 81.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 HD21 ' A' ' 41' ' ' LEU . 34.0 m -65.58 -40.06 86.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.471 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.5 -39.04 84.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -59.62 -38.43 81.31 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.676 177.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.604 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 72.4 mt -68.09 -38.41 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.574 0.702 . . . . 0.0 110.853 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.07 -30.83 65.52 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.89 -32.55 73.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.313 1.045 . . . . 0.0 109.994 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 59.5 m -71.84 -43.17 66.0 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.474 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.5 mt -71.8 133.06 84.55 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.574 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 36.0 Cg_endo -91.44 161.84 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.507 2.804 . . . . 0.0 113.549 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.481 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.0 mm -61.63 129.98 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 121.156 0.503 . . . . 0.0 111.019 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.72 11.94 51.95 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.707 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.4 -170.48 1.81 Allowed 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -147.79 166.78 26.52 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.852 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -150.45 125.2 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.463 -2.371 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.772 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.58 105.53 16.23 Favored 'General case' 0 C--N 1.268 -2.969 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -111.83 151.61 28.87 Favored 'General case' 0 C--O 1.208 -1.083 0 C-N-CA 125.593 1.557 . . . . 0.0 110.777 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 22.8 tt0 -111.01 121.73 46.1 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.748 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.7 mp -108.62 164.42 12.38 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 126.654 1.982 . . . . 0.0 109.272 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.5 t -140.69 112.46 7.57 Favored 'General case' 0 C--O 1.19 -2.026 0 CA-C-O 122.339 1.066 . . . . 0.0 111.992 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 7.7 tpp180 -95.3 129.99 42.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.78 -17.52 0.96 Allowed Glycine 0 C--N 1.294 -1.769 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.053 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -107.23 126.94 28.9 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 C--O 1.246 0.917 0 C-N-CA 124.126 3.217 . . . . 0.0 112.573 -174.599 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.446 -1.308 0 CA-C-O 121.154 0.398 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -76.31 107.14 8.35 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 124.97 1.308 . . . . 0.0 107.659 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.596 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.1 t80 -101.73 129.87 48.0 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -138.17 11.8 2.82 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.284 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.538 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtt180 52.59 8.43 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.804 2.042 . . . . 0.0 114.789 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -131.96 116.75 15.83 Favored Pre-proline 0 N--CA 1.415 -2.176 0 C-N-CA 122.458 0.303 . . . . 0.0 110.974 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.56 -18.05 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 110.785 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 p -76.15 -29.72 57.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.851 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -107.38 -10.96 15.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.051 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -93.5 149.82 20.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' N ' HD12 ' A' ' 11' ' ' LEU . 45.9 mtmt -105.79 135.54 47.04 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.731 0.776 . . . . 0.0 110.998 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.58 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 151.17 170.15 17.75 Favored Glycine 1 C--N 1.244 -4.583 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -172.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -92.32 122.35 34.7 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.397 1.098 . . . . 0.0 108.443 175.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.6 m-85 -98.66 117.45 33.14 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 122.611 1.196 . . . . 0.0 110.027 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 34.1 mt -114.35 152.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.065 0 CA-C-N 112.755 -2.021 . . . . 0.0 109.357 -172.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -129.31 108.47 10.33 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -131.54 135.08 46.75 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.872 0.844 . . . . 0.0 109.81 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.8 ttmt -89.45 126.65 35.65 Favored 'General case' 0 C--N 1.257 -3.436 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.782 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.411 HD22 ' CA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -106.47 116.94 32.8 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 56.5 ttt180 -77.89 107.44 10.42 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.931 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 64.7 tttt -61.85 97.34 0.08 Allowed 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -86.23 -155.36 0.25 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 124.758 1.223 . . . . 0.0 108.818 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 m -54.21 -41.3 68.5 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.991 0.916 . . . . 0.0 110.816 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -96.16 -8.85 32.06 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.189 0.519 . . . . 0.0 109.958 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.581 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 96.32 -120.67 6.7 Favored Glycine 1 N--CA 1.391 -4.315 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.502 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 34.2 m-85 -89.58 141.74 28.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.401 0.6 . . . . 0.0 109.576 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.22 1.11 84.31 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.966 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.419 ' HB2' HG22 ' A' ' 43' ' ' ILE . 19.4 p90 -114.58 162.37 16.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.725 0.774 . . . . 0.0 111.099 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.616 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 40.6 p -115.18 154.34 29.18 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -143.81 144.24 23.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.664 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 33' ' ' GLY . 9.8 p -149.33 170.02 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.26 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 32' ' ' VAL . . . 124.05 -68.83 0.48 Allowed Glycine 0 CA--C 1.452 -3.906 0 CA-C-N 115.124 -0.943 . . . . 0.0 113.796 172.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -75.39 58.02 2.86 Favored Glycine 2 CA--C 1.406 -6.73 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.45 -12.78 47.08 Favored 'General case' 0 C--N 1.261 -3.251 0 O-C-N 124.449 0.735 . . . . 0.0 110.797 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 38' ' ' ASP . 6.1 pt-20 -158.23 165.14 19.22 Favored Pre-proline 0 CA--C 1.452 -2.812 0 C-N-CA 116.519 -2.072 . . . . 0.0 111.205 -173.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.5 Cg_endo -68.37 47.01 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.764 2.309 . . . . 0.0 111.529 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 36' ' ' GLU . 27.2 m-20 -165.44 -22.69 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.356 2.262 . . . . 0.0 109.248 -172.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.707 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 37.9 mt-10 -112.83 126.25 55.23 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.259 5.2 m-30 -78.78 157.43 28.44 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 128.076 3.36 . . . . 0.0 111.365 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD12 ' HA3' ' A' ' 34' ' ' GLY . 6.9 mp -90.08 144.71 25.65 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 117.506 -1.678 . . . . 0.0 107.093 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.8 mt-30 -143.54 151.01 39.72 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.419 HG22 ' HB2' ' A' ' 29' ' ' PHE . 19.3 mm -68.39 117.8 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.616 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 20.8 tptm -63.05 -43.37 98.81 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 60' ' ' THR . 40.2 t 166.14 174.97 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 125.596 1.81 . . . . 0.0 109.993 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.3 152.41 45.85 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.704 0.764 . . . . 0.0 112.923 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.4 t -85.35 128.61 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.51 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 89.1 mt -68.88 -15.9 63.62 Favored 'General case' 0 N--CA 1.387 -3.612 0 CA-C-N 112.733 -2.03 . . . . 0.0 113.59 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.26 -5.36 40.44 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 114.154 -1.385 . . . . 0.0 111.245 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -91.71 162.96 28.11 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.99 -31.79 65.43 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 124.541 3.494 . . . . 0.0 113.576 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.411 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -59.3 -42.67 91.87 Favored 'General case' 0 C--O 1.279 2.641 0 CA-C-O 121.706 0.765 . . . . 0.0 111.42 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.74 -37.35 49.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.899 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 50' ' ' GLY . 8.6 mp -68.82 -40.28 79.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.74 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.55 -26.1 61.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.72 2.78 77.42 Favored Glycine 0 CA--C 1.495 -1.181 0 CA-C-N 112.888 -1.96 . . . . 0.0 113.826 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -91.46 -21.28 21.01 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.21 149.28 23.25 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.575 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.37 154.73 40.34 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.395 0.617 . . . . 0.0 110.625 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.441 HG23 ' HA ' ' A' ' 45' ' ' SER . 67.8 p -61.37 106.04 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.761 0.824 . . . . 0.0 111.493 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 110.79 -2.27 28.88 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 119.311 -0.716 . . . . 0.0 113.563 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' CB ' ' HG3' ' A' ' 99' ' ' ARG . 2.8 p30 -69.71 138.67 53.09 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -87.76 120.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.471 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 31.3 mm -71.62 124.37 27.96 Favored 'Isoleucine or valine' 1 C--O 1.324 4.978 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 172.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG11 HD13 ' A' ' 73' ' ' LEU . 37.0 t -115.63 -40.9 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.064 -2.789 . . . . 0.0 111.036 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.456 ' HA ' HG21 ' A' ' 72' ' ' VAL . 24.7 m -149.82 150.38 31.89 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.7 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 HG22 ' A' ' 72' ' ' VAL . 2.9 m -121.99 142.11 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 169.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.8 m120 54.61 28.11 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.548 0.689 . . . . 0.0 111.379 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 54.9 42.32 31.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.668 1.699 . . . . 0.0 111.832 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' HG11 ' A' ' 72' ' ' VAL . 88.8 m -122.12 122.82 40.1 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.898 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.54 100.17 0.49 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.926 0.869 . . . . 0.0 111.055 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 66' ' ' SER . 17.4 m -105.04 17.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.596 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.1 tp -60.61 112.96 2.2 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.44 44.98 0.3 Allowed Glycine 0 N--CA 1.496 2.645 0 O-C-N 125.649 1.843 . . . . 0.0 111.272 -170.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.583 ' O ' HG22 ' A' ' 76' ' ' THR . 8.4 t60 -45.37 -67.62 0.27 Allowed 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 75' ' ' HIS . 3.1 p -166.9 142.78 4.36 Favored 'General case' 0 C--N 1.262 -3.219 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 148.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.521 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.04 -35.21 33.19 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 120.695 1.588 . . . . 0.0 111.205 173.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.14 96.39 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.654 0.264 . . . . 0.0 110.929 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.424 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 16.9 mm-40 -69.65 -41.57 75.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 77' ' ' HIS . 21.1 m -63.66 -39.82 86.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.154 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.62 -40.77 90.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -61.06 -36.81 80.59 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.558 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.9 mm -70.45 -37.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 123.683 0.793 . . . . 0.0 112.057 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.33 -29.01 62.39 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -76.34 -20.18 57.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.407 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 37.6 t -78.04 -26.39 48.35 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.6 mt -90.07 130.11 43.53 Favored Pre-proline 0 N--CA 1.398 -3.032 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.134 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.0 Cg_endo -89.49 162.44 5.41 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 123.697 2.932 . . . . 0.0 112.954 -173.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.504 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.3 mm -60.12 133.6 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 CA-C-O 121.538 0.685 . . . . 0.0 110.902 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.76 60.33 Favored Glycine 0 C--N 1.289 -2.078 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.019 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . . . -102.38 -167.92 1.46 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.9 m -151.52 163.39 39.13 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 121.929 -0.482 . . . . 0.0 109.919 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -145.83 125.26 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 C-N-CA 119.569 -0.853 . . . . 0.0 111.76 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.08 107.16 12.65 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 66' ' ' SER . 63.6 mt -104.96 135.59 46.01 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 124.433 1.093 . . . . 0.0 111.75 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 38.8 mt-10 -90.52 120.47 31.64 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 7.9 mt -105.65 164.63 11.76 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.58 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.8 t -141.37 109.16 5.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 122.254 1.026 . . . . 0.0 110.906 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HG3' ' CB ' ' A' ' 62' ' ' ASP 0.33 23.7 mtm180 -96.18 117.97 31.81 Favored 'General case' 0 C--N 1.257 -3.422 0 O-C-N 121.331 -0.856 . . . . 0.0 113.133 174.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.55 -29.73 0.1 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.287 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -101.64 135.46 19.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.547 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.242 0.701 0 C-N-CA 123.257 2.638 . . . . 0.0 111.231 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.444 -1.423 0 N-CA-C 110.228 -0.72 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -89.93 104.8 17.34 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.553 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.9 t80 -105.15 131.15 53.0 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 HD23 ' A' ' 11' ' ' LEU . 8.8 t -140.38 19.05 2.4 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.246 1.022 . . . . 0.0 110.704 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 57.6 mtt180 58.41 -13.13 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.96 2.104 . . . . 0.0 115.961 172.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.561 ' OD1' ' HB2' ' A' ' 9' ' ' SER . 23.7 t-20 -113.57 119.48 41.52 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 110.927 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.4 -32.82 74.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.179 3.252 . . . . 0.0 112.814 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.561 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 26.4 m -75.69 -22.48 56.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.408 0.683 . . . . 0.0 110.954 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -90.29 -19.56 23.96 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.898 0.879 . . . . 0.0 111.033 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 HD23 HG23 ' A' ' 5' ' ' THR . 51.0 mt -74.48 172.37 12.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.092 0.948 . . . . 0.0 111.485 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -108.39 -170.39 1.67 Allowed 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.607 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 90.16 165.71 40.81 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.09 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 22.2 ttpt -95.86 137.7 34.55 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 30.8 m-85 -104.88 111.89 24.81 Favored 'General case' 0 CA--C 1.458 -2.592 0 CA-C-O 122.687 1.232 . . . . 0.0 110.226 -173.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.484 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.4 mt -108.46 113.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.9 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.007 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.87 128.42 34.41 Favored 'General case' 0 C--N 1.252 -3.631 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.915 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' HB2' ' A' ' 95' ' ' LEU . 7.4 t -133.62 157.01 46.83 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.399 -173.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.817 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -130.58 119.02 21.89 Favored 'General case' 0 C--N 1.247 -3.865 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 172.121 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.492 ' HG ' ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -106.67 117.47 34.14 Favored 'General case' 0 C--N 1.277 -2.576 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.837 -174.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -70.66 105.66 3.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.51 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.632 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 62.6 tttt -69.34 97.76 1.0 Allowed 'General case' 0 C--O 1.161 -3.603 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 165.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -86.66 -155.27 0.26 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.6 m -63.31 -33.12 74.82 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 1.3 tmt_? -83.53 -20.97 32.93 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.603 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 94.14 -129.19 9.79 Favored Glycine 0 N--CA 1.401 -3.649 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.8 m-85 -86.98 146.97 25.94 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 118.134 0.967 . . . . 0.0 110.212 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.38 0.74 66.15 Favored Glycine 0 C--O 1.22 -0.775 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.533 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 5.8 p90 -115.67 163.48 15.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.514 . . . . 0.0 110.642 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.6 p -123.71 147.53 47.38 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.84 150.14 26.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.391 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.49 152.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.523 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.84 -132.12 9.7 Favored Glycine 1 N--CA 1.395 -4.06 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 47.58 37.46 13.42 Favored Glycine 0 CA--C 1.476 -2.363 0 C-N-CA 124.212 0.911 . . . . 0.0 113.55 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -69.03 -29.4 67.54 Favored 'General case' 0 CA--C 1.459 -2.547 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -162.38 166.74 13.46 Favored Pre-proline 0 CA--C 1.455 -2.702 0 C-N-CA 118.352 -1.339 . . . . 0.0 109.243 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.7 Cg_endo -66.19 58.72 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.005 2.47 . . . . 0.0 109.583 170.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 174.54 -9.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.746 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.527 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.5 mm-40 -128.34 124.53 36.68 Favored 'General case' 0 C--O 1.281 2.744 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 73' ' ' LEU 0.276 5.9 m-30 -76.66 158.81 30.75 Favored 'General case' 1 N--CA 1.549 4.52 0 C-N-CA 130.914 3.685 . . . . 0.0 113.609 -168.246 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 HD23 HG22 ' A' ' 80' ' ' VAL . 6.2 mp -92.4 138.86 31.15 Favored 'General case' 0 C--O 1.178 -2.659 0 C-N-CA 117.068 -1.853 . . . . 0.0 106.951 170.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 18.1 mt-30 -136.16 154.18 51.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 62' ' ' ASP . 20.7 mm -71.34 115.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' SER . 31.0 ttpt -65.01 -41.63 95.18 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.477 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 166.72 173.72 0.03 OUTLIER 'General case' 0 C--N 1.371 1.503 0 O-C-N 125.186 1.554 . . . . 0.0 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' CD2' ' HB3' ' A' ' 58' ' ' MET . 1.4 pp -141.6 152.2 43.8 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 123.816 0.846 . . . . 0.0 111.819 -172.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 t -82.85 124.41 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.793 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.88 -3.75 13.83 Favored 'General case' 0 N--CA 1.379 -3.975 0 CA-C-N 112.836 -1.984 . . . . 0.0 112.937 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -95.79 -22.97 17.17 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.658 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.35 162.77 36.83 Favored Glycine 0 N--CA 1.398 -3.892 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.586 -170.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -51.39 -30.32 33.98 Favored 'Trans proline' 0 C--O 1.197 -1.553 0 C-N-CA 125.178 3.919 . . . . 0.0 112.952 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.97 81.52 Favored 'General case' 0 C--O 1.258 1.524 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.34 -36.2 54.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.644 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.31 -40.6 70.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.733 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.37 -21.6 62.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.81 39.88 75.84 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -111.26 -37.62 5.25 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.677 0.275 . . . . 0.0 111.463 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.425 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 1.1 mpt? -95.93 153.14 17.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.403 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.78 158.38 43.69 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 45' ' ' SER . 49.0 p -64.22 108.67 1.64 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.007 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.56 -11.64 9.61 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.709 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 43' ' ' ILE . 2.9 m-20 -62.86 136.69 57.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.547 1.173 . . . . 0.0 108.803 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -88.25 123.36 40.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 177.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.59 123.52 30.28 Favored 'Isoleucine or valine' 1 C--O 1.34 5.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG11 HD11 ' A' ' 73' ' ' LEU . 46.0 t -115.53 -36.14 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 127.444 2.965 . . . . 0.0 111.375 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 65.6 m -148.57 159.62 43.9 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.515 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.45 130.18 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 108.016 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.23 31.48 20.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.461 0.648 . . . . 0.0 110.728 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 71.2 1.4 3.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.495 1.518 . . . . 0.0 112.593 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.3 m -90.95 121.97 33.23 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.404 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.8 t -58.86 114.8 2.72 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.416 ' CG2' HG13 ' A' ' 80' ' ' VAL . 2.0 p -124.23 19.39 4.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.553 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.8 tp -59.15 112.85 1.86 Allowed 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.11 39.76 0.06 OUTLIER Glycine 0 C--O 1.186 -2.879 0 O-C-N 125.737 1.898 . . . . 0.0 112.792 -170.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.594 ' O ' HG23 ' A' ' 76' ' ' THR . 4.6 t60 -43.38 -65.75 0.46 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.9 p -167.33 143.84 4.35 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 151.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.553 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.85 -35.13 30.99 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 120.099 1.318 . . . . 0.0 109.702 171.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -46.95 87.17 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.436 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 13.3 mm-40 -66.35 -43.08 87.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 77' ' ' HIS . 15.3 m -64.44 -44.89 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.533 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 84.5 t -64.51 -42.12 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.74 -37.89 83.3 Favored 'General case' 0 C--O 1.212 -0.887 0 O-C-N 123.151 0.282 . . . . 0.0 111.47 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.568 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.9 mm -67.48 -38.28 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.307 0.575 . . . . 0.0 112.148 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.54 -32.19 65.88 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.523 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 25.6 mt-30 -67.78 -32.07 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.211 1.005 . . . . 0.0 109.691 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.2 m -72.33 -40.6 67.31 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.886 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.417 HG22 ' HD3' ' A' ' 22' ' ' LYS . 30.8 mt -70.34 133.05 87.47 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.475 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 15.0 Cg_endo -87.21 162.65 8.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.57 2.847 . . . . 0.0 113.433 -172.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.461 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.9 mm -60.22 134.8 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.609 0.719 . . . . 0.0 111.074 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.37 8.26 66.4 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.365 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.24 128.08 51.94 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 p -89.79 159.14 17.18 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.13 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -141.78 125.6 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.183 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.913 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.3 104.5 15.2 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.411 ' HB2' HG22 ' A' ' 18' ' ' THR . 27.9 mt -109.68 159.72 16.9 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 126.138 1.775 . . . . 0.0 109.305 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.44 122.71 48.5 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 75.7 mt -109.14 163.14 13.61 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.21 1.004 . . . . 0.0 108.766 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.607 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -142.91 116.58 9.22 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.412 175.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.457 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 ttm180 -104.73 125.57 50.95 Favored 'General case' 0 C--N 1.258 -3.374 0 O-C-N 120.729 -1.232 . . . . 0.0 108.764 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.9 -22.03 0.23 Allowed Glycine 0 CA--C 1.472 -2.639 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -90.89 134.62 29.99 Favored Pre-proline 0 N--CA 1.422 -1.835 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.475 0.426 0 C-N-CA 123.803 3.002 . . . . 0.0 112.939 -175.109 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.443 -1.46 0 CA-C-O 121.98 0.742 . . . . 0.0 113.57 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -88.83 105.3 17.64 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.58 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.8 t80 -108.76 135.24 50.31 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 7' ' ' ASN . 9.5 t -143.3 12.7 1.78 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.313 1.054 . . . . 0.0 110.239 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.54 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 7.1 mtm180 59.76 -11.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.008 2.123 . . . . 0.0 114.88 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 51.2 t-20 -111.35 115.98 51.48 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.1 0.476 . . . . 0.0 110.626 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 4.2 Cg_endo -56.46 -28.19 72.13 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.649 2.9 . . . . 0.0 112.84 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.61 -27.19 63.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -91.42 -22.45 20.45 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.843 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.3 mt -72.09 179.48 3.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.108 0.956 . . . . 0.0 112.208 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -108.87 -166.37 1.11 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.069 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.604 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.17 167.56 41.66 Favored Glycine 0 C--N 1.304 -1.23 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.751 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 33.4 tttp -97.53 143.39 28.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.7 m-85 -106.95 112.04 24.81 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.415 1.103 . . . . 0.0 109.419 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.4 mt -112.3 148.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.442 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.09 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.56 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.9 t60 -124.76 120.02 30.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -140.34 131.5 26.45 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.741 0.781 . . . . 0.0 111.294 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 31.7 ttmt -88.16 125.95 34.88 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.327 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.38 117.4 33.95 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.912 -176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 41.3 ttm180 -77.44 107.42 9.87 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.699 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 76.3 tttt -64.54 97.39 0.2 Allowed 'General case' 0 C--O 1.178 -2.699 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 t -91.86 -153.53 0.34 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 125.347 1.459 . . . . 0.0 108.216 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 p -52.68 -46.8 67.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.982 0.513 . . . . 0.0 111.564 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -84.07 -17.23 40.97 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.514 0.674 . . . . 0.0 109.904 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.614 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 95.68 -105.61 3.27 Favored Glycine 1 N--CA 1.377 -5.295 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 40.5 m-85 -97.1 140.22 31.93 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.687 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.87 4.83 84.94 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.638 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 43' ' ' ILE . 27.4 p90 -111.99 163.04 14.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.454 0.645 . . . . 0.0 110.499 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' HE3' ' A' ' 44' ' ' LYS . 43.7 p -117.6 149.15 41.15 Favored 'General case' 0 N--CA 1.401 -2.891 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -141.24 139.16 33.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 C-N-CA 119.246 -0.981 . . . . 0.0 112.06 -173.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 33' ' ' GLY . 13.1 p -149.24 167.24 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.942 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' N ' HG21 ' A' ' 32' ' ' VAL . . . 128.55 -65.11 0.59 Allowed Glycine 0 CA--C 1.453 -3.795 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.175 173.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.695 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -74.9 57.64 2.66 Favored Glycine 2 CA--C 1.42 -5.897 0 C-N-CA 125.649 1.595 . . . . 0.0 116.284 -167.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.88 -11.95 50.79 Favored 'General case' 0 C--N 1.257 -3.438 0 O-C-N 124.123 0.543 . . . . 0.0 111.571 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.51 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 6.9 pt-20 -160.92 167.35 13.69 Favored Pre-proline 0 CA--C 1.451 -2.859 0 C-N-CA 116.11 -2.236 . . . . 0.0 110.615 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.1 Cg_endo -68.23 54.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.351 2.034 . . . . 0.0 110.198 172.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 20.7 t70 -176.41 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.685 1.594 . . . . 0.0 109.93 -170.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.695 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 51.3 mm-40 -114.36 128.42 56.34 Favored 'General case' 0 C--O 1.276 2.45 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.267 8.5 m-30 -79.56 156.4 27.74 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 128.101 3.375 . . . . 0.0 111.19 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.513 HD11 ' HA3' ' A' ' 34' ' ' GLY . 5.2 mp -87.33 142.21 28.06 Favored 'General case' 0 C--O 1.178 -2.692 0 C-N-CA 117.103 -1.839 . . . . 0.0 107.684 174.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 49.6 mt-30 -138.97 154.61 48.31 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 62' ' ' ASP . 31.2 mm -76.41 111.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HE3' ' OG1' ' A' ' 30' ' ' THR . 0.5 OUTLIER -61.98 -37.54 85.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 60' ' ' THR . 48.5 t 164.68 173.22 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 125.37 1.669 . . . . 0.0 109.479 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -137.2 151.58 48.93 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-O 122.044 0.926 . . . . 0.0 113.063 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.54 117.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 113.454 -1.703 . . . . 0.0 106.748 176.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.66 -23.08 49.49 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 112.976 -1.92 . . . . 0.0 112.896 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -96.68 -2.04 45.38 Favored 'General case' 0 C--N 1.267 -3.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.219 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.33 167.64 26.35 Favored Glycine 0 N--CA 1.422 -2.256 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.366 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.25 -31.03 74.57 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 124.187 3.258 . . . . 0.0 112.979 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.36 -44.94 89.01 Favored 'General case' 0 C--O 1.274 2.371 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.36 55.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.294 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.81 -35.43 64.87 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.82 -24.47 65.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.96 22.02 78.34 Favored Glycine 0 CA--C 1.49 -1.524 0 CA-C-N 112.515 -2.13 . . . . 0.0 113.79 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -109.44 -32.71 7.05 Favored 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.5 ttm -96.07 142.22 28.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.47 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.01 166.2 23.27 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.076 0.941 . . . . 0.0 111.082 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 45' ' ' SER . 65.9 p -70.74 111.77 6.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.081 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.7 -11.64 15.66 Favored Glycine 0 C--N 1.309 -0.929 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.903 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.656 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.8 m-20 -63.54 134.62 55.86 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -91.66 124.73 44.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.44 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 13.1 mm -73.17 123.9 29.03 Favored 'Isoleucine or valine' 1 C--O 1.32 4.764 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.501 HG12 HD13 ' A' ' 73' ' ' LEU . 42.9 t -115.53 -34.49 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 O-C-N 126.979 2.674 . . . . 0.0 110.447 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 36.5 m -148.98 146.71 27.93 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.954 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.412 HG12 ' CG1' ' A' ' 72' ' ' VAL . 7.1 p -124.75 132.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.0 m120 61.11 23.75 13.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 110.978 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.7 t70 66.66 21.46 10.62 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.743 1.617 . . . . 0.0 112.015 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 72' ' ' VAL . 56.2 m -102.91 120.43 40.61 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 171.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.7 t -66.7 110.33 3.19 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.445 ' CA ' ' HB2' ' A' ' 75' ' ' HIS . 35.7 m -122.67 28.88 2.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.563 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.58 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 39.0 tp -60.98 112.92 2.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.82 42.29 0.23 Allowed Glycine 0 C--N 1.376 2.763 0 O-C-N 125.339 1.649 . . . . 0.0 111.374 -170.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.589 ' O ' HG21 ' A' ' 76' ' ' THR . 5.3 t60 -43.31 -66.11 0.41 Allowed 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.589 HG21 ' O ' ' A' ' 75' ' ' HIS . 7.2 p -167.31 143.31 4.21 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 151.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -49.69 -35.69 22.59 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 120.31 1.414 . . . . 0.0 110.572 173.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.13 71.37 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.934 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 8.5 mm100 -60.27 -44.5 95.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.23 -43.31 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.606 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 91.6 t -64.92 -41.29 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -60.91 -38.58 86.22 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.692 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.588 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.8 mm -68.58 -33.21 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.313 0.577 . . . . 0.0 112.478 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -73.25 -30.12 63.23 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 87.5 mt-30 -76.64 -19.9 57.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.824 1.25 . . . . 0.0 110.821 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.7 m -79.68 -44.33 21.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.923 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.6 mt -67.24 136.46 93.74 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.199 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -90.99 161.18 3.93 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 123.081 2.52 . . . . 0.0 112.969 -173.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.0 mm -63.88 134.76 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-O 120.912 0.386 . . . . 0.0 110.705 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.04 54.16 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.312 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.03 -170.0 1.82 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -175.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 20.8 m -151.06 157.38 42.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.81 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.46 125.66 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.807 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.56 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 14.4 m-20 -76.44 105.3 7.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.7 mt -103.86 138.41 40.48 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 124.139 0.976 . . . . 0.0 110.484 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.3 tt0 -101.05 118.38 36.87 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 81.5 mt -107.14 150.06 26.99 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 124.776 1.23 . . . . 0.0 109.99 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.632 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 9.4 t -118.11 106.21 12.63 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.132 0.968 . . . . 0.0 108.553 172.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.656 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 36.2 ttp180 -104.66 127.76 52.51 Favored 'General case' 0 C--N 1.248 -3.823 0 O-C-N 120.811 -1.181 . . . . 0.0 109.954 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.8 -27.55 0.4 Allowed Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.41 141.54 39.54 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 C--O 1.238 0.494 0 C-N-CA 123.288 2.659 . . . . 0.0 111.643 -179.008 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.443 -1.478 0 CA-C-O 121.589 0.579 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -100.74 111.97 24.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.626 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.7 t80 -106.52 143.06 35.17 Favored 'General case' 0 C--N 1.268 -2.957 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.964 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -147.13 9.68 0.98 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.146 0.974 . . . . 0.0 110.443 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtm180 53.28 4.71 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 127.241 2.217 . . . . 0.0 114.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.43 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.4 t-20 -130.2 119.91 18.9 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HB3' HG12 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -60.94 -19.1 61.05 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.072 3.182 . . . . 0.0 112.835 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -80.43 -24.57 39.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -98.33 -19.9 17.5 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.847 0.356 . . . . 0.0 111.718 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 42.8 tp -84.99 160.46 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.286 0.565 . . . . 0.0 110.848 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.516 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 58.7 mttm -97.56 -171.23 2.14 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.896 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.65 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.15 163.95 39.87 Favored Glycine 0 C--N 1.299 -1.506 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 28.2 tttp -93.37 137.97 32.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.607 -1.237 . . . . 0.0 108.828 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.635 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 95.9 m-85 -106.05 110.68 23.02 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 122.561 1.172 . . . . 0.0 109.066 -177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.49 HD13 ' NH2' ' A' ' 99' ' ' ARG . 15.1 mt -114.8 147.33 18.3 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.875 0 CA-C-N 112.36 -2.2 . . . . 0.0 107.94 -173.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -117.35 132.08 56.66 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.917 0.865 . . . . 0.0 111.867 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -140.1 127.58 21.47 Favored 'General case' 0 C--N 1.263 -3.186 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.245 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.836 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttmt -90.15 122.27 32.95 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.843 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.79 116.78 32.52 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.9 ttt180 -76.85 107.83 9.46 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.279 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.1 tttt -64.08 97.32 0.17 Allowed 'General case' 0 C--O 1.181 -2.512 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 167.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -82.11 -158.24 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -96.58 -0.29 48.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 83.78 -129.05 8.9 Favored Glycine 0 N--CA 1.406 -3.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.57 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.8 m-85 -90.28 141.98 28.17 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 120.875 0.369 . . . . 0.0 110.207 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.99 86.84 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.143 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -111.15 163.3 14.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.475 0.655 . . . . 0.0 110.76 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 69.2 p -115.99 152.27 33.83 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -140.41 143.59 29.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.618 -174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 33' ' ' GLY . 8.8 p -144.89 167.94 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.453 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.487 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' H ' HG21 ' A' ' 32' ' ' VAL . . . 111.86 -141.64 16.74 Favored Glycine 1 N--CA 1.388 -4.526 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 -177.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.6 35.66 16.72 Favored Glycine 0 CA--C 1.473 -2.571 0 CA-C-N 117.396 0.598 . . . . 0.0 111.98 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 16.8 t70 -67.0 -29.55 69.42 Favored 'General case' 0 CA--C 1.46 -2.517 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -172.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.41 166.64 13.6 Favored Pre-proline 0 CA--C 1.467 -2.246 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.024 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 20.1 Cg_endo -65.93 58.77 0.42 Allowed 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.561 2.174 . . . . 0.0 109.945 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.567 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 11.9 t70 179.24 -16.14 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.233 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 33.9 mm-40 -122.59 123.94 42.35 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.512 ' CE1' HD13 ' A' ' 73' ' ' LEU . 6.0 m-30 -76.91 159.28 30.13 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 130.711 3.604 . . . . 0.0 113.762 -169.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 80' ' ' VAL . 8.0 mp -89.03 146.98 24.51 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.8 mt-30 -142.84 157.69 44.36 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 62' ' ' ASP . 39.4 mm -74.45 109.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.7 tttp -57.82 -41.05 81.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.464 ' HA ' HG21 ' A' ' 60' ' ' THR . 31.2 t 163.04 174.98 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 O-C-N 125.827 1.954 . . . . 0.0 109.808 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.53 150.3 44.94 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.535 0.683 . . . . 0.0 111.826 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -75.77 123.87 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . 1.9 pt? -68.76 -5.21 19.3 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -100.0 -6.56 26.31 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.181 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.53 163.76 32.7 Favored Glycine 0 N--CA 1.408 -3.186 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.3 -31.59 30.22 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 124.78 3.654 . . . . 0.0 113.249 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.47 84.53 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.425 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.422 ' HB1' ' HA ' ' A' ' 48' ' ' LEU . . . -77.33 -33.95 55.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.058 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.4 mp -70.47 -40.0 73.91 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 124.187 0.995 . . . . 0.0 112.377 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.611 ' OD2' ' HE3' ' A' ' 57' ' ' LYS . 24.4 t70 -66.33 -24.15 66.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.694 1.235 . . . . 0.0 108.326 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.8 19.67 78.24 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.586 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HE3' ' OD2' ' A' ' 55' ' ' ASP . 25.6 mtmt -122.02 -18.9 6.81 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -102.19 130.83 48.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.699 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.58 162.91 22.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.403 1.097 . . . . 0.0 111.777 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 45' ' ' SER . 80.7 p -72.57 108.69 5.75 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.657 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.1 -16.14 9.34 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.642 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.663 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 13.5 m-20 -61.13 131.8 51.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -85.96 123.58 39.62 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.726 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.415 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 15.4 mm -74.06 124.36 31.3 Favored 'Isoleucine or valine' 1 C--O 1.326 5.115 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD11 ' A' ' 73' ' ' LEU . 42.0 t -115.85 -41.06 2.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 110.881 -2.872 . . . . 0.0 111.201 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 68.0 m -144.85 149.27 35.09 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.032 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.47 HG12 ' CG1' ' A' ' 93' ' ' VAL . 25.1 t -111.7 115.04 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 66.1 -78.83 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.846 1.341 . . . . 0.0 109.634 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -156.22 24.31 0.36 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.36 1.076 . . . . 0.0 110.316 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.532 ' O ' HG11 ' A' ' 72' ' ' VAL . 27.1 m -106.87 117.99 35.51 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 32.3 t -64.9 108.23 1.71 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 70' ' ' THR . 28.2 m -117.53 20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.408 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.626 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 36.3 tp -61.64 112.76 2.37 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 39.54 0.06 OUTLIER Glycine 0 C--N 1.385 3.286 0 O-C-N 125.484 1.74 . . . . 0.0 112.273 -171.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.49 ' O ' HG21 ' A' ' 76' ' ' THR . 3.0 t60 -42.31 -65.24 0.49 Allowed 'General case' 0 C--N 1.37 1.481 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 75' ' ' HIS . 6.1 p -166.36 143.11 4.99 Favored 'General case' 0 C--N 1.257 -3.423 0 N-CA-C 100.812 -3.773 . . . . 0.0 100.812 150.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.54 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.8 -31.37 26.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 121.018 1.735 . . . . 0.0 111.233 173.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.09 -50.26 74.07 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.478 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 13.3 mm100 -64.55 -42.01 95.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 77' ' ' HIS . 11.0 m -66.57 -41.85 89.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.05 -38.98 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -37.24 86.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.565 ' O ' ' HB2' ' A' ' 86' ' ' SER . 2.1 mm -67.56 -35.7 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.56 0.695 . . . . 0.0 112.146 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -73.55 -30.49 63.09 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.74 -26.68 62.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.657 0.783 . . . . 0.0 110.41 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -70.96 -42.5 69.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.768 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 20.6 mt -72.16 130.08 86.85 Favored Pre-proline 0 N--CA 1.408 -2.567 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.017 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.3 Cg_endo -91.86 162.42 3.35 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 123.514 2.809 . . . . 0.0 112.947 -173.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.491 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.3 mm -59.43 132.79 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-O 121.296 0.57 . . . . 0.0 111.217 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.65 56.54 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.443 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.9 -169.54 1.69 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 8.1 m -150.6 159.93 44.16 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.836 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -142.0 125.01 14.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.766 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.225 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.08 102.16 11.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.76 135.57 40.04 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.221 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 35.5 tt0 -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.805 175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.0 mt -106.33 144.81 32.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.0 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.65 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 10.2 t -112.44 107.78 16.68 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.005 0.907 . . . . 0.0 108.82 172.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.663 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 26.9 ttp180 -101.59 131.74 47.62 Favored 'General case' 0 C--N 1.25 -3.747 0 O-C-N 121.021 -1.049 . . . . 0.0 109.874 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.66 1.41 Allowed Glycine 0 C--N 1.307 -1.061 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.42 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.88 128.73 31.52 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.245 0.849 0 C-N-CA 123.834 3.022 . . . . 0.0 113.12 -174.458 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.448 -1.194 0 CA-C-O 121.092 0.371 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.402 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 44.0 t80 -86.6 104.47 16.06 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.608 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -106.91 131.07 54.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -140.11 13.53 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.045 0.926 . . . . 0.0 109.912 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.451 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 6.2 mtm180 53.07 7.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -132.77 121.27 17.0 Favored Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.001 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.21 -22.74 66.28 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 124.262 3.308 . . . . 0.0 113.152 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -79.23 -30.61 43.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.363 0.602 . . . . 0.0 109.478 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -90.41 -24.0 20.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.519 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 38.3 tp -82.26 152.95 26.13 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.35 144.83 42.1 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-O 121.73 0.776 . . . . 0.0 109.767 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.679 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 155.19 -178.13 32.02 Favored Glycine 1 C--N 1.249 -4.292 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -173.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.564 ' HE2' ' CG1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -98.6 121.73 40.92 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.506 ' CD2' ' HB2' ' A' ' 98' ' ' CYS . 85.9 m-85 -100.1 119.25 38.01 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.131 0.967 . . . . 0.0 109.506 -174.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.564 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 44.7 mt -117.42 141.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.95 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.68 -170.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -107.06 126.44 52.35 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.53 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 9.0 t -137.55 157.54 46.31 Favored 'General case' 0 C--O 1.179 -2.633 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.329 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.813 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 35.6 ttpt -130.35 122.99 28.92 Favored 'General case' 0 C--N 1.261 -3.278 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.441 ' CD2' ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -107.09 117.07 33.1 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 58.0 ttp180 -73.84 105.43 5.11 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.918 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.596 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 70.0 tttt -64.16 97.17 0.17 Allowed 'General case' 0 C--O 1.18 -2.602 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -84.53 -154.88 0.18 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -58.99 -38.34 78.93 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.449 0.7 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -90.01 -19.94 23.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.596 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 99.84 -118.9 6.32 Favored Glycine 1 N--CA 1.388 -4.541 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 38.4 m-85 -90.55 136.51 33.02 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 117.674 0.737 . . . . 0.0 110.515 -176.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 9.71 76.79 Favored Glycine 0 C--O 1.212 -1.253 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.613 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 9.3 p90 -121.14 162.67 19.69 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.345 0.572 . . . . 0.0 110.375 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -123.13 147.34 46.9 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 77' ' ' HIS . 15.5 m -121.61 146.22 27.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-O 121.284 0.564 . . . . 0.0 111.622 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.85 152.04 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.515 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.89 -129.59 8.33 Favored Glycine 1 N--CA 1.395 -4.08 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 45.06 38.04 5.93 Favored Glycine 0 CA--C 1.472 -2.597 0 C-N-CA 124.935 1.255 . . . . 0.0 114.072 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 6.6 m-20 -67.09 -24.4 65.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.405 -176.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -170.82 169.76 3.28 Favored Pre-proline 0 CA--C 1.46 -2.518 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.092 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.9 Cg_endo -65.48 59.05 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.858 2.372 . . . . 0.0 110.709 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 19.4 t70 175.02 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.511 1.525 . . . . 0.0 110.218 -173.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.572 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 7.7 mm-40 -123.93 123.96 41.56 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 172.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.557 ' CE1' HD13 ' A' ' 73' ' ' LEU . 5.1 m-30 -76.99 159.63 29.78 Favored 'General case' 1 N--CA 1.55 4.543 0 C-N-CA 131.492 3.917 . . . . 0.0 114.569 -170.119 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 80' ' ' VAL . 5.9 mp -95.08 140.07 30.53 Favored 'General case' 0 C--O 1.188 -2.141 0 C-N-CA 117.73 -1.588 . . . . 0.0 107.725 172.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 51.0 mt-30 -130.86 158.43 40.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 172.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 62' ' ' ASP . 22.3 mm -81.32 115.48 23.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -66.86 -48.66 68.13 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 46.0 t 174.37 173.99 0.19 Allowed 'General case' 0 CA--C 1.497 -1.06 0 O-C-N 123.996 0.81 . . . . 0.0 111.879 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.57 152.28 39.46 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.808 -172.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.41 116.23 9.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -69.56 -10.06 56.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.292 1.044 . . . . 0.0 112.908 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.92 -7.98 38.43 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.025 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.525 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.37 173.41 37.27 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.57 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.27 -27.93 77.36 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 124.175 3.25 . . . . 0.0 112.872 -173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.441 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.45 -49.75 76.59 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.692 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 48' ' ' LEU . . . -76.44 -32.28 58.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.894 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 50' ' ' GLY . 6.8 mp -65.59 -46.27 80.04 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.714 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.74 -35.7 80.62 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.41 -17.72 52.75 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 112.878 -1.964 . . . . 0.0 113.267 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 2.9 mptm? -77.27 -27.43 53.14 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 46.7 tpp -94.19 127.08 39.82 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -170.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -136.73 156.55 48.38 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.27 1.033 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -61.97 114.42 3.36 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.71 1.204 . . . . 0.0 110.336 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.26 -14.43 25.69 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.192 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.51 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.8 m-20 -67.08 141.25 57.54 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.251 0.1 OUTLIER -93.41 123.15 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 113.244 178.34 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.1 mm -73.25 123.62 28.57 Favored 'Isoleucine or valine' 1 C--O 1.337 5.66 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG13 HD11 ' A' ' 73' ' ' LEU . 47.1 t -115.87 -36.05 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 O-C-N 127.506 3.004 . . . . 0.0 111.985 -176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 60.4 m -151.61 162.85 40.28 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.487 -1.383 . . . . 0.0 114.012 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 72' ' ' VAL . 48.6 t -134.38 127.16 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.624 0 C-N-CA 125.017 1.327 . . . . 0.0 107.527 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.2 m120 65.65 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 108.761 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -149.96 31.35 0.7 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.743 0.782 . . . . 0.0 109.165 170.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 m -116.48 126.84 53.94 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.496 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 24.2 t -67.39 115.08 6.62 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.408 HG12 HG23 ' A' ' 67' ' ' VAL . 2.0 p -119.98 15.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.608 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.4 tp -59.34 113.67 2.28 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.2 48.02 0.14 Allowed Glycine 0 C--N 1.379 2.967 0 O-C-N 125.433 1.708 . . . . 0.0 111.846 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 76' ' ' THR . 3.0 t60 -50.93 -68.35 0.18 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 75' ' ' HIS . 13.9 p -166.55 143.93 5.06 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 152.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.595 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.68 -33.36 22.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 120.088 1.313 . . . . 0.0 110.977 172.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.61 93.19 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.897 -0.502 . . . . 0.0 110.958 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 10.1 mm-40 -65.2 -43.3 92.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 77' ' ' HIS . 17.1 m -62.66 -43.98 99.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.003 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.84 -40.78 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.639 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -62.18 -38.34 88.71 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.639 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 28.1 mt -65.02 -40.39 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.636 0.732 . . . . 0.0 111.329 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.23 -33.59 71.85 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.673 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.38 -20.22 60.8 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.183 0.993 . . . . 0.0 110.96 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.573 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.0 m -76.41 -48.75 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.4 mt -66.2 135.52 95.02 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -87.98 161.55 7.39 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.258 2.639 . . . . 0.0 113.68 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.505 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.2 mm -63.6 132.49 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.99 11.95 55.89 Favored Glycine 0 C--N 1.288 -2.096 0 C-N-CA 119.783 -1.198 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.35 -171.71 2.13 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.7 m -151.25 156.44 40.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -140.97 125.47 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.867 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.226 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 18' ' ' THR . 10.6 m-20 -79.31 104.2 9.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.39 157.42 16.92 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 125.497 1.519 . . . . 0.0 108.254 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -117.01 121.38 41.21 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 76.1 mt -105.06 164.34 11.87 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 125.107 1.363 . . . . 0.0 109.69 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.679 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 12.4 t -141.05 116.54 10.15 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.843 0.83 . . . . 0.0 109.923 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 31.1 mtm180 -98.6 135.49 40.05 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 121.279 -0.888 . . . . 0.0 113.115 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.62 -25.13 0.84 Allowed Glycine 0 CA--C 1.466 -3.0 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.298 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.408 ' HH ' HD12 ' A' ' 11' ' ' LEU . 22.7 m-85 -81.85 140.64 47.08 Favored Pre-proline 0 N--CA 1.42 -1.954 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.482 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--N 1.359 1.122 0 C-N-CA 123.799 2.999 . . . . 0.0 111.147 179.356 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.247 0.929 0 N-CA-C 111.424 -0.26 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -79.63 105.43 10.93 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.587 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 4.8 t80 -108.25 139.55 42.78 Favored 'General case' 0 C--N 1.265 -3.088 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 7' ' ' ASN . 10.2 t -144.48 10.56 1.44 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.489 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 9.5 mtp180 58.01 -19.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.766 2.026 . . . . 0.0 115.466 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 5' ' ' THR . 4.2 t-20 -105.84 113.12 64.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 C-N-CA 122.714 0.406 . . . . 0.0 109.973 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 5.2 Cg_endo -50.87 -27.87 21.89 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 124.077 3.185 . . . . 0.0 113.635 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.5 t -74.03 -25.71 60.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.02 0.438 . . . . 0.0 110.996 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.439 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 14.5 mm-40 -91.51 -35.3 14.39 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.435 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 40' ' ' PHE . 39.0 tp -71.89 155.82 39.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.903 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.4 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 63.8 mttm -106.55 158.57 16.83 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.48 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.783 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 131.31 173.65 13.42 Favored Glycine 0 C--N 1.265 -3.369 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' CE ' HG12 ' A' ' 16' ' ' ILE . 7.6 ttpt -94.4 123.51 37.85 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 95.1 m-85 -101.75 111.55 23.83 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 122.778 1.275 . . . . 0.0 109.85 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.479 HG12 ' CE ' ' A' ' 14' ' ' LYS . 34.7 mt -105.87 145.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.739 0 CA-C-N 111.839 -2.437 . . . . 0.0 109.651 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.456 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 4.3 t60 -130.61 115.17 16.37 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 t -139.92 137.73 35.04 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.296 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.6 ttmp? -87.59 125.37 34.31 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.632 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.82 121.11 44.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 11.9 ttp180 -81.21 108.87 15.21 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.397 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 73.7 tttt -62.88 97.47 0.11 Allowed 'General case' 0 C--O 1.182 -2.454 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 169.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -90.93 -154.39 0.35 Allowed 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 124.812 1.245 . . . . 0.0 108.228 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -54.59 -43.94 72.59 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.75 0.82 . . . . 0.0 111.029 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmt_? -85.18 -18.87 32.78 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.567 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 97.15 -114.52 5.0 Favored Glycine 0 N--CA 1.397 -3.955 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -177.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 31.8 m-85 -93.95 141.33 28.64 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.37 -2.92 84.91 Favored Glycine 0 C--O 1.217 -0.959 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.757 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.414 ' HB2' HG23 ' A' ' 43' ' ' ILE . 17.9 p90 -111.97 162.7 15.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 38.8 p -123.59 155.58 37.39 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.4 148.64 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-O 121.631 0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.02 149.93 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.283 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.79 -137.17 12.6 Favored Glycine 0 N--CA 1.398 -3.864 0 N-CA-C 108.236 -1.945 . . . . 0.0 108.236 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 52.34 32.28 36.94 Favored Glycine 0 CA--C 1.47 -2.728 0 N-CA-C 111.786 -0.525 . . . . 0.0 111.786 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -71.62 -19.76 62.07 Favored 'General case' 0 N--CA 1.411 -2.416 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.951 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.65 166.78 8.66 Favored Pre-proline 0 CA--C 1.468 -2.183 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_endo -66.85 58.18 0.54 Allowed 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.715 2.277 . . . . 0.0 109.737 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 22.1 t70 176.6 -15.06 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.476 -169.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.488 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 26.9 mt-10 -123.19 126.12 46.39 Favored 'General case' 0 C--O 1.269 2.116 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 171.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.25 7.3 m-85 -77.85 158.59 29.4 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 131.04 3.736 . . . . 0.0 113.535 -168.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 6.0 mp -89.82 143.29 26.92 Favored 'General case' 0 CA--C 1.457 -2.624 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 171.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.12 152.81 49.09 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 62' ' ' ASP . 26.7 mm -69.09 109.09 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 84.1 tttt -55.3 -41.26 72.1 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 124.872 1.357 . . . . 0.0 107.448 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.0 t 162.41 173.52 0.02 OUTLIER 'General case' 0 C--N 1.366 1.326 0 O-C-N 125.395 1.684 . . . . 0.0 109.605 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.59 147.27 42.78 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 121.989 0.9 . . . . 0.0 111.976 -173.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.401 HG11 ' H ' ' A' ' 49' ' ' ASP . 13.8 t -83.34 130.06 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.972 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 94.7 mt -69.32 -13.52 62.43 Favored 'General case' 0 N--CA 1.38 -3.941 0 CA-C-N 112.799 -2.001 . . . . 0.0 112.849 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.401 ' H ' HG11 ' A' ' 47' ' ' VAL . 14.7 t70 -86.0 -24.2 26.54 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.244 173.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.09 155.15 36.13 Favored Glycine 0 N--CA 1.401 -3.679 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.556 -172.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.8 -31.48 33.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 125.052 3.834 . . . . 0.0 113.385 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.53 95.59 Favored 'General case' 0 C--O 1.261 1.701 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.199 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.88 -35.33 50.95 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.496 177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.94 -43.41 88.11 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.981 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.48 -21.85 55.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.909 1.338 . . . . 0.0 107.409 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.9 73.46 Favored Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 113.228 -1.806 . . . . 0.0 112.586 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -98.31 -28.48 13.65 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 120.859 0.362 . . . . 0.0 110.084 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -98.03 149.63 22.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.211 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.71 153.4 47.21 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.5 p -60.09 111.67 1.6 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.48 -5.43 24.76 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.215 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' GLN . 5.4 m-20 -60.31 126.07 26.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.102 0.951 . . . . 0.0 108.603 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 41' ' ' LEU 0.256 0.2 OUTLIER -80.2 112.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.957 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.1 mm -66.98 125.3 24.09 Favored 'Isoleucine or valine' 1 C--O 1.332 5.397 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.466 HG11 HD12 ' A' ' 73' ' ' LEU . 48.5 t -115.36 -42.91 3.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 O-C-N 127.585 3.053 . . . . 0.0 112.085 -174.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 69.6 m -147.77 156.78 43.1 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.853 -1.154 . . . . 0.0 112.359 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.405 HG11 ' HB ' ' A' ' 72' ' ' VAL . 6.3 p -135.98 128.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.1 m120 58.53 30.33 19.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.603 0.716 . . . . 0.0 110.65 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 68.06 17.22 9.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.893 1.277 . . . . 0.0 113.28 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.8 m -107.78 125.49 51.49 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.412 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 54.0 t -59.99 110.14 1.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 124.418 1.074 . . . . 0.0 109.783 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.405 ' HB ' HG11 ' A' ' 67' ' ' VAL . 2.0 p -119.8 16.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.587 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 30.6 tp -59.9 113.23 2.18 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.5 43.17 0.07 OUTLIER Glycine 0 N--CA 1.5 2.945 0 O-C-N 125.762 1.914 . . . . 0.0 112.559 -170.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.551 ' O ' HG21 ' A' ' 76' ' ' THR . 3.2 t60 -46.42 -66.83 0.35 Allowed 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.551 HG21 ' O ' ' A' ' 75' ' ' HIS . 20.1 p -166.52 143.85 5.07 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 151.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.606 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -50.88 -33.59 24.67 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 120.295 1.407 . . . . 0.0 110.876 173.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.17 86.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.967 -0.458 . . . . 0.0 110.866 174.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 14.3 mm-40 -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 77' ' ' HIS . 13.1 m -64.63 -44.5 96.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -66.56 -38.19 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.541 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -64.32 -33.93 76.96 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.296 177.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.9 mm -70.8 -36.53 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.732 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.18 -31.42 64.21 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.309 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -70.44 -27.91 64.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.522 1.129 . . . . 0.0 110.634 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -73.17 -34.34 65.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.576 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.0 mt -80.78 134.72 53.13 Favored Pre-proline 0 N--CA 1.412 -2.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.976 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 91' ' ' ALA . 19.5 Cg_endo -91.99 162.3 3.27 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 123.585 2.857 . . . . 0.0 113.134 -174.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.2 mm -62.85 133.01 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.22 0.533 . . . . 0.0 110.885 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.76 12.3 53.44 Favored Glycine 0 C--N 1.293 -1.848 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.674 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -101.76 -170.82 1.88 Allowed 'General case' 0 C--O 1.207 -1.164 0 O-C-N 122.704 -0.292 . . . . 0.0 110.292 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.9 m -151.21 155.51 38.98 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.657 -0.652 . . . . 0.0 109.358 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.02 127.88 10.67 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.657 0 C-N-CA 118.582 -1.247 . . . . 0.0 113.119 -174.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.456 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 22.2 m-20 -80.32 106.88 12.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.533 0.682 . . . . 0.0 109.168 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.1 mt -105.59 142.65 34.95 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.806 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.492 ' OE2' ' HB3' ' A' ' 15' ' ' PHE . 16.7 tp10 -107.1 127.69 53.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -136.2 155.83 49.57 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 124.046 0.938 . . . . 0.0 111.281 -178.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.783 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -119.95 117.13 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.509 1.147 . . . . 0.0 112.936 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -88.88 111.14 21.71 Favored 'General case' 0 C--N 1.266 -3.058 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.07 -35.63 0.09 OUTLIER Glycine 0 CA--C 1.479 -2.19 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.568 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.62 136.99 24.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.128 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.889 2.392 . . . . 0.0 108.062 173.644 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.44 -1.628 0 CA-C-O 121.379 0.491 . . . . 0.0 112.97 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.449 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 23.8 t80 -82.27 105.19 13.14 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.609 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -101.46 133.57 45.9 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 7' ' ' ASN . 8.9 t -141.15 8.89 2.08 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.903 0.858 . . . . 0.0 110.437 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.511 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 8.3 mtm180 63.9 -27.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.556 1.943 . . . . 0.0 114.964 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 52.8 t-20 -100.54 122.25 50.26 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 6.1 Cg_endo -55.52 -27.84 61.58 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 124.006 3.137 . . . . 0.0 112.691 175.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 t -75.52 -25.72 57.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.129 0.49 . . . . 0.0 110.314 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -88.9 -24.26 22.54 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.691 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 41.2 tp -83.33 157.51 22.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 36.6 mtmm -119.69 148.71 43.05 Favored 'General case' 0 N--CA 1.381 -3.908 0 CA-C-O 121.676 0.751 . . . . 0.0 110.524 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 150.37 178.22 25.06 Favored Glycine 0 C--N 1.257 -3.837 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -171.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -88.41 124.28 33.79 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.6 m-85 -102.8 120.3 40.36 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.103 -1.439 . . . . 0.0 109.949 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.7 mt -120.39 135.97 58.94 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.579 -170.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -114.01 115.58 27.84 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.371 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.408 ' HB ' ' CB ' ' A' ' 57' ' ' LYS . 4.2 t -140.33 131.28 26.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.889 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.83 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttpt -92.3 124.95 36.75 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.81 120.62 42.51 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.782 -173.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 15.9 tpp180 -76.21 103.47 6.26 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.635 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 51.2 tttt -59.06 96.97 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.947 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 165.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.444 ' HB2' ' HG3' ' A' ' 21' ' ' ARG . 4.9 t -134.65 139.33 45.2 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.1 p 50.82 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.973 1.709 . . . . 0.0 113.215 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.555 ' HD2' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmm_? -76.2 -21.83 56.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.707 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 94.43 24.56 18.37 Favored Glycine 1 N--CA 1.393 -4.213 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.697 174.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 155.8 170.39 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 130.393 3.477 . . . . 0.0 105.525 167.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.49 4.0 17.74 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.218 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 43' ' ' ILE . 8.2 p90 -123.8 163.8 20.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -122.09 147.69 45.8 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.19 147.9 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.988 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 158.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.963 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.984 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.75 -130.12 9.04 Favored Glycine 1 N--CA 1.394 -4.13 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 50.25 37.11 30.56 Favored Glycine 0 CA--C 1.478 -2.268 0 C-N-CA 123.92 0.772 . . . . 0.0 113.513 175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -67.13 -21.39 65.84 Favored 'General case' 0 CA--C 1.477 -1.845 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.097 -175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -170.78 169.37 3.47 Favored Pre-proline 0 CA--C 1.474 -1.961 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.356 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 21.2 Cg_endo -66.61 51.36 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.923 2.416 . . . . 0.0 111.279 171.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 5.8 m-20 -176.84 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 127.105 2.162 . . . . 0.0 111.352 -170.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.532 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 18.6 mm-40 -128.66 123.85 34.24 Favored 'General case' 0 C--O 1.272 2.238 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.529 ' CE1' HD12 ' A' ' 73' ' ' LEU . 6.5 m-30 -77.15 159.67 29.57 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 131.14 3.776 . . . . 0.0 114.58 -168.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -92.87 144.28 25.43 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 172.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.7 mt-30 -138.28 153.19 49.06 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 62' ' ' ASP . 25.0 mm -70.93 111.21 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.402 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 45' ' ' SER . 38.8 ttpt -67.54 -36.5 81.11 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.47 ' HA ' HG21 ' A' ' 60' ' ' THR . 41.1 t 170.53 172.9 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 O-C-N 125.159 1.537 . . . . 0.0 111.221 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -144.76 149.47 35.58 Favored 'General case' 0 N--CA 1.408 -2.562 0 C-N-CA 124.257 1.023 . . . . 0.0 110.879 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.65 127.64 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.651 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.25 -3.38 10.59 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.571 -2.104 . . . . 0.0 112.264 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -103.13 -18.06 15.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.4 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.98 163.0 32.98 Favored Glycine 0 N--CA 1.41 -3.07 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.729 -170.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -50.27 -32.96 34.86 Favored 'Trans proline' 0 C--O 1.201 -1.372 0 C-N-CA 125.063 3.842 . . . . 0.0 112.617 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.51 -47.86 80.82 Favored 'General case' 0 C--O 1.271 2.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.357 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.18 -36.55 54.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.43 -35.45 65.8 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.108 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.69 -22.41 66.08 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.3 24.0 76.17 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.403 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' CB ' ' HB ' ' A' ' 18' ' ' THR . 23.7 mmtp -110.18 -35.69 6.03 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.4 ttm -102.27 143.08 32.49 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.167 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.44 163.93 29.33 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.619 0.723 . . . . 0.0 109.176 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -67.83 114.42 6.4 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 123.709 0.804 . . . . 0.0 108.837 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.62 -22.07 7.43 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.035 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 43' ' ' ILE . 8.1 m-20 -62.18 134.69 56.89 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.706 0.753 . . . . 0.0 110.986 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -82.52 121.51 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.408 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.0 mm -72.58 122.83 25.98 Favored 'Isoleucine or valine' 1 C--O 1.334 5.525 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 73' ' ' LEU . 48.1 t -115.29 -37.61 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 110.402 -3.09 . . . . 0.0 111.652 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.429 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.0 m -150.76 151.43 32.36 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.302 -1.499 . . . . 0.0 114.424 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG13 ' CG1' ' A' ' 93' ' ' VAL . 25.3 t -118.73 114.8 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.629 1.172 . . . . 0.0 109.037 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 52.74 36.69 21.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.312 0.577 . . . . 0.0 112.308 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 72.73 15.41 4.84 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.166 1.786 . . . . 0.0 112.164 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 72' ' ' VAL . 28.6 m -99.1 119.14 37.34 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 169.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.4 t -69.22 110.01 4.37 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.678 0.752 . . . . 0.0 109.491 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 80' ' ' VAL . 23.9 m -114.47 18.3 7.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.444 -176.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.609 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 28.5 tp -59.79 113.4 2.25 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.21 45.72 0.14 Allowed Glycine 0 C--N 1.378 2.9 0 O-C-N 125.661 1.85 . . . . 0.0 111.896 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.536 ' O ' HG21 ' A' ' 76' ' ' THR . 8.9 t60 -45.15 -66.68 0.37 Allowed 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.536 HG21 ' O ' ' A' ' 75' ' ' HIS . 10.8 p -166.9 143.83 4.67 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 150.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -51.0 -36.94 42.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 121.008 1.731 . . . . 0.0 110.886 174.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.43 95.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.501 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.469 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 18.6 mm-40 -69.97 -39.81 75.74 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 77' ' ' HIS . 20.9 m -66.54 -41.6 88.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.859 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.63 -40.89 90.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.646 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.4 tmtm? -59.03 -44.58 91.78 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.765 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.646 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.4 mm -66.34 -35.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -70.98 -36.59 72.57 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -68.24 -23.38 64.79 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 124.338 1.055 . . . . 0.0 111.352 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.5 m -75.63 -30.09 59.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.938 176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.447 HG21 ' HD3' ' A' ' 22' ' ' LYS . 51.9 mt -83.24 133.29 47.98 Favored Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.646 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 9.8 Cg_endo -88.08 161.99 7.24 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.552 2.835 . . . . 0.0 112.637 -173.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.499 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 35.5 mm -66.52 133.73 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.87 54.5 Favored Glycine 0 C--N 1.287 -2.173 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.237 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.604 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -101.73 -177.25 3.37 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.475 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 2.9 p -145.54 152.48 39.8 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.78 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.8 t -136.67 125.42 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.34 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.74 102.85 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 70.0 mt -99.65 139.77 34.82 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.724 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -96.55 118.36 32.89 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 90.4 mt -107.52 164.54 12.12 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 125.283 1.433 . . . . 0.0 109.382 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 19.3 t -142.22 107.77 5.07 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-O 122.387 1.089 . . . . 0.0 110.684 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -85.05 117.75 24.2 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.42 -24.19 0.21 Allowed Glycine 0 CA--C 1.473 -2.558 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.587 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 35.9 m-85 -94.22 133.46 27.27 Favored Pre-proline 0 C--N 1.286 -2.173 0 CA-C-O 121.075 0.464 . . . . 0.0 110.364 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.246 0.914 0 C-N-CA 123.605 2.87 . . . . 0.0 111.969 -177.219 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 36.3 Cg_endo . . . . . 0 N--CA 1.449 -1.111 0 CA-C-O 121.21 0.421 . . . . 0.0 111.896 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -82.58 105.51 13.68 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.622 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.5 t80 -105.18 138.42 41.41 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.126 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 7' ' ' ASN . 9.5 t -154.51 22.97 0.47 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.217 0.532 . . . . 0.0 111.008 174.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 58.11 -30.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 128.446 2.698 . . . . 0.0 116.431 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.416 ' H ' ' C ' ' A' ' 5' ' ' THR . 4.4 t-20 -99.88 113.87 65.36 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -55.22 -32.68 81.54 Favored 'Trans proline' 0 C--O 1.221 -0.329 0 C-N-CA 123.482 2.788 . . . . 0.0 111.46 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -71.34 -11.97 61.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.285 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.411 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 21.4 mm-40 -105.03 -22.35 13.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.474 0.71 . . . . 0.0 111.344 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.4 mm? -79.67 169.48 17.91 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -177.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.87 -170.42 2.04 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.834 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.11 177.76 52.05 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 13.6 ttpt -110.16 132.18 54.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.5 m-85 -99.09 110.79 23.32 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 123.161 1.458 . . . . 0.0 110.8 -174.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.438 HG12 ' CE ' ' A' ' 14' ' ' LYS . 30.5 mt -107.09 151.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.835 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.28 -174.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.43 121.49 25.99 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.352 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 t -138.51 138.91 38.48 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.58 0.705 . . . . 0.0 110.151 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 28.6 ttmt -93.8 125.04 38.2 Favored 'General case' 0 C--N 1.259 -3.346 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.7 117.05 33.03 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 37.8 ttt180 -76.7 108.56 9.8 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.909 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 73.6 tttt -65.05 97.14 0.22 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t -87.61 -154.83 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -54.4 -41.54 69.39 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.154 0.581 . . . . 0.0 110.767 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -87.15 -20.47 26.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.805 0.812 . . . . 0.0 109.77 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.575 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 99.28 -116.33 5.55 Favored Glycine 1 N--CA 1.386 -4.695 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 31.0 m-85 -93.9 146.79 23.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.14 0.34 66.4 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.642 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 31' ' ' VAL . 10.0 p90 -111.24 163.14 14.25 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.546 0.689 . . . . 0.0 111.606 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.6 p -116.85 156.4 27.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG23 ' CE2' ' A' ' 29' ' ' PHE . 2.6 t -132.35 142.44 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.348 -173.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -152.7 160.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.91 -1.52 30.19 Favored Glycine 1 CA--C 1.447 -4.189 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 168.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.684 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -116.39 43.98 1.55 Allowed Glycine 1 CA--C 1.408 -6.637 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -170.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.32 -12.41 29.56 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 113.009 -1.595 . . . . 0.0 112.17 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -165.45 167.25 9.52 Favored Pre-proline 0 CA--C 1.46 -2.512 0 C-N-CA 117.203 -1.799 . . . . 0.0 110.888 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -67.32 57.52 0.64 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 122.463 2.108 . . . . 0.0 110.165 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 26.8 t70 -179.67 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.478 1.911 . . . . 0.0 109.625 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.699 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 26.7 mt-10 -113.47 124.58 52.75 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-O 117.009 -1.472 . . . . 0.0 107.274 171.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 73' ' ' LEU 0.305 6.5 m-30 -79.35 155.38 28.46 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 128.288 3.492 . . . . 0.0 111.733 -176.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.563 HD11 ' HA3' ' A' ' 34' ' ' GLY . 6.6 mp -87.1 143.34 27.36 Favored 'General case' 0 C--O 1.175 -2.867 0 C-N-CA 116.582 -2.047 . . . . 0.0 108.901 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.5 mt-30 -138.42 157.54 46.01 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 29' ' ' PHE . 25.3 mm -75.48 109.91 9.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.577 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.2 tttp -56.8 -37.71 71.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 125.183 1.552 . . . . 0.0 107.07 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' HG23 ' A' ' 60' ' ' THR . 42.0 t 159.36 173.13 0.01 OUTLIER 'General case' 0 C--N 1.364 1.239 0 O-C-N 125.769 1.918 . . . . 0.0 109.231 172.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pp -136.74 149.37 47.81 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.44 118.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.263 1.2 pt? -69.59 -5.06 22.01 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -94.64 -3.48 49.44 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.354 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 54' ' ' LEU . . . -91.62 161.78 27.47 Favored Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.2 -29.9 30.86 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 124.952 3.768 . . . . 0.0 113.38 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.07 -46.71 84.98 Favored 'General case' 0 C--O 1.275 2.41 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.694 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.07 -32.38 56.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.532 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 50' ' ' GLY . 9.1 mp -68.69 -45.2 72.28 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.996 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.9 -26.93 67.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.12 16.7 79.54 Favored Glycine 0 CA--C 1.487 -1.711 0 CA-C-N 112.933 -1.939 . . . . 0.0 113.842 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -109.53 -24.48 10.96 Favored 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 122.278 0.231 . . . . 0.0 111.573 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.43 140.53 31.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.025 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 41.4 tt0 -149.38 146.89 27.72 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.986 0.898 . . . . 0.0 111.69 -172.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 45' ' ' SER . 5.3 p -49.61 103.52 0.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 126.313 1.845 . . . . 0.0 112.416 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.9 -2.52 31.78 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-O 119.375 -0.68 . . . . 0.0 113.049 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.24 146.95 48.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -98.59 121.22 48.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.491 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 29.7 mm -69.88 123.96 24.81 Favored 'Isoleucine or valine' 0 C--O 1.305 3.975 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.481 HG13 HD13 ' A' ' 73' ' ' LEU . 43.7 t -115.19 -38.66 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 111.662 -2.517 . . . . 0.0 110.272 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 40.0 m -145.11 142.97 30.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.885 -178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.57 131.82 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 m120 63.8 23.82 13.56 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.873 0.844 . . . . 0.0 108.958 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.37 -0.66 2.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.408 1.883 . . . . 0.0 112.079 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 72' ' ' VAL . 76.8 m -78.86 119.81 22.58 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.67 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.411 -2.397 0 O-C-N 124.777 1.298 . . . . 0.0 110.29 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 80' ' ' VAL . 35.6 m -115.87 26.55 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.535 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.622 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.5 tp -59.71 113.79 2.43 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.26 41.48 0.22 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 125.344 1.653 . . . . 0.0 112.177 -170.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 76' ' ' THR . 14.5 t60 -45.72 -66.73 0.36 Allowed 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.1 p -167.14 143.5 4.38 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 149.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -50.16 -38.61 40.33 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 119.342 0.974 . . . . 0.0 110.658 174.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.53 95.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.082 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 68.3 mm-40 -66.37 -43.2 86.6 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.473 HG21 HD21 ' A' ' 41' ' ' LEU . 33.4 m -66.81 -40.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.502 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.94 -39.27 85.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.674 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.92 -40.02 79.4 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.706 176.383 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.674 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 57.9 mt -66.75 -36.78 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.713 0.768 . . . . 0.0 110.802 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -71.49 -30.29 65.8 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.421 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.99 -26.32 59.48 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.487 1.115 . . . . 0.0 110.27 174.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 52.4 m -72.39 -49.29 34.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.995 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 44.3 mt -62.98 134.83 95.92 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.789 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.3 Cg_endo -90.51 161.84 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.482 2.788 . . . . 0.0 113.302 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.4 mm -65.37 132.35 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 121.452 0.644 . . . . 0.0 110.379 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.06 54.13 Favored Glycine 0 C--N 1.288 -2.092 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.793 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.427 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -98.66 -170.43 1.94 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -175.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 13.3 m -151.14 158.93 44.62 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.81 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.21 126.68 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.772 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.63 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.528 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 15.1 m-20 -78.79 104.14 9.21 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.7 mt -102.42 136.96 41.31 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 124.624 1.169 . . . . 0.0 109.884 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 37.6 tt0 -101.02 121.06 41.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 6.0 mt -107.54 165.04 11.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.048 1.339 . . . . 0.0 108.764 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.598 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 21.1 t -137.97 105.23 5.48 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.103 0.954 . . . . 0.0 110.634 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 59' ' ' GLU . 76.5 mtm180 -96.46 119.98 35.93 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 121.229 -0.92 . . . . 0.0 110.506 174.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.26 -33.95 0.15 Allowed Glycine 0 CA--C 1.474 -2.517 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.62 133.4 23.62 Favored Pre-proline 0 N--CA 1.424 -1.744 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 122.929 2.419 . . . . 0.0 111.395 -178.27 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 52.1 Cg_endo . . . . . 0 CA--C 1.545 1.063 0 CA-C-O 121.359 0.483 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -81.61 103.71 11.52 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.607 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -113.7 118.43 34.31 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.385 -176.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 7' ' ' ASN . 12.4 t -134.7 17.67 3.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.86 0.838 . . . . 0.0 110.267 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.425 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.7 mtp180 59.59 -20.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.018 2.127 . . . . 0.0 115.762 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.464 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 3.3 t-20 -99.84 112.32 63.58 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-O 121.227 0.537 . . . . 0.0 111.086 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 1.8 Cg_endo -50.89 -37.1 54.98 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.989 3.126 . . . . 0.0 111.846 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -68.04 -20.31 64.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.763 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 8.3 mm-40 -95.14 -23.54 17.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.573 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 mt -76.3 179.45 5.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.061 0.934 . . . . 0.0 110.421 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -107.65 -177.02 3.23 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.505 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.55 166.21 27.41 Favored Glycine 0 C--N 1.283 -2.405 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.074 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 29.2 tttp -93.03 138.96 31.02 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.674 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.0 m-85 -113.44 111.57 22.17 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.94 1.352 . . . . 0.0 110.835 -175.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.482 HG12 ' CE ' ' A' ' 14' ' ' LYS . 5.9 mt -109.36 151.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 CA-C-N 112.235 -2.257 . . . . 0.0 108.114 -173.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.468 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 2.8 t60 -130.71 119.77 22.86 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 3.6 t -139.18 129.35 25.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.975 0.893 . . . . 0.0 111.056 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.826 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 36.5 ttpt -90.66 123.65 34.45 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.192 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.18 119.57 39.74 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.477 -173.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.0 ttm180 -77.43 111.03 12.7 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.863 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.0 tttt -69.26 97.23 0.92 Allowed 'General case' 0 C--O 1.177 -2.742 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 89' ' ' ILE . 29.4 t -82.05 -155.81 0.15 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -67.45 -31.06 70.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.588 0.709 . . . . 0.0 109.092 174.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.16 -13.33 57.35 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.798 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.555 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 81.29 -125.63 6.98 Favored Glycine 1 N--CA 1.389 -4.485 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 30.3 m-85 -88.52 142.7 27.49 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.699 0.75 . . . . 0.0 110.176 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.81 82.85 Favored Glycine 0 C--N 1.315 -0.61 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.923 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.2 p90 -110.66 162.72 14.46 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.244 0.545 . . . . 0.0 110.341 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 47.3 p -116.76 150.82 37.64 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.67 135.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.863 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.536 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 9.9 p -151.94 165.75 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.954 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 113.15 -0.47 25.39 Favored Glycine 0 CA--C 1.471 -2.687 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 172.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -120.54 44.55 1.35 Allowed Glycine 1 CA--C 1.395 -7.417 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -171.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 7.8 m-20 -59.09 -13.33 6.63 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.606 -1.797 . . . . 0.0 113.04 -174.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.489 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 4.2 pt-20 -160.04 166.42 15.89 Favored Pre-proline 0 CA--C 1.455 -2.703 0 C-N-CA 117.177 -1.809 . . . . 0.0 110.631 -174.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 36.8 Cg_endo -67.61 51.62 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.818 2.345 . . . . 0.0 110.585 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.502 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 7.7 t70 -179.39 -12.88 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.674 1.19 . . . . 0.0 110.037 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.65 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 30.5 mt-10 -116.48 127.35 54.49 Favored 'General case' 0 C--O 1.276 2.465 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 167.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.472 ' CD1' HD12 ' A' ' 73' ' ' LEU . 11.6 m-85 -80.36 155.31 27.24 Favored 'General case' 0 N--CA 1.524 3.254 0 O-C-N 127.942 3.276 . . . . 0.0 111.898 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.571 HD12 ' HA3' ' A' ' 34' ' ' GLY . 4.3 mp -84.33 145.72 28.1 Favored 'General case' 0 C--O 1.177 -2.755 0 C-N-CA 117.391 -1.724 . . . . 0.0 107.929 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.7 mt-30 -142.37 149.25 39.14 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.1 mm -71.35 112.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 18.5 tptm -65.87 -35.03 79.52 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 60' ' ' THR . 37.5 t 160.69 172.97 0.01 OUTLIER 'General case' 0 C--N 1.357 0.926 0 O-C-N 125.271 1.607 . . . . 0.0 110.297 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -138.55 148.53 44.32 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.541 0.686 . . . . 0.0 111.705 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.9 119.06 28.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HA ' ' CB ' ' A' ' 53' ' ' ALA 0.26 1.1 pt? -69.44 -4.4 18.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.04 -27.13 48.72 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.196 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.08 171.11 36.82 Favored Glycine 0 N--CA 1.417 -2.62 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.754 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.54 -32.23 52.55 Favored 'Trans proline' 0 C--O 1.204 -1.179 1 C-N-CA 125.328 4.018 . . . . 0.0 113.871 -173.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -48.65 79.04 Favored 'General case' 0 C--O 1.273 2.333 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.65 -32.94 53.57 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.997 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 50' ' ' GLY . 6.0 mp -68.21 -40.59 82.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 57' ' ' LYS . 33.2 t70 -68.52 -30.02 68.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.75 6.56 87.09 Favored Glycine 0 CA--C 1.493 -1.294 0 CA-C-N 112.423 -2.171 . . . . 0.0 114.113 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 54.0 mttm -98.17 -25.2 14.98 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.6 ttm -96.24 140.63 30.65 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.259 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.54 153.0 50.29 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.771 0.795 . . . . 0.0 110.18 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.407 HG23 ' HA ' ' A' ' 45' ' ' SER . 81.6 p -67.03 114.66 5.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.918 1.287 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.26 -20.87 15.88 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 121.961 -0.462 . . . . 0.0 112.41 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.2 m-20 -60.45 136.42 58.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -87.32 125.7 41.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.345 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 17.5 mm -73.74 125.15 32.4 Favored 'Isoleucine or valine' 1 C--O 1.307 4.105 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.484 HG13 HD13 ' A' ' 73' ' ' LEU . 48.4 t -114.42 -34.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.481 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.445 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 68.6 m -150.55 153.36 35.64 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.154 -0.966 . . . . 0.0 112.231 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.447 HG13 ' HB ' ' A' ' 72' ' ' VAL . 7.3 p -131.03 127.31 60.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m120 63.25 20.14 12.09 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.647 0.203 . . . . 0.0 110.544 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 79.07 -1.02 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.95 1.7 . . . . 0.0 111.965 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.3 m -85.83 123.17 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.445 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 28.2 t -62.71 109.42 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 67' ' ' VAL . 3.6 p -120.54 18.16 6.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.569 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.607 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.7 tp -59.59 113.41 2.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.93 43.71 0.14 Allowed Glycine 0 C--N 1.37 2.471 0 O-C-N 125.355 1.659 . . . . 0.0 112.174 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.526 ' O ' HG21 ' A' ' 76' ' ' THR . 3.9 t60 -45.11 -65.94 0.47 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 75' ' ' HIS . 12.8 p -165.79 142.42 5.32 Favored 'General case' 0 C--N 1.264 -3.132 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 152.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.581 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -50.69 -31.52 16.67 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 120.119 1.327 . . . . 0.0 111.351 171.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.19 85.61 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 122.156 -0.34 . . . . 0.0 110.8 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.519 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 47.7 mm-40 -64.16 -40.99 97.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 77' ' ' HIS . 12.6 m -63.44 -45.65 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.825 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.4 t -65.55 -40.07 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.4 -39.18 89.75 Favored 'General case' 0 C--O 1.199 -1.6 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.76 177.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.634 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.3 mm -67.0 -34.63 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.652 0.739 . . . . 0.0 112.026 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -75.1 -29.39 60.58 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.446 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -76.59 -19.91 57.35 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.105 0.962 . . . . 0.0 111.105 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 75.1 m -75.25 -37.72 60.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.018 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.5 mt -78.65 135.58 60.06 Favored Pre-proline 0 N--CA 1.421 -1.923 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.057 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.5 Cg_endo -90.9 161.94 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.455 2.77 . . . . 0.0 112.926 -173.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.497 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 20.8 mm -63.45 132.51 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 121.519 0.676 . . . . 0.0 111.452 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.12 53.21 Favored Glycine 0 C--N 1.294 -1.782 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.918 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.35 -170.27 1.84 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 122.484 0.314 . . . . 0.0 110.242 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 11.1 m -151.22 157.78 43.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.826 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -145.22 125.07 6.51 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.965 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.468 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 11.3 m-20 -77.52 104.18 7.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.77 142.22 33.43 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 124.607 1.163 . . . . 0.0 110.579 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 12.0 tp10 -101.84 125.72 48.57 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 84.8 mt -115.36 152.9 31.98 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.331 1.452 . . . . 0.0 110.957 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.674 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 6.5 t -125.78 107.81 10.88 Favored 'General case' 0 C--O 1.188 -2.168 0 C-N-CA 124.202 1.001 . . . . 0.0 110.016 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 35.3 ttm180 -93.37 118.95 31.92 Favored 'General case' 0 C--N 1.254 -3.569 0 O-C-N 120.341 -1.474 . . . . 0.0 109.045 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.54 -30.49 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.04 133.0 25.84 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 C--O 1.244 0.799 0 C-N-CA 123.35 2.7 . . . . 0.0 111.63 -178.704 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 CA-C-O 121.372 0.488 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -98.28 105.88 18.08 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.609 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.9 t80 -95.79 139.79 31.51 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.748 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -148.82 14.61 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.297 0.57 . . . . 0.0 111.416 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.499 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.2 mtm180 55.11 -0.1 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.848 2.059 . . . . 0.0 115.934 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -134.13 123.49 16.84 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HB3' HG12 ' A' ' 65' ' ' VAL . 4.3 Cg_endo -60.0 -22.7 70.23 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.845 3.03 . . . . 0.0 112.83 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -77.95 -29.8 50.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -87.2 -30.18 21.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.534 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 45.4 tp -81.06 160.4 24.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.684 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.485 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 49.5 mtmt -102.84 -179.26 3.91 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.624 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 105.27 168.52 23.9 Favored Glycine 0 C--N 1.281 -2.481 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -175.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -90.57 119.79 31.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 99.2 m-85 -98.5 114.62 27.09 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-O 121.92 0.867 . . . . 0.0 109.849 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.0 mt -117.73 136.01 56.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 CA-C-N 113.87 -1.513 . . . . 0.0 110.284 -171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.493 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.9 t-80 -105.95 113.99 27.86 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.261 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 t -139.96 133.5 30.21 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-O 122.073 0.94 . . . . 0.0 111.65 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.819 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -88.03 127.25 35.39 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.151 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.91 118.57 37.09 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 43.0 ttp180 -78.47 107.75 11.35 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.4 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 72.0 tttt -63.86 97.32 0.16 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 168.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -85.06 -155.41 0.21 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.86 -39.86 90.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -84.96 -13.35 50.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.33 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.581 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 91.2 -121.96 6.53 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 39.7 m-85 -93.39 145.04 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.655 0.727 . . . . 0.0 109.85 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.66 -0.18 72.87 Favored Glycine 0 C--O 1.214 -1.131 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.861 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.7 p90 -108.28 163.52 13.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.391 0.615 . . . . 0.0 110.646 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.469 ' OG1' ' HE2' ' A' ' 44' ' ' LYS . 46.5 p -121.46 151.02 40.7 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.63 141.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.976 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.449 HG21 ' N ' ' A' ' 33' ' ' GLY . 11.5 p -149.75 167.0 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.474 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' N ' HG21 ' A' ' 32' ' ' VAL . . . 127.19 -64.45 0.59 Allowed Glycine 0 CA--C 1.474 -2.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.402 173.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.732 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -71.53 60.52 1.2 Allowed Glycine 1 CA--C 1.41 -6.474 0 C-N-CA 126.951 2.215 . . . . 0.0 116.236 -169.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -22.0 66.55 Favored 'General case' 0 C--N 1.245 -3.97 0 O-C-N 124.669 0.864 . . . . 0.0 109.739 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 10.0 pt-20 -154.27 165.33 18.22 Favored Pre-proline 0 CA--C 1.456 -2.649 0 C-N-CA 116.1 -2.24 . . . . 0.0 111.21 -171.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -68.1 55.65 0.76 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.829 2.352 . . . . 0.0 109.796 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -178.05 -20.71 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.703 -1.589 . . . . 0.0 109.886 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.732 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 13.4 mm-40 -114.79 128.46 56.31 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.466 ' CZ ' HD23 ' A' ' 11' ' ' LEU 0.25 7.5 m-30 -79.41 157.23 27.62 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 128.78 3.8 . . . . 0.0 111.773 -179.185 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.509 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 6.5 mp -88.63 149.51 23.5 Favored 'General case' 0 C--O 1.189 -2.081 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 9.7 mt-30 -145.31 153.32 41.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 62' ' ' ASP . 21.0 mm -69.91 110.51 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.469 ' HE2' ' OG1' ' A' ' 30' ' ' THR . 3.8 tmmm? -65.01 -33.88 77.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 60' ' ' THR . 37.1 t 162.03 172.64 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 O-C-N 124.975 1.422 . . . . 0.0 109.775 173.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -136.24 144.55 44.9 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 121.785 0.802 . . . . 0.0 109.947 -174.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.38 126.3 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mp -68.92 -4.2 15.65 Favored 'General case' 1 N--CA 1.377 -4.112 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.307 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -97.55 -21.4 17.11 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.595 177.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.19 167.73 34.59 Favored Glycine 0 N--CA 1.404 -3.447 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.494 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.602 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.6 Cg_endo -53.65 -31.23 59.27 Favored 'Trans proline' 0 C--O 1.187 -2.046 0 C-N-CA 124.731 3.62 . . . . 0.0 113.037 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.66 76.37 Favored 'General case' 0 C--O 1.264 1.85 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.12 -34.32 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.098 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.23 -38.22 69.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.352 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -73.07 -18.24 61.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 122.273 1.035 . . . . 0.0 108.504 175.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.01 32.59 82.7 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 113.251 -1.795 . . . . 0.0 113.836 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -124.25 -0.72 8.25 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.519 ' HB3' HD22 ' A' ' 46' ' ' LEU . 28.1 mtt -112.71 141.87 45.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.847 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -135.9 149.89 49.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 45' ' ' SER . 32.5 p -63.17 114.64 3.88 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.763 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.82 -14.34 19.7 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.475 176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.1 m-20 -61.73 132.33 52.82 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -81.8 129.47 37.44 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.686 0 CA-C-N 118.607 0.64 . . . . 0.0 112.32 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.509 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 38.5 mm -79.53 127.58 39.07 Favored 'Isoleucine or valine' 1 C--O 1.322 4.918 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 173.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG13 HD11 ' A' ' 73' ' ' LEU . 40.2 t -115.86 -47.44 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 O-C-N 127.085 2.741 . . . . 0.0 111.873 -176.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -140.88 165.17 28.26 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 117.995 -1.482 . . . . 0.0 113.767 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 72' ' ' VAL . 40.0 t -138.07 120.66 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 C-N-CA 124.855 1.262 . . . . 0.0 108.175 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.9 m120 67.21 -79.34 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.468 1.105 . . . . 0.0 110.154 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -158.15 24.88 0.25 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.336 1.065 . . . . 0.0 109.655 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.8 m -117.19 123.84 47.65 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 t -68.07 108.01 2.94 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 80' ' ' VAL . 1.7 p -111.99 16.82 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 122.13 0.967 . . . . 0.0 108.606 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.609 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.7 tp -60.89 112.84 2.21 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.23 45.51 0.13 Allowed Glycine 0 C--N 1.378 2.874 0 O-C-N 125.754 1.909 . . . . 0.0 111.664 -170.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.595 ' O ' HG23 ' A' ' 76' ' ' THR . 2.5 t60 -48.41 -66.98 0.31 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 75' ' ' HIS . 8.6 p -166.62 142.64 4.6 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 151.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.5 -31.61 15.92 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 120.288 1.404 . . . . 0.0 111.516 173.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -48.31 82.24 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 122.116 -0.365 . . . . 0.0 110.723 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 11.9 mm-40 -61.81 -44.08 97.57 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 122.938 0.495 . . . . 0.0 112.091 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' HIS . 9.7 m -64.26 -44.31 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.63 -42.77 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -67.07 -29.15 68.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.383 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 86' ' ' SER . 2.1 mm -68.94 -40.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 123.117 0.567 . . . . 0.0 111.748 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.33 -33.96 67.71 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -73.27 -19.49 61.05 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.368 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 30.1 t -77.44 -43.17 33.4 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 mt -69.06 133.79 89.77 Favored Pre-proline 0 N--CA 1.423 -1.81 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.767 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.8 Cg_endo -89.56 161.84 5.34 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.163 2.576 . . . . 0.0 113.197 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.501 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.6 mm -60.83 132.49 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.833 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 12.19 55.96 Favored Glycine 0 C--N 1.288 -2.123 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.834 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.73 -172.13 2.1 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 19.8 m -151.17 156.87 41.86 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.77 -0.581 . . . . 0.0 109.614 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -143.43 125.49 11.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.672 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.597 -175.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 17.3 m-20 -78.42 108.26 11.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.6 mt -108.45 136.03 48.75 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.443 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -91.58 124.65 35.91 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 10.7 mt -107.56 160.06 15.96 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.624 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 14.7 t -131.65 108.0 9.2 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 123.726 0.81 . . . . 0.0 108.993 174.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -96.89 147.12 24.29 Favored 'General case' 0 C--N 1.247 -3.853 0 O-C-N 120.706 -1.246 . . . . 0.0 109.904 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.04 -17.49 4.58 Favored Glycine 0 CA--C 1.482 -1.988 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.91 130.51 28.63 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 C--O 1.243 0.745 0 C-N-CA 123.551 2.834 . . . . 0.0 112.546 -174.032 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 CA--C 1.545 1.039 0 CA-C-O 121.071 0.363 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -73.79 104.25 4.62 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.587 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.4 t80 -105.46 128.61 53.64 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.277 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -144.24 20.35 1.74 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.105 0.955 . . . . 0.0 109.835 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 15.2 mtm180 57.48 -14.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 127.479 2.312 . . . . 0.0 116.374 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.8 t-20 -112.59 117.03 47.55 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.728 -0.607 . . . . 0.0 110.97 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 6.9 Cg_endo -53.22 -25.51 30.36 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.232 3.288 . . . . 0.0 113.37 174.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -71.61 -27.43 63.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -91.17 -21.24 21.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 24.5 mt -78.04 175.66 9.89 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.858 0.837 . . . . 0.0 110.641 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -105.11 -167.59 1.36 Allowed 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.72 175.01 45.76 Favored Glycine 0 C--N 1.284 -2.334 0 C-N-CA 119.315 -1.422 . . . . 0.0 112.155 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 4.0 tmmm? -113.62 148.56 36.03 Favored 'General case' 0 C--O 1.194 -1.849 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.2 m-85 -123.6 117.76 25.78 Favored 'General case' 0 CA--C 1.463 -2.387 0 CA-C-O 121.784 0.802 . . . . 0.0 110.807 -165.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.52 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 2.2 mp -111.75 138.1 41.8 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.786 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -102.67 118.67 37.36 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 7.9 t -129.26 157.93 40.49 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.345 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.824 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -129.46 122.05 28.53 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 58' ' ' MET . 0.3 OUTLIER -107.69 117.42 34.05 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.085 -176.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 19.2 tpp85 -72.38 106.69 4.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.6 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.573 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 67.9 tttt -66.79 96.97 0.44 Allowed 'General case' 0 C--O 1.171 -3.026 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 166.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.457 ' O ' HG21 ' A' ' 89' ' ' ILE . 21.4 t -85.01 -155.43 0.21 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -56.53 -41.03 76.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.931 0.332 . . . . 0.0 111.371 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -86.09 -20.65 28.42 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.795 0.807 . . . . 0.0 109.82 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 103.52 -122.35 7.41 Favored Glycine 1 N--CA 1.388 -4.556 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 46.0 m-85 -88.09 142.57 27.67 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 117.214 0.507 . . . . 0.0 110.328 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.47 9.34 74.23 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.139 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.418 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 6.3 p90 -122.11 162.98 20.28 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.04 0.447 . . . . 0.0 109.939 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.4 p -116.85 155.19 29.44 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 t -134.48 140.21 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.103 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.8 p -153.15 157.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.03 171.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 116.3 0.11 20.62 Favored Glycine 1 CA--C 1.441 -4.537 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 169.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.725 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -120.73 46.01 1.17 Allowed Glycine 1 CA--C 1.395 -7.438 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.57 -25.3 64.45 Favored 'General case' 0 C--N 1.264 -3.127 0 CA-C-N 113.228 -1.486 . . . . 0.0 111.498 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.476 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt-20 -155.98 167.61 13.95 Favored Pre-proline 0 CA--C 1.463 -2.388 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.843 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -65.28 55.31 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.933 2.422 . . . . 0.0 111.084 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 14.8 t70 178.37 -12.91 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 -175.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.725 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 62.7 mt-10 -117.83 123.94 47.15 Favored 'General case' 0 C--O 1.265 1.904 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.301 7.2 m-30 -79.22 156.12 28.29 Favored 'General case' 1 N--CA 1.554 4.755 0 O-C-N 127.687 3.117 . . . . 0.0 112.329 -175.233 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.571 HD12 ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -86.88 142.46 28.02 Favored 'General case' 0 CA--C 1.46 -2.498 0 C-N-CA 115.948 -2.301 . . . . 0.0 107.748 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.2 mt-30 -139.88 151.2 45.45 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ASP . 21.5 mm -70.82 112.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.62 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 40.2 ttmt -59.66 -41.69 91.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.4 t 163.56 173.6 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 O-C-N 125.224 1.577 . . . . 0.0 109.801 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.68 152.38 45.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.95 0.881 . . . . 0.0 113.297 -172.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 49' ' ' ASP . 21.1 t -87.58 129.55 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.028 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.26 -4.2 16.9 Favored 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 112.509 -2.132 . . . . 0.0 112.325 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.404 ' H ' HG12 ' A' ' 47' ' ' VAL . 10.3 t70 -99.32 -20.11 16.7 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.097 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.424 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -88.3 155.9 26.57 Favored Glycine 1 N--CA 1.393 -4.182 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.72 -171.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.29 -26.66 27.92 Favored 'Trans proline' 0 C--O 1.198 -1.485 0 C-N-CA 125.009 3.806 . . . . 0.0 113.156 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.72 85.0 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.114 0.483 . . . . 0.0 111.728 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.17 -36.65 54.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.404 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 50' ' ' GLY . 8.3 mp -71.56 -36.93 71.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.052 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.51 -15.51 60.39 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.26 41.07 99.73 Favored Glycine 0 CA--C 1.49 -1.507 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.913 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -129.05 -23.88 2.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.281 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -94.95 142.17 27.8 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.172 177.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.01 151.49 52.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -59.0 114.7 2.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.007 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.423 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 112.69 -11.83 25.38 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.238 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 9.7 m-20 -59.94 132.85 55.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 117.645 0.723 . . . . 0.0 109.56 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -86.94 119.3 34.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.2 mm -70.9 123.02 24.06 Favored 'Isoleucine or valine' 1 C--O 1.316 4.56 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.467 HG12 HD11 ' A' ' 73' ' ' LEU . 40.0 t -114.42 -33.83 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-N 111.36 -2.654 . . . . 0.0 110.258 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -150.0 162.05 41.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG13 ' HB ' ' A' ' 72' ' ' VAL . 6.6 p -145.31 133.43 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 56.56 31.51 19.19 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.915 0.325 . . . . 0.0 111.828 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.66 15.9 10.25 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.592 1.157 . . . . 0.0 112.861 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -108.38 129.71 55.24 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.462 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 20.3 t -68.72 112.72 5.63 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' HB ' HG13 ' A' ' 67' ' ' VAL . 3.2 p -117.64 17.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.62 -175.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.587 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 32.1 tp -58.89 113.3 2.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 45.12 0.18 Allowed Glycine 0 N--CA 1.499 2.879 0 O-C-N 125.381 1.676 . . . . 0.0 111.801 -171.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.604 ' O ' HG23 ' A' ' 76' ' ' THR . 3.9 t60 -47.78 -66.48 0.4 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.3 p -167.1 143.19 4.31 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 151.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.563 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.33 -31.77 15.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 119.987 1.267 . . . . 0.0 110.536 171.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.22 77.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.941 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 71.0 mm-40 -64.67 -40.42 95.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 77' ' ' HIS . 13.5 m -65.56 -45.7 91.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.053 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 77' ' ' HIS . 88.0 t -65.69 -37.46 80.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.2 tmtm? -58.26 -45.61 87.5 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.627 175.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.68 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.05 -36.8 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.386 0.613 . . . . 0.0 112.387 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -74.73 -31.36 61.81 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -69.31 -32.12 71.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.163 0.985 . . . . 0.0 110.768 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.2 m -69.58 -37.99 77.17 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.851 1.26 . . . . 0.0 110.122 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 21.8 mt -77.63 133.12 67.26 Favored Pre-proline 0 N--CA 1.411 -2.417 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.182 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.1 Cg_endo -88.66 162.73 6.4 Favored 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 123.611 2.874 . . . . 0.0 112.864 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.92 135.0 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 121.212 0.529 . . . . 0.0 110.534 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.08 58.83 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.57 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -100.94 179.61 4.34 Favored 'General case' 0 C--O 1.187 -2.184 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 6.2 m -140.66 163.71 32.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.824 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -150.39 125.52 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.337 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 18' ' ' THR . 4.3 m-20 -82.72 106.46 14.58 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.047 0.927 . . . . 0.0 109.548 174.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.4 mt -108.29 159.06 16.93 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 126.52 1.928 . . . . 0.0 108.852 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -116.89 123.64 47.5 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 81.2 mt -106.87 160.86 15.19 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.825 1.25 . . . . 0.0 109.793 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.0 t -135.36 111.0 9.23 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.422 1.106 . . . . 0.0 110.796 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.471 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 19.4 tpp85 -89.99 112.99 24.57 Favored 'General case' 0 C--N 1.266 -3.063 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.4 -26.57 0.31 Allowed Glycine 0 C--N 1.292 -1.879 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.912 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.61 129.69 35.68 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.665 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo . . . . . 0 C--O 1.241 0.632 0 C-N-CA 123.927 3.085 . . . . 0.0 113.785 -173.919 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo . . . . . 0 N--CA 1.439 -1.734 0 CA-C-O 121.005 0.336 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.34 105.12 2.44 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.555 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 5.1 t80 -107.56 135.36 49.14 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -144.17 17.98 1.74 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.111 0.958 . . . . 0.0 110.316 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.482 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 21.4 mtt180 59.4 -27.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.408 2.683 . . . . 0.0 116.57 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -104.65 123.38 40.42 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.84 -29.73 64.62 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 C-N-CA 123.737 2.958 . . . . 0.0 112.246 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.75 -26.17 63.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -92.2 -24.32 19.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 HD11 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -86.65 153.74 21.53 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.497 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.491 ' N ' HD11 ' A' ' 11' ' ' LEU . 46.6 mtmt -110.2 133.47 53.2 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 122.066 0.936 . . . . 0.0 110.697 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.538 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 156.83 170.6 22.02 Favored Glycine 1 C--N 1.247 -4.378 0 CA-C-N 113.048 -1.887 . . . . 0.0 108.999 -173.445 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 37.9 tptt -89.54 117.55 28.52 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.877 0.838 . . . . 0.0 109.825 174.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.3 m-85 -101.98 113.98 27.69 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.93 0.872 . . . . 0.0 109.77 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.6 mt -118.74 131.22 72.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.638 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.67 108.29 19.47 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -174.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -133.77 145.62 49.97 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 122.09 0.947 . . . . 0.0 111.271 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.846 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -87.96 130.84 34.82 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.149 177.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.66 117.38 33.77 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 40.8 ttt180 -77.12 111.94 13.25 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.087 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.57 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 74.6 tttt -66.96 96.83 0.45 Allowed 'General case' 0 C--O 1.187 -2.235 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -94.62 -154.26 0.41 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 124.322 1.049 . . . . 0.0 109.107 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -47.84 -41.97 25.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.894 1.278 . . . . 0.0 111.716 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.65 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.5 mmp_? -105.53 10.41 33.14 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.827 -0.546 . . . . 0.0 111.717 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 82.34 -125.3 6.88 Favored Glycine 1 N--CA 1.384 -4.769 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.0 m-85 -86.02 145.98 26.85 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.765 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.83 -2.93 86.2 Favored Glycine 0 CA--C 1.499 -0.945 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.336 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.437 ' HB2' HG22 ' A' ' 43' ' ' ILE . 20.9 p90 -109.93 162.9 14.06 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.893 0.854 . . . . 0.0 111.488 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.2 p -118.43 145.96 44.82 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.67 146.81 30.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.896 -173.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -144.38 165.92 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.873 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.371 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 114.29 -141.39 16.96 Favored Glycine 1 N--CA 1.394 -4.152 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 51.83 33.24 35.1 Favored Glycine 0 CA--C 1.471 -2.689 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.12 -27.95 67.75 Favored 'General case' 0 CA--C 1.455 -2.697 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -170.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 6.6 pt-20 -161.64 166.76 14.13 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.431 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 23.2 Cg_endo -66.63 58.88 0.52 Allowed 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.605 2.204 . . . . 0.0 109.353 169.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 21.7 t70 173.44 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.716 1.606 . . . . 0.0 110.661 -171.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 22.6 mt-10 -124.28 127.98 48.46 Favored 'General case' 0 C--O 1.269 2.127 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 73' ' ' LEU . 8.6 m-30 -77.1 158.49 30.44 Favored 'General case' 0 N--CA 1.518 2.934 0 O-C-N 128.959 3.912 . . . . 0.0 113.258 -167.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD22 HG22 ' A' ' 80' ' ' VAL . 7.1 mp -89.2 144.69 25.92 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 172.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.0 mt-30 -143.97 151.76 40.18 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 29' ' ' PHE . 22.2 mm -69.69 112.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.53 -39.18 72.94 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 60' ' ' THR . 43.0 t 161.23 173.33 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.638 1.836 . . . . 0.0 108.666 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.86 148.18 48.53 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-O 121.644 0.735 . . . . 0.0 112.209 -175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 49' ' ' ASP . 43.3 t -83.94 121.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.214 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 mp -63.44 -3.48 2.1 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.583 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 47' ' ' VAL . 12.3 t70 -90.94 -30.7 16.71 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 124.594 1.158 . . . . 0.0 108.889 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.419 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -94.64 174.38 33.23 Favored Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 115.354 -168.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -52.35 -34.73 61.86 Favored 'Trans proline' 0 C--O 1.2 -1.389 1 C-N-CA 125.453 4.102 . . . . 0.0 113.815 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.1 81.1 Favored 'General case' 0 C--O 1.264 1.843 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.78 -37.77 48.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.585 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -69.49 -36.64 76.72 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.198 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.71 -18.52 61.52 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.648 1.213 . . . . 0.0 108.112 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.23 35.23 91.35 Favored Glycine 0 CA--C 1.491 -1.449 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.227 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -115.69 -48.2 2.78 Favored 'General case' 0 N--CA 1.402 -2.867 0 C-N-CA 123.099 0.56 . . . . 0.0 112.479 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.57 151.37 19.38 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -149.68 147.47 28.12 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-O 122.01 0.909 . . . . 0.0 111.673 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 45' ' ' SER . 81.9 p -52.69 105.28 0.11 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.168 1.387 . . . . 0.0 112.346 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.06 -12.89 16.98 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-O 118.629 -1.095 . . . . 0.0 113.187 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' GLN . 2.8 p30 -64.66 143.33 58.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.625 -1.23 . . . . 0.0 107.846 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -90.85 117.42 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.0 mm -69.87 125.08 27.27 Favored 'Isoleucine or valine' 1 C--O 1.327 5.163 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG12 HD11 ' A' ' 73' ' ' LEU . 46.3 t -115.77 -37.33 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 111.136 -2.756 . . . . 0.0 112.197 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.9 m -149.89 157.28 43.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.381 -1.45 . . . . 0.0 112.617 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG21 HG12 ' A' ' 72' ' ' VAL . 77.0 t -134.37 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m120 57.89 31.52 20.67 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.808 0.692 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 72.63 1.74 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.621 1.968 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.8 m -89.65 122.2 32.55 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.2 t -65.5 108.89 2.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.172 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.42 HG12 HG21 ' A' ' 67' ' ' VAL . 1.4 p -114.68 14.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.605 -175.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.555 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.6 tp -58.67 113.72 2.16 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.04 46.39 0.1 Allowed Glycine 0 C--N 1.378 2.864 0 O-C-N 125.857 1.973 . . . . 0.0 112.228 -170.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 76' ' ' THR . 2.8 t60 -48.03 -67.35 0.28 Allowed 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' HIS . 14.2 p -165.98 143.22 5.4 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 152.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.633 ' O ' HG21 ' A' ' 80' ' ' VAL . 1.4 t-80 -53.43 -31.26 44.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 120.664 1.574 . . . . 0.0 111.463 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.23 90.58 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.99 -0.444 . . . . 0.0 110.516 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.483 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 23.2 mm-40 -64.19 -44.0 93.34 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.633 HG21 ' O ' ' A' ' 77' ' ' HIS . 11.2 m -62.19 -41.81 92.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.242 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.07 -38.83 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -63.05 -33.54 75.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.291 176.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 86' ' ' SER . 32.9 mt -67.63 -42.21 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.491 0.662 . . . . 0.0 111.104 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.56 -30.72 67.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.187 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -71.24 -33.16 69.58 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.18 0.992 . . . . 0.0 110.209 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 31.0 t -65.26 -49.07 70.99 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.139 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 12.0 mt -64.88 133.75 95.84 Favored Pre-proline 0 N--CA 1.426 -1.674 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.537 175.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' HB1' ' A' ' 91' ' ' ALA . 20.0 Cg_endo -90.75 162.33 4.15 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 123.563 2.842 . . . . 0.0 113.119 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.4 mm -62.66 134.76 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-O 121.058 0.456 . . . . 0.0 110.28 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.74 56.68 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -102.0 -169.14 1.64 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -176.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 27.1 m -151.34 163.85 38.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.846 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -148.41 124.71 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.085 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.503 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.66 104.99 13.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.2 mt -108.27 152.33 24.75 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 125.28 1.432 . . . . 0.0 111.94 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -104.17 119.48 39.04 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.5 mp -111.37 164.49 12.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.305 1.442 . . . . 0.0 108.559 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.538 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 38.9 t -145.23 111.69 5.74 Favored 'General case' 0 C--O 1.191 -1.991 0 CA-C-O 122.352 1.072 . . . . 0.0 112.931 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -99.4 120.06 38.99 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 120.957 -1.089 . . . . 0.0 111.202 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.4 -33.43 0.09 OUTLIER Glycine 0 CA--C 1.471 -2.677 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -96.1 141.83 23.71 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 CA--C 1.503 -1.066 0 C-N-CA 122.834 2.356 . . . . 0.0 110.171 179.292 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.724 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.95 -50.4 10.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.19 0.519 . . . . 0.0 110.495 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.0 mtt -110.15 57.51 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.315 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 152.53 -136.15 5.26 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.282 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? 47.94 71.57 1.55 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.934 1.294 . . . . 0.0 113.422 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.81 -164.49 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.606 2.204 . . . . 0.0 109.261 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -83.24 105.45 14.21 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.582 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 3.1 t80 -103.03 124.61 48.85 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -130.78 11.18 5.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.926 0.869 . . . . 0.0 111.577 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.582 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 40.2 mtt180 55.21 6.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.774 1.63 . . . . 0.0 114.955 173.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -133.91 121.76 16.05 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -59.27 -27.16 84.26 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 123.611 2.874 . . . . 0.0 112.307 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 m -80.02 -24.4 40.82 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.521 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.53 -28.03 15.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 44.2 tp -70.24 155.16 41.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.053 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 24.4 mtmm -90.02 -175.71 4.66 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.561 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 109.02 178.16 21.49 Favored Glycine 0 C--N 1.278 -2.662 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.729 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 1.6 tmpt? -91.07 134.19 34.71 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 91.8 m-85 -122.84 128.26 50.14 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 119.061 0.846 . . . . 0.0 109.867 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.548 HG13 ' HE3' ' A' ' 14' ' ' LYS . 73.8 mt -137.73 127.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -104.49 104.73 14.63 Favored 'General case' 0 N--CA 1.396 -3.144 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -124.07 143.86 50.2 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.799 0.809 . . . . 0.0 110.853 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.801 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.4 ttmp? -88.35 126.38 35.17 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.14 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.18 117.33 33.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 42.3 ttt-85 -77.07 113.89 15.28 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.405 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 70.9 tttt -69.64 97.52 1.06 Allowed 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.41 ' O ' HG21 ' A' ' 89' ' ' ILE . 32.2 t -83.59 -155.21 0.17 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.675 1.19 . . . . 0.0 108.514 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -59.4 -40.93 88.21 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.501 0.667 . . . . 0.0 109.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.02 -20.85 34.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.804 0.812 . . . . 0.0 109.521 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 98.18 -120.53 6.83 Favored Glycine 1 N--CA 1.378 -5.232 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.7 m-85 -91.57 141.72 28.42 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.565 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.21 1.27 87.59 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.107 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -110.81 163.34 13.88 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.817 0.818 . . . . 0.0 112.161 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 63.0 p -123.2 152.87 40.81 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -127.11 154.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.123 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.83 150.63 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.071 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.75 -138.74 13.89 Favored Glycine 1 N--CA 1.393 -4.175 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.61 28.9 31.03 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.1 -29.39 68.3 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt-20 -154.49 163.09 25.4 Favored Pre-proline 0 CA--C 1.456 -2.64 0 C-N-CA 118.025 -1.47 . . . . 0.0 109.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.0 Cg_endo -68.3 52.83 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.215 0 C-N-CA 123.076 2.517 . . . . 0.0 109.896 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 171.19 3.28 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.368 -168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.449 ' HG3' ' CG ' ' A' ' 36' ' ' GLU . 25.7 mt-10 -132.88 130.21 39.41 Favored 'General case' 0 C--O 1.275 2.44 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 163.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.646 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.256 5.2 m-30 -76.8 158.8 30.61 Favored 'General case' 0 N--CA 1.525 3.305 0 O-C-N 128.898 3.874 . . . . 0.0 114.008 -167.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 4.8 mp -93.09 141.69 28.12 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.21 151.44 47.69 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.1 mm -68.37 109.93 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 41.4 ttmt -58.36 -38.1 76.57 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.408 ' HA ' HG23 ' A' ' 60' ' ' THR . 40.9 t 161.77 173.13 0.01 OUTLIER 'General case' 0 C--N 1.362 1.148 0 O-C-N 125.659 1.849 . . . . 0.0 109.825 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 pp -141.16 149.2 41.18 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.784 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.414 HG13 ' H ' ' A' ' 49' ' ' ASP . 16.9 t -80.1 127.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.81 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.72 -3.69 1.66 Allowed 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 127.423 2.289 . . . . 0.0 113.567 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.414 ' H ' HG13 ' A' ' 47' ' ' VAL . 18.5 t70 -102.61 -25.56 13.53 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.492 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.42 ' O ' HD11 ' A' ' 54' ' ' LEU . . . -85.69 162.93 36.41 Favored Glycine 0 N--CA 1.399 -3.822 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.908 -171.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.12 -33.51 35.57 Favored 'Trans proline' 0 C--O 1.188 -2.003 0 C-N-CA 125.006 3.804 . . . . 0.0 113.486 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.7 78.98 Favored 'General case' 0 C--O 1.28 2.702 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.33 -34.54 55.27 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.389 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.42 HD11 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -68.7 -42.5 77.67 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.977 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.704 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 34.7 t70 -64.16 -38.73 92.12 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.903 1.335 . . . . 0.0 107.483 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 -15.75 44.4 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 112.522 -2.126 . . . . 0.0 114.098 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.704 ' HB2' ' OD2' ' A' ' 55' ' ' ASP . 45.8 mtmt -79.14 -17.25 55.37 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.6 ttm -106.93 135.07 49.11 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.111 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.26 164.57 27.78 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.34 0.591 . . . . 0.0 109.903 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 45' ' ' SER . 77.7 p -63.08 118.26 7.62 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.354 1.062 . . . . 0.0 110.083 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 104.67 -5.76 44.0 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.125 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.638 ' OD2' ' HB2' ' A' ' 99' ' ' ARG . 3.0 m-20 -63.19 127.27 30.48 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -77.46 114.93 18.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 175.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 mm -67.8 122.11 18.33 Favored 'Isoleucine or valine' 1 C--O 1.331 5.369 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 73' ' ' LEU . 61.9 t -114.11 -38.4 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 110.759 -2.928 . . . . 0.0 110.73 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.1 m -151.27 160.57 43.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.163 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.402 HG11 ' HB ' ' A' ' 72' ' ' VAL . 3.6 p -140.59 127.92 22.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.44 31.98 18.01 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 t70 71.31 1.8 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.179 1.392 . . . . 0.0 111.956 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.2 m -88.84 123.92 33.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.58 104.76 1.67 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.675 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.402 ' HB ' HG11 ' A' ' 67' ' ' VAL . 3.2 p -113.76 17.14 7.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.646 HD11 ' CE1' ' A' ' 40' ' ' PHE . 28.5 tp -59.69 112.95 2.0 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 29.72 45.85 0.09 OUTLIER Glycine 0 N--CA 1.499 2.859 0 O-C-N 125.269 1.606 . . . . 0.0 112.917 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.506 ' O ' HG21 ' A' ' 76' ' ' THR . 5.0 t60 -47.98 -68.39 0.19 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.599 ' OG1' ' HG2' ' A' ' 79' ' ' GLN . 22.1 p -166.16 143.98 5.48 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 151.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.609 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.61 -31.7 26.02 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 119.948 1.249 . . . . 0.0 110.519 172.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.01 83.12 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 121.971 -0.456 . . . . 0.0 110.72 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.599 ' HG2' ' OG1' ' A' ' 76' ' ' THR . 55.3 mm-40 -64.91 -43.2 93.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 77' ' ' HIS . 15.8 m -60.16 -43.13 92.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.115 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 71.2 t -64.73 -41.98 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.666 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -57.24 -41.93 80.5 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.518 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.666 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 34.1 mt -67.18 -36.15 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 122.038 0.923 . . . . 0.0 111.686 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.87 -25.84 61.24 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.354 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 25.8 mt-30 -76.32 -24.33 54.31 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 67.6 m -73.75 -28.61 61.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.957 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.7 mt -92.78 133.84 28.57 Favored Pre-proline 0 N--CA 1.411 -2.407 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.556 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 16.3 Cg_endo -92.38 162.13 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.844 3.029 . . . . 0.0 113.393 -174.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.499 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.0 mm -62.72 131.86 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 CA-C-O 121.302 0.573 . . . . 0.0 111.072 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.64 12.17 51.45 Favored Glycine 0 C--N 1.294 -1.79 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.806 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.05 -171.24 2.01 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 14.8 m -151.27 157.48 42.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.801 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.4 125.54 6.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 C-N-CA 118.393 -1.323 . . . . 0.0 112.972 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.7 107.38 11.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.1 mt -107.75 144.53 34.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.592 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -97.49 115.75 28.39 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 75.0 mt -113.07 123.76 51.02 Favored 'General case' 0 C--O 1.25 1.119 0 C-N-CA 124.82 1.248 . . . . 0.0 110.55 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -101.68 122.11 43.28 Favored 'General case' 0 C--O 1.154 -3.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.638 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 43.8 ttp180 -116.97 144.07 44.99 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 120.072 -1.642 . . . . 0.0 110.713 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.42 -19.27 3.4 Favored Glycine 0 C--N 1.287 -2.151 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -90.66 132.47 34.91 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.97 147.19 95.67 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 123.265 2.643 . . . . 0.0 112.396 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 mt -53.11 127.03 45.77 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.692 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.56 -42.79 3.29 Favored 'Trans proline' 0 CA--C 1.485 -1.94 0 C-N-CA 123.497 2.798 . . . . 0.0 110.444 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.56 141.04 39.27 Favored 'General case' 0 N--CA 1.39 -3.429 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -127.36 85.82 60.06 Favored Pre-proline 0 N--CA 1.393 -3.275 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.335 -168.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.441 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 89.0 Cg_endo -92.99 -54.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.265 1.977 . . . . 0.0 112.632 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.441 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 36.7 t70 -85.26 -5.9 59.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.973 0.892 . . . . 0.0 110.078 -177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.51 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 6.5 t70 -97.01 110.68 55.02 Favored Pre-proline 0 CA--C 1.469 -2.144 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.529 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 65.7 Cg_endo -75.31 -38.64 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.554 2.169 . . . . 0.0 111.008 -174.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.563 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 17.9 t30 -54.75 -7.62 0.18 Allowed 'General case' 0 C--N 1.264 -3.109 1 C-N-CA 133.146 4.578 . . . . 0.0 114.737 -167.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 110' ' ' PRO . 41.3 p -92.79 -29.18 16.13 Favored 'General case' 0 N--CA 1.397 -3.116 0 CA-C-O 121.274 0.559 . . . . 0.0 112.094 -171.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 p -152.41 -164.15 1.89 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.2 -171.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.08 157.02 0.93 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 110.634 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.326 12.2 p 53.35 66.73 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 123.448 1.594 . . . . 0.0 111.725 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 2.6 t -120.59 -176.65 3.28 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.38 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.7 m -56.38 145.6 26.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.29 1.436 . . . . 0.0 109.06 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.0 9.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 123.02 1.391 . . . . 0.0 110.683 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.18 5.65 35.08 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.049 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.71 90.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 CA-C-N 112.988 -1.914 . . . . 0.0 106.823 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.0 mt -121.76 133.78 54.92 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.52 141.42 33.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -58.8 -22.04 57.56 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.148 0.979 . . . . 0.0 111.723 177.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.85 135.37 48.81 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 C--O 1.261 1.665 0 C-N-CA 123.774 2.982 . . . . 0.0 112.834 179.568 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 1' ' ' LYS . . . . . . . . 0 CA--C 1.489 -1.579 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -152.4 23.29 0.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.483 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 50.8 ttm -95.38 -46.54 6.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -98.9 -71.25 1.0 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' -3' ' ' GLY . 31.9 mmmt 50.1 68.42 3.46 Favored Pre-proline 0 C--O 1.242 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 112.143 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -96.7 -168.83 0.13 Allowed 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 123.035 2.49 . . . . 0.0 111.25 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -83.88 104.76 14.23 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -116.67 124.96 51.01 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 t -134.42 19.58 3.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.48 0.657 . . . . 0.0 110.616 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.509 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 30.8 mtm180 54.32 5.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.431 1.892 . . . . 0.0 115.167 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 9' ' ' SER . 23.8 t-20 -133.35 123.77 17.84 Favored Pre-proline 0 C--N 1.298 -1.649 0 CA-C-O 120.963 0.411 . . . . 0.0 111.136 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' HD3' ' SG ' ' A' ' 71' ' ' CYS . 14.8 Cg_endo -64.13 -12.59 33.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.887 3.725 . . . . 0.0 114.425 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 33.2 t -90.67 -36.75 14.18 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -74.39 -39.07 62.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.569 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.477 HD23 ' CZ ' ' A' ' 40' ' ' PHE . 52.5 tp -73.03 158.77 34.77 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 61.3 mttm -119.31 -174.26 2.68 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.01 -131.55 7.29 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.263 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 3.2 tmpt? -140.53 127.96 21.33 Favored 'General case' 0 C--N 1.257 -3.432 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 98' ' ' CYS . 98.4 m-85 -122.63 123.31 40.87 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 118.666 0.666 . . . . 0.0 110.198 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.64 HD12 ' CE ' ' A' ' 14' ' ' LYS . 70.0 mt -132.05 131.66 61.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.899 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 94' ' ' ASP . 3.7 t60 -103.29 113.31 26.7 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -138.67 142.5 39.01 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.748 0.785 . . . . 0.0 110.55 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.826 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -87.58 133.44 33.8 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.053 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -108.47 117.57 34.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 21.2 ttt180 -77.43 110.54 12.28 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 66.2 tttt -65.76 96.78 0.3 Allowed 'General case' 0 C--O 1.19 -2.059 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 170.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -90.0 -154.79 0.34 Allowed 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.674 1.19 . . . . 0.0 108.927 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -57.06 -38.76 73.72 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.782 0.833 . . . . 0.0 110.495 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.424 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 mmp_? -90.45 -14.85 32.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 109.785 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.581 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 93.7 -115.47 4.97 Favored Glycine 1 N--CA 1.395 -4.058 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 38.6 m-85 -99.88 138.59 36.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 117.907 0.853 . . . . 0.0 109.095 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.08 80.73 Favored Glycine 0 C--O 1.207 -1.591 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.892 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -106.49 163.35 12.94 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.438 0.637 . . . . 0.0 111.162 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 73.6 p -125.96 146.12 50.0 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 m -123.03 148.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.933 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.96 154.59 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.689 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.95 -138.3 14.19 Favored Glycine 1 N--CA 1.386 -4.674 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.84 32.18 25.55 Favored Glycine 0 CA--C 1.47 -2.765 0 C-N-CA 123.559 0.6 . . . . 0.0 112.242 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -35.74 81.95 Favored 'General case' 0 CA--C 1.451 -2.855 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.17 165.47 18.51 Favored Pre-proline 0 CA--C 1.462 -2.441 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.293 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.3 Cg_endo -67.27 58.96 0.66 Allowed 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.766 2.311 . . . . 0.0 109.349 170.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 37.2 t70 174.4 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.393 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.1 mt-10 -128.91 127.42 41.74 Favored 'General case' 0 C--O 1.279 2.631 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.595 ' CE1' HD11 ' A' ' 73' ' ' LEU . 7.0 m-30 -77.22 158.82 30.09 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 129.023 3.952 . . . . 0.0 113.694 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.48 HD23 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -92.22 143.0 26.87 Favored 'General case' 0 CA--C 1.46 -2.516 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.724 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.4 mt-30 -136.46 152.78 50.94 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 62' ' ' ASP . 30.2 mm -71.83 108.93 3.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 39.5 ttpt -60.66 -36.99 80.08 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.42 ' HA ' HG23 ' A' ' 60' ' ' THR . 39.9 t 161.14 173.41 0.01 OUTLIER 'General case' 0 C--N 1.372 1.573 0 O-C-N 125.711 1.882 . . . . 0.0 109.53 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.63 152.11 51.54 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.63 113.43 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . 0.9 OUTLIER -69.35 -6.96 33.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.306 1.05 . . . . 0.0 113.101 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.72 -3.86 48.48 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.914 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.425 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -97.79 174.81 29.51 Favored Glycine 0 N--CA 1.423 -2.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.595 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.54 -29.2 84.11 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 123.973 3.115 . . . . 0.0 113.404 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.0 -46.93 86.94 Favored 'General case' 0 C--O 1.268 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 111.95 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . . . -77.14 -35.66 55.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.043 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 50' ' ' GLY . 9.3 mp -71.54 -34.62 70.17 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.23 -19.97 60.33 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.776 1.275 . . . . 0.0 107.637 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.36 31.74 81.78 Favored Glycine 0 CA--C 1.491 -1.459 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.922 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.28 -29.65 4.78 Favored 'General case' 0 N--CA 1.394 -3.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.3 ttm -101.19 139.76 36.43 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.539 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.14 156.58 46.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.91 0.862 . . . . 0.0 109.477 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.42 HG23 ' HA ' ' A' ' 45' ' ' SER . 51.6 p -64.25 115.76 5.34 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 124.861 1.265 . . . . 0.0 109.601 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 117.61 -20.06 11.17 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.577 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.2 m-20 -58.96 135.85 57.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -87.32 117.89 32.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 C-N-CA 122.79 0.436 . . . . 0.0 111.392 175.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 mm -68.46 123.2 21.32 Favored 'Isoleucine or valine' 1 C--O 1.332 5.432 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 73' ' ' LEU . 46.4 t -115.6 -41.11 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 127.441 2.963 . . . . 0.0 111.793 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 66.4 m -147.04 161.84 40.01 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.17 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.49 134.58 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 m120 65.68 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.718 0.636 . . . . 0.0 110.054 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -163.96 33.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.813 1.768 . . . . 0.0 108.008 169.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.8 m -123.74 128.94 50.3 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.787 -1.551 . . . . 0.0 107.762 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.55 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 t -71.29 121.44 18.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.402 ' H ' ' HA ' ' A' ' 66' ' ' SER . 4.7 p -121.23 20.15 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.595 HD11 ' CE1' ' A' ' 40' ' ' PHE . 34.0 tp -60.24 113.09 2.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.45 44.81 0.09 OUTLIER Glycine 0 N--CA 1.503 3.119 0 O-C-N 125.632 1.832 . . . . 0.0 111.729 -171.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t60 -49.44 -65.62 0.53 Allowed 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.7 p -166.75 143.81 4.82 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 152.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -50.8 -34.21 26.67 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 119.904 1.229 . . . . 0.0 110.902 172.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.94 96.49 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 122.192 -0.317 . . . . 0.0 110.929 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 8.2 mm-40 -67.51 -41.39 84.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 77' ' ' HIS . 20.2 m -63.45 -45.88 96.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.96 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.96 -39.51 85.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -56.22 -43.14 78.28 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 123.445 0.465 . . . . 0.0 110.975 175.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.665 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.7 mm -65.16 -36.8 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.432 0.634 . . . . 0.0 112.265 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -75.45 -32.83 60.79 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.192 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -73.05 -21.75 60.74 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.337 1.055 . . . . 0.0 111.305 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.3 m -77.9 -35.19 51.01 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.34 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.6 mt -77.88 133.25 66.08 Favored Pre-proline 0 N--CA 1.417 -2.098 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.238 177.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 13.6 Cg_endo -90.18 161.74 4.73 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.114 2.543 . . . . 0.0 112.972 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.505 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.4 mm -62.76 133.17 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.128 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.98 54.13 Favored Glycine 0 C--N 1.296 -1.649 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.672 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' C ' ' HG ' ' A' ' 92' ' ' SER . . . -99.44 -172.41 2.25 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.7 m -151.1 153.63 35.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.826 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.5 125.53 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.127 0 C-N-CA 117.343 -1.743 . . . . 0.0 113.353 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 8.5 m-20 -78.85 105.2 10.0 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.44 146.61 34.22 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 124.279 1.031 . . . . 0.0 109.672 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -107.93 117.01 33.0 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.539 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 68.9 mt -107.48 134.36 50.63 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 125.626 1.57 . . . . 0.0 110.697 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.712 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 31.1 t -106.97 123.99 48.98 Favored 'General case' 0 C--O 1.164 -3.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.484 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.595 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 2.9 mtm180 -103.73 123.93 47.95 Favored 'General case' 0 C--N 1.259 -3.331 0 O-C-N 120.641 -1.287 . . . . 0.0 109.525 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.1 -23.5 0.17 Allowed Glycine 0 C--N 1.271 -3.039 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.609 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.412 ' HH ' HD13 ' A' ' 11' ' ' LEU . 38.6 m-85 -96.94 139.21 21.42 Favored Pre-proline 0 N--CA 1.431 -1.382 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.637 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 101' ' ' TYR . 20.6 Cg_exo -64.89 143.96 81.35 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.341 2.694 . . . . 0.0 112.587 -174.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.5 mt -51.63 123.57 23.83 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 124.466 1.106 . . . . 0.0 110.452 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 12.4 Cg_exo -70.52 -150.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.854 3.036 . . . . 0.0 113.144 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 107' ' ' PRO . 54.4 t80 -68.15 131.43 45.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.549 1.166 . . . . 0.0 110.74 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -115.75 85.74 14.75 Favored Pre-proline 0 N--CA 1.395 -3.203 0 CA-C-N 112.287 -2.233 . . . . 0.0 109.595 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HB3' ' CE2' ' A' ' 105' ' ' PHE . 72.9 Cg_endo -86.41 -58.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 122.298 1.999 . . . . 0.0 113.581 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 37.3 t70 -99.1 -7.05 27.28 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.516 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.53 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 6.3 t70 -75.86 121.34 84.86 Favored Pre-proline 0 CA--C 1.457 -2.62 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.612 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 20.7 Cg_endo -86.34 -28.63 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.282 1.988 . . . . 0.0 111.308 -173.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.612 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 21.2 t-20 -59.51 -8.81 2.05 Favored 'General case' 0 N--CA 1.4 -2.935 0 C-N-CA 130.139 3.375 . . . . 0.0 113.281 -169.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 110' ' ' PRO . 79.1 p -93.07 -19.32 21.65 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.591 -171.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -85.18 153.84 22.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.26 120.3 16.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.522 0.201 . . . . 0.0 111.153 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.5 t 65.04 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.967 1.307 . . . . 0.0 109.985 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 110' ' ' PRO . 1.1 m -139.2 -168.51 2.46 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . 0.303 42.6 p 69.46 115.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 125.891 1.676 . . . . 0.0 112.736 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.3 t 61.65 27.03 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -171.69 111.96 0.32 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.055 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.1 mt -112.41 90.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -91.47 124.52 35.7 Favored 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.3 t70 78.6 134.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 O-C-N 125.463 1.727 . . . . 0.0 111.749 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.16 42.81 1.79 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.581 0.705 . . . . 0.0 109.929 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -77.19 145.72 73.49 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.356 0.95 0 C-N-CA 123.09 2.526 . . . . 0.0 111.5 174.731 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 63.2 -92.13 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.369 1.068 . . . . 0.0 109.911 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 64.7 mtt -133.48 20.35 3.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.429 0.633 . . . . 0.0 109.9 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 113.07 90.66 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.436 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.408 ' HG3' ' HG2' ' A' ' 39' ' ' GLU . 3.8 mppt? 61.56 96.84 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.574 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.56 -169.31 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.572 2.181 . . . . 0.0 108.737 170.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.01 103.81 4.63 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.595 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.5 t80 -111.29 128.98 56.11 Favored 'General case' 0 C--N 1.268 -2.94 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -139.46 13.45 2.56 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.226 0.536 . . . . 0.0 110.846 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.471 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtm180 55.25 6.47 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.139 1.776 . . . . 0.0 114.937 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -133.03 120.41 16.25 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD3' ' SG ' ' A' ' 71' ' ' CYS . 23.8 Cg_exo -54.2 -32.49 70.82 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 124.472 3.448 . . . . 0.0 112.535 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -72.81 -21.93 60.89 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.59 0.709 . . . . 0.0 111.15 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -94.44 -25.94 16.69 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.571 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.417 HD23 ' CZ ' ' A' ' 40' ' ' PHE . 42.4 tp -81.31 152.39 27.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.741 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -121.16 146.67 46.52 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.608 0.718 . . . . 0.0 110.151 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.747 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 158.35 -169.2 34.85 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -173.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.555 ' CE ' HG12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -103.76 108.66 20.07 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 118.401 1.1 . . . . 0.0 109.052 171.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 52.2 m-85 -90.04 120.22 31.05 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.941 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.555 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.7 mt -118.15 138.57 48.43 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.075 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -110.0 118.44 36.44 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -140.73 127.86 20.88 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.457 0.646 . . . . 0.0 112.678 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.827 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -88.51 126.41 35.24 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.428 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.64 119.75 40.3 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 13.3 ttp180 -79.29 106.35 11.26 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.723 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.586 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.8 tttt -62.71 97.52 0.1 Allowed 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 89' ' ' ILE . 37.3 t -81.69 -157.24 0.18 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 124.335 1.054 . . . . 0.0 108.798 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -63.35 -34.68 78.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.6 tmt_? -81.94 -20.71 38.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 87.58 -118.4 4.99 Favored Glycine 1 N--CA 1.391 -4.325 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.452 ' CE2' ' HD2' ' A' ' 22' ' ' LYS . 44.9 m-85 -94.56 144.14 25.83 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.888 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.23 3.28 63.99 Favored Glycine 0 C--O 1.203 -1.803 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.479 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -114.58 163.14 15.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.333 0.587 . . . . 0.0 110.358 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 55.9 p -122.71 148.65 45.06 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.7 m -121.87 143.76 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 CA-C-O 121.608 0.718 . . . . 0.0 111.113 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.66 148.5 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.083 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 118.4 -137.57 13.07 Favored Glycine 2 N--CA 1.381 -5.012 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.8 31.7 16.85 Favored Glycine 0 CA--C 1.467 -2.943 0 O-C-N 124.358 0.681 . . . . 0.0 111.528 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -70.14 -22.98 62.94 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.14 166.03 8.66 Favored Pre-proline 0 CA--C 1.463 -2.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 18.0 Cg_endo -66.56 58.18 0.5 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.389 2.06 . . . . 0.0 109.831 171.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 23.5 t70 177.08 -11.92 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.454 -171.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 17.7 mt-10 -124.63 124.98 43.38 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 169.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.609 ' CE1' HD12 ' A' ' 73' ' ' LEU 0.252 4.9 m-30 -76.78 159.26 30.27 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 131.044 3.738 . . . . 0.0 113.932 -169.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 80' ' ' VAL . 8.0 mp -92.56 144.33 25.45 Favored 'General case' 0 C--O 1.183 -2.432 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.3 mt-30 -139.23 156.93 46.74 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 62' ' ' ASP . 26.3 mm -72.42 111.45 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.261 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 36.8 ttpt -63.06 -40.97 99.29 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 37.8 t 165.15 174.4 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 125.148 1.53 . . . . 0.0 109.81 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.425 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 pp -142.64 147.61 36.05 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.94 0.876 . . . . 0.0 112.712 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.0 116.39 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.984 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.724 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.89 -24.59 62.47 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.403 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -94.46 -2.51 51.69 Favored 'General case' 0 C--N 1.258 -3.373 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.656 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -99.65 170.46 23.12 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.505 -174.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.77 -29.25 79.99 Favored 'Trans proline' 0 C--O 1.196 -1.586 0 C-N-CA 124.203 3.269 . . . . 0.0 113.312 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.49 98.73 Favored 'General case' 0 C--O 1.269 2.112 0 CA-C-O 121.459 0.647 . . . . 0.0 111.479 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.46 47.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.77 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 50' ' ' GLY . 9.4 mp -70.48 -38.96 74.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.581 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.74 -24.91 62.71 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.85 74.03 Favored Glycine 0 CA--C 1.483 -1.923 0 CA-C-N 112.304 -2.225 . . . . 0.0 113.164 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -118.04 -2.04 11.32 Favored 'General case' 0 N--CA 1.385 -3.696 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.98 134.82 52.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.447 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.35 151.83 45.56 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 45' ' ' SER . 76.2 p -64.91 110.22 2.37 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.378 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.31 -19.65 7.16 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-O 119.254 -0.748 . . . . 0.0 113.237 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 43' ' ' ILE . 13.5 m-20 -61.33 132.23 52.89 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.005 0.902 . . . . 0.0 109.461 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.257 0.1 OUTLIER -82.38 120.54 34.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 177.528 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mm -71.86 123.09 25.53 Favored 'Isoleucine or valine' 1 C--O 1.333 5.488 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.51 HG12 HD13 ' A' ' 73' ' ' LEU . 52.8 t -115.56 -40.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 127.442 2.964 . . . . 0.0 111.28 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -146.25 162.14 38.73 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.319 -0.863 . . . . 0.0 112.906 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.412 HG12 ' CG2' ' A' ' 83' ' ' ILE . 52.7 t -139.82 126.54 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 C-N-CA 125.443 1.497 . . . . 0.0 107.197 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 m120 57.55 30.71 19.17 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.67 0.606 . . . . 0.0 110.947 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.9 t70 77.93 -8.12 1.72 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.043 1.337 . . . . 0.0 111.882 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.1 m -86.51 121.16 28.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 49.7 t -60.89 112.88 2.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.492 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG23 HG13 ' A' ' 80' ' ' VAL . 3.2 p -119.98 18.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 40' ' ' PHE . 38.5 tp -60.52 112.42 1.97 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.17 39.05 0.06 OUTLIER Glycine 0 N--CA 1.504 3.233 0 O-C-N 125.007 1.442 . . . . 0.0 112.107 -171.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 76' ' ' THR . 5.8 t60 -42.85 -64.34 0.64 Allowed 'General case' 0 C--N 1.373 1.604 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 75' ' ' HIS . 5.3 p -166.99 142.99 4.34 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 150.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.634 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -51.57 -32.15 27.25 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 120.951 1.705 . . . . 0.0 110.889 173.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.33 77.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.811 0.338 . . . . 0.0 110.619 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 12.6 mm-40 -65.23 -40.79 94.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.634 HG21 ' O ' ' A' ' 77' ' ' HIS . 11.0 m -63.65 -44.47 98.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.94 -40.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -56.73 -41.64 77.85 Favored 'General case' 0 C--O 1.196 -1.74 0 O-C-N 123.465 0.478 . . . . 0.0 110.835 175.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.665 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.5 mm -65.91 -36.05 76.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 0.0 112.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.39 -26.94 56.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.92 -30.05 61.15 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.179 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -66.29 -42.98 87.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.101 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.4 mt -76.22 131.88 74.46 Favored Pre-proline 0 N--CA 1.404 -2.769 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.683 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 91' ' ' ALA . 37.0 Cg_endo -92.42 161.91 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.175 2.584 . . . . 0.0 112.92 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 26.8 mm -58.68 132.35 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.36 11.41 54.18 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.98 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.409 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . . . -101.77 -169.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.4 m -151.62 157.44 42.16 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -147.3 124.94 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.601 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.5 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.45 103.79 8.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.2 mt -100.01 148.95 23.97 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 125.092 1.357 . . . . 0.0 109.045 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 29.0 tt0 -111.18 119.13 37.91 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.75 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 96.1 mt -106.18 164.6 11.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.646 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.747 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 7.9 t -142.09 117.28 10.08 Favored 'General case' 0 C--O 1.18 -2.577 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -100.99 145.25 28.93 Favored 'General case' 0 C--N 1.261 -3.267 0 O-C-N 120.472 -1.393 . . . . 0.0 109.734 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.15 -27.93 1.55 Allowed Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -84.88 130.82 51.13 Favored Pre-proline 0 N--CA 1.427 -1.619 0 CA-C-O 121.051 0.453 . . . . 0.0 110.51 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.76 83.52 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 123.459 2.772 . . . . 0.0 114.208 -173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' HD2' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -54.04 124.59 45.71 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.401 175.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HD2' HD23 ' A' ' 103' ' ' LEU . 7.7 Cg_exo -72.64 -74.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.179 2.586 . . . . 0.0 110.825 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.5 134.24 33.69 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 65.9 t0 -128.18 100.01 24.01 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-O 122.06 0.933 . . . . 0.0 109.217 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.476 ' CD ' ' H ' ' A' ' 108' ' ' ASP . 42.5 Cg_endo -92.8 -31.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.259 2.64 . . . . 0.0 112.379 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.476 ' H ' ' CD ' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -73.32 -26.96 61.27 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.907 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.405 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 6.9 t70 -113.4 124.03 32.14 Favored Pre-proline 0 CA--C 1.448 -2.966 0 C-N-CA 118.167 -1.413 . . . . 0.0 107.323 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.675 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 67.0 Cg_endo -71.47 -35.64 7.86 Favored 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 122.364 2.043 . . . . 0.0 112.327 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.675 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 46.6 m-80 -62.99 6.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 126.644 1.978 . . . . 0.0 114.592 -165.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.468 ' H ' ' C ' ' A' ' 110' ' ' PRO . 57.6 p -101.93 20.92 15.55 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-O 121.14 0.495 . . . . 0.0 111.961 -170.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 37.8 t -151.22 -175.3 5.11 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.444 ' O ' HG21 ' A' ' 116' ' ' THR . 57.2 tp -82.17 156.67 24.33 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p 57.53 38.21 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.394 1.478 . . . . 0.0 111.509 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 114' ' ' LEU . 44.0 p -106.53 -158.02 0.64 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.74 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -74.14 0.82 12.73 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.624 1.102 . . . . 0.0 113.878 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -74.82 129.34 36.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.46 43.09 1.11 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 110.484 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.3 mm -125.06 113.07 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -113.71 24.95 11.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.283 1.04 . . . . 0.0 108.726 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -116.09 160.62 20.08 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.299 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.442 ' HB3' ' HZ2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -86.84 32.18 0.68 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.588 0.709 . . . . 0.0 110.997 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -88.53 139.49 29.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.88 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 C--O 1.255 1.35 0 C-N-CA 123.35 2.7 . . . . 0.0 112.788 178.347 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.88 57.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.387 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 39.2 ttm -116.09 -69.44 0.85 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -75.97 154.07 44.44 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 55.66 70.85 1.39 Allowed Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -93.96 -166.29 0.13 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.375 2.717 . . . . 0.0 111.505 -174.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.76 103.74 14.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.59 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.2 t80 -115.94 126.68 54.19 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.451 ' CG2' HD23 ' A' ' 11' ' ' LEU . 5.8 t -139.4 23.67 2.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.887 0.851 . . . . 0.0 110.884 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 60.0 mtt180 53.03 4.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 127.381 2.272 . . . . 0.0 116.136 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.7 t-20 -134.4 122.98 16.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.56 -31.58 70.45 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 123.753 2.969 . . . . 0.0 112.602 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -71.2 -26.81 63.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.397 0.618 . . . . 0.0 110.221 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -93.22 -15.26 26.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.344 0.592 . . . . 0.0 110.85 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.451 HD23 ' CG2' ' A' ' 5' ' ' THR . 33.3 mt -76.43 -173.68 2.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.51 1.147 . . . . 0.0 111.767 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -120.5 178.52 4.64 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.567 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.98 164.57 35.27 Favored Glycine 0 C--N 1.281 -2.476 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.204 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 34.0 tptt -88.25 126.83 35.37 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.654 0.782 . . . . 0.0 109.678 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 93.4 m-85 -104.79 119.63 39.47 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.016 0.912 . . . . 0.0 110.583 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.53 HD12 ' NH2' ' A' ' 99' ' ' ARG . 8.5 mt -121.67 146.56 26.57 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.116 -172.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -117.29 127.34 53.98 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -139.05 156.86 46.86 Favored 'General case' 0 C--O 1.184 -2.369 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.803 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 38.2 ttpt -127.26 123.57 36.79 Favored 'General case' 0 C--N 1.258 -3.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -106.81 116.4 31.86 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.75 -170.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 32.8 ttp-105 -79.01 102.38 8.31 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.268 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.6 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 70.6 tttt -59.54 97.79 0.04 OUTLIER 'General case' 0 C--O 1.179 -2.649 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 t -84.82 -155.3 0.2 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.792 1.237 . . . . 0.0 109.173 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -61.13 -36.36 79.53 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.396 0.617 . . . . 0.0 109.468 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -86.69 -16.78 35.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.736 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.6 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 88.38 -112.17 3.87 Favored Glycine 1 N--CA 1.391 -4.308 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 44.1 m-85 -97.09 135.12 39.53 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.172 0.51 . . . . 0.0 109.919 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.93 -3.42 90.6 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.896 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 27' ' ' PHE . 9.7 p90 -113.58 163.68 14.64 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.604 0.716 . . . . 0.0 111.903 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.2 p -124.08 148.06 47.4 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.369 1.468 . . . . 0.0 107.281 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' CE1' ' A' ' 77' ' ' HIS . 15.4 m -121.66 148.23 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.75 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.41 153.48 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.434 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.43 -131.79 9.59 Favored Glycine 0 N--CA 1.398 -3.877 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.65 36.33 24.87 Favored Glycine 0 CA--C 1.466 -2.97 0 O-C-N 124.593 0.82 . . . . 0.0 111.902 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.08 -31.05 70.42 Favored 'General case' 0 CA--C 1.449 -2.932 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -161.4 166.87 14.16 Favored Pre-proline 0 CA--C 1.45 -2.869 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.216 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -66.72 64.04 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.126 1.884 . . . . 0.0 108.468 168.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 12.9 t70 170.69 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.376 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 21.3 mt-10 -127.58 127.4 43.82 Favored 'General case' 0 C--O 1.276 2.457 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 73' ' ' LEU . 9.7 m-85 -76.92 159.25 30.15 Favored 'General case' 0 N--CA 1.532 3.639 0 O-C-N 128.836 3.835 . . . . 0.0 113.319 -167.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.48 HD23 HG21 ' A' ' 80' ' ' VAL . 5.1 mp -92.34 143.2 26.63 Favored 'General case' 0 CA--C 1.469 -2.161 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.8 mt-30 -135.5 154.28 51.46 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.9 mm -75.35 111.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.39 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 45' ' ' SER . 47.6 tptt -60.83 -47.29 87.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.521 ' HA ' HG21 ' A' ' 60' ' ' THR . 39.9 t 173.2 172.71 0.13 Allowed 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.871 1.357 . . . . 0.0 111.183 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pp -143.1 145.74 33.13 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 123.764 0.826 . . . . 0.0 111.128 -175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.18 121.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.494 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 1.8 pt? -69.42 -5.24 22.45 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.965 0.888 . . . . 0.0 112.585 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -85.4 -26.65 26.29 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.903 -1.499 . . . . 0.0 108.917 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.424 ' O ' HD11 ' A' ' 54' ' ' LEU . . . -90.44 172.08 37.34 Favored Glycine 0 N--CA 1.402 -3.586 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.676 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.87 -26.37 48.06 Favored 'Trans proline' 0 C--O 1.201 -1.375 0 C-N-CA 124.911 3.741 . . . . 0.0 113.325 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.26 -52.66 64.64 Favored 'General case' 0 C--O 1.291 3.244 0 C-N-CA 123.377 0.671 . . . . 0.0 112.789 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.36 -33.53 55.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.456 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 50' ' ' GLY . 7.3 mp -70.31 -35.59 73.76 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.097 -176.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.34 -21.84 65.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.59 11.83 84.86 Favored Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 112.61 -2.087 . . . . 0.0 113.47 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -107.62 -43.02 4.6 Favored 'General case' 1 N--CA 1.376 -4.132 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.0 ptp -95.92 154.7 17.1 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 116.631 -2.028 . . . . 0.0 112.296 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.42 161.19 38.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.749 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.521 HG21 ' HA ' ' A' ' 45' ' ' SER . 75.0 p -65.86 113.7 4.56 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.25 -14.18 10.24 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.716 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 99' ' ' ARG . 2.4 m-20 -65.95 152.69 43.99 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.44 125.18 55.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.989 -0.444 . . . . 0.0 111.571 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 mm -75.52 124.09 32.77 Favored 'Isoleucine or valine' 1 C--O 1.323 4.938 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 73' ' ' LEU . 57.7 t -115.11 -36.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 111.037 -2.801 . . . . 0.0 111.247 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 70.3 m -150.8 160.24 44.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.001 -1.062 . . . . 0.0 113.081 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 95' ' ' LEU . 55.0 t -142.18 129.59 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.5 m120 55.12 41.61 31.47 Favored 'General case' 0 C--O 1.256 1.437 0 O-C-N 123.776 0.673 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 25.26 5.69 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.47 1.108 . . . . 0.0 113.215 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 m -114.72 125.95 54.31 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.435 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 27.4 t -67.08 110.82 3.57 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 67' ' ' VAL . 2.2 p -117.35 16.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.59 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 32.6 tp -57.95 112.85 1.63 Allowed 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.03 40.3 0.05 OUTLIER Glycine 0 N--CA 1.497 2.701 0 O-C-N 125.511 1.757 . . . . 0.0 112.934 -170.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 76' ' ' THR . 4.7 t60 -43.71 -66.48 0.38 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.8 p -166.35 143.51 5.13 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 150.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -51.47 -31.37 23.2 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 119.699 1.136 . . . . 0.0 110.775 172.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.65 85.51 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.942 -0.474 . . . . 0.0 110.946 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.476 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 21.9 mm-40 -65.34 -42.18 93.13 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 77' ' ' HIS . 18.4 m -62.11 -43.71 98.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.26 -39.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -61.0 -41.62 96.88 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.02 176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' SER . 37.1 mt -62.01 -40.96 89.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.34 0.59 . . . . 0.0 111.635 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -70.89 -34.97 72.11 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.804 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -72.77 -19.64 61.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.06 0.944 . . . . 0.0 111.676 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 53.4 m -79.79 -27.81 40.35 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.132 0.973 . . . . 0.0 109.372 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.2 mt -85.17 134.65 40.47 Favored Pre-proline 0 N--CA 1.416 -2.141 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.607 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.5 Cg_endo -92.66 161.68 2.85 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 123.347 2.698 . . . . 0.0 113.039 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.512 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.65 133.55 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.63 12.49 53.43 Favored Glycine 0 C--N 1.289 -2.042 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.955 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.431 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -100.3 -170.26 1.85 Allowed 'General case' 0 C--O 1.199 -1.6 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.594 ' OG ' ' HG2' ' A' ' 19' ' ' LYS . 3.3 t -151.36 159.72 44.13 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.0 t -147.68 126.15 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.507 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.04 112.93 17.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 67' ' ' VAL . 45.2 mt -109.89 144.55 38.21 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 126.387 1.875 . . . . 0.0 109.962 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.409 ' CB ' ' HB2' ' A' ' 66' ' ' SER . 8.9 tp10 -103.45 118.61 37.14 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 23.7 mt -105.6 165.07 11.41 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.903 1.281 . . . . 0.0 108.784 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -142.94 111.05 6.03 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.781 0.801 . . . . 0.0 110.96 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.53 ' NH2' HD12 ' A' ' 16' ' ' ILE . 13.1 mtm180 -97.0 129.69 44.43 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.211 -0.931 . . . . 0.0 112.213 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.07 -17.78 0.82 Allowed Glycine 0 C--N 1.277 -2.702 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.512 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.12 148.85 40.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.862 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 131.76 47.94 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.889 2.392 . . . . 0.0 111.538 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD23 ' HD2' ' A' ' 104' ' ' PRO . 2.0 tt -58.54 135.6 85.87 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HD2' HD23 ' A' ' 103' ' ' LEU . 3.8 Cg_exo -42.05 158.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 125.672 4.248 . . . . 0.0 116.102 -178.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.541 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 70.6 t80 -44.44 134.2 5.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.916 -1.947 . . . . 0.0 113.081 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -104.14 99.77 18.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.766 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 73.2 Cg_endo -97.18 -57.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.095 0 C-N-CA 122.187 1.925 . . . . 0.0 110.179 168.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.453 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 31.0 t70 -138.77 31.44 2.26 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -76.22 128.15 83.35 Favored Pre-proline 0 CA--C 1.489 -1.404 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.541 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HG2' ' ND2' ' A' ' 111' ' ' ASN 0.386 7.5 Cg_endo -62.93 -48.08 7.36 Favored 'Trans proline' 0 CA--C 1.459 -3.275 0 C-N-CA 122.041 1.827 . . . . 0.0 112.648 174.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 48.1 m-80 -59.57 -25.6 64.7 Favored 'General case' 0 N--CA 1.414 -2.255 0 O-C-N 125.921 2.013 . . . . 0.0 113.508 -159.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -92.96 -27.31 17.12 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.765 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 m -94.22 173.19 7.77 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 125.478 1.511 . . . . 0.0 110.378 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.62 36.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.045 0.938 . . . . 0.0 111.074 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.0 p -155.42 40.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -77.39 132.48 38.55 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 115.053 -172.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.1 p 45.59 63.61 1.73 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 125.058 1.474 . . . . 0.0 108.836 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -37.34 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.103 2.161 . . . . 0.0 115.385 -167.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.0 32.39 4.8 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.64 116.53 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.03 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.42 31.23 6.4 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.227 0.537 . . . . 0.0 109.904 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -149.58 131.37 15.07 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 75.29 -43.67 0.51 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.878 1.671 . . . . 0.0 112.254 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.459 ' OE2' ' HD2' ' A' ' 125' ' ' PRO . 10.4 tp10 -66.31 144.71 98.83 Favored Pre-proline 0 C--N 1.291 -1.938 0 C-N-CA 125.221 1.409 . . . . 0.0 108.332 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.459 ' HD2' ' OE2' ' A' ' 124' ' ' GLU . 6.3 Cg_exo . . . . . 0 C--N 1.371 1.759 1 C-N-CA 125.377 4.051 . . . . 0.0 114.571 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 55.16 37.73 29.36 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.243 1.02 . . . . 0.0 110.268 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 40.0 tpp 165.83 90.36 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -50.6 126.35 24.6 Favored Glycine 0 CA--C 1.476 -2.401 0 O-C-N 124.653 1.221 . . . . 0.0 112.686 -174.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -62.07 -47.63 90.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -98.17 -178.0 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.395 2.063 . . . . 0.0 112.371 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.12 107.26 18.95 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.593 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.1 t80 -99.11 129.8 45.39 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 7' ' ' ASN . 14.6 t -138.1 10.82 2.82 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.873 0.845 . . . . 0.0 110.628 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 31.3 mtt180 58.25 -22.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.557 2.343 . . . . 0.0 115.738 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 5' ' ' THR . 56.1 t-20 -104.6 117.74 58.25 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HB3' HG11 ' A' ' 65' ' ' VAL . 9.3 Cg_endo -57.39 -26.05 68.99 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.965 3.11 . . . . 0.0 112.956 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -74.11 -30.29 62.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.124 0.487 . . . . 0.0 110.002 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -89.36 -29.61 18.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 41.2 tp -72.07 155.85 39.84 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.548 0.689 . . . . 0.0 111.619 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 9.2 mtmp? -90.18 -167.17 1.77 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.614 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.622 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 91.13 173.58 43.65 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.183 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -97.44 129.6 44.63 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.5 m-85 -103.16 113.74 27.47 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-O 122.538 1.161 . . . . 0.0 110.04 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -116.55 143.7 26.06 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.908 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.51 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.7 t60 -110.62 131.02 55.41 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 8.8 t -139.29 156.76 46.82 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.2 ttmp? -125.24 122.83 38.08 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -108.35 116.68 32.43 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.393 -174.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.0 ttp180 -75.09 107.77 7.38 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.021 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.554 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.7 tttt -66.71 95.68 0.36 Allowed 'General case' 0 C--O 1.171 -3.07 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 167.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t -89.55 -155.26 0.35 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 m -60.95 -32.81 72.33 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 122.56 0.344 . . . . 0.0 110.397 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -83.11 -21.02 33.78 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.368 0.604 . . . . 0.0 109.55 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.554 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 73.12 80.16 0.45 Allowed Glycine 0 N--CA 1.417 -2.584 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' N ' ' HA ' ' A' ' 22' ' ' LYS . 24.3 m-85 80.49 168.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.736 2.014 . . . . 0.0 110.07 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.18 10.99 5.6 Favored Glycine 0 CA--C 1.497 -1.077 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.018 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -119.49 162.93 18.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.235 0.54 . . . . 0.0 109.758 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.4 p -119.41 153.83 34.61 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -144.85 141.41 23.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.117 -174.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.505 HG21 ' N ' ' A' ' 33' ' ' GLY . 14.6 p -151.83 166.12 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.353 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.505 ' N ' HG21 ' A' ' 32' ' ' VAL . . . 109.6 3.06 30.74 Favored Glycine 0 CA--C 1.454 -3.766 0 N-CA-C 116.521 1.368 . . . . 0.0 116.521 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.725 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -117.06 48.89 0.9 Allowed Glycine 1 CA--C 1.41 -6.516 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -168.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' N ' ' HB2' ' A' ' 39' ' ' GLU . 3.2 t70 -56.26 -29.16 60.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 112.841 -1.679 . . . . 0.0 110.239 -173.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.442 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.6 pt-20 -163.81 171.96 5.46 Favored Pre-proline 0 CA--C 1.465 -2.293 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.093 -172.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 21.9 Cg_endo -64.73 54.9 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.011 2.474 . . . . 0.0 110.898 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -177.53 -19.62 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.305 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.725 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 2.8 mt-10 -119.53 122.73 42.31 Favored 'General case' 0 C--O 1.265 1.885 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 171.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.296 5.4 m-30 -78.92 155.99 28.78 Favored 'General case' 0 N--CA 1.533 3.703 0 O-C-N 127.78 3.175 . . . . 0.0 112.722 -176.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD12 ' HA3' ' A' ' 34' ' ' GLY . 7.4 mp -85.75 143.08 28.54 Favored 'General case' 0 C--O 1.179 -2.607 0 C-N-CA 117.153 -1.819 . . . . 0.0 108.112 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.0 mt-30 -139.31 151.24 46.25 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.9 mm -72.38 110.95 5.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 58.3 tttm -59.39 -38.99 81.96 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.443 ' HA ' HG23 ' A' ' 60' ' ' THR . 30.7 t 163.78 172.34 0.02 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.637 1.836 . . . . 0.0 110.646 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -141.58 152.14 43.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.866 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.9 t -81.61 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . 1.6 pt? -68.63 -11.12 59.67 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -95.15 -7.29 39.69 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.073 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.26 163.0 37.18 Favored Glycine 0 N--CA 1.404 -3.461 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.765 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.83 -30.37 38.14 Favored 'Trans proline' 0 C--O 1.211 -0.873 0 C-N-CA 124.718 3.612 . . . . 0.0 112.897 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -57.87 -45.82 85.78 Favored 'General case' 0 C--O 1.271 2.223 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.798 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 48' ' ' LEU . . . -76.9 -31.94 57.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.645 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.32 -40.62 64.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.069 0.547 . . . . 0.0 112.419 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.76 -25.62 67.35 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.02 5.33 65.08 Favored Glycine 0 CA--C 1.483 -1.935 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.939 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.89 -28.78 14.53 Favored 'General case' 1 N--CA 1.378 -4.061 0 C-N-CA 122.782 0.433 . . . . 0.0 111.551 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.8 ttm -97.04 140.49 31.48 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.064 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -137.97 161.9 35.5 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -71.01 107.53 4.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.825 0.85 . . . . 0.0 111.264 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.83 -16.6 9.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.207 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.532 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 2.9 m-20 -61.9 134.45 56.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -84.62 124.89 40.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.276 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.75 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.4 mm -73.8 124.58 31.36 Favored 'Isoleucine or valine' 1 C--O 1.32 4.78 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 170.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 73' ' ' LEU . 47.9 t -115.09 -40.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 111.481 -2.6 . . . . 0.0 110.939 -176.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.2 m -146.27 166.29 26.71 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.193 -1.003 . . . . 0.0 113.345 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.412 HG22 ' CD2' ' A' ' 95' ' ' LEU . 39.8 t -139.7 120.69 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 125.313 1.445 . . . . 0.0 107.493 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.7 m120 67.53 -75.75 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.471 1.107 . . . . 0.0 109.809 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.07 4.14 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.322 0.649 . . . . 0.0 110.862 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -96.94 121.82 39.23 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.489 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 72.1 m -70.71 88.2 0.71 Allowed 'General case' 0 N--CA 1.398 -3.045 0 O-C-N 124.639 1.212 . . . . 0.0 108.366 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG23 ' CD2' ' A' ' 75' ' ' HIS . 3.8 p -97.73 19.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.43 -171.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.593 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.3 tp -58.82 113.19 1.94 Allowed 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.84 44.92 0.1 OUTLIER Glycine 0 C--N 1.384 3.246 0 O-C-N 125.996 2.06 . . . . 0.0 111.661 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.576 ' O ' HG21 ' A' ' 76' ' ' THR . 3.5 t60 -48.42 -64.26 0.85 Allowed 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.576 HG21 ' O ' ' A' ' 75' ' ' HIS . 12.0 p -166.42 142.79 4.83 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 151.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.635 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.35 -31.58 22.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 120.498 1.499 . . . . 0.0 111.373 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.56 77.0 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 122.029 -0.419 . . . . 0.0 110.438 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 11.9 mm-40 -64.46 -39.01 93.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 77' ' ' HIS . 11.6 m -64.16 -43.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.2 -37.8 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.1 tmtm? -57.78 -42.84 84.94 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.298 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.645 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.3 mm -66.21 -33.72 65.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.642 0.734 . . . . 0.0 112.628 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -76.09 -28.92 57.74 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.297 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -72.89 -28.26 62.38 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.373 1.069 . . . . 0.0 110.663 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.59 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.8 m -65.57 -38.66 90.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.455 175.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 22.1 mt -82.89 133.76 48.08 Favored Pre-proline 0 N--CA 1.405 -2.681 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.03 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.1 Cg_endo -90.71 161.98 4.2 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.086 2.524 . . . . 0.0 113.234 -173.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.523 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.1 mm -60.77 133.84 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.457 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 11.62 56.63 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.133 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.92 -169.72 1.72 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -151.34 165.73 33.16 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.2 t -150.35 126.21 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.887 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.51 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -78.65 107.02 11.03 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.194 -1.002 . . . . 0.0 108.743 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.412 ' CD2' HG22 ' A' ' 67' ' ' VAL . 56.7 mt -103.84 152.45 21.9 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.801 1.64 . . . . 0.0 108.391 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 30.1 tt0 -111.11 123.42 50.17 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 76.6 mt -105.65 153.87 21.23 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.759 1.223 . . . . 0.0 110.247 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.644 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 9.6 t -124.26 107.12 10.85 Favored 'General case' 0 C--O 1.186 -2.241 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.476 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.532 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 40.4 ttp180 -101.39 138.62 38.15 Favored 'General case' 1 C--N 1.243 -4.052 0 O-C-N 120.59 -1.319 . . . . 0.0 110.494 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.51 -32.84 0.84 Allowed Glycine 0 CA--C 1.464 -3.123 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.45 137.59 45.03 Favored Pre-proline 0 N--CA 1.412 -2.34 0 CA-C-N 113.871 -1.165 . . . . 0.0 108.434 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -85.62 164.41 10.7 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.964 2.443 . . . . 0.0 112.242 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 13.3 mt -57.09 121.22 44.93 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.244 173.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 30.7 Cg_endo -76.52 -79.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.154 2.569 . . . . 0.0 114.763 -170.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -138.78 143.61 39.02 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-O 121.837 0.827 . . . . 0.0 109.835 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -116.4 85.51 16.27 Favored Pre-proline 0 N--CA 1.392 -3.334 0 CA-C-N 113.003 -1.908 . . . . 0.0 110.529 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.438 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 48.5 Cg_endo -85.77 -59.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.78 1.654 . . . . 0.0 110.787 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.438 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 29.0 t70 -112.58 32.96 5.24 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.922 1.82 . . . . 0.0 108.663 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 111' ' ' ASN . 5.9 t70 -104.53 109.53 62.95 Favored Pre-proline 0 CA--C 1.435 -3.445 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 170.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.605 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 97.5 Cg_endo -75.09 -35.04 3.31 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 121.664 1.576 . . . . 0.0 110.683 -175.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.605 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 74.3 m-20 -51.19 -10.15 0.08 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 130.251 3.42 . . . . 0.0 114.704 -167.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 110' ' ' PRO . 76.2 p -97.65 -10.34 25.24 Favored 'General case' 0 N--CA 1.384 -3.747 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.632 -169.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.4 p -148.76 128.79 13.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.465 ' HG ' ' H ' ' A' ' 115' ' ' VAL . 6.3 tp 63.58 -154.28 0.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.179 1.392 . . . . 0.0 110.854 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.465 ' H ' ' HG ' ' A' ' 114' ' ' LEU . 13.2 m -66.06 78.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 122.491 1.139 . . . . 0.0 112.573 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 p -134.57 -169.25 2.3 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.338 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.585 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 78.3 p 64.86 21.93 12.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.127 1.371 . . . . 0.0 112.119 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.3 p -91.42 125.69 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.91 74.03 5.65 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.1 0.476 . . . . 0.0 111.961 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -99.13 89.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.41 138.16 47.16 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.155 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -148.08 154.18 39.87 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -77.98 -28.34 49.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.018 0.437 . . . . 0.0 111.809 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -102.58 133.01 20.73 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.577 2.851 . . . . 0.0 112.117 179.234 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.803 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -133.81 -46.74 0.8 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 62.6 mtt -86.25 93.78 9.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 144.87 -94.17 0.17 Allowed Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.465 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 29.6 mmmt 50.46 61.2 13.85 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 40.5 Cg_endo -107.44 -172.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 123.15 2.567 . . . . 0.0 111.79 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -94.5 111.15 22.9 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.598 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -107.81 123.17 48.17 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 7' ' ' ASN . 12.4 t -133.3 12.41 4.19 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.339 0.59 . . . . 0.0 110.279 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtp180 60.47 -29.7 0.05 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.446 2.298 . . . . 0.0 115.381 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 5' ' ' THR . 55.6 t-20 -95.92 117.38 66.39 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HB3' HG12 ' A' ' 65' ' ' VAL . 6.4 Cg_endo -59.36 -22.79 67.27 Favored 'Trans proline' 0 C--O 1.21 -0.924 0 C-N-CA 123.772 2.982 . . . . 0.0 113.134 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -76.92 -25.37 52.85 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.804 -0.56 . . . . 0.0 109.562 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -93.82 -19.32 21.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.574 0.702 . . . . 0.0 110.22 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 12' ' ' LYS . 3.4 tm? -88.14 145.78 25.74 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.369 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' N ' HD11 ' A' ' 11' ' ' LEU . 57.3 mttm -103.32 137.74 41.03 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-O 121.873 0.844 . . . . 0.0 110.581 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.665 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 152.82 169.52 18.15 Favored Glycine 1 C--N 1.246 -4.417 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.237 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.47 122.3 40.37 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.908 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.2 m-85 -96.53 111.34 23.5 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.784 1.278 . . . . 0.0 112.157 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.48 HD12 ' HG3' ' A' ' 99' ' ' ARG . 5.9 mm -92.55 152.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 CA-C-N 112.779 -2.009 . . . . 0.0 108.436 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 113.05 14.47 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 t -139.37 132.88 30.3 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.918 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.813 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.9 ttpt -92.95 125.92 37.78 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -106.28 117.3 33.69 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -175.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.437 ' HD3' ' OG ' ' A' ' 92' ' ' SER . 18.6 tpp180 -74.59 103.83 5.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.954 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 69.9 tttt -62.17 97.29 0.08 Allowed 'General case' 0 C--O 1.177 -2.733 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.0 t -129.71 125.87 36.94 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t 62.18 -77.73 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.127 1.371 . . . . 0.0 110.534 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -85.48 -20.63 29.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.614 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 107.83 -110.43 3.16 Favored Glycine 1 N--CA 1.385 -4.73 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 44.1 m-85 -92.45 135.7 33.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.268 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.56 3.55 84.71 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.812 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CE2' HG22 ' A' ' 31' ' ' VAL . 10.0 p90 -119.07 162.92 17.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.194 0.521 . . . . 0.0 110.434 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 21.5 p -113.15 145.81 40.3 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 29' ' ' PHE . 1.6 t -119.19 143.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.505 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.33 149.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.785 0 CA-C-O 121.336 0.588 . . . . 0.0 109.428 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.25 -138.52 11.02 Favored Glycine 1 N--CA 1.391 -4.317 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.63 36.97 19.46 Favored Glycine 0 CA--C 1.456 -3.598 0 O-C-N 124.517 0.775 . . . . 0.0 111.346 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -69.93 -27.71 65.0 Favored 'General case' 0 CA--C 1.463 -2.394 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -164.28 167.69 10.19 Favored Pre-proline 0 CA--C 1.464 -2.354 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.057 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.707 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.4 Cg_endo -67.21 56.03 0.55 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.394 2.063 . . . . 0.0 110.277 172.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.416 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 21.5 t70 177.97 -7.86 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.338 -169.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 22.9 mm-40 -129.29 125.34 36.58 Favored 'General case' 0 C--O 1.276 2.493 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' CE1' HD12 ' A' ' 73' ' ' LEU 0.253 6.0 m-30 -76.44 158.93 30.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 129.871 3.268 . . . . 0.0 112.514 -169.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 6.7 mp -88.97 147.77 24.13 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.5 mt-30 -144.18 155.6 43.97 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 62' ' ' ASP . 20.4 mm -72.98 115.91 14.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 38.4 ttmt -58.95 -44.65 91.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.477 ' HA ' HG23 ' A' ' 60' ' ' THR . 21.0 t 169.62 173.65 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 125.144 1.527 . . . . 0.0 110.453 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -144.27 144.91 31.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-O 121.647 0.737 . . . . 0.0 111.899 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.438 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 14.5 t -73.26 122.92 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.769 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.2 mt -61.31 -15.01 31.19 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 112.489 -2.141 . . . . 0.0 113.121 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -92.72 -13.66 29.04 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.767 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -91.53 163.62 28.74 Favored Glycine 0 N--CA 1.415 -2.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.425 -172.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.44 -28.73 45.71 Favored 'Trans proline' 0 C--O 1.205 -1.136 0 C-N-CA 124.72 3.613 . . . . 0.0 112.798 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -57.85 -50.77 72.17 Favored 'General case' 0 C--O 1.264 1.853 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.052 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.26 -33.49 55.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 50' ' ' GLY . 7.8 mp -72.57 -33.72 66.96 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.049 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.43 -27.79 66.5 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.416 ' C ' ' HE3' ' A' ' 57' ' ' LYS . . . 78.61 3.59 86.91 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 112.51 -2.132 . . . . 0.0 113.352 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HE3' ' C ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -96.18 -31.8 12.79 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.0 ttm -97.97 142.0 30.24 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.616 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -139.25 159.16 42.8 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 122.226 1.012 . . . . 0.0 110.061 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 45' ' ' SER . 65.7 p -63.85 115.65 5.03 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.564 1.146 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 111.74 -15.96 26.28 Favored Glycine 0 N--CA 1.435 -1.425 0 O-C-N 121.767 -0.583 . . . . 0.0 112.799 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 43' ' ' ILE . 17.4 m-20 -61.08 134.28 56.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -83.38 126.47 40.13 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 CA-C-N 118.905 0.775 . . . . 0.0 113.035 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 12.7 mm -76.78 125.27 36.43 Favored 'Isoleucine or valine' 1 C--O 1.321 4.866 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG13 HD13 ' A' ' 73' ' ' LEU . 25.9 t -115.68 -37.6 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 111.435 -2.62 . . . . 0.0 111.035 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.468 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.9 m -144.51 149.75 36.43 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.227 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 ' OD1' ' A' ' 68' ' ' ASN . 12.4 p -134.58 133.43 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' OD1' HG21 ' A' ' 67' ' ' VAL . 21.7 m120 60.13 27.84 17.35 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.02 0.914 . . . . 0.0 110.398 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 72.97 2.48 4.39 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.668 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.7 m -90.56 126.88 36.08 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 31.7 t -66.49 108.0 2.25 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 66' ' ' SER . 29.6 m -123.18 27.87 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.841 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.598 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.0 tp -59.88 113.54 2.34 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.7 41.57 0.26 Allowed Glycine 0 C--N 1.376 2.767 0 O-C-N 125.191 1.557 . . . . 0.0 112.205 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.568 ' O ' HG21 ' A' ' 76' ' ' THR . 8.8 t60 -44.01 -67.86 0.24 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.568 HG21 ' O ' ' A' ' 75' ' ' HIS . 18.2 p -166.1 143.46 5.36 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 149.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -50.77 -37.15 40.49 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 120.098 1.317 . . . . 0.0 110.711 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.409 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.532 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 9.0 mm-40 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.453 HG23 HD21 ' A' ' 41' ' ' LEU . 34.0 m -69.17 -39.88 79.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.591 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.511 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 71.1 t -65.45 -37.43 80.04 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.28 -38.55 83.93 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 122.887 0.117 . . . . 0.0 111.277 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 86' ' ' SER . 63.1 mt -65.58 -35.73 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.612 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.6 -31.52 65.25 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.356 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 71.1 mm-40 -72.82 -26.56 61.53 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 122.084 0.945 . . . . 0.0 109.901 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.2 m -73.66 -47.06 42.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.602 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 20.9 mt -66.68 136.58 94.74 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.302 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 30.5 Cg_endo -91.64 162.49 3.49 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.185 3.257 . . . . 0.0 113.125 -174.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.504 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 28.8 mm -62.29 135.25 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 121.07 0.462 . . . . 0.0 110.63 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.85 57.14 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.554 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.14 -172.42 2.16 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -149.01 158.87 44.52 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -142.49 125.27 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.211 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -79.33 104.17 9.77 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.44 143.84 32.47 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 125.357 1.463 . . . . 0.0 111.514 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 38.0 tt0 -104.41 127.04 52.01 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.336 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 67.1 mt -115.11 157.83 23.03 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.573 1.171 . . . . 0.0 110.027 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.665 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.6 t -129.83 111.17 12.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.548 1.166 . . . . 0.0 110.157 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.48 ' HG3' HD12 ' A' ' 16' ' ' ILE . 3.7 mmm180 -88.54 120.9 30.35 Favored 'General case' 0 C--N 1.245 -3.958 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 157.32 -22.06 0.43 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.7 138.56 21.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.21 146.98 21.9 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 124.756 3.638 . . . . 0.0 112.936 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.447 HD23 ' HD2' ' A' ' 104' ' ' PRO . 1.2 tt -70.33 125.26 91.93 Favored Pre-proline 0 N--CA 1.413 -2.319 0 C-N-CA 124.422 1.089 . . . . 0.0 109.195 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.447 ' HD2' HD23 ' A' ' 103' ' ' LEU . 45.0 Cg_exo -64.64 -173.25 0.23 Allowed 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 124.322 3.348 . . . . 0.0 113.302 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -82.37 128.61 34.4 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.774 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -117.69 85.16 21.15 Favored Pre-proline 0 N--CA 1.39 -3.428 0 CA-C-N 111.846 -2.434 . . . . 0.0 110.542 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 57.5 Cg_endo -87.51 -54.99 0.02 OUTLIER 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.004 1.802 . . . . 0.0 111.994 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.412 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 5.0 p-10 -82.12 -9.84 59.39 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.647 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -89.47 121.57 69.14 Favored Pre-proline 0 CA--C 1.478 -1.809 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.108 -176.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.491 ' HB2' ' HA ' ' A' ' 116' ' ' THR 0.348 18.3 Cg_endo -69.44 -42.77 3.42 Favored 'Trans proline' 0 CA--C 1.469 -2.77 0 C-N-CA 123.071 2.514 . . . . 0.0 113.174 177.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.61 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 42.6 m-80 -58.27 -14.13 6.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.295 -161.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.2 p -99.76 -20.45 16.23 Favored 'General case' 0 N--CA 1.395 -3.186 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.473 -172.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -132.27 -157.98 0.86 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.64 -169.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -65.05 162.76 16.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 123.614 0.571 . . . . 0.0 109.944 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p 49.0 45.07 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 123.083 1.42 . . . . 0.0 111.344 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.61 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -75.53 158.96 31.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.605 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.4 t -82.12 53.57 2.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.883 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.2 m -96.18 155.68 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.492 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.37 75.65 3.9 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.209 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.66 58.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.86 29.46 2.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.124 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.61 140.1 17.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -135.57 113.16 10.81 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.15 134.5 80.48 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 C--O 1.262 1.717 0 C-N-CA 123.384 2.723 . . . . 0.0 112.123 178.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 64.65 -79.23 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.467 1.107 . . . . 0.0 112.204 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' MET . . . . . 0.411 ' HB3' ' HB3' ' A' ' 105' ' ' PHE . 21.2 ptp -142.67 153.96 43.89 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.456 ' HA3' ' OE1' ' A' ' 39' ' ' GLU . . . 78.46 -148.35 32.35 Favored Glycine 0 N--CA 1.425 -2.069 0 O-C-N 123.986 0.804 . . . . 0.0 112.347 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 38.73 65.33 3.19 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.688 1.595 . . . . 0.0 114.952 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -101.54 -162.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.283 0 C-N-CA 123.769 2.979 . . . . 0.0 111.326 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -84.53 104.22 14.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.613 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -111.27 130.04 55.79 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 7' ' ' ASN . 10.7 t -143.43 16.39 1.85 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.628 0.728 . . . . 0.0 110.063 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 16.0 mtm180 58.06 -21.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 127.993 2.517 . . . . 0.0 115.683 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.464 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -99.89 113.37 65.11 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-O 120.894 0.378 . . . . 0.0 111.5 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 1.3 Cg_endo -48.14 -36.1 27.91 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.582 3.522 . . . . 0.0 112.705 174.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -73.97 -17.04 61.05 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.063 0.459 . . . . 0.0 111.61 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 20.8 mm-40 -94.93 -17.28 22.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.228 0.537 . . . . 0.0 110.201 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.5 mt -80.15 178.36 8.31 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 122.109 0.957 . . . . 0.0 109.697 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -114.48 -161.33 0.77 Allowed 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.665 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.87 176.69 38.14 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.081 -1.533 . . . . 0.0 112.799 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.1 OUTLIER -103.29 132.09 49.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.633 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.4 m-85 -108.07 111.77 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.486 1.136 . . . . 0.0 111.535 -175.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.504 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 21.3 mt -112.46 149.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.03 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.896 -174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -130.45 104.64 7.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -123.58 129.48 51.24 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 122.318 1.056 . . . . 0.0 111.581 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.813 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.4 ttmt -88.77 122.07 31.8 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.572 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' CD2' ' HA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -106.01 117.35 33.81 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 27.3 ttp-105 -79.27 107.36 11.97 Favored 'General case' 0 N--CA 1.394 -3.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.754 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.586 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 64.6 tttt -64.08 97.88 0.19 Allowed 'General case' 0 C--O 1.176 -2.781 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 169.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 89' ' ' ILE . 22.9 t -80.46 -155.81 0.12 Allowed 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 124.54 1.136 . . . . 0.0 109.16 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 m -58.55 -41.47 85.66 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -85.86 -21.46 28.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.586 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 102.27 -124.8 8.31 Favored Glycine 1 N--CA 1.392 -4.266 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 35.9 m-85 -86.74 145.7 26.55 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.729 0.764 . . . . 0.0 110.48 -176.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.63 1.63 64.03 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.908 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE2' HG23 ' A' ' 31' ' ' VAL . 6.7 p90 -114.27 163.06 15.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.453 0.644 . . . . 0.0 111.813 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -116.13 148.53 40.22 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 29' ' ' PHE . 4.0 t -127.23 143.68 39.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.125 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 33' ' ' GLY . 9.0 p -152.23 163.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.956 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 32' ' ' VAL . . . 124.76 -65.04 0.55 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 172.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -76.11 58.81 3.16 Favored Glycine 2 CA--C 1.408 -6.64 0 C-N-CA 125.621 1.581 . . . . 0.0 116.971 -166.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -66.21 -9.07 28.51 Favored 'General case' 0 C--N 1.253 -3.629 0 O-C-N 124.32 0.659 . . . . 0.0 111.75 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt-20 -160.62 166.36 15.69 Favored Pre-proline 0 CA--C 1.452 -2.799 0 C-N-CA 116.078 -2.249 . . . . 0.0 111.849 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.4 Cg_endo -67.62 53.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.807 2.338 . . . . 0.0 110.287 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -177.61 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.498 1.519 . . . . 0.0 109.872 -171.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.647 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 34.3 mt-10 -117.72 129.75 55.9 Favored 'General case' 0 C--O 1.272 2.256 0 CA-C-O 116.649 -1.643 . . . . 0.0 106.75 169.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.263 6.8 m-30 -79.33 156.4 28.03 Favored 'General case' 0 N--CA 1.523 3.18 0 O-C-N 128.675 3.735 . . . . 0.0 111.927 -177.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD12 ' HA3' ' A' ' 34' ' ' GLY . 6.3 mp -91.68 143.17 26.83 Favored 'General case' 0 CA--C 1.455 -2.689 0 C-N-CA 117.153 -1.819 . . . . 0.0 107.437 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.54 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 14.1 mt-30 -139.36 154.74 47.92 Favored 'General case' 0 C--N 1.266 -3.04 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.7 mm -75.11 109.48 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.431 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.22 -37.01 79.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.5 t 161.87 173.66 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 125.388 1.68 . . . . 0.0 109.344 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.3 pp -137.33 151.87 49.09 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 123.257 0.623 . . . . 0.0 111.469 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.08 116.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HA ' ' HB1' ' A' ' 53' ' ' ALA 0.264 0.8 OUTLIER -69.38 -4.17 17.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -174.389 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.49 -2.67 54.14 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.406 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.42 167.11 24.56 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.818 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.32 -31.78 58.3 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 124.624 3.549 . . . . 0.0 113.411 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -57.84 -44.55 86.57 Favored 'General case' 0 C--O 1.273 2.293 0 CA-C-O 121.753 0.787 . . . . 0.0 111.522 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 48' ' ' LEU . . . -76.74 -35.21 57.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.328 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.21 -28.21 53.75 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.36 -20.86 62.11 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.27 63.58 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.962 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -29.76 7.39 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.637 -172.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 51.2 ttm -96.96 132.84 42.35 Favored 'General case' 0 N--CA 1.407 -2.593 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.187 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -124.29 156.94 36.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 122.193 0.997 . . . . 0.0 109.336 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -71.48 107.76 4.55 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.297 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.08 -11.96 9.24 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.755 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 8.6 m-20 -64.44 151.46 44.16 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.401 1.101 . . . . 0.0 108.654 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -99.94 123.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 175.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 10.8 mm -71.29 122.31 23.1 Favored 'Isoleucine or valine' 1 C--O 1.322 4.883 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 171.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG12 HD12 ' A' ' 73' ' ' LEU . 44.4 t -114.69 -34.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 O-C-N 127.122 2.764 . . . . 0.0 109.905 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 39.4 m -147.66 148.84 31.49 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.457 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 ' CG1' ' A' ' 72' ' ' VAL . 8.4 p -125.28 133.11 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.57 27.24 16.39 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.519 0.676 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.35 26.13 14.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 123.484 1.612 . . . . 0.0 111.466 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.9 m -109.16 124.54 50.99 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.24 105.57 0.93 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.101 0.876 . . . . 0.0 109.927 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG1' HG12 ' A' ' 67' ' ' VAL . 35.7 m -121.18 27.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.406 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.613 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 43.8 tp -60.9 113.28 2.43 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.18 45.88 0.3 Allowed Glycine 0 N--CA 1.492 2.397 0 O-C-N 125.557 1.786 . . . . 0.0 111.606 -170.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.591 ' O ' HG21 ' A' ' 76' ' ' THR . 5.9 t60 -46.83 -69.14 0.14 Allowed 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 175.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.591 HG21 ' O ' ' A' ' 75' ' ' HIS . 21.5 p -164.86 144.0 6.89 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 148.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -49.84 -36.14 25.69 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 119.718 1.145 . . . . 0.0 110.437 173.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.01 91.89 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.481 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.564 ' NE2' ' HG1' ' A' ' 76' ' ' THR . 2.1 mp0 -64.05 -44.08 93.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.45 HG21 HD21 ' A' ' 41' ' ' LEU . 28.8 m -70.34 -43.5 78.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.808 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.1 -36.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.657 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.58 -43.27 99.17 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.328 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.657 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.7 -36.54 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.24 0.543 . . . . 0.0 112.435 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.33 -32.64 68.81 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.316 0.579 . . . . 0.0 110.173 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.576 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 7.8 mm-40 -75.55 -26.3 57.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.749 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.8 m -72.02 -40.36 68.5 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.765 1.226 . . . . 0.0 109.275 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.439 HG23 ' HD3' ' A' ' 22' ' ' LYS . 23.5 mt -69.81 135.45 87.8 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.994 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 16.3 Cg_endo -90.39 162.53 4.51 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 123.679 2.919 . . . . 0.0 113.208 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.479 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.7 mm -59.92 135.1 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.031 175.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.71 10.26 63.42 Favored Glycine 0 C--N 1.291 -1.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.843 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.53 133.57 49.16 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 6.7 m -100.79 159.42 15.2 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.538 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -144.74 125.5 8.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.648 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.623 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.42 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 23.4 m-20 -79.11 109.42 13.4 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.5 mt -104.63 136.91 43.28 Favored 'General case' 0 C--N 1.277 -2.557 0 C-N-CA 124.842 1.257 . . . . 0.0 109.836 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 40.8 tt0 -97.6 122.99 41.32 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 95.9 mt -112.65 148.84 33.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 125.154 1.382 . . . . 0.0 109.713 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.665 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 8.1 t -124.56 115.18 20.43 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.915 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 18.9 ttm180 -102.01 141.98 34.0 Favored 'General case' 0 C--N 1.256 -3.489 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.067 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.71 -17.06 3.98 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.354 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -92.01 139.97 24.59 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.16 134.26 24.54 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 124.712 3.608 . . . . 0.0 113.935 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.5 tt -62.24 137.06 95.8 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 125.102 1.361 . . . . 0.0 109.611 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -49.88 156.52 3.28 Favored 'Trans proline' 0 CA--C 1.504 -0.977 0 C-N-CA 124.951 3.767 . . . . 0.0 115.367 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.473 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 t80 -80.1 138.1 36.88 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-N 112.876 -1.965 . . . . 0.0 110.034 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.82 100.84 49.9 Favored Pre-proline 1 N--CA 1.375 -4.208 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.16 -175.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 59.3 Cg_endo -97.9 -56.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.293 1.995 . . . . 0.0 111.862 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.411 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 36.7 t70 -111.11 11.46 21.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 0.0 109.733 -177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.69 126.06 92.39 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.627 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.549 ' O ' ' HB ' ' A' ' 116' ' ' THR 0.292 35.9 Cg_endo -74.7 -44.57 0.36 Allowed 'Trans proline' 0 CA--C 1.484 -2.002 0 C-N-CA 122.398 2.065 . . . . 0.0 111.804 178.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.82 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 0.0 OUTLIER -58.39 -21.26 49.77 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.993 -2.821 . . . . 0.0 113.019 -164.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.5 p -93.68 -20.36 20.24 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.225 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.0 m -115.21 172.71 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.814 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.8 tp -85.09 65.85 9.44 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.962 0.887 . . . . 0.0 110.527 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.6 p -173.3 40.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.82 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 1.2 t -95.48 129.8 42.52 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -168.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m 45.13 77.42 0.08 Allowed 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.61 -2.087 . . . . 0.0 114.118 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.51 129.7 31.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.595 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.97 16.53 4.85 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.001 0.905 . . . . 0.0 112.251 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.37 71.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.4 mt -83.35 119.96 25.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.789 0.804 . . . . 0.0 110.296 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -99.16 113.84 26.29 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.693 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -142.7 52.2 1.42 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.91 136.97 73.15 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.559 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 C--O 1.254 1.28 0 C-N-CA 122.882 2.388 . . . . 0.0 110.93 173.72 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.875 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 65.52 -80.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.282 1.433 . . . . 0.0 112.455 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -119.84 90.78 3.4 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 135.08 -124.16 3.31 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.449 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.415 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 1.1 tppp? 48.35 67.54 4.39 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 125.191 1.396 . . . . 0.0 112.424 -174.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 1.8 Cg_endo -87.27 -175.77 1.65 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.128 2.552 . . . . 0.0 111.094 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.19 104.83 3.2 Favored 'General case' 0 N--CA 1.411 -2.377 0 C-N-CA 124.349 1.06 . . . . 0.0 108.562 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.612 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.7 t80 -98.94 139.12 35.07 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -147.51 10.28 0.96 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.963 0.887 . . . . 0.0 110.79 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.514 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 14.1 mtp180 52.9 6.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.803 2.041 . . . . 0.0 115.092 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -134.09 122.1 16.05 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -54.98 -34.93 88.6 Favored 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 124.135 3.223 . . . . 0.0 112.345 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -71.81 -21.99 61.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.563 0.697 . . . . 0.0 111.21 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -92.45 -24.27 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.435 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 42.5 tp -85.91 159.2 19.73 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.829 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 53.4 mttp -99.13 -171.23 2.05 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.96 177.93 27.94 Favored Glycine 0 C--N 1.292 -1.865 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.911 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -99.81 122.67 43.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 98' ' ' CYS . 98.5 m-85 -103.87 117.97 35.59 Favored 'General case' 0 C--N 1.253 -3.628 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.25 126.74 68.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.463 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -99.95 111.95 24.24 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 57' ' ' LYS . 14.8 t -133.1 147.59 52.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.018 0.913 . . . . 0.0 110.73 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.852 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 22.0 ttpp -90.17 132.31 35.54 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.608 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -109.68 119.27 38.88 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 72.5 ttt180 -81.48 109.47 15.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.965 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.596 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.5 tttt -63.95 96.51 0.14 Allowed 'General case' 0 C--O 1.184 -2.377 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -90.03 -154.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 124.457 1.103 . . . . 0.0 109.061 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 m -52.35 -40.63 62.2 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.878 0.871 . . . . 0.0 111.695 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -95.6 -9.41 32.27 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.012 0.434 . . . . 0.0 110.065 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.596 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.01 -119.08 6.25 Favored Glycine 1 N--CA 1.392 -4.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.428 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 46.2 m-85 -91.46 139.88 30.29 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 117.763 0.782 . . . . 0.0 108.935 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.94 3.01 87.28 Favored Glycine 0 C--N 1.315 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.897 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HB2' HG21 ' A' ' 43' ' ' ILE . 12.1 p90 -116.33 162.69 17.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.353 0.597 . . . . 0.0 111.324 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 26.3 p -116.19 152.91 32.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.53 143.86 38.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.464 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 33' ' ' GLY . 10.6 p -152.66 155.61 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 171.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 136.25 -72.94 0.45 Allowed Glycine 0 CA--C 1.459 -3.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.0 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.833 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -62.11 58.51 0.03 OUTLIER Glycine 1 CA--C 1.442 -4.505 0 C-N-CA 127.454 2.454 . . . . 0.0 117.459 -169.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.49 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 17.3 t70 -63.09 -27.98 69.77 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -154.82 166.31 16.32 Favored Pre-proline 0 CA--C 1.454 -2.727 0 C-N-CA 116.192 -2.203 . . . . 0.0 110.941 -170.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.7 Cg_endo -68.42 55.79 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.308 2.005 . . . . 0.0 109.718 171.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -178.63 -17.15 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.008 1.723 . . . . 0.0 110.06 -171.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.833 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 19.1 mm-40 -115.89 127.03 54.68 Favored 'General case' 0 C--O 1.273 2.301 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.269 6.0 m-30 -79.02 157.68 28.04 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 128.77 3.794 . . . . 0.0 111.628 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.499 HD12 ' HA3' ' A' ' 34' ' ' GLY . 5.3 mp -88.25 143.53 26.98 Favored 'General case' 0 C--O 1.185 -2.319 0 C-N-CA 117.149 -1.821 . . . . 0.0 107.105 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.2 mt-30 -140.25 154.68 46.94 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 HG21 ' HB2' ' A' ' 29' ' ' PHE . 18.9 mm -73.96 113.24 11.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 19.2 ttmm -57.14 -38.04 72.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 125.13 1.519 . . . . 0.0 107.16 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 60' ' ' THR . 34.8 t 159.86 173.35 0.01 OUTLIER 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.428 1.891 . . . . 0.0 109.114 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.4 147.82 41.98 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.414 0.626 . . . . 0.0 111.671 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -76.53 128.06 37.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -64.53 -15.45 60.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.12 6.83 46.32 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.957 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.25 158.81 21.79 Favored Glycine 0 N--CA 1.398 -3.847 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.21 -30.52 42.12 Favored 'Trans proline' 0 C--O 1.202 -1.318 0 C-N-CA 124.429 3.42 . . . . 0.0 112.884 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -60.1 -44.59 94.73 Favored 'General case' 0 C--O 1.278 2.565 0 CA-C-O 121.551 0.691 . . . . 0.0 111.982 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.55 -35.02 53.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.811 -1.541 . . . . 0.0 111.022 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.1 -46.02 72.1 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.313 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 38.3 t70 -63.67 -34.58 78.17 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -8.77 58.25 Favored Glycine 0 CA--C 1.492 -1.393 0 CA-C-N 112.484 -2.144 . . . . 0.0 114.082 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HB2' ' OD2' ' A' ' 55' ' ' ASP . 46.1 mttp -86.7 -14.53 42.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 123.117 0.567 . . . . 0.0 112.081 -176.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 ttm -104.02 144.96 30.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -143.67 155.52 44.25 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 121.447 0.642 . . . . 0.0 110.103 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 ' HA ' ' A' ' 45' ' ' SER . 77.8 p -63.21 108.45 1.28 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.86 -0.31 31.92 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.121 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.54 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.0 p30 -73.43 146.94 44.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.425 -1.71 . . . . 0.0 107.292 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -94.65 120.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 26.6 mm -71.08 125.16 28.93 Favored 'Isoleucine or valine' 1 C--O 1.319 4.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.499 HG12 HD11 ' A' ' 73' ' ' LEU . 48.6 t -115.27 -41.36 3.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.614 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HA ' HG22 ' A' ' 72' ' ' VAL . 66.5 m -145.34 147.42 32.29 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.281 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.1 132.0 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.03 29.57 14.67 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.452 0.644 . . . . 0.0 111.101 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 67.58 11.51 8.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.7 m -93.47 122.85 36.33 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.2 t -66.04 103.6 0.98 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.455 ' CA ' ' HB2' ' A' ' 75' ' ' HIS . 33.6 m -117.84 25.67 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.884 0.849 . . . . 0.0 110.501 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.612 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.2 tp -61.43 113.28 2.57 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 35.46 40.72 0.3 Allowed Glycine 0 N--CA 1.497 2.725 0 O-C-N 125.188 1.555 . . . . 0.0 111.785 -170.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.55 ' O ' HG21 ' A' ' 76' ' ' THR . 7.0 t60 -43.98 -67.22 0.3 Allowed 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.55 HG21 ' O ' ' A' ' 75' ' ' HIS . 2.4 p -167.35 143.57 4.25 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 150.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 -36.55 26.7 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 120.194 1.361 . . . . 0.0 110.119 172.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.2 81.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.448 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.562 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 7.3 mm-40 -66.8 -44.26 81.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 HD21 ' A' ' 41' ' ' LEU . 34.0 m -65.58 -40.06 86.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.471 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.5 -39.04 84.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -59.62 -38.43 81.31 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.676 177.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.604 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 72.4 mt -68.09 -38.41 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.574 0.702 . . . . 0.0 110.853 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.07 -30.83 65.52 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.89 -32.55 73.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.313 1.045 . . . . 0.0 109.994 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 59.5 m -71.84 -43.17 66.0 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.474 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.5 mt -71.8 133.06 84.55 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.574 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 36.0 Cg_endo -91.44 161.84 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.507 2.804 . . . . 0.0 113.549 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.481 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.0 mm -61.63 129.98 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 121.156 0.503 . . . . 0.0 111.019 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.72 11.94 51.95 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.707 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.4 -170.48 1.81 Allowed 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -147.79 166.78 26.52 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.852 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -150.45 125.2 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.463 -2.371 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.772 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.58 105.53 16.23 Favored 'General case' 0 C--N 1.268 -2.969 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -111.83 151.61 28.87 Favored 'General case' 0 C--O 1.208 -1.083 0 C-N-CA 125.593 1.557 . . . . 0.0 110.777 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 22.8 tt0 -111.01 121.73 46.1 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.748 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.7 mp -108.62 164.42 12.38 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 126.654 1.982 . . . . 0.0 109.272 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.5 t -140.69 112.46 7.57 Favored 'General case' 0 C--O 1.19 -2.026 0 CA-C-O 122.339 1.066 . . . . 0.0 111.992 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 7.7 tpp180 -95.3 129.99 42.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.78 -17.52 0.96 Allowed Glycine 0 C--N 1.294 -1.769 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.053 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -107.23 126.94 28.9 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.14 150.69 71.96 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 124.126 3.217 . . . . 0.0 112.573 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 6.4 mt -57.34 124.48 67.01 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.239 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 7.4 Cg_exo -66.75 -46.76 3.24 Favored 'Trans proline' 0 CA--C 1.49 -1.684 0 C-N-CA 123.339 2.693 . . . . 0.0 110.787 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.435 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 86.0 t80 -138.66 141.67 39.04 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.291 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.43 100.69 42.76 Favored Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 124.286 0.991 . . . . 0.0 111.813 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 59.9 Cg_endo -99.45 -64.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.643 0 C-N-CA 122.588 2.192 . . . . 0.0 111.621 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 5.6 t70 -119.68 31.72 6.42 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.989 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.532 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 34.8 t70 -86.48 108.73 19.03 Favored Pre-proline 0 CA--C 1.457 -2.633 0 C-N-CA 117.466 -1.694 . . . . 0.0 106.573 168.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.658 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 73.2 Cg_endo -73.4 -30.84 9.73 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.161 1.908 . . . . 0.0 110.309 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.658 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 26.6 t30 -65.27 -2.31 2.96 Favored 'General case' 0 N--CA 1.389 -3.523 0 C-N-CA 131.358 3.863 . . . . 0.0 112.683 -168.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.483 ' H ' ' C ' ' A' ' 110' ' ' PRO . 23.7 p -92.36 -22.37 19.72 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.366 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.9 m -92.17 162.17 14.43 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.31 -1.313 . . . . 0.0 107.994 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.98 141.52 47.75 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.26 21.8 m 49.26 38.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.774 1.63 . . . . 0.0 114.247 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 110' ' ' PRO . 1.1 m -110.56 -172.88 2.12 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 110' ' ' PRO . 10.9 p 59.56 96.1 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.075 0.95 . . . . 0.0 112.376 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -69.07 74.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.589 1.185 . . . . 0.0 112.688 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.71 33.2 2.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.544 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.0 mt 60.73 58.24 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.27 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.0 mt -127.27 117.43 22.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.835 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -125.28 51.14 1.71 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -92.55 80.36 4.84 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.728 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -101.88 136.65 19.48 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--O 1.262 1.724 0 C-N-CA 123.024 2.483 . . . . 0.0 112.225 176.79 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.785 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -64.34 0.91 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 117.558 0.679 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -111.9 19.0 18.34 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 98.88 -146.76 18.27 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.533 ' HG2' ' OE1' ' A' ' 39' ' ' GLU . 46.8 mmtm -108.6 -61.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 CA-C-N 118.69 1.245 . . . . 0.0 110.242 168.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 1' ' ' LYS . 44.2 Cg_endo -104.34 -164.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.814 1.676 . . . . 0.0 111.594 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -76.31 107.14 8.35 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 124.97 1.308 . . . . 0.0 107.659 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.596 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.1 t80 -101.73 129.87 48.0 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -138.17 11.8 2.82 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.284 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.538 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtt180 52.59 8.43 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.804 2.042 . . . . 0.0 114.789 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -131.96 116.75 15.83 Favored Pre-proline 0 N--CA 1.415 -2.176 0 C-N-CA 122.458 0.303 . . . . 0.0 110.974 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.56 -18.05 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 110.785 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 p -76.15 -29.72 57.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.851 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -107.38 -10.96 15.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.051 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -93.5 149.82 20.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' N ' HD12 ' A' ' 11' ' ' LEU . 45.9 mtmt -105.79 135.54 47.04 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.731 0.776 . . . . 0.0 110.998 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.58 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 151.17 170.15 17.75 Favored Glycine 1 C--N 1.244 -4.583 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -172.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -92.32 122.35 34.7 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.397 1.098 . . . . 0.0 108.443 175.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.6 m-85 -98.66 117.45 33.14 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 122.611 1.196 . . . . 0.0 110.027 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 34.1 mt -114.35 152.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.065 0 CA-C-N 112.755 -2.021 . . . . 0.0 109.357 -172.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -129.31 108.47 10.33 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -131.54 135.08 46.75 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.872 0.844 . . . . 0.0 109.81 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.8 ttmt -89.45 126.65 35.65 Favored 'General case' 0 C--N 1.257 -3.436 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.782 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.411 HD22 ' CA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -106.47 116.94 32.8 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 56.5 ttt180 -77.89 107.44 10.42 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.931 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 64.7 tttt -61.85 97.34 0.08 Allowed 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -86.23 -155.36 0.25 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 124.758 1.223 . . . . 0.0 108.818 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 m -54.21 -41.3 68.5 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.991 0.916 . . . . 0.0 110.816 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -96.16 -8.85 32.06 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.189 0.519 . . . . 0.0 109.958 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.581 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 96.32 -120.67 6.7 Favored Glycine 1 N--CA 1.391 -4.315 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.502 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 34.2 m-85 -89.58 141.74 28.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.401 0.6 . . . . 0.0 109.576 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.22 1.11 84.31 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.966 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.419 ' HB2' HG22 ' A' ' 43' ' ' ILE . 19.4 p90 -114.58 162.37 16.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.725 0.774 . . . . 0.0 111.099 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.616 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 40.6 p -115.18 154.34 29.18 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -143.81 144.24 23.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.664 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 33' ' ' GLY . 9.8 p -149.33 170.02 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.26 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 32' ' ' VAL . . . 124.05 -68.83 0.48 Allowed Glycine 0 CA--C 1.452 -3.906 0 CA-C-N 115.124 -0.943 . . . . 0.0 113.796 172.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -75.39 58.02 2.86 Favored Glycine 2 CA--C 1.406 -6.73 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.45 -12.78 47.08 Favored 'General case' 0 C--N 1.261 -3.251 0 O-C-N 124.449 0.735 . . . . 0.0 110.797 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 38' ' ' ASP . 6.1 pt-20 -158.23 165.14 19.22 Favored Pre-proline 0 CA--C 1.452 -2.812 0 C-N-CA 116.519 -2.072 . . . . 0.0 111.205 -173.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.5 Cg_endo -68.37 47.01 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.764 2.309 . . . . 0.0 111.529 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 36' ' ' GLU . 27.2 m-20 -165.44 -22.69 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.356 2.262 . . . . 0.0 109.248 -172.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.707 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 37.9 mt-10 -112.83 126.25 55.23 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.259 5.2 m-30 -78.78 157.43 28.44 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 128.076 3.36 . . . . 0.0 111.365 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD12 ' HA3' ' A' ' 34' ' ' GLY . 6.9 mp -90.08 144.71 25.65 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 117.506 -1.678 . . . . 0.0 107.093 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.8 mt-30 -143.54 151.01 39.72 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.419 HG22 ' HB2' ' A' ' 29' ' ' PHE . 19.3 mm -68.39 117.8 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.616 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 20.8 tptm -63.05 -43.37 98.81 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 60' ' ' THR . 40.2 t 166.14 174.97 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 125.596 1.81 . . . . 0.0 109.993 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.3 152.41 45.85 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.704 0.764 . . . . 0.0 112.923 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.4 t -85.35 128.61 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.51 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 89.1 mt -68.88 -15.9 63.62 Favored 'General case' 0 N--CA 1.387 -3.612 0 CA-C-N 112.733 -2.03 . . . . 0.0 113.59 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.26 -5.36 40.44 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 114.154 -1.385 . . . . 0.0 111.245 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -91.71 162.96 28.11 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.99 -31.79 65.43 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 124.541 3.494 . . . . 0.0 113.576 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.411 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -59.3 -42.67 91.87 Favored 'General case' 0 C--O 1.279 2.641 0 CA-C-O 121.706 0.765 . . . . 0.0 111.42 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.74 -37.35 49.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.899 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 50' ' ' GLY . 8.6 mp -68.82 -40.28 79.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.74 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.55 -26.1 61.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.72 2.78 77.42 Favored Glycine 0 CA--C 1.495 -1.181 0 CA-C-N 112.888 -1.96 . . . . 0.0 113.826 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -91.46 -21.28 21.01 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.21 149.28 23.25 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.575 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.37 154.73 40.34 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.395 0.617 . . . . 0.0 110.625 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.441 HG23 ' HA ' ' A' ' 45' ' ' SER . 67.8 p -61.37 106.04 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.761 0.824 . . . . 0.0 111.493 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 110.79 -2.27 28.88 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 119.311 -0.716 . . . . 0.0 113.563 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' CB ' ' HG3' ' A' ' 99' ' ' ARG . 2.8 p30 -69.71 138.67 53.09 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -87.76 120.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.471 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 31.3 mm -71.62 124.37 27.96 Favored 'Isoleucine or valine' 1 C--O 1.324 4.978 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 172.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG11 HD13 ' A' ' 73' ' ' LEU . 37.0 t -115.63 -40.9 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.064 -2.789 . . . . 0.0 111.036 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.456 ' HA ' HG21 ' A' ' 72' ' ' VAL . 24.7 m -149.82 150.38 31.89 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.7 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 HG22 ' A' ' 72' ' ' VAL . 2.9 m -121.99 142.11 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 169.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.8 m120 54.61 28.11 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.548 0.689 . . . . 0.0 111.379 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 54.9 42.32 31.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.668 1.699 . . . . 0.0 111.832 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' HG11 ' A' ' 72' ' ' VAL . 88.8 m -122.12 122.82 40.1 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.898 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.54 100.17 0.49 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.926 0.869 . . . . 0.0 111.055 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 66' ' ' SER . 17.4 m -105.04 17.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.596 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.1 tp -60.61 112.96 2.2 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.44 44.98 0.3 Allowed Glycine 0 N--CA 1.496 2.645 0 O-C-N 125.649 1.843 . . . . 0.0 111.272 -170.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.583 ' O ' HG22 ' A' ' 76' ' ' THR . 8.4 t60 -45.37 -67.62 0.27 Allowed 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 75' ' ' HIS . 3.1 p -166.9 142.78 4.36 Favored 'General case' 0 C--N 1.262 -3.219 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 148.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.521 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.04 -35.21 33.19 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 120.695 1.588 . . . . 0.0 111.205 173.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.14 96.39 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.654 0.264 . . . . 0.0 110.929 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.424 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 16.9 mm-40 -69.65 -41.57 75.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 77' ' ' HIS . 21.1 m -63.66 -39.82 86.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.154 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.62 -40.77 90.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -61.06 -36.81 80.59 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.558 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.9 mm -70.45 -37.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 123.683 0.793 . . . . 0.0 112.057 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.33 -29.01 62.39 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -76.34 -20.18 57.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.407 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 37.6 t -78.04 -26.39 48.35 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.6 mt -90.07 130.11 43.53 Favored Pre-proline 0 N--CA 1.398 -3.032 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.134 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.0 Cg_endo -89.49 162.44 5.41 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 123.697 2.932 . . . . 0.0 112.954 -173.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.504 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.3 mm -60.12 133.6 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 CA-C-O 121.538 0.685 . . . . 0.0 110.902 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.76 60.33 Favored Glycine 0 C--N 1.289 -2.078 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.019 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . . . -102.38 -167.92 1.46 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.9 m -151.52 163.39 39.13 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 121.929 -0.482 . . . . 0.0 109.919 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -145.83 125.26 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 C-N-CA 119.569 -0.853 . . . . 0.0 111.76 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.08 107.16 12.65 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 66' ' ' SER . 63.6 mt -104.96 135.59 46.01 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 124.433 1.093 . . . . 0.0 111.75 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 38.8 mt-10 -90.52 120.47 31.64 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 7.9 mt -105.65 164.63 11.76 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.58 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.8 t -141.37 109.16 5.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 122.254 1.026 . . . . 0.0 110.906 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HG3' ' CB ' ' A' ' 62' ' ' ASP 0.33 23.7 mtm180 -96.18 117.97 31.81 Favored 'General case' 0 C--N 1.257 -3.422 0 O-C-N 121.331 -0.856 . . . . 0.0 113.133 174.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.55 -29.73 0.1 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.287 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -101.64 135.46 19.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.547 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.72 161.77 44.64 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.257 2.638 . . . . 0.0 111.231 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.4 mt -50.41 127.06 23.17 Favored Pre-proline 0 N--CA 1.44 -0.96 0 C-N-CA 124.452 1.101 . . . . 0.0 111.195 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.94 -81.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.048 3.165 . . . . 0.0 117.045 -170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -128.22 146.56 50.7 Favored 'General case' 0 N--CA 1.424 -1.725 0 O-C-N 121.861 -0.524 . . . . 0.0 111.041 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.96 104.84 12.63 Favored Pre-proline 0 C--N 1.302 -1.498 0 C-N-CA 124.689 1.196 . . . . 0.0 110.621 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 58.3 Cg_endo -99.76 -64.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.282 1.988 . . . . 0.0 112.698 172.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.412 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 8.5 p-10 -88.22 -11.58 46.26 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.47 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -91.97 142.67 26.68 Favored Pre-proline 0 CA--C 1.463 -2.375 0 C-N-CA 118.427 -1.309 . . . . 0.0 113.392 -167.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 119' ' ' ALA 0.285 50.2 Cg_endo -81.56 -40.93 0.14 Allowed 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.798 1.666 . . . . 0.0 111.699 167.051 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.531 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 55.5 m-80 -48.68 -17.12 0.15 Allowed 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -163.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.9 p -82.64 -38.93 22.8 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -170.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.2 m -158.79 125.82 4.81 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.0 mt 50.57 111.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.76 2.024 . . . . 0.0 114.765 173.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.0 t 60.68 77.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 111' ' ' ASN . 1.6 p -124.66 166.79 15.51 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.058 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' A' ' 110' ' ' PRO . 32.7 t 63.71 114.67 0.02 OUTLIER 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.444 1.097 . . . . 0.0 111.309 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.6 t 59.36 46.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.79 1.281 . . . . 0.0 108.256 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 110' ' ' PRO . . . -159.93 69.13 0.4 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.879 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.97 91.12 3.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.31 12.19 23.34 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.772 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -85.02 -7.79 58.98 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.015 -1.902 . . . . 0.0 107.158 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 75.89 71.27 0.08 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.193 2.197 . . . . 0.0 113.742 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -101.94 142.87 25.47 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--O 1.254 1.308 0 C-N-CA 123.033 2.488 . . . . 0.0 112.703 177.1 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -150.81 -163.5 1.79 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' MET . . . . . 0.501 ' HA ' ' CB ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -68.03 -31.92 71.93 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.231 175.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -136.17 -93.06 0.36 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.491 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.1 OUTLIER 58.51 71.75 0.96 Allowed Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 124.781 1.233 . . . . 0.0 113.695 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -104.07 -172.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 123.42 2.747 . . . . 0.0 110.228 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -89.93 104.8 17.34 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.553 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.9 t80 -105.15 131.15 53.0 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 HD23 ' A' ' 11' ' ' LEU . 8.8 t -140.38 19.05 2.4 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.246 1.022 . . . . 0.0 110.704 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 57.6 mtt180 58.41 -13.13 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.96 2.104 . . . . 0.0 115.961 172.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.561 ' OD1' ' HB2' ' A' ' 9' ' ' SER . 23.7 t-20 -113.57 119.48 41.52 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 110.927 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.4 -32.82 74.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.179 3.252 . . . . 0.0 112.814 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.561 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 26.4 m -75.69 -22.48 56.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.408 0.683 . . . . 0.0 110.954 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -90.29 -19.56 23.96 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.898 0.879 . . . . 0.0 111.033 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD23 HG23 ' A' ' 5' ' ' THR . 51.0 mt -74.48 172.37 12.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.092 0.948 . . . . 0.0 111.485 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -108.39 -170.39 1.67 Allowed 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.607 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 90.16 165.71 40.81 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.09 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 22.2 ttpt -95.86 137.7 34.55 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 30.8 m-85 -104.88 111.89 24.81 Favored 'General case' 0 CA--C 1.458 -2.592 0 CA-C-O 122.687 1.232 . . . . 0.0 110.226 -173.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.484 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.4 mt -108.46 113.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.9 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.007 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.87 128.42 34.41 Favored 'General case' 0 C--N 1.252 -3.631 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.915 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' HB2' ' A' ' 95' ' ' LEU . 7.4 t -133.62 157.01 46.83 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.399 -173.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.817 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -130.58 119.02 21.89 Favored 'General case' 0 C--N 1.247 -3.865 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 172.121 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.492 ' HG ' ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -106.67 117.47 34.14 Favored 'General case' 0 C--N 1.277 -2.576 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.837 -174.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -70.66 105.66 3.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.51 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.632 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 62.6 tttt -69.34 97.76 1.0 Allowed 'General case' 0 C--O 1.161 -3.603 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 165.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -86.66 -155.27 0.26 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.6 m -63.31 -33.12 74.82 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 1.3 tmt_? -83.53 -20.97 32.93 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.603 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 94.14 -129.19 9.79 Favored Glycine 0 N--CA 1.401 -3.649 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.8 m-85 -86.98 146.97 25.94 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 118.134 0.967 . . . . 0.0 110.212 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.38 0.74 66.15 Favored Glycine 0 C--O 1.22 -0.775 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.533 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 5.8 p90 -115.67 163.48 15.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.514 . . . . 0.0 110.642 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.6 p -123.71 147.53 47.38 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.84 150.14 26.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.391 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.49 152.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.523 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.84 -132.12 9.7 Favored Glycine 1 N--CA 1.395 -4.06 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 47.58 37.46 13.42 Favored Glycine 0 CA--C 1.476 -2.363 0 C-N-CA 124.212 0.911 . . . . 0.0 113.55 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -69.03 -29.4 67.54 Favored 'General case' 0 CA--C 1.459 -2.547 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -162.38 166.74 13.46 Favored Pre-proline 0 CA--C 1.455 -2.702 0 C-N-CA 118.352 -1.339 . . . . 0.0 109.243 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.7 Cg_endo -66.19 58.72 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.005 2.47 . . . . 0.0 109.583 170.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 174.54 -9.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.746 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.527 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.5 mm-40 -128.34 124.53 36.68 Favored 'General case' 0 C--O 1.281 2.744 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 73' ' ' LEU 0.276 5.9 m-30 -76.66 158.81 30.75 Favored 'General case' 1 N--CA 1.549 4.52 0 C-N-CA 130.914 3.685 . . . . 0.0 113.609 -168.246 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 HD23 HG22 ' A' ' 80' ' ' VAL . 6.2 mp -92.4 138.86 31.15 Favored 'General case' 0 C--O 1.178 -2.659 0 C-N-CA 117.068 -1.853 . . . . 0.0 106.951 170.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 18.1 mt-30 -136.16 154.18 51.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 62' ' ' ASP . 20.7 mm -71.34 115.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' SER . 31.0 ttpt -65.01 -41.63 95.18 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.477 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 166.72 173.72 0.03 OUTLIER 'General case' 0 C--N 1.371 1.503 0 O-C-N 125.186 1.554 . . . . 0.0 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' CD2' ' HB3' ' A' ' 58' ' ' MET . 1.4 pp -141.6 152.2 43.8 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 123.816 0.846 . . . . 0.0 111.819 -172.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 t -82.85 124.41 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.793 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.88 -3.75 13.83 Favored 'General case' 0 N--CA 1.379 -3.975 0 CA-C-N 112.836 -1.984 . . . . 0.0 112.937 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -95.79 -22.97 17.17 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.658 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.35 162.77 36.83 Favored Glycine 0 N--CA 1.398 -3.892 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.586 -170.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -51.39 -30.32 33.98 Favored 'Trans proline' 0 C--O 1.197 -1.553 0 C-N-CA 125.178 3.919 . . . . 0.0 112.952 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.97 81.52 Favored 'General case' 0 C--O 1.258 1.524 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.34 -36.2 54.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.644 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.31 -40.6 70.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.733 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.37 -21.6 62.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.81 39.88 75.84 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -111.26 -37.62 5.25 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.677 0.275 . . . . 0.0 111.463 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.425 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 1.1 mpt? -95.93 153.14 17.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.403 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.78 158.38 43.69 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 45' ' ' SER . 49.0 p -64.22 108.67 1.64 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.007 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.56 -11.64 9.61 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.709 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 43' ' ' ILE . 2.9 m-20 -62.86 136.69 57.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.547 1.173 . . . . 0.0 108.803 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -88.25 123.36 40.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 177.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.59 123.52 30.28 Favored 'Isoleucine or valine' 1 C--O 1.34 5.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG11 HD11 ' A' ' 73' ' ' LEU . 46.0 t -115.53 -36.14 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 127.444 2.965 . . . . 0.0 111.375 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 65.6 m -148.57 159.62 43.9 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.515 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.45 130.18 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 108.016 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.23 31.48 20.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.461 0.648 . . . . 0.0 110.728 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 71.2 1.4 3.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.495 1.518 . . . . 0.0 112.593 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.3 m -90.95 121.97 33.23 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.404 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.8 t -58.86 114.8 2.72 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.416 ' CG2' HG13 ' A' ' 80' ' ' VAL . 2.0 p -124.23 19.39 4.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.553 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.8 tp -59.15 112.85 1.86 Allowed 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.11 39.76 0.06 OUTLIER Glycine 0 C--O 1.186 -2.879 0 O-C-N 125.737 1.898 . . . . 0.0 112.792 -170.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.594 ' O ' HG23 ' A' ' 76' ' ' THR . 4.6 t60 -43.38 -65.75 0.46 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.9 p -167.33 143.84 4.35 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 151.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.553 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.85 -35.13 30.99 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 120.099 1.318 . . . . 0.0 109.702 171.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -46.95 87.17 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.436 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 13.3 mm-40 -66.35 -43.08 87.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 77' ' ' HIS . 15.3 m -64.44 -44.89 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.533 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 84.5 t -64.51 -42.12 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.74 -37.89 83.3 Favored 'General case' 0 C--O 1.212 -0.887 0 O-C-N 123.151 0.282 . . . . 0.0 111.47 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.568 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.9 mm -67.48 -38.28 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.307 0.575 . . . . 0.0 112.148 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.54 -32.19 65.88 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.523 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 25.6 mt-30 -67.78 -32.07 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.211 1.005 . . . . 0.0 109.691 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.2 m -72.33 -40.6 67.31 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.886 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.417 HG22 ' HD3' ' A' ' 22' ' ' LYS . 30.8 mt -70.34 133.05 87.47 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.475 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 15.0 Cg_endo -87.21 162.65 8.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.57 2.847 . . . . 0.0 113.433 -172.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.461 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.9 mm -60.22 134.8 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.609 0.719 . . . . 0.0 111.074 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.37 8.26 66.4 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.365 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.24 128.08 51.94 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 p -89.79 159.14 17.18 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.13 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -141.78 125.6 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.183 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.913 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.3 104.5 15.2 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.411 ' HB2' HG22 ' A' ' 18' ' ' THR . 27.9 mt -109.68 159.72 16.9 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 126.138 1.775 . . . . 0.0 109.305 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.44 122.71 48.5 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 75.7 mt -109.14 163.14 13.61 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.21 1.004 . . . . 0.0 108.766 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.607 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -142.91 116.58 9.22 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.412 175.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.457 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 ttm180 -104.73 125.57 50.95 Favored 'General case' 0 C--N 1.258 -3.374 0 O-C-N 120.729 -1.232 . . . . 0.0 108.764 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.9 -22.03 0.23 Allowed Glycine 0 CA--C 1.472 -2.639 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -90.89 134.62 29.99 Favored Pre-proline 0 N--CA 1.422 -1.835 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.58 152.57 81.28 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.803 3.002 . . . . 0.0 112.939 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.9 128.41 86.84 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 123.477 0.711 . . . . 0.0 110.654 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.9 -158.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.054 2.503 . . . . 0.0 113.389 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.501 ' CB ' ' HA ' ' A' ' -1' ' ' MET . 66.9 t80 -79.96 150.63 30.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 123.153 1.454 . . . . 0.0 111.293 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -115.41 86.32 14.67 Favored Pre-proline 0 N--CA 1.388 -3.574 0 CA-C-N 111.726 -2.488 . . . . 0.0 110.887 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.431 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 73.6 Cg_endo -88.3 -49.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.516 2.144 . . . . 0.0 111.378 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.431 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 20.3 t70 -59.38 -22.99 62.19 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 125.183 1.393 . . . . 0.0 110.832 176.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -108.53 102.98 49.69 Favored Pre-proline 0 CA--C 1.473 -2.009 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.879 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.53 ' HG2' ' N ' ' A' ' 111' ' ' ASN 0.285 54.7 Cg_endo -76.65 -29.41 5.75 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.371 2.047 . . . . 0.0 108.89 170.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.53 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 57.2 m-20 -47.58 -2.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 1 C-N-CA 132.67 4.388 . . . . 0.0 116.014 -168.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 110' ' ' PRO . 26.4 p -107.04 6.38 28.94 Favored 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -168.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.0 m -146.19 110.26 4.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.773 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.8 mt 55.66 -154.22 0.31 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.279 0.631 . . . . 0.0 110.374 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.6 m -56.46 84.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 122.04 0.924 . . . . 0.0 112.745 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 p -134.67 167.16 21.34 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.428 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . 61.8 p 61.9 101.53 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.406 1.082 . . . . 0.0 109.411 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.9 m -52.23 96.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -175.02 114.98 0.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.3 mm -122.04 103.5 13.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 122.049 0.928 . . . . 0.0 112.399 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -116.37 22.59 12.72 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.94 146.05 26.4 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.605 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -86.79 -10.68 52.99 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.098 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.05 139.62 96.69 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.495 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 C--O 1.256 1.382 0 C-N-CA 123.818 3.012 . . . . 0.0 112.463 174.558 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.273 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.23 -85.27 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' MET . . . . . 0.443 ' HA ' ' HE3' ' A' ' -1' ' ' MET . 7.5 mmt -101.75 0.03 35.18 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 173.51 -97.26 0.11 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 59.16 69.69 1.29 Allowed Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.417 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -108.61 -175.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.931 2.42 . . . . 0.0 113.57 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -88.83 105.3 17.64 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.58 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.8 t80 -108.76 135.24 50.31 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 7' ' ' ASN . 9.5 t -143.3 12.7 1.78 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.313 1.054 . . . . 0.0 110.239 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.54 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 7.1 mtm180 59.76 -11.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.008 2.123 . . . . 0.0 114.88 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 51.2 t-20 -111.35 115.98 51.48 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.1 0.476 . . . . 0.0 110.626 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 4.2 Cg_endo -56.46 -28.19 72.13 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.649 2.9 . . . . 0.0 112.84 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.61 -27.19 63.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -91.42 -22.45 20.45 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.843 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.3 mt -72.09 179.48 3.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.108 0.956 . . . . 0.0 112.208 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -108.87 -166.37 1.11 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.069 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.604 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.17 167.56 41.66 Favored Glycine 0 C--N 1.304 -1.23 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.751 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 33.4 tttp -97.53 143.39 28.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.7 m-85 -106.95 112.04 24.81 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.415 1.103 . . . . 0.0 109.419 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.4 mt -112.3 148.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.442 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.09 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.56 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.9 t60 -124.76 120.02 30.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -140.34 131.5 26.45 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.741 0.781 . . . . 0.0 111.294 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 31.7 ttmt -88.16 125.95 34.88 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.327 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.38 117.4 33.95 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.912 -176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 41.3 ttm180 -77.44 107.42 9.87 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.699 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 76.3 tttt -64.54 97.39 0.2 Allowed 'General case' 0 C--O 1.178 -2.699 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 t -91.86 -153.53 0.34 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 125.347 1.459 . . . . 0.0 108.216 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 p -52.68 -46.8 67.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.982 0.513 . . . . 0.0 111.564 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -84.07 -17.23 40.97 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.514 0.674 . . . . 0.0 109.904 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.614 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 95.68 -105.61 3.27 Favored Glycine 1 N--CA 1.377 -5.295 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 40.5 m-85 -97.1 140.22 31.93 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.687 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.87 4.83 84.94 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.638 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 43' ' ' ILE . 27.4 p90 -111.99 163.04 14.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.454 0.645 . . . . 0.0 110.499 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' HE3' ' A' ' 44' ' ' LYS . 43.7 p -117.6 149.15 41.15 Favored 'General case' 0 N--CA 1.401 -2.891 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -141.24 139.16 33.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 C-N-CA 119.246 -0.981 . . . . 0.0 112.06 -173.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 33' ' ' GLY . 13.1 p -149.24 167.24 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.942 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' N ' HG21 ' A' ' 32' ' ' VAL . . . 128.55 -65.11 0.59 Allowed Glycine 0 CA--C 1.453 -3.795 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.175 173.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.695 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -74.9 57.64 2.66 Favored Glycine 2 CA--C 1.42 -5.897 0 C-N-CA 125.649 1.595 . . . . 0.0 116.284 -167.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.88 -11.95 50.79 Favored 'General case' 0 C--N 1.257 -3.438 0 O-C-N 124.123 0.543 . . . . 0.0 111.571 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.51 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 6.9 pt-20 -160.92 167.35 13.69 Favored Pre-proline 0 CA--C 1.451 -2.859 0 C-N-CA 116.11 -2.236 . . . . 0.0 110.615 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.1 Cg_endo -68.23 54.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.351 2.034 . . . . 0.0 110.198 172.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 20.7 t70 -176.41 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.685 1.594 . . . . 0.0 109.93 -170.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.695 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 51.3 mm-40 -114.36 128.42 56.34 Favored 'General case' 0 C--O 1.276 2.45 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.267 8.5 m-30 -79.56 156.4 27.74 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 128.101 3.375 . . . . 0.0 111.19 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.513 HD11 ' HA3' ' A' ' 34' ' ' GLY . 5.2 mp -87.33 142.21 28.06 Favored 'General case' 0 C--O 1.178 -2.692 0 C-N-CA 117.103 -1.839 . . . . 0.0 107.684 174.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 49.6 mt-30 -138.97 154.61 48.31 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 62' ' ' ASP . 31.2 mm -76.41 111.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HE3' ' OG1' ' A' ' 30' ' ' THR . 0.5 OUTLIER -61.98 -37.54 85.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 60' ' ' THR . 48.5 t 164.68 173.22 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 125.37 1.669 . . . . 0.0 109.479 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -137.2 151.58 48.93 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-O 122.044 0.926 . . . . 0.0 113.063 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.54 117.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 113.454 -1.703 . . . . 0.0 106.748 176.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.66 -23.08 49.49 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 112.976 -1.92 . . . . 0.0 112.896 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -96.68 -2.04 45.38 Favored 'General case' 0 C--N 1.267 -3.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.219 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.33 167.64 26.35 Favored Glycine 0 N--CA 1.422 -2.256 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.366 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.25 -31.03 74.57 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 124.187 3.258 . . . . 0.0 112.979 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.36 -44.94 89.01 Favored 'General case' 0 C--O 1.274 2.371 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.36 55.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.294 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.81 -35.43 64.87 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.82 -24.47 65.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.96 22.02 78.34 Favored Glycine 0 CA--C 1.49 -1.524 0 CA-C-N 112.515 -2.13 . . . . 0.0 113.79 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -109.44 -32.71 7.05 Favored 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.5 ttm -96.07 142.22 28.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.47 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.01 166.2 23.27 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.076 0.941 . . . . 0.0 111.082 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 45' ' ' SER . 65.9 p -70.74 111.77 6.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.081 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.7 -11.64 15.66 Favored Glycine 0 C--N 1.309 -0.929 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.903 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.656 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.8 m-20 -63.54 134.62 55.86 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -91.66 124.73 44.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.44 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 13.1 mm -73.17 123.9 29.03 Favored 'Isoleucine or valine' 1 C--O 1.32 4.764 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.501 HG12 HD13 ' A' ' 73' ' ' LEU . 42.9 t -115.53 -34.49 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 O-C-N 126.979 2.674 . . . . 0.0 110.447 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 36.5 m -148.98 146.71 27.93 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.954 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.412 HG12 ' CG1' ' A' ' 72' ' ' VAL . 7.1 p -124.75 132.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.0 m120 61.11 23.75 13.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 110.978 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.7 t70 66.66 21.46 10.62 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.743 1.617 . . . . 0.0 112.015 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 72' ' ' VAL . 56.2 m -102.91 120.43 40.61 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 171.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.7 t -66.7 110.33 3.19 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.445 ' CA ' ' HB2' ' A' ' 75' ' ' HIS . 35.7 m -122.67 28.88 2.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.563 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.58 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 39.0 tp -60.98 112.92 2.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.82 42.29 0.23 Allowed Glycine 0 C--N 1.376 2.763 0 O-C-N 125.339 1.649 . . . . 0.0 111.374 -170.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.589 ' O ' HG21 ' A' ' 76' ' ' THR . 5.3 t60 -43.31 -66.11 0.41 Allowed 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.589 HG21 ' O ' ' A' ' 75' ' ' HIS . 7.2 p -167.31 143.31 4.21 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 151.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -49.69 -35.69 22.59 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 120.31 1.414 . . . . 0.0 110.572 173.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.13 71.37 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.934 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 8.5 mm100 -60.27 -44.5 95.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.23 -43.31 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.606 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 91.6 t -64.92 -41.29 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -60.91 -38.58 86.22 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.692 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.588 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.8 mm -68.58 -33.21 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.313 0.577 . . . . 0.0 112.478 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -73.25 -30.12 63.23 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 87.5 mt-30 -76.64 -19.9 57.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.824 1.25 . . . . 0.0 110.821 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.7 m -79.68 -44.33 21.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.923 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.6 mt -67.24 136.46 93.74 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.199 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -90.99 161.18 3.93 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 123.081 2.52 . . . . 0.0 112.969 -173.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.0 mm -63.88 134.76 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-O 120.912 0.386 . . . . 0.0 110.705 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.04 54.16 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.312 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.03 -170.0 1.82 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -175.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 20.8 m -151.06 157.38 42.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.81 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.46 125.66 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.807 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.56 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 14.4 m-20 -76.44 105.3 7.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.7 mt -103.86 138.41 40.48 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 124.139 0.976 . . . . 0.0 110.484 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.3 tt0 -101.05 118.38 36.87 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 81.5 mt -107.14 150.06 26.99 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 124.776 1.23 . . . . 0.0 109.99 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.632 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 9.4 t -118.11 106.21 12.63 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.132 0.968 . . . . 0.0 108.553 172.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.656 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 36.2 ttp180 -104.66 127.76 52.51 Favored 'General case' 0 C--N 1.248 -3.823 0 O-C-N 120.811 -1.181 . . . . 0.0 109.954 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.8 -27.55 0.4 Allowed Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.41 141.54 39.54 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.25 160.5 29.44 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.288 2.659 . . . . 0.0 111.643 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.3 mt -57.89 142.71 78.71 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 124.081 0.952 . . . . 0.0 112.502 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -67.81 -68.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.431 2.087 . . . . 0.0 110.698 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.43 133.59 33.0 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-O 122.013 0.911 . . . . 0.0 109.001 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -122.41 93.53 48.42 Favored Pre-proline 0 N--CA 1.388 -3.554 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.637 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 60.3 Cg_endo -91.62 -61.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.017 1.812 . . . . 0.0 112.737 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.437 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 36.8 t70 -85.93 -11.3 53.51 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.747 -174.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -88.08 115.58 63.56 Favored Pre-proline 0 CA--C 1.468 -2.181 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.022 -177.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.539 ' HG2' ' N ' ' A' ' 111' ' ' ASN 0.269 53.0 Cg_endo -73.39 -38.2 2.76 Favored 'Trans proline' 0 CA--C 1.481 -2.164 0 C-N-CA 122.32 2.013 . . . . 0.0 112.286 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.808 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 38.6 m-80 -57.4 -13.03 2.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 111.626 -2.534 . . . . 0.0 114.376 -164.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 p -93.11 -21.18 19.85 Favored 'General case' 0 N--CA 1.39 -3.437 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.002 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 115' ' ' VAL . 16.7 m -111.02 160.42 16.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.216 -174.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -72.5 39.78 0.08 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 122.424 1.107 . . . . 0.0 113.678 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 113' ' ' SER . 4.3 p -166.32 86.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.808 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -132.99 -177.49 4.53 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.469 -1.241 . . . . 0.0 112.469 -169.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -51.18 108.48 0.25 Allowed 'General case' 0 N--CA 1.407 -2.576 0 C-N-CA 127.459 2.303 . . . . 0.0 109.392 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 t 61.71 46.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.3 1.048 . . . . 0.0 110.162 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.02 114.99 6.96 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.6 mm 62.01 59.78 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-O 122.164 0.983 . . . . 0.0 108.495 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.63 132.41 41.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.803 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.51 152.64 20.84 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.27 45.85 0.48 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.579 0.704 . . . . 0.0 112.797 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -101.93 136.4 19.51 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 C-N-CA 123.009 2.473 . . . . 0.0 111.872 177.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.553 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -99.62 -40.05 7.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.325 0.584 . . . . 0.0 109.775 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.38 75.87 9.73 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.031 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 129.91 -86.65 0.31 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.184 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.5 tptp 56.38 65.13 4.34 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.935 1.294 . . . . 0.0 110.355 -174.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -105.56 -165.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.286 2.658 . . . . 0.0 112.789 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -100.74 111.97 24.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.626 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.7 t80 -106.52 143.06 35.17 Favored 'General case' 0 C--N 1.268 -2.957 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.964 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -147.13 9.68 0.98 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.146 0.974 . . . . 0.0 110.443 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtm180 53.28 4.71 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 127.241 2.217 . . . . 0.0 114.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.43 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.4 t-20 -130.2 119.91 18.9 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HB3' HG12 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -60.94 -19.1 61.05 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.072 3.182 . . . . 0.0 112.835 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -80.43 -24.57 39.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -98.33 -19.9 17.5 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.847 0.356 . . . . 0.0 111.718 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 42.8 tp -84.99 160.46 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.286 0.565 . . . . 0.0 110.848 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.516 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 58.7 mttm -97.56 -171.23 2.14 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.896 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.65 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.15 163.95 39.87 Favored Glycine 0 C--N 1.299 -1.506 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 28.2 tttp -93.37 137.97 32.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.607 -1.237 . . . . 0.0 108.828 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.635 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 95.9 m-85 -106.05 110.68 23.02 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 122.561 1.172 . . . . 0.0 109.066 -177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.49 HD13 ' NH2' ' A' ' 99' ' ' ARG . 15.1 mt -114.8 147.33 18.3 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.875 0 CA-C-N 112.36 -2.2 . . . . 0.0 107.94 -173.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -117.35 132.08 56.66 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.917 0.865 . . . . 0.0 111.867 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -140.1 127.58 21.47 Favored 'General case' 0 C--N 1.263 -3.186 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.245 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.836 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttmt -90.15 122.27 32.95 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.843 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.79 116.78 32.52 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.9 ttt180 -76.85 107.83 9.46 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.279 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.1 tttt -64.08 97.32 0.17 Allowed 'General case' 0 C--O 1.181 -2.512 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 167.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -82.11 -158.24 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -96.58 -0.29 48.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.574 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 83.78 -129.05 8.9 Favored Glycine 0 N--CA 1.406 -3.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.57 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.8 m-85 -90.28 141.98 28.17 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 120.875 0.369 . . . . 0.0 110.207 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.99 86.84 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.143 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -111.15 163.3 14.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.475 0.655 . . . . 0.0 110.76 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 69.2 p -115.99 152.27 33.83 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -140.41 143.59 29.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.618 -174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 33' ' ' GLY . 8.8 p -144.89 167.94 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.453 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.487 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' H ' HG21 ' A' ' 32' ' ' VAL . . . 111.86 -141.64 16.74 Favored Glycine 1 N--CA 1.388 -4.526 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 -177.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.6 35.66 16.72 Favored Glycine 0 CA--C 1.473 -2.571 0 CA-C-N 117.396 0.598 . . . . 0.0 111.98 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 16.8 t70 -67.0 -29.55 69.42 Favored 'General case' 0 CA--C 1.46 -2.517 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -172.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.41 166.64 13.6 Favored Pre-proline 0 CA--C 1.467 -2.246 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.024 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 20.1 Cg_endo -65.93 58.77 0.42 Allowed 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.561 2.174 . . . . 0.0 109.945 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.567 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 11.9 t70 179.24 -16.14 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.233 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 33.9 mm-40 -122.59 123.94 42.35 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.512 ' CE1' HD13 ' A' ' 73' ' ' LEU . 6.0 m-30 -76.91 159.28 30.13 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 130.711 3.604 . . . . 0.0 113.762 -169.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 80' ' ' VAL . 8.0 mp -89.03 146.98 24.51 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.8 mt-30 -142.84 157.69 44.36 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 62' ' ' ASP . 39.4 mm -74.45 109.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.7 tttp -57.82 -41.05 81.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.464 ' HA ' HG21 ' A' ' 60' ' ' THR . 31.2 t 163.04 174.98 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 O-C-N 125.827 1.954 . . . . 0.0 109.808 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.53 150.3 44.94 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.535 0.683 . . . . 0.0 111.826 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -75.77 123.87 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . 1.9 pt? -68.76 -5.21 19.3 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -100.0 -6.56 26.31 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.181 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.53 163.76 32.7 Favored Glycine 0 N--CA 1.408 -3.186 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.3 -31.59 30.22 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 124.78 3.654 . . . . 0.0 113.249 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.47 84.53 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.425 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.422 ' HB1' ' HA ' ' A' ' 48' ' ' LEU . . . -77.33 -33.95 55.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.058 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.4 mp -70.47 -40.0 73.91 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 124.187 0.995 . . . . 0.0 112.377 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.611 ' OD2' ' HE3' ' A' ' 57' ' ' LYS . 24.4 t70 -66.33 -24.15 66.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.694 1.235 . . . . 0.0 108.326 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.8 19.67 78.24 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.586 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HE3' ' OD2' ' A' ' 55' ' ' ASP . 25.6 mtmt -122.02 -18.9 6.81 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -102.19 130.83 48.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.699 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.58 162.91 22.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.403 1.097 . . . . 0.0 111.777 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 45' ' ' SER . 80.7 p -72.57 108.69 5.75 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.657 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.1 -16.14 9.34 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.642 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.663 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 13.5 m-20 -61.13 131.8 51.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -85.96 123.58 39.62 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.726 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.415 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 15.4 mm -74.06 124.36 31.3 Favored 'Isoleucine or valine' 1 C--O 1.326 5.115 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD11 ' A' ' 73' ' ' LEU . 42.0 t -115.85 -41.06 2.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 110.881 -2.872 . . . . 0.0 111.201 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 68.0 m -144.85 149.27 35.09 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.032 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.47 HG12 ' CG1' ' A' ' 93' ' ' VAL . 25.1 t -111.7 115.04 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 66.1 -78.83 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.846 1.341 . . . . 0.0 109.634 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -156.22 24.31 0.36 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.36 1.076 . . . . 0.0 110.316 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.532 ' O ' HG11 ' A' ' 72' ' ' VAL . 27.1 m -106.87 117.99 35.51 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 32.3 t -64.9 108.23 1.71 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 70' ' ' THR . 28.2 m -117.53 20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.408 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.626 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 36.3 tp -61.64 112.76 2.37 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 39.54 0.06 OUTLIER Glycine 0 C--N 1.385 3.286 0 O-C-N 125.484 1.74 . . . . 0.0 112.273 -171.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.49 ' O ' HG21 ' A' ' 76' ' ' THR . 3.0 t60 -42.31 -65.24 0.49 Allowed 'General case' 0 C--N 1.37 1.481 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 75' ' ' HIS . 6.1 p -166.36 143.11 4.99 Favored 'General case' 0 C--N 1.257 -3.423 0 N-CA-C 100.812 -3.773 . . . . 0.0 100.812 150.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.54 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.8 -31.37 26.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 121.018 1.735 . . . . 0.0 111.233 173.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.09 -50.26 74.07 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.478 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 13.3 mm100 -64.55 -42.01 95.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 77' ' ' HIS . 11.0 m -66.57 -41.85 89.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.05 -38.98 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -37.24 86.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.565 ' O ' ' HB2' ' A' ' 86' ' ' SER . 2.1 mm -67.56 -35.7 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.56 0.695 . . . . 0.0 112.146 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -73.55 -30.49 63.09 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.74 -26.68 62.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.657 0.783 . . . . 0.0 110.41 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -70.96 -42.5 69.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.768 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 20.6 mt -72.16 130.08 86.85 Favored Pre-proline 0 N--CA 1.408 -2.567 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.017 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.3 Cg_endo -91.86 162.42 3.35 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 123.514 2.809 . . . . 0.0 112.947 -173.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.491 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.3 mm -59.43 132.79 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-O 121.296 0.57 . . . . 0.0 111.217 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.65 56.54 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.443 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.9 -169.54 1.69 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 8.1 m -150.6 159.93 44.16 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.836 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -142.0 125.01 14.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.766 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.225 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.08 102.16 11.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.76 135.57 40.04 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.221 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 35.5 tt0 -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.805 175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.0 mt -106.33 144.81 32.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.0 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.65 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 10.2 t -112.44 107.78 16.68 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.005 0.907 . . . . 0.0 108.82 172.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.663 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 26.9 ttp180 -101.59 131.74 47.62 Favored 'General case' 0 C--N 1.25 -3.747 0 O-C-N 121.021 -1.049 . . . . 0.0 109.874 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.66 1.41 Allowed Glycine 0 C--N 1.307 -1.061 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.42 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.88 128.73 31.52 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.35 160.3 48.32 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.834 3.022 . . . . 0.0 113.12 -174.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mt -59.29 131.19 87.58 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.006 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.404 ' HG3' ' OE1' ' A' ' 42' ' ' GLN . 6.0 Cg_exo -71.29 -39.8 3.6 Favored 'Trans proline' 0 CA--C 1.49 -1.699 0 C-N-CA 122.847 2.364 . . . . 0.0 110.166 176.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -139.17 148.82 43.69 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.597 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -116.04 88.33 21.63 Favored Pre-proline 0 N--CA 1.395 -3.179 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.31 -173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 73.7 Cg_endo -93.87 -57.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.028 1.819 . . . . 0.0 112.783 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.416 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 19.3 t70 -91.37 -12.9 33.55 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.321 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -78.38 119.7 78.31 Favored Pre-proline 0 CA--C 1.45 -2.873 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.606 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 89.0 Cg_endo -75.05 -44.66 0.32 Allowed 'Trans proline' 0 N--CA 1.418 -2.919 0 C-N-CA 121.683 1.589 . . . . 0.0 111.306 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.606 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 14.6 m-80 -55.8 1.01 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 129.467 3.107 . . . . 0.0 114.702 -162.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 110' ' ' PRO . 76.1 p -99.51 -20.72 16.26 Favored 'General case' 1 N--CA 1.374 -4.234 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.47 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 11.8 p -165.29 142.82 5.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.734 -170.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 113' ' ' SER 0.33 3.7 pp 64.46 -166.35 0.23 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.954 1.702 . . . . 0.0 111.79 -177.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.57 ' N ' ' HB2' ' A' ' 122' ' ' ASP . 3.9 p -63.13 90.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.945 0.879 . . . . 0.0 110.453 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 110' ' ' PRO . 2.7 p -134.0 175.77 9.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 121.901 -0.499 . . . . 0.0 112.253 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.431 ' HB2' ' OD1' ' A' ' 111' ' ' ASN . 15.1 m -63.72 127.42 31.28 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 123.281 0.363 . . . . 0.0 110.997 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.5 p 55.32 20.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.402 1.881 . . . . 0.0 112.791 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.41 94.79 1.63 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.353 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.84 82.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.09 54.76 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.57 ' HB2' ' N ' ' A' ' 115' ' ' VAL . 38.1 t70 -96.22 -84.57 0.35 Allowed 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.851 -172.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -176.15 31.21 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 125.64 1.576 . . . . 0.0 107.762 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.9 pm0 -73.76 169.82 17.01 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.578 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 6.0 Cg_exo . . . . . 0 C--N 1.376 1.981 1 C-N-CA 126.624 4.883 . . . . 0.0 115.618 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . 0.8 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -126.63 23.3 6.8 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-O 121.736 0.779 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' MET . . . . . 0.41 ' HE3' ' HB3' ' A' ' 105' ' ' PHE . 58.4 ttm -159.66 35.14 0.19 Allowed 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 176.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 133.31 -165.76 23.97 Favored Glycine 0 N--CA 1.406 -3.305 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.349 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.498 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER 49.97 55.27 16.8 Favored Pre-proline 0 C--N 1.305 -1.344 0 C-N-CA 124.306 1.042 . . . . 0.0 113.008 -178.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 37.2 Cg_endo -106.22 -176.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.636 2.224 . . . . 0.0 111.719 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.402 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 44.0 t80 -86.6 104.47 16.06 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.608 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -106.91 131.07 54.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -140.11 13.53 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.045 0.926 . . . . 0.0 109.912 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.451 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 6.2 mtm180 53.07 7.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -132.77 121.27 17.0 Favored Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.001 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.21 -22.74 66.28 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 124.262 3.308 . . . . 0.0 113.152 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -79.23 -30.61 43.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.363 0.602 . . . . 0.0 109.478 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -90.41 -24.0 20.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.519 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.434 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 38.3 tp -82.26 152.95 26.13 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.35 144.83 42.1 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-O 121.73 0.776 . . . . 0.0 109.767 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.679 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 155.19 -178.13 32.02 Favored Glycine 1 C--N 1.249 -4.292 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -173.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.564 ' HE2' ' CG1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -98.6 121.73 40.92 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.506 ' CD2' ' HB2' ' A' ' 98' ' ' CYS . 85.9 m-85 -100.1 119.25 38.01 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.131 0.967 . . . . 0.0 109.506 -174.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.564 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 44.7 mt -117.42 141.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.95 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.68 -170.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -107.06 126.44 52.35 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.53 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 9.0 t -137.55 157.54 46.31 Favored 'General case' 0 C--O 1.179 -2.633 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.329 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.813 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 35.6 ttpt -130.35 122.99 28.92 Favored 'General case' 0 C--N 1.261 -3.278 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.441 ' CD2' ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -107.09 117.07 33.1 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 58.0 ttp180 -73.84 105.43 5.11 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.918 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.596 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 70.0 tttt -64.16 97.17 0.17 Allowed 'General case' 0 C--O 1.18 -2.602 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -84.53 -154.88 0.18 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -58.99 -38.34 78.93 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.449 0.7 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -90.01 -19.94 23.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.596 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 99.84 -118.9 6.32 Favored Glycine 1 N--CA 1.388 -4.541 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 38.4 m-85 -90.55 136.51 33.02 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 117.674 0.737 . . . . 0.0 110.515 -176.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 9.71 76.79 Favored Glycine 0 C--O 1.212 -1.253 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.613 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 9.3 p90 -121.14 162.67 19.69 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.345 0.572 . . . . 0.0 110.375 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -123.13 147.34 46.9 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 77' ' ' HIS . 15.5 m -121.61 146.22 27.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-O 121.284 0.564 . . . . 0.0 111.622 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.85 152.04 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.515 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.89 -129.59 8.33 Favored Glycine 1 N--CA 1.395 -4.08 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 45.06 38.04 5.93 Favored Glycine 0 CA--C 1.472 -2.597 0 C-N-CA 124.935 1.255 . . . . 0.0 114.072 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 6.6 m-20 -67.09 -24.4 65.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.405 -176.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -170.82 169.76 3.28 Favored Pre-proline 0 CA--C 1.46 -2.518 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.092 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.9 Cg_endo -65.48 59.05 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.858 2.372 . . . . 0.0 110.709 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 19.4 t70 175.02 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.511 1.525 . . . . 0.0 110.218 -173.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.572 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 7.7 mm-40 -123.93 123.96 41.56 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 172.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.557 ' CE1' HD13 ' A' ' 73' ' ' LEU . 5.1 m-30 -76.99 159.63 29.78 Favored 'General case' 1 N--CA 1.55 4.543 0 C-N-CA 131.492 3.917 . . . . 0.0 114.569 -170.119 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 80' ' ' VAL . 5.9 mp -95.08 140.07 30.53 Favored 'General case' 0 C--O 1.188 -2.141 0 C-N-CA 117.73 -1.588 . . . . 0.0 107.725 172.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 51.0 mt-30 -130.86 158.43 40.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 172.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 62' ' ' ASP . 22.3 mm -81.32 115.48 23.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -66.86 -48.66 68.13 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 46.0 t 174.37 173.99 0.19 Allowed 'General case' 0 CA--C 1.497 -1.06 0 O-C-N 123.996 0.81 . . . . 0.0 111.879 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.57 152.28 39.46 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.808 -172.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.41 116.23 9.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -69.56 -10.06 56.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.292 1.044 . . . . 0.0 112.908 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.92 -7.98 38.43 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.025 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.525 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.37 173.41 37.27 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.57 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.27 -27.93 77.36 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 124.175 3.25 . . . . 0.0 112.872 -173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.441 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.45 -49.75 76.59 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.692 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 48' ' ' LEU . . . -76.44 -32.28 58.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.894 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 50' ' ' GLY . 6.8 mp -65.59 -46.27 80.04 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.714 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.74 -35.7 80.62 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.41 -17.72 52.75 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 112.878 -1.964 . . . . 0.0 113.267 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 2.9 mptm? -77.27 -27.43 53.14 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 46.7 tpp -94.19 127.08 39.82 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -170.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -136.73 156.55 48.38 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.27 1.033 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -61.97 114.42 3.36 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.71 1.204 . . . . 0.0 110.336 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.26 -14.43 25.69 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.192 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.51 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.8 m-20 -67.08 141.25 57.54 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.251 0.1 OUTLIER -93.41 123.15 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 113.244 178.34 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.1 mm -73.25 123.62 28.57 Favored 'Isoleucine or valine' 1 C--O 1.337 5.66 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG13 HD11 ' A' ' 73' ' ' LEU . 47.1 t -115.87 -36.05 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 O-C-N 127.506 3.004 . . . . 0.0 111.985 -176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 60.4 m -151.61 162.85 40.28 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.487 -1.383 . . . . 0.0 114.012 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 72' ' ' VAL . 48.6 t -134.38 127.16 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.624 0 C-N-CA 125.017 1.327 . . . . 0.0 107.527 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.2 m120 65.65 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 108.761 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -149.96 31.35 0.7 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.743 0.782 . . . . 0.0 109.165 170.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 m -116.48 126.84 53.94 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.496 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 24.2 t -67.39 115.08 6.62 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.408 HG12 HG23 ' A' ' 67' ' ' VAL . 2.0 p -119.98 15.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.608 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.4 tp -59.34 113.67 2.28 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.2 48.02 0.14 Allowed Glycine 0 C--N 1.379 2.967 0 O-C-N 125.433 1.708 . . . . 0.0 111.846 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 76' ' ' THR . 3.0 t60 -50.93 -68.35 0.18 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 75' ' ' HIS . 13.9 p -166.55 143.93 5.06 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 152.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.595 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.68 -33.36 22.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 120.088 1.313 . . . . 0.0 110.977 172.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.61 93.19 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.897 -0.502 . . . . 0.0 110.958 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 10.1 mm-40 -65.2 -43.3 92.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 77' ' ' HIS . 17.1 m -62.66 -43.98 99.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.003 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.84 -40.78 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.639 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -62.18 -38.34 88.71 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.639 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 28.1 mt -65.02 -40.39 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.636 0.732 . . . . 0.0 111.329 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.23 -33.59 71.85 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.673 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.38 -20.22 60.8 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.183 0.993 . . . . 0.0 110.96 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.573 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.0 m -76.41 -48.75 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.4 mt -66.2 135.52 95.02 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -87.98 161.55 7.39 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.258 2.639 . . . . 0.0 113.68 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.505 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.2 mm -63.6 132.49 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.99 11.95 55.89 Favored Glycine 0 C--N 1.288 -2.096 0 C-N-CA 119.783 -1.198 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.35 -171.71 2.13 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.7 m -151.25 156.44 40.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -140.97 125.47 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.867 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.226 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 18' ' ' THR . 10.6 m-20 -79.31 104.2 9.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.39 157.42 16.92 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 125.497 1.519 . . . . 0.0 108.254 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -117.01 121.38 41.21 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 76.1 mt -105.06 164.34 11.87 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 125.107 1.363 . . . . 0.0 109.69 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.679 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 12.4 t -141.05 116.54 10.15 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.843 0.83 . . . . 0.0 109.923 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 31.1 mtm180 -98.6 135.49 40.05 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 121.279 -0.888 . . . . 0.0 113.115 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.62 -25.13 0.84 Allowed Glycine 0 CA--C 1.466 -3.0 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.298 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.408 ' HH ' HD12 ' A' ' 11' ' ' LEU . 22.7 m-85 -81.85 140.64 47.08 Favored Pre-proline 0 N--CA 1.42 -1.954 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.482 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.35 141.57 71.38 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.799 2.999 . . . . 0.0 111.147 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.47 132.52 94.26 Favored Pre-proline 0 N--CA 1.42 -1.948 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.13 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' -2' ' ' ALA . 6.0 Cg_exo -42.27 137.19 3.64 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 125.142 3.895 . . . . 0.0 116.586 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.41 ' HB3' ' HE3' ' A' ' -1' ' ' MET . 82.3 t80 -52.63 149.37 6.07 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.946 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.81 101.82 51.79 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.994 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 73.4 Cg_endo -99.41 -61.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.249 0 C-N-CA 122.351 2.034 . . . . 0.0 111.128 170.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.411 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 16.6 t70 -121.05 18.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.427 1.108 . . . . 0.0 108.099 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' OD1' ' HD2' ' A' ' 110' ' ' PRO . 27.7 t0 -71.61 120.26 78.85 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.63 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.545 ' HG2' ' N ' ' A' ' 111' ' ' ASN 0.281 41.8 Cg_endo -69.35 -35.61 13.51 Favored 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 122.712 2.275 . . . . 0.0 110.458 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.781 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 55.6 m-80 -57.84 -11.88 2.66 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.697 -2.501 . . . . 0.0 114.015 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -104.0 -8.1 19.85 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-O 121.619 0.723 . . . . 0.0 110.666 -173.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -131.17 172.8 11.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.73 155.83 39.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.6 t 69.78 46.22 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 123.217 1.484 . . . . 0.0 107.272 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.781 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -89.55 -175.47 4.7 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.778 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.6 m -70.44 40.54 0.05 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 127.082 2.153 . . . . 0.0 112.674 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p -110.15 3.13 9.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 123.016 1.388 . . . . 0.0 108.141 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.02 83.19 0.14 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.792 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.31 85.73 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.0 111.18 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -80.92 95.48 6.76 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 121.503 0.668 . . . . 0.0 110.395 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 8.66 20.67 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.808 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -76.27 142.07 71.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.346 2.698 . . . . 0.0 112.554 177.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.636 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.198 0.499 . . . . 0.0 110.692 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.53 175.8 11.73 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 64.67 -116.39 8.94 Favored Glycine 0 C--O 1.245 0.796 0 O-C-N 123.783 0.677 . . . . 0.0 113.831 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt 59.51 66.81 2.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.93 1.292 . . . . 0.0 112.916 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -90.64 -178.84 1.48 Allowed 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.09 2.527 . . . . 0.0 111.424 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -79.63 105.43 10.93 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.587 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 4.8 t80 -108.25 139.55 42.78 Favored 'General case' 0 C--N 1.265 -3.088 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 7' ' ' ASN . 10.2 t -144.48 10.56 1.44 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.489 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 9.5 mtp180 58.01 -19.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.766 2.026 . . . . 0.0 115.466 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 5' ' ' THR . 4.2 t-20 -105.84 113.12 64.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 C-N-CA 122.714 0.406 . . . . 0.0 109.973 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 5.2 Cg_endo -50.87 -27.87 21.89 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 124.077 3.185 . . . . 0.0 113.635 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.5 t -74.03 -25.71 60.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.02 0.438 . . . . 0.0 110.996 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.439 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 14.5 mm-40 -91.51 -35.3 14.39 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.435 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 40' ' ' PHE . 39.0 tp -71.89 155.82 39.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.903 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 63.8 mttm -106.55 158.57 16.83 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.48 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.783 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 131.31 173.65 13.42 Favored Glycine 0 C--N 1.265 -3.369 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' CE ' HG12 ' A' ' 16' ' ' ILE . 7.6 ttpt -94.4 123.51 37.85 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 95.1 m-85 -101.75 111.55 23.83 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 122.778 1.275 . . . . 0.0 109.85 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.479 HG12 ' CE ' ' A' ' 14' ' ' LYS . 34.7 mt -105.87 145.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.739 0 CA-C-N 111.839 -2.437 . . . . 0.0 109.651 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.456 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 4.3 t60 -130.61 115.17 16.37 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 t -139.92 137.73 35.04 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.296 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.6 ttmp? -87.59 125.37 34.31 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.632 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.82 121.11 44.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 11.9 ttp180 -81.21 108.87 15.21 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.397 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 73.7 tttt -62.88 97.47 0.11 Allowed 'General case' 0 C--O 1.182 -2.454 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 169.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -90.93 -154.39 0.35 Allowed 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 124.812 1.245 . . . . 0.0 108.228 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -54.59 -43.94 72.59 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.75 0.82 . . . . 0.0 111.029 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmt_? -85.18 -18.87 32.78 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.567 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 97.15 -114.52 5.0 Favored Glycine 0 N--CA 1.397 -3.955 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -177.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 31.8 m-85 -93.95 141.33 28.64 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.37 -2.92 84.91 Favored Glycine 0 C--O 1.217 -0.959 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.757 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.414 ' HB2' HG23 ' A' ' 43' ' ' ILE . 17.9 p90 -111.97 162.7 15.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 38.8 p -123.59 155.58 37.39 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.4 148.64 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-O 121.631 0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.02 149.93 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.283 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.79 -137.17 12.6 Favored Glycine 0 N--CA 1.398 -3.864 0 N-CA-C 108.236 -1.945 . . . . 0.0 108.236 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 52.34 32.28 36.94 Favored Glycine 0 CA--C 1.47 -2.728 0 N-CA-C 111.786 -0.525 . . . . 0.0 111.786 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -71.62 -19.76 62.07 Favored 'General case' 0 N--CA 1.411 -2.416 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.951 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.65 166.78 8.66 Favored Pre-proline 0 CA--C 1.468 -2.183 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_endo -66.85 58.18 0.54 Allowed 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.715 2.277 . . . . 0.0 109.737 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 22.1 t70 176.6 -15.06 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.476 -169.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.488 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 26.9 mt-10 -123.19 126.12 46.39 Favored 'General case' 0 C--O 1.269 2.116 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 171.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.25 7.3 m-85 -77.85 158.59 29.4 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 131.04 3.736 . . . . 0.0 113.535 -168.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 6.0 mp -89.82 143.29 26.92 Favored 'General case' 0 CA--C 1.457 -2.624 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 171.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.12 152.81 49.09 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 62' ' ' ASP . 26.7 mm -69.09 109.09 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 84.1 tttt -55.3 -41.26 72.1 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 124.872 1.357 . . . . 0.0 107.448 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.0 t 162.41 173.52 0.02 OUTLIER 'General case' 0 C--N 1.366 1.326 0 O-C-N 125.395 1.684 . . . . 0.0 109.605 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.59 147.27 42.78 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 121.989 0.9 . . . . 0.0 111.976 -173.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.401 HG11 ' H ' ' A' ' 49' ' ' ASP . 13.8 t -83.34 130.06 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.972 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 94.7 mt -69.32 -13.52 62.43 Favored 'General case' 0 N--CA 1.38 -3.941 0 CA-C-N 112.799 -2.001 . . . . 0.0 112.849 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.401 ' H ' HG11 ' A' ' 47' ' ' VAL . 14.7 t70 -86.0 -24.2 26.54 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.244 173.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.09 155.15 36.13 Favored Glycine 0 N--CA 1.401 -3.679 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.556 -172.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.8 -31.48 33.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 125.052 3.834 . . . . 0.0 113.385 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.53 95.59 Favored 'General case' 0 C--O 1.261 1.701 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.199 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.88 -35.33 50.95 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.496 177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.94 -43.41 88.11 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.981 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.48 -21.85 55.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.909 1.338 . . . . 0.0 107.409 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.9 73.46 Favored Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 113.228 -1.806 . . . . 0.0 112.586 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -98.31 -28.48 13.65 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 120.859 0.362 . . . . 0.0 110.084 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -98.03 149.63 22.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.211 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.71 153.4 47.21 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.5 p -60.09 111.67 1.6 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.48 -5.43 24.76 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.215 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' GLN . 5.4 m-20 -60.31 126.07 26.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.102 0.951 . . . . 0.0 108.603 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 41' ' ' LEU 0.256 0.2 OUTLIER -80.2 112.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.957 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.1 mm -66.98 125.3 24.09 Favored 'Isoleucine or valine' 1 C--O 1.332 5.397 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.466 HG11 HD12 ' A' ' 73' ' ' LEU . 48.5 t -115.36 -42.91 3.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 O-C-N 127.585 3.053 . . . . 0.0 112.085 -174.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 69.6 m -147.77 156.78 43.1 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.853 -1.154 . . . . 0.0 112.359 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.405 HG11 ' HB ' ' A' ' 72' ' ' VAL . 6.3 p -135.98 128.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.1 m120 58.53 30.33 19.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.603 0.716 . . . . 0.0 110.65 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 68.06 17.22 9.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.893 1.277 . . . . 0.0 113.28 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.8 m -107.78 125.49 51.49 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.412 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 54.0 t -59.99 110.14 1.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 124.418 1.074 . . . . 0.0 109.783 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.405 ' HB ' HG11 ' A' ' 67' ' ' VAL . 2.0 p -119.8 16.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.587 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 30.6 tp -59.9 113.23 2.18 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.5 43.17 0.07 OUTLIER Glycine 0 N--CA 1.5 2.945 0 O-C-N 125.762 1.914 . . . . 0.0 112.559 -170.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.551 ' O ' HG21 ' A' ' 76' ' ' THR . 3.2 t60 -46.42 -66.83 0.35 Allowed 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.551 HG21 ' O ' ' A' ' 75' ' ' HIS . 20.1 p -166.52 143.85 5.07 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 151.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.606 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -50.88 -33.59 24.67 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 120.295 1.407 . . . . 0.0 110.876 173.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.17 86.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.967 -0.458 . . . . 0.0 110.866 174.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 14.3 mm-40 -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 77' ' ' HIS . 13.1 m -64.63 -44.5 96.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -66.56 -38.19 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.541 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -64.32 -33.93 76.96 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.296 177.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.9 mm -70.8 -36.53 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.732 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.18 -31.42 64.21 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.309 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -70.44 -27.91 64.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.522 1.129 . . . . 0.0 110.634 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -73.17 -34.34 65.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.576 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.0 mt -80.78 134.72 53.13 Favored Pre-proline 0 N--CA 1.412 -2.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.976 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 91' ' ' ALA . 19.5 Cg_endo -91.99 162.3 3.27 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 123.585 2.857 . . . . 0.0 113.134 -174.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.2 mm -62.85 133.01 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.22 0.533 . . . . 0.0 110.885 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.76 12.3 53.44 Favored Glycine 0 C--N 1.293 -1.848 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.674 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -101.76 -170.82 1.88 Allowed 'General case' 0 C--O 1.207 -1.164 0 O-C-N 122.704 -0.292 . . . . 0.0 110.292 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.9 m -151.21 155.51 38.98 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.657 -0.652 . . . . 0.0 109.358 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.02 127.88 10.67 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.657 0 C-N-CA 118.582 -1.247 . . . . 0.0 113.119 -174.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.456 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 22.2 m-20 -80.32 106.88 12.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.533 0.682 . . . . 0.0 109.168 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.1 mt -105.59 142.65 34.95 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.806 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.492 ' OE2' ' HB3' ' A' ' 15' ' ' PHE . 16.7 tp10 -107.1 127.69 53.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -136.2 155.83 49.57 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 124.046 0.938 . . . . 0.0 111.281 -178.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.783 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -119.95 117.13 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.509 1.147 . . . . 0.0 112.936 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -88.88 111.14 21.71 Favored 'General case' 0 C--N 1.266 -3.058 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.07 -35.63 0.09 OUTLIER Glycine 0 CA--C 1.479 -2.19 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.568 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.62 136.99 24.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.128 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.05 160.89 46.33 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.889 2.392 . . . . 0.0 108.062 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.3 mt -53.86 129.32 56.25 Favored Pre-proline 0 N--CA 1.432 -1.349 0 O-C-N 123.648 0.592 . . . . 0.0 111.261 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.14 -44.95 0.73 Allowed 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 123.325 2.684 . . . . 0.0 114.317 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -138.19 149.74 46.11 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.797 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -110.61 98.68 38.23 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 121.55 0.69 . . . . 0.0 111.338 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.453 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 58.7 Cg_endo -96.18 -58.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.284 0 C-N-CA 122.154 1.903 . . . . 0.0 110.403 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.453 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 30.7 t70 -117.61 7.62 12.66 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 125.798 1.639 . . . . 0.0 108.862 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 112' ' ' THR . 21.0 t0 -72.99 110.26 8.06 Favored Pre-proline 0 CA--C 1.48 -1.741 0 CA-C-O 122.677 1.227 . . . . 0.0 112.39 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.584 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 57.2 Cg_endo -80.12 -32.42 1.4 Allowed 'Trans proline' 0 N--CA 1.433 -2.088 0 C-N-CA 122.038 1.825 . . . . 0.0 109.771 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.584 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 8.6 t-20 -52.68 -5.5 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 1 C-N-CA 132.012 4.125 . . . . 0.0 114.075 -168.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 110' ' ' PRO . 27.1 p -93.88 3.58 55.18 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.819 -169.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 m -146.03 104.72 3.86 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.102 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt 52.9 -151.34 0.31 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.612 0.765 . . . . 0.0 110.651 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.0 m -57.18 101.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.816 0.817 . . . . 0.0 111.391 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.61 166.15 25.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.676 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 m 71.81 32.64 1.88 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.211 1.005 . . . . 0.0 109.414 -172.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.27 112.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.481 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.92 70.28 1.1 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.6 mm -82.52 87.12 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.71 0.767 . . . . 0.0 109.081 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -114.06 36.58 3.64 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.603 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.39 156.99 43.2 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 tpmt? 67.48 18.6 10.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 123.018 1.389 . . . . 0.0 107.896 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.29 145.08 29.37 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 113.276 -1.784 . . . . 0.0 108.577 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.917 2.411 . . . . 0.0 111.847 173.791 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 1' ' ' LYS . . . . . . . . 0 C--O 1.223 -0.539 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.42 64.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.372 1.069 . . . . 0.0 113.884 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -91.68 9.79 30.94 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.991 0.425 . . . . 0.0 111.477 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -130.08 -96.07 0.76 Allowed Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.531 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 28.9 mmmt 52.14 54.75 14.42 Favored Pre-proline 0 N--CA 1.482 1.142 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 97.3 Cg_endo -108.77 170.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.628 0 C-N-CA 122.987 2.458 . . . . 0.0 112.97 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.449 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 23.8 t80 -82.27 105.19 13.14 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.609 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -101.46 133.57 45.9 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 7' ' ' ASN . 8.9 t -141.15 8.89 2.08 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.903 0.858 . . . . 0.0 110.437 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.511 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 8.3 mtm180 63.9 -27.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.556 1.943 . . . . 0.0 114.964 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 52.8 t-20 -100.54 122.25 50.26 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 6.1 Cg_endo -55.52 -27.84 61.58 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 124.006 3.137 . . . . 0.0 112.691 175.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 t -75.52 -25.72 57.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.129 0.49 . . . . 0.0 110.314 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -88.9 -24.26 22.54 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.691 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 41.2 tp -83.33 157.51 22.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 36.6 mtmm -119.69 148.71 43.05 Favored 'General case' 0 N--CA 1.381 -3.908 0 CA-C-O 121.676 0.751 . . . . 0.0 110.524 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 150.37 178.22 25.06 Favored Glycine 0 C--N 1.257 -3.837 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -171.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -88.41 124.28 33.79 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.6 m-85 -102.8 120.3 40.36 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.103 -1.439 . . . . 0.0 109.949 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.7 mt -120.39 135.97 58.94 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.579 -170.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -114.01 115.58 27.84 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.371 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.408 ' HB ' ' CB ' ' A' ' 57' ' ' LYS . 4.2 t -140.33 131.28 26.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.889 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.83 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttpt -92.3 124.95 36.75 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.81 120.62 42.51 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.782 -173.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 15.9 tpp180 -76.21 103.47 6.26 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.635 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 51.2 tttt -59.06 96.97 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.947 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 165.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.444 ' HB2' ' HG3' ' A' ' 21' ' ' ARG . 4.9 t -134.65 139.33 45.2 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.1 p 50.82 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.973 1.709 . . . . 0.0 113.215 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.555 ' HD2' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmm_? -76.2 -21.83 56.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.707 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 94.43 24.56 18.37 Favored Glycine 1 N--CA 1.393 -4.213 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.697 174.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 155.8 170.39 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 130.393 3.477 . . . . 0.0 105.525 167.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.49 4.0 17.74 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.218 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 43' ' ' ILE . 8.2 p90 -123.8 163.8 20.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -122.09 147.69 45.8 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.19 147.9 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.988 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 158.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.963 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.984 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.75 -130.12 9.04 Favored Glycine 1 N--CA 1.394 -4.13 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 50.25 37.11 30.56 Favored Glycine 0 CA--C 1.478 -2.268 0 C-N-CA 123.92 0.772 . . . . 0.0 113.513 175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -67.13 -21.39 65.84 Favored 'General case' 0 CA--C 1.477 -1.845 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.097 -175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -170.78 169.37 3.47 Favored Pre-proline 0 CA--C 1.474 -1.961 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.356 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 21.2 Cg_endo -66.61 51.36 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.923 2.416 . . . . 0.0 111.279 171.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 5.8 m-20 -176.84 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 127.105 2.162 . . . . 0.0 111.352 -170.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.532 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 18.6 mm-40 -128.66 123.85 34.24 Favored 'General case' 0 C--O 1.272 2.238 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.529 ' CE1' HD12 ' A' ' 73' ' ' LEU . 6.5 m-30 -77.15 159.67 29.57 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 131.14 3.776 . . . . 0.0 114.58 -168.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -92.87 144.28 25.43 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 172.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.7 mt-30 -138.28 153.19 49.06 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 62' ' ' ASP . 25.0 mm -70.93 111.21 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.402 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 45' ' ' SER . 38.8 ttpt -67.54 -36.5 81.11 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.47 ' HA ' HG21 ' A' ' 60' ' ' THR . 41.1 t 170.53 172.9 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 O-C-N 125.159 1.537 . . . . 0.0 111.221 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -144.76 149.47 35.58 Favored 'General case' 0 N--CA 1.408 -2.562 0 C-N-CA 124.257 1.023 . . . . 0.0 110.879 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.65 127.64 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.651 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.25 -3.38 10.59 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.571 -2.104 . . . . 0.0 112.264 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -103.13 -18.06 15.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.4 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.98 163.0 32.98 Favored Glycine 0 N--CA 1.41 -3.07 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.729 -170.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -50.27 -32.96 34.86 Favored 'Trans proline' 0 C--O 1.201 -1.372 0 C-N-CA 125.063 3.842 . . . . 0.0 112.617 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.51 -47.86 80.82 Favored 'General case' 0 C--O 1.271 2.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.357 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.18 -36.55 54.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.43 -35.45 65.8 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.108 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.69 -22.41 66.08 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.3 24.0 76.17 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.403 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' CB ' ' HB ' ' A' ' 18' ' ' THR . 23.7 mmtp -110.18 -35.69 6.03 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.4 ttm -102.27 143.08 32.49 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.167 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.44 163.93 29.33 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.619 0.723 . . . . 0.0 109.176 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -67.83 114.42 6.4 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 123.709 0.804 . . . . 0.0 108.837 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.62 -22.07 7.43 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.035 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 43' ' ' ILE . 8.1 m-20 -62.18 134.69 56.89 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.706 0.753 . . . . 0.0 110.986 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -82.52 121.51 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.408 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.0 mm -72.58 122.83 25.98 Favored 'Isoleucine or valine' 1 C--O 1.334 5.525 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 73' ' ' LEU . 48.1 t -115.29 -37.61 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 110.402 -3.09 . . . . 0.0 111.652 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.429 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.0 m -150.76 151.43 32.36 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.302 -1.499 . . . . 0.0 114.424 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG13 ' CG1' ' A' ' 93' ' ' VAL . 25.3 t -118.73 114.8 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.629 1.172 . . . . 0.0 109.037 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 52.74 36.69 21.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.312 0.577 . . . . 0.0 112.308 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 72.73 15.41 4.84 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.166 1.786 . . . . 0.0 112.164 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 72' ' ' VAL . 28.6 m -99.1 119.14 37.34 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 169.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.4 t -69.22 110.01 4.37 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.678 0.752 . . . . 0.0 109.491 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 80' ' ' VAL . 23.9 m -114.47 18.3 7.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.444 -176.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.609 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 28.5 tp -59.79 113.4 2.25 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.711 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.21 45.72 0.14 Allowed Glycine 0 C--N 1.378 2.9 0 O-C-N 125.661 1.85 . . . . 0.0 111.896 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.536 ' O ' HG21 ' A' ' 76' ' ' THR . 8.9 t60 -45.15 -66.68 0.37 Allowed 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.536 HG21 ' O ' ' A' ' 75' ' ' HIS . 10.8 p -166.9 143.83 4.67 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 150.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -51.0 -36.94 42.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 121.008 1.731 . . . . 0.0 110.886 174.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.43 95.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.501 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.469 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 18.6 mm-40 -69.97 -39.81 75.74 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 77' ' ' HIS . 20.9 m -66.54 -41.6 88.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.859 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.63 -40.89 90.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.646 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.4 tmtm? -59.03 -44.58 91.78 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.765 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.646 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.4 mm -66.34 -35.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -70.98 -36.59 72.57 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -68.24 -23.38 64.79 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 124.338 1.055 . . . . 0.0 111.352 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.5 m -75.63 -30.09 59.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.938 176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.447 HG21 ' HD3' ' A' ' 22' ' ' LYS . 51.9 mt -83.24 133.29 47.98 Favored Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.646 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 9.8 Cg_endo -88.08 161.99 7.24 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.552 2.835 . . . . 0.0 112.637 -173.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.499 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 35.5 mm -66.52 133.73 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.87 54.5 Favored Glycine 0 C--N 1.287 -2.173 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.237 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.604 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -101.73 -177.25 3.37 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.475 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 2.9 p -145.54 152.48 39.8 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.78 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.8 t -136.67 125.42 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.34 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.74 102.85 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 70.0 mt -99.65 139.77 34.82 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.724 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -96.55 118.36 32.89 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 90.4 mt -107.52 164.54 12.12 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 125.283 1.433 . . . . 0.0 109.382 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 19.3 t -142.22 107.77 5.07 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-O 122.387 1.089 . . . . 0.0 110.684 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -85.05 117.75 24.2 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.42 -24.19 0.21 Allowed Glycine 0 CA--C 1.473 -2.558 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.587 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 35.9 m-85 -94.22 133.46 27.27 Favored Pre-proline 0 C--N 1.286 -2.173 0 CA-C-O 121.075 0.464 . . . . 0.0 110.364 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.43 150.6 88.12 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 123.605 2.87 . . . . 0.0 111.969 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 3.6 mt -54.06 121.65 31.19 Favored Pre-proline 0 N--CA 1.436 -1.153 0 C-N-CA 124.089 0.956 . . . . 0.0 112.214 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 84.1 Cg_exo -55.68 173.97 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 125.084 3.856 . . . . 0.0 115.9 -177.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.423 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 88.7 t80 -73.34 139.95 46.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 112.69 -2.05 . . . . 0.0 111.021 -178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.84 101.68 50.27 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 124.446 1.098 . . . . 0.0 110.236 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.447 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 63.3 Cg_endo -102.46 -60.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.61 2.206 . . . . 0.0 113.306 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.447 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 20.2 t70 -82.83 -16.94 45.77 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.753 -176.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -92.37 141.49 24.93 Favored Pre-proline 0 N--CA 1.385 -3.718 0 CA-C-O 122.004 0.907 . . . . 0.0 112.241 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.527 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 93.7 Cg_endo -85.6 -33.59 0.21 Allowed 'Trans proline' 0 N--CA 1.426 -2.49 0 C-N-CA 122.19 1.927 . . . . 0.0 110.961 171.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.527 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 1.5 m-20 -32.5 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 131.602 3.961 . . . . 0.0 116.633 -164.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -93.84 2.33 56.22 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -167.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.6 m -93.09 25.33 3.31 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.457 -0.777 . . . . 0.0 113.026 -175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.2 mt 56.59 18.52 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.6 p -156.78 -1.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-O 123.266 1.508 . . . . 0.0 108.44 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.7 157.27 19.11 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 112.901 -1.954 . . . . 0.0 110.065 -175.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.2 m 60.77 40.69 15.76 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -167.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.1 114.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 112.075 -2.33 . . . . 0.0 115.611 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.94 20.65 11.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.91 1.338 . . . . 0.0 107.944 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.91 68.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.113 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -107.23 24.02 13.5 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.469 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 53.43 69.1 0.74 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.73 1.212 . . . . 0.0 111.66 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.99 12.73 35.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.588 -176.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.85 135.89 63.12 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.259 1.525 0 C-N-CA 123.774 2.982 . . . . 0.0 113.275 179.473 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.222 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -154.64 -73.14 0.12 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 117.412 0.606 . . . . 0.0 111.125 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.9 ptp -92.85 32.29 1.28 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.496 0.665 . . . . 0.0 111.097 -176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 167.92 -131.55 2.36 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.9 tptt 53.45 73.21 0.96 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 124.379 1.071 . . . . 0.0 112.081 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 36.3 Cg_endo -100.34 -178.42 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.315 2.677 . . . . 0.0 111.896 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -82.58 105.51 13.68 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.622 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.5 t80 -105.18 138.42 41.41 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.126 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 7' ' ' ASN . 9.5 t -154.51 22.97 0.47 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.217 0.532 . . . . 0.0 111.008 174.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 58.11 -30.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 128.446 2.698 . . . . 0.0 116.431 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.416 ' H ' ' C ' ' A' ' 5' ' ' THR . 4.4 t-20 -99.88 113.87 65.36 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -55.22 -32.68 81.54 Favored 'Trans proline' 0 C--O 1.221 -0.329 0 C-N-CA 123.482 2.788 . . . . 0.0 111.46 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -71.34 -11.97 61.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.285 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 21.4 mm-40 -105.03 -22.35 13.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.474 0.71 . . . . 0.0 111.344 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.4 mm? -79.67 169.48 17.91 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -177.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.87 -170.42 2.04 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.834 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.11 177.76 52.05 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 13.6 ttpt -110.16 132.18 54.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.5 m-85 -99.09 110.79 23.32 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 123.161 1.458 . . . . 0.0 110.8 -174.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.438 HG12 ' CE ' ' A' ' 14' ' ' LYS . 30.5 mt -107.09 151.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.835 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.28 -174.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.43 121.49 25.99 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.352 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 t -138.51 138.91 38.48 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.58 0.705 . . . . 0.0 110.151 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 28.6 ttmt -93.8 125.04 38.2 Favored 'General case' 0 C--N 1.259 -3.346 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.7 117.05 33.03 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 37.8 ttt180 -76.7 108.56 9.8 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.909 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 73.6 tttt -65.05 97.14 0.22 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t -87.61 -154.83 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -54.4 -41.54 69.39 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.154 0.581 . . . . 0.0 110.767 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -87.15 -20.47 26.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.805 0.812 . . . . 0.0 109.77 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.575 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 99.28 -116.33 5.55 Favored Glycine 1 N--CA 1.386 -4.695 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 31.0 m-85 -93.9 146.79 23.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.14 0.34 66.4 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.642 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 31' ' ' VAL . 10.0 p90 -111.24 163.14 14.25 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.546 0.689 . . . . 0.0 111.606 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.6 p -116.85 156.4 27.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG23 ' CE2' ' A' ' 29' ' ' PHE . 2.6 t -132.35 142.44 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.348 -173.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -152.7 160.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.91 -1.52 30.19 Favored Glycine 1 CA--C 1.447 -4.189 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 168.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.684 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -116.39 43.98 1.55 Allowed Glycine 1 CA--C 1.408 -6.637 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -170.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.32 -12.41 29.56 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 113.009 -1.595 . . . . 0.0 112.17 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -165.45 167.25 9.52 Favored Pre-proline 0 CA--C 1.46 -2.512 0 C-N-CA 117.203 -1.799 . . . . 0.0 110.888 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -67.32 57.52 0.64 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 122.463 2.108 . . . . 0.0 110.165 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 26.8 t70 -179.67 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.478 1.911 . . . . 0.0 109.625 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.699 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 26.7 mt-10 -113.47 124.58 52.75 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-O 117.009 -1.472 . . . . 0.0 107.274 171.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 73' ' ' LEU 0.305 6.5 m-30 -79.35 155.38 28.46 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 128.288 3.492 . . . . 0.0 111.733 -176.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.563 HD11 ' HA3' ' A' ' 34' ' ' GLY . 6.6 mp -87.1 143.34 27.36 Favored 'General case' 0 C--O 1.175 -2.867 0 C-N-CA 116.582 -2.047 . . . . 0.0 108.901 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.5 mt-30 -138.42 157.54 46.01 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 29' ' ' PHE . 25.3 mm -75.48 109.91 9.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.577 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.2 tttp -56.8 -37.71 71.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 125.183 1.552 . . . . 0.0 107.07 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' HG23 ' A' ' 60' ' ' THR . 42.0 t 159.36 173.13 0.01 OUTLIER 'General case' 0 C--N 1.364 1.239 0 O-C-N 125.769 1.918 . . . . 0.0 109.231 172.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pp -136.74 149.37 47.81 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.44 118.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.263 1.2 pt? -69.59 -5.06 22.01 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -94.64 -3.48 49.44 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.354 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 54' ' ' LEU . . . -91.62 161.78 27.47 Favored Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.2 -29.9 30.86 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 124.952 3.768 . . . . 0.0 113.38 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.07 -46.71 84.98 Favored 'General case' 0 C--O 1.275 2.41 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.694 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.07 -32.38 56.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.532 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 50' ' ' GLY . 9.1 mp -68.69 -45.2 72.28 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.996 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.9 -26.93 67.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.12 16.7 79.54 Favored Glycine 0 CA--C 1.487 -1.711 0 CA-C-N 112.933 -1.939 . . . . 0.0 113.842 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -109.53 -24.48 10.96 Favored 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 122.278 0.231 . . . . 0.0 111.573 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.43 140.53 31.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.025 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 41.4 tt0 -149.38 146.89 27.72 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.986 0.898 . . . . 0.0 111.69 -172.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 45' ' ' SER . 5.3 p -49.61 103.52 0.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 126.313 1.845 . . . . 0.0 112.416 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.9 -2.52 31.78 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-O 119.375 -0.68 . . . . 0.0 113.049 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.24 146.95 48.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -98.59 121.22 48.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.491 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 29.7 mm -69.88 123.96 24.81 Favored 'Isoleucine or valine' 0 C--O 1.305 3.975 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.481 HG13 HD13 ' A' ' 73' ' ' LEU . 43.7 t -115.19 -38.66 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 111.662 -2.517 . . . . 0.0 110.272 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 40.0 m -145.11 142.97 30.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.885 -178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.57 131.82 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 m120 63.8 23.82 13.56 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.873 0.844 . . . . 0.0 108.958 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.37 -0.66 2.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.408 1.883 . . . . 0.0 112.079 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 72' ' ' VAL . 76.8 m -78.86 119.81 22.58 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.67 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.411 -2.397 0 O-C-N 124.777 1.298 . . . . 0.0 110.29 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 80' ' ' VAL . 35.6 m -115.87 26.55 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.535 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.622 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.5 tp -59.71 113.79 2.43 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.26 41.48 0.22 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 125.344 1.653 . . . . 0.0 112.177 -170.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 76' ' ' THR . 14.5 t60 -45.72 -66.73 0.36 Allowed 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.1 p -167.14 143.5 4.38 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 149.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.43 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -50.16 -38.61 40.33 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 119.342 0.974 . . . . 0.0 110.658 174.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.53 95.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.082 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 68.3 mm-40 -66.37 -43.2 86.6 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG21 HD21 ' A' ' 41' ' ' LEU . 33.4 m -66.81 -40.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.502 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.94 -39.27 85.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.674 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.92 -40.02 79.4 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.706 176.383 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.674 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 57.9 mt -66.75 -36.78 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.713 0.768 . . . . 0.0 110.802 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -71.49 -30.29 65.8 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.421 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.99 -26.32 59.48 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.487 1.115 . . . . 0.0 110.27 174.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 52.4 m -72.39 -49.29 34.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.995 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 44.3 mt -62.98 134.83 95.92 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.789 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.3 Cg_endo -90.51 161.84 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.482 2.788 . . . . 0.0 113.302 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.4 mm -65.37 132.35 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 121.452 0.644 . . . . 0.0 110.379 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.06 54.13 Favored Glycine 0 C--N 1.288 -2.092 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.793 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.427 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -98.66 -170.43 1.94 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -175.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 13.3 m -151.14 158.93 44.62 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.81 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.21 126.68 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.772 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.63 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.528 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 15.1 m-20 -78.79 104.14 9.21 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.7 mt -102.42 136.96 41.31 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 124.624 1.169 . . . . 0.0 109.884 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 37.6 tt0 -101.02 121.06 41.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 6.0 mt -107.54 165.04 11.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.048 1.339 . . . . 0.0 108.764 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.598 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 21.1 t -137.97 105.23 5.48 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.103 0.954 . . . . 0.0 110.634 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 59' ' ' GLU . 76.5 mtm180 -96.46 119.98 35.93 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 121.229 -0.92 . . . . 0.0 110.506 174.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.26 -33.95 0.15 Allowed Glycine 0 CA--C 1.474 -2.517 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.62 133.4 23.62 Favored Pre-proline 0 N--CA 1.424 -1.744 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.34 170.39 19.54 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.929 2.419 . . . . 0.0 111.395 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.85 128.42 88.87 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.459 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -76.09 -34.32 3.03 Favored 'Trans proline' 0 CA--C 1.49 -1.72 0 C-N-CA 122.426 2.084 . . . . 0.0 110.864 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.485 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 34.4 t80 -139.0 141.99 38.31 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 113.307 -1.77 . . . . 0.0 106.374 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -113.56 85.9 9.67 Favored Pre-proline 0 N--CA 1.387 -3.618 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.403 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 83.1 Cg_endo -89.9 -55.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.568 2.179 . . . . 0.0 112.257 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 36.8 t70 -84.0 -16.36 44.29 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.652 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.478 ' OD2' HG23 ' A' ' 112' ' ' THR . 19.0 t0 -78.01 115.29 49.31 Favored Pre-proline 0 CA--C 1.45 -2.892 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.619 ' CD ' ' H ' ' A' ' 111' ' ' ASN . 14.6 Cg_endo -87.54 -29.04 0.39 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 121.424 1.416 . . . . 0.0 109.622 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.619 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 9.9 t30 -64.55 4.24 0.41 Allowed 'General case' 0 N--CA 1.386 -3.66 1 C-N-CA 132.566 4.347 . . . . 0.0 114.026 -164.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.478 HG23 ' OD2' ' A' ' 109' ' ' ASP . 29.1 p -96.93 4.59 51.51 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.174 -175.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 116' ' ' THR . 22.5 t -130.7 -177.08 4.2 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.28 142.77 39.31 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.086 0.403 . . . . 0.0 111.028 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p 44.96 53.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.035 1.734 . . . . 0.0 112.775 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.465 ' HB ' ' C ' ' A' ' 110' ' ' PRO . 12.0 p -106.99 -73.67 0.68 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.256 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.4 t -124.93 159.1 31.96 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 168.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.16 67.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.767 0.794 . . . . 0.0 112.205 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 121' ' ' LEU . . . -170.76 59.79 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.49 100.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.521 -174.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 119' ' ' ALA . 70.8 mt -118.2 131.49 56.38 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 121.713 0.768 . . . . 0.0 111.73 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -135.89 120.06 17.75 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.98 103.21 9.71 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.3 135.96 86.66 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--N 1.355 0.91 0 C-N-CA 123.765 2.977 . . . . 0.0 113.126 -179.395 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.49 -18.54 14.34 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.628 0.728 . . . . 0.0 110.478 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.1 mmt -105.81 41.78 1.34 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 149.62 -143.26 10.58 Favored Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 107.131 -2.387 . . . . 0.0 107.131 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? 53.01 68.54 2.92 Favored Pre-proline 0 CA--C 1.57 1.743 0 O-C-N 124.625 0.838 . . . . 0.0 112.034 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 52.1 Cg_endo -94.52 -163.81 0.1 OUTLIER 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.944 2.43 . . . . 0.0 112.457 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -81.61 103.71 11.52 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.607 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -113.7 118.43 34.31 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.385 -176.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 7' ' ' ASN . 12.4 t -134.7 17.67 3.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.86 0.838 . . . . 0.0 110.267 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.425 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.7 mtp180 59.59 -20.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.018 2.127 . . . . 0.0 115.762 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.464 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 3.3 t-20 -99.84 112.32 63.58 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-O 121.227 0.537 . . . . 0.0 111.086 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 1.8 Cg_endo -50.89 -37.1 54.98 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.989 3.126 . . . . 0.0 111.846 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -68.04 -20.31 64.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.763 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 8.3 mm-40 -95.14 -23.54 17.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.573 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 mt -76.3 179.45 5.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.061 0.934 . . . . 0.0 110.421 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -107.65 -177.02 3.23 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.505 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.55 166.21 27.41 Favored Glycine 0 C--N 1.283 -2.405 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.074 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 29.2 tttp -93.03 138.96 31.02 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.674 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.0 m-85 -113.44 111.57 22.17 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.94 1.352 . . . . 0.0 110.835 -175.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.482 HG12 ' CE ' ' A' ' 14' ' ' LYS . 5.9 mt -109.36 151.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 CA-C-N 112.235 -2.257 . . . . 0.0 108.114 -173.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.468 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 2.8 t60 -130.71 119.77 22.86 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 3.6 t -139.18 129.35 25.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.975 0.893 . . . . 0.0 111.056 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.826 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 36.5 ttpt -90.66 123.65 34.45 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.192 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.18 119.57 39.74 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.477 -173.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.0 ttm180 -77.43 111.03 12.7 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.863 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.0 tttt -69.26 97.23 0.92 Allowed 'General case' 0 C--O 1.177 -2.742 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 89' ' ' ILE . 29.4 t -82.05 -155.81 0.15 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -67.45 -31.06 70.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.588 0.709 . . . . 0.0 109.092 174.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.16 -13.33 57.35 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.798 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 81.29 -125.63 6.98 Favored Glycine 1 N--CA 1.389 -4.485 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 30.3 m-85 -88.52 142.7 27.49 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.699 0.75 . . . . 0.0 110.176 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.81 82.85 Favored Glycine 0 C--N 1.315 -0.61 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.923 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.2 p90 -110.66 162.72 14.46 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.244 0.545 . . . . 0.0 110.341 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 47.3 p -116.76 150.82 37.64 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.67 135.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.863 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.536 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 9.9 p -151.94 165.75 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.954 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 113.15 -0.47 25.39 Favored Glycine 0 CA--C 1.471 -2.687 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 172.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -120.54 44.55 1.35 Allowed Glycine 1 CA--C 1.395 -7.417 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -171.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 7.8 m-20 -59.09 -13.33 6.63 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.606 -1.797 . . . . 0.0 113.04 -174.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.489 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 4.2 pt-20 -160.04 166.42 15.89 Favored Pre-proline 0 CA--C 1.455 -2.703 0 C-N-CA 117.177 -1.809 . . . . 0.0 110.631 -174.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 36.8 Cg_endo -67.61 51.62 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.818 2.345 . . . . 0.0 110.585 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 7.7 t70 -179.39 -12.88 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.674 1.19 . . . . 0.0 110.037 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.65 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 30.5 mt-10 -116.48 127.35 54.49 Favored 'General case' 0 C--O 1.276 2.465 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 167.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.472 ' CD1' HD12 ' A' ' 73' ' ' LEU . 11.6 m-85 -80.36 155.31 27.24 Favored 'General case' 0 N--CA 1.524 3.254 0 O-C-N 127.942 3.276 . . . . 0.0 111.898 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.571 HD12 ' HA3' ' A' ' 34' ' ' GLY . 4.3 mp -84.33 145.72 28.1 Favored 'General case' 0 C--O 1.177 -2.755 0 C-N-CA 117.391 -1.724 . . . . 0.0 107.929 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.7 mt-30 -142.37 149.25 39.14 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.1 mm -71.35 112.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 18.5 tptm -65.87 -35.03 79.52 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 60' ' ' THR . 37.5 t 160.69 172.97 0.01 OUTLIER 'General case' 0 C--N 1.357 0.926 0 O-C-N 125.271 1.607 . . . . 0.0 110.297 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -138.55 148.53 44.32 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.541 0.686 . . . . 0.0 111.705 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.9 119.06 28.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HA ' ' CB ' ' A' ' 53' ' ' ALA 0.26 1.1 pt? -69.44 -4.4 18.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.04 -27.13 48.72 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.196 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.08 171.11 36.82 Favored Glycine 0 N--CA 1.417 -2.62 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.754 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.54 -32.23 52.55 Favored 'Trans proline' 0 C--O 1.204 -1.179 1 C-N-CA 125.328 4.018 . . . . 0.0 113.871 -173.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -48.65 79.04 Favored 'General case' 0 C--O 1.273 2.333 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.65 -32.94 53.57 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.997 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 50' ' ' GLY . 6.0 mp -68.21 -40.59 82.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 57' ' ' LYS . 33.2 t70 -68.52 -30.02 68.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.75 6.56 87.09 Favored Glycine 0 CA--C 1.493 -1.294 0 CA-C-N 112.423 -2.171 . . . . 0.0 114.113 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 54.0 mttm -98.17 -25.2 14.98 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.6 ttm -96.24 140.63 30.65 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.259 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.54 153.0 50.29 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.771 0.795 . . . . 0.0 110.18 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.407 HG23 ' HA ' ' A' ' 45' ' ' SER . 81.6 p -67.03 114.66 5.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.918 1.287 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.26 -20.87 15.88 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 121.961 -0.462 . . . . 0.0 112.41 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.2 m-20 -60.45 136.42 58.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -87.32 125.7 41.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.345 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 17.5 mm -73.74 125.15 32.4 Favored 'Isoleucine or valine' 1 C--O 1.307 4.105 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.484 HG13 HD13 ' A' ' 73' ' ' LEU . 48.4 t -114.42 -34.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.481 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.445 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 68.6 m -150.55 153.36 35.64 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.154 -0.966 . . . . 0.0 112.231 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.447 HG13 ' HB ' ' A' ' 72' ' ' VAL . 7.3 p -131.03 127.31 60.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m120 63.25 20.14 12.09 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.647 0.203 . . . . 0.0 110.544 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 79.07 -1.02 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.95 1.7 . . . . 0.0 111.965 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.3 m -85.83 123.17 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.445 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 28.2 t -62.71 109.42 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 67' ' ' VAL . 3.6 p -120.54 18.16 6.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.569 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.607 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.7 tp -59.59 113.41 2.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.93 43.71 0.14 Allowed Glycine 0 C--N 1.37 2.471 0 O-C-N 125.355 1.659 . . . . 0.0 112.174 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.526 ' O ' HG21 ' A' ' 76' ' ' THR . 3.9 t60 -45.11 -65.94 0.47 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 75' ' ' HIS . 12.8 p -165.79 142.42 5.32 Favored 'General case' 0 C--N 1.264 -3.132 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 152.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.581 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -50.69 -31.52 16.67 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 120.119 1.327 . . . . 0.0 111.351 171.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.19 85.61 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 122.156 -0.34 . . . . 0.0 110.8 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.519 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 47.7 mm-40 -64.16 -40.99 97.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 77' ' ' HIS . 12.6 m -63.44 -45.65 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.825 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.4 t -65.55 -40.07 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.4 -39.18 89.75 Favored 'General case' 0 C--O 1.199 -1.6 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.76 177.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.634 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.3 mm -67.0 -34.63 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.652 0.739 . . . . 0.0 112.026 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -75.1 -29.39 60.58 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.446 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -76.59 -19.91 57.35 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.105 0.962 . . . . 0.0 111.105 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 75.1 m -75.25 -37.72 60.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.018 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.5 mt -78.65 135.58 60.06 Favored Pre-proline 0 N--CA 1.421 -1.923 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.057 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.5 Cg_endo -90.9 161.94 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.455 2.77 . . . . 0.0 112.926 -173.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.497 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 20.8 mm -63.45 132.51 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 121.519 0.676 . . . . 0.0 111.452 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.12 53.21 Favored Glycine 0 C--N 1.294 -1.782 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.918 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.35 -170.27 1.84 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 122.484 0.314 . . . . 0.0 110.242 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 11.1 m -151.22 157.78 43.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.826 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -145.22 125.07 6.51 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.965 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.468 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 11.3 m-20 -77.52 104.18 7.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.77 142.22 33.43 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 124.607 1.163 . . . . 0.0 110.579 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 12.0 tp10 -101.84 125.72 48.57 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 84.8 mt -115.36 152.9 31.98 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.331 1.452 . . . . 0.0 110.957 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.674 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 6.5 t -125.78 107.81 10.88 Favored 'General case' 0 C--O 1.188 -2.168 0 C-N-CA 124.202 1.001 . . . . 0.0 110.016 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 35.3 ttm180 -93.37 118.95 31.92 Favored 'General case' 0 C--N 1.254 -3.569 0 O-C-N 120.341 -1.474 . . . . 0.0 109.045 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.54 -30.49 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.04 133.0 25.84 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.85 156.38 66.37 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.35 2.7 . . . . 0.0 111.63 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 mt -45.81 135.81 6.29 Favored Pre-proline 0 CA--C 1.51 -0.564 0 C-N-CA 124.729 1.212 . . . . 0.0 112.048 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.47 -170.34 0.72 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.597 2.198 . . . . 0.0 114.022 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -80.55 147.51 30.77 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.98 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.72 88.81 40.3 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.951 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.485 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 68.1 Cg_endo -97.39 -60.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.668 2.245 . . . . 0.0 111.857 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 26.2 t70 -72.71 -23.69 60.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.845 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 7.7 m-20 -88.51 131.14 42.98 Favored Pre-proline 0 N--CA 1.385 -3.687 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.548 -175.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 109' ' ' ASP 0.255 60.4 Cg_endo -82.38 -30.99 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.94 1.76 . . . . 0.0 108.457 163.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 117' ' ' SER . 77.1 m-20 -33.24 -11.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.86 1 C-N-CA 134.308 5.043 . . . . 0.0 119.626 -167.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -107.61 15.21 24.94 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -170.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 m -110.65 -167.33 1.17 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.94 129.98 38.68 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t 68.53 46.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.774 1.273 . . . . 0.0 109.388 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -126.19 -177.29 3.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.303 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 16.3 m 66.26 36.89 5.18 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.5 t 57.74 69.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.346 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.836 0.827 . . . . 0.0 112.088 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.8 mm -98.99 79.2 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.38 54.43 3.15 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.452 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -133.74 144.87 49.35 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.79 65.6 7.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.007 0.908 . . . . 0.0 111.979 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -102.02 134.12 20.28 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 CA--C 1.544 1.02 0 C-N-CA 123.664 2.909 . . . . 0.0 112.965 -178.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.382 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 62.18 68.97 0.64 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 123.6 0.76 . . . . 0.0 111.804 176.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 16.9 tpt -178.08 -42.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.376 1.07 . . . . 0.0 109.147 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 176.69 -101.89 0.16 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.4 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.1 OUTLIER 55.09 68.08 2.77 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.459 1.104 . . . . 0.0 112.676 178.102 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -104.89 -162.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.311 2.674 . . . . 0.0 111.81 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -98.28 105.88 18.08 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.609 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.9 t80 -95.79 139.79 31.51 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.748 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -148.82 14.61 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.297 0.57 . . . . 0.0 111.416 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.499 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.2 mtm180 55.11 -0.1 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.848 2.059 . . . . 0.0 115.934 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -134.13 123.49 16.84 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HB3' HG12 ' A' ' 65' ' ' VAL . 4.3 Cg_endo -60.0 -22.7 70.23 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.845 3.03 . . . . 0.0 112.83 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -77.95 -29.8 50.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -87.2 -30.18 21.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.534 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 45.4 tp -81.06 160.4 24.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.684 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.485 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 49.5 mtmt -102.84 -179.26 3.91 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.624 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 105.27 168.52 23.9 Favored Glycine 0 C--N 1.281 -2.481 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -175.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -90.57 119.79 31.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 99.2 m-85 -98.5 114.62 27.09 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-O 121.92 0.867 . . . . 0.0 109.849 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.0 mt -117.73 136.01 56.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 CA-C-N 113.87 -1.513 . . . . 0.0 110.284 -171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.493 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.9 t-80 -105.95 113.99 27.86 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.261 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 t -139.96 133.5 30.21 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-O 122.073 0.94 . . . . 0.0 111.65 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.819 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -88.03 127.25 35.39 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.151 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.91 118.57 37.09 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 43.0 ttp180 -78.47 107.75 11.35 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.4 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 72.0 tttt -63.86 97.32 0.16 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 168.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -85.06 -155.41 0.21 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.86 -39.86 90.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -84.96 -13.35 50.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.33 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.581 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 91.2 -121.96 6.53 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 39.7 m-85 -93.39 145.04 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.655 0.727 . . . . 0.0 109.85 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.66 -0.18 72.87 Favored Glycine 0 C--O 1.214 -1.131 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.861 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.7 p90 -108.28 163.52 13.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.391 0.615 . . . . 0.0 110.646 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.469 ' OG1' ' HE2' ' A' ' 44' ' ' LYS . 46.5 p -121.46 151.02 40.7 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.63 141.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.976 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.449 HG21 ' N ' ' A' ' 33' ' ' GLY . 11.5 p -149.75 167.0 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.474 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' N ' HG21 ' A' ' 32' ' ' VAL . . . 127.19 -64.45 0.59 Allowed Glycine 0 CA--C 1.474 -2.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.402 173.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.732 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -71.53 60.52 1.2 Allowed Glycine 1 CA--C 1.41 -6.474 0 C-N-CA 126.951 2.215 . . . . 0.0 116.236 -169.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -22.0 66.55 Favored 'General case' 0 C--N 1.245 -3.97 0 O-C-N 124.669 0.864 . . . . 0.0 109.739 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 10.0 pt-20 -154.27 165.33 18.22 Favored Pre-proline 0 CA--C 1.456 -2.649 0 C-N-CA 116.1 -2.24 . . . . 0.0 111.21 -171.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -68.1 55.65 0.76 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.829 2.352 . . . . 0.0 109.796 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -178.05 -20.71 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.703 -1.589 . . . . 0.0 109.886 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.732 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 13.4 mm-40 -114.79 128.46 56.31 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.466 ' CZ ' HD23 ' A' ' 11' ' ' LEU 0.25 7.5 m-30 -79.41 157.23 27.62 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 128.78 3.8 . . . . 0.0 111.773 -179.185 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.509 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 6.5 mp -88.63 149.51 23.5 Favored 'General case' 0 C--O 1.189 -2.081 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 9.7 mt-30 -145.31 153.32 41.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 62' ' ' ASP . 21.0 mm -69.91 110.51 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.469 ' HE2' ' OG1' ' A' ' 30' ' ' THR . 3.8 tmmm? -65.01 -33.88 77.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 60' ' ' THR . 37.1 t 162.03 172.64 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 O-C-N 124.975 1.422 . . . . 0.0 109.775 173.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -136.24 144.55 44.9 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 121.785 0.802 . . . . 0.0 109.947 -174.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.38 126.3 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mp -68.92 -4.2 15.65 Favored 'General case' 1 N--CA 1.377 -4.112 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.307 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -97.55 -21.4 17.11 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.595 177.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.19 167.73 34.59 Favored Glycine 0 N--CA 1.404 -3.447 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.494 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.602 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.6 Cg_endo -53.65 -31.23 59.27 Favored 'Trans proline' 0 C--O 1.187 -2.046 0 C-N-CA 124.731 3.62 . . . . 0.0 113.037 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.66 76.37 Favored 'General case' 0 C--O 1.264 1.85 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.12 -34.32 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.098 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.23 -38.22 69.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.352 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -73.07 -18.24 61.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 122.273 1.035 . . . . 0.0 108.504 175.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.01 32.59 82.7 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 113.251 -1.795 . . . . 0.0 113.836 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -124.25 -0.72 8.25 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.519 ' HB3' HD22 ' A' ' 46' ' ' LEU . 28.1 mtt -112.71 141.87 45.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.847 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -135.9 149.89 49.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 45' ' ' SER . 32.5 p -63.17 114.64 3.88 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.763 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.82 -14.34 19.7 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.475 176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.1 m-20 -61.73 132.33 52.82 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -81.8 129.47 37.44 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.686 0 CA-C-N 118.607 0.64 . . . . 0.0 112.32 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.509 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 38.5 mm -79.53 127.58 39.07 Favored 'Isoleucine or valine' 1 C--O 1.322 4.918 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 173.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG13 HD11 ' A' ' 73' ' ' LEU . 40.2 t -115.86 -47.44 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 O-C-N 127.085 2.741 . . . . 0.0 111.873 -176.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -140.88 165.17 28.26 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 117.995 -1.482 . . . . 0.0 113.767 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 72' ' ' VAL . 40.0 t -138.07 120.66 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 C-N-CA 124.855 1.262 . . . . 0.0 108.175 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.9 m120 67.21 -79.34 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.468 1.105 . . . . 0.0 110.154 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -158.15 24.88 0.25 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.336 1.065 . . . . 0.0 109.655 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.8 m -117.19 123.84 47.65 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 t -68.07 108.01 2.94 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 80' ' ' VAL . 1.7 p -111.99 16.82 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 122.13 0.967 . . . . 0.0 108.606 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.609 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.7 tp -60.89 112.84 2.21 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.23 45.51 0.13 Allowed Glycine 0 C--N 1.378 2.874 0 O-C-N 125.754 1.909 . . . . 0.0 111.664 -170.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.595 ' O ' HG23 ' A' ' 76' ' ' THR . 2.5 t60 -48.41 -66.98 0.31 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 75' ' ' HIS . 8.6 p -166.62 142.64 4.6 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 151.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.5 -31.61 15.92 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 120.288 1.404 . . . . 0.0 111.516 173.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -48.31 82.24 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 122.116 -0.365 . . . . 0.0 110.723 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 11.9 mm-40 -61.81 -44.08 97.57 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 122.938 0.495 . . . . 0.0 112.091 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' HIS . 9.7 m -64.26 -44.31 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.63 -42.77 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -67.07 -29.15 68.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.383 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 86' ' ' SER . 2.1 mm -68.94 -40.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 123.117 0.567 . . . . 0.0 111.748 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.33 -33.96 67.71 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -73.27 -19.49 61.05 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.368 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 30.1 t -77.44 -43.17 33.4 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 mt -69.06 133.79 89.77 Favored Pre-proline 0 N--CA 1.423 -1.81 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.767 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.8 Cg_endo -89.56 161.84 5.34 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.163 2.576 . . . . 0.0 113.197 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.501 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.6 mm -60.83 132.49 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.833 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 12.19 55.96 Favored Glycine 0 C--N 1.288 -2.123 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.834 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.73 -172.13 2.1 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 19.8 m -151.17 156.87 41.86 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.77 -0.581 . . . . 0.0 109.614 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -143.43 125.49 11.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.672 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.597 -175.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 17.3 m-20 -78.42 108.26 11.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.6 mt -108.45 136.03 48.75 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.443 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -91.58 124.65 35.91 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 10.7 mt -107.56 160.06 15.96 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.624 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 14.7 t -131.65 108.0 9.2 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 123.726 0.81 . . . . 0.0 108.993 174.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -96.89 147.12 24.29 Favored 'General case' 0 C--N 1.247 -3.853 0 O-C-N 120.706 -1.246 . . . . 0.0 109.904 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.04 -17.49 4.58 Favored Glycine 0 CA--C 1.482 -1.988 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.91 130.51 28.63 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.94 157.27 60.14 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 123.551 2.834 . . . . 0.0 112.546 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.18 124.12 37.22 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.501 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.426 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 67.4 Cg_endo -77.06 -51.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 123.499 2.799 . . . . 0.0 115.698 -168.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 85.9 t80 -130.37 126.28 36.7 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 120.91 0.386 . . . . 0.0 111.477 -169.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -102.58 105.17 42.68 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.024 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 48.7 Cg_endo -94.7 -61.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.316 0 C-N-CA 122.357 2.038 . . . . 0.0 109.939 169.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.409 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 6.1 p-10 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.405 -2.681 0 C-N-CA 125.567 1.547 . . . . 0.0 108.421 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -76.98 124.09 87.4 Favored Pre-proline 0 CA--C 1.469 -2.152 0 CA-C-O 121.994 0.902 . . . . 0.0 109.786 -172.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.649 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 95.6 Cg_endo -76.58 -38.69 0.9 Allowed 'Trans proline' 0 N--CA 1.42 -2.815 0 C-N-CA 121.538 1.492 . . . . 0.0 111.133 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.649 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 44.8 m-80 -60.18 -14.46 17.51 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 127.092 2.157 . . . . 0.0 113.387 -165.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 p -105.2 31.06 5.13 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 114.183 -1.372 . . . . 0.0 113.087 -170.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 57.1 p -148.06 -157.09 0.78 Allowed 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.846 -0.534 . . . . 0.0 110.692 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.89 144.56 29.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.122 -1.806 . . . . 0.0 106.122 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.265 10.3 p 45.54 74.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 123.071 1.415 . . . . 0.0 110.216 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 111' ' ' ASN . 50.5 p -91.53 -137.99 0.16 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.87 -171.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.8 p -50.14 141.08 11.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 124.865 1.266 . . . . 0.0 109.81 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.93 83.14 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.26 1.028 . . . . 0.0 110.284 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.22 36.89 0.48 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.32 104.84 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.628 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -109.56 20.19 18.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 t0 72.45 155.71 0.16 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 127.143 2.177 . . . . 0.0 111.404 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -118.33 38.62 3.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.328 1.061 . . . . 0.0 111.707 -173.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.488 ' OE2' ' HD2' ' A' ' 125' ' ' PRO . 7.9 tp10 -98.32 147.55 33.27 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.488 ' HD2' ' OE2' ' A' ' 124' ' ' GLU . 19.2 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.643 2.228 . . . . 0.0 112.027 174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.659 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 176.53 -50.84 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.8 ttp -148.14 58.62 1.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 104.07 125.36 5.59 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.806 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.553 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 48.2 tptt -104.65 -66.16 0.04 OUTLIER Pre-proline 0 N--CA 1.426 -1.631 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.601 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 1' ' ' LYS . 38.0 Cg_endo -106.34 -175.9 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.377 2.051 . . . . 0.0 111.741 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -73.79 104.25 4.62 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.587 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.4 t80 -105.46 128.61 53.64 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.277 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -144.24 20.35 1.74 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.105 0.955 . . . . 0.0 109.835 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 15.2 mtm180 57.48 -14.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 127.479 2.312 . . . . 0.0 116.374 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.8 t-20 -112.59 117.03 47.55 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.728 -0.607 . . . . 0.0 110.97 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 6.9 Cg_endo -53.22 -25.51 30.36 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.232 3.288 . . . . 0.0 113.37 174.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -71.61 -27.43 63.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -91.17 -21.24 21.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 24.5 mt -78.04 175.66 9.89 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.858 0.837 . . . . 0.0 110.641 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -105.11 -167.59 1.36 Allowed 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.72 175.01 45.76 Favored Glycine 0 C--N 1.284 -2.334 0 C-N-CA 119.315 -1.422 . . . . 0.0 112.155 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 4.0 tmmm? -113.62 148.56 36.03 Favored 'General case' 0 C--O 1.194 -1.849 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.2 m-85 -123.6 117.76 25.78 Favored 'General case' 0 CA--C 1.463 -2.387 0 CA-C-O 121.784 0.802 . . . . 0.0 110.807 -165.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.52 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 2.2 mp -111.75 138.1 41.8 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.786 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -102.67 118.67 37.36 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 7.9 t -129.26 157.93 40.49 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.345 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.824 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -129.46 122.05 28.53 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 58' ' ' MET . 0.3 OUTLIER -107.69 117.42 34.05 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.085 -176.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 19.2 tpp85 -72.38 106.69 4.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.6 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.573 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 67.9 tttt -66.79 96.97 0.44 Allowed 'General case' 0 C--O 1.171 -3.026 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 166.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.457 ' O ' HG21 ' A' ' 89' ' ' ILE . 21.4 t -85.01 -155.43 0.21 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -56.53 -41.03 76.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.931 0.332 . . . . 0.0 111.371 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -86.09 -20.65 28.42 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.795 0.807 . . . . 0.0 109.82 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 103.52 -122.35 7.41 Favored Glycine 1 N--CA 1.388 -4.556 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 46.0 m-85 -88.09 142.57 27.67 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 117.214 0.507 . . . . 0.0 110.328 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.47 9.34 74.23 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.139 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.418 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 6.3 p90 -122.11 162.98 20.28 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.04 0.447 . . . . 0.0 109.939 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.4 p -116.85 155.19 29.44 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 t -134.48 140.21 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.103 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.8 p -153.15 157.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.03 171.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 116.3 0.11 20.62 Favored Glycine 1 CA--C 1.441 -4.537 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 169.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.725 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -120.73 46.01 1.17 Allowed Glycine 1 CA--C 1.395 -7.438 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.57 -25.3 64.45 Favored 'General case' 0 C--N 1.264 -3.127 0 CA-C-N 113.228 -1.486 . . . . 0.0 111.498 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.476 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt-20 -155.98 167.61 13.95 Favored Pre-proline 0 CA--C 1.463 -2.388 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.843 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -65.28 55.31 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.933 2.422 . . . . 0.0 111.084 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 14.8 t70 178.37 -12.91 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 -175.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.725 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 62.7 mt-10 -117.83 123.94 47.15 Favored 'General case' 0 C--O 1.265 1.904 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.301 7.2 m-30 -79.22 156.12 28.29 Favored 'General case' 1 N--CA 1.554 4.755 0 O-C-N 127.687 3.117 . . . . 0.0 112.329 -175.233 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.571 HD12 ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -86.88 142.46 28.02 Favored 'General case' 0 CA--C 1.46 -2.498 0 C-N-CA 115.948 -2.301 . . . . 0.0 107.748 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.2 mt-30 -139.88 151.2 45.45 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ASP . 21.5 mm -70.82 112.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.62 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 40.2 ttmt -59.66 -41.69 91.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.4 t 163.56 173.6 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 O-C-N 125.224 1.577 . . . . 0.0 109.801 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.68 152.38 45.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.95 0.881 . . . . 0.0 113.297 -172.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 49' ' ' ASP . 21.1 t -87.58 129.55 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.028 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.26 -4.2 16.9 Favored 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 112.509 -2.132 . . . . 0.0 112.325 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.404 ' H ' HG12 ' A' ' 47' ' ' VAL . 10.3 t70 -99.32 -20.11 16.7 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.097 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.424 ' O ' HD12 ' A' ' 54' ' ' LEU . . . -88.3 155.9 26.57 Favored Glycine 1 N--CA 1.393 -4.182 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.72 -171.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.29 -26.66 27.92 Favored 'Trans proline' 0 C--O 1.198 -1.485 0 C-N-CA 125.009 3.806 . . . . 0.0 113.156 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.72 85.0 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.114 0.483 . . . . 0.0 111.728 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.17 -36.65 54.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.404 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 50' ' ' GLY . 8.3 mp -71.56 -36.93 71.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.052 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.51 -15.51 60.39 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.26 41.07 99.73 Favored Glycine 0 CA--C 1.49 -1.507 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.913 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -129.05 -23.88 2.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.281 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -94.95 142.17 27.8 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.172 177.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.01 151.49 52.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -59.0 114.7 2.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.007 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.423 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 112.69 -11.83 25.38 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.238 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 9.7 m-20 -59.94 132.85 55.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 117.645 0.723 . . . . 0.0 109.56 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -86.94 119.3 34.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.2 mm -70.9 123.02 24.06 Favored 'Isoleucine or valine' 1 C--O 1.316 4.56 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.467 HG12 HD11 ' A' ' 73' ' ' LEU . 40.0 t -114.42 -33.83 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-N 111.36 -2.654 . . . . 0.0 110.258 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -150.0 162.05 41.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG13 ' HB ' ' A' ' 72' ' ' VAL . 6.6 p -145.31 133.43 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 56.56 31.51 19.19 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.915 0.325 . . . . 0.0 111.828 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.66 15.9 10.25 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.592 1.157 . . . . 0.0 112.861 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -108.38 129.71 55.24 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.462 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 20.3 t -68.72 112.72 5.63 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' HB ' HG13 ' A' ' 67' ' ' VAL . 3.2 p -117.64 17.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.62 -175.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.587 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 32.1 tp -58.89 113.3 2.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 45.12 0.18 Allowed Glycine 0 N--CA 1.499 2.879 0 O-C-N 125.381 1.676 . . . . 0.0 111.801 -171.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.604 ' O ' HG23 ' A' ' 76' ' ' THR . 3.9 t60 -47.78 -66.48 0.4 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.3 p -167.1 143.19 4.31 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 151.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.563 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.33 -31.77 15.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 119.987 1.267 . . . . 0.0 110.536 171.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.22 77.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.941 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 71.0 mm-40 -64.67 -40.42 95.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 77' ' ' HIS . 13.5 m -65.56 -45.7 91.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.053 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 77' ' ' HIS . 88.0 t -65.69 -37.46 80.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.2 tmtm? -58.26 -45.61 87.5 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.627 175.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.68 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.05 -36.8 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.386 0.613 . . . . 0.0 112.387 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -74.73 -31.36 61.81 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -69.31 -32.12 71.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.163 0.985 . . . . 0.0 110.768 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.2 m -69.58 -37.99 77.17 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.851 1.26 . . . . 0.0 110.122 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 21.8 mt -77.63 133.12 67.26 Favored Pre-proline 0 N--CA 1.411 -2.417 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.182 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.1 Cg_endo -88.66 162.73 6.4 Favored 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 123.611 2.874 . . . . 0.0 112.864 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.92 135.0 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 121.212 0.529 . . . . 0.0 110.534 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.08 58.83 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.57 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -100.94 179.61 4.34 Favored 'General case' 0 C--O 1.187 -2.184 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 6.2 m -140.66 163.71 32.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.824 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -150.39 125.52 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.337 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 18' ' ' THR . 4.3 m-20 -82.72 106.46 14.58 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.047 0.927 . . . . 0.0 109.548 174.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.4 mt -108.29 159.06 16.93 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 126.52 1.928 . . . . 0.0 108.852 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -116.89 123.64 47.5 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 81.2 mt -106.87 160.86 15.19 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.825 1.25 . . . . 0.0 109.793 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.0 t -135.36 111.0 9.23 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.422 1.106 . . . . 0.0 110.796 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.471 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 19.4 tpp85 -89.99 112.99 24.57 Favored 'General case' 0 C--N 1.266 -3.063 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.4 -26.57 0.31 Allowed Glycine 0 C--N 1.292 -1.879 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.912 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.61 129.69 35.68 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.665 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 141.63 94.19 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.927 3.085 . . . . 0.0 113.785 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.51 124.11 18.47 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.684 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -79.34 -51.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.394 2.729 . . . . 0.0 114.783 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -124.58 138.7 54.3 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.24 108.56 61.65 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.294 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.36 -64.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.669 0 C-N-CA 122.007 1.805 . . . . 0.0 109.653 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.5 30.22 1.38 Allowed 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -116.27 112.32 41.81 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.608 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.674 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 55.7 Cg_endo -78.44 -28.01 4.8 Favored 'Trans proline' 0 CA--C 1.491 -1.667 0 C-N-CA 123.109 2.539 . . . . 0.0 110.458 -174.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.674 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -70.84 8.07 0.99 Allowed 'General case' 0 C--N 1.263 -3.183 0 C-N-CA 129.932 3.293 . . . . 0.0 111.764 -169.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.57 ' H ' ' C ' ' A' ' 110' ' ' PRO . 25.5 p -91.5 -13.62 31.85 Favored 'General case' 0 N--CA 1.387 -3.619 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.481 -173.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 116' ' ' THR . 15.8 m -112.13 147.55 35.86 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -61.27 128.56 36.95 Favored 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 123.814 0.696 . . . . 0.0 111.088 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.341 9.8 p 58.03 35.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 126.624 1.969 . . . . 0.0 114.89 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 110' ' ' PRO . 26.8 m -82.19 -84.29 0.12 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.041 -1.464 . . . . 0.0 107.705 168.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.9 m -116.4 61.24 0.72 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -158.27 130.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.277 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -102.94 47.76 0.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.204 0.526 . . . . 0.0 111.278 -174.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.45 104.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.09 41.76 1.36 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.302 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 t70 71.21 -177.39 0.2 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.186 1.394 . . . . 0.0 110.19 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.502 ' HZ1' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 63.54 25.71 14.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.898 1.679 . . . . 0.0 111.983 176.124 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.77 135.75 92.39 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.686 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 123.845 3.03 . . . . 0.0 112.995 -179.945 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.443 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.27 131.42 21.89 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 92.0 mtp 65.14 51.14 1.7 Allowed 'General case' 0 C--O 1.248 0.984 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 163.03 -132.47 2.77 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 39' ' ' GLU . 48.7 tptt 47.59 63.26 10.51 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.158 0.983 . . . . 0.0 111.635 177.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.27 173.78 6.48 Favored 'Trans proline' 0 N--CA 1.439 -1.734 0 C-N-CA 122.699 2.266 . . . . 0.0 111.751 -174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.34 105.12 2.44 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.555 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 5.1 t80 -107.56 135.36 49.14 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -144.17 17.98 1.74 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.111 0.958 . . . . 0.0 110.316 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.482 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 21.4 mtt180 59.4 -27.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.408 2.683 . . . . 0.0 116.57 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -104.65 123.38 40.42 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.84 -29.73 64.62 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 C-N-CA 123.737 2.958 . . . . 0.0 112.246 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.75 -26.17 63.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -92.2 -24.32 19.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 HD11 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -86.65 153.74 21.53 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.497 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' N ' HD11 ' A' ' 11' ' ' LEU . 46.6 mtmt -110.2 133.47 53.2 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 122.066 0.936 . . . . 0.0 110.697 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.538 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 156.83 170.6 22.02 Favored Glycine 1 C--N 1.247 -4.378 0 CA-C-N 113.048 -1.887 . . . . 0.0 108.999 -173.445 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 37.9 tptt -89.54 117.55 28.52 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.877 0.838 . . . . 0.0 109.825 174.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.3 m-85 -101.98 113.98 27.69 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.93 0.872 . . . . 0.0 109.77 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.6 mt -118.74 131.22 72.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.638 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.67 108.29 19.47 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -174.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -133.77 145.62 49.97 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 122.09 0.947 . . . . 0.0 111.271 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.846 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -87.96 130.84 34.82 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.149 177.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.66 117.38 33.77 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 40.8 ttt180 -77.12 111.94 13.25 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.087 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.57 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 74.6 tttt -66.96 96.83 0.45 Allowed 'General case' 0 C--O 1.187 -2.235 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -94.62 -154.26 0.41 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 124.322 1.049 . . . . 0.0 109.107 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -47.84 -41.97 25.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.894 1.278 . . . . 0.0 111.716 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.65 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.5 mmp_? -105.53 10.41 33.14 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.827 -0.546 . . . . 0.0 111.717 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 82.34 -125.3 6.88 Favored Glycine 1 N--CA 1.384 -4.769 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.0 m-85 -86.02 145.98 26.85 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.765 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.83 -2.93 86.2 Favored Glycine 0 CA--C 1.499 -0.945 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.336 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.437 ' HB2' HG22 ' A' ' 43' ' ' ILE . 20.9 p90 -109.93 162.9 14.06 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.893 0.854 . . . . 0.0 111.488 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.2 p -118.43 145.96 44.82 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.67 146.81 30.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.896 -173.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -144.38 165.92 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.873 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.371 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 114.29 -141.39 16.96 Favored Glycine 1 N--CA 1.394 -4.152 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 51.83 33.24 35.1 Favored Glycine 0 CA--C 1.471 -2.689 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.12 -27.95 67.75 Favored 'General case' 0 CA--C 1.455 -2.697 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -170.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 6.6 pt-20 -161.64 166.76 14.13 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.431 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 23.2 Cg_endo -66.63 58.88 0.52 Allowed 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.605 2.204 . . . . 0.0 109.353 169.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 21.7 t70 173.44 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.716 1.606 . . . . 0.0 110.661 -171.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 1' ' ' LYS . 22.6 mt-10 -124.28 127.98 48.46 Favored 'General case' 0 C--O 1.269 2.127 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 73' ' ' LEU . 8.6 m-30 -77.1 158.49 30.44 Favored 'General case' 0 N--CA 1.518 2.934 0 O-C-N 128.959 3.912 . . . . 0.0 113.258 -167.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD22 HG22 ' A' ' 80' ' ' VAL . 7.1 mp -89.2 144.69 25.92 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 172.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.0 mt-30 -143.97 151.76 40.18 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 29' ' ' PHE . 22.2 mm -69.69 112.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.53 -39.18 72.94 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 60' ' ' THR . 43.0 t 161.23 173.33 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.638 1.836 . . . . 0.0 108.666 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.86 148.18 48.53 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-O 121.644 0.735 . . . . 0.0 112.209 -175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 49' ' ' ASP . 43.3 t -83.94 121.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.214 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 mp -63.44 -3.48 2.1 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.583 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 47' ' ' VAL . 12.3 t70 -90.94 -30.7 16.71 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 124.594 1.158 . . . . 0.0 108.889 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -94.64 174.38 33.23 Favored Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 115.354 -168.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -52.35 -34.73 61.86 Favored 'Trans proline' 0 C--O 1.2 -1.389 1 C-N-CA 125.453 4.102 . . . . 0.0 113.815 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.1 81.1 Favored 'General case' 0 C--O 1.264 1.843 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.78 -37.77 48.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.585 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -69.49 -36.64 76.72 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.198 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.71 -18.52 61.52 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.648 1.213 . . . . 0.0 108.112 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.23 35.23 91.35 Favored Glycine 0 CA--C 1.491 -1.449 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.227 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -115.69 -48.2 2.78 Favored 'General case' 0 N--CA 1.402 -2.867 0 C-N-CA 123.099 0.56 . . . . 0.0 112.479 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.57 151.37 19.38 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -149.68 147.47 28.12 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-O 122.01 0.909 . . . . 0.0 111.673 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 45' ' ' SER . 81.9 p -52.69 105.28 0.11 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.168 1.387 . . . . 0.0 112.346 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.06 -12.89 16.98 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-O 118.629 -1.095 . . . . 0.0 113.187 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' GLN . 2.8 p30 -64.66 143.33 58.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.625 -1.23 . . . . 0.0 107.846 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -90.85 117.42 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.0 mm -69.87 125.08 27.27 Favored 'Isoleucine or valine' 1 C--O 1.327 5.163 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG12 HD11 ' A' ' 73' ' ' LEU . 46.3 t -115.77 -37.33 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 111.136 -2.756 . . . . 0.0 112.197 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.9 m -149.89 157.28 43.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.381 -1.45 . . . . 0.0 112.617 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG21 HG12 ' A' ' 72' ' ' VAL . 77.0 t -134.37 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m120 57.89 31.52 20.67 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.808 0.692 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 72.63 1.74 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.621 1.968 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.8 m -89.65 122.2 32.55 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.2 t -65.5 108.89 2.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.172 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.42 HG12 HG21 ' A' ' 67' ' ' VAL . 1.4 p -114.68 14.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.605 -175.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.555 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.6 tp -58.67 113.72 2.16 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.04 46.39 0.1 Allowed Glycine 0 C--N 1.378 2.864 0 O-C-N 125.857 1.973 . . . . 0.0 112.228 -170.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 76' ' ' THR . 2.8 t60 -48.03 -67.35 0.28 Allowed 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' HIS . 14.2 p -165.98 143.22 5.4 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 152.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.633 ' O ' HG21 ' A' ' 80' ' ' VAL . 1.4 t-80 -53.43 -31.26 44.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 120.664 1.574 . . . . 0.0 111.463 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.23 90.58 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.99 -0.444 . . . . 0.0 110.516 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.483 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 23.2 mm-40 -64.19 -44.0 93.34 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.633 HG21 ' O ' ' A' ' 77' ' ' HIS . 11.2 m -62.19 -41.81 92.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.242 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.07 -38.83 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -63.05 -33.54 75.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.291 176.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 86' ' ' SER . 32.9 mt -67.63 -42.21 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.491 0.662 . . . . 0.0 111.104 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.56 -30.72 67.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.187 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -71.24 -33.16 69.58 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.18 0.992 . . . . 0.0 110.209 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 31.0 t -65.26 -49.07 70.99 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.139 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 12.0 mt -64.88 133.75 95.84 Favored Pre-proline 0 N--CA 1.426 -1.674 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.537 175.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' HB1' ' A' ' 91' ' ' ALA . 20.0 Cg_endo -90.75 162.33 4.15 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 123.563 2.842 . . . . 0.0 113.119 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.4 mm -62.66 134.76 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-O 121.058 0.456 . . . . 0.0 110.28 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.74 56.68 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -102.0 -169.14 1.64 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -176.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 27.1 m -151.34 163.85 38.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.846 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -148.41 124.71 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.085 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.503 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.66 104.99 13.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.2 mt -108.27 152.33 24.75 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 125.28 1.432 . . . . 0.0 111.94 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -104.17 119.48 39.04 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.5 mp -111.37 164.49 12.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.305 1.442 . . . . 0.0 108.559 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.538 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 38.9 t -145.23 111.69 5.74 Favored 'General case' 0 C--O 1.191 -1.991 0 CA-C-O 122.352 1.072 . . . . 0.0 112.931 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -99.4 120.06 38.99 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 120.957 -1.089 . . . . 0.0 111.202 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.4 -33.43 0.09 OUTLIER Glycine 0 CA--C 1.471 -2.677 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -96.1 141.83 23.71 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.09 -178.56 2.55 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.834 2.356 . . . . 0.0 110.171 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.7 mt -59.23 120.36 46.97 Favored Pre-proline 0 N--CA 1.412 -2.331 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.71 -44.82 0.89 Allowed 'Trans proline' 0 CA--C 1.493 -1.574 0 C-N-CA 123.195 2.597 . . . . 0.0 114.993 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -129.55 149.8 51.16 Favored 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.493 -170.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 102.58 48.67 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.059 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 57.7 Cg_endo -96.67 -65.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.691 2.26 . . . . 0.0 110.519 170.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 38.8 t70 -123.35 25.82 8.17 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.449 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.4 114.75 45.65 Favored Pre-proline 0 CA--C 1.476 -1.891 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.95 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.66 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 53.1 Cg_endo -79.7 -38.07 0.41 Allowed 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.747 1.631 . . . . 0.0 111.438 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.66 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 17.8 m-80 -55.68 -13.97 1.96 Allowed 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 129.193 2.997 . . . . 0.0 113.046 -165.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 110' ' ' PRO . 31.8 p -88.91 -12.2 42.39 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.829 -170.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.1 m -96.61 -165.54 1.29 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.215 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.73 156.29 20.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.26 15.1 m 47.96 33.01 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 126.303 1.841 . . . . 0.0 114.886 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' SER . 1.9 p -120.17 -178.7 3.73 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 37.1 m 77.86 176.21 0.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -168.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -109.93 23.77 3.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.517 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.21 82.39 1.6 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 110.881 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.4 113.08 39.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -130.41 29.48 4.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.78 -18.35 11.37 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 114.273 -1.33 . . . . 0.0 113.388 -170.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -91.01 77.26 6.11 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-O 121.878 0.847 . . . . 0.0 111.031 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.17 141.47 23.01 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.534 2.156 . . . . 0.0 111.198 174.103 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.448 -1.181 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -83.24 105.45 14.21 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 3.1 t80 -103.03 124.61 48.85 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -130.78 11.18 5.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.926 0.869 . . . . 0.0 111.577 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.604 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 40.2 mtt180 55.21 6.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.774 1.63 . . . . 0.0 114.955 173.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -133.91 121.76 16.05 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HB3' HG11 ' A' ' 65' ' ' VAL . 8.5 Cg_exo -59.27 -27.16 84.26 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 123.611 2.874 . . . . 0.0 112.307 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 m -80.02 -24.4 40.82 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.521 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.53 -28.03 15.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 44.2 tp -70.24 155.16 41.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.053 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 24.4 mtmm -90.02 -175.71 4.66 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.571 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 109.02 178.16 21.49 Favored Glycine 0 C--N 1.278 -2.662 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.729 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.7 ' HE2' ' H ' ' A' ' 99' ' ' ARG . 1.6 tmpt? -91.07 134.19 34.71 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 91.8 m-85 -122.84 128.26 50.14 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 119.061 0.846 . . . . 0.0 109.867 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.532 HG13 ' HE3' ' A' ' 14' ' ' LYS . 73.8 mt -137.73 127.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.3 t60 -104.49 104.73 14.63 Favored 'General case' 0 N--CA 1.396 -3.144 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -124.07 143.86 50.2 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.799 0.809 . . . . 0.0 110.853 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.4 ttmp? -88.35 126.38 35.17 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.14 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.572 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -108.18 117.33 33.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 42.3 ttt-85 -77.07 113.89 15.28 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.405 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.715 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.9 tttt -69.64 97.52 1.06 Allowed 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 89' ' ' ILE . 32.2 t -83.59 -155.21 0.17 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.675 1.19 . . . . 0.0 108.514 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -59.4 -40.93 88.21 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.501 0.667 . . . . 0.0 109.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.02 -20.85 34.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.804 0.812 . . . . 0.0 109.521 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.715 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 98.18 -120.53 6.83 Favored Glycine 1 N--CA 1.378 -5.232 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.7 m-85 -91.57 141.72 28.42 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.565 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.21 1.27 87.59 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.107 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.478 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.3 p90 -110.81 163.34 13.88 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.817 0.818 . . . . 0.0 112.161 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 63.0 p -123.2 152.87 40.81 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 77' ' ' HIS . 6.7 m -127.11 154.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.123 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.83 150.63 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.071 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.75 -138.74 13.89 Favored Glycine 1 N--CA 1.393 -4.175 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.61 28.9 31.03 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.1 -29.39 68.3 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -171.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt-20 -154.49 163.09 25.4 Favored Pre-proline 0 CA--C 1.456 -2.64 0 C-N-CA 118.025 -1.47 . . . . 0.0 109.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.0 Cg_endo -68.3 52.83 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.215 0 C-N-CA 123.076 2.517 . . . . 0.0 109.896 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 171.19 3.28 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.368 -168.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HG3' ' CG ' ' A' ' 36' ' ' GLU . 25.7 mt-10 -132.88 130.21 39.41 Favored 'General case' 0 C--O 1.275 2.44 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 163.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.606 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.256 5.2 m-30 -76.8 158.8 30.61 Favored 'General case' 0 N--CA 1.525 3.305 0 O-C-N 128.898 3.874 . . . . 0.0 114.008 -167.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 80' ' ' VAL . 4.8 mp -93.09 141.69 28.12 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.21 151.44 47.69 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 29' ' ' PHE . 33.1 mm -68.37 109.93 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 41.4 ttmt -58.36 -38.1 76.57 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.9 t 161.77 173.13 0.01 OUTLIER 'General case' 0 C--N 1.362 1.148 0 O-C-N 125.659 1.849 . . . . 0.0 109.825 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.552 HD22 ' HB1' ' A' ' 52' ' ' ALA . 1.5 pp -141.16 149.2 41.18 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.784 -173.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 49' ' ' ASP . 16.9 t -80.1 127.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.81 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.72 -3.69 1.66 Allowed 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 127.423 2.289 . . . . 0.0 113.567 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' H ' HG12 ' A' ' 47' ' ' VAL . 18.5 t70 -102.61 -25.56 13.53 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.492 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.425 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -85.69 162.93 36.41 Favored Glycine 0 N--CA 1.399 -3.822 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.908 -171.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.12 -33.51 35.57 Favored 'Trans proline' 0 C--O 1.188 -2.003 0 C-N-CA 125.006 3.804 . . . . 0.0 113.486 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.552 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.82 -48.7 78.98 Favored 'General case' 0 C--O 1.28 2.702 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HB2' HD13 ' A' ' 46' ' ' LEU . . . -77.33 -34.54 55.27 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.389 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -68.7 -42.5 77.67 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.977 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.717 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 34.7 t70 -64.16 -38.73 92.12 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.903 1.335 . . . . 0.0 107.483 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 -15.75 44.4 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 112.522 -2.126 . . . . 0.0 114.098 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.717 ' HB2' ' OD2' ' A' ' 55' ' ' ASP . 45.8 mtmt -79.14 -17.25 55.37 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.6 ttm -106.93 135.07 49.11 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.111 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.26 164.57 27.78 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.34 0.591 . . . . 0.0 109.903 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 45' ' ' SER . 77.7 p -63.08 118.26 7.62 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.354 1.062 . . . . 0.0 110.083 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 104.67 -5.76 44.0 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.125 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.692 ' OD2' ' HB2' ' A' ' 99' ' ' ARG . 3.0 m-20 -63.19 127.27 30.48 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.644 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -77.46 114.93 18.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 175.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 5.0 mm -67.8 122.11 18.33 Favored 'Isoleucine or valine' 1 C--O 1.331 5.369 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.563 HG13 HD13 ' A' ' 73' ' ' LEU . 61.9 t -114.11 -38.4 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 110.759 -2.928 . . . . 0.0 110.73 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.424 ' HA ' HG12 ' A' ' 72' ' ' VAL . 70.1 m -151.27 160.57 43.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.163 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 83' ' ' ILE . 3.6 p -140.59 127.92 22.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.44 31.98 18.01 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 t70 71.31 1.8 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.179 1.392 . . . . 0.0 111.956 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.2 m -88.84 123.92 33.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.4 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.0 t -67.58 104.76 1.67 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.675 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -113.76 17.14 7.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 40' ' ' PHE . 28.5 tp -59.69 112.95 2.0 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 29.72 45.85 0.09 OUTLIER Glycine 0 N--CA 1.499 2.859 0 O-C-N 125.269 1.606 . . . . 0.0 112.917 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 76' ' ' THR . 6.3 t-160 -47.98 -68.39 0.19 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 79' ' ' GLN . 22.1 p -166.16 143.98 5.48 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 151.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.524 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.9 t60 -51.61 -31.7 26.02 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 119.948 1.249 . . . . 0.0 110.519 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.01 83.12 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 121.971 -0.456 . . . . 0.0 110.72 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HG2' ' OG1' ' A' ' 76' ' ' THR . 55.3 mm-40 -64.91 -43.2 93.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 41' ' ' LEU . 15.8 m -60.16 -43.13 92.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.115 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 71.2 t -64.73 -41.98 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -57.24 -41.93 80.5 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.518 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.665 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 34.1 mt -67.18 -36.15 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 122.038 0.923 . . . . 0.0 111.686 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.87 -25.84 61.24 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.354 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 88.1 mt-30 -76.32 -24.33 54.31 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 67.6 m -73.75 -28.61 61.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.957 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.7 mt -92.78 133.84 28.57 Favored Pre-proline 0 N--CA 1.411 -2.407 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.556 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_endo -92.38 162.13 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.844 3.029 . . . . 0.0 113.393 -174.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.0 mm -62.72 131.86 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 CA-C-O 121.302 0.573 . . . . 0.0 111.072 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.64 12.17 51.45 Favored Glycine 0 C--N 1.294 -1.79 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.806 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.05 -171.24 2.01 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 14.8 m -151.27 157.48 42.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.4 125.54 6.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 C-N-CA 118.393 -1.323 . . . . 0.0 112.972 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 11.0 m-20 -78.7 107.38 11.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 71.1 mt -107.75 144.53 34.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.592 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -97.49 115.75 28.39 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 75.0 mt -113.07 123.76 51.02 Favored 'General case' 0 C--O 1.25 1.119 0 C-N-CA 124.82 1.248 . . . . 0.0 110.55 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -101.68 122.11 43.28 Favored 'General case' 0 C--O 1.154 -3.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.7 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 43.8 ttp180 -116.97 144.07 44.99 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 120.072 -1.642 . . . . 0.0 110.713 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.42 -19.27 3.4 Favored Glycine 0 C--N 1.287 -2.151 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -90.66 132.47 34.91 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 C-N-CA 123.265 2.643 . . . . 0.0 112.396 -176.239 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.433 -2.072 0 CA-C-O 121.332 0.472 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -83.88 104.76 14.23 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -116.67 124.96 51.01 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 t -134.42 19.58 3.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.48 0.657 . . . . 0.0 110.616 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.543 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 30.8 mtm180 54.32 5.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.431 1.892 . . . . 0.0 115.167 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 9' ' ' SER . 23.8 t-20 -133.35 123.77 17.84 Favored Pre-proline 0 C--N 1.298 -1.649 0 CA-C-O 120.963 0.411 . . . . 0.0 111.136 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HB3' HG11 ' A' ' 65' ' ' VAL . 14.8 Cg_endo -64.13 -12.59 33.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.887 3.725 . . . . 0.0 114.425 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.507 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 33.2 t -90.67 -36.75 14.18 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -74.39 -39.07 62.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.569 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 52.5 tp -73.03 158.77 34.77 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -119.31 -174.26 2.68 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.01 -131.55 7.29 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.263 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.746 ' HE2' ' H ' ' A' ' 99' ' ' ARG . 3.2 tmpt? -140.53 127.96 21.33 Favored 'General case' 0 C--N 1.257 -3.432 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.4 m-85 -122.63 123.31 40.87 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 118.666 0.666 . . . . 0.0 110.198 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.545 HG13 ' HE3' ' A' ' 14' ' ' LYS . 70.0 mt -132.05 131.66 61.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.899 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 94' ' ' ASP . 3.7 t60 -103.29 113.31 26.7 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -138.67 142.5 39.01 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.748 0.785 . . . . 0.0 110.55 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.812 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -87.58 133.44 33.8 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.053 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.571 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -108.47 117.57 34.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 21.2 ttt180 -77.43 110.54 12.28 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.695 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 66.2 tttt -65.76 96.78 0.3 Allowed 'General case' 0 C--O 1.19 -2.059 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 170.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -90.0 -154.79 0.34 Allowed 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.674 1.19 . . . . 0.0 108.927 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -57.06 -38.76 73.72 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.782 0.833 . . . . 0.0 110.495 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 mmp_? -90.45 -14.85 32.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 109.785 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 93.7 -115.47 4.97 Favored Glycine 1 N--CA 1.395 -4.058 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.571 ' HD1' HD12 ' A' ' 20' ' ' LEU . 38.6 m-85 -99.88 138.59 36.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 117.907 0.853 . . . . 0.0 109.095 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.08 80.73 Favored Glycine 0 C--O 1.207 -1.591 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.892 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.495 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.2 p90 -106.49 163.35 12.94 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.438 0.637 . . . . 0.0 111.162 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 73.6 p -125.96 146.12 50.0 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG11 HD23 ' A' ' 41' ' ' LEU . 12.3 m -123.03 148.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.933 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.96 154.59 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.689 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.95 -138.3 14.19 Favored Glycine 1 N--CA 1.386 -4.674 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.84 32.18 25.55 Favored Glycine 0 CA--C 1.47 -2.765 0 C-N-CA 123.559 0.6 . . . . 0.0 112.242 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -35.74 81.95 Favored 'General case' 0 CA--C 1.451 -2.855 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.17 165.47 18.51 Favored Pre-proline 0 CA--C 1.462 -2.441 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.293 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.3 Cg_endo -67.27 58.96 0.66 Allowed 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.766 2.311 . . . . 0.0 109.349 170.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.415 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 37.2 t70 174.4 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.393 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.1 mt-10 -128.91 127.42 41.74 Favored 'General case' 0 C--O 1.279 2.631 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CE1' HD11 ' A' ' 73' ' ' LEU . 7.0 m-30 -77.22 158.82 30.09 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 129.023 3.952 . . . . 0.0 113.694 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -92.22 143.0 26.87 Favored 'General case' 0 CA--C 1.46 -2.516 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.724 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.4 mt-30 -136.46 152.78 50.94 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 ' HB2' ' A' ' 29' ' ' PHE . 30.2 mm -71.83 108.93 3.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 39.5 ttpt -60.66 -36.99 80.08 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.507 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.9 t 161.14 173.41 0.01 OUTLIER 'General case' 0 C--N 1.372 1.573 0 O-C-N 125.711 1.882 . . . . 0.0 109.53 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -134.63 152.11 51.54 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.63 113.43 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.9 OUTLIER -69.35 -6.96 33.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.306 1.05 . . . . 0.0 113.101 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.72 -3.86 48.48 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.914 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -97.79 174.81 29.51 Favored Glycine 0 N--CA 1.423 -2.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.595 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.8 Cg_endo -57.54 -29.2 84.11 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 123.973 3.115 . . . . 0.0 113.404 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -59.0 -46.93 86.94 Favored 'General case' 0 C--O 1.268 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 111.95 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.14 -35.66 55.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.043 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 50' ' ' GLY . 9.3 mp -71.54 -34.62 70.17 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.23 -19.97 60.33 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.776 1.275 . . . . 0.0 107.637 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.36 31.74 81.78 Favored Glycine 0 CA--C 1.491 -1.459 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.922 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.28 -29.65 4.78 Favored 'General case' 0 N--CA 1.394 -3.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.3 ttm -101.19 139.76 36.43 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.539 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.14 156.58 46.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.91 0.862 . . . . 0.0 109.477 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 45' ' ' SER . 51.6 p -64.25 115.76 5.34 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 124.861 1.265 . . . . 0.0 109.601 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 117.61 -20.06 11.17 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.588 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.2 m-20 -58.96 135.85 57.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -87.32 117.89 32.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 C-N-CA 122.79 0.436 . . . . 0.0 111.392 175.052 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 4.3 mm -68.46 123.2 21.32 Favored 'Isoleucine or valine' 1 C--O 1.332 5.432 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 8' ' ' PRO . 46.4 t -115.6 -41.11 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 127.441 2.963 . . . . 0.0 111.793 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 66.4 m -147.04 161.84 40.01 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.17 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.491 HG12 ' HB ' ' A' ' 72' ' ' VAL . 7.2 p -137.49 134.58 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 65.68 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.718 0.636 . . . . 0.0 110.054 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -163.96 33.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.813 1.768 . . . . 0.0 108.008 169.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.8 m -123.74 128.94 50.3 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.787 -1.551 . . . . 0.0 107.762 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.564 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 t -71.29 121.44 18.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 80' ' ' VAL . 4.7 p -121.23 20.15 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.589 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.0 tp -60.24 113.09 2.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.45 44.81 0.09 OUTLIER Glycine 0 N--CA 1.503 3.119 0 O-C-N 125.632 1.832 . . . . 0.0 111.729 -171.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 76' ' ' THR . 7.1 t-160 -49.44 -65.62 0.53 Allowed 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.7 p -166.75 143.81 4.82 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 152.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.565 ' HA ' HG22 ' A' ' 80' ' ' VAL . 2.0 t60 -50.8 -34.21 26.67 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 119.904 1.229 . . . . 0.0 110.902 172.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.94 96.49 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 122.192 -0.317 . . . . 0.0 110.929 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 8.2 mm-40 -67.51 -41.39 84.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 41' ' ' LEU . 20.2 m -63.45 -45.88 96.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.96 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.96 -39.51 85.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.662 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -56.22 -43.14 78.28 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 123.445 0.465 . . . . 0.0 110.975 175.302 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.662 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.7 mm -65.16 -36.8 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.432 0.634 . . . . 0.0 112.265 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -75.45 -32.83 60.79 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.192 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -73.05 -21.75 60.74 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.337 1.055 . . . . 0.0 111.305 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.3 m -77.9 -35.19 51.01 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.34 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.6 mt -77.88 133.25 66.08 Favored Pre-proline 0 N--CA 1.417 -2.098 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.238 177.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 13.6 Cg_endo -90.18 161.74 4.73 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.114 2.543 . . . . 0.0 112.972 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.551 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.4 mm -62.76 133.17 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.128 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.98 54.13 Favored Glycine 0 C--N 1.296 -1.649 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.672 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.44 -172.41 2.25 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.7 m -151.1 153.63 35.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.5 125.53 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.127 0 C-N-CA 117.343 -1.743 . . . . 0.0 113.353 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 8.5 m-20 -78.85 105.2 10.0 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.44 146.61 34.22 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 124.279 1.031 . . . . 0.0 109.672 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -107.93 117.01 33.0 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.539 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 68.9 mt -107.48 134.36 50.63 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 125.626 1.57 . . . . 0.0 110.697 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 31.1 t -106.97 123.99 48.98 Favored 'General case' 0 C--O 1.164 -3.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.484 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.746 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 2.9 mtm180 -103.73 123.93 47.95 Favored 'General case' 0 C--N 1.259 -3.331 0 O-C-N 120.641 -1.287 . . . . 0.0 109.525 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.1 -23.5 0.17 Allowed Glycine 0 C--N 1.271 -3.039 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.609 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 38.6 m-85 -96.94 139.21 21.42 Favored Pre-proline 0 N--CA 1.431 -1.382 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.637 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 101' ' ' TYR . 20.6 Cg_exo . . . . . 0 C--O 1.247 0.937 0 C-N-CA 123.341 2.694 . . . . 0.0 112.587 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.451 -1.002 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.01 103.81 4.63 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.5 t80 -111.29 128.98 56.11 Favored 'General case' 0 C--N 1.268 -2.94 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -139.46 13.45 2.56 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.226 0.536 . . . . 0.0 110.846 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.49 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtm180 55.25 6.47 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.139 1.776 . . . . 0.0 114.937 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -133.03 120.41 16.25 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HD3' ' SG ' ' A' ' 71' ' ' CYS . 23.8 Cg_exo -54.2 -32.49 70.82 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 124.472 3.448 . . . . 0.0 112.535 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -72.81 -21.93 60.89 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.59 0.709 . . . . 0.0 111.15 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -94.44 -25.94 16.69 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.571 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.43 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 42.4 tp -81.31 152.39 27.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.741 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -121.16 146.67 46.52 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.608 0.718 . . . . 0.0 110.151 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 158.35 -169.2 34.85 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -173.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.559 ' CE ' HG12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -103.76 108.66 20.07 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 118.401 1.1 . . . . 0.0 109.052 171.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 52.2 m-85 -90.04 120.22 31.05 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.941 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.559 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.7 mt -118.15 138.57 48.43 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.075 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -110.0 118.44 36.44 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -140.73 127.86 20.88 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.457 0.646 . . . . 0.0 112.678 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -88.51 126.41 35.24 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.428 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.531 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -107.64 119.75 40.3 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 13.3 ttp180 -79.29 106.35 11.26 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.723 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.724 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.8 tttt -62.71 97.52 0.1 Allowed 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 89' ' ' ILE . 37.3 t -81.69 -157.24 0.18 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 124.335 1.054 . . . . 0.0 108.798 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -63.35 -34.68 78.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.6 tmt_? -81.94 -20.71 38.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.724 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 87.58 -118.4 4.99 Favored Glycine 1 N--CA 1.391 -4.325 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.9 m-85 -94.56 144.14 25.83 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.888 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.23 3.28 63.99 Favored Glycine 0 C--O 1.203 -1.803 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.479 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.43 ' HB2' HG23 ' A' ' 43' ' ' ILE . 8.5 p90 -114.58 163.14 15.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.333 0.587 . . . . 0.0 110.358 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 55.9 p -122.71 148.65 45.06 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.505 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.7 m -121.87 143.76 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 CA-C-O 121.608 0.718 . . . . 0.0 111.113 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.66 148.5 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.083 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 118.4 -137.57 13.07 Favored Glycine 2 N--CA 1.381 -5.012 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.8 31.7 16.85 Favored Glycine 0 CA--C 1.467 -2.943 0 O-C-N 124.358 0.681 . . . . 0.0 111.528 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -70.14 -22.98 62.94 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.14 166.03 8.66 Favored Pre-proline 0 CA--C 1.463 -2.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 18.0 Cg_endo -66.56 58.18 0.5 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.389 2.06 . . . . 0.0 109.831 171.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 23.5 t70 177.08 -11.92 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.454 -171.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -124.63 124.98 43.38 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.252 4.9 m-30 -76.78 159.26 30.27 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 131.044 3.738 . . . . 0.0 113.932 -169.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.864 HD21 HG21 ' A' ' 80' ' ' VAL . 8.0 mp -92.56 144.33 25.45 Favored 'General case' 0 C--O 1.183 -2.432 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 66.9 mt-30 -139.23 156.93 46.74 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG21 HD23 ' A' ' 46' ' ' LEU . 26.3 mm -72.42 111.45 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.261 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.53 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 36.8 ttpt -63.06 -40.97 99.29 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.559 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.8 t 165.15 174.4 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 125.148 1.53 . . . . 0.0 109.81 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 pp -142.64 147.61 36.05 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.94 0.876 . . . . 0.0 112.712 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 49' ' ' ASP . 44.3 t -69.0 116.39 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.984 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.724 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.89 -24.59 62.47 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.403 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.425 ' H ' HG12 ' A' ' 47' ' ' VAL . 9.9 m-20 -94.46 -2.51 51.69 Favored 'General case' 0 C--N 1.258 -3.373 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.656 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.411 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -99.65 170.46 23.12 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.505 -174.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.7 Cg_endo -56.77 -29.25 79.99 Favored 'Trans proline' 0 C--O 1.196 -1.586 0 C-N-CA 124.203 3.269 . . . . 0.0 113.312 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -62.42 -41.49 98.73 Favored 'General case' 0 C--O 1.269 2.112 0 CA-C-O 121.459 0.647 . . . . 0.0 111.479 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.46 47.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.77 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 50' ' ' GLY . 9.4 mp -70.48 -38.96 74.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.581 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.74 -24.91 62.71 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.85 74.03 Favored Glycine 0 CA--C 1.483 -1.923 0 CA-C-N 112.304 -2.225 . . . . 0.0 113.164 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -118.04 -2.04 11.32 Favored 'General case' 0 N--CA 1.385 -3.696 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.98 134.82 52.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.447 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.35 151.83 45.56 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.559 HG22 ' HA ' ' A' ' 45' ' ' SER . 76.2 p -64.91 110.22 2.37 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.378 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 124.31 -19.65 7.16 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-O 119.254 -0.748 . . . . 0.0 113.237 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 13.5 m-20 -61.33 132.23 52.89 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.005 0.902 . . . . 0.0 109.461 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.257 0.1 OUTLIER -82.38 120.54 34.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 177.528 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mm -71.86 123.09 25.53 Favored 'Isoleucine or valine' 1 C--O 1.333 5.488 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.534 HG13 HD13 ' A' ' 73' ' ' LEU . 52.8 t -115.56 -40.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 127.442 2.964 . . . . 0.0 111.28 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -146.25 162.14 38.73 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.319 -0.863 . . . . 0.0 112.906 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG23 HG11 ' A' ' 72' ' ' VAL . 52.7 t -139.82 126.54 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 C-N-CA 125.443 1.497 . . . . 0.0 107.197 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 m120 57.55 30.71 19.17 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.67 0.606 . . . . 0.0 110.947 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.9 t70 77.93 -8.12 1.72 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.043 1.337 . . . . 0.0 111.882 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.1 m -86.51 121.16 28.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.522 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 49.7 t -60.89 112.88 2.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.492 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -119.98 18.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.588 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.5 tp -60.52 112.42 1.97 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.17 39.05 0.06 OUTLIER Glycine 0 N--CA 1.504 3.233 0 O-C-N 125.007 1.442 . . . . 0.0 112.107 -171.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.518 ' O ' HG23 ' A' ' 76' ' ' THR . 7.1 t-160 -42.85 -64.34 0.64 Allowed 'General case' 0 C--N 1.373 1.604 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.3 p -166.99 142.99 4.34 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 150.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.573 ' HA ' HG22 ' A' ' 80' ' ' VAL . 2.5 t60 -51.57 -32.15 27.25 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 120.951 1.705 . . . . 0.0 110.889 173.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.33 77.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.811 0.338 . . . . 0.0 110.619 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -65.23 -40.79 94.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.864 HG21 HD21 ' A' ' 41' ' ' LEU . 11.0 m -63.65 -44.47 98.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.94 -40.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.663 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -56.73 -41.64 77.85 Favored 'General case' 0 C--O 1.196 -1.74 0 O-C-N 123.465 0.478 . . . . 0.0 110.835 175.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.663 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.5 mm -65.91 -36.05 76.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 0.0 112.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.39 -26.94 56.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.92 -30.05 61.15 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.179 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -66.29 -42.98 87.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.101 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.498 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.4 mt -76.22 131.88 74.46 Favored Pre-proline 0 N--CA 1.404 -2.769 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.683 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.0 Cg_endo -92.42 161.91 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.175 2.584 . . . . 0.0 112.92 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.562 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 26.8 mm -58.68 132.35 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.36 11.41 54.18 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.98 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.77 -169.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.4 m -151.62 157.44 42.16 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -147.3 124.94 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.601 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.5 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 10.2 m-20 -78.45 103.79 8.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.44 HD22 HG22 ' A' ' 67' ' ' VAL . 52.2 mt -100.01 148.95 23.97 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 125.092 1.357 . . . . 0.0 109.045 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 29.0 tt0 -111.18 119.13 37.91 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.75 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 96.1 mt -106.18 164.6 11.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.646 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 7.9 t -142.09 117.28 10.08 Favored 'General case' 0 C--O 1.18 -2.577 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -100.99 145.25 28.93 Favored 'General case' 0 C--N 1.261 -3.267 0 O-C-N 120.472 -1.393 . . . . 0.0 109.734 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.15 -27.93 1.55 Allowed Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -84.88 130.82 51.13 Favored Pre-proline 0 N--CA 1.427 -1.619 0 CA-C-O 121.051 0.453 . . . . 0.0 110.51 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 123.459 2.772 . . . . 0.0 114.208 -173.878 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.443 -1.468 0 CA-C-O 121.036 0.348 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.76 103.74 14.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.2 t80 -115.94 126.68 54.19 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.468 ' CG2' HD23 ' A' ' 11' ' ' LEU . 5.8 t -139.4 23.67 2.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.887 0.851 . . . . 0.0 110.884 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 60.0 mtt180 53.03 4.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 127.381 2.272 . . . . 0.0 116.136 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.7 t-20 -134.4 122.98 16.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.7 Cg_exo -54.56 -31.58 70.45 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 123.753 2.969 . . . . 0.0 112.602 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -71.2 -26.81 63.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.397 0.618 . . . . 0.0 110.221 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -93.22 -15.26 26.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.344 0.592 . . . . 0.0 110.85 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . 33.3 mt -76.43 -173.68 2.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.51 1.147 . . . . 0.0 111.767 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -120.5 178.52 4.64 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.568 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.98 164.57 35.27 Favored Glycine 0 C--N 1.281 -2.476 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.204 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 34.0 tptt -88.25 126.83 35.37 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.654 0.782 . . . . 0.0 109.678 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 11' ' ' LEU . 93.4 m-85 -104.79 119.63 39.47 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.016 0.912 . . . . 0.0 110.583 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.521 HD13 ' NH2' ' A' ' 99' ' ' ARG . 8.5 mt -121.67 146.56 26.57 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.116 -172.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -117.29 127.34 53.98 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -139.05 156.86 46.86 Favored 'General case' 0 C--O 1.184 -2.369 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 38.2 ttpt -127.26 123.57 36.79 Favored 'General case' 0 C--N 1.258 -3.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.497 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.81 116.4 31.86 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.75 -170.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 32.8 ttp-105 -79.01 102.38 8.31 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.268 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.692 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.6 tttt -59.54 97.79 0.04 OUTLIER 'General case' 0 C--O 1.179 -2.649 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 t -84.82 -155.3 0.2 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.792 1.237 . . . . 0.0 109.173 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -61.13 -36.36 79.53 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.396 0.617 . . . . 0.0 109.468 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -86.69 -16.78 35.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.736 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.692 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 88.38 -112.17 3.87 Favored Glycine 1 N--CA 1.391 -4.308 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.497 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.1 m-85 -97.09 135.12 39.53 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.172 0.51 . . . . 0.0 109.919 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.93 -3.42 90.6 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.896 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' HB2' HG23 ' A' ' 43' ' ' ILE . 9.7 p90 -113.58 163.68 14.64 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.604 0.716 . . . . 0.0 111.903 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.2 p -124.08 148.06 47.4 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.369 1.468 . . . . 0.0 107.281 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.428 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.4 m -121.66 148.23 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.75 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.41 153.48 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.434 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.43 -131.79 9.59 Favored Glycine 0 N--CA 1.398 -3.877 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.65 36.33 24.87 Favored Glycine 0 CA--C 1.466 -2.97 0 O-C-N 124.593 0.82 . . . . 0.0 111.902 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.08 -31.05 70.42 Favored 'General case' 0 CA--C 1.449 -2.932 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -161.4 166.87 14.16 Favored Pre-proline 0 CA--C 1.45 -2.869 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.216 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -66.72 64.04 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.126 1.884 . . . . 0.0 108.468 168.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.46 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 12.9 t70 170.69 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.376 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 21.3 mt-10 -127.58 127.4 43.82 Favored 'General case' 0 C--O 1.276 2.457 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 73' ' ' LEU . 9.7 m-85 -76.92 159.25 30.15 Favored 'General case' 0 N--CA 1.532 3.639 0 O-C-N 128.836 3.835 . . . . 0.0 113.319 -167.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD21 HG21 ' A' ' 80' ' ' VAL . 5.1 mp -92.34 143.2 26.63 Favored 'General case' 0 CA--C 1.469 -2.161 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.8 mt-30 -135.5 154.28 51.46 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 29' ' ' PHE . 20.9 mm -75.35 111.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.39 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 45' ' ' SER . 47.6 tptt -60.83 -47.29 87.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.632 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.9 t 173.2 172.71 0.13 Allowed 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.871 1.357 . . . . 0.0 111.183 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.1 pp -143.1 145.74 33.13 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 123.764 0.826 . . . . 0.0 111.128 -175.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 49' ' ' ASP . 22.0 t -75.18 121.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 1.8 pt? -69.42 -5.24 22.45 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.965 0.888 . . . . 0.0 112.585 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' H ' HG12 ' A' ' 47' ' ' VAL . 19.7 t70 -85.4 -26.65 26.29 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.903 -1.499 . . . . 0.0 108.917 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.44 172.08 37.34 Favored Glycine 0 N--CA 1.402 -3.586 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.676 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HG2' HD11 ' A' ' 20' ' ' LEU . 14.2 Cg_endo -54.87 -26.37 48.06 Favored 'Trans proline' 0 C--O 1.201 -1.375 0 C-N-CA 124.911 3.741 . . . . 0.0 113.325 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -58.26 -52.66 64.64 Favored 'General case' 0 C--O 1.291 3.244 0 C-N-CA 123.377 0.671 . . . . 0.0 112.789 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.36 -33.53 55.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.456 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.3 mp -70.31 -35.59 73.76 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.097 -176.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.34 -21.84 65.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.59 11.83 84.86 Favored Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 112.61 -2.087 . . . . 0.0 113.47 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -107.62 -43.02 4.6 Favored 'General case' 1 N--CA 1.376 -4.132 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.406 ' HB3' HD11 ' A' ' 97' ' ' LEU . 17.0 ptp -95.92 154.7 17.1 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 116.631 -2.028 . . . . 0.0 112.296 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.42 161.19 38.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.749 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 45' ' ' SER . 75.0 p -65.86 113.7 4.56 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.25 -14.18 10.24 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.716 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.4 m-20 -65.95 152.69 43.99 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.44 125.18 55.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.989 -0.444 . . . . 0.0 111.571 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.456 HD13 HD23 ' A' ' 97' ' ' LEU . 10.4 mm -75.52 124.09 32.77 Favored 'Isoleucine or valine' 1 C--O 1.323 4.938 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.594 HG13 HD13 ' A' ' 73' ' ' LEU . 57.7 t -115.11 -36.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 111.037 -2.801 . . . . 0.0 111.247 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 70.3 m -150.8 160.24 44.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.001 -1.062 . . . . 0.0 113.081 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG23 HG11 ' A' ' 72' ' ' VAL . 55.0 t -142.18 129.59 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.5 m120 55.12 41.61 31.47 Favored 'General case' 0 C--O 1.256 1.437 0 O-C-N 123.776 0.673 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 25.26 5.69 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.47 1.108 . . . . 0.0 113.215 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 m -114.72 125.95 54.31 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 27.4 t -67.08 110.82 3.57 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 80' ' ' VAL . 2.2 p -117.35 16.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 65' ' ' VAL . 32.6 tp -57.95 112.85 1.63 Allowed 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.03 40.3 0.05 OUTLIER Glycine 0 N--CA 1.497 2.701 0 O-C-N 125.511 1.757 . . . . 0.0 112.934 -170.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.549 ' O ' HG23 ' A' ' 76' ' ' THR . 5.4 t-160 -43.71 -66.48 0.38 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.8 p -166.35 143.51 5.13 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 150.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.555 ' HA ' HG22 ' A' ' 80' ' ' VAL . 2.1 t60 -51.47 -31.37 23.2 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 119.699 1.136 . . . . 0.0 110.775 172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.65 85.51 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.942 -0.474 . . . . 0.0 110.946 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -65.34 -42.18 93.13 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.784 HG21 HD21 ' A' ' 41' ' ' LEU . 18.4 m -62.11 -43.71 98.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.26 -39.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -61.0 -41.62 96.88 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.02 176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' SER . 37.1 mt -62.01 -40.96 89.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.34 0.59 . . . . 0.0 111.635 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -70.89 -34.97 72.11 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.804 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -72.77 -19.64 61.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.06 0.944 . . . . 0.0 111.676 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 53.4 m -79.79 -27.81 40.35 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.132 0.973 . . . . 0.0 109.372 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.463 HG22 ' HD3' ' A' ' 22' ' ' LYS . 43.2 mt -85.17 134.65 40.47 Favored Pre-proline 0 N--CA 1.416 -2.141 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.607 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 18.5 Cg_endo -92.66 161.68 2.85 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 123.347 2.698 . . . . 0.0 113.039 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.65 133.55 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.63 12.49 53.43 Favored Glycine 0 C--N 1.289 -2.042 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.955 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.3 -170.26 1.85 Allowed 'General case' 0 C--O 1.199 -1.6 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 3.3 t -151.36 159.72 44.13 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.0 t -147.68 126.15 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.507 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.04 112.93 17.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.451 ' CD2' HG22 ' A' ' 67' ' ' VAL . 45.2 mt -109.89 144.55 38.21 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 126.387 1.875 . . . . 0.0 109.962 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.45 118.61 37.14 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 64' ' ' ILE . 23.7 mt -105.6 165.07 11.41 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.903 1.281 . . . . 0.0 108.784 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -142.94 111.05 6.03 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.781 0.801 . . . . 0.0 110.96 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.521 ' NH2' HD13 ' A' ' 16' ' ' ILE . 13.1 mtm180 -97.0 129.69 44.43 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.211 -0.931 . . . . 0.0 112.213 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.07 -17.78 0.82 Allowed Glycine 0 C--N 1.277 -2.702 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.512 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.12 148.85 40.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.862 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.352 0.755 0 C-N-CA 122.889 2.392 . . . . 0.0 111.538 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.554 1.523 0 CA-C-O 121.29 0.454 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.12 107.26 18.95 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 2.1 t80 -99.11 129.8 45.39 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 7' ' ' ASN . 14.6 t -138.1 10.82 2.82 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.873 0.845 . . . . 0.0 110.628 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 31.3 mtt180 58.25 -22.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.557 2.343 . . . . 0.0 115.738 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.479 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 56.1 t-20 -104.6 117.74 58.25 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HB3' HG11 ' A' ' 65' ' ' VAL . 9.3 Cg_endo -57.39 -26.05 68.99 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.965 3.11 . . . . 0.0 112.956 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -74.11 -30.29 62.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.124 0.487 . . . . 0.0 110.002 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -89.36 -29.61 18.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 41.2 tp -72.07 155.85 39.84 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.548 0.689 . . . . 0.0 111.619 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 9.2 mtmp? -90.18 -167.17 1.77 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.614 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 91.13 173.58 43.65 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.183 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -97.44 129.6 44.63 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.5 m-85 -103.16 113.74 27.47 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-O 122.538 1.161 . . . . 0.0 110.04 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -116.55 143.7 26.06 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.908 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.56 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.7 t60 -110.62 131.02 55.41 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 8.8 t -139.29 156.76 46.82 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.2 ttmp? -125.24 122.83 38.08 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -108.35 116.68 32.43 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.393 -174.372 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.0 ttp180 -75.09 107.77 7.38 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.021 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.626 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.7 tttt -66.71 95.68 0.36 Allowed 'General case' 0 C--O 1.171 -3.07 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 167.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t -89.55 -155.26 0.35 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 m -60.95 -32.81 72.33 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 122.56 0.344 . . . . 0.0 110.397 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -83.11 -21.02 33.78 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.368 0.604 . . . . 0.0 109.55 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 73.12 80.16 0.45 Allowed Glycine 0 N--CA 1.417 -2.584 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 20' ' ' LEU . 24.3 m-85 80.49 168.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.736 2.014 . . . . 0.0 110.07 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.18 10.99 5.6 Favored Glycine 0 CA--C 1.497 -1.077 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.018 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' HG23 ' A' ' 43' ' ' ILE . 19.4 p90 -119.49 162.93 18.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.235 0.54 . . . . 0.0 109.758 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.4 p -119.41 153.83 34.61 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -144.85 141.41 23.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.117 -174.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.6 p -151.83 166.12 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.353 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.6 3.06 30.74 Favored Glycine 0 CA--C 1.454 -3.766 0 N-CA-C 116.521 1.368 . . . . 0.0 116.521 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.802 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -117.06 48.89 0.9 Allowed Glycine 1 CA--C 1.41 -6.516 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -168.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.26 -29.16 60.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 112.841 -1.679 . . . . 0.0 110.239 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.6 pt-20 -163.81 171.96 5.46 Favored Pre-proline 0 CA--C 1.465 -2.293 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.093 -172.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 36' ' ' GLU . 21.9 Cg_endo -64.73 54.9 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.011 2.474 . . . . 0.0 110.898 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -177.53 -19.62 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.305 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.72 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 2.8 mt-10 -119.53 122.73 42.31 Favored 'General case' 0 C--O 1.265 1.885 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 171.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.296 5.4 m-30 -78.92 155.99 28.78 Favored 'General case' 0 N--CA 1.533 3.703 0 O-C-N 127.78 3.175 . . . . 0.0 112.722 -176.086 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.802 HD12 ' HA3' ' A' ' 34' ' ' GLY . 7.4 mp -85.75 143.08 28.54 Favored 'General case' 0 C--O 1.179 -2.607 0 C-N-CA 117.153 -1.819 . . . . 0.0 108.112 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.0 mt-30 -139.31 151.24 46.25 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.9 mm -72.38 110.95 5.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 58.3 tttm -59.39 -38.99 81.96 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.598 ' HA ' HG22 ' A' ' 60' ' ' THR . 30.7 t 163.78 172.34 0.02 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.637 1.836 . . . . 0.0 110.646 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -141.58 152.14 43.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.866 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 49' ' ' ASP . 56.9 t -81.61 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.6 pt? -68.63 -11.12 59.67 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.452 ' H ' HG12 ' A' ' 47' ' ' VAL . 6.3 m-20 -95.15 -7.29 39.69 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.073 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.26 163.0 37.18 Favored Glycine 0 N--CA 1.404 -3.461 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.765 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.83 -30.37 38.14 Favored 'Trans proline' 0 C--O 1.211 -0.873 0 C-N-CA 124.718 3.612 . . . . 0.0 112.897 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.87 -45.82 85.78 Favored 'General case' 0 C--O 1.271 2.223 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.798 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.9 -31.94 57.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.645 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.32 -40.62 64.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.069 0.547 . . . . 0.0 112.419 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.76 -25.62 67.35 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.02 5.33 65.08 Favored Glycine 0 CA--C 1.483 -1.935 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.939 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.89 -28.78 14.53 Favored 'General case' 1 N--CA 1.378 -4.061 0 C-N-CA 122.782 0.433 . . . . 0.0 111.551 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.8 ttm -97.04 140.49 31.48 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.064 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -137.97 161.9 35.5 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -71.01 107.53 4.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.825 0.85 . . . . 0.0 111.264 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.83 -16.6 9.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.207 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 2.9 m-20 -61.9 134.45 56.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -84.62 124.89 40.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.276 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.75 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 14.4 mm -73.8 124.58 31.36 Favored 'Isoleucine or valine' 1 C--O 1.32 4.78 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 170.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 8' ' ' PRO . 47.9 t -115.09 -40.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 111.481 -2.6 . . . . 0.0 110.939 -176.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.2 m -146.27 166.29 26.71 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.193 -1.003 . . . . 0.0 113.345 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG23 HG11 ' A' ' 72' ' ' VAL . 39.8 t -139.7 120.69 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 125.313 1.445 . . . . 0.0 107.493 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 67.53 -75.75 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.471 1.107 . . . . 0.0 109.809 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.07 4.14 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.322 0.649 . . . . 0.0 110.862 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -96.94 121.82 39.23 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 72.1 m -70.71 88.2 0.71 Allowed 'General case' 0 N--CA 1.398 -3.045 0 O-C-N 124.639 1.212 . . . . 0.0 108.366 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 80' ' ' VAL . 3.8 p -97.73 19.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.43 -171.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.581 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.3 tp -58.82 113.19 1.94 Allowed 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.84 44.92 0.1 OUTLIER Glycine 0 C--N 1.384 3.246 0 O-C-N 125.996 2.06 . . . . 0.0 111.661 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.563 ' O ' HG23 ' A' ' 76' ' ' THR . 7.7 t-160 -48.42 -64.26 0.85 Allowed 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 75' ' ' HIS . 12.0 p -166.42 142.79 4.83 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 151.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.35 -31.58 22.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 120.498 1.499 . . . . 0.0 111.373 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.56 77.0 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 122.029 -0.419 . . . . 0.0 110.438 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -64.46 -39.01 93.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 41' ' ' LEU . 11.6 m -64.16 -43.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.2 -37.8 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.1 tmtm? -57.78 -42.84 84.94 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.298 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.649 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.3 mm -66.21 -33.72 65.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.642 0.734 . . . . 0.0 112.628 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -76.09 -28.92 57.74 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.297 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -72.89 -28.26 62.38 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.373 1.069 . . . . 0.0 110.663 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.8 m -65.57 -38.66 90.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.455 175.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.513 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 22.1 mt -82.89 133.76 48.08 Favored Pre-proline 0 N--CA 1.405 -2.681 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.03 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.1 Cg_endo -90.71 161.98 4.2 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.086 2.524 . . . . 0.0 113.234 -173.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.565 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.1 mm -60.77 133.84 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.457 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 11.62 56.63 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.133 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.92 -169.72 1.72 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -151.34 165.73 33.16 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.2 t -150.35 126.21 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.887 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.56 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -78.65 107.02 11.03 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.194 -1.002 . . . . 0.0 108.743 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.464 ' CD2' HG22 ' A' ' 67' ' ' VAL . 56.7 mt -103.84 152.45 21.9 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.801 1.64 . . . . 0.0 108.391 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 30.1 tt0 -111.11 123.42 50.17 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 76.6 mt -105.65 153.87 21.23 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.759 1.223 . . . . 0.0 110.247 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.641 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 9.6 t -124.26 107.12 10.85 Favored 'General case' 0 C--O 1.186 -2.241 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.476 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 40.4 ttp180 -101.39 138.62 38.15 Favored 'General case' 1 C--N 1.243 -4.052 0 O-C-N 120.59 -1.319 . . . . 0.0 110.494 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.51 -32.84 0.84 Allowed Glycine 0 CA--C 1.464 -3.123 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.45 137.59 45.03 Favored Pre-proline 0 N--CA 1.412 -2.34 0 CA-C-N 113.871 -1.165 . . . . 0.0 108.434 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 C--N 1.317 -1.106 0 C-N-CA 122.964 2.443 . . . . 0.0 112.242 -177.256 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.438 -1.774 0 CA-C-O 121.35 0.479 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -94.5 111.15 22.9 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.594 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -107.81 123.17 48.17 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -133.3 12.41 4.19 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.339 0.59 . . . . 0.0 110.279 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.529 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtp180 60.47 -29.7 0.05 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.446 2.298 . . . . 0.0 115.381 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 55.6 t-20 -95.92 117.38 66.39 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.4 Cg_endo -59.36 -22.79 67.27 Favored 'Trans proline' 0 C--O 1.21 -0.924 0 C-N-CA 123.772 2.982 . . . . 0.0 113.134 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -76.92 -25.37 52.85 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.804 -0.56 . . . . 0.0 109.562 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -93.82 -19.32 21.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.574 0.702 . . . . 0.0 110.22 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.4 tm? -88.14 145.78 25.74 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.369 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' N ' HD13 ' A' ' 11' ' ' LEU . 57.3 mttm -103.32 137.74 41.03 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-O 121.873 0.844 . . . . 0.0 110.581 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 152.82 169.52 18.15 Favored Glycine 1 C--N 1.246 -4.417 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.237 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.47 122.3 40.37 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.908 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.2 m-85 -96.53 111.34 23.5 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.784 1.278 . . . . 0.0 112.157 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.477 HD11 ' HG3' ' A' ' 99' ' ' ARG . 5.9 mm -92.55 152.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 CA-C-N 112.779 -2.009 . . . . 0.0 108.436 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 113.05 14.47 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 t -139.37 132.88 30.3 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.918 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.9 ttpt -92.95 125.92 37.78 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.509 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.28 117.3 33.69 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -175.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.444 ' HD3' ' OG ' ' A' ' 92' ' ' SER . 18.6 tpp180 -74.59 103.83 5.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.954 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.653 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 69.9 tttt -62.17 97.29 0.08 Allowed 'General case' 0 C--O 1.177 -2.733 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.0 t -129.71 125.87 36.94 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t 62.18 -77.73 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.127 1.371 . . . . 0.0 110.534 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -85.48 -20.63 29.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.653 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 107.83 -110.43 3.16 Favored Glycine 1 N--CA 1.385 -4.73 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.509 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.1 m-85 -92.45 135.7 33.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.268 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.56 3.55 84.71 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.812 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE2' HG22 ' A' ' 31' ' ' VAL . 10.0 p90 -119.07 162.92 17.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.194 0.521 . . . . 0.0 110.434 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 21.5 p -113.15 145.81 40.3 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.665 HG11 HD23 ' A' ' 41' ' ' LEU . 1.6 t -119.19 143.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.505 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.33 149.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.785 0 CA-C-O 121.336 0.588 . . . . 0.0 109.428 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.25 -138.52 11.02 Favored Glycine 1 N--CA 1.391 -4.317 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.63 36.97 19.46 Favored Glycine 0 CA--C 1.456 -3.598 0 O-C-N 124.517 0.775 . . . . 0.0 111.346 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 3.1 t70 -69.93 -27.71 65.0 Favored 'General case' 0 CA--C 1.463 -2.394 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -170.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.9 pt-20 -164.28 167.69 10.19 Favored Pre-proline 0 CA--C 1.464 -2.354 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.057 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.4 Cg_endo -67.21 56.03 0.55 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.394 2.063 . . . . 0.0 110.277 172.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 177.97 -7.86 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.338 -169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 22.9 mm-40 -129.29 125.34 36.58 Favored 'General case' 0 C--O 1.276 2.493 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.253 6.0 m-30 -76.44 158.93 30.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 129.871 3.268 . . . . 0.0 112.514 -169.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 80' ' ' VAL . 6.7 mp -88.97 147.77 24.13 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.5 mt-30 -144.18 155.6 43.97 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 62' ' ' ASP . 20.4 mm -72.98 115.91 14.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 38.4 ttmt -58.95 -44.65 91.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.59 ' HA ' HG22 ' A' ' 60' ' ' THR . 21.0 t 169.62 173.65 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 125.144 1.527 . . . . 0.0 110.453 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -144.27 144.91 31.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-O 121.647 0.737 . . . . 0.0 111.899 -175.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 49' ' ' ASP . 14.5 t -73.26 122.92 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.769 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.2 mt -61.31 -15.01 31.19 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 112.489 -2.141 . . . . 0.0 113.121 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.1 t70 -92.72 -13.66 29.04 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.767 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.53 163.62 28.74 Favored Glycine 0 N--CA 1.415 -2.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.425 -172.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.44 -28.73 45.71 Favored 'Trans proline' 0 C--O 1.205 -1.136 0 C-N-CA 124.72 3.613 . . . . 0.0 112.798 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.85 -50.77 72.17 Favored 'General case' 0 C--O 1.264 1.853 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.052 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.26 -33.49 55.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.8 mp -72.57 -33.72 66.96 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.049 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.43 -27.79 66.5 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' HE3' ' A' ' 57' ' ' LYS . . . 78.61 3.59 86.91 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 112.51 -2.132 . . . . 0.0 113.352 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HE3' ' C ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -96.18 -31.8 12.79 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.0 ttm -97.97 142.0 30.24 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.616 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -139.25 159.16 42.8 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 122.226 1.012 . . . . 0.0 110.061 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.7 p -63.85 115.65 5.03 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.564 1.146 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 111.74 -15.96 26.28 Favored Glycine 0 N--CA 1.435 -1.425 0 O-C-N 121.767 -0.583 . . . . 0.0 112.799 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 43' ' ' ILE . 17.4 m-20 -61.08 134.28 56.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -83.38 126.47 40.13 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 CA-C-N 118.905 0.775 . . . . 0.0 113.035 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 12.7 mm -76.78 125.27 36.43 Favored 'Isoleucine or valine' 1 C--O 1.321 4.866 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 8' ' ' PRO . 25.9 t -115.68 -37.6 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 111.435 -2.62 . . . . 0.0 111.035 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.696 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.9 m -144.51 149.75 36.43 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.227 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.625 HG12 HG21 ' A' ' 72' ' ' VAL . 12.4 p -134.58 133.43 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.487 ' OD1' HG22 ' A' ' 67' ' ' VAL . 21.7 m120 60.13 27.84 17.35 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.02 0.914 . . . . 0.0 110.398 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 72.97 2.48 4.39 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.668 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.7 m -90.56 126.88 36.08 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 31.7 t -66.49 108.0 2.25 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.696 HG22 ' HA ' ' A' ' 66' ' ' SER . 29.6 m -123.18 27.87 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.841 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.594 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.0 tp -59.88 113.54 2.34 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.7 41.57 0.26 Allowed Glycine 0 C--N 1.376 2.767 0 O-C-N 125.191 1.557 . . . . 0.0 112.205 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t-160 -44.01 -67.86 0.24 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 75' ' ' HIS . 18.2 p -166.1 143.46 5.36 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 149.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 2.7 t60 -50.77 -37.15 40.49 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 120.098 1.317 . . . . 0.0 110.711 173.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.409 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.499 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 9.0 mm-40 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 41' ' ' LEU . 34.0 m -69.17 -39.88 79.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.591 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 71.1 t -65.45 -37.43 80.04 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.28 -38.55 83.93 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 122.887 0.117 . . . . 0.0 111.277 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' SER . 63.1 mt -65.58 -35.73 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.612 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.6 -31.52 65.25 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.356 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 71.1 mm-40 -72.82 -26.56 61.53 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 122.084 0.945 . . . . 0.0 109.901 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.2 m -73.66 -47.06 42.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.602 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.506 HG22 ' HD3' ' A' ' 22' ' ' LYS . 20.9 mt -66.68 136.58 94.74 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.302 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 30.5 Cg_endo -91.64 162.49 3.49 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.185 3.257 . . . . 0.0 113.125 -174.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 28.8 mm -62.29 135.25 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 121.07 0.462 . . . . 0.0 110.63 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.85 57.14 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.554 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.14 -172.42 2.16 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.444 ' OG ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -149.01 158.87 44.52 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -142.49 125.27 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.211 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -79.33 104.17 9.77 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.44 143.84 32.47 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 125.357 1.463 . . . . 0.0 111.514 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 38.0 tt0 -104.41 127.04 52.01 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.336 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 67.1 mt -115.11 157.83 23.03 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.573 1.171 . . . . 0.0 110.027 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.6 t -129.83 111.17 12.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.548 1.166 . . . . 0.0 110.157 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HG3' HD11 ' A' ' 16' ' ' ILE . 3.7 mmm180 -88.54 120.9 30.35 Favored 'General case' 0 C--N 1.245 -3.958 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 157.32 -22.06 0.43 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.7 138.56 21.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 C--N 1.365 1.421 0 C-N-CA 124.756 3.638 . . . . 0.0 112.936 -179.318 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 74.4 Cg_endo . . . . . 0 CA--C 1.55 1.283 0 CA-C-O 121.153 0.397 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -84.53 104.22 14.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.606 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -111.27 130.04 55.79 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 t -143.43 16.39 1.85 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.628 0.728 . . . . 0.0 110.063 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HG2' ' HE1' ' A' ' 4' ' ' PHE . 16.0 mtm180 58.06 -21.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 127.993 2.517 . . . . 0.0 115.683 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.537 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -99.89 113.37 65.11 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-O 120.894 0.378 . . . . 0.0 111.5 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 1.3 Cg_endo -48.14 -36.1 27.91 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.582 3.522 . . . . 0.0 112.705 174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -73.97 -17.04 61.05 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.063 0.459 . . . . 0.0 111.61 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 20.8 mm-40 -94.93 -17.28 22.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.228 0.537 . . . . 0.0 110.201 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 73' ' ' LEU . 20.5 mt -80.15 178.36 8.31 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 122.109 0.957 . . . . 0.0 109.697 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -114.48 -161.33 0.77 Allowed 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.665 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.87 176.69 38.14 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.081 -1.533 . . . . 0.0 112.799 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.1 OUTLIER -103.29 132.09 49.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.4 m-85 -108.07 111.77 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.486 1.136 . . . . 0.0 111.535 -175.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.534 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 21.3 mt -112.46 149.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.03 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.896 -174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -130.45 104.64 7.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -123.58 129.48 51.24 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 122.318 1.056 . . . . 0.0 111.581 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.4 ttmt -88.77 122.07 31.8 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.572 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.464 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.01 117.35 33.81 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.101 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 27.3 ttp-105 -79.27 107.36 11.97 Favored 'General case' 0 N--CA 1.394 -3.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.754 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.75 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 64.6 tttt -64.08 97.88 0.19 Allowed 'General case' 0 C--O 1.176 -2.781 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 169.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' ILE . 22.9 t -80.46 -155.81 0.12 Allowed 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 124.54 1.136 . . . . 0.0 109.16 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 m -58.55 -41.47 85.66 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -85.86 -21.46 28.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.75 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 102.27 -124.8 8.31 Favored Glycine 1 N--CA 1.392 -4.266 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 35.9 m-85 -86.74 145.7 26.55 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.729 0.764 . . . . 0.0 110.48 -176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.63 1.63 64.03 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.908 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 31' ' ' VAL . 6.7 p90 -114.27 163.06 15.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.453 0.644 . . . . 0.0 111.813 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -116.13 148.53 40.22 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.586 HG11 HD23 ' A' ' 41' ' ' LEU . 4.0 t -127.23 143.68 39.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.125 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -152.23 163.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.956 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.76 -65.04 0.55 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -76.11 58.81 3.16 Favored Glycine 2 CA--C 1.408 -6.64 0 C-N-CA 125.621 1.581 . . . . 0.0 116.971 -166.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -66.21 -9.07 28.51 Favored 'General case' 0 C--N 1.253 -3.629 0 O-C-N 124.32 0.659 . . . . 0.0 111.75 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt-20 -160.62 166.36 15.69 Favored Pre-proline 0 CA--C 1.452 -2.799 0 C-N-CA 116.078 -2.249 . . . . 0.0 111.849 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.4 Cg_endo -67.62 53.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.807 2.338 . . . . 0.0 110.287 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 29.6 t70 -177.61 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.498 1.519 . . . . 0.0 109.872 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.655 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 34.3 mt-10 -117.72 129.75 55.9 Favored 'General case' 0 C--O 1.272 2.256 0 CA-C-O 116.649 -1.643 . . . . 0.0 106.75 169.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.263 6.8 m-30 -79.33 156.4 28.03 Favored 'General case' 0 N--CA 1.523 3.18 0 O-C-N 128.675 3.735 . . . . 0.0 111.927 -177.304 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.901 HD21 HG21 ' A' ' 80' ' ' VAL . 6.3 mp -91.68 143.17 26.83 Favored 'General case' 0 CA--C 1.455 -2.689 0 C-N-CA 117.153 -1.819 . . . . 0.0 107.437 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 14.1 mt-30 -139.36 154.74 47.92 Favored 'General case' 0 C--N 1.266 -3.04 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 29' ' ' PHE . 19.7 mm -75.11 109.48 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.431 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.22 -37.01 79.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.5 t 161.87 173.66 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 125.388 1.68 . . . . 0.0 109.344 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.495 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.3 pp -137.33 151.87 49.09 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 123.257 0.623 . . . . 0.0 111.469 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.08 116.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.264 0.8 OUTLIER -69.38 -4.17 17.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -174.389 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.49 -2.67 54.14 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.406 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.42 167.11 24.56 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.818 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 20' ' ' LEU . 9.2 Cg_endo -53.32 -31.78 58.3 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 124.624 3.549 . . . . 0.0 113.411 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.84 -44.55 86.57 Favored 'General case' 0 C--O 1.273 2.293 0 CA-C-O 121.753 0.787 . . . . 0.0 111.522 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.74 -35.21 57.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.328 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.21 -28.21 53.75 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.36 -20.86 62.11 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.27 63.58 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.962 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -29.76 7.39 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.637 -172.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 51.2 ttm -96.96 132.84 42.35 Favored 'General case' 0 N--CA 1.407 -2.593 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.187 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -124.29 156.94 36.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 122.193 0.997 . . . . 0.0 109.336 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 45' ' ' SER . 82.7 p -71.48 107.76 4.55 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.297 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 122.08 -11.96 9.24 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.755 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 8.6 m-20 -64.44 151.46 44.16 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.401 1.101 . . . . 0.0 108.654 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -99.94 123.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 175.125 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 10.8 mm -71.29 122.31 23.1 Favored 'Isoleucine or valine' 1 C--O 1.322 4.883 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 171.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG13 HD13 ' A' ' 73' ' ' LEU . 44.4 t -114.69 -34.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 O-C-N 127.122 2.764 . . . . 0.0 109.905 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.571 ' HA ' HG22 ' A' ' 72' ' ' VAL . 39.4 m -147.66 148.84 31.49 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.457 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.641 HG12 HG11 ' A' ' 72' ' ' VAL . 8.4 p -125.28 133.11 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.57 27.24 16.39 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.519 0.676 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.35 26.13 14.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 123.484 1.612 . . . . 0.0 111.466 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.9 m -109.16 124.54 50.99 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.24 105.57 0.93 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.101 0.876 . . . . 0.0 109.927 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.641 HG11 HG12 ' A' ' 67' ' ' VAL . 35.7 m -121.18 27.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.406 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.606 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 43.8 tp -60.9 113.28 2.43 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.18 45.88 0.3 Allowed Glycine 0 N--CA 1.492 2.397 0 O-C-N 125.557 1.786 . . . . 0.0 111.606 -170.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t-160 -46.83 -69.14 0.14 Allowed 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 175.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 75' ' ' HIS . 21.5 p -164.86 144.0 6.89 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 148.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -49.84 -36.14 25.69 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 119.718 1.145 . . . . 0.0 110.437 173.065 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.01 91.89 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.481 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -44.08 93.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.901 HG21 HD21 ' A' ' 41' ' ' LEU . 28.8 m -70.34 -43.5 78.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.808 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.1 -36.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.58 -43.27 99.17 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.328 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.658 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.7 -36.54 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.24 0.543 . . . . 0.0 112.435 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.33 -32.64 68.81 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.316 0.579 . . . . 0.0 110.173 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.565 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 7.8 mm-40 -75.55 -26.3 57.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.749 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.8 m -72.02 -40.36 68.5 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.765 1.226 . . . . 0.0 109.275 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 22' ' ' LYS . 23.5 mt -69.81 135.45 87.8 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.994 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 16.3 Cg_endo -90.39 162.53 4.51 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 123.679 2.919 . . . . 0.0 113.208 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.7 mm -59.92 135.1 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.031 175.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.71 10.26 63.42 Favored Glycine 0 C--N 1.291 -1.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.843 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.53 133.57 49.16 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 6.7 m -100.79 159.42 15.2 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.538 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -144.74 125.5 8.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.648 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.623 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 23.4 m-20 -79.11 109.42 13.4 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.5 mt -104.63 136.91 43.28 Favored 'General case' 0 C--N 1.277 -2.557 0 C-N-CA 124.842 1.257 . . . . 0.0 109.836 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 40.8 tt0 -97.6 122.99 41.32 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 95.9 mt -112.65 148.84 33.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 125.154 1.382 . . . . 0.0 109.713 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.665 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 8.1 t -124.56 115.18 20.43 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.915 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -102.01 141.98 34.0 Favored 'General case' 0 C--N 1.256 -3.489 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.067 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.71 -17.06 3.98 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.354 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -92.01 139.97 24.59 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 C--N 1.361 1.204 0 C-N-CA 124.712 3.608 . . . . 0.0 113.935 -175.145 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.448 -1.184 0 N-CA-C 111.094 -0.387 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.19 104.83 3.2 Favored 'General case' 0 N--CA 1.411 -2.377 0 C-N-CA 124.349 1.06 . . . . 0.0 108.562 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.606 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.7 t80 -98.94 139.12 35.07 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -147.51 10.28 0.96 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.963 0.887 . . . . 0.0 110.79 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.544 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 14.1 mtp180 52.9 6.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.803 2.041 . . . . 0.0 115.092 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -134.09 122.1 16.05 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HB3' HG11 ' A' ' 65' ' ' VAL . 3.4 Cg_exo -54.98 -34.93 88.6 Favored 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 124.135 3.223 . . . . 0.0 112.345 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -71.81 -21.99 61.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.563 0.697 . . . . 0.0 111.21 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -92.45 -24.27 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 42.5 tp -85.91 159.2 19.73 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.829 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.4 mttp -99.13 -171.23 2.05 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.96 177.93 27.94 Favored Glycine 0 C--N 1.292 -1.865 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.911 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -99.81 122.67 43.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.5 m-85 -103.87 117.97 35.59 Favored 'General case' 0 C--N 1.253 -3.628 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.41 HG13 ' HE3' ' A' ' 14' ' ' LYS . 66.4 mt -127.25 126.74 68.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.463 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -99.95 111.95 24.24 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.507 ' OG1' ' HD2' ' A' ' 57' ' ' LYS . 14.8 t -133.1 147.59 52.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.018 0.913 . . . . 0.0 110.73 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.808 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 22.0 ttpp -90.17 132.31 35.54 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.608 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -109.68 119.27 38.88 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 72.5 ttt180 -81.48 109.47 15.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.965 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.5 tttt -63.95 96.51 0.14 Allowed 'General case' 0 C--O 1.184 -2.377 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -90.03 -154.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 124.457 1.103 . . . . 0.0 109.061 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 m -52.35 -40.63 62.2 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.878 0.871 . . . . 0.0 111.695 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -95.6 -9.41 32.27 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.012 0.434 . . . . 0.0 110.065 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.734 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.01 -119.08 6.25 Favored Glycine 1 N--CA 1.392 -4.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.589 ' HD1' HD12 ' A' ' 20' ' ' LEU . 46.2 m-85 -91.46 139.88 30.29 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 117.763 0.782 . . . . 0.0 108.935 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.94 3.01 87.28 Favored Glycine 0 C--N 1.315 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.897 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.523 ' HB2' HG23 ' A' ' 43' ' ' ILE . 12.1 p90 -116.33 162.69 17.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.353 0.597 . . . . 0.0 111.324 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 26.3 p -116.19 152.91 32.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG11 HD23 ' A' ' 41' ' ' LEU . 4.6 t -126.53 143.86 38.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.464 -174.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.66 155.61 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.25 -72.94 0.45 Allowed Glycine 0 CA--C 1.459 -3.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.0 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.858 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -62.11 58.51 0.03 OUTLIER Glycine 1 CA--C 1.442 -4.505 0 C-N-CA 127.454 2.454 . . . . 0.0 117.459 -169.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.638 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 17.3 t70 -63.09 -27.98 69.77 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -154.82 166.31 16.32 Favored Pre-proline 0 CA--C 1.454 -2.727 0 C-N-CA 116.192 -2.203 . . . . 0.0 110.941 -170.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.7 Cg_endo -68.42 55.79 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.308 2.005 . . . . 0.0 109.718 171.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -178.63 -17.15 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.008 1.723 . . . . 0.0 110.06 -171.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.858 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 19.1 mm-40 -115.89 127.03 54.68 Favored 'General case' 0 C--O 1.273 2.301 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.269 6.0 m-30 -79.02 157.68 28.04 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 128.77 3.794 . . . . 0.0 111.628 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 80' ' ' VAL . 5.3 mp -88.25 143.53 26.98 Favored 'General case' 0 C--O 1.185 -2.319 0 C-N-CA 117.149 -1.821 . . . . 0.0 107.105 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 46.6 mt-30 -140.25 154.68 46.94 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.523 HG23 ' HB2' ' A' ' 29' ' ' PHE . 18.9 mm -73.96 113.24 11.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 19.2 ttmm -57.14 -38.04 72.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 125.13 1.519 . . . . 0.0 107.16 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.512 ' HA ' HG22 ' A' ' 60' ' ' THR . 34.8 t 159.86 173.35 0.01 OUTLIER 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.428 1.891 . . . . 0.0 109.114 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -139.4 147.82 41.98 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.414 0.626 . . . . 0.0 111.671 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 49' ' ' ASP . 44.3 t -76.53 128.06 37.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.51 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -64.53 -15.45 60.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.47 ' H ' HG12 ' A' ' 47' ' ' VAL . 2.3 m-20 -99.12 6.83 46.32 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.957 176.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.25 158.81 21.79 Favored Glycine 0 N--CA 1.398 -3.847 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HG2' HD11 ' A' ' 20' ' ' LEU . 10.1 Cg_endo -52.21 -30.52 42.12 Favored 'Trans proline' 0 C--O 1.202 -1.318 0 C-N-CA 124.429 3.42 . . . . 0.0 112.884 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -60.1 -44.59 94.73 Favored 'General case' 0 C--O 1.278 2.565 0 CA-C-O 121.551 0.691 . . . . 0.0 111.982 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.55 -35.02 53.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.811 -1.541 . . . . 0.0 111.022 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.1 -46.02 72.1 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.313 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 38.3 t70 -63.67 -34.58 78.17 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -8.77 58.25 Favored Glycine 0 CA--C 1.492 -1.393 0 CA-C-N 112.484 -2.144 . . . . 0.0 114.082 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 46.1 mttp -86.7 -14.53 42.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 123.117 0.567 . . . . 0.0 112.081 -176.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 ttm -104.02 144.96 30.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -143.67 155.52 44.25 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 121.447 0.642 . . . . 0.0 110.103 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 45' ' ' SER . 77.8 p -63.21 108.45 1.28 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.86 -0.31 31.92 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.121 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.606 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.0 p30 -73.43 146.94 44.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.425 -1.71 . . . . 0.0 107.292 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -94.65 120.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 26.6 mm -71.08 125.16 28.93 Favored 'Isoleucine or valine' 1 C--O 1.319 4.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 73' ' ' LEU . 48.6 t -115.27 -41.36 3.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.614 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.632 ' HA ' HG22 ' A' ' 72' ' ' VAL . 66.5 m -145.34 147.42 32.29 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.281 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 72' ' ' VAL . 6.4 p -125.1 132.0 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 56.03 29.57 14.67 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.452 0.644 . . . . 0.0 111.101 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 67.58 11.51 8.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.7 m -93.47 122.85 36.33 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.2 t -66.04 103.6 0.98 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.632 HG22 ' HA ' ' A' ' 66' ' ' SER . 33.6 m -117.84 25.67 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.884 0.849 . . . . 0.0 110.501 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.606 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.2 tp -61.43 113.28 2.57 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 35.46 40.72 0.3 Allowed Glycine 0 N--CA 1.497 2.725 0 O-C-N 125.188 1.555 . . . . 0.0 111.785 -170.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 76' ' ' THR . 6.8 t-160 -43.98 -67.22 0.3 Allowed 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.4 p -167.35 143.57 4.25 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 150.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.522 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -49.8 -36.55 26.7 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 120.194 1.361 . . . . 0.0 110.119 172.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.2 81.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.448 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.53 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 7.3 mm-40 -66.8 -44.26 81.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 41' ' ' LEU . 34.0 m -65.58 -40.06 86.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.471 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.5 -39.04 84.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -59.62 -38.43 81.31 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.676 177.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.599 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 72.4 mt -68.09 -38.41 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.574 0.702 . . . . 0.0 110.853 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.07 -30.83 65.52 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.89 -32.55 73.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.313 1.045 . . . . 0.0 109.994 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 59.5 m -71.84 -43.17 66.0 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.474 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.5 mt -71.8 133.06 84.55 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.574 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 36.0 Cg_endo -91.44 161.84 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.507 2.804 . . . . 0.0 113.549 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.0 mm -61.63 129.98 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 121.156 0.503 . . . . 0.0 111.019 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.72 11.94 51.95 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.707 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.4 -170.48 1.81 Allowed 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -147.79 166.78 26.52 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -150.45 125.2 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.463 -2.371 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.772 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.58 105.53 16.23 Favored 'General case' 0 C--N 1.268 -2.969 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -111.83 151.61 28.87 Favored 'General case' 0 C--O 1.208 -1.083 0 C-N-CA 125.593 1.557 . . . . 0.0 110.777 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 22.8 tt0 -111.01 121.73 46.1 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.748 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.7 mp -108.62 164.42 12.38 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 126.654 1.982 . . . . 0.0 109.272 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.5 t -140.69 112.46 7.57 Favored 'General case' 0 C--O 1.19 -2.026 0 CA-C-O 122.339 1.066 . . . . 0.0 111.992 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.606 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 7.7 tpp180 -95.3 129.99 42.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.78 -17.52 0.96 Allowed Glycine 0 C--N 1.294 -1.769 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.053 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -107.23 126.94 28.9 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 C--O 1.246 0.917 0 C-N-CA 124.126 3.217 . . . . 0.0 112.573 -174.599 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.446 -1.308 0 CA-C-O 121.154 0.398 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -76.31 107.14 8.35 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 124.97 1.308 . . . . 0.0 107.659 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.587 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.1 t80 -101.73 129.87 48.0 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -138.17 11.8 2.82 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.284 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtt180 52.59 8.43 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.804 2.042 . . . . 0.0 114.789 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.407 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 7.9 m120 -131.96 116.75 15.83 Favored Pre-proline 0 N--CA 1.415 -2.176 0 C-N-CA 122.458 0.303 . . . . 0.0 110.974 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -63.56 -18.05 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 110.785 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 7' ' ' ASN . 7.8 p -76.15 -29.72 57.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.851 177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -107.38 -10.96 15.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.051 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -93.5 149.82 20.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.466 ' N ' HD13 ' A' ' 11' ' ' LEU . 45.9 mtmt -105.79 135.54 47.04 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.731 0.776 . . . . 0.0 110.998 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.569 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 151.17 170.15 17.75 Favored Glycine 1 C--N 1.244 -4.583 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -172.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -92.32 122.35 34.7 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.397 1.098 . . . . 0.0 108.443 175.179 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.6 m-85 -98.66 117.45 33.14 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 122.611 1.196 . . . . 0.0 110.027 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.469 HG12 ' HE3' ' A' ' 14' ' ' LYS . 34.1 mt -114.35 152.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.065 0 CA-C-N 112.755 -2.021 . . . . 0.0 109.357 -172.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 12.4 t60 -129.31 108.47 10.33 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.415 ' CG2' HD11 ' A' ' 97' ' ' LEU . 7.7 t -131.54 135.08 46.75 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.872 0.844 . . . . 0.0 109.81 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.8 ttmt -89.45 126.65 35.65 Favored 'General case' 0 C--N 1.257 -3.436 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.782 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.498 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.47 116.94 32.8 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 56.5 ttt180 -77.89 107.44 10.42 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.931 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.735 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 64.7 tttt -61.85 97.34 0.08 Allowed 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -86.23 -155.36 0.25 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 124.758 1.223 . . . . 0.0 108.818 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 m -54.21 -41.3 68.5 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.991 0.916 . . . . 0.0 110.816 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -96.16 -8.85 32.06 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.189 0.519 . . . . 0.0 109.958 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.735 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 96.32 -120.67 6.7 Favored Glycine 1 N--CA 1.391 -4.315 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.514 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 34.2 m-85 -89.58 141.74 28.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.401 0.6 . . . . 0.0 109.576 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.22 1.11 84.31 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.966 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' HB2' HG23 ' A' ' 43' ' ' ILE . 19.4 p90 -114.58 162.37 16.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.725 0.774 . . . . 0.0 111.099 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 40.6 p -115.18 154.34 29.18 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 41' ' ' LEU . 3.3 p -143.81 144.24 23.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.664 -174.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.33 170.02 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.26 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.05 -68.83 0.48 Allowed Glycine 0 CA--C 1.452 -3.906 0 CA-C-N 115.124 -0.943 . . . . 0.0 113.796 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -75.39 58.02 2.86 Favored Glycine 2 CA--C 1.406 -6.73 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' HIS . 13.4 m-20 -64.45 -12.78 47.08 Favored 'General case' 0 C--N 1.261 -3.251 0 O-C-N 124.449 0.735 . . . . 0.0 110.797 176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 38' ' ' ASP . 6.1 pt-20 -158.23 165.14 19.22 Favored Pre-proline 0 CA--C 1.452 -2.812 0 C-N-CA 116.519 -2.072 . . . . 0.0 111.205 -173.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.5 Cg_endo -68.37 47.01 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.764 2.309 . . . . 0.0 111.529 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 36' ' ' GLU . 27.2 m-20 -165.44 -22.69 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.356 2.262 . . . . 0.0 109.248 -172.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.716 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 37.9 mt-10 -112.83 126.25 55.23 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.259 5.2 m-30 -78.78 157.43 28.44 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 128.076 3.36 . . . . 0.0 111.365 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 80' ' ' VAL . 6.9 mp -90.08 144.71 25.65 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 117.506 -1.678 . . . . 0.0 107.093 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.8 mt-30 -143.54 151.01 39.72 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 29' ' ' PHE . 19.3 mm -68.39 117.8 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.625 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 20.8 tptm -63.05 -43.37 98.81 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.534 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.2 t 166.14 174.97 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 125.596 1.81 . . . . 0.0 109.993 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.3 152.41 45.85 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.704 0.764 . . . . 0.0 112.923 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 49' ' ' ASP . 49.4 t -85.35 128.61 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.51 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 89.1 mt -68.88 -15.9 63.62 Favored 'General case' 0 N--CA 1.387 -3.612 0 CA-C-N 112.733 -2.03 . . . . 0.0 113.59 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.49 ' H ' HG12 ' A' ' 47' ' ' VAL . 3.9 m-20 -96.26 -5.36 40.44 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 114.154 -1.385 . . . . 0.0 111.245 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.71 162.96 28.11 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.6 Cg_endo -53.99 -31.79 65.43 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 124.541 3.494 . . . . 0.0 113.576 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -59.3 -42.67 91.87 Favored 'General case' 0 C--O 1.279 2.641 0 CA-C-O 121.706 0.765 . . . . 0.0 111.42 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.74 -37.35 49.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.899 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 8.6 mp -68.82 -40.28 79.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.74 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.55 -26.1 61.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.72 2.78 77.42 Favored Glycine 0 CA--C 1.495 -1.181 0 CA-C-N 112.888 -1.96 . . . . 0.0 113.826 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -91.46 -21.28 21.01 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.21 149.28 23.25 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.575 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.37 154.73 40.34 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.395 0.617 . . . . 0.0 110.625 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 45' ' ' SER . 67.8 p -61.37 106.04 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.761 0.824 . . . . 0.0 111.493 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 110.79 -2.27 28.88 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 119.311 -0.716 . . . . 0.0 113.563 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.55 ' CB ' ' HG3' ' A' ' 99' ' ' ARG . 2.8 p30 -69.71 138.67 53.09 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.5 OUTLIER -87.76 120.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.486 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 31.3 mm -71.62 124.37 27.96 Favored 'Isoleucine or valine' 1 C--O 1.324 4.978 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 172.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 73' ' ' LEU . 37.0 t -115.63 -40.9 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.064 -2.789 . . . . 0.0 111.036 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.55 ' HA ' HG22 ' A' ' 72' ' ' VAL . 24.7 m -149.82 150.38 31.89 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.7 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.722 HG13 HG21 ' A' ' 72' ' ' VAL . 2.9 m -121.99 142.11 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 169.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.8 m120 54.61 28.11 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.548 0.689 . . . . 0.0 111.379 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 54.9 42.32 31.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.668 1.699 . . . . 0.0 111.832 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 72' ' ' VAL . 88.8 m -122.12 122.82 40.1 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.898 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.54 100.17 0.49 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.926 0.869 . . . . 0.0 111.055 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.722 HG21 HG13 ' A' ' 67' ' ' VAL . 17.4 m -105.04 17.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.587 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.1 tp -60.61 112.96 2.2 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.44 44.98 0.3 Allowed Glycine 0 N--CA 1.496 2.645 0 O-C-N 125.649 1.843 . . . . 0.0 111.272 -170.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 76' ' ' THR . 6.2 t-160 -45.37 -67.62 0.27 Allowed 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' HIS . 3.1 p -166.9 142.78 4.36 Favored 'General case' 0 C--N 1.262 -3.219 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 148.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.653 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.04 -35.21 33.19 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 120.695 1.588 . . . . 0.0 111.205 173.38 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.14 96.39 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.654 0.264 . . . . 0.0 110.929 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -69.65 -41.57 75.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.876 HG21 HD21 ' A' ' 41' ' ' LEU . 21.1 m -63.66 -39.82 86.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.154 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.62 -40.77 90.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -61.06 -36.81 80.59 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.556 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.9 mm -70.45 -37.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 123.683 0.793 . . . . 0.0 112.057 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.33 -29.01 62.39 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -76.34 -20.18 57.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.407 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 37.6 t -78.04 -26.39 48.35 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.501 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.6 mt -90.07 130.11 43.53 Favored Pre-proline 0 N--CA 1.398 -3.032 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.134 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.0 Cg_endo -89.49 162.44 5.41 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 123.697 2.932 . . . . 0.0 112.954 -173.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.557 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.3 mm -60.12 133.6 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 CA-C-O 121.538 0.685 . . . . 0.0 110.902 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.76 60.33 Favored Glycine 0 C--N 1.289 -2.078 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.019 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.38 -167.92 1.46 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.9 m -151.52 163.39 39.13 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 121.929 -0.482 . . . . 0.0 109.919 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -145.83 125.26 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 C-N-CA 119.569 -0.853 . . . . 0.0 111.76 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.08 107.16 12.65 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' SER . 63.6 mt -104.96 135.59 46.01 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 124.433 1.093 . . . . 0.0 111.75 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 38.8 mt-10 -90.52 120.47 31.64 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 7.9 mt -105.65 164.63 11.76 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.569 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.8 t -141.37 109.16 5.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 122.254 1.026 . . . . 0.0 110.906 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.55 ' HG3' ' CB ' ' A' ' 62' ' ' ASP 0.33 23.7 mtm180 -96.18 117.97 31.81 Favored 'General case' 0 C--N 1.257 -3.422 0 O-C-N 121.331 -0.856 . . . . 0.0 113.133 174.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.55 -29.73 0.1 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.287 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -101.64 135.46 19.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.547 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.242 0.701 0 C-N-CA 123.257 2.638 . . . . 0.0 111.231 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.444 -1.423 0 N-CA-C 110.228 -0.72 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -89.93 104.8 17.34 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.552 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.9 t80 -105.15 131.15 53.0 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 HD23 ' A' ' 11' ' ' LEU . 8.8 t -140.38 19.05 2.4 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.246 1.022 . . . . 0.0 110.704 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 57.6 mtt180 58.41 -13.13 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.96 2.104 . . . . 0.0 115.961 172.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.533 ' OD1' ' HB2' ' A' ' 9' ' ' SER . 23.7 t-20 -113.57 119.48 41.52 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 110.927 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.1 Cg_exo -54.4 -32.82 74.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.179 3.252 . . . . 0.0 112.814 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.533 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 26.4 m -75.69 -22.48 56.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.408 0.683 . . . . 0.0 110.954 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 22.3 mm-40 -90.29 -19.56 23.96 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.898 0.879 . . . . 0.0 111.033 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD11 HD21 ' A' ' 73' ' ' LEU . 51.0 mt -74.48 172.37 12.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.092 0.948 . . . . 0.0 111.485 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -108.39 -170.39 1.67 Allowed 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 90.16 165.71 40.81 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.09 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 22.2 ttpt -95.86 137.7 34.55 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.464 ' HZ ' ' HB2' ' A' ' 11' ' ' LEU . 30.8 m-85 -104.88 111.89 24.81 Favored 'General case' 0 CA--C 1.458 -2.592 0 CA-C-O 122.687 1.232 . . . . 0.0 110.226 -173.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.461 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.4 mt -108.46 113.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.9 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.007 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.87 128.42 34.41 Favored 'General case' 0 C--N 1.252 -3.631 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.915 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 95' ' ' LEU . 7.4 t -133.62 157.01 46.83 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.399 -173.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -130.58 119.02 21.89 Favored 'General case' 0 C--N 1.247 -3.865 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 172.121 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' HG ' ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -106.67 117.47 34.14 Favored 'General case' 0 C--N 1.277 -2.576 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.837 -174.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 23.4 tpp180 -70.66 105.66 3.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.51 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.744 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 62.6 tttt -69.34 97.76 1.0 Allowed 'General case' 0 C--O 1.161 -3.603 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 165.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -86.66 -155.27 0.26 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.6 m -63.31 -33.12 74.82 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.541 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 1.3 tmt_? -83.53 -20.97 32.93 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.744 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 94.14 -129.19 9.79 Favored Glycine 0 N--CA 1.401 -3.649 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.8 m-85 -86.98 146.97 25.94 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 118.134 0.967 . . . . 0.0 110.212 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 20' ' ' LEU . . . -94.38 0.74 66.15 Favored Glycine 0 C--O 1.22 -0.775 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.533 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 5.8 p90 -115.67 163.48 15.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.514 . . . . 0.0 110.642 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 61.6 p -123.71 147.53 47.38 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.84 150.14 26.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.391 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.49 152.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.523 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.84 -132.12 9.7 Favored Glycine 1 N--CA 1.395 -4.06 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 47.58 37.46 13.42 Favored Glycine 0 CA--C 1.476 -2.363 0 C-N-CA 124.212 0.911 . . . . 0.0 113.55 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 29.3 t70 -69.03 -29.4 67.54 Favored 'General case' 0 CA--C 1.459 -2.547 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -174.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -162.38 166.74 13.46 Favored Pre-proline 0 CA--C 1.455 -2.702 0 C-N-CA 118.352 -1.339 . . . . 0.0 109.243 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.7 Cg_endo -66.19 58.72 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.005 2.47 . . . . 0.0 109.583 170.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 174.54 -9.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.746 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.5 mm-40 -128.34 124.53 36.68 Favored 'General case' 0 C--O 1.281 2.744 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.521 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.276 5.9 m-30 -76.66 158.81 30.75 Favored 'General case' 1 N--CA 1.549 4.52 0 C-N-CA 130.914 3.685 . . . . 0.0 113.609 -168.246 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 80' ' ' VAL . 6.2 mp -92.4 138.86 31.15 Favored 'General case' 0 C--O 1.178 -2.659 0 C-N-CA 117.068 -1.853 . . . . 0.0 106.951 170.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.592 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 18.1 mt-30 -136.16 154.18 51.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 20.7 mm -71.34 115.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' SER . 31.0 ttpt -65.01 -41.63 95.18 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 166.72 173.72 0.03 OUTLIER 'General case' 0 C--N 1.371 1.503 0 O-C-N 125.186 1.554 . . . . 0.0 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 58' ' ' MET . 1.4 pp -141.6 152.2 43.8 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 123.816 0.846 . . . . 0.0 111.819 -172.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 49' ' ' ASP . 14.0 t -82.85 124.41 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.793 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.88 -3.75 13.83 Favored 'General case' 0 N--CA 1.379 -3.975 0 CA-C-N 112.836 -1.984 . . . . 0.0 112.937 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' H ' HG12 ' A' ' 47' ' ' VAL . 17.0 t70 -95.79 -22.97 17.17 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.658 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.35 162.77 36.83 Favored Glycine 0 N--CA 1.398 -3.892 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.586 -170.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -51.39 -30.32 33.98 Favored 'Trans proline' 0 C--O 1.197 -1.553 0 C-N-CA 125.178 3.919 . . . . 0.0 112.952 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.06 -47.97 81.52 Favored 'General case' 0 C--O 1.258 1.524 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.34 -36.2 54.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.644 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.31 -40.6 70.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.733 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.37 -21.6 62.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.81 39.88 75.84 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -111.26 -37.62 5.25 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.677 0.275 . . . . 0.0 111.463 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.429 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 1.1 mpt? -95.93 153.14 17.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.403 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.78 158.38 43.69 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 45' ' ' SER . 49.0 p -64.22 108.67 1.64 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.007 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.486 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.56 -11.64 9.61 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.709 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 2.9 m-20 -62.86 136.69 57.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.547 1.173 . . . . 0.0 108.803 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -88.25 123.36 40.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 177.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.59 123.52 30.28 Favored 'Isoleucine or valine' 1 C--O 1.34 5.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 HD13 ' A' ' 73' ' ' LEU . 46.0 t -115.53 -36.14 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 127.444 2.965 . . . . 0.0 111.375 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 65.6 m -148.57 159.62 43.9 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.515 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG12 ' HB ' ' A' ' 72' ' ' VAL . 4.3 p -141.45 130.18 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 108.016 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.23 31.48 20.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.461 0.648 . . . . 0.0 110.728 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 71.2 1.4 3.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.495 1.518 . . . . 0.0 112.593 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.3 m -90.95 121.97 33.23 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.8 t -58.86 114.8 2.72 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -124.23 19.39 4.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.57 HD13 HG13 ' A' ' 65' ' ' VAL . 27.8 tp -59.15 112.85 1.86 Allowed 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.11 39.76 0.06 OUTLIER Glycine 0 C--O 1.186 -2.879 0 O-C-N 125.737 1.898 . . . . 0.0 112.792 -170.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 76' ' ' THR . 6.4 t-160 -43.38 -65.75 0.46 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.9 p -167.33 143.84 4.35 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 151.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.581 ' HA ' HG22 ' A' ' 80' ' ' VAL . 1.4 t60 -50.85 -35.13 30.99 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 120.099 1.318 . . . . 0.0 109.702 171.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -46.95 87.17 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.436 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -66.35 -43.08 87.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 41' ' ' LEU . 15.3 m -64.44 -44.89 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 84.5 t -64.51 -42.12 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.74 -37.89 83.3 Favored 'General case' 0 C--O 1.212 -0.887 0 O-C-N 123.151 0.282 . . . . 0.0 111.47 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.57 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.9 mm -67.48 -38.28 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.307 0.575 . . . . 0.0 112.148 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.54 -32.19 65.88 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.523 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 84.4 mt-30 -67.78 -32.07 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.211 1.005 . . . . 0.0 109.691 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.2 m -72.33 -40.6 67.31 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.886 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.478 HG22 ' HD3' ' A' ' 22' ' ' LYS . 30.8 mt -70.34 133.05 87.47 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.475 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 15.0 Cg_endo -87.21 162.65 8.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.57 2.847 . . . . 0.0 113.433 -172.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.526 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.9 mm -60.22 134.8 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.609 0.719 . . . . 0.0 111.074 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.37 8.26 66.4 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.365 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.536 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.24 128.08 51.94 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.415 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 1.9 p -89.79 159.14 17.18 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.13 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -141.78 125.6 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.183 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.913 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.3 104.5 15.2 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.492 ' HB2' HG23 ' A' ' 18' ' ' THR . 27.9 mt -109.68 159.72 16.9 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 126.138 1.775 . . . . 0.0 109.305 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.44 122.71 48.5 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 75.7 mt -109.14 163.14 13.61 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.21 1.004 . . . . 0.0 108.766 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -142.91 116.58 9.22 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.412 175.003 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.493 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 ttm180 -104.73 125.57 50.95 Favored 'General case' 0 C--N 1.258 -3.374 0 O-C-N 120.729 -1.232 . . . . 0.0 108.764 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.9 -22.03 0.23 Allowed Glycine 0 CA--C 1.472 -2.639 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -90.89 134.62 29.99 Favored Pre-proline 0 N--CA 1.422 -1.835 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.475 0.426 0 C-N-CA 123.803 3.002 . . . . 0.0 112.939 -175.109 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.443 ' HG3' ' H ' ' A' ' 40' ' ' PHE . 40.2 Cg_endo . . . . . 0 N--CA 1.443 -1.46 0 CA-C-O 121.98 0.742 . . . . 0.0 113.57 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -88.83 105.3 17.64 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.8 t80 -108.76 135.24 50.31 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -143.3 12.7 1.78 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.313 1.054 . . . . 0.0 110.239 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.566 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 7.1 mtm180 59.76 -11.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.008 2.123 . . . . 0.0 114.88 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.495 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 51.2 t-20 -111.35 115.98 51.48 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.1 0.476 . . . . 0.0 110.626 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 4.2 Cg_endo -56.46 -28.19 72.13 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.649 2.9 . . . . 0.0 112.84 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.61 -27.19 63.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -91.42 -22.45 20.45 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.843 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.595 HD11 HD21 ' A' ' 73' ' ' LEU . 44.3 mt -72.09 179.48 3.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.108 0.956 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -108.87 -166.37 1.11 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.069 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.588 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.17 167.56 41.66 Favored Glycine 0 C--N 1.304 -1.23 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.751 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 33.4 tttp -97.53 143.39 28.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.7 m-85 -106.95 112.04 24.81 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.415 1.103 . . . . 0.0 109.419 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' HE3' ' A' ' 14' ' ' LYS . 14.4 mt -112.3 148.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.442 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.09 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.592 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.9 t60 -124.76 120.02 30.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -140.34 131.5 26.45 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.741 0.781 . . . . 0.0 111.294 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 31.7 ttmt -88.16 125.95 34.88 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.327 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.38 117.4 33.95 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.912 -176.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 41.3 ttm180 -77.44 107.42 9.87 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.699 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.644 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 76.3 tttt -64.54 97.39 0.2 Allowed 'General case' 0 C--O 1.178 -2.699 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 t -91.86 -153.53 0.34 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 125.347 1.459 . . . . 0.0 108.216 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 p -52.68 -46.8 67.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.982 0.513 . . . . 0.0 111.564 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 31.2 mmt180 -84.07 -17.23 40.97 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.514 0.674 . . . . 0.0 109.904 173.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.644 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 95.68 -105.61 3.27 Favored Glycine 1 N--CA 1.377 -5.295 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.507 ' HD1' HD12 ' A' ' 20' ' ' LEU . 40.5 m-85 -97.1 140.22 31.93 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.687 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.87 4.83 84.94 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.638 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' HB2' HG23 ' A' ' 43' ' ' ILE . 27.4 p90 -111.99 163.04 14.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.454 0.645 . . . . 0.0 110.499 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HE3' ' A' ' 44' ' ' LYS . 43.7 p -117.6 149.15 41.15 Favored 'General case' 0 N--CA 1.401 -2.891 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.51 HG21 HD23 ' A' ' 41' ' ' LEU . 3.3 p -141.24 139.16 33.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 C-N-CA 119.246 -0.981 . . . . 0.0 112.06 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 33' ' ' GLY . 13.1 p -149.24 167.24 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.942 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 128.55 -65.11 0.59 Allowed Glycine 0 CA--C 1.453 -3.795 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.175 173.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -74.9 57.64 2.66 Favored Glycine 2 CA--C 1.42 -5.897 0 C-N-CA 125.649 1.595 . . . . 0.0 116.284 -167.599 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.88 -11.95 50.79 Favored 'General case' 0 C--N 1.257 -3.438 0 O-C-N 124.123 0.543 . . . . 0.0 111.571 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.551 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 6.9 pt-20 -160.92 167.35 13.69 Favored Pre-proline 0 CA--C 1.451 -2.859 0 C-N-CA 116.11 -2.236 . . . . 0.0 110.615 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.1 Cg_endo -68.23 54.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.351 2.034 . . . . 0.0 110.198 172.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -176.41 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.685 1.594 . . . . 0.0 109.93 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.708 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 51.3 mm-40 -114.36 128.42 56.34 Favored 'General case' 0 C--O 1.276 2.45 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.443 ' H ' ' HG3' ' A' ' 2' ' ' PRO 0.267 8.5 m-30 -79.56 156.4 27.74 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 128.101 3.375 . . . . 0.0 111.19 -178.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -87.33 142.21 28.06 Favored 'General case' 0 C--O 1.178 -2.692 0 C-N-CA 117.103 -1.839 . . . . 0.0 107.684 174.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.505 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 49.6 mt-30 -138.97 154.61 48.31 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG23 ' HB2' ' A' ' 29' ' ' PHE . 31.2 mm -76.41 111.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HE3' ' OG1' ' A' ' 30' ' ' THR . 0.5 OUTLIER -61.98 -37.54 85.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.59 ' HA ' HG22 ' A' ' 60' ' ' THR . 48.5 t 164.68 173.22 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 125.37 1.669 . . . . 0.0 109.479 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -137.2 151.58 48.93 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-O 122.044 0.926 . . . . 0.0 113.063 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 49' ' ' ASP . 40.7 t -73.54 117.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 113.454 -1.703 . . . . 0.0 106.748 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.66 -23.08 49.49 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 112.976 -1.92 . . . . 0.0 112.896 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.455 ' H ' HG12 ' A' ' 47' ' ' VAL . 31.8 m-20 -96.68 -2.04 45.38 Favored 'General case' 0 C--N 1.267 -3.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.219 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.33 167.64 26.35 Favored Glycine 0 N--CA 1.422 -2.256 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.366 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.1 Cg_endo -55.25 -31.03 74.57 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 124.187 3.258 . . . . 0.0 112.979 -176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.36 -44.94 89.01 Favored 'General case' 0 C--O 1.274 2.371 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.36 55.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.294 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.81 -35.43 64.87 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.82 -24.47 65.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.96 22.02 78.34 Favored Glycine 0 CA--C 1.49 -1.524 0 CA-C-N 112.515 -2.13 . . . . 0.0 113.79 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -109.44 -32.71 7.05 Favored 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.5 ttm -96.07 142.22 28.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.47 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.01 166.2 23.27 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.076 0.941 . . . . 0.0 111.082 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.9 p -70.74 111.77 6.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.081 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.7 -11.64 15.66 Favored Glycine 0 C--N 1.309 -0.929 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.903 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.662 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.8 m-20 -63.54 134.62 55.86 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -91.66 124.73 44.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 13.1 mm -73.17 123.9 29.03 Favored 'Isoleucine or valine' 1 C--O 1.32 4.764 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 HD13 ' A' ' 73' ' ' LEU . 42.9 t -115.53 -34.49 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 O-C-N 126.979 2.674 . . . . 0.0 110.447 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.583 ' HA ' HG22 ' A' ' 72' ' ' VAL . 36.5 m -148.98 146.71 27.93 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.954 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.591 HG12 HG11 ' A' ' 72' ' ' VAL . 7.1 p -124.75 132.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.0 m120 61.11 23.75 13.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 110.978 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.7 t70 66.66 21.46 10.62 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.743 1.617 . . . . 0.0 112.015 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' HG13 ' A' ' 72' ' ' VAL . 56.2 m -102.91 120.43 40.61 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 171.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.7 t -66.7 110.33 3.19 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG11 HG12 ' A' ' 67' ' ' VAL . 35.7 m -122.67 28.88 2.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.563 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.595 HD21 HD11 ' A' ' 11' ' ' LEU . 39.0 tp -60.98 112.92 2.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.82 42.29 0.23 Allowed Glycine 0 C--N 1.376 2.763 0 O-C-N 125.339 1.649 . . . . 0.0 111.374 -170.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' HG23 ' A' ' 76' ' ' THR . 6.6 t-160 -43.31 -66.11 0.41 Allowed 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' HIS . 7.2 p -167.31 143.31 4.21 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 151.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -49.69 -35.69 22.59 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 120.31 1.414 . . . . 0.0 110.572 173.189 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.13 71.37 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.934 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -60.27 -44.5 95.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 41' ' ' LEU . 35.8 m -71.23 -43.31 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.606 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 91.6 t -64.92 -41.29 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -60.91 -38.58 86.22 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.692 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.591 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.8 mm -68.58 -33.21 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.313 0.577 . . . . 0.0 112.478 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -73.25 -30.12 63.23 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 87.5 mt-30 -76.64 -19.9 57.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.824 1.25 . . . . 0.0 110.821 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.7 m -79.68 -44.33 21.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.923 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.491 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.6 mt -67.24 136.46 93.74 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.199 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -90.99 161.18 3.93 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 123.081 2.52 . . . . 0.0 112.969 -173.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.566 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.0 mm -63.88 134.76 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-O 120.912 0.386 . . . . 0.0 110.705 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.04 54.16 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.312 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.03 -170.0 1.82 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -175.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 20.8 m -151.06 157.38 42.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.46 125.66 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.807 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.592 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 14.4 m-20 -76.44 105.3 7.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.7 mt -103.86 138.41 40.48 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 124.139 0.976 . . . . 0.0 110.484 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.3 tt0 -101.05 118.38 36.87 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 81.5 mt -107.14 150.06 26.99 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 124.776 1.23 . . . . 0.0 109.99 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.636 ' HB3' HG13 ' A' ' 63' ' ' VAL . 9.4 t -118.11 106.21 12.63 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.132 0.968 . . . . 0.0 108.553 172.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.662 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 36.2 ttp180 -104.66 127.76 52.51 Favored 'General case' 0 C--N 1.248 -3.823 0 O-C-N 120.811 -1.181 . . . . 0.0 109.954 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.8 -27.55 0.4 Allowed Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.41 141.54 39.54 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 C--O 1.238 0.494 0 C-N-CA 123.288 2.659 . . . . 0.0 111.643 -179.008 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.443 -1.478 0 CA-C-O 121.589 0.579 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -100.74 111.97 24.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.62 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.7 t80 -106.52 143.06 35.17 Favored 'General case' 0 C--N 1.268 -2.957 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.964 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -147.13 9.68 0.98 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.146 0.974 . . . . 0.0 110.443 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.525 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtm180 53.28 4.71 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 127.241 2.217 . . . . 0.0 114.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.491 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.4 t-20 -130.2 119.91 18.9 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HB3' HG11 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -60.94 -19.1 61.05 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.072 3.182 . . . . 0.0 112.835 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -80.43 -24.57 39.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -98.33 -19.9 17.5 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.847 0.356 . . . . 0.0 111.718 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 42.8 tp -84.99 160.46 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.286 0.565 . . . . 0.0 110.848 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.487 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 58.7 mttm -97.56 -171.23 2.14 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.896 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.15 163.95 39.87 Favored Glycine 0 C--N 1.299 -1.506 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 28.2 tttp -93.37 137.97 32.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.607 -1.237 . . . . 0.0 108.828 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 95.9 m-85 -106.05 110.68 23.02 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 122.561 1.172 . . . . 0.0 109.066 -177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 HD13 ' NH2' ' A' ' 99' ' ' ARG . 15.1 mt -114.8 147.33 18.3 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.875 0 CA-C-N 112.36 -2.2 . . . . 0.0 107.94 -173.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -117.35 132.08 56.66 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.917 0.865 . . . . 0.0 111.867 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -140.1 127.58 21.47 Favored 'General case' 0 C--N 1.263 -3.186 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.245 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.796 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttmt -90.15 122.27 32.95 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.843 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.435 HD21 ' CA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -106.79 116.78 32.52 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.596 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.9 ttt180 -76.85 107.83 9.46 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.279 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.731 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.1 tttt -64.08 97.32 0.17 Allowed 'General case' 0 C--O 1.181 -2.512 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 167.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -82.11 -158.24 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -96.58 -0.29 48.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.731 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 83.78 -129.05 8.9 Favored Glycine 0 N--CA 1.406 -3.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.57 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.8 m-85 -90.28 141.98 28.17 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 120.875 0.369 . . . . 0.0 110.207 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.99 86.84 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.143 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.412 ' HB2' HG23 ' A' ' 43' ' ' ILE . 21.3 p90 -111.15 163.3 14.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.475 0.655 . . . . 0.0 110.76 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 69.2 p -115.99 152.27 33.83 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG21 HD23 ' A' ' 41' ' ' LEU . 4.8 p -140.41 143.59 29.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.618 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 33' ' ' GLY . 8.8 p -144.89 167.94 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.453 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.487 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 32' ' ' VAL . . . 111.86 -141.64 16.74 Favored Glycine 1 N--CA 1.388 -4.526 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 -177.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.6 35.66 16.72 Favored Glycine 0 CA--C 1.473 -2.571 0 CA-C-N 117.396 0.598 . . . . 0.0 111.98 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 16.8 t70 -67.0 -29.55 69.42 Favored 'General case' 0 CA--C 1.46 -2.517 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -172.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.41 166.64 13.6 Favored Pre-proline 0 CA--C 1.467 -2.246 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.024 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 20.1 Cg_endo -65.93 58.77 0.42 Allowed 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.561 2.174 . . . . 0.0 109.945 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 11.9 t70 179.24 -16.14 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.233 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 33.9 mm-40 -122.59 123.94 42.35 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 73' ' ' LEU . 6.0 m-30 -76.91 159.28 30.13 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 130.711 3.604 . . . . 0.0 113.762 -169.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 80' ' ' VAL . 8.0 mp -89.03 146.98 24.51 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.8 mt-30 -142.84 157.69 44.36 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.437 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 39.4 mm -74.45 109.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.7 tttp -57.82 -41.05 81.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 60' ' ' THR . 31.2 t 163.04 174.98 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 O-C-N 125.827 1.954 . . . . 0.0 109.808 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.486 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -139.53 150.3 44.94 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.535 0.683 . . . . 0.0 111.826 -175.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 49' ' ' ASP . 60.8 t -75.77 123.87 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 173.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.9 pt? -68.76 -5.21 19.3 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 47' ' ' VAL . 6.3 m-20 -100.0 -6.56 26.31 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.181 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.53 163.76 32.7 Favored Glycine 0 N--CA 1.408 -3.186 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.3 -31.59 30.22 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 124.78 3.654 . . . . 0.0 113.249 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.78 -46.47 84.53 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.425 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.33 -33.95 55.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.058 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.4 mp -70.47 -40.0 73.91 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 124.187 0.995 . . . . 0.0 112.377 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.613 ' OD2' ' HE3' ' A' ' 57' ' ' LYS . 24.4 t70 -66.33 -24.15 66.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.694 1.235 . . . . 0.0 108.326 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.8 19.67 78.24 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.586 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.613 ' HE3' ' OD2' ' A' ' 55' ' ' ASP . 25.6 mtmt -122.02 -18.9 6.81 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -102.19 130.83 48.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.699 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.58 162.91 22.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.403 1.097 . . . . 0.0 111.777 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 45' ' ' SER . 80.7 p -72.57 108.69 5.75 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.657 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.1 -16.14 9.34 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.642 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.678 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 13.5 m-20 -61.13 131.8 51.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.6 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.262 0.2 OUTLIER -85.96 123.58 39.62 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.726 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 15.4 mm -74.06 124.36 31.3 Favored 'Isoleucine or valine' 1 C--O 1.326 5.115 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 8' ' ' PRO . 42.0 t -115.85 -41.06 2.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 110.881 -2.872 . . . . 0.0 111.201 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.579 ' HA ' HG22 ' A' ' 72' ' ' VAL . 68.0 m -144.85 149.27 35.09 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.032 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.775 HG23 HG21 ' A' ' 72' ' ' VAL . 25.1 t -111.7 115.04 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 66.1 -78.83 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.846 1.341 . . . . 0.0 109.634 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -156.22 24.31 0.36 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.36 1.076 . . . . 0.0 110.316 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.538 ' O ' HG13 ' A' ' 72' ' ' VAL . 27.1 m -106.87 117.99 35.51 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 32.3 t -64.9 108.23 1.71 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.775 HG21 HG23 ' A' ' 67' ' ' VAL . 28.2 m -117.53 20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.408 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.62 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 36.3 tp -61.64 112.76 2.37 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 39.54 0.06 OUTLIER Glycine 0 C--N 1.385 3.286 0 O-C-N 125.484 1.74 . . . . 0.0 112.273 -171.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.473 ' O ' HG23 ' A' ' 76' ' ' THR . 4.9 t-160 -42.31 -65.24 0.49 Allowed 'General case' 0 C--N 1.37 1.481 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.1 p -166.36 143.11 4.99 Favored 'General case' 0 C--N 1.257 -3.423 0 N-CA-C 100.812 -3.773 . . . . 0.0 100.812 150.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.615 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.8 -31.37 26.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 121.018 1.735 . . . . 0.0 111.233 173.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.09 -50.26 74.07 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -64.55 -42.01 95.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 41' ' ' LEU . 11.0 m -66.57 -41.85 89.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.05 -38.98 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -37.24 86.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 86' ' ' SER . 2.1 mm -67.56 -35.7 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.56 0.695 . . . . 0.0 112.146 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -73.55 -30.49 63.09 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.74 -26.68 62.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.657 0.783 . . . . 0.0 110.41 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -70.96 -42.5 69.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.768 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 20.6 mt -72.16 130.08 86.85 Favored Pre-proline 0 N--CA 1.408 -2.567 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.017 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.3 Cg_endo -91.86 162.42 3.35 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 123.514 2.809 . . . . 0.0 112.947 -173.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.3 mm -59.43 132.79 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-O 121.296 0.57 . . . . 0.0 111.217 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.65 56.54 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.443 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.9 -169.54 1.69 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 8.1 m -150.6 159.93 44.16 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -142.0 125.01 14.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.766 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.225 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.08 102.16 11.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.76 135.57 40.04 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.221 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 35.5 tt0 -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.805 175.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.0 mt -106.33 144.81 32.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.0 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 10.2 t -112.44 107.78 16.68 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.005 0.907 . . . . 0.0 108.82 172.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.678 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 26.9 ttp180 -101.59 131.74 47.62 Favored 'General case' 0 C--N 1.25 -3.747 0 O-C-N 121.021 -1.049 . . . . 0.0 109.874 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.66 1.41 Allowed Glycine 0 C--N 1.307 -1.061 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.42 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.88 128.73 31.52 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.245 0.849 0 C-N-CA 123.834 3.022 . . . . 0.0 113.12 -174.458 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.448 -1.194 0 CA-C-O 121.092 0.371 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.412 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 44.0 t80 -86.6 104.47 16.06 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.597 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -106.91 131.07 54.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -140.11 13.53 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.045 0.926 . . . . 0.0 109.912 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 6.2 mtm180 53.07 7.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 54.5 t-20 -132.77 121.27 17.0 Favored Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.001 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -59.21 -22.74 66.28 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 124.262 3.308 . . . . 0.0 113.152 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -79.23 -30.61 43.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.363 0.602 . . . . 0.0 109.478 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -90.41 -24.0 20.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.519 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 38.3 tp -82.26 152.95 26.13 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.35 144.83 42.1 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-O 121.73 0.776 . . . . 0.0 109.767 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.655 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 155.19 -178.13 32.02 Favored Glycine 1 C--N 1.249 -4.292 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -173.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HE2' ' CG1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -98.6 121.73 40.92 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.055 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' A' ' 98' ' ' CYS . 85.9 m-85 -100.1 119.25 38.01 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.131 0.967 . . . . 0.0 109.506 -174.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.602 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 44.7 mt -117.42 141.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.95 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.68 -170.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -107.06 126.44 52.35 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.53 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 9.0 t -137.55 157.54 46.31 Favored 'General case' 0 C--O 1.179 -2.633 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.329 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 35.6 ttpt -130.35 122.99 28.92 Favored 'General case' 0 C--N 1.261 -3.278 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.09 117.07 33.1 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 58.0 ttp180 -73.84 105.43 5.11 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.918 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.727 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.0 tttt -64.16 97.17 0.17 Allowed 'General case' 0 C--O 1.18 -2.602 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -84.53 -154.88 0.18 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -58.99 -38.34 78.93 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.449 0.7 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -90.01 -19.94 23.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.727 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 99.84 -118.9 6.32 Favored Glycine 1 N--CA 1.388 -4.541 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.477 ' HD1' HD12 ' A' ' 20' ' ' LEU . 38.4 m-85 -90.55 136.51 33.02 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 117.674 0.737 . . . . 0.0 110.515 -176.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 9.71 76.79 Favored Glycine 0 C--O 1.212 -1.253 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.613 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 9.3 p90 -121.14 162.67 19.69 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.345 0.572 . . . . 0.0 110.375 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -123.13 147.34 46.9 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.5 m -121.61 146.22 27.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-O 121.284 0.564 . . . . 0.0 111.622 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.85 152.04 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.515 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.89 -129.59 8.33 Favored Glycine 1 N--CA 1.395 -4.08 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 45.06 38.04 5.93 Favored Glycine 0 CA--C 1.472 -2.597 0 C-N-CA 124.935 1.255 . . . . 0.0 114.072 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 6.6 m-20 -67.09 -24.4 65.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.405 -176.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.3 pt-20 -170.82 169.76 3.28 Favored Pre-proline 0 CA--C 1.46 -2.518 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.092 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.9 Cg_endo -65.48 59.05 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.858 2.372 . . . . 0.0 110.709 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 19.4 t70 175.02 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.511 1.525 . . . . 0.0 110.218 -173.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 7.7 mm-40 -123.93 123.96 41.56 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 172.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.525 ' CE1' HD11 ' A' ' 73' ' ' LEU . 5.1 m-30 -76.99 159.63 29.78 Favored 'General case' 1 N--CA 1.55 4.543 0 C-N-CA 131.492 3.917 . . . . 0.0 114.569 -170.119 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.87 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -95.08 140.07 30.53 Favored 'General case' 0 C--O 1.188 -2.141 0 C-N-CA 117.73 -1.588 . . . . 0.0 107.725 172.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 51.0 mt-30 -130.86 158.43 40.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 172.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 62' ' ' ASP . 22.3 mm -81.32 115.48 23.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -66.86 -48.66 68.13 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.656 ' HA ' HG22 ' A' ' 60' ' ' THR . 46.0 t 174.37 173.99 0.19 Allowed 'General case' 0 CA--C 1.497 -1.06 0 O-C-N 123.996 0.81 . . . . 0.0 111.879 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.57 152.28 39.46 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.808 -172.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.41 116.23 9.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -69.56 -10.06 56.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.292 1.044 . . . . 0.0 112.908 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.92 -7.98 38.43 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.025 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.541 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.37 173.41 37.27 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.57 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 15.2 Cg_endo -57.27 -27.93 77.36 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 124.175 3.25 . . . . 0.0 112.872 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.45 -49.75 76.59 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.692 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.44 -32.28 58.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.894 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 50' ' ' GLY . 6.8 mp -65.59 -46.27 80.04 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.714 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 35.4 t70 -62.74 -35.7 80.62 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.41 -17.72 52.75 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 112.878 -1.964 . . . . 0.0 113.267 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 2.9 mptm? -77.27 -27.43 53.14 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 46.7 tpp -94.19 127.08 39.82 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -170.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -136.73 156.55 48.38 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.27 1.033 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -61.97 114.42 3.36 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.71 1.204 . . . . 0.0 110.336 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.26 -14.43 25.69 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.192 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.8 m-20 -67.08 141.25 57.54 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.251 0.1 OUTLIER -93.41 123.15 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 113.244 178.34 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.1 mm -73.25 123.62 28.57 Favored 'Isoleucine or valine' 1 C--O 1.337 5.66 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 73' ' ' LEU . 47.1 t -115.87 -36.05 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 O-C-N 127.506 3.004 . . . . 0.0 111.985 -176.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 60.4 m -151.61 162.85 40.28 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.487 -1.383 . . . . 0.0 114.012 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.685 HG23 HG11 ' A' ' 72' ' ' VAL . 48.6 t -134.38 127.16 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.624 0 C-N-CA 125.017 1.327 . . . . 0.0 107.527 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 65.65 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 108.761 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -149.96 31.35 0.7 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.743 0.782 . . . . 0.0 109.165 170.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 m -116.48 126.84 53.94 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.505 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 24.2 t -67.39 115.08 6.62 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.732 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -119.98 15.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.597 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.4 tp -59.34 113.67 2.28 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.2 48.02 0.14 Allowed Glycine 0 C--N 1.379 2.967 0 O-C-N 125.433 1.708 . . . . 0.0 111.846 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.544 ' O ' HG23 ' A' ' 76' ' ' THR . 7.7 t-160 -50.93 -68.35 0.18 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 75' ' ' HIS . 13.9 p -166.55 143.93 5.06 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 152.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.563 ' HA ' HG22 ' A' ' 80' ' ' VAL . 1.3 t60 -50.68 -33.36 22.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 120.088 1.313 . . . . 0.0 110.977 172.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.61 93.19 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.897 -0.502 . . . . 0.0 110.958 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' OE1' ' HD2' ' A' ' 82' ' ' LYS . 10.1 mm-40 -65.2 -43.3 92.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.87 HG21 HD21 ' A' ' 41' ' ' LEU . 17.1 m -62.66 -43.98 99.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.003 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.84 -40.78 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.636 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -62.18 -38.34 88.71 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.636 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 28.1 mt -65.02 -40.39 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.636 0.732 . . . . 0.0 111.329 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.23 -33.59 71.85 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.673 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.38 -20.22 60.8 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.183 0.993 . . . . 0.0 110.96 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.0 m -76.41 -48.75 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.413 HG22 ' HD3' ' A' ' 22' ' ' LYS . 21.4 mt -66.2 135.52 95.02 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -87.98 161.55 7.39 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.258 2.639 . . . . 0.0 113.68 -172.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.559 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.2 mm -63.6 132.49 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.99 11.95 55.89 Favored Glycine 0 C--N 1.288 -2.096 0 C-N-CA 119.783 -1.198 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.35 -171.71 2.13 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.7 m -151.25 156.44 40.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -140.97 125.47 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.867 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.226 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' THR . 10.6 m-20 -79.31 104.2 9.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.39 157.42 16.92 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 125.497 1.519 . . . . 0.0 108.254 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -117.01 121.38 41.21 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 76.1 mt -105.06 164.34 11.87 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 125.107 1.363 . . . . 0.0 109.69 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.655 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 12.4 t -141.05 116.54 10.15 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.843 0.83 . . . . 0.0 109.923 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 31.1 mtm180 -98.6 135.49 40.05 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 121.279 -0.888 . . . . 0.0 113.115 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.62 -25.13 0.84 Allowed Glycine 0 CA--C 1.466 -3.0 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.298 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 22.7 m-85 -81.85 140.64 47.08 Favored Pre-proline 0 N--CA 1.42 -1.954 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.482 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--N 1.359 1.122 0 C-N-CA 123.799 2.999 . . . . 0.0 111.147 179.356 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.247 0.929 0 N-CA-C 111.424 -0.26 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -79.63 105.43 10.93 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.592 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 4.8 t80 -108.25 139.55 42.78 Favored 'General case' 0 C--N 1.265 -3.088 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 7' ' ' ASN . 10.2 t -144.48 10.56 1.44 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.522 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 9.5 mtp180 58.01 -19.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.766 2.026 . . . . 0.0 115.466 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -105.84 113.12 64.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 C-N-CA 122.714 0.406 . . . . 0.0 109.973 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' HG11 ' A' ' 65' ' ' VAL . 5.2 Cg_endo -50.87 -27.87 21.89 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 124.077 3.185 . . . . 0.0 113.635 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.5 t -74.03 -25.71 60.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.02 0.438 . . . . 0.0 110.996 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 14.5 mm-40 -91.51 -35.3 14.39 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.435 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 39.0 tp -71.89 155.82 39.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.903 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -106.55 158.57 16.83 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.48 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.768 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 131.31 173.65 13.42 Favored Glycine 0 C--N 1.265 -3.369 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' CE ' HG12 ' A' ' 16' ' ' ILE . 7.6 ttpt -94.4 123.51 37.85 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 95.1 m-85 -101.75 111.55 23.83 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 122.778 1.275 . . . . 0.0 109.85 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG12 ' CE ' ' A' ' 14' ' ' LYS . 34.7 mt -105.87 145.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.739 0 CA-C-N 111.839 -2.437 . . . . 0.0 109.651 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.504 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 4.3 t60 -130.61 115.17 16.37 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 57' ' ' LYS . 2.2 t -139.92 137.73 35.04 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.296 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.6 ttmp? -87.59 125.37 34.31 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.632 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -107.82 121.11 44.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 11.9 ttp180 -81.21 108.87 15.21 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.397 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.646 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 73.7 tttt -62.88 97.47 0.11 Allowed 'General case' 0 C--O 1.182 -2.454 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 169.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -90.93 -154.39 0.35 Allowed 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 124.812 1.245 . . . . 0.0 108.228 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -54.59 -43.94 72.59 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.75 0.82 . . . . 0.0 111.029 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmt_? -85.18 -18.87 32.78 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.15 -114.52 5.0 Favored Glycine 0 N--CA 1.397 -3.955 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -177.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.505 ' HD1' HD12 ' A' ' 20' ' ' LEU . 31.8 m-85 -93.95 141.33 28.64 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.37 -2.92 84.91 Favored Glycine 0 C--O 1.217 -0.959 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.757 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.525 ' HB2' HG23 ' A' ' 43' ' ' ILE . 17.9 p90 -111.97 162.7 15.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 38.8 p -123.59 155.58 37.39 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' CE1' ' A' ' 77' ' ' HIS . 17.1 m -127.4 148.64 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-O 121.631 0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.02 149.93 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.283 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.79 -137.17 12.6 Favored Glycine 0 N--CA 1.398 -3.864 0 N-CA-C 108.236 -1.945 . . . . 0.0 108.236 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 52.34 32.28 36.94 Favored Glycine 0 CA--C 1.47 -2.728 0 N-CA-C 111.786 -0.525 . . . . 0.0 111.786 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -71.62 -19.76 62.07 Favored 'General case' 0 N--CA 1.411 -2.416 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.951 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.1 pt-20 -166.65 166.78 8.66 Favored Pre-proline 0 CA--C 1.468 -2.183 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_endo -66.85 58.18 0.54 Allowed 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.715 2.277 . . . . 0.0 109.737 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 22.1 t70 176.6 -15.06 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.476 -169.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 26.9 mt-10 -123.19 126.12 46.39 Favored 'General case' 0 C--O 1.269 2.116 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 171.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.25 7.3 m-85 -77.85 158.59 29.4 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 131.04 3.736 . . . . 0.0 113.535 -168.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 80' ' ' VAL . 6.0 mp -89.82 143.29 26.92 Favored 'General case' 0 CA--C 1.457 -2.624 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 171.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.12 152.81 49.09 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 29' ' ' PHE . 26.7 mm -69.09 109.09 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 84.1 tttt -55.3 -41.26 72.1 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 124.872 1.357 . . . . 0.0 107.448 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.554 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 162.41 173.52 0.02 OUTLIER 'General case' 0 C--N 1.366 1.326 0 O-C-N 125.395 1.684 . . . . 0.0 109.605 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -138.59 147.27 42.78 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 121.989 0.9 . . . . 0.0 111.976 -173.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ASP . 13.8 t -83.34 130.06 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.972 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 94.7 mt -69.32 -13.52 62.43 Favored 'General case' 0 N--CA 1.38 -3.941 0 CA-C-N 112.799 -2.001 . . . . 0.0 112.849 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . 14.7 t70 -86.0 -24.2 26.54 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.244 173.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -81.09 155.15 36.13 Favored Glycine 0 N--CA 1.401 -3.679 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.556 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 20' ' ' LEU . 9.7 Cg_endo -50.8 -31.48 33.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 125.052 3.834 . . . . 0.0 113.385 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -60.4 -44.53 95.59 Favored 'General case' 0 C--O 1.261 1.701 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.199 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.88 -35.33 50.95 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.496 177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 6.6 mp -65.94 -43.41 88.11 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.981 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.48 -21.85 55.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.909 1.338 . . . . 0.0 107.409 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.9 73.46 Favored Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 113.228 -1.806 . . . . 0.0 112.586 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HB3' HG21 ' A' ' 18' ' ' THR . 72.6 mmtt -98.31 -28.48 13.65 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 120.859 0.362 . . . . 0.0 110.084 -173.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.427 ' HB3' HD22 ' A' ' 46' ' ' LEU . 1.3 mpt? -98.03 149.63 22.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.211 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.71 153.4 47.21 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.5 p -60.09 111.67 1.6 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 113.48 -5.43 24.76 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.215 175.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 43' ' ' ILE . 5.4 m-20 -60.31 126.07 26.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.102 0.951 . . . . 0.0 108.603 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.256 0.2 OUTLIER -80.2 112.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.957 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 97' ' ' LEU . 22.1 mm -66.98 125.3 24.09 Favored 'Isoleucine or valine' 1 C--O 1.332 5.397 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 HD22 ' A' ' 73' ' ' LEU . 48.5 t -115.36 -42.91 3.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 O-C-N 127.585 3.053 . . . . 0.0 112.085 -174.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 69.6 m -147.77 156.78 43.1 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.853 -1.154 . . . . 0.0 112.359 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG11 HG21 ' A' ' 83' ' ' ILE . 6.3 p -135.98 128.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.1 m120 58.53 30.33 19.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.603 0.716 . . . . 0.0 110.65 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 68.06 17.22 9.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.893 1.277 . . . . 0.0 113.28 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.8 m -107.78 125.49 51.49 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.417 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 54.0 t -59.99 110.14 1.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 124.418 1.074 . . . . 0.0 109.783 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -119.8 16.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.592 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 30.6 tp -59.9 113.23 2.18 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.5 43.17 0.07 OUTLIER Glycine 0 N--CA 1.5 2.945 0 O-C-N 125.762 1.914 . . . . 0.0 112.559 -170.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' THR . 6.5 t-160 -46.42 -66.83 0.35 Allowed 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.1 p -166.52 143.85 5.07 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 151.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.589 ' HA ' HG22 ' A' ' 80' ' ' VAL . 2.3 t60 -50.88 -33.59 24.67 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 120.295 1.407 . . . . 0.0 110.876 173.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.17 86.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.967 -0.458 . . . . 0.0 110.866 174.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 41' ' ' LEU . 13.1 m -64.63 -44.5 96.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -66.56 -38.19 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -64.32 -33.93 76.96 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.296 177.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.588 HG21 HG11 ' A' ' 67' ' ' VAL . 3.9 mm -70.8 -36.53 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.732 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.18 -31.42 64.21 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.309 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -70.44 -27.91 64.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.522 1.129 . . . . 0.0 110.634 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -73.17 -34.34 65.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.576 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.0 mt -80.78 134.72 53.13 Favored Pre-proline 0 N--CA 1.412 -2.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.976 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -91.99 162.3 3.27 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 123.585 2.857 . . . . 0.0 113.134 -174.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.533 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.2 mm -62.85 133.01 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.22 0.533 . . . . 0.0 110.885 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.76 12.3 53.44 Favored Glycine 0 C--N 1.293 -1.848 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.674 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.76 -170.82 1.88 Allowed 'General case' 0 C--O 1.207 -1.164 0 O-C-N 122.704 -0.292 . . . . 0.0 110.292 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.9 m -151.21 155.51 38.98 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.657 -0.652 . . . . 0.0 109.358 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.02 127.88 10.67 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.657 0 C-N-CA 118.582 -1.247 . . . . 0.0 113.119 -174.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 22.2 m-20 -80.32 106.88 12.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.533 0.682 . . . . 0.0 109.168 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 71.1 mt -105.59 142.65 34.95 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.806 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' OE2' ' HB3' ' A' ' 15' ' ' PHE . 16.7 tp10 -107.1 127.69 53.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB3' HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -136.2 155.83 49.57 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 124.046 0.938 . . . . 0.0 111.281 -178.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.768 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -119.95 117.13 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.509 1.147 . . . . 0.0 112.936 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 18.8 tpp85 -88.88 111.14 21.71 Favored 'General case' 0 C--N 1.266 -3.058 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.07 -35.63 0.09 OUTLIER Glycine 0 CA--C 1.479 -2.19 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.568 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.62 136.99 24.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.128 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.889 2.392 . . . . 0.0 108.062 173.644 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HG3' ' H ' ' A' ' 40' ' ' PHE . 97.3 Cg_endo . . . . . 0 N--CA 1.44 -1.628 0 CA-C-O 121.379 0.491 . . . . 0.0 112.97 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.46 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 23.8 t80 -82.27 105.19 13.14 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.605 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -101.46 133.57 45.9 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -141.15 8.89 2.08 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.903 0.858 . . . . 0.0 110.437 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.489 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 8.3 mtm180 63.9 -27.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.556 1.943 . . . . 0.0 114.964 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -100.54 122.25 50.26 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.1 Cg_endo -55.52 -27.84 61.58 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 124.006 3.137 . . . . 0.0 112.691 175.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 t -75.52 -25.72 57.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.129 0.49 . . . . 0.0 110.314 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -88.9 -24.26 22.54 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.691 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.436 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 41.2 tp -83.33 157.51 22.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.415 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 36.6 mtmm -119.69 148.71 43.05 Favored 'General case' 0 N--CA 1.381 -3.908 0 CA-C-O 121.676 0.751 . . . . 0.0 110.524 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.624 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 150.37 178.22 25.06 Favored Glycine 0 C--N 1.257 -3.837 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -171.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -88.41 124.28 33.79 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.6 m-85 -102.8 120.3 40.36 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.103 -1.439 . . . . 0.0 109.949 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.433 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 64.7 mt -120.39 135.97 58.94 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.579 -170.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 t-80 -114.01 115.58 27.84 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.371 -176.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 4.2 t -140.33 131.28 26.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.889 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttpt -92.3 124.95 36.75 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.81 120.62 42.51 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.782 -173.007 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 15.9 tpp180 -76.21 103.47 6.26 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.635 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.723 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 51.2 tttt -59.06 96.97 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.947 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 165.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.565 ' HB2' ' HG3' ' A' ' 21' ' ' ARG . 4.9 t -134.65 139.33 45.2 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.1 p 50.82 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.973 1.709 . . . . 0.0 113.215 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmm_? -76.2 -21.83 56.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.723 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 94.43 24.56 18.37 Favored Glycine 1 N--CA 1.393 -4.213 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.697 174.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.553 ' HD1' HD12 ' A' ' 20' ' ' LEU . 30.8 m-85 155.8 170.39 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 130.393 3.477 . . . . 0.0 105.525 167.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.49 4.0 17.74 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.218 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.517 ' HB2' HG23 ' A' ' 43' ' ' ILE . 8.2 p90 -123.8 163.8 20.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -122.09 147.69 45.8 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.19 147.9 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.988 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 158.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.963 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.984 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.75 -130.12 9.04 Favored Glycine 1 N--CA 1.394 -4.13 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.25 37.11 30.56 Favored Glycine 0 CA--C 1.478 -2.268 0 C-N-CA 123.92 0.772 . . . . 0.0 113.513 175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 42.2 m-20 -67.13 -21.39 65.84 Favored 'General case' 0 CA--C 1.477 -1.845 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.097 -175.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.9 pt-20 -170.78 169.37 3.47 Favored Pre-proline 0 CA--C 1.474 -1.961 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.356 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 21.2 Cg_endo -66.61 51.36 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.923 2.416 . . . . 0.0 111.279 171.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 5.8 m-20 -176.84 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 127.105 2.162 . . . . 0.0 111.352 -170.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 18.6 mm-40 -128.66 123.85 34.24 Favored 'General case' 0 C--O 1.272 2.238 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 73' ' ' LEU . 6.5 m-30 -77.15 159.67 29.57 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 131.14 3.776 . . . . 0.0 114.58 -168.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.832 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -92.87 144.28 25.43 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 172.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.7 mt-30 -138.28 153.19 49.06 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 62' ' ' ASP . 25.0 mm -70.93 111.21 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.402 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 45' ' ' SER . 38.8 ttpt -67.54 -36.5 81.11 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.588 ' HA ' HG22 ' A' ' 60' ' ' THR . 41.1 t 170.53 172.9 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 O-C-N 125.159 1.537 . . . . 0.0 111.221 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -144.76 149.47 35.58 Favored 'General case' 0 N--CA 1.408 -2.562 0 C-N-CA 124.257 1.023 . . . . 0.0 110.879 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 49' ' ' ASP . 15.4 t -78.65 127.64 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.651 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.25 -3.38 10.59 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.571 -2.104 . . . . 0.0 112.264 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.2 t70 -103.13 -18.06 15.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.4 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.98 163.0 32.98 Favored Glycine 0 N--CA 1.41 -3.07 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.729 -170.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -50.27 -32.96 34.86 Favored 'Trans proline' 0 C--O 1.201 -1.372 0 C-N-CA 125.063 3.842 . . . . 0.0 112.617 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.469 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -57.51 -47.86 80.82 Favored 'General case' 0 C--O 1.271 2.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.357 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.18 -36.55 54.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.43 -35.45 65.8 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.108 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.69 -22.41 66.08 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.3 24.0 76.17 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.403 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 23.7 mmtp -110.18 -35.69 6.03 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.4 ttm -102.27 143.08 32.49 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.167 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.44 163.93 29.33 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.619 0.723 . . . . 0.0 109.176 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -67.83 114.42 6.4 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 123.709 0.804 . . . . 0.0 108.837 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.443 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 122.62 -22.07 7.43 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.035 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' O ' HG12 ' A' ' 43' ' ' ILE . 8.1 m-20 -62.18 134.69 56.89 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.706 0.753 . . . . 0.0 110.986 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.262 0.2 OUTLIER -82.52 121.51 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.408 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.0 mm -72.58 122.83 25.98 Favored 'Isoleucine or valine' 1 C--O 1.334 5.525 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -115.29 -37.61 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 110.402 -3.09 . . . . 0.0 111.652 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.62 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.0 m -150.76 151.43 32.36 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.302 -1.499 . . . . 0.0 114.424 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.723 HG23 HG21 ' A' ' 72' ' ' VAL . 25.3 t -118.73 114.8 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.629 1.172 . . . . 0.0 109.037 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 52.74 36.69 21.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.312 0.577 . . . . 0.0 112.308 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 72.73 15.41 4.84 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.166 1.786 . . . . 0.0 112.164 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 72' ' ' VAL . 28.6 m -99.1 119.14 37.34 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 169.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.4 t -69.22 110.01 4.37 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.678 0.752 . . . . 0.0 109.491 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.723 HG21 HG23 ' A' ' 67' ' ' VAL . 23.9 m -114.47 18.3 7.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.444 -176.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.605 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 28.5 tp -59.79 113.4 2.25 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.668 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.21 45.72 0.14 Allowed Glycine 0 C--N 1.378 2.9 0 O-C-N 125.661 1.85 . . . . 0.0 111.896 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 76' ' ' THR . 4.8 t-160 -45.15 -66.68 0.37 Allowed 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.8 p -166.9 143.83 4.67 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 150.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 2.4 t60 -51.0 -36.94 42.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 121.008 1.731 . . . . 0.0 110.886 174.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.43 95.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.501 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -69.97 -39.81 75.74 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.832 HG21 HD21 ' A' ' 41' ' ' LEU . 20.9 m -66.54 -41.6 88.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.859 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.63 -40.89 90.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.646 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.4 tmtm? -59.03 -44.58 91.78 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.765 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.646 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.4 mm -66.34 -35.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -70.98 -36.59 72.57 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -68.24 -23.38 64.79 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 124.338 1.055 . . . . 0.0 111.352 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.5 m -75.63 -30.09 59.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.938 176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.529 HG22 ' HD3' ' A' ' 22' ' ' LYS . 51.9 mt -83.24 133.29 47.98 Favored Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.646 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 9.8 Cg_endo -88.08 161.99 7.24 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.552 2.835 . . . . 0.0 112.637 -173.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.536 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 35.5 mm -66.52 133.73 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.87 54.5 Favored Glycine 0 C--N 1.287 -2.173 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.237 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.618 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -101.73 -177.25 3.37 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.565 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 2.9 p -145.54 152.48 39.8 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.78 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.8 t -136.67 125.42 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.34 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.42 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.3 m-20 -78.74 102.85 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 70.0 mt -99.65 139.77 34.82 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.724 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -96.55 118.36 32.89 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 90.4 mt -107.52 164.54 12.12 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 125.283 1.433 . . . . 0.0 109.382 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.645 ' HB3' HG13 ' A' ' 63' ' ' VAL . 19.3 t -142.22 107.77 5.07 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-O 122.387 1.089 . . . . 0.0 110.684 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -85.05 117.75 24.2 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.42 -24.19 0.21 Allowed Glycine 0 CA--C 1.473 -2.558 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.587 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 35.9 m-85 -94.22 133.46 27.27 Favored Pre-proline 0 C--N 1.286 -2.173 0 CA-C-O 121.075 0.464 . . . . 0.0 110.364 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.246 0.914 0 C-N-CA 123.605 2.87 . . . . 0.0 111.969 -177.219 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 36.3 Cg_endo . . . . . 0 N--CA 1.449 -1.111 0 CA-C-O 121.21 0.421 . . . . 0.0 111.896 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -82.58 105.51 13.68 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.617 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.5 t80 -105.18 138.42 41.41 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.126 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -154.51 22.97 0.47 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.217 0.532 . . . . 0.0 111.008 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.456 ' HG2' ' HE1' ' A' ' 4' ' ' PHE . 20.2 mtm180 58.11 -30.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 128.446 2.698 . . . . 0.0 116.431 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.4 t-20 -99.88 113.87 65.36 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 65' ' ' VAL . 5.6 Cg_exo -55.22 -32.68 81.54 Favored 'Trans proline' 0 C--O 1.221 -0.329 0 C-N-CA 123.482 2.788 . . . . 0.0 111.46 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -71.34 -11.97 61.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.285 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.493 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 21.4 mm-40 -105.03 -22.35 13.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.474 0.71 . . . . 0.0 111.344 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.4 mm? -79.67 169.48 17.91 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -177.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.87 -170.42 2.04 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.834 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.11 177.76 52.05 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 13.6 ttpt -110.16 132.18 54.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.5 m-85 -99.09 110.79 23.32 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 123.161 1.458 . . . . 0.0 110.8 -174.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.428 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 30.5 mt -107.09 151.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.835 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.28 -174.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.43 121.49 25.99 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.352 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 t -138.51 138.91 38.48 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.58 0.705 . . . . 0.0 110.151 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.784 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 28.6 ttmt -93.8 125.04 38.2 Favored 'General case' 0 C--N 1.259 -3.346 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -105.7 117.05 33.03 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.251 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 37.8 ttt180 -76.7 108.56 9.8 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.909 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.671 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 73.6 tttt -65.05 97.14 0.22 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 89' ' ' ILE . 21.5 t -87.61 -154.83 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -54.4 -41.54 69.39 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.154 0.581 . . . . 0.0 110.767 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -87.15 -20.47 26.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.805 0.812 . . . . 0.0 109.77 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 99.28 -116.33 5.55 Favored Glycine 1 N--CA 1.386 -4.695 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HD1' HD12 ' A' ' 20' ' ' LEU . 31.0 m-85 -93.9 146.79 23.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.14 0.34 66.4 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.642 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.487 ' HB2' HG23 ' A' ' 43' ' ' ILE . 10.0 p90 -111.24 163.14 14.25 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.546 0.689 . . . . 0.0 111.606 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.6 p -116.85 156.4 27.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.583 HG11 HD23 ' A' ' 41' ' ' LEU . 2.6 t -132.35 142.44 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.348 -173.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -152.7 160.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.736 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.91 -1.52 30.19 Favored Glycine 1 CA--C 1.447 -4.189 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 168.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.828 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -116.39 43.98 1.55 Allowed Glycine 1 CA--C 1.408 -6.637 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -170.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.32 -12.41 29.56 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 113.009 -1.595 . . . . 0.0 112.17 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 6.6 pt-20 -165.45 167.25 9.52 Favored Pre-proline 0 CA--C 1.46 -2.512 0 C-N-CA 117.203 -1.799 . . . . 0.0 110.888 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -67.32 57.52 0.64 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 122.463 2.108 . . . . 0.0 110.165 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 26.8 t70 -179.67 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.478 1.911 . . . . 0.0 109.625 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.736 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 26.7 mt-10 -113.47 124.58 52.75 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-O 117.009 -1.472 . . . . 0.0 107.274 171.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.305 6.5 m-30 -79.35 155.38 28.46 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 128.288 3.492 . . . . 0.0 111.733 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.925 HD21 HG21 ' A' ' 80' ' ' VAL . 6.6 mp -87.1 143.34 27.36 Favored 'General case' 0 C--O 1.175 -2.867 0 C-N-CA 116.582 -2.047 . . . . 0.0 108.901 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.5 mt-30 -138.42 157.54 46.01 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 29' ' ' PHE . 25.3 mm -75.48 109.91 9.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.2 tttp -56.8 -37.71 71.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 125.183 1.552 . . . . 0.0 107.07 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.601 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.0 t 159.36 173.13 0.01 OUTLIER 'General case' 0 C--N 1.364 1.239 0 O-C-N 125.769 1.918 . . . . 0.0 109.231 172.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pp -136.74 149.37 47.81 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.44 118.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.263 1.2 pt? -69.59 -5.06 22.01 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -94.64 -3.48 49.44 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.354 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.62 161.78 27.47 Favored Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 8.6 Cg_endo -51.2 -29.9 30.86 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 124.952 3.768 . . . . 0.0 113.38 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.07 -46.71 84.98 Favored 'General case' 0 C--O 1.275 2.41 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.694 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.07 -32.38 56.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.532 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 9.1 mp -68.69 -45.2 72.28 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.996 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.9 -26.93 67.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.12 16.7 79.54 Favored Glycine 0 CA--C 1.487 -1.711 0 CA-C-N 112.933 -1.939 . . . . 0.0 113.842 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -109.53 -24.48 10.96 Favored 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 122.278 0.231 . . . . 0.0 111.573 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.43 140.53 31.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.025 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 41.4 tt0 -149.38 146.89 27.72 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.986 0.898 . . . . 0.0 111.69 -172.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 45' ' ' SER . 5.3 p -49.61 103.52 0.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 126.313 1.845 . . . . 0.0 112.416 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.9 -2.52 31.78 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-O 119.375 -0.68 . . . . 0.0 113.049 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.24 146.95 48.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -98.59 121.22 48.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.127 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.503 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 29.7 mm -69.88 123.96 24.81 Favored 'Isoleucine or valine' 0 C--O 1.305 3.975 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 73' ' ' LEU . 43.7 t -115.19 -38.66 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 111.662 -2.517 . . . . 0.0 110.272 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.562 ' HA ' HG22 ' A' ' 72' ' ' VAL . 40.0 m -145.11 142.97 30.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.885 -178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 72' ' ' VAL . 7.1 p -119.57 131.82 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 m120 63.8 23.82 13.56 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.873 0.844 . . . . 0.0 108.958 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.37 -0.66 2.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.408 1.883 . . . . 0.0 112.079 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 72' ' ' VAL . 76.8 m -78.86 119.81 22.58 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.67 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.411 -2.397 0 O-C-N 124.777 1.298 . . . . 0.0 110.29 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.571 HG21 HG12 ' A' ' 67' ' ' VAL . 35.6 m -115.87 26.55 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.535 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.617 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.5 tp -59.71 113.79 2.43 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.26 41.48 0.22 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 125.344 1.653 . . . . 0.0 112.177 -170.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.523 ' O ' HG23 ' A' ' 76' ' ' THR . 6.2 t-160 -45.72 -66.73 0.36 Allowed 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.1 p -167.14 143.5 4.38 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 149.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 1.8 t60 -50.16 -38.61 40.33 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 119.342 0.974 . . . . 0.0 110.658 174.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.53 95.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.082 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -66.37 -43.2 86.6 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.925 HG21 HD21 ' A' ' 41' ' ' LEU . 33.4 m -66.81 -40.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.502 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.94 -39.27 85.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.674 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.92 -40.02 79.4 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.706 176.383 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.674 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 57.9 mt -66.75 -36.78 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.713 0.768 . . . . 0.0 110.802 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -71.49 -30.29 65.8 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.421 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.99 -26.32 59.48 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.487 1.115 . . . . 0.0 110.27 174.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 52.4 m -72.39 -49.29 34.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.995 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.447 HG22 ' HD3' ' A' ' 22' ' ' LYS . 44.3 mt -62.98 134.83 95.92 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.789 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 14.3 Cg_endo -90.51 161.84 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.482 2.788 . . . . 0.0 113.302 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.532 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.4 mm -65.37 132.35 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 121.452 0.644 . . . . 0.0 110.379 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.06 54.13 Favored Glycine 0 C--N 1.288 -2.092 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.793 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -98.66 -170.43 1.94 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -175.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 13.3 m -151.14 158.93 44.62 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.21 126.68 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.772 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.63 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.538 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 15.1 m-20 -78.79 104.14 9.21 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.7 mt -102.42 136.96 41.31 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 124.624 1.169 . . . . 0.0 109.884 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 37.6 tt0 -101.02 121.06 41.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 6.0 mt -107.54 165.04 11.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.048 1.339 . . . . 0.0 108.764 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.584 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 21.1 t -137.97 105.23 5.48 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.103 0.954 . . . . 0.0 110.634 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 59' ' ' GLU . 76.5 mtm180 -96.46 119.98 35.93 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 121.229 -0.92 . . . . 0.0 110.506 174.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.26 -33.95 0.15 Allowed Glycine 0 CA--C 1.474 -2.517 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.62 133.4 23.62 Favored Pre-proline 0 N--CA 1.424 -1.744 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 122.929 2.419 . . . . 0.0 111.395 -178.27 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 52.1 Cg_endo . . . . . 0 CA--C 1.545 1.063 0 CA-C-O 121.359 0.483 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -81.61 103.71 11.52 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.602 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -113.7 118.43 34.31 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.385 -176.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -134.7 17.67 3.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.86 0.838 . . . . 0.0 110.267 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.456 ' HA ' HD23 ' A' ' 73' ' ' LEU . 1.7 mtp180 59.59 -20.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.018 2.127 . . . . 0.0 115.762 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.551 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 3.3 t-20 -99.84 112.32 63.58 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-O 121.227 0.537 . . . . 0.0 111.086 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.8 Cg_endo -50.89 -37.1 54.98 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.989 3.126 . . . . 0.0 111.846 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -68.04 -20.31 64.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.763 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 8.3 mm-40 -95.14 -23.54 17.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.573 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 73' ' ' LEU . 19.7 mt -76.3 179.45 5.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.061 0.934 . . . . 0.0 110.421 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -107.65 -177.02 3.23 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.55 166.21 27.41 Favored Glycine 0 C--N 1.283 -2.405 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.074 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 29.2 tttp -93.03 138.96 31.02 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.0 m-85 -113.44 111.57 22.17 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.94 1.352 . . . . 0.0 110.835 -175.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.468 HG12 ' CE ' ' A' ' 14' ' ' LYS . 5.9 mt -109.36 151.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 CA-C-N 112.235 -2.257 . . . . 0.0 108.114 -173.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.515 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 2.8 t60 -130.71 119.77 22.86 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 3.6 t -139.18 129.35 25.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.975 0.893 . . . . 0.0 111.056 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.809 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 36.5 ttpt -90.66 123.65 34.45 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.192 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.479 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.18 119.57 39.74 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.477 -173.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.0 ttm180 -77.43 111.03 12.7 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.863 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.68 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.0 tttt -69.26 97.23 0.92 Allowed 'General case' 0 C--O 1.177 -2.742 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 89' ' ' ILE . 29.4 t -82.05 -155.81 0.15 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -67.45 -31.06 70.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.588 0.709 . . . . 0.0 109.092 174.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.16 -13.33 57.35 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.798 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.68 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 81.29 -125.63 6.98 Favored Glycine 1 N--CA 1.389 -4.485 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 30.3 m-85 -88.52 142.7 27.49 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.699 0.75 . . . . 0.0 110.176 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.81 82.85 Favored Glycine 0 C--N 1.315 -0.61 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.923 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.2 p90 -110.66 162.72 14.46 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.244 0.545 . . . . 0.0 110.341 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 47.3 p -116.76 150.82 37.64 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.67 135.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.863 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.642 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 9.9 p -151.94 165.75 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.954 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 113.15 -0.47 25.39 Favored Glycine 0 CA--C 1.471 -2.687 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 172.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.756 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -120.54 44.55 1.35 Allowed Glycine 1 CA--C 1.395 -7.417 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -171.025 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 7.8 m-20 -59.09 -13.33 6.63 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.606 -1.797 . . . . 0.0 113.04 -174.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 4.2 pt-20 -160.04 166.42 15.89 Favored Pre-proline 0 CA--C 1.455 -2.703 0 C-N-CA 117.177 -1.809 . . . . 0.0 110.631 -174.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 36.8 Cg_endo -67.61 51.62 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.818 2.345 . . . . 0.0 110.585 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 7.7 t70 -179.39 -12.88 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.674 1.19 . . . . 0.0 110.037 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.64 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 30.5 mt-10 -116.48 127.35 54.49 Favored 'General case' 0 C--O 1.276 2.465 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 167.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 73' ' ' LEU . 11.6 m-85 -80.36 155.31 27.24 Favored 'General case' 0 N--CA 1.524 3.254 0 O-C-N 127.942 3.276 . . . . 0.0 111.898 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.756 HD12 ' HA3' ' A' ' 34' ' ' GLY . 4.3 mp -84.33 145.72 28.1 Favored 'General case' 0 C--O 1.177 -2.755 0 C-N-CA 117.391 -1.724 . . . . 0.0 107.929 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.7 mt-30 -142.37 149.25 39.14 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 29' ' ' PHE . 33.1 mm -71.35 112.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 18.5 tptm -65.87 -35.03 79.52 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.516 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.5 t 160.69 172.97 0.01 OUTLIER 'General case' 0 C--N 1.357 0.926 0 O-C-N 125.271 1.607 . . . . 0.0 110.297 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.494 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.6 pp -138.55 148.53 44.32 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.541 0.686 . . . . 0.0 111.705 -173.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.9 119.06 28.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 53' ' ' ALA 0.26 1.1 pt? -69.44 -4.4 18.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.04 -27.13 48.72 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.196 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.437 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.08 171.11 36.82 Favored Glycine 0 N--CA 1.417 -2.62 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.754 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 8.8 Cg_endo -52.54 -32.23 52.55 Favored 'Trans proline' 0 C--O 1.204 -1.179 1 C-N-CA 125.328 4.018 . . . . 0.0 113.871 -173.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.76 -48.65 79.04 Favored 'General case' 0 C--O 1.273 2.333 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.65 -32.94 53.57 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.997 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 6.0 mp -68.21 -40.59 82.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' OD2' ' HD2' ' A' ' 57' ' ' LYS . 33.2 t70 -68.52 -30.02 68.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.75 6.56 87.09 Favored Glycine 0 CA--C 1.493 -1.294 0 CA-C-N 112.423 -2.171 . . . . 0.0 114.113 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 54.0 mttm -98.17 -25.2 14.98 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.6 ttm -96.24 140.63 30.65 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.259 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.54 153.0 50.29 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.771 0.795 . . . . 0.0 110.18 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 45' ' ' SER . 81.6 p -67.03 114.66 5.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.918 1.287 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.26 -20.87 15.88 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 121.961 -0.462 . . . . 0.0 112.41 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 9.2 m-20 -60.45 136.42 58.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -87.32 125.7 41.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.345 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 17.5 mm -73.74 125.15 32.4 Favored 'Isoleucine or valine' 1 C--O 1.307 4.105 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 8' ' ' PRO . 48.4 t -114.42 -34.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.481 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 68.6 m -150.55 153.36 35.64 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.154 -0.966 . . . . 0.0 112.231 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG11 HG21 ' A' ' 83' ' ' ILE . 7.3 p -131.03 127.31 60.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m120 63.25 20.14 12.09 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.647 0.203 . . . . 0.0 110.544 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 79.07 -1.02 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.95 1.7 . . . . 0.0 111.965 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.3 m -85.83 123.17 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.452 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 28.2 t -62.71 109.42 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.782 HG22 HG12 ' A' ' 80' ' ' VAL . 3.6 p -120.54 18.16 6.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.569 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.602 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.7 tp -59.59 113.41 2.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.93 43.71 0.14 Allowed Glycine 0 C--N 1.37 2.471 0 O-C-N 125.355 1.659 . . . . 0.0 112.174 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.495 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t-160 -45.11 -65.94 0.47 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 75' ' ' HIS . 12.8 p -165.79 142.42 5.32 Favored 'General case' 0 C--N 1.264 -3.132 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 152.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.642 ' CE1' ' HA ' ' A' ' 32' ' ' VAL . 1.7 t60 -50.69 -31.52 16.67 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 120.119 1.327 . . . . 0.0 111.351 171.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.19 85.61 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 122.156 -0.34 . . . . 0.0 110.8 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -64.16 -40.99 97.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.782 HG12 HG22 ' A' ' 72' ' ' VAL . 12.6 m -63.44 -45.65 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.825 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.4 t -65.55 -40.07 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.4 -39.18 89.75 Favored 'General case' 0 C--O 1.199 -1.6 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.76 177.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.635 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.3 mm -67.0 -34.63 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.652 0.739 . . . . 0.0 112.026 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -75.1 -29.39 60.58 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.446 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -76.59 -19.91 57.35 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.105 0.962 . . . . 0.0 111.105 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 75.1 m -75.25 -37.72 60.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.018 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.5 mt -78.65 135.58 60.06 Favored Pre-proline 0 N--CA 1.421 -1.923 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.057 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.5 Cg_endo -90.9 161.94 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.455 2.77 . . . . 0.0 112.926 -173.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.538 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 20.8 mm -63.45 132.51 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 121.519 0.676 . . . . 0.0 111.452 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.12 53.21 Favored Glycine 0 C--N 1.294 -1.782 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.918 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.35 -170.27 1.84 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 122.484 0.314 . . . . 0.0 110.242 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 11.1 m -151.22 157.78 43.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.809 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -145.22 125.07 6.51 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.965 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.515 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 11.3 m-20 -77.52 104.18 7.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.77 142.22 33.43 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 124.607 1.163 . . . . 0.0 110.579 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -101.84 125.72 48.57 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 84.8 mt -115.36 152.9 31.98 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.331 1.452 . . . . 0.0 110.957 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.66 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 6.5 t -125.78 107.81 10.88 Favored 'General case' 0 C--O 1.188 -2.168 0 C-N-CA 124.202 1.001 . . . . 0.0 110.016 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.462 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 35.3 ttm180 -93.37 118.95 31.92 Favored 'General case' 0 C--N 1.254 -3.569 0 O-C-N 120.341 -1.474 . . . . 0.0 109.045 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.54 -30.49 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.04 133.0 25.84 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 C--O 1.244 0.799 0 C-N-CA 123.35 2.7 . . . . 0.0 111.63 -178.704 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 CA-C-O 121.372 0.488 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -98.28 105.88 18.08 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.603 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.9 t80 -95.79 139.79 31.51 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.748 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -148.82 14.61 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.297 0.57 . . . . 0.0 111.416 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.524 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.2 mtm180 55.11 -0.1 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.848 2.059 . . . . 0.0 115.934 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -134.13 123.49 16.84 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.526 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.3 Cg_endo -60.0 -22.7 70.23 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.845 3.03 . . . . 0.0 112.83 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -77.95 -29.8 50.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -87.2 -30.18 21.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.534 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 45.4 tp -81.06 160.4 24.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.684 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 49.5 mtmt -102.84 -179.26 3.91 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.625 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 105.27 168.52 23.9 Favored Glycine 0 C--N 1.281 -2.481 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -175.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -90.57 119.79 31.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 99.2 m-85 -98.5 114.62 27.09 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-O 121.92 0.867 . . . . 0.0 109.849 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.44 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 62.0 mt -117.73 136.01 56.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 CA-C-N 113.87 -1.513 . . . . 0.0 110.284 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.9 t-80 -105.95 113.99 27.86 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.261 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 t -139.96 133.5 30.21 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-O 122.073 0.94 . . . . 0.0 111.65 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.767 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -88.03 127.25 35.39 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.151 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -107.91 118.57 37.09 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 43.0 ttp180 -78.47 107.75 11.35 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.4 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.724 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 72.0 tttt -63.86 97.32 0.16 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 168.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -85.06 -155.41 0.21 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.86 -39.86 90.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -84.96 -13.35 50.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.33 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.724 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 91.2 -121.96 6.53 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.507 ' HD1' HD12 ' A' ' 20' ' ' LEU . 39.7 m-85 -93.39 145.04 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.655 0.727 . . . . 0.0 109.85 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.66 -0.18 72.87 Favored Glycine 0 C--O 1.214 -1.131 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.861 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.548 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.7 p90 -108.28 163.52 13.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.391 0.615 . . . . 0.0 110.646 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.476 ' OG1' ' HE2' ' A' ' 44' ' ' LYS . 46.5 p -121.46 151.02 40.7 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.63 141.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.976 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 33' ' ' GLY . 11.5 p -149.75 167.0 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.474 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 127.19 -64.45 0.59 Allowed Glycine 0 CA--C 1.474 -2.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.402 173.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -71.53 60.52 1.2 Allowed Glycine 1 CA--C 1.41 -6.474 0 C-N-CA 126.951 2.215 . . . . 0.0 116.236 -169.289 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -22.0 66.55 Favored 'General case' 0 C--N 1.245 -3.97 0 O-C-N 124.669 0.864 . . . . 0.0 109.739 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.455 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 10.0 pt-20 -154.27 165.33 18.22 Favored Pre-proline 0 CA--C 1.456 -2.649 0 C-N-CA 116.1 -2.24 . . . . 0.0 111.21 -171.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -68.1 55.65 0.76 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.829 2.352 . . . . 0.0 109.796 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -178.05 -20.71 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.703 -1.589 . . . . 0.0 109.886 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.746 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 13.4 mm-40 -114.79 128.46 56.31 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.477 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.25 7.5 m-30 -79.41 157.23 27.62 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 128.78 3.8 . . . . 0.0 111.773 -179.185 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -88.63 149.51 23.5 Favored 'General case' 0 C--O 1.189 -2.081 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 9.7 mt-30 -145.31 153.32 41.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 29' ' ' PHE . 21.0 mm -69.91 110.51 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HE2' ' OG1' ' A' ' 30' ' ' THR . 3.8 tmmm? -65.01 -33.88 77.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.562 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.1 t 162.03 172.64 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 O-C-N 124.975 1.422 . . . . 0.0 109.775 173.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -136.24 144.55 44.9 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 121.785 0.802 . . . . 0.0 109.947 -174.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 49' ' ' ASP . 11.0 t -78.38 126.3 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mp -68.92 -4.2 15.65 Favored 'General case' 1 N--CA 1.377 -4.112 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.307 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.506 ' H ' HG12 ' A' ' 47' ' ' VAL . 20.5 t70 -97.55 -21.4 17.11 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.595 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.19 167.73 34.59 Favored Glycine 0 N--CA 1.404 -3.447 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.494 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.6 Cg_endo -53.65 -31.23 59.27 Favored 'Trans proline' 0 C--O 1.187 -2.046 0 C-N-CA 124.731 3.62 . . . . 0.0 113.037 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.66 76.37 Favored 'General case' 0 C--O 1.264 1.85 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.12 -34.32 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.098 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.23 -38.22 69.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.352 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -73.07 -18.24 61.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 122.273 1.035 . . . . 0.0 108.504 175.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.01 32.59 82.7 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 113.251 -1.795 . . . . 0.0 113.836 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 36.4 mtmt -124.25 -0.72 8.25 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.646 ' HB3' HD22 ' A' ' 46' ' ' LEU . 28.1 mtt -112.71 141.87 45.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.847 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -135.9 149.89 49.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 45' ' ' SER . 32.5 p -63.17 114.64 3.88 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.763 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.82 -14.34 19.7 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.475 176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.1 m-20 -61.73 132.33 52.82 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -81.8 129.47 37.44 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.686 0 CA-C-N 118.607 0.64 . . . . 0.0 112.32 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 38.5 mm -79.53 127.58 39.07 Favored 'Isoleucine or valine' 1 C--O 1.322 4.918 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 173.408 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 73' ' ' LEU . 40.2 t -115.86 -47.44 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 O-C-N 127.085 2.741 . . . . 0.0 111.873 -176.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' A' ' 72' ' ' VAL . 50.1 m -140.88 165.17 28.26 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 117.995 -1.482 . . . . 0.0 113.767 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.668 HG23 HG11 ' A' ' 72' ' ' VAL . 40.0 t -138.07 120.66 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 C-N-CA 124.855 1.262 . . . . 0.0 108.175 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 67.21 -79.34 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.468 1.105 . . . . 0.0 110.154 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -158.15 24.88 0.25 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.336 1.065 . . . . 0.0 109.655 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.8 m -117.19 123.84 47.65 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 t -68.07 108.01 2.94 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 80' ' ' VAL . 1.7 p -111.99 16.82 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 122.13 0.967 . . . . 0.0 108.606 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.603 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.7 tp -60.89 112.84 2.21 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.23 45.51 0.13 Allowed Glycine 0 C--N 1.378 2.874 0 O-C-N 125.754 1.909 . . . . 0.0 111.664 -170.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 76' ' ' THR . 7.0 t-160 -48.41 -66.98 0.31 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' HIS . 8.6 p -166.62 142.64 4.6 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 151.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.594 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.5 -31.61 15.92 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 120.288 1.404 . . . . 0.0 111.516 173.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -48.31 82.24 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 122.116 -0.365 . . . . 0.0 110.723 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.417 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 11.9 mm-40 -61.81 -44.08 97.57 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 122.938 0.495 . . . . 0.0 112.091 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.701 HG21 HD21 ' A' ' 41' ' ' LEU . 9.7 m -64.26 -44.31 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.63 -42.77 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -67.07 -29.15 68.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.383 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 86' ' ' SER . 2.1 mm -68.94 -40.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 123.117 0.567 . . . . 0.0 111.748 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.33 -33.96 67.71 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -73.27 -19.49 61.05 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.368 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 30.1 t -77.44 -43.17 33.4 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 mt -69.06 133.79 89.77 Favored Pre-proline 0 N--CA 1.423 -1.81 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.767 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.8 Cg_endo -89.56 161.84 5.34 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.163 2.576 . . . . 0.0 113.197 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.6 mm -60.83 132.49 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.833 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 12.19 55.96 Favored Glycine 0 C--N 1.288 -2.123 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.834 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.418 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.73 -172.13 2.1 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 19.8 m -151.17 156.87 41.86 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.77 -0.581 . . . . 0.0 109.614 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -143.43 125.49 11.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.672 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.597 -175.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.535 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 17.3 m-20 -78.42 108.26 11.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 67' ' ' VAL . 72.6 mt -108.45 136.03 48.75 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.443 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -91.58 124.65 35.91 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 10.7 mt -107.56 160.06 15.96 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.625 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 14.7 t -131.65 108.0 9.2 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 123.726 0.81 . . . . 0.0 108.993 174.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -96.89 147.12 24.29 Favored 'General case' 0 C--N 1.247 -3.853 0 O-C-N 120.706 -1.246 . . . . 0.0 109.904 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.04 -17.49 4.58 Favored Glycine 0 CA--C 1.482 -1.988 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.91 130.51 28.63 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 C--O 1.243 0.745 0 C-N-CA 123.551 2.834 . . . . 0.0 112.546 -174.032 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 CA--C 1.545 1.039 0 CA-C-O 121.071 0.363 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -73.79 104.25 4.62 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.585 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.4 t80 -105.46 128.61 53.64 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.277 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -144.24 20.35 1.74 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.105 0.955 . . . . 0.0 109.835 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.484 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 15.2 mtm180 57.48 -14.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 127.479 2.312 . . . . 0.0 116.374 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.8 t-20 -112.59 117.03 47.55 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.728 -0.607 . . . . 0.0 110.97 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 6.9 Cg_endo -53.22 -25.51 30.36 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.232 3.288 . . . . 0.0 113.37 174.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -71.61 -27.43 63.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -91.17 -21.24 21.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.512 HD11 HD21 ' A' ' 73' ' ' LEU . 24.5 mt -78.04 175.66 9.89 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.858 0.837 . . . . 0.0 110.641 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -105.11 -167.59 1.36 Allowed 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.72 175.01 45.76 Favored Glycine 0 C--N 1.284 -2.334 0 C-N-CA 119.315 -1.422 . . . . 0.0 112.155 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 4.0 tmmm? -113.62 148.56 36.03 Favored 'General case' 0 C--O 1.194 -1.849 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.2 m-85 -123.6 117.76 25.78 Favored 'General case' 0 CA--C 1.463 -2.387 0 CA-C-O 121.784 0.802 . . . . 0.0 110.807 -165.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.49 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 2.2 mp -111.75 138.1 41.8 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.786 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -102.67 118.67 37.36 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 7.9 t -129.26 157.93 40.49 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.345 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.795 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -129.46 122.05 28.53 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.527 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.69 117.42 34.05 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.085 -176.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 19.2 tpp85 -72.38 106.69 4.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.6 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.72 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 67.9 tttt -66.79 96.97 0.44 Allowed 'General case' 0 C--O 1.171 -3.026 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 166.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 89' ' ' ILE . 21.4 t -85.01 -155.43 0.21 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -56.53 -41.03 76.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.931 0.332 . . . . 0.0 111.371 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -86.09 -20.65 28.42 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.795 0.807 . . . . 0.0 109.82 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.72 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 103.52 -122.35 7.41 Favored Glycine 1 N--CA 1.388 -4.556 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.527 ' HD1' HD12 ' A' ' 20' ' ' LEU . 46.0 m-85 -88.09 142.57 27.67 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 117.214 0.507 . . . . 0.0 110.328 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.47 9.34 74.23 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.139 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.472 ' HB2' HG23 ' A' ' 43' ' ' ILE . 6.3 p90 -122.11 162.98 20.28 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.04 0.447 . . . . 0.0 109.939 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.4 p -116.85 155.19 29.44 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 41' ' ' LEU . 6.1 t -134.48 140.21 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.103 -175.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.8 p -153.15 157.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.03 171.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 116.3 0.11 20.62 Favored Glycine 1 CA--C 1.441 -4.537 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 169.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.831 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -120.73 46.01 1.17 Allowed Glycine 1 CA--C 1.395 -7.438 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.096 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.57 -25.3 64.45 Favored 'General case' 0 C--N 1.264 -3.127 0 CA-C-N 113.228 -1.486 . . . . 0.0 111.498 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt-20 -155.98 167.61 13.95 Favored Pre-proline 0 CA--C 1.463 -2.388 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.843 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -65.28 55.31 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.933 2.422 . . . . 0.0 111.084 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 14.8 t70 178.37 -12.91 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 -175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.713 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 62.7 mt-10 -117.83 123.94 47.15 Favored 'General case' 0 C--O 1.265 1.904 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.301 7.2 m-30 -79.22 156.12 28.29 Favored 'General case' 1 N--CA 1.554 4.755 0 O-C-N 127.687 3.117 . . . . 0.0 112.329 -175.233 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.831 HD12 ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -86.88 142.46 28.02 Favored 'General case' 0 CA--C 1.46 -2.498 0 C-N-CA 115.948 -2.301 . . . . 0.0 107.748 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 48.6 mt-30 -139.88 151.2 45.45 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.487 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 21.5 mm -70.82 112.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.623 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 40.2 ttmt -59.66 -41.69 91.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.591 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.4 t 163.56 173.6 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 O-C-N 125.224 1.577 . . . . 0.0 109.801 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.68 152.38 45.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.95 0.881 . . . . 0.0 113.297 -172.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 49' ' ' ASP . 21.1 t -87.58 129.55 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.028 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.26 -4.2 16.9 Favored 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 112.509 -2.132 . . . . 0.0 112.325 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.576 ' H ' HG12 ' A' ' 47' ' ' VAL . 10.3 t70 -99.32 -20.11 16.7 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.097 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.3 155.9 26.57 Favored Glycine 1 N--CA 1.393 -4.182 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.72 -171.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 11.6 Cg_endo -52.29 -26.66 27.92 Favored 'Trans proline' 0 C--O 1.198 -1.485 0 C-N-CA 125.009 3.806 . . . . 0.0 113.156 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.08 -46.72 85.0 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.114 0.483 . . . . 0.0 111.728 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.17 -36.65 54.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.404 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 8.3 mp -71.56 -36.93 71.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.052 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.51 -15.51 60.39 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.26 41.07 99.73 Favored Glycine 0 CA--C 1.49 -1.507 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.913 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -129.05 -23.88 2.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.281 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.428 ' SD ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -94.95 142.17 27.8 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.172 177.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.01 151.49 52.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -59.0 114.7 2.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.007 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 112.69 -11.83 25.38 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.238 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 9.7 m-20 -59.94 132.85 55.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 117.645 0.723 . . . . 0.0 109.56 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -86.94 119.3 34.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.2 mm -70.9 123.02 24.06 Favored 'Isoleucine or valine' 1 C--O 1.316 4.56 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 73' ' ' LEU . 40.0 t -114.42 -33.83 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-N 111.36 -2.654 . . . . 0.0 110.258 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -150.0 162.05 41.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.52 HG12 ' HB ' ' A' ' 72' ' ' VAL . 6.6 p -145.31 133.43 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 56.56 31.51 19.19 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.915 0.325 . . . . 0.0 111.828 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.66 15.9 10.25 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.592 1.157 . . . . 0.0 112.861 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -108.38 129.71 55.24 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.47 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 20.3 t -68.72 112.72 5.63 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.736 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -117.64 17.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.62 -175.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.585 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 32.1 tp -58.89 113.3 2.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 45.12 0.18 Allowed Glycine 0 N--CA 1.499 2.879 0 O-C-N 125.381 1.676 . . . . 0.0 111.801 -171.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 76' ' ' THR . 7.5 t-160 -47.78 -66.48 0.4 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.3 p -167.1 143.19 4.31 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 151.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.578 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -50.33 -31.77 15.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 119.987 1.267 . . . . 0.0 110.536 171.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.22 77.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.941 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.442 ' HG2' ' OG1' ' A' ' 76' ' ' THR . 71.0 mm-40 -64.67 -40.42 95.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.805 HG21 HD21 ' A' ' 41' ' ' LEU . 13.5 m -65.56 -45.7 91.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.053 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 77' ' ' HIS . 88.0 t -65.69 -37.46 80.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.2 tmtm? -58.26 -45.61 87.5 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.627 175.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.678 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.05 -36.8 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.386 0.613 . . . . 0.0 112.387 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -74.73 -31.36 61.81 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -69.31 -32.12 71.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.163 0.985 . . . . 0.0 110.768 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.2 m -69.58 -37.99 77.17 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.851 1.26 . . . . 0.0 110.122 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.48 HG22 ' HD3' ' A' ' 22' ' ' LYS . 21.8 mt -77.63 133.12 67.26 Favored Pre-proline 0 N--CA 1.411 -2.417 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.182 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.1 Cg_endo -88.66 162.73 6.4 Favored 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 123.611 2.874 . . . . 0.0 112.864 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.531 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.92 135.0 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 121.212 0.529 . . . . 0.0 110.534 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.08 58.83 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.57 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.607 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -100.94 179.61 4.34 Favored 'General case' 0 C--O 1.187 -2.184 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.495 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 6.2 m -140.66 163.71 32.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -150.39 125.52 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.337 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' THR . 4.3 m-20 -82.72 106.46 14.58 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.047 0.927 . . . . 0.0 109.548 174.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.4 mt -108.29 159.06 16.93 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 126.52 1.928 . . . . 0.0 108.852 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -116.89 123.64 47.5 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 81.2 mt -106.87 160.86 15.19 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.825 1.25 . . . . 0.0 109.793 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.634 ' HB3' HG13 ' A' ' 63' ' ' VAL . 16.0 t -135.36 111.0 9.23 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.422 1.106 . . . . 0.0 110.796 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.496 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 19.4 tpp85 -89.99 112.99 24.57 Favored 'General case' 0 C--N 1.266 -3.063 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.4 -26.57 0.31 Allowed Glycine 0 C--N 1.292 -1.879 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.912 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.61 129.69 35.68 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.665 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo . . . . . 0 C--O 1.241 0.632 0 C-N-CA 123.927 3.085 . . . . 0.0 113.785 -173.919 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 39' ' ' GLU . 6.0 Cg_endo . . . . . 0 N--CA 1.439 -1.734 0 CA-C-O 121.005 0.336 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.34 105.12 2.44 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.554 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 5.1 t80 -107.56 135.36 49.14 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -144.17 17.98 1.74 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.111 0.958 . . . . 0.0 110.316 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.501 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 21.4 mtt180 59.4 -27.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.408 2.683 . . . . 0.0 116.57 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 50.3 t-20 -104.65 123.38 40.42 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.2 Cg_exo -54.84 -29.73 64.62 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 C-N-CA 123.737 2.958 . . . . 0.0 112.246 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.75 -26.17 63.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -92.2 -24.32 19.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -86.65 153.74 21.53 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.497 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.508 ' N ' HD13 ' A' ' 11' ' ' LEU . 46.6 mtmt -110.2 133.47 53.2 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 122.066 0.936 . . . . 0.0 110.697 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.515 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 156.83 170.6 22.02 Favored Glycine 1 C--N 1.247 -4.378 0 CA-C-N 113.048 -1.887 . . . . 0.0 108.999 -173.445 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 37.9 tptt -89.54 117.55 28.52 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.877 0.838 . . . . 0.0 109.825 174.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.3 m-85 -101.98 113.98 27.69 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.93 0.872 . . . . 0.0 109.77 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.6 mt -118.74 131.22 72.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.638 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -107.67 108.29 19.47 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -174.006 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -133.77 145.62 49.97 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 122.09 0.947 . . . . 0.0 111.271 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -87.96 130.84 34.82 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.149 177.466 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -109.66 117.38 33.77 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 40.8 ttt180 -77.12 111.94 13.25 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.087 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.668 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.6 tttt -66.96 96.83 0.45 Allowed 'General case' 0 C--O 1.187 -2.235 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -94.62 -154.26 0.41 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 124.322 1.049 . . . . 0.0 109.107 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -47.84 -41.97 25.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.894 1.278 . . . . 0.0 111.716 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.688 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.5 mmp_? -105.53 10.41 33.14 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.827 -0.546 . . . . 0.0 111.717 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.668 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 82.34 -125.3 6.88 Favored Glycine 1 N--CA 1.384 -4.769 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.0 m-85 -86.02 145.98 26.85 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.765 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.83 -2.93 86.2 Favored Glycine 0 CA--C 1.499 -0.945 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.336 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.543 ' HB2' HG23 ' A' ' 43' ' ' ILE . 20.9 p90 -109.93 162.9 14.06 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.893 0.854 . . . . 0.0 111.488 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.2 p -118.43 145.96 44.82 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG21 HD23 ' A' ' 41' ' ' LEU . 7.2 p -134.67 146.81 30.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.896 -173.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -144.38 165.92 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.873 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.371 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 114.29 -141.39 16.96 Favored Glycine 1 N--CA 1.394 -4.152 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 51.83 33.24 35.1 Favored Glycine 0 CA--C 1.471 -2.689 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.12 -27.95 67.75 Favored 'General case' 0 CA--C 1.455 -2.697 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -170.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 6.6 pt-20 -161.64 166.76 14.13 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.431 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 23.2 Cg_endo -66.63 58.88 0.52 Allowed 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.605 2.204 . . . . 0.0 109.353 169.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 21.7 t70 173.44 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.716 1.606 . . . . 0.0 110.661 -171.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 22.6 mt-10 -124.28 127.98 48.46 Favored 'General case' 0 C--O 1.269 2.127 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.447 ' CE1' HD11 ' A' ' 73' ' ' LEU . 8.6 m-30 -77.1 158.49 30.44 Favored 'General case' 0 N--CA 1.518 2.934 0 O-C-N 128.959 3.912 . . . . 0.0 113.258 -167.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 80' ' ' VAL . 7.1 mp -89.2 144.69 25.92 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 172.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.0 mt-30 -143.97 151.76 40.18 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 29' ' ' PHE . 22.2 mm -69.69 112.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.53 -39.18 72.94 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.485 ' HA ' HG22 ' A' ' 60' ' ' THR . 43.0 t 161.23 173.33 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.638 1.836 . . . . 0.0 108.666 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -135.86 148.18 48.53 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-O 121.644 0.735 . . . . 0.0 112.209 -175.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ASP . 43.3 t -83.94 121.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.214 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 6.2 mp -63.44 -3.48 2.1 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.583 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . 12.3 t70 -90.94 -30.7 16.71 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 124.594 1.158 . . . . 0.0 108.889 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -94.64 174.38 33.23 Favored Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 115.354 -168.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -52.35 -34.73 61.86 Favored 'Trans proline' 0 C--O 1.2 -1.389 1 C-N-CA 125.453 4.102 . . . . 0.0 113.815 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -58.03 -48.1 81.1 Favored 'General case' 0 C--O 1.264 1.843 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.78 -37.77 48.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.585 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -69.49 -36.64 76.72 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.198 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.71 -18.52 61.52 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.648 1.213 . . . . 0.0 108.112 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.23 35.23 91.35 Favored Glycine 0 CA--C 1.491 -1.449 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.227 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -115.69 -48.2 2.78 Favored 'General case' 0 N--CA 1.402 -2.867 0 C-N-CA 123.099 0.56 . . . . 0.0 112.479 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.57 151.37 19.38 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -149.68 147.47 28.12 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-O 122.01 0.909 . . . . 0.0 111.673 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 45' ' ' SER . 81.9 p -52.69 105.28 0.11 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.168 1.387 . . . . 0.0 112.346 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.06 -12.89 16.98 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-O 118.629 -1.095 . . . . 0.0 113.187 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.66 143.33 58.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.625 -1.23 . . . . 0.0 107.846 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -90.85 117.42 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 28.0 mm -69.87 125.08 27.27 Favored 'Isoleucine or valine' 1 C--O 1.327 5.163 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 73' ' ' LEU . 46.3 t -115.77 -37.33 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 111.136 -2.756 . . . . 0.0 112.197 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.9 m -149.89 157.28 43.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.381 -1.45 . . . . 0.0 112.617 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.677 HG23 HG11 ' A' ' 72' ' ' VAL . 77.0 t -134.37 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m120 57.89 31.52 20.67 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.808 0.692 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 72.63 1.74 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.621 1.968 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.8 m -89.65 122.2 32.55 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.42 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.2 t -65.5 108.89 2.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.172 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 80' ' ' VAL . 1.4 p -114.68 14.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.605 -175.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.554 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.6 tp -58.67 113.72 2.16 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.04 46.39 0.1 Allowed Glycine 0 C--N 1.378 2.864 0 O-C-N 125.857 1.973 . . . . 0.0 112.228 -170.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.492 ' O ' HG23 ' A' ' 76' ' ' THR . 6.6 t-160 -48.03 -67.35 0.28 Allowed 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 75' ' ' HIS . 14.2 p -165.98 143.22 5.4 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 152.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.562 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.4 t-80 -53.43 -31.26 44.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 120.664 1.574 . . . . 0.0 111.463 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.23 90.58 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.99 -0.444 . . . . 0.0 110.516 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.5 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 14.5 mm100 -64.19 -44.0 93.34 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 41' ' ' LEU . 11.2 m -62.19 -41.81 92.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.242 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.07 -38.83 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -63.05 -33.54 75.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.291 176.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 86' ' ' SER . 32.9 mt -67.63 -42.21 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.491 0.662 . . . . 0.0 111.104 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.56 -30.72 67.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.187 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -71.24 -33.16 69.58 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.18 0.992 . . . . 0.0 110.209 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 31.0 t -65.26 -49.07 70.99 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.139 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 12.0 mt -64.88 133.75 95.84 Favored Pre-proline 0 N--CA 1.426 -1.674 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.537 175.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.0 Cg_endo -90.75 162.33 4.15 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 123.563 2.842 . . . . 0.0 113.119 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.547 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.4 mm -62.66 134.76 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-O 121.058 0.456 . . . . 0.0 110.28 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.74 56.68 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.0 -169.14 1.64 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -176.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.618 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 27.1 m -151.34 163.85 38.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.818 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -148.41 124.71 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.085 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.503 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.66 104.99 13.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 63.2 mt -108.27 152.33 24.75 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 125.28 1.432 . . . . 0.0 111.94 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -104.17 119.48 39.04 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.5 mp -111.37 164.49 12.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.305 1.442 . . . . 0.0 108.559 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.564 ' HB3' HG13 ' A' ' 63' ' ' VAL . 38.9 t -145.23 111.69 5.74 Favored 'General case' 0 C--O 1.191 -1.991 0 CA-C-O 122.352 1.072 . . . . 0.0 112.931 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -99.4 120.06 38.99 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 120.957 -1.089 . . . . 0.0 111.202 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.4 -33.43 0.09 OUTLIER Glycine 0 CA--C 1.471 -2.677 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -96.1 141.83 23.71 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 CA--C 1.503 -1.066 0 C-N-CA 122.834 2.356 . . . . 0.0 110.171 179.292 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.724 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.95 -50.4 10.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.19 0.519 . . . . 0.0 110.495 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.0 mtt -110.15 57.51 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.315 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 152.53 -136.15 5.26 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.282 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? 47.94 71.57 1.55 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.934 1.294 . . . . 0.0 113.422 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.81 -164.49 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.606 2.204 . . . . 0.0 109.261 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -83.24 105.45 14.21 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 3.1 t80 -103.03 124.61 48.85 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -130.78 11.18 5.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.926 0.869 . . . . 0.0 111.577 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.604 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 40.2 mtt180 55.21 6.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.774 1.63 . . . . 0.0 114.955 173.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -133.91 121.76 16.05 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HB3' HG11 ' A' ' 65' ' ' VAL . 8.5 Cg_exo -59.27 -27.16 84.26 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 123.611 2.874 . . . . 0.0 112.307 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 m -80.02 -24.4 40.82 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.521 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.53 -28.03 15.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 44.2 tp -70.24 155.16 41.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.053 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 24.4 mtmm -90.02 -175.71 4.66 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.571 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 109.02 178.16 21.49 Favored Glycine 0 C--N 1.278 -2.662 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.729 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.7 ' HE2' ' H ' ' A' ' 99' ' ' ARG . 1.6 tmpt? -91.07 134.19 34.71 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 91.8 m-85 -122.84 128.26 50.14 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 119.061 0.846 . . . . 0.0 109.867 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.532 HG13 ' HE3' ' A' ' 14' ' ' LYS . 73.8 mt -137.73 127.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.3 t60 -104.49 104.73 14.63 Favored 'General case' 0 N--CA 1.396 -3.144 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -124.07 143.86 50.2 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.799 0.809 . . . . 0.0 110.853 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.4 ttmp? -88.35 126.38 35.17 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.14 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.572 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -108.18 117.33 33.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 42.3 ttt-85 -77.07 113.89 15.28 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.405 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.715 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.9 tttt -69.64 97.52 1.06 Allowed 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 89' ' ' ILE . 32.2 t -83.59 -155.21 0.17 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.675 1.19 . . . . 0.0 108.514 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -59.4 -40.93 88.21 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.501 0.667 . . . . 0.0 109.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.02 -20.85 34.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.804 0.812 . . . . 0.0 109.521 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.715 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 98.18 -120.53 6.83 Favored Glycine 1 N--CA 1.378 -5.232 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.7 m-85 -91.57 141.72 28.42 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.565 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.21 1.27 87.59 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.107 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.478 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.3 p90 -110.81 163.34 13.88 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.817 0.818 . . . . 0.0 112.161 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 63.0 p -123.2 152.87 40.81 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 77' ' ' HIS . 6.7 m -127.11 154.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.123 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.83 150.63 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.071 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.75 -138.74 13.89 Favored Glycine 1 N--CA 1.393 -4.175 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.61 28.9 31.03 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.1 -29.39 68.3 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -171.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt-20 -154.49 163.09 25.4 Favored Pre-proline 0 CA--C 1.456 -2.64 0 C-N-CA 118.025 -1.47 . . . . 0.0 109.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.0 Cg_endo -68.3 52.83 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.215 0 C-N-CA 123.076 2.517 . . . . 0.0 109.896 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 171.19 3.28 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.368 -168.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HG3' ' CG ' ' A' ' 36' ' ' GLU . 25.7 mt-10 -132.88 130.21 39.41 Favored 'General case' 0 C--O 1.275 2.44 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 163.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.606 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.256 5.2 m-30 -76.8 158.8 30.61 Favored 'General case' 0 N--CA 1.525 3.305 0 O-C-N 128.898 3.874 . . . . 0.0 114.008 -167.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 80' ' ' VAL . 4.8 mp -93.09 141.69 28.12 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.21 151.44 47.69 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 29' ' ' PHE . 33.1 mm -68.37 109.93 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 41.4 ttmt -58.36 -38.1 76.57 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.9 t 161.77 173.13 0.01 OUTLIER 'General case' 0 C--N 1.362 1.148 0 O-C-N 125.659 1.849 . . . . 0.0 109.825 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.552 HD22 ' HB1' ' A' ' 52' ' ' ALA . 1.5 pp -141.16 149.2 41.18 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.784 -173.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 49' ' ' ASP . 16.9 t -80.1 127.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.81 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.72 -3.69 1.66 Allowed 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 127.423 2.289 . . . . 0.0 113.567 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' H ' HG12 ' A' ' 47' ' ' VAL . 18.5 t70 -102.61 -25.56 13.53 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.492 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.425 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -85.69 162.93 36.41 Favored Glycine 0 N--CA 1.399 -3.822 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.908 -171.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.12 -33.51 35.57 Favored 'Trans proline' 0 C--O 1.188 -2.003 0 C-N-CA 125.006 3.804 . . . . 0.0 113.486 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.552 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.82 -48.7 78.98 Favored 'General case' 0 C--O 1.28 2.702 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HB2' HD13 ' A' ' 46' ' ' LEU . . . -77.33 -34.54 55.27 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.389 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -68.7 -42.5 77.67 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.977 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.717 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 34.7 t70 -64.16 -38.73 92.12 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.903 1.335 . . . . 0.0 107.483 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 -15.75 44.4 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 112.522 -2.126 . . . . 0.0 114.098 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.717 ' HB2' ' OD2' ' A' ' 55' ' ' ASP . 45.8 mtmt -79.14 -17.25 55.37 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.6 ttm -106.93 135.07 49.11 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.111 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.26 164.57 27.78 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.34 0.591 . . . . 0.0 109.903 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 45' ' ' SER . 77.7 p -63.08 118.26 7.62 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.354 1.062 . . . . 0.0 110.083 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 104.67 -5.76 44.0 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.125 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.692 ' OD2' ' HB2' ' A' ' 99' ' ' ARG . 3.0 m-20 -63.19 127.27 30.48 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.644 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -77.46 114.93 18.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 175.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 5.0 mm -67.8 122.11 18.33 Favored 'Isoleucine or valine' 1 C--O 1.331 5.369 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.563 HG13 HD13 ' A' ' 73' ' ' LEU . 61.9 t -114.11 -38.4 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 110.759 -2.928 . . . . 0.0 110.73 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.424 ' HA ' HG12 ' A' ' 72' ' ' VAL . 70.1 m -151.27 160.57 43.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.163 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 83' ' ' ILE . 3.6 p -140.59 127.92 22.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.44 31.98 18.01 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 t70 71.31 1.8 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.179 1.392 . . . . 0.0 111.956 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.2 m -88.84 123.92 33.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.4 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.0 t -67.58 104.76 1.67 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.675 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -113.76 17.14 7.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 40' ' ' PHE . 28.5 tp -59.69 112.95 2.0 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 29.72 45.85 0.09 OUTLIER Glycine 0 N--CA 1.499 2.859 0 O-C-N 125.269 1.606 . . . . 0.0 112.917 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 76' ' ' THR . 6.3 t-160 -47.98 -68.39 0.19 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 79' ' ' GLN . 22.1 p -166.16 143.98 5.48 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 151.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.524 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.9 t60 -51.61 -31.7 26.02 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 119.948 1.249 . . . . 0.0 110.519 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.01 83.12 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 121.971 -0.456 . . . . 0.0 110.72 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HG2' ' OG1' ' A' ' 76' ' ' THR . 55.3 mm-40 -64.91 -43.2 93.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 41' ' ' LEU . 15.8 m -60.16 -43.13 92.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.115 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 71.2 t -64.73 -41.98 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -57.24 -41.93 80.5 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.518 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.665 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 34.1 mt -67.18 -36.15 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 122.038 0.923 . . . . 0.0 111.686 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.87 -25.84 61.24 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.354 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 88.1 mt-30 -76.32 -24.33 54.31 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 67.6 m -73.75 -28.61 61.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.957 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.7 mt -92.78 133.84 28.57 Favored Pre-proline 0 N--CA 1.411 -2.407 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.556 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_endo -92.38 162.13 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.844 3.029 . . . . 0.0 113.393 -174.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.0 mm -62.72 131.86 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 CA-C-O 121.302 0.573 . . . . 0.0 111.072 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.64 12.17 51.45 Favored Glycine 0 C--N 1.294 -1.79 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.806 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.05 -171.24 2.01 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 14.8 m -151.27 157.48 42.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.4 125.54 6.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 C-N-CA 118.393 -1.323 . . . . 0.0 112.972 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 11.0 m-20 -78.7 107.38 11.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 71.1 mt -107.75 144.53 34.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.592 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -97.49 115.75 28.39 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 75.0 mt -113.07 123.76 51.02 Favored 'General case' 0 C--O 1.25 1.119 0 C-N-CA 124.82 1.248 . . . . 0.0 110.55 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -101.68 122.11 43.28 Favored 'General case' 0 C--O 1.154 -3.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.7 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 43.8 ttp180 -116.97 144.07 44.99 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 120.072 -1.642 . . . . 0.0 110.713 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.42 -19.27 3.4 Favored Glycine 0 C--N 1.287 -2.151 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -90.66 132.47 34.91 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.97 147.19 95.67 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 123.265 2.643 . . . . 0.0 112.396 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 9.8 mt -53.11 127.03 45.77 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.692 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 6.3 Cg_exo -69.56 -42.79 3.29 Favored 'Trans proline' 0 CA--C 1.485 -1.94 0 C-N-CA 123.497 2.798 . . . . 0.0 110.444 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.56 141.04 39.27 Favored 'General case' 0 N--CA 1.39 -3.429 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -127.36 85.82 60.06 Favored Pre-proline 0 N--CA 1.393 -3.275 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.335 -168.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -92.99 -54.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.265 1.977 . . . . 0.0 112.632 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.26 -5.9 59.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.973 0.892 . . . . 0.0 110.078 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 6.5 t70 -97.01 110.68 55.02 Favored Pre-proline 0 CA--C 1.469 -2.144 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.753 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 65.7 Cg_endo -75.31 -38.64 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.554 2.169 . . . . 0.0 111.008 -174.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 17.9 t30 -54.75 -7.62 0.18 Allowed 'General case' 0 C--N 1.264 -3.109 1 C-N-CA 133.146 4.578 . . . . 0.0 114.737 -167.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.3 p -92.79 -29.18 16.13 Favored 'General case' 0 N--CA 1.397 -3.116 0 CA-C-O 121.274 0.559 . . . . 0.0 112.094 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 p -152.41 -164.15 1.89 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.2 -171.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.08 157.02 0.93 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 110.634 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.326 12.2 p 53.35 66.73 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 123.448 1.594 . . . . 0.0 111.725 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.753 ' HA ' ' HB2' ' A' ' 110' ' ' PRO . 2.6 t -120.59 -176.65 3.28 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.38 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.491 ' HB2' HG12 ' A' ' 120' ' ' ILE . 69.7 m -56.38 145.6 26.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.29 1.436 . . . . 0.0 109.06 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.0 9.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 123.02 1.391 . . . . 0.0 110.683 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.18 5.65 35.08 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.049 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 117' ' ' SER . 49.7 mm -119.71 90.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 CA-C-N 112.988 -1.914 . . . . 0.0 106.823 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.0 mt -121.76 133.78 54.92 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.52 141.42 33.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -58.8 -22.04 57.56 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.148 0.979 . . . . 0.0 111.723 177.04 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.85 135.37 48.81 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 C--O 1.261 1.665 0 C-N-CA 123.774 2.982 . . . . 0.0 112.834 179.568 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.579 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -152.4 23.29 0.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.483 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 50.8 ttm -95.38 -46.54 6.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -98.9 -71.25 1.0 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 50.1 68.42 3.46 Favored Pre-proline 0 C--O 1.242 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 112.143 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -96.7 -168.83 0.13 Allowed 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 123.035 2.49 . . . . 0.0 111.25 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -83.88 104.76 14.23 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -116.67 124.96 51.01 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 t -134.42 19.58 3.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.48 0.657 . . . . 0.0 110.616 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.543 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 30.8 mtm180 54.32 5.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.431 1.892 . . . . 0.0 115.167 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 9' ' ' SER . 23.8 t-20 -133.35 123.77 17.84 Favored Pre-proline 0 C--N 1.298 -1.649 0 CA-C-O 120.963 0.411 . . . . 0.0 111.136 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HB3' HG11 ' A' ' 65' ' ' VAL . 14.8 Cg_endo -64.13 -12.59 33.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.887 3.725 . . . . 0.0 114.425 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.507 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 33.2 t -90.67 -36.75 14.18 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -74.39 -39.07 62.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.569 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 52.5 tp -73.03 158.77 34.77 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -119.31 -174.26 2.68 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.01 -131.55 7.29 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.263 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.746 ' HE2' ' H ' ' A' ' 99' ' ' ARG . 3.2 tmpt? -140.53 127.96 21.33 Favored 'General case' 0 C--N 1.257 -3.432 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.4 m-85 -122.63 123.31 40.87 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 118.666 0.666 . . . . 0.0 110.198 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.545 HG13 ' HE3' ' A' ' 14' ' ' LYS . 70.0 mt -132.05 131.66 61.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.899 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 94' ' ' ASP . 3.7 t60 -103.29 113.31 26.7 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -138.67 142.5 39.01 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.748 0.785 . . . . 0.0 110.55 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.812 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -87.58 133.44 33.8 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.053 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.571 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -108.47 117.57 34.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 21.2 ttt180 -77.43 110.54 12.28 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.695 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 66.2 tttt -65.76 96.78 0.3 Allowed 'General case' 0 C--O 1.19 -2.059 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 170.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -90.0 -154.79 0.34 Allowed 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.674 1.19 . . . . 0.0 108.927 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -57.06 -38.76 73.72 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.782 0.833 . . . . 0.0 110.495 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 mmp_? -90.45 -14.85 32.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 109.785 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 93.7 -115.47 4.97 Favored Glycine 1 N--CA 1.395 -4.058 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.571 ' HD1' HD12 ' A' ' 20' ' ' LEU . 38.6 m-85 -99.88 138.59 36.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 117.907 0.853 . . . . 0.0 109.095 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.08 80.73 Favored Glycine 0 C--O 1.207 -1.591 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.892 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.495 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.2 p90 -106.49 163.35 12.94 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.438 0.637 . . . . 0.0 111.162 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 73.6 p -125.96 146.12 50.0 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG11 HD23 ' A' ' 41' ' ' LEU . 12.3 m -123.03 148.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.933 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.96 154.59 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.689 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.95 -138.3 14.19 Favored Glycine 1 N--CA 1.386 -4.674 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.84 32.18 25.55 Favored Glycine 0 CA--C 1.47 -2.765 0 C-N-CA 123.559 0.6 . . . . 0.0 112.242 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -35.74 81.95 Favored 'General case' 0 CA--C 1.451 -2.855 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.17 165.47 18.51 Favored Pre-proline 0 CA--C 1.462 -2.441 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.293 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.3 Cg_endo -67.27 58.96 0.66 Allowed 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.766 2.311 . . . . 0.0 109.349 170.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.415 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 37.2 t70 174.4 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.393 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.1 mt-10 -128.91 127.42 41.74 Favored 'General case' 0 C--O 1.279 2.631 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CE1' HD11 ' A' ' 73' ' ' LEU . 7.0 m-30 -77.22 158.82 30.09 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 129.023 3.952 . . . . 0.0 113.694 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -92.22 143.0 26.87 Favored 'General case' 0 CA--C 1.46 -2.516 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.724 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.4 mt-30 -136.46 152.78 50.94 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 ' HB2' ' A' ' 29' ' ' PHE . 30.2 mm -71.83 108.93 3.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 39.5 ttpt -60.66 -36.99 80.08 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.507 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.9 t 161.14 173.41 0.01 OUTLIER 'General case' 0 C--N 1.372 1.573 0 O-C-N 125.711 1.882 . . . . 0.0 109.53 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -134.63 152.11 51.54 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.63 113.43 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.9 OUTLIER -69.35 -6.96 33.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.306 1.05 . . . . 0.0 113.101 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.72 -3.86 48.48 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.914 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -97.79 174.81 29.51 Favored Glycine 0 N--CA 1.423 -2.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.595 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.8 Cg_endo -57.54 -29.2 84.11 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 123.973 3.115 . . . . 0.0 113.404 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -59.0 -46.93 86.94 Favored 'General case' 0 C--O 1.268 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 111.95 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.14 -35.66 55.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.043 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 50' ' ' GLY . 9.3 mp -71.54 -34.62 70.17 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.23 -19.97 60.33 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.776 1.275 . . . . 0.0 107.637 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.36 31.74 81.78 Favored Glycine 0 CA--C 1.491 -1.459 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.922 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.28 -29.65 4.78 Favored 'General case' 0 N--CA 1.394 -3.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.3 ttm -101.19 139.76 36.43 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.539 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.14 156.58 46.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.91 0.862 . . . . 0.0 109.477 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 45' ' ' SER . 51.6 p -64.25 115.76 5.34 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 124.861 1.265 . . . . 0.0 109.601 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 117.61 -20.06 11.17 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.588 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.2 m-20 -58.96 135.85 57.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -87.32 117.89 32.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 C-N-CA 122.79 0.436 . . . . 0.0 111.392 175.052 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 4.3 mm -68.46 123.2 21.32 Favored 'Isoleucine or valine' 1 C--O 1.332 5.432 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 8' ' ' PRO . 46.4 t -115.6 -41.11 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 127.441 2.963 . . . . 0.0 111.793 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 66.4 m -147.04 161.84 40.01 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.17 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.491 HG12 ' HB ' ' A' ' 72' ' ' VAL . 7.2 p -137.49 134.58 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 65.68 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.718 0.636 . . . . 0.0 110.054 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -163.96 33.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.813 1.768 . . . . 0.0 108.008 169.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.8 m -123.74 128.94 50.3 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.787 -1.551 . . . . 0.0 107.762 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.564 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 t -71.29 121.44 18.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 80' ' ' VAL . 4.7 p -121.23 20.15 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.589 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.0 tp -60.24 113.09 2.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.45 44.81 0.09 OUTLIER Glycine 0 N--CA 1.503 3.119 0 O-C-N 125.632 1.832 . . . . 0.0 111.729 -171.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 76' ' ' THR . 7.1 t-160 -49.44 -65.62 0.53 Allowed 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.7 p -166.75 143.81 4.82 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 152.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.565 ' HA ' HG22 ' A' ' 80' ' ' VAL . 2.0 t60 -50.8 -34.21 26.67 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 119.904 1.229 . . . . 0.0 110.902 172.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.94 96.49 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 122.192 -0.317 . . . . 0.0 110.929 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 8.2 mm-40 -67.51 -41.39 84.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 41' ' ' LEU . 20.2 m -63.45 -45.88 96.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.96 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.96 -39.51 85.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.662 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -56.22 -43.14 78.28 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 123.445 0.465 . . . . 0.0 110.975 175.302 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.662 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.7 mm -65.16 -36.8 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.432 0.634 . . . . 0.0 112.265 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -75.45 -32.83 60.79 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.192 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -73.05 -21.75 60.74 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.337 1.055 . . . . 0.0 111.305 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.3 m -77.9 -35.19 51.01 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.34 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.6 mt -77.88 133.25 66.08 Favored Pre-proline 0 N--CA 1.417 -2.098 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.238 177.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 13.6 Cg_endo -90.18 161.74 4.73 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.114 2.543 . . . . 0.0 112.972 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.551 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.4 mm -62.76 133.17 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.128 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.98 54.13 Favored Glycine 0 C--N 1.296 -1.649 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.672 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.44 -172.41 2.25 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.7 m -151.1 153.63 35.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.5 125.53 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.127 0 C-N-CA 117.343 -1.743 . . . . 0.0 113.353 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 8.5 m-20 -78.85 105.2 10.0 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.44 146.61 34.22 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 124.279 1.031 . . . . 0.0 109.672 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -107.93 117.01 33.0 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.539 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 68.9 mt -107.48 134.36 50.63 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 125.626 1.57 . . . . 0.0 110.697 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 31.1 t -106.97 123.99 48.98 Favored 'General case' 0 C--O 1.164 -3.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.484 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.746 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 2.9 mtm180 -103.73 123.93 47.95 Favored 'General case' 0 C--N 1.259 -3.331 0 O-C-N 120.641 -1.287 . . . . 0.0 109.525 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.1 -23.5 0.17 Allowed Glycine 0 C--N 1.271 -3.039 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.609 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 38.6 m-85 -96.94 139.21 21.42 Favored Pre-proline 0 N--CA 1.431 -1.382 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.637 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 101' ' ' TYR . 20.6 Cg_exo -64.89 143.96 81.35 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.341 2.694 . . . . 0.0 112.587 -174.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.5 mt -51.63 123.57 23.83 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 124.466 1.106 . . . . 0.0 110.452 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 12.4 Cg_exo -70.52 -150.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.854 3.036 . . . . 0.0 113.144 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.415 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 54.4 t80 -68.15 131.43 45.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.549 1.166 . . . . 0.0 110.74 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -115.75 85.74 14.75 Favored Pre-proline 0 N--CA 1.395 -3.203 0 CA-C-N 112.287 -2.233 . . . . 0.0 109.595 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 72.9 Cg_endo -86.41 -58.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 122.298 1.999 . . . . 0.0 113.581 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.1 -7.05 27.28 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.516 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.54 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 6.3 t70 -75.86 121.34 84.86 Favored Pre-proline 0 CA--C 1.457 -2.62 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 117' ' ' SER . 20.7 Cg_endo -86.34 -28.63 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.282 1.988 . . . . 0.0 111.308 -173.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.54 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 21.2 t-20 -59.51 -8.81 2.05 Favored 'General case' 0 N--CA 1.4 -2.935 0 C-N-CA 130.139 3.375 . . . . 0.0 113.281 -169.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 79.1 p -93.07 -19.32 21.65 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.591 -171.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -85.18 153.84 22.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.26 120.3 16.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.522 0.201 . . . . 0.0 111.153 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.5 t 65.04 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.967 1.307 . . . . 0.0 109.985 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 110' ' ' PRO . 1.1 m -139.2 -168.51 2.46 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 110' ' ' PRO 0.303 42.6 p 69.46 115.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 125.891 1.676 . . . . 0.0 112.736 -176.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.3 t 61.65 27.03 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -171.69 111.96 0.32 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.055 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.1 mt -112.41 90.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -91.47 124.52 35.7 Favored 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.3 t70 78.6 134.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 O-C-N 125.463 1.727 . . . . 0.0 111.749 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.16 42.81 1.79 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.581 0.705 . . . . 0.0 109.929 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -77.19 145.72 73.49 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.356 0.95 0 C-N-CA 123.09 2.526 . . . . 0.0 111.5 174.731 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 63.2 -92.13 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.369 1.068 . . . . 0.0 109.911 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 64.7 mtt -133.48 20.35 3.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.429 0.633 . . . . 0.0 109.9 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 113.07 90.66 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.436 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.416 ' HG3' ' HG2' ' A' ' 39' ' ' GLU . 3.8 mppt? 61.56 96.84 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.574 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.56 -169.31 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.572 2.181 . . . . 0.0 108.737 170.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.01 103.81 4.63 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.5 t80 -111.29 128.98 56.11 Favored 'General case' 0 C--N 1.268 -2.94 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -139.46 13.45 2.56 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.226 0.536 . . . . 0.0 110.846 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.49 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtm180 55.25 6.47 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.139 1.776 . . . . 0.0 114.937 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -133.03 120.41 16.25 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HD3' ' SG ' ' A' ' 71' ' ' CYS . 23.8 Cg_exo -54.2 -32.49 70.82 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 124.472 3.448 . . . . 0.0 112.535 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -72.81 -21.93 60.89 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.59 0.709 . . . . 0.0 111.15 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -94.44 -25.94 16.69 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.571 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.43 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 42.4 tp -81.31 152.39 27.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.741 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -121.16 146.67 46.52 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.608 0.718 . . . . 0.0 110.151 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 158.35 -169.2 34.85 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -173.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.559 ' CE ' HG12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -103.76 108.66 20.07 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 118.401 1.1 . . . . 0.0 109.052 171.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 52.2 m-85 -90.04 120.22 31.05 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.941 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.559 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.7 mt -118.15 138.57 48.43 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.075 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -110.0 118.44 36.44 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -140.73 127.86 20.88 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.457 0.646 . . . . 0.0 112.678 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -88.51 126.41 35.24 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.428 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.531 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -107.64 119.75 40.3 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 13.3 ttp180 -79.29 106.35 11.26 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.723 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.724 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.8 tttt -62.71 97.52 0.1 Allowed 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 89' ' ' ILE . 37.3 t -81.69 -157.24 0.18 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 124.335 1.054 . . . . 0.0 108.798 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -63.35 -34.68 78.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.6 tmt_? -81.94 -20.71 38.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.724 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 87.58 -118.4 4.99 Favored Glycine 1 N--CA 1.391 -4.325 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.9 m-85 -94.56 144.14 25.83 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.888 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.23 3.28 63.99 Favored Glycine 0 C--O 1.203 -1.803 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.479 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.43 ' HB2' HG23 ' A' ' 43' ' ' ILE . 8.5 p90 -114.58 163.14 15.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.333 0.587 . . . . 0.0 110.358 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 55.9 p -122.71 148.65 45.06 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.505 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.7 m -121.87 143.76 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 CA-C-O 121.608 0.718 . . . . 0.0 111.113 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.66 148.5 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.083 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 118.4 -137.57 13.07 Favored Glycine 2 N--CA 1.381 -5.012 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.8 31.7 16.85 Favored Glycine 0 CA--C 1.467 -2.943 0 O-C-N 124.358 0.681 . . . . 0.0 111.528 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -70.14 -22.98 62.94 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.14 166.03 8.66 Favored Pre-proline 0 CA--C 1.463 -2.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 18.0 Cg_endo -66.56 58.18 0.5 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.389 2.06 . . . . 0.0 109.831 171.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 23.5 t70 177.08 -11.92 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.454 -171.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HG2' ' HG3' ' A' ' 1' ' ' LYS . 17.7 mt-10 -124.63 124.98 43.38 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 169.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.252 4.9 m-30 -76.78 159.26 30.27 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 131.044 3.738 . . . . 0.0 113.932 -169.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.864 HD21 HG21 ' A' ' 80' ' ' VAL . 8.0 mp -92.56 144.33 25.45 Favored 'General case' 0 C--O 1.183 -2.432 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.3 mt-30 -139.23 156.93 46.74 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG21 HD23 ' A' ' 46' ' ' LEU . 26.3 mm -72.42 111.45 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.261 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 36.8 ttpt -63.06 -40.97 99.29 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.559 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.8 t 165.15 174.4 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 125.148 1.53 . . . . 0.0 109.81 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 pp -142.64 147.61 36.05 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.94 0.876 . . . . 0.0 112.712 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 49' ' ' ASP . 44.3 t -69.0 116.39 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.984 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.724 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.89 -24.59 62.47 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.403 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.425 ' H ' HG12 ' A' ' 47' ' ' VAL . 9.9 m-20 -94.46 -2.51 51.69 Favored 'General case' 0 C--N 1.258 -3.373 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.656 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.411 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -99.65 170.46 23.12 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.505 -174.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.7 Cg_endo -56.77 -29.25 79.99 Favored 'Trans proline' 0 C--O 1.196 -1.586 0 C-N-CA 124.203 3.269 . . . . 0.0 113.312 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -62.42 -41.49 98.73 Favored 'General case' 0 C--O 1.269 2.112 0 CA-C-O 121.459 0.647 . . . . 0.0 111.479 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.46 47.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.77 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 50' ' ' GLY . 9.4 mp -70.48 -38.96 74.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.581 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.74 -24.91 62.71 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.85 74.03 Favored Glycine 0 CA--C 1.483 -1.923 0 CA-C-N 112.304 -2.225 . . . . 0.0 113.164 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -118.04 -2.04 11.32 Favored 'General case' 0 N--CA 1.385 -3.696 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.98 134.82 52.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.447 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.35 151.83 45.56 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.559 HG22 ' HA ' ' A' ' 45' ' ' SER . 76.2 p -64.91 110.22 2.37 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.378 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 124.31 -19.65 7.16 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-O 119.254 -0.748 . . . . 0.0 113.237 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 13.5 m-20 -61.33 132.23 52.89 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.005 0.902 . . . . 0.0 109.461 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.257 0.1 OUTLIER -82.38 120.54 34.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 177.528 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mm -71.86 123.09 25.53 Favored 'Isoleucine or valine' 1 C--O 1.333 5.488 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.534 HG13 HD13 ' A' ' 73' ' ' LEU . 52.8 t -115.56 -40.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 127.442 2.964 . . . . 0.0 111.28 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -146.25 162.14 38.73 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.319 -0.863 . . . . 0.0 112.906 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG23 HG11 ' A' ' 72' ' ' VAL . 52.7 t -139.82 126.54 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 C-N-CA 125.443 1.497 . . . . 0.0 107.197 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 m120 57.55 30.71 19.17 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.67 0.606 . . . . 0.0 110.947 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.9 t70 77.93 -8.12 1.72 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.043 1.337 . . . . 0.0 111.882 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.1 m -86.51 121.16 28.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.522 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 49.7 t -60.89 112.88 2.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.492 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -119.98 18.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.588 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.5 tp -60.52 112.42 1.97 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.17 39.05 0.06 OUTLIER Glycine 0 N--CA 1.504 3.233 0 O-C-N 125.007 1.442 . . . . 0.0 112.107 -171.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.518 ' O ' HG23 ' A' ' 76' ' ' THR . 7.1 t-160 -42.85 -64.34 0.64 Allowed 'General case' 0 C--N 1.373 1.604 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.3 p -166.99 142.99 4.34 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 150.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.573 ' HA ' HG22 ' A' ' 80' ' ' VAL . 2.5 t60 -51.57 -32.15 27.25 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 120.951 1.705 . . . . 0.0 110.889 173.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.33 77.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.811 0.338 . . . . 0.0 110.619 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -65.23 -40.79 94.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.864 HG21 HD21 ' A' ' 41' ' ' LEU . 11.0 m -63.65 -44.47 98.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.94 -40.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.663 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -56.73 -41.64 77.85 Favored 'General case' 0 C--O 1.196 -1.74 0 O-C-N 123.465 0.478 . . . . 0.0 110.835 175.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.663 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.5 mm -65.91 -36.05 76.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 0.0 112.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.39 -26.94 56.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.92 -30.05 61.15 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.179 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -66.29 -42.98 87.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.101 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.498 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.4 mt -76.22 131.88 74.46 Favored Pre-proline 0 N--CA 1.404 -2.769 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.683 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.0 Cg_endo -92.42 161.91 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.175 2.584 . . . . 0.0 112.92 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.562 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 26.8 mm -58.68 132.35 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.36 11.41 54.18 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.98 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.77 -169.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.4 m -151.62 157.44 42.16 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -147.3 124.94 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.601 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.5 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 10.2 m-20 -78.45 103.79 8.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.44 HD22 HG22 ' A' ' 67' ' ' VAL . 52.2 mt -100.01 148.95 23.97 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 125.092 1.357 . . . . 0.0 109.045 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 29.0 tt0 -111.18 119.13 37.91 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.75 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 96.1 mt -106.18 164.6 11.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.646 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 7.9 t -142.09 117.28 10.08 Favored 'General case' 0 C--O 1.18 -2.577 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -100.99 145.25 28.93 Favored 'General case' 0 C--N 1.261 -3.267 0 O-C-N 120.472 -1.393 . . . . 0.0 109.734 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.15 -27.93 1.55 Allowed Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -84.88 130.82 51.13 Favored Pre-proline 0 N--CA 1.427 -1.619 0 CA-C-O 121.051 0.453 . . . . 0.0 110.51 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.76 83.52 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 123.459 2.772 . . . . 0.0 114.208 -173.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.483 HD23 ' HD2' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -54.04 124.59 45.71 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.401 175.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.483 ' HD2' HD23 ' A' ' 103' ' ' LEU . 7.7 Cg_exo -72.64 -74.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.179 2.586 . . . . 0.0 110.825 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.5 134.24 33.69 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 65.9 t0 -128.18 100.01 24.01 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-O 122.06 0.933 . . . . 0.0 109.217 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -92.8 -31.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.259 2.64 . . . . 0.0 112.379 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -26.96 61.27 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.907 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 6.9 t70 -113.4 124.03 32.14 Favored Pre-proline 0 CA--C 1.448 -2.966 0 C-N-CA 118.167 -1.413 . . . . 0.0 107.323 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.539 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 67.0 Cg_endo -71.47 -35.64 7.86 Favored 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 122.364 2.043 . . . . 0.0 112.327 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.539 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 46.6 m-80 -62.99 6.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 126.644 1.978 . . . . 0.0 114.592 -165.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 110' ' ' PRO . 57.6 p -101.93 20.92 15.55 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-O 121.14 0.495 . . . . 0.0 111.961 -170.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 37.8 t -151.22 -175.3 5.11 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 116' ' ' THR . 57.2 tp -82.17 156.67 24.33 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p 57.53 38.21 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.394 1.478 . . . . 0.0 111.509 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 114' ' ' LEU . 44.0 p -106.53 -158.02 0.64 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.74 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -74.14 0.82 12.73 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.624 1.102 . . . . 0.0 113.878 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -74.82 129.34 36.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.46 43.09 1.11 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 110.484 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.3 mm -125.06 113.07 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -113.71 24.95 11.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.283 1.04 . . . . 0.0 108.726 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -116.09 160.62 20.08 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.299 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.84 32.18 0.68 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.588 0.709 . . . . 0.0 110.997 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -88.53 139.49 29.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.88 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 C--O 1.255 1.35 0 C-N-CA 123.35 2.7 . . . . 0.0 112.788 178.347 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.88 57.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.387 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 39.2 ttm -116.09 -69.44 0.85 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -75.97 154.07 44.44 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 55.66 70.85 1.39 Allowed Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -93.96 -166.29 0.13 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.375 2.717 . . . . 0.0 111.505 -174.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.76 103.74 14.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.2 t80 -115.94 126.68 54.19 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.468 ' CG2' HD23 ' A' ' 11' ' ' LEU . 5.8 t -139.4 23.67 2.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.887 0.851 . . . . 0.0 110.884 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 60.0 mtt180 53.03 4.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 127.381 2.272 . . . . 0.0 116.136 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.7 t-20 -134.4 122.98 16.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.7 Cg_exo -54.56 -31.58 70.45 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 123.753 2.969 . . . . 0.0 112.602 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -71.2 -26.81 63.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.397 0.618 . . . . 0.0 110.221 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -93.22 -15.26 26.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.344 0.592 . . . . 0.0 110.85 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . 33.3 mt -76.43 -173.68 2.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.51 1.147 . . . . 0.0 111.767 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -120.5 178.52 4.64 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.568 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.98 164.57 35.27 Favored Glycine 0 C--N 1.281 -2.476 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.204 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 34.0 tptt -88.25 126.83 35.37 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.654 0.782 . . . . 0.0 109.678 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 11' ' ' LEU . 93.4 m-85 -104.79 119.63 39.47 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.016 0.912 . . . . 0.0 110.583 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.521 HD13 ' NH2' ' A' ' 99' ' ' ARG . 8.5 mt -121.67 146.56 26.57 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.116 -172.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -117.29 127.34 53.98 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -139.05 156.86 46.86 Favored 'General case' 0 C--O 1.184 -2.369 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 38.2 ttpt -127.26 123.57 36.79 Favored 'General case' 0 C--N 1.258 -3.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.497 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.81 116.4 31.86 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.75 -170.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 32.8 ttp-105 -79.01 102.38 8.31 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.268 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.692 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.6 tttt -59.54 97.79 0.04 OUTLIER 'General case' 0 C--O 1.179 -2.649 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 t -84.82 -155.3 0.2 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.792 1.237 . . . . 0.0 109.173 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -61.13 -36.36 79.53 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.396 0.617 . . . . 0.0 109.468 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -86.69 -16.78 35.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.736 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.692 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 88.38 -112.17 3.87 Favored Glycine 1 N--CA 1.391 -4.308 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.497 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.1 m-85 -97.09 135.12 39.53 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.172 0.51 . . . . 0.0 109.919 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.93 -3.42 90.6 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.896 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' HB2' HG23 ' A' ' 43' ' ' ILE . 9.7 p90 -113.58 163.68 14.64 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.604 0.716 . . . . 0.0 111.903 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.2 p -124.08 148.06 47.4 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.369 1.468 . . . . 0.0 107.281 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.428 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.4 m -121.66 148.23 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.75 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.41 153.48 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.434 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.43 -131.79 9.59 Favored Glycine 0 N--CA 1.398 -3.877 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.65 36.33 24.87 Favored Glycine 0 CA--C 1.466 -2.97 0 O-C-N 124.593 0.82 . . . . 0.0 111.902 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.08 -31.05 70.42 Favored 'General case' 0 CA--C 1.449 -2.932 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -161.4 166.87 14.16 Favored Pre-proline 0 CA--C 1.45 -2.869 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.216 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -66.72 64.04 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.126 1.884 . . . . 0.0 108.468 168.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.46 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 12.9 t70 170.69 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.376 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 21.3 mt-10 -127.58 127.4 43.82 Favored 'General case' 0 C--O 1.276 2.457 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 73' ' ' LEU . 9.7 m-85 -76.92 159.25 30.15 Favored 'General case' 0 N--CA 1.532 3.639 0 O-C-N 128.836 3.835 . . . . 0.0 113.319 -167.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD21 HG21 ' A' ' 80' ' ' VAL . 5.1 mp -92.34 143.2 26.63 Favored 'General case' 0 CA--C 1.469 -2.161 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.8 mt-30 -135.5 154.28 51.46 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 29' ' ' PHE . 20.9 mm -75.35 111.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.39 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 45' ' ' SER . 47.6 tptt -60.83 -47.29 87.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.632 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.9 t 173.2 172.71 0.13 Allowed 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.871 1.357 . . . . 0.0 111.183 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.1 pp -143.1 145.74 33.13 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 123.764 0.826 . . . . 0.0 111.128 -175.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 49' ' ' ASP . 22.0 t -75.18 121.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 1.8 pt? -69.42 -5.24 22.45 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.965 0.888 . . . . 0.0 112.585 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' H ' HG12 ' A' ' 47' ' ' VAL . 19.7 t70 -85.4 -26.65 26.29 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.903 -1.499 . . . . 0.0 108.917 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.44 172.08 37.34 Favored Glycine 0 N--CA 1.402 -3.586 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.676 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HG2' HD11 ' A' ' 20' ' ' LEU . 14.2 Cg_endo -54.87 -26.37 48.06 Favored 'Trans proline' 0 C--O 1.201 -1.375 0 C-N-CA 124.911 3.741 . . . . 0.0 113.325 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -58.26 -52.66 64.64 Favored 'General case' 0 C--O 1.291 3.244 0 C-N-CA 123.377 0.671 . . . . 0.0 112.789 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.36 -33.53 55.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.456 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.3 mp -70.31 -35.59 73.76 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.097 -176.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.34 -21.84 65.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.59 11.83 84.86 Favored Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 112.61 -2.087 . . . . 0.0 113.47 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -107.62 -43.02 4.6 Favored 'General case' 1 N--CA 1.376 -4.132 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.406 ' HB3' HD11 ' A' ' 97' ' ' LEU . 17.0 ptp -95.92 154.7 17.1 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 116.631 -2.028 . . . . 0.0 112.296 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.42 161.19 38.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.749 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 45' ' ' SER . 75.0 p -65.86 113.7 4.56 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.25 -14.18 10.24 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.716 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.4 m-20 -65.95 152.69 43.99 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.44 125.18 55.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.989 -0.444 . . . . 0.0 111.571 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.456 HD13 HD23 ' A' ' 97' ' ' LEU . 10.4 mm -75.52 124.09 32.77 Favored 'Isoleucine or valine' 1 C--O 1.323 4.938 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.594 HG13 HD13 ' A' ' 73' ' ' LEU . 57.7 t -115.11 -36.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 111.037 -2.801 . . . . 0.0 111.247 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 70.3 m -150.8 160.24 44.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.001 -1.062 . . . . 0.0 113.081 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG23 HG11 ' A' ' 72' ' ' VAL . 55.0 t -142.18 129.59 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.5 m120 55.12 41.61 31.47 Favored 'General case' 0 C--O 1.256 1.437 0 O-C-N 123.776 0.673 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 25.26 5.69 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.47 1.108 . . . . 0.0 113.215 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 m -114.72 125.95 54.31 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 27.4 t -67.08 110.82 3.57 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 80' ' ' VAL . 2.2 p -117.35 16.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 65' ' ' VAL . 32.6 tp -57.95 112.85 1.63 Allowed 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.03 40.3 0.05 OUTLIER Glycine 0 N--CA 1.497 2.701 0 O-C-N 125.511 1.757 . . . . 0.0 112.934 -170.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.549 ' O ' HG23 ' A' ' 76' ' ' THR . 5.4 t-160 -43.71 -66.48 0.38 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.8 p -166.35 143.51 5.13 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 150.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.555 ' HA ' HG22 ' A' ' 80' ' ' VAL . 2.1 t60 -51.47 -31.37 23.2 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 119.699 1.136 . . . . 0.0 110.775 172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.65 85.51 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.942 -0.474 . . . . 0.0 110.946 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -65.34 -42.18 93.13 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.784 HG21 HD21 ' A' ' 41' ' ' LEU . 18.4 m -62.11 -43.71 98.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.26 -39.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -61.0 -41.62 96.88 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.02 176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' SER . 37.1 mt -62.01 -40.96 89.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.34 0.59 . . . . 0.0 111.635 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -70.89 -34.97 72.11 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.804 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -72.77 -19.64 61.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.06 0.944 . . . . 0.0 111.676 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 53.4 m -79.79 -27.81 40.35 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.132 0.973 . . . . 0.0 109.372 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.463 HG22 ' HD3' ' A' ' 22' ' ' LYS . 43.2 mt -85.17 134.65 40.47 Favored Pre-proline 0 N--CA 1.416 -2.141 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.607 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 18.5 Cg_endo -92.66 161.68 2.85 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 123.347 2.698 . . . . 0.0 113.039 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.65 133.55 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.63 12.49 53.43 Favored Glycine 0 C--N 1.289 -2.042 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.955 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.3 -170.26 1.85 Allowed 'General case' 0 C--O 1.199 -1.6 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 3.3 t -151.36 159.72 44.13 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.0 t -147.68 126.15 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.507 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.04 112.93 17.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.451 ' CD2' HG22 ' A' ' 67' ' ' VAL . 45.2 mt -109.89 144.55 38.21 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 126.387 1.875 . . . . 0.0 109.962 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.45 118.61 37.14 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 64' ' ' ILE . 23.7 mt -105.6 165.07 11.41 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.903 1.281 . . . . 0.0 108.784 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -142.94 111.05 6.03 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.781 0.801 . . . . 0.0 110.96 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.521 ' NH2' HD13 ' A' ' 16' ' ' ILE . 13.1 mtm180 -97.0 129.69 44.43 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.211 -0.931 . . . . 0.0 112.213 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.07 -17.78 0.82 Allowed Glycine 0 C--N 1.277 -2.702 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.512 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.12 148.85 40.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.862 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 131.76 47.94 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.889 2.392 . . . . 0.0 111.538 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' A' ' 104' ' ' PRO . 2.0 tt -58.54 135.6 85.87 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.498 ' HD2' HD23 ' A' ' 103' ' ' LEU . 3.8 Cg_exo -42.05 158.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 125.672 4.248 . . . . 0.0 116.102 -178.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.547 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 70.6 t80 -44.44 134.2 5.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.916 -1.947 . . . . 0.0 113.081 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -104.14 99.77 18.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.766 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 73.2 Cg_endo -97.18 -57.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.095 0 C-N-CA 122.187 1.925 . . . . 0.0 110.179 168.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -138.77 31.44 2.26 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -76.22 128.15 83.35 Favored Pre-proline 0 CA--C 1.489 -1.404 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.541 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.708 ' HB2' ' H ' ' A' ' 117' ' ' SER 0.386 7.5 Cg_endo -62.93 -48.08 7.36 Favored 'Trans proline' 0 CA--C 1.459 -3.275 0 C-N-CA 122.041 1.827 . . . . 0.0 112.648 174.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.653 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 48.1 m-80 -59.57 -25.6 64.7 Favored 'General case' 0 N--CA 1.414 -2.255 0 O-C-N 125.921 2.013 . . . . 0.0 113.508 -159.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -92.96 -27.31 17.12 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.765 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 m -94.22 173.19 7.77 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 125.478 1.511 . . . . 0.0 110.378 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.62 36.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.045 0.938 . . . . 0.0 111.074 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.0 p -155.42 40.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.653 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -77.39 132.48 38.55 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 115.053 -172.205 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.708 ' H ' ' HB2' ' A' ' 110' ' ' PRO . 78.1 p 45.59 63.61 1.73 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 125.058 1.474 . . . . 0.0 108.836 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -37.34 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.103 2.161 . . . . 0.0 115.385 -167.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.0 32.39 4.8 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.64 116.53 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.03 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.42 31.23 6.4 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.227 0.537 . . . . 0.0 109.904 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -149.58 131.37 15.07 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 75.29 -43.67 0.51 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.878 1.671 . . . . 0.0 112.254 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.463 ' OE2' ' HD2' ' A' ' 125' ' ' PRO . 10.4 tp10 -66.31 144.71 98.83 Favored Pre-proline 0 C--N 1.291 -1.938 0 C-N-CA 125.221 1.409 . . . . 0.0 108.332 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.463 ' HD2' ' OE2' ' A' ' 124' ' ' GLU . 6.3 Cg_exo . . . . . 0 C--N 1.371 1.759 1 C-N-CA 125.377 4.051 . . . . 0.0 114.571 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 55.16 37.73 29.36 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.243 1.02 . . . . 0.0 110.268 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 40.0 tpp 165.83 90.36 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.458 ' HA2' ' HG2' ' A' ' 39' ' ' GLU . . . -50.6 126.35 24.6 Favored Glycine 0 CA--C 1.476 -2.401 0 O-C-N 124.653 1.221 . . . . 0.0 112.686 -174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -62.07 -47.63 90.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -98.17 -178.0 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.395 2.063 . . . . 0.0 112.371 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.12 107.26 18.95 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 2.1 t80 -99.11 129.8 45.39 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 7' ' ' ASN . 14.6 t -138.1 10.82 2.82 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.873 0.845 . . . . 0.0 110.628 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 31.3 mtt180 58.25 -22.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.557 2.343 . . . . 0.0 115.738 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.479 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 56.1 t-20 -104.6 117.74 58.25 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HB3' HG11 ' A' ' 65' ' ' VAL . 9.3 Cg_endo -57.39 -26.05 68.99 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.965 3.11 . . . . 0.0 112.956 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -74.11 -30.29 62.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.124 0.487 . . . . 0.0 110.002 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -89.36 -29.61 18.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 41.2 tp -72.07 155.85 39.84 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.548 0.689 . . . . 0.0 111.619 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 9.2 mtmp? -90.18 -167.17 1.77 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.614 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 91.13 173.58 43.65 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.183 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -97.44 129.6 44.63 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.5 m-85 -103.16 113.74 27.47 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-O 122.538 1.161 . . . . 0.0 110.04 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -116.55 143.7 26.06 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.908 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.56 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.7 t60 -110.62 131.02 55.41 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 8.8 t -139.29 156.76 46.82 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.2 ttmp? -125.24 122.83 38.08 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -108.35 116.68 32.43 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.393 -174.372 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.0 ttp180 -75.09 107.77 7.38 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.021 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.626 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.7 tttt -66.71 95.68 0.36 Allowed 'General case' 0 C--O 1.171 -3.07 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 167.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t -89.55 -155.26 0.35 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 m -60.95 -32.81 72.33 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 122.56 0.344 . . . . 0.0 110.397 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -83.11 -21.02 33.78 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.368 0.604 . . . . 0.0 109.55 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 73.12 80.16 0.45 Allowed Glycine 0 N--CA 1.417 -2.584 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 20' ' ' LEU . 24.3 m-85 80.49 168.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.736 2.014 . . . . 0.0 110.07 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.18 10.99 5.6 Favored Glycine 0 CA--C 1.497 -1.077 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.018 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' HG23 ' A' ' 43' ' ' ILE . 19.4 p90 -119.49 162.93 18.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.235 0.54 . . . . 0.0 109.758 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.4 p -119.41 153.83 34.61 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -144.85 141.41 23.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.117 -174.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.6 p -151.83 166.12 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.353 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.6 3.06 30.74 Favored Glycine 0 CA--C 1.454 -3.766 0 N-CA-C 116.521 1.368 . . . . 0.0 116.521 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.802 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -117.06 48.89 0.9 Allowed Glycine 1 CA--C 1.41 -6.516 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -168.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.26 -29.16 60.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 112.841 -1.679 . . . . 0.0 110.239 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.6 pt-20 -163.81 171.96 5.46 Favored Pre-proline 0 CA--C 1.465 -2.293 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.093 -172.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 36' ' ' GLU . 21.9 Cg_endo -64.73 54.9 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.011 2.474 . . . . 0.0 110.898 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -177.53 -19.62 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.305 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.72 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 2.8 mt-10 -119.53 122.73 42.31 Favored 'General case' 0 C--O 1.265 1.885 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 171.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.296 5.4 m-30 -78.92 155.99 28.78 Favored 'General case' 0 N--CA 1.533 3.703 0 O-C-N 127.78 3.175 . . . . 0.0 112.722 -176.086 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.802 HD12 ' HA3' ' A' ' 34' ' ' GLY . 7.4 mp -85.75 143.08 28.54 Favored 'General case' 0 C--O 1.179 -2.607 0 C-N-CA 117.153 -1.819 . . . . 0.0 108.112 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.0 mt-30 -139.31 151.24 46.25 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.9 mm -72.38 110.95 5.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 58.3 tttm -59.39 -38.99 81.96 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.598 ' HA ' HG22 ' A' ' 60' ' ' THR . 30.7 t 163.78 172.34 0.02 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.637 1.836 . . . . 0.0 110.646 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -141.58 152.14 43.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.866 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 49' ' ' ASP . 56.9 t -81.61 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.6 pt? -68.63 -11.12 59.67 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' H ' HG12 ' A' ' 47' ' ' VAL . 6.3 m-20 -95.15 -7.29 39.69 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.073 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.26 163.0 37.18 Favored Glycine 0 N--CA 1.404 -3.461 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.765 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.83 -30.37 38.14 Favored 'Trans proline' 0 C--O 1.211 -0.873 0 C-N-CA 124.718 3.612 . . . . 0.0 112.897 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.87 -45.82 85.78 Favored 'General case' 0 C--O 1.271 2.223 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.798 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.9 -31.94 57.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.645 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.32 -40.62 64.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.069 0.547 . . . . 0.0 112.419 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.76 -25.62 67.35 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.02 5.33 65.08 Favored Glycine 0 CA--C 1.483 -1.935 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.939 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.89 -28.78 14.53 Favored 'General case' 1 N--CA 1.378 -4.061 0 C-N-CA 122.782 0.433 . . . . 0.0 111.551 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.8 ttm -97.04 140.49 31.48 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.064 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -137.97 161.9 35.5 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -71.01 107.53 4.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.825 0.85 . . . . 0.0 111.264 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.83 -16.6 9.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.207 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 2.9 m-20 -61.9 134.45 56.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -84.62 124.89 40.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.276 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.75 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 14.4 mm -73.8 124.58 31.36 Favored 'Isoleucine or valine' 1 C--O 1.32 4.78 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 170.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 8' ' ' PRO . 47.9 t -115.09 -40.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 111.481 -2.6 . . . . 0.0 110.939 -176.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.2 m -146.27 166.29 26.71 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.193 -1.003 . . . . 0.0 113.345 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG23 HG11 ' A' ' 72' ' ' VAL . 39.8 t -139.7 120.69 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 125.313 1.445 . . . . 0.0 107.493 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 67.53 -75.75 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.471 1.107 . . . . 0.0 109.809 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.07 4.14 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.322 0.649 . . . . 0.0 110.862 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -96.94 121.82 39.23 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 72.1 m -70.71 88.2 0.71 Allowed 'General case' 0 N--CA 1.398 -3.045 0 O-C-N 124.639 1.212 . . . . 0.0 108.366 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 80' ' ' VAL . 3.8 p -97.73 19.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.43 -171.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.581 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.3 tp -58.82 113.19 1.94 Allowed 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.84 44.92 0.1 OUTLIER Glycine 0 C--N 1.384 3.246 0 O-C-N 125.996 2.06 . . . . 0.0 111.661 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.563 ' O ' HG23 ' A' ' 76' ' ' THR . 7.7 t-160 -48.42 -64.26 0.85 Allowed 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 75' ' ' HIS . 12.0 p -166.42 142.79 4.83 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 151.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.35 -31.58 22.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 120.498 1.499 . . . . 0.0 111.373 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.56 77.0 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 122.029 -0.419 . . . . 0.0 110.438 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -64.46 -39.01 93.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 41' ' ' LEU . 11.6 m -64.16 -43.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.2 -37.8 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.1 tmtm? -57.78 -42.84 84.94 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.298 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.649 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.3 mm -66.21 -33.72 65.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.642 0.734 . . . . 0.0 112.628 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -76.09 -28.92 57.74 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.297 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -72.89 -28.26 62.38 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.373 1.069 . . . . 0.0 110.663 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.8 m -65.57 -38.66 90.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.455 175.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.513 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 22.1 mt -82.89 133.76 48.08 Favored Pre-proline 0 N--CA 1.405 -2.681 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.03 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.1 Cg_endo -90.71 161.98 4.2 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.086 2.524 . . . . 0.0 113.234 -173.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.565 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.1 mm -60.77 133.84 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.457 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 11.62 56.63 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.133 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.92 -169.72 1.72 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -151.34 165.73 33.16 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.2 t -150.35 126.21 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.887 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.56 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -78.65 107.02 11.03 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.194 -1.002 . . . . 0.0 108.743 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' CD2' HG22 ' A' ' 67' ' ' VAL . 56.7 mt -103.84 152.45 21.9 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.801 1.64 . . . . 0.0 108.391 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 30.1 tt0 -111.11 123.42 50.17 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 76.6 mt -105.65 153.87 21.23 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.759 1.223 . . . . 0.0 110.247 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.641 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 9.6 t -124.26 107.12 10.85 Favored 'General case' 0 C--O 1.186 -2.241 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.476 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 40.4 ttp180 -101.39 138.62 38.15 Favored 'General case' 1 C--N 1.243 -4.052 0 O-C-N 120.59 -1.319 . . . . 0.0 110.494 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.51 -32.84 0.84 Allowed Glycine 0 CA--C 1.464 -3.123 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.45 137.59 45.03 Favored Pre-proline 0 N--CA 1.412 -2.34 0 CA-C-N 113.871 -1.165 . . . . 0.0 108.434 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -85.62 164.41 10.7 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.964 2.443 . . . . 0.0 112.242 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 13.3 mt -57.09 121.22 44.93 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.244 173.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 30.7 Cg_endo -76.52 -79.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.154 2.569 . . . . 0.0 114.763 -170.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -138.78 143.61 39.02 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-O 121.837 0.827 . . . . 0.0 109.835 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -116.4 85.51 16.27 Favored Pre-proline 0 N--CA 1.392 -3.334 0 CA-C-N 113.003 -1.908 . . . . 0.0 110.529 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.77 -59.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.78 1.654 . . . . 0.0 110.787 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -112.58 32.96 5.24 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.922 1.82 . . . . 0.0 108.663 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 111' ' ' ASN . 5.9 t70 -104.53 109.53 62.95 Favored Pre-proline 0 CA--C 1.435 -3.445 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 170.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.459 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 97.5 Cg_endo -75.09 -35.04 3.31 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 121.664 1.576 . . . . 0.0 110.683 -175.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.591 ' OD1' ' HA ' ' A' ' 117' ' ' SER . 74.3 m-20 -51.19 -10.15 0.08 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 130.251 3.42 . . . . 0.0 114.704 -167.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 110' ' ' PRO . 76.2 p -97.65 -10.34 25.24 Favored 'General case' 0 N--CA 1.384 -3.747 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.632 -169.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.4 p -148.76 128.79 13.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 115' ' ' VAL . 6.3 tp 63.58 -154.28 0.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.179 1.392 . . . . 0.0 110.854 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' H ' ' HG ' ' A' ' 114' ' ' LEU . 13.2 m -66.06 78.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 122.491 1.139 . . . . 0.0 112.573 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 p -134.57 -169.25 2.3 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.338 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.591 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 78.3 p 64.86 21.93 12.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.127 1.371 . . . . 0.0 112.119 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.3 p -91.42 125.69 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.91 74.03 5.65 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.1 0.476 . . . . 0.0 111.961 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -99.13 89.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.41 138.16 47.16 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.155 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -148.08 154.18 39.87 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -77.98 -28.34 49.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.018 0.437 . . . . 0.0 111.809 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -102.58 133.01 20.73 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.577 2.851 . . . . 0.0 112.117 179.234 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.803 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -133.81 -46.74 0.8 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 62.6 mtt -86.25 93.78 9.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 144.87 -94.17 0.17 Allowed Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.463 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 29.6 mmmt 50.46 61.2 13.85 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 40.5 Cg_endo -107.44 -172.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 123.15 2.567 . . . . 0.0 111.79 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -94.5 111.15 22.9 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.594 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -107.81 123.17 48.17 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -133.3 12.41 4.19 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.339 0.59 . . . . 0.0 110.279 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.529 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtp180 60.47 -29.7 0.05 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.446 2.298 . . . . 0.0 115.381 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 55.6 t-20 -95.92 117.38 66.39 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.4 Cg_endo -59.36 -22.79 67.27 Favored 'Trans proline' 0 C--O 1.21 -0.924 0 C-N-CA 123.772 2.982 . . . . 0.0 113.134 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -76.92 -25.37 52.85 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.804 -0.56 . . . . 0.0 109.562 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -93.82 -19.32 21.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.574 0.702 . . . . 0.0 110.22 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.4 tm? -88.14 145.78 25.74 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.369 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' N ' HD13 ' A' ' 11' ' ' LEU . 57.3 mttm -103.32 137.74 41.03 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-O 121.873 0.844 . . . . 0.0 110.581 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 152.82 169.52 18.15 Favored Glycine 1 C--N 1.246 -4.417 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.237 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.47 122.3 40.37 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.908 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.2 m-85 -96.53 111.34 23.5 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.784 1.278 . . . . 0.0 112.157 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.477 HD11 ' HG3' ' A' ' 99' ' ' ARG . 5.9 mm -92.55 152.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 CA-C-N 112.779 -2.009 . . . . 0.0 108.436 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 113.05 14.47 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 t -139.37 132.88 30.3 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.918 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.9 ttpt -92.95 125.92 37.78 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.509 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.28 117.3 33.69 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -175.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.444 ' HD3' ' OG ' ' A' ' 92' ' ' SER . 18.6 tpp180 -74.59 103.83 5.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.954 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.653 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 69.9 tttt -62.17 97.29 0.08 Allowed 'General case' 0 C--O 1.177 -2.733 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.0 t -129.71 125.87 36.94 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t 62.18 -77.73 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.127 1.371 . . . . 0.0 110.534 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -85.48 -20.63 29.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.653 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 107.83 -110.43 3.16 Favored Glycine 1 N--CA 1.385 -4.73 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.509 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.1 m-85 -92.45 135.7 33.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.268 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.56 3.55 84.71 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.812 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE2' HG22 ' A' ' 31' ' ' VAL . 10.0 p90 -119.07 162.92 17.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.194 0.521 . . . . 0.0 110.434 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 21.5 p -113.15 145.81 40.3 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.665 HG11 HD23 ' A' ' 41' ' ' LEU . 1.6 t -119.19 143.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.505 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.33 149.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.785 0 CA-C-O 121.336 0.588 . . . . 0.0 109.428 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.25 -138.52 11.02 Favored Glycine 1 N--CA 1.391 -4.317 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.63 36.97 19.46 Favored Glycine 0 CA--C 1.456 -3.598 0 O-C-N 124.517 0.775 . . . . 0.0 111.346 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 3.1 t70 -69.93 -27.71 65.0 Favored 'General case' 0 CA--C 1.463 -2.394 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -170.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.9 pt-20 -164.28 167.69 10.19 Favored Pre-proline 0 CA--C 1.464 -2.354 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.057 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.4 Cg_endo -67.21 56.03 0.55 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.394 2.063 . . . . 0.0 110.277 172.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 177.97 -7.86 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.338 -169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 22.9 mm-40 -129.29 125.34 36.58 Favored 'General case' 0 C--O 1.276 2.493 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.253 6.0 m-30 -76.44 158.93 30.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 129.871 3.268 . . . . 0.0 112.514 -169.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 80' ' ' VAL . 6.7 mp -88.97 147.77 24.13 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.5 mt-30 -144.18 155.6 43.97 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 62' ' ' ASP . 20.4 mm -72.98 115.91 14.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 38.4 ttmt -58.95 -44.65 91.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.59 ' HA ' HG22 ' A' ' 60' ' ' THR . 21.0 t 169.62 173.65 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 125.144 1.527 . . . . 0.0 110.453 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -144.27 144.91 31.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-O 121.647 0.737 . . . . 0.0 111.899 -175.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 49' ' ' ASP . 14.5 t -73.26 122.92 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.769 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.2 mt -61.31 -15.01 31.19 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 112.489 -2.141 . . . . 0.0 113.121 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.1 t70 -92.72 -13.66 29.04 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.767 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.53 163.62 28.74 Favored Glycine 0 N--CA 1.415 -2.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.425 -172.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.44 -28.73 45.71 Favored 'Trans proline' 0 C--O 1.205 -1.136 0 C-N-CA 124.72 3.613 . . . . 0.0 112.798 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.85 -50.77 72.17 Favored 'General case' 0 C--O 1.264 1.853 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.052 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.26 -33.49 55.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.8 mp -72.57 -33.72 66.96 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.049 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.43 -27.79 66.5 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' HE3' ' A' ' 57' ' ' LYS . . . 78.61 3.59 86.91 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 112.51 -2.132 . . . . 0.0 113.352 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HE3' ' C ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -96.18 -31.8 12.79 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.0 ttm -97.97 142.0 30.24 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.616 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -139.25 159.16 42.8 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 122.226 1.012 . . . . 0.0 110.061 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.7 p -63.85 115.65 5.03 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.564 1.146 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 111.74 -15.96 26.28 Favored Glycine 0 N--CA 1.435 -1.425 0 O-C-N 121.767 -0.583 . . . . 0.0 112.799 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 43' ' ' ILE . 17.4 m-20 -61.08 134.28 56.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -83.38 126.47 40.13 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 CA-C-N 118.905 0.775 . . . . 0.0 113.035 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 12.7 mm -76.78 125.27 36.43 Favored 'Isoleucine or valine' 1 C--O 1.321 4.866 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 8' ' ' PRO . 25.9 t -115.68 -37.6 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 111.435 -2.62 . . . . 0.0 111.035 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.696 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.9 m -144.51 149.75 36.43 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.227 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.625 HG12 HG21 ' A' ' 72' ' ' VAL . 12.4 p -134.58 133.43 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.487 ' OD1' HG22 ' A' ' 67' ' ' VAL . 21.7 m120 60.13 27.84 17.35 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.02 0.914 . . . . 0.0 110.398 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 72.97 2.48 4.39 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.668 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.7 m -90.56 126.88 36.08 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 31.7 t -66.49 108.0 2.25 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.696 HG22 ' HA ' ' A' ' 66' ' ' SER . 29.6 m -123.18 27.87 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.841 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.594 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.0 tp -59.88 113.54 2.34 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.7 41.57 0.26 Allowed Glycine 0 C--N 1.376 2.767 0 O-C-N 125.191 1.557 . . . . 0.0 112.205 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t-160 -44.01 -67.86 0.24 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 75' ' ' HIS . 18.2 p -166.1 143.46 5.36 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 149.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 2.7 t60 -50.77 -37.15 40.49 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 120.098 1.317 . . . . 0.0 110.711 173.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.409 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.499 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 9.0 mm-40 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 41' ' ' LEU . 34.0 m -69.17 -39.88 79.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.591 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 71.1 t -65.45 -37.43 80.04 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.28 -38.55 83.93 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 122.887 0.117 . . . . 0.0 111.277 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' SER . 63.1 mt -65.58 -35.73 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.612 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.6 -31.52 65.25 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.356 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 71.1 mm-40 -72.82 -26.56 61.53 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 122.084 0.945 . . . . 0.0 109.901 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.2 m -73.66 -47.06 42.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.602 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.506 HG22 ' HD3' ' A' ' 22' ' ' LYS . 20.9 mt -66.68 136.58 94.74 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.302 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 30.5 Cg_endo -91.64 162.49 3.49 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.185 3.257 . . . . 0.0 113.125 -174.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 28.8 mm -62.29 135.25 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 121.07 0.462 . . . . 0.0 110.63 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.85 57.14 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.554 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.14 -172.42 2.16 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.444 ' OG ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -149.01 158.87 44.52 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -142.49 125.27 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.211 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -79.33 104.17 9.77 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.44 143.84 32.47 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 125.357 1.463 . . . . 0.0 111.514 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 38.0 tt0 -104.41 127.04 52.01 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.336 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 67.1 mt -115.11 157.83 23.03 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.573 1.171 . . . . 0.0 110.027 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.6 t -129.83 111.17 12.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.548 1.166 . . . . 0.0 110.157 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HG3' HD11 ' A' ' 16' ' ' ILE . 3.7 mmm180 -88.54 120.9 30.35 Favored 'General case' 0 C--N 1.245 -3.958 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 157.32 -22.06 0.43 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.7 138.56 21.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.21 146.98 21.9 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 124.756 3.638 . . . . 0.0 112.936 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.472 HD23 ' HD2' ' A' ' 104' ' ' PRO . 1.2 tt -70.33 125.26 91.93 Favored Pre-proline 0 N--CA 1.413 -2.319 0 C-N-CA 124.422 1.089 . . . . 0.0 109.195 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.472 ' HD2' HD23 ' A' ' 103' ' ' LEU . 45.0 Cg_exo -64.64 -173.25 0.23 Allowed 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 124.322 3.348 . . . . 0.0 113.302 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -82.37 128.61 34.4 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.774 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -117.69 85.16 21.15 Favored Pre-proline 0 N--CA 1.39 -3.428 0 CA-C-N 111.846 -2.434 . . . . 0.0 110.542 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.51 -54.99 0.02 OUTLIER 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.004 1.802 . . . . 0.0 111.994 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.12 -9.84 59.39 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.647 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.41 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -89.47 121.57 69.14 Favored Pre-proline 0 CA--C 1.478 -1.809 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.108 -176.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.735 ' HB2' ' HA ' ' A' ' 116' ' ' THR 0.348 18.3 Cg_endo -69.44 -42.77 3.42 Favored 'Trans proline' 0 CA--C 1.469 -2.77 0 C-N-CA 123.071 2.514 . . . . 0.0 113.174 177.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.689 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 42.6 m-80 -58.27 -14.13 6.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.295 -161.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.2 p -99.76 -20.45 16.23 Favored 'General case' 0 N--CA 1.395 -3.186 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.473 -172.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -132.27 -157.98 0.86 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.64 -169.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -65.05 162.76 16.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 123.614 0.571 . . . . 0.0 109.944 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p 49.0 45.07 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 123.083 1.42 . . . . 0.0 111.344 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.735 ' HA ' ' HB2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -75.53 158.96 31.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.605 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.4 t -82.12 53.57 2.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.883 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.2 m -96.18 155.68 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.492 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.37 75.65 3.9 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.209 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.66 58.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.86 29.46 2.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.124 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.61 140.1 17.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.57 113.16 10.81 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.15 134.5 80.48 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 C--O 1.262 1.717 0 C-N-CA 123.384 2.723 . . . . 0.0 112.123 178.965 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 64.65 -79.23 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.467 1.107 . . . . 0.0 112.204 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' MET . . . . . 0.457 ' HB3' ' HB3' ' A' ' 105' ' ' PHE . 21.2 ptp -142.67 153.96 43.89 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.463 ' HA3' ' OE1' ' A' ' 39' ' ' GLU . . . 78.46 -148.35 32.35 Favored Glycine 0 N--CA 1.425 -2.069 0 O-C-N 123.986 0.804 . . . . 0.0 112.347 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 38.73 65.33 3.19 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.688 1.595 . . . . 0.0 114.952 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 74.4 Cg_endo -101.54 -162.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.283 0 C-N-CA 123.769 2.979 . . . . 0.0 111.326 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -84.53 104.22 14.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.606 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -111.27 130.04 55.79 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 t -143.43 16.39 1.85 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.628 0.728 . . . . 0.0 110.063 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HG2' ' HE1' ' A' ' 4' ' ' PHE . 16.0 mtm180 58.06 -21.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 127.993 2.517 . . . . 0.0 115.683 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.537 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -99.89 113.37 65.11 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-O 120.894 0.378 . . . . 0.0 111.5 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 1.3 Cg_endo -48.14 -36.1 27.91 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.582 3.522 . . . . 0.0 112.705 174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -73.97 -17.04 61.05 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.063 0.459 . . . . 0.0 111.61 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 20.8 mm-40 -94.93 -17.28 22.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.228 0.537 . . . . 0.0 110.201 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 73' ' ' LEU . 20.5 mt -80.15 178.36 8.31 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 122.109 0.957 . . . . 0.0 109.697 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -114.48 -161.33 0.77 Allowed 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.665 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.87 176.69 38.14 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.081 -1.533 . . . . 0.0 112.799 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.1 OUTLIER -103.29 132.09 49.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.4 m-85 -108.07 111.77 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.486 1.136 . . . . 0.0 111.535 -175.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.534 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 21.3 mt -112.46 149.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.03 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.896 -174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -130.45 104.64 7.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -123.58 129.48 51.24 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 122.318 1.056 . . . . 0.0 111.581 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.4 ttmt -88.77 122.07 31.8 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.572 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.464 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.01 117.35 33.81 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.101 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 27.3 ttp-105 -79.27 107.36 11.97 Favored 'General case' 0 N--CA 1.394 -3.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.754 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.75 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 64.6 tttt -64.08 97.88 0.19 Allowed 'General case' 0 C--O 1.176 -2.781 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 169.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' ILE . 22.9 t -80.46 -155.81 0.12 Allowed 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 124.54 1.136 . . . . 0.0 109.16 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 m -58.55 -41.47 85.66 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -85.86 -21.46 28.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.75 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 102.27 -124.8 8.31 Favored Glycine 1 N--CA 1.392 -4.266 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 35.9 m-85 -86.74 145.7 26.55 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.729 0.764 . . . . 0.0 110.48 -176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.63 1.63 64.03 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.908 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 31' ' ' VAL . 6.7 p90 -114.27 163.06 15.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.453 0.644 . . . . 0.0 111.813 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -116.13 148.53 40.22 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.586 HG11 HD23 ' A' ' 41' ' ' LEU . 4.0 t -127.23 143.68 39.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.125 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 104' ' ' PRO . 9.0 p -152.23 163.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.956 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.76 -65.04 0.55 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -76.11 58.81 3.16 Favored Glycine 2 CA--C 1.408 -6.64 0 C-N-CA 125.621 1.581 . . . . 0.0 116.971 -166.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -66.21 -9.07 28.51 Favored 'General case' 0 C--N 1.253 -3.629 0 O-C-N 124.32 0.659 . . . . 0.0 111.75 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt-20 -160.62 166.36 15.69 Favored Pre-proline 0 CA--C 1.452 -2.799 0 C-N-CA 116.078 -2.249 . . . . 0.0 111.849 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.4 Cg_endo -67.62 53.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.807 2.338 . . . . 0.0 110.287 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 29.6 t70 -177.61 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.498 1.519 . . . . 0.0 109.872 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.655 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 34.3 mt-10 -117.72 129.75 55.9 Favored 'General case' 0 C--O 1.272 2.256 0 CA-C-O 116.649 -1.643 . . . . 0.0 106.75 169.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.263 6.8 m-30 -79.33 156.4 28.03 Favored 'General case' 0 N--CA 1.523 3.18 0 O-C-N 128.675 3.735 . . . . 0.0 111.927 -177.304 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.901 HD21 HG21 ' A' ' 80' ' ' VAL . 6.3 mp -91.68 143.17 26.83 Favored 'General case' 0 CA--C 1.455 -2.689 0 C-N-CA 117.153 -1.819 . . . . 0.0 107.437 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 14.1 mt-30 -139.36 154.74 47.92 Favored 'General case' 0 C--N 1.266 -3.04 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 29' ' ' PHE . 19.7 mm -75.11 109.48 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.431 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.22 -37.01 79.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.5 t 161.87 173.66 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 125.388 1.68 . . . . 0.0 109.344 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.495 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.3 pp -137.33 151.87 49.09 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 123.257 0.623 . . . . 0.0 111.469 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.08 116.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.264 0.8 OUTLIER -69.38 -4.17 17.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -174.389 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.49 -2.67 54.14 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.406 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.42 167.11 24.56 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.818 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 20' ' ' LEU . 9.2 Cg_endo -53.32 -31.78 58.3 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 124.624 3.549 . . . . 0.0 113.411 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.84 -44.55 86.57 Favored 'General case' 0 C--O 1.273 2.293 0 CA-C-O 121.753 0.787 . . . . 0.0 111.522 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.74 -35.21 57.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.328 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.21 -28.21 53.75 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.36 -20.86 62.11 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.27 63.58 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.962 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -29.76 7.39 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.637 -172.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 51.2 ttm -96.96 132.84 42.35 Favored 'General case' 0 N--CA 1.407 -2.593 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.187 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -124.29 156.94 36.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 122.193 0.997 . . . . 0.0 109.336 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 45' ' ' SER . 82.7 p -71.48 107.76 4.55 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.297 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 122.08 -11.96 9.24 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.755 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 8.6 m-20 -64.44 151.46 44.16 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.401 1.101 . . . . 0.0 108.654 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -99.94 123.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 175.125 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 10.8 mm -71.29 122.31 23.1 Favored 'Isoleucine or valine' 1 C--O 1.322 4.883 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 171.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG13 HD13 ' A' ' 73' ' ' LEU . 44.4 t -114.69 -34.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 O-C-N 127.122 2.764 . . . . 0.0 109.905 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.571 ' HA ' HG22 ' A' ' 72' ' ' VAL . 39.4 m -147.66 148.84 31.49 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.457 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.641 HG12 HG11 ' A' ' 72' ' ' VAL . 8.4 p -125.28 133.11 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.57 27.24 16.39 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.519 0.676 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.35 26.13 14.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 123.484 1.612 . . . . 0.0 111.466 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.9 m -109.16 124.54 50.99 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.24 105.57 0.93 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.101 0.876 . . . . 0.0 109.927 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.641 HG11 HG12 ' A' ' 67' ' ' VAL . 35.7 m -121.18 27.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.406 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.606 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 43.8 tp -60.9 113.28 2.43 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.18 45.88 0.3 Allowed Glycine 0 N--CA 1.492 2.397 0 O-C-N 125.557 1.786 . . . . 0.0 111.606 -170.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t-160 -46.83 -69.14 0.14 Allowed 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 175.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 75' ' ' HIS . 21.5 p -164.86 144.0 6.89 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 148.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -49.84 -36.14 25.69 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 119.718 1.145 . . . . 0.0 110.437 173.065 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.01 91.89 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.481 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -44.08 93.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.901 HG21 HD21 ' A' ' 41' ' ' LEU . 28.8 m -70.34 -43.5 78.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.808 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.1 -36.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.58 -43.27 99.17 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.328 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.658 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.7 -36.54 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.24 0.543 . . . . 0.0 112.435 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.33 -32.64 68.81 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.316 0.579 . . . . 0.0 110.173 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.565 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 7.8 mm-40 -75.55 -26.3 57.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.749 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.8 m -72.02 -40.36 68.5 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.765 1.226 . . . . 0.0 109.275 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 22' ' ' LYS . 23.5 mt -69.81 135.45 87.8 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.994 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 16.3 Cg_endo -90.39 162.53 4.51 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 123.679 2.919 . . . . 0.0 113.208 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.7 mm -59.92 135.1 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.031 175.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.71 10.26 63.42 Favored Glycine 0 C--N 1.291 -1.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.843 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.53 133.57 49.16 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 6.7 m -100.79 159.42 15.2 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.538 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -144.74 125.5 8.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.648 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.623 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 23.4 m-20 -79.11 109.42 13.4 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.5 mt -104.63 136.91 43.28 Favored 'General case' 0 C--N 1.277 -2.557 0 C-N-CA 124.842 1.257 . . . . 0.0 109.836 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 40.8 tt0 -97.6 122.99 41.32 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 95.9 mt -112.65 148.84 33.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 125.154 1.382 . . . . 0.0 109.713 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.665 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 8.1 t -124.56 115.18 20.43 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.915 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -102.01 141.98 34.0 Favored 'General case' 0 C--N 1.256 -3.489 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.067 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.71 -17.06 3.98 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.354 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -92.01 139.97 24.59 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.16 134.26 24.54 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 124.712 3.608 . . . . 0.0 113.935 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.468 HD23 ' HD2' ' A' ' 104' ' ' PRO . 1.5 tt -62.24 137.06 95.8 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 125.102 1.361 . . . . 0.0 109.611 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' HD2' HD23 ' A' ' 103' ' ' LEU . 18.2 Cg_exo -49.88 156.52 3.28 Favored 'Trans proline' 0 CA--C 1.504 -0.977 0 C-N-CA 124.951 3.767 . . . . 0.0 115.367 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.492 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 t80 -80.1 138.1 36.88 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-N 112.876 -1.965 . . . . 0.0 110.034 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 109' ' ' ASP . 0.3 OUTLIER -111.82 100.84 49.9 Favored Pre-proline 1 N--CA 1.375 -4.208 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.16 -175.512 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 59.3 Cg_endo -97.9 -56.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.293 1.995 . . . . 0.0 111.862 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -111.11 11.46 21.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 0.0 109.733 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 106' ' ' ASP . 8.6 t70 -68.69 126.06 92.39 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.627 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.541 ' O ' ' HB ' ' A' ' 116' ' ' THR 0.292 35.9 Cg_endo -74.7 -44.57 0.36 Allowed 'Trans proline' 0 CA--C 1.484 -2.002 0 C-N-CA 122.398 2.065 . . . . 0.0 111.804 178.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.831 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 0.0 OUTLIER -58.39 -21.26 49.77 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.993 -2.821 . . . . 0.0 113.019 -164.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.5 p -93.68 -20.36 20.24 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.225 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.0 m -115.21 172.71 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.814 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.8 tp -85.09 65.85 9.44 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.962 0.887 . . . . 0.0 110.527 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.6 p -173.3 40.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.831 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 1.2 t -95.48 129.8 42.52 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -168.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m 45.13 77.42 0.08 Allowed 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.61 -2.087 . . . . 0.0 114.118 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 120' ' ' ILE . 89.8 t -66.51 129.7 31.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.595 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.97 16.53 4.85 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.001 0.905 . . . . 0.0 112.251 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.542 ' H ' HG12 ' A' ' 118' ' ' VAL . 53.7 mt -143.37 71.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.4 mt -83.35 119.96 25.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.789 0.804 . . . . 0.0 110.296 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -99.16 113.84 26.29 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.693 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -142.7 52.2 1.42 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.91 136.97 73.15 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.559 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 C--O 1.254 1.28 0 C-N-CA 122.882 2.388 . . . . 0.0 110.93 173.72 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.875 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 65.52 -80.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.282 1.433 . . . . 0.0 112.455 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -119.84 90.78 3.4 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 135.08 -124.16 3.31 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.449 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 1.1 tppp? 48.35 67.54 4.39 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 125.191 1.396 . . . . 0.0 112.424 -174.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 1.8 Cg_endo -87.27 -175.77 1.65 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.128 2.552 . . . . 0.0 111.094 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.19 104.83 3.2 Favored 'General case' 0 N--CA 1.411 -2.377 0 C-N-CA 124.349 1.06 . . . . 0.0 108.562 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.606 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.7 t80 -98.94 139.12 35.07 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -147.51 10.28 0.96 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.963 0.887 . . . . 0.0 110.79 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.544 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 14.1 mtp180 52.9 6.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.803 2.041 . . . . 0.0 115.092 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -134.09 122.1 16.05 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HB3' HG11 ' A' ' 65' ' ' VAL . 3.4 Cg_exo -54.98 -34.93 88.6 Favored 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 124.135 3.223 . . . . 0.0 112.345 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -71.81 -21.99 61.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.563 0.697 . . . . 0.0 111.21 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -92.45 -24.27 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 42.5 tp -85.91 159.2 19.73 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.829 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.4 mttp -99.13 -171.23 2.05 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.96 177.93 27.94 Favored Glycine 0 C--N 1.292 -1.865 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.911 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -99.81 122.67 43.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.5 m-85 -103.87 117.97 35.59 Favored 'General case' 0 C--N 1.253 -3.628 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.41 HG13 ' HE3' ' A' ' 14' ' ' LYS . 66.4 mt -127.25 126.74 68.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.463 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -99.95 111.95 24.24 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.507 ' OG1' ' HD2' ' A' ' 57' ' ' LYS . 14.8 t -133.1 147.59 52.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.018 0.913 . . . . 0.0 110.73 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.808 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 22.0 ttpp -90.17 132.31 35.54 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.608 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -109.68 119.27 38.88 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 72.5 ttt180 -81.48 109.47 15.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.965 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.5 tttt -63.95 96.51 0.14 Allowed 'General case' 0 C--O 1.184 -2.377 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -90.03 -154.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 124.457 1.103 . . . . 0.0 109.061 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 m -52.35 -40.63 62.2 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.878 0.871 . . . . 0.0 111.695 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -95.6 -9.41 32.27 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.012 0.434 . . . . 0.0 110.065 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.734 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.01 -119.08 6.25 Favored Glycine 1 N--CA 1.392 -4.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.589 ' HD1' HD12 ' A' ' 20' ' ' LEU . 46.2 m-85 -91.46 139.88 30.29 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 117.763 0.782 . . . . 0.0 108.935 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.94 3.01 87.28 Favored Glycine 0 C--N 1.315 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.897 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.523 ' HB2' HG23 ' A' ' 43' ' ' ILE . 12.1 p90 -116.33 162.69 17.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.353 0.597 . . . . 0.0 111.324 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 26.3 p -116.19 152.91 32.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG11 HD23 ' A' ' 41' ' ' LEU . 4.6 t -126.53 143.86 38.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.464 -174.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.66 155.61 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.25 -72.94 0.45 Allowed Glycine 0 CA--C 1.459 -3.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.0 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.858 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -62.11 58.51 0.03 OUTLIER Glycine 1 CA--C 1.442 -4.505 0 C-N-CA 127.454 2.454 . . . . 0.0 117.459 -169.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.638 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 17.3 t70 -63.09 -27.98 69.77 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -154.82 166.31 16.32 Favored Pre-proline 0 CA--C 1.454 -2.727 0 C-N-CA 116.192 -2.203 . . . . 0.0 110.941 -170.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.7 Cg_endo -68.42 55.79 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.308 2.005 . . . . 0.0 109.718 171.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -178.63 -17.15 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.008 1.723 . . . . 0.0 110.06 -171.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.858 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 19.1 mm-40 -115.89 127.03 54.68 Favored 'General case' 0 C--O 1.273 2.301 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.269 6.0 m-30 -79.02 157.68 28.04 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 128.77 3.794 . . . . 0.0 111.628 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 80' ' ' VAL . 5.3 mp -88.25 143.53 26.98 Favored 'General case' 0 C--O 1.185 -2.319 0 C-N-CA 117.149 -1.821 . . . . 0.0 107.105 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 46.6 mt-30 -140.25 154.68 46.94 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.523 HG23 ' HB2' ' A' ' 29' ' ' PHE . 18.9 mm -73.96 113.24 11.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 19.2 ttmm -57.14 -38.04 72.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 125.13 1.519 . . . . 0.0 107.16 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.512 ' HA ' HG22 ' A' ' 60' ' ' THR . 34.8 t 159.86 173.35 0.01 OUTLIER 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.428 1.891 . . . . 0.0 109.114 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -139.4 147.82 41.98 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.414 0.626 . . . . 0.0 111.671 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 49' ' ' ASP . 44.3 t -76.53 128.06 37.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.51 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -64.53 -15.45 60.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.47 ' H ' HG12 ' A' ' 47' ' ' VAL . 2.3 m-20 -99.12 6.83 46.32 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.957 176.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.25 158.81 21.79 Favored Glycine 0 N--CA 1.398 -3.847 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HG2' HD11 ' A' ' 20' ' ' LEU . 10.1 Cg_endo -52.21 -30.52 42.12 Favored 'Trans proline' 0 C--O 1.202 -1.318 0 C-N-CA 124.429 3.42 . . . . 0.0 112.884 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -60.1 -44.59 94.73 Favored 'General case' 0 C--O 1.278 2.565 0 CA-C-O 121.551 0.691 . . . . 0.0 111.982 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.55 -35.02 53.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.811 -1.541 . . . . 0.0 111.022 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.1 -46.02 72.1 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.313 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 38.3 t70 -63.67 -34.58 78.17 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -8.77 58.25 Favored Glycine 0 CA--C 1.492 -1.393 0 CA-C-N 112.484 -2.144 . . . . 0.0 114.082 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 46.1 mttp -86.7 -14.53 42.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 123.117 0.567 . . . . 0.0 112.081 -176.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 ttm -104.02 144.96 30.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -143.67 155.52 44.25 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 121.447 0.642 . . . . 0.0 110.103 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 45' ' ' SER . 77.8 p -63.21 108.45 1.28 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.86 -0.31 31.92 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.121 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.606 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.0 p30 -73.43 146.94 44.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.425 -1.71 . . . . 0.0 107.292 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -94.65 120.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 26.6 mm -71.08 125.16 28.93 Favored 'Isoleucine or valine' 1 C--O 1.319 4.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 73' ' ' LEU . 48.6 t -115.27 -41.36 3.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.614 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.632 ' HA ' HG22 ' A' ' 72' ' ' VAL . 66.5 m -145.34 147.42 32.29 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.281 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 72' ' ' VAL . 6.4 p -125.1 132.0 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 56.03 29.57 14.67 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.452 0.644 . . . . 0.0 111.101 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 67.58 11.51 8.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.7 m -93.47 122.85 36.33 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.2 t -66.04 103.6 0.98 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.632 HG22 ' HA ' ' A' ' 66' ' ' SER . 33.6 m -117.84 25.67 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.884 0.849 . . . . 0.0 110.501 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.606 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.2 tp -61.43 113.28 2.57 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 35.46 40.72 0.3 Allowed Glycine 0 N--CA 1.497 2.725 0 O-C-N 125.188 1.555 . . . . 0.0 111.785 -170.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 76' ' ' THR . 6.8 t-160 -43.98 -67.22 0.3 Allowed 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.4 p -167.35 143.57 4.25 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 150.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.522 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -49.8 -36.55 26.7 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 120.194 1.361 . . . . 0.0 110.119 172.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.2 81.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.448 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 7.3 mm-40 -66.8 -44.26 81.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 41' ' ' LEU . 34.0 m -65.58 -40.06 86.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.471 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.5 -39.04 84.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -59.62 -38.43 81.31 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.676 177.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.599 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 72.4 mt -68.09 -38.41 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.574 0.702 . . . . 0.0 110.853 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.07 -30.83 65.52 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.89 -32.55 73.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.313 1.045 . . . . 0.0 109.994 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 59.5 m -71.84 -43.17 66.0 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.474 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.5 mt -71.8 133.06 84.55 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.574 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 36.0 Cg_endo -91.44 161.84 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.507 2.804 . . . . 0.0 113.549 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.0 mm -61.63 129.98 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 121.156 0.503 . . . . 0.0 111.019 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.72 11.94 51.95 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.707 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.4 -170.48 1.81 Allowed 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -147.79 166.78 26.52 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -150.45 125.2 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.463 -2.371 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.772 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.58 105.53 16.23 Favored 'General case' 0 C--N 1.268 -2.969 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -111.83 151.61 28.87 Favored 'General case' 0 C--O 1.208 -1.083 0 C-N-CA 125.593 1.557 . . . . 0.0 110.777 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 22.8 tt0 -111.01 121.73 46.1 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.748 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.7 mp -108.62 164.42 12.38 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 126.654 1.982 . . . . 0.0 109.272 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.5 t -140.69 112.46 7.57 Favored 'General case' 0 C--O 1.19 -2.026 0 CA-C-O 122.339 1.066 . . . . 0.0 111.992 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.606 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 7.7 tpp180 -95.3 129.99 42.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.78 -17.52 0.96 Allowed Glycine 0 C--N 1.294 -1.769 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.053 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -107.23 126.94 28.9 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.14 150.69 71.96 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 124.126 3.217 . . . . 0.0 112.573 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 6.4 mt -57.34 124.48 67.01 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.239 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 7.4 Cg_exo -66.75 -46.76 3.24 Favored 'Trans proline' 0 CA--C 1.49 -1.684 0 C-N-CA 123.339 2.693 . . . . 0.0 110.787 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 86.0 t80 -138.66 141.67 39.04 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.291 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.43 100.69 42.76 Favored Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 124.286 0.991 . . . . 0.0 111.813 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.468 ' HG3' ' HG2' ' A' ' 44' ' ' LYS . 59.9 Cg_endo -99.45 -64.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.643 0 C-N-CA 122.588 2.192 . . . . 0.0 111.621 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -119.68 31.72 6.42 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.989 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 34.8 t70 -86.48 108.73 19.03 Favored Pre-proline 0 CA--C 1.457 -2.633 0 C-N-CA 117.466 -1.694 . . . . 0.0 106.573 168.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' HB3' ' A' ' 117' ' ' SER . 73.2 Cg_endo -73.4 -30.84 9.73 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.161 1.908 . . . . 0.0 110.309 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.547 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 26.6 t30 -65.27 -2.31 2.96 Favored 'General case' 0 N--CA 1.389 -3.523 0 C-N-CA 131.358 3.863 . . . . 0.0 112.683 -168.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.467 HG23 ' OD2' ' A' ' 109' ' ' ASP . 23.7 p -92.36 -22.37 19.72 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.366 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.9 m -92.17 162.17 14.43 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.31 -1.313 . . . . 0.0 107.994 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.98 141.52 47.75 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.26 21.8 m 49.26 38.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.774 1.63 . . . . 0.0 114.247 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 110' ' ' PRO . 1.1 m -110.56 -172.88 2.12 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.592 ' HB3' ' HG2' ' A' ' 110' ' ' PRO . 10.9 p 59.56 96.1 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.075 0.95 . . . . 0.0 112.376 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -69.07 74.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.589 1.185 . . . . 0.0 112.688 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.71 33.2 2.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.544 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.0 mt 60.73 58.24 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.27 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.0 mt -127.27 117.43 22.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.835 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -125.28 51.14 1.71 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -92.55 80.36 4.84 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.728 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -101.88 136.65 19.48 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--O 1.262 1.724 0 C-N-CA 123.024 2.483 . . . . 0.0 112.225 176.79 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.785 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -64.34 0.91 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 117.558 0.679 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -111.9 19.0 18.34 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 98.88 -146.76 18.27 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.594 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 46.8 mmtm -108.6 -61.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 CA-C-N 118.69 1.245 . . . . 0.0 110.242 168.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 1' ' ' LYS . 44.2 Cg_endo -104.34 -164.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.814 1.676 . . . . 0.0 111.594 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -76.31 107.14 8.35 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 124.97 1.308 . . . . 0.0 107.659 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.587 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.1 t80 -101.73 129.87 48.0 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -138.17 11.8 2.82 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.284 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtt180 52.59 8.43 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.804 2.042 . . . . 0.0 114.789 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.407 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 7.9 m120 -131.96 116.75 15.83 Favored Pre-proline 0 N--CA 1.415 -2.176 0 C-N-CA 122.458 0.303 . . . . 0.0 110.974 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -63.56 -18.05 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 110.785 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 7' ' ' ASN . 7.8 p -76.15 -29.72 57.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.851 177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -107.38 -10.96 15.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.051 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -93.5 149.82 20.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.466 ' N ' HD13 ' A' ' 11' ' ' LEU . 45.9 mtmt -105.79 135.54 47.04 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.731 0.776 . . . . 0.0 110.998 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.569 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 151.17 170.15 17.75 Favored Glycine 1 C--N 1.244 -4.583 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -172.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -92.32 122.35 34.7 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.397 1.098 . . . . 0.0 108.443 175.179 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.6 m-85 -98.66 117.45 33.14 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 122.611 1.196 . . . . 0.0 110.027 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.469 HG12 ' HE3' ' A' ' 14' ' ' LYS . 34.1 mt -114.35 152.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.065 0 CA-C-N 112.755 -2.021 . . . . 0.0 109.357 -172.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 12.4 t60 -129.31 108.47 10.33 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.415 ' CG2' HD11 ' A' ' 97' ' ' LEU . 7.7 t -131.54 135.08 46.75 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.872 0.844 . . . . 0.0 109.81 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.8 ttmt -89.45 126.65 35.65 Favored 'General case' 0 C--N 1.257 -3.436 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.782 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.498 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.47 116.94 32.8 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 56.5 ttt180 -77.89 107.44 10.42 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.931 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.735 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 64.7 tttt -61.85 97.34 0.08 Allowed 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -86.23 -155.36 0.25 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 124.758 1.223 . . . . 0.0 108.818 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 m -54.21 -41.3 68.5 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.991 0.916 . . . . 0.0 110.816 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -96.16 -8.85 32.06 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.189 0.519 . . . . 0.0 109.958 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.735 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 96.32 -120.67 6.7 Favored Glycine 1 N--CA 1.391 -4.315 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.514 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 34.2 m-85 -89.58 141.74 28.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.401 0.6 . . . . 0.0 109.576 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.22 1.11 84.31 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.966 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' HB2' HG23 ' A' ' 43' ' ' ILE . 19.4 p90 -114.58 162.37 16.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.725 0.774 . . . . 0.0 111.099 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 40.6 p -115.18 154.34 29.18 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 41' ' ' LEU . 3.3 p -143.81 144.24 23.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.664 -174.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.33 170.02 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.26 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.05 -68.83 0.48 Allowed Glycine 0 CA--C 1.452 -3.906 0 CA-C-N 115.124 -0.943 . . . . 0.0 113.796 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -75.39 58.02 2.86 Favored Glycine 2 CA--C 1.406 -6.73 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' HIS . 13.4 m-20 -64.45 -12.78 47.08 Favored 'General case' 0 C--N 1.261 -3.251 0 O-C-N 124.449 0.735 . . . . 0.0 110.797 176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 38' ' ' ASP . 6.1 pt-20 -158.23 165.14 19.22 Favored Pre-proline 0 CA--C 1.452 -2.812 0 C-N-CA 116.519 -2.072 . . . . 0.0 111.205 -173.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.5 Cg_endo -68.37 47.01 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.764 2.309 . . . . 0.0 111.529 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 36' ' ' GLU . 27.2 m-20 -165.44 -22.69 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.356 2.262 . . . . 0.0 109.248 -172.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.716 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 37.9 mt-10 -112.83 126.25 55.23 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.259 5.2 m-30 -78.78 157.43 28.44 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 128.076 3.36 . . . . 0.0 111.365 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 80' ' ' VAL . 6.9 mp -90.08 144.71 25.65 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 117.506 -1.678 . . . . 0.0 107.093 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.8 mt-30 -143.54 151.01 39.72 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 29' ' ' PHE . 19.3 mm -68.39 117.8 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.625 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 20.8 tptm -63.05 -43.37 98.81 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.534 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.2 t 166.14 174.97 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 125.596 1.81 . . . . 0.0 109.993 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.3 152.41 45.85 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.704 0.764 . . . . 0.0 112.923 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 49' ' ' ASP . 49.4 t -85.35 128.61 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.51 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 89.1 mt -68.88 -15.9 63.62 Favored 'General case' 0 N--CA 1.387 -3.612 0 CA-C-N 112.733 -2.03 . . . . 0.0 113.59 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.49 ' H ' HG12 ' A' ' 47' ' ' VAL . 3.9 m-20 -96.26 -5.36 40.44 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 114.154 -1.385 . . . . 0.0 111.245 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.71 162.96 28.11 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.6 Cg_endo -53.99 -31.79 65.43 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 124.541 3.494 . . . . 0.0 113.576 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -59.3 -42.67 91.87 Favored 'General case' 0 C--O 1.279 2.641 0 CA-C-O 121.706 0.765 . . . . 0.0 111.42 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.74 -37.35 49.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.899 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 8.6 mp -68.82 -40.28 79.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.74 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.55 -26.1 61.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.72 2.78 77.42 Favored Glycine 0 CA--C 1.495 -1.181 0 CA-C-N 112.888 -1.96 . . . . 0.0 113.826 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -91.46 -21.28 21.01 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.21 149.28 23.25 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.575 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.37 154.73 40.34 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.395 0.617 . . . . 0.0 110.625 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 45' ' ' SER . 67.8 p -61.37 106.04 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.761 0.824 . . . . 0.0 111.493 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 110.79 -2.27 28.88 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 119.311 -0.716 . . . . 0.0 113.563 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.55 ' CB ' ' HG3' ' A' ' 99' ' ' ARG . 2.8 p30 -69.71 138.67 53.09 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.5 OUTLIER -87.76 120.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.486 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 31.3 mm -71.62 124.37 27.96 Favored 'Isoleucine or valine' 1 C--O 1.324 4.978 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 172.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 73' ' ' LEU . 37.0 t -115.63 -40.9 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.064 -2.789 . . . . 0.0 111.036 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.55 ' HA ' HG22 ' A' ' 72' ' ' VAL . 24.7 m -149.82 150.38 31.89 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.7 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.722 HG13 HG21 ' A' ' 72' ' ' VAL . 2.9 m -121.99 142.11 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 169.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.8 m120 54.61 28.11 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.548 0.689 . . . . 0.0 111.379 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 54.9 42.32 31.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.668 1.699 . . . . 0.0 111.832 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 72' ' ' VAL . 88.8 m -122.12 122.82 40.1 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.898 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.54 100.17 0.49 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.926 0.869 . . . . 0.0 111.055 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.722 HG21 HG13 ' A' ' 67' ' ' VAL . 17.4 m -105.04 17.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.587 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.1 tp -60.61 112.96 2.2 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.44 44.98 0.3 Allowed Glycine 0 N--CA 1.496 2.645 0 O-C-N 125.649 1.843 . . . . 0.0 111.272 -170.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 76' ' ' THR . 6.2 t-160 -45.37 -67.62 0.27 Allowed 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' HIS . 3.1 p -166.9 142.78 4.36 Favored 'General case' 0 C--N 1.262 -3.219 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 148.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.653 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.04 -35.21 33.19 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 120.695 1.588 . . . . 0.0 111.205 173.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.14 96.39 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.654 0.264 . . . . 0.0 110.929 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -69.65 -41.57 75.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.876 HG21 HD21 ' A' ' 41' ' ' LEU . 21.1 m -63.66 -39.82 86.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.154 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.62 -40.77 90.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -61.06 -36.81 80.59 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.556 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.9 mm -70.45 -37.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 123.683 0.793 . . . . 0.0 112.057 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.33 -29.01 62.39 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -76.34 -20.18 57.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.407 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 37.6 t -78.04 -26.39 48.35 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.501 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.6 mt -90.07 130.11 43.53 Favored Pre-proline 0 N--CA 1.398 -3.032 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.134 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.0 Cg_endo -89.49 162.44 5.41 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 123.697 2.932 . . . . 0.0 112.954 -173.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.557 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.3 mm -60.12 133.6 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 CA-C-O 121.538 0.685 . . . . 0.0 110.902 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.76 60.33 Favored Glycine 0 C--N 1.289 -2.078 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.019 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.38 -167.92 1.46 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.9 m -151.52 163.39 39.13 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 121.929 -0.482 . . . . 0.0 109.919 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -145.83 125.26 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 C-N-CA 119.569 -0.853 . . . . 0.0 111.76 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.08 107.16 12.65 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' SER . 63.6 mt -104.96 135.59 46.01 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 124.433 1.093 . . . . 0.0 111.75 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 38.8 mt-10 -90.52 120.47 31.64 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 7.9 mt -105.65 164.63 11.76 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.569 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.8 t -141.37 109.16 5.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 122.254 1.026 . . . . 0.0 110.906 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.55 ' HG3' ' CB ' ' A' ' 62' ' ' ASP 0.33 23.7 mtm180 -96.18 117.97 31.81 Favored 'General case' 0 C--N 1.257 -3.422 0 O-C-N 121.331 -0.856 . . . . 0.0 113.133 174.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.55 -29.73 0.1 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.287 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -101.64 135.46 19.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.547 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.72 161.77 44.64 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.257 2.638 . . . . 0.0 111.231 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 14.4 mt -50.41 127.06 23.17 Favored Pre-proline 0 N--CA 1.44 -0.96 0 C-N-CA 124.452 1.101 . . . . 0.0 111.195 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 66.4 Cg_endo -78.94 -81.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.048 3.165 . . . . 0.0 117.045 -170.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -128.22 146.56 50.7 Favored 'General case' 0 N--CA 1.424 -1.725 0 O-C-N 121.861 -0.524 . . . . 0.0 111.041 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' HB2' HG21 ' A' ' 112' ' ' THR . 0.7 OUTLIER -132.96 104.84 12.63 Favored Pre-proline 0 C--N 1.302 -1.498 0 C-N-CA 124.689 1.196 . . . . 0.0 110.621 -178.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -99.76 -64.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.282 1.988 . . . . 0.0 112.698 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -88.22 -11.58 46.26 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.47 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -91.97 142.67 26.68 Favored Pre-proline 0 CA--C 1.463 -2.375 0 C-N-CA 118.427 -1.309 . . . . 0.0 113.392 -167.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.541 ' HB3' ' O ' ' A' ' 119' ' ' ALA 0.285 50.2 Cg_endo -81.56 -40.93 0.14 Allowed 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.798 1.666 . . . . 0.0 111.699 167.051 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.718 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 55.5 m-80 -48.68 -17.12 0.15 Allowed 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -163.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.457 HG21 ' HB2' ' A' ' 106' ' ' ASP . 46.9 p -82.64 -38.93 22.8 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -170.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.2 m -158.79 125.82 4.81 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.0 mt 50.57 111.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.76 2.024 . . . . 0.0 114.765 173.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.0 t 60.68 77.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 111' ' ' ASN . 1.6 p -124.66 166.79 15.51 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.058 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 110' ' ' PRO . 32.7 t 63.71 114.67 0.02 OUTLIER 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.444 1.097 . . . . 0.0 111.309 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.6 t 59.36 46.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.79 1.281 . . . . 0.0 108.256 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 110' ' ' PRO . . . -159.93 69.13 0.4 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.879 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.97 91.12 3.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.31 12.19 23.34 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.772 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -85.02 -7.79 58.98 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.015 -1.902 . . . . 0.0 107.158 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 75.89 71.27 0.08 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.193 2.197 . . . . 0.0 113.742 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -101.94 142.87 25.47 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--O 1.254 1.308 0 C-N-CA 123.033 2.488 . . . . 0.0 112.703 177.1 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -150.81 -163.5 1.79 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' MET . . . . . 0.582 ' HA ' ' HB3' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -68.03 -31.92 71.93 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.231 175.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -136.17 -93.06 0.36 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.477 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.1 OUTLIER 58.51 71.75 0.96 Allowed Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 124.781 1.233 . . . . 0.0 113.695 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -104.07 -172.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 123.42 2.747 . . . . 0.0 110.228 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -89.93 104.8 17.34 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.552 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.9 t80 -105.15 131.15 53.0 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 HD23 ' A' ' 11' ' ' LEU . 8.8 t -140.38 19.05 2.4 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.246 1.022 . . . . 0.0 110.704 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 57.6 mtt180 58.41 -13.13 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.96 2.104 . . . . 0.0 115.961 172.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.533 ' OD1' ' HB2' ' A' ' 9' ' ' SER . 23.7 t-20 -113.57 119.48 41.52 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 110.927 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.1 Cg_exo -54.4 -32.82 74.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.179 3.252 . . . . 0.0 112.814 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.533 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 26.4 m -75.69 -22.48 56.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.408 0.683 . . . . 0.0 110.954 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 22.3 mm-40 -90.29 -19.56 23.96 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.898 0.879 . . . . 0.0 111.033 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD11 HD21 ' A' ' 73' ' ' LEU . 51.0 mt -74.48 172.37 12.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.092 0.948 . . . . 0.0 111.485 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -108.39 -170.39 1.67 Allowed 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 90.16 165.71 40.81 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.09 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 22.2 ttpt -95.86 137.7 34.55 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.464 ' HZ ' ' HB2' ' A' ' 11' ' ' LEU . 30.8 m-85 -104.88 111.89 24.81 Favored 'General case' 0 CA--C 1.458 -2.592 0 CA-C-O 122.687 1.232 . . . . 0.0 110.226 -173.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.461 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.4 mt -108.46 113.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.9 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.007 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.87 128.42 34.41 Favored 'General case' 0 C--N 1.252 -3.631 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.915 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 95' ' ' LEU . 7.4 t -133.62 157.01 46.83 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.399 -173.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -130.58 119.02 21.89 Favored 'General case' 0 C--N 1.247 -3.865 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 172.121 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' HG ' ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -106.67 117.47 34.14 Favored 'General case' 0 C--N 1.277 -2.576 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.837 -174.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 23.4 tpp180 -70.66 105.66 3.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.51 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.744 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 62.6 tttt -69.34 97.76 1.0 Allowed 'General case' 0 C--O 1.161 -3.603 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 165.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -86.66 -155.27 0.26 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.6 m -63.31 -33.12 74.82 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.541 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 1.3 tmt_? -83.53 -20.97 32.93 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.744 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 94.14 -129.19 9.79 Favored Glycine 0 N--CA 1.401 -3.649 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.8 m-85 -86.98 146.97 25.94 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 118.134 0.967 . . . . 0.0 110.212 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 20' ' ' LEU . . . -94.38 0.74 66.15 Favored Glycine 0 C--O 1.22 -0.775 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.533 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 5.8 p90 -115.67 163.48 15.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.514 . . . . 0.0 110.642 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 61.6 p -123.71 147.53 47.38 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.84 150.14 26.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.391 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.49 152.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.523 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.84 -132.12 9.7 Favored Glycine 1 N--CA 1.395 -4.06 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 47.58 37.46 13.42 Favored Glycine 0 CA--C 1.476 -2.363 0 C-N-CA 124.212 0.911 . . . . 0.0 113.55 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 29.3 t70 -69.03 -29.4 67.54 Favored 'General case' 0 CA--C 1.459 -2.547 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -174.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -162.38 166.74 13.46 Favored Pre-proline 0 CA--C 1.455 -2.702 0 C-N-CA 118.352 -1.339 . . . . 0.0 109.243 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.7 Cg_endo -66.19 58.72 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.005 2.47 . . . . 0.0 109.583 170.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 174.54 -9.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.746 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.5 mm-40 -128.34 124.53 36.68 Favored 'General case' 0 C--O 1.281 2.744 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.521 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.276 5.9 m-30 -76.66 158.81 30.75 Favored 'General case' 1 N--CA 1.549 4.52 0 C-N-CA 130.914 3.685 . . . . 0.0 113.609 -168.246 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 80' ' ' VAL . 6.2 mp -92.4 138.86 31.15 Favored 'General case' 0 C--O 1.178 -2.659 0 C-N-CA 117.068 -1.853 . . . . 0.0 106.951 170.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.592 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 18.1 mt-30 -136.16 154.18 51.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 20.7 mm -71.34 115.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' SER . 31.0 ttpt -65.01 -41.63 95.18 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 166.72 173.72 0.03 OUTLIER 'General case' 0 C--N 1.371 1.503 0 O-C-N 125.186 1.554 . . . . 0.0 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 58' ' ' MET . 1.4 pp -141.6 152.2 43.8 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 123.816 0.846 . . . . 0.0 111.819 -172.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 49' ' ' ASP . 14.0 t -82.85 124.41 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.793 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.88 -3.75 13.83 Favored 'General case' 0 N--CA 1.379 -3.975 0 CA-C-N 112.836 -1.984 . . . . 0.0 112.937 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' H ' HG12 ' A' ' 47' ' ' VAL . 17.0 t70 -95.79 -22.97 17.17 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.658 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.35 162.77 36.83 Favored Glycine 0 N--CA 1.398 -3.892 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.586 -170.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -51.39 -30.32 33.98 Favored 'Trans proline' 0 C--O 1.197 -1.553 0 C-N-CA 125.178 3.919 . . . . 0.0 112.952 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.06 -47.97 81.52 Favored 'General case' 0 C--O 1.258 1.524 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.34 -36.2 54.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.644 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.31 -40.6 70.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.733 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.37 -21.6 62.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.81 39.88 75.84 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -111.26 -37.62 5.25 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.677 0.275 . . . . 0.0 111.463 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.429 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 1.1 mpt? -95.93 153.14 17.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.403 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.78 158.38 43.69 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 45' ' ' SER . 49.0 p -64.22 108.67 1.64 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.007 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.486 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.56 -11.64 9.61 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.709 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 2.9 m-20 -62.86 136.69 57.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.547 1.173 . . . . 0.0 108.803 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -88.25 123.36 40.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 177.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.59 123.52 30.28 Favored 'Isoleucine or valine' 1 C--O 1.34 5.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 HD13 ' A' ' 73' ' ' LEU . 46.0 t -115.53 -36.14 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 127.444 2.965 . . . . 0.0 111.375 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 65.6 m -148.57 159.62 43.9 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.515 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG12 ' HB ' ' A' ' 72' ' ' VAL . 4.3 p -141.45 130.18 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 108.016 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.23 31.48 20.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.461 0.648 . . . . 0.0 110.728 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 71.2 1.4 3.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.495 1.518 . . . . 0.0 112.593 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.3 m -90.95 121.97 33.23 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.8 t -58.86 114.8 2.72 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -124.23 19.39 4.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.57 HD13 HG13 ' A' ' 65' ' ' VAL . 27.8 tp -59.15 112.85 1.86 Allowed 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.11 39.76 0.06 OUTLIER Glycine 0 C--O 1.186 -2.879 0 O-C-N 125.737 1.898 . . . . 0.0 112.792 -170.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 76' ' ' THR . 6.4 t-160 -43.38 -65.75 0.46 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.9 p -167.33 143.84 4.35 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 151.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.581 ' HA ' HG22 ' A' ' 80' ' ' VAL . 1.4 t60 -50.85 -35.13 30.99 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 120.099 1.318 . . . . 0.0 109.702 171.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -46.95 87.17 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.436 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -66.35 -43.08 87.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 41' ' ' LEU . 15.3 m -64.44 -44.89 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 84.5 t -64.51 -42.12 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.74 -37.89 83.3 Favored 'General case' 0 C--O 1.212 -0.887 0 O-C-N 123.151 0.282 . . . . 0.0 111.47 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.57 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.9 mm -67.48 -38.28 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.307 0.575 . . . . 0.0 112.148 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.54 -32.19 65.88 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.523 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 84.4 mt-30 -67.78 -32.07 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.211 1.005 . . . . 0.0 109.691 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.2 m -72.33 -40.6 67.31 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.886 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.478 HG22 ' HD3' ' A' ' 22' ' ' LYS . 30.8 mt -70.34 133.05 87.47 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.475 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 15.0 Cg_endo -87.21 162.65 8.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.57 2.847 . . . . 0.0 113.433 -172.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.526 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.9 mm -60.22 134.8 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.609 0.719 . . . . 0.0 111.074 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.37 8.26 66.4 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.365 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.536 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.24 128.08 51.94 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.415 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 1.9 p -89.79 159.14 17.18 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.13 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -141.78 125.6 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.183 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.913 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.3 104.5 15.2 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.492 ' HB2' HG23 ' A' ' 18' ' ' THR . 27.9 mt -109.68 159.72 16.9 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 126.138 1.775 . . . . 0.0 109.305 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.44 122.71 48.5 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 75.7 mt -109.14 163.14 13.61 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.21 1.004 . . . . 0.0 108.766 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -142.91 116.58 9.22 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.412 175.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.493 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 ttm180 -104.73 125.57 50.95 Favored 'General case' 0 C--N 1.258 -3.374 0 O-C-N 120.729 -1.232 . . . . 0.0 108.764 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.9 -22.03 0.23 Allowed Glycine 0 CA--C 1.472 -2.639 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -90.89 134.62 29.99 Favored Pre-proline 0 N--CA 1.422 -1.835 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.58 152.57 81.28 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.803 3.002 . . . . 0.0 112.939 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 6.1 mt -59.9 128.41 86.84 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 123.477 0.711 . . . . 0.0 110.654 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 90.6 Cg_endo -83.9 -158.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.054 2.503 . . . . 0.0 113.389 -177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.582 ' HB3' ' HA ' ' A' ' -1' ' ' MET . 66.9 t80 -79.96 150.63 30.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 123.153 1.454 . . . . 0.0 111.293 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -115.41 86.32 14.67 Favored Pre-proline 0 N--CA 1.388 -3.574 0 CA-C-N 111.726 -2.488 . . . . 0.0 110.887 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -88.3 -49.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.516 2.144 . . . . 0.0 111.378 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -59.38 -22.99 62.19 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 125.183 1.393 . . . . 0.0 110.832 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.499 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -108.53 102.98 49.69 Favored Pre-proline 0 CA--C 1.473 -2.009 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.879 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.499 ' HD2' ' HA ' ' A' ' 109' ' ' ASP 0.285 54.7 Cg_endo -76.65 -29.41 5.75 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.371 2.047 . . . . 0.0 108.89 170.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 110' ' ' PRO . 57.2 m-20 -47.58 -2.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 1 C-N-CA 132.67 4.388 . . . . 0.0 116.014 -168.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 110' ' ' PRO . 26.4 p -107.04 6.38 28.94 Favored 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -168.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.0 m -146.19 110.26 4.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.773 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.8 mt 55.66 -154.22 0.31 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.279 0.631 . . . . 0.0 110.374 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.6 m -56.46 84.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 122.04 0.924 . . . . 0.0 112.745 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.436 ' HB ' ' HA ' ' A' ' 111' ' ' ASN . 2.0 p -134.67 167.16 21.34 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.431 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . 61.8 p 61.9 101.53 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.406 1.082 . . . . 0.0 109.411 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.9 m -52.23 96.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -175.02 114.98 0.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.3 mm -122.04 103.5 13.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 122.049 0.928 . . . . 0.0 112.399 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -116.37 22.59 12.72 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.94 146.05 26.4 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.605 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -86.79 -10.68 52.99 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.098 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.05 139.62 96.69 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.495 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 C--O 1.256 1.382 0 C-N-CA 123.818 3.012 . . . . 0.0 112.463 174.558 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 1' ' ' LYS . . . . . . . . 0 CA--C 1.494 -1.273 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.23 -85.27 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 7.5 mmt -101.75 0.03 35.18 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 173.51 -97.26 0.11 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.416 ' HB2' ' HA2' ' A' ' -3' ' ' GLY . 24.9 mmmt 59.16 69.69 1.29 Allowed Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.417 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' HG3' ' H ' ' A' ' 40' ' ' PHE . 40.2 Cg_endo -108.61 -175.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.931 2.42 . . . . 0.0 113.57 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -88.83 105.3 17.64 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.576 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.8 t80 -108.76 135.24 50.31 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -143.3 12.7 1.78 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.313 1.054 . . . . 0.0 110.239 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.566 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 7.1 mtm180 59.76 -11.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.008 2.123 . . . . 0.0 114.88 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.495 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 51.2 t-20 -111.35 115.98 51.48 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.1 0.476 . . . . 0.0 110.626 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 4.2 Cg_endo -56.46 -28.19 72.13 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.649 2.9 . . . . 0.0 112.84 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.61 -27.19 63.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -91.42 -22.45 20.45 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.843 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.595 HD11 HD21 ' A' ' 73' ' ' LEU . 44.3 mt -72.09 179.48 3.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.108 0.956 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -108.87 -166.37 1.11 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.069 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.588 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.17 167.56 41.66 Favored Glycine 0 C--N 1.304 -1.23 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.751 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 33.4 tttp -97.53 143.39 28.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.7 m-85 -106.95 112.04 24.81 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.415 1.103 . . . . 0.0 109.419 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' HE3' ' A' ' 14' ' ' LYS . 14.4 mt -112.3 148.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.442 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.09 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.592 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.9 t60 -124.76 120.02 30.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -140.34 131.5 26.45 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.741 0.781 . . . . 0.0 111.294 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 31.7 ttmt -88.16 125.95 34.88 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.327 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.38 117.4 33.95 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.912 -176.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 41.3 ttm180 -77.44 107.42 9.87 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.699 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.644 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 76.3 tttt -64.54 97.39 0.2 Allowed 'General case' 0 C--O 1.178 -2.699 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 t -91.86 -153.53 0.34 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 125.347 1.459 . . . . 0.0 108.216 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 p -52.68 -46.8 67.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.982 0.513 . . . . 0.0 111.564 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 31.2 mmt180 -84.07 -17.23 40.97 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.514 0.674 . . . . 0.0 109.904 173.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.644 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 95.68 -105.61 3.27 Favored Glycine 1 N--CA 1.377 -5.295 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.507 ' HD1' HD12 ' A' ' 20' ' ' LEU . 40.5 m-85 -97.1 140.22 31.93 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.687 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.87 4.83 84.94 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.638 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' HB2' HG23 ' A' ' 43' ' ' ILE . 27.4 p90 -111.99 163.04 14.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.454 0.645 . . . . 0.0 110.499 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HE3' ' A' ' 44' ' ' LYS . 43.7 p -117.6 149.15 41.15 Favored 'General case' 0 N--CA 1.401 -2.891 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.51 HG21 HD23 ' A' ' 41' ' ' LEU . 3.3 p -141.24 139.16 33.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 C-N-CA 119.246 -0.981 . . . . 0.0 112.06 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 33' ' ' GLY . 13.1 p -149.24 167.24 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.942 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 128.55 -65.11 0.59 Allowed Glycine 0 CA--C 1.453 -3.795 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.175 173.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -74.9 57.64 2.66 Favored Glycine 2 CA--C 1.42 -5.897 0 C-N-CA 125.649 1.595 . . . . 0.0 116.284 -167.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.88 -11.95 50.79 Favored 'General case' 0 C--N 1.257 -3.438 0 O-C-N 124.123 0.543 . . . . 0.0 111.571 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.551 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 6.9 pt-20 -160.92 167.35 13.69 Favored Pre-proline 0 CA--C 1.451 -2.859 0 C-N-CA 116.11 -2.236 . . . . 0.0 110.615 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.1 Cg_endo -68.23 54.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.351 2.034 . . . . 0.0 110.198 172.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -176.41 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.685 1.594 . . . . 0.0 109.93 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.708 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 51.3 mm-40 -114.36 128.42 56.34 Favored 'General case' 0 C--O 1.276 2.45 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.443 ' H ' ' HG3' ' A' ' 2' ' ' PRO 0.267 8.5 m-30 -79.56 156.4 27.74 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 128.101 3.375 . . . . 0.0 111.19 -178.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -87.33 142.21 28.06 Favored 'General case' 0 C--O 1.178 -2.692 0 C-N-CA 117.103 -1.839 . . . . 0.0 107.684 174.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.505 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 49.6 mt-30 -138.97 154.61 48.31 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG23 ' HB2' ' A' ' 29' ' ' PHE . 31.2 mm -76.41 111.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HE3' ' OG1' ' A' ' 30' ' ' THR . 0.5 OUTLIER -61.98 -37.54 85.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.59 ' HA ' HG22 ' A' ' 60' ' ' THR . 48.5 t 164.68 173.22 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 125.37 1.669 . . . . 0.0 109.479 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -137.2 151.58 48.93 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-O 122.044 0.926 . . . . 0.0 113.063 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 49' ' ' ASP . 40.7 t -73.54 117.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 113.454 -1.703 . . . . 0.0 106.748 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.66 -23.08 49.49 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 112.976 -1.92 . . . . 0.0 112.896 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' H ' HG12 ' A' ' 47' ' ' VAL . 31.8 m-20 -96.68 -2.04 45.38 Favored 'General case' 0 C--N 1.267 -3.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.219 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.33 167.64 26.35 Favored Glycine 0 N--CA 1.422 -2.256 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.366 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.1 Cg_endo -55.25 -31.03 74.57 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 124.187 3.258 . . . . 0.0 112.979 -176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.36 -44.94 89.01 Favored 'General case' 0 C--O 1.274 2.371 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.36 55.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.294 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.81 -35.43 64.87 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.82 -24.47 65.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.96 22.02 78.34 Favored Glycine 0 CA--C 1.49 -1.524 0 CA-C-N 112.515 -2.13 . . . . 0.0 113.79 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -109.44 -32.71 7.05 Favored 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.5 ttm -96.07 142.22 28.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.47 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.01 166.2 23.27 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.076 0.941 . . . . 0.0 111.082 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.9 p -70.74 111.77 6.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.081 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.7 -11.64 15.66 Favored Glycine 0 C--N 1.309 -0.929 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.903 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.662 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.8 m-20 -63.54 134.62 55.86 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -91.66 124.73 44.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 13.1 mm -73.17 123.9 29.03 Favored 'Isoleucine or valine' 1 C--O 1.32 4.764 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 HD13 ' A' ' 73' ' ' LEU . 42.9 t -115.53 -34.49 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 O-C-N 126.979 2.674 . . . . 0.0 110.447 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.583 ' HA ' HG22 ' A' ' 72' ' ' VAL . 36.5 m -148.98 146.71 27.93 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.954 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.591 HG12 HG11 ' A' ' 72' ' ' VAL . 7.1 p -124.75 132.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.0 m120 61.11 23.75 13.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 110.978 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.7 t70 66.66 21.46 10.62 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.743 1.617 . . . . 0.0 112.015 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' HG13 ' A' ' 72' ' ' VAL . 56.2 m -102.91 120.43 40.61 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 171.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.7 t -66.7 110.33 3.19 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG11 HG12 ' A' ' 67' ' ' VAL . 35.7 m -122.67 28.88 2.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.563 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.595 HD21 HD11 ' A' ' 11' ' ' LEU . 39.0 tp -60.98 112.92 2.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.82 42.29 0.23 Allowed Glycine 0 C--N 1.376 2.763 0 O-C-N 125.339 1.649 . . . . 0.0 111.374 -170.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' HG23 ' A' ' 76' ' ' THR . 6.6 t-160 -43.31 -66.11 0.41 Allowed 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' HIS . 7.2 p -167.31 143.31 4.21 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 151.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -49.69 -35.69 22.59 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 120.31 1.414 . . . . 0.0 110.572 173.189 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.13 71.37 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.934 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -60.27 -44.5 95.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 41' ' ' LEU . 35.8 m -71.23 -43.31 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.606 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 91.6 t -64.92 -41.29 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -60.91 -38.58 86.22 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.692 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.591 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.8 mm -68.58 -33.21 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.313 0.577 . . . . 0.0 112.478 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -73.25 -30.12 63.23 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 87.5 mt-30 -76.64 -19.9 57.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.824 1.25 . . . . 0.0 110.821 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.7 m -79.68 -44.33 21.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.923 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.491 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.6 mt -67.24 136.46 93.74 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.199 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -90.99 161.18 3.93 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 123.081 2.52 . . . . 0.0 112.969 -173.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.566 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.0 mm -63.88 134.76 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-O 120.912 0.386 . . . . 0.0 110.705 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.04 54.16 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.312 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.03 -170.0 1.82 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -175.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 20.8 m -151.06 157.38 42.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.46 125.66 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.807 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.592 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 14.4 m-20 -76.44 105.3 7.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.7 mt -103.86 138.41 40.48 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 124.139 0.976 . . . . 0.0 110.484 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.3 tt0 -101.05 118.38 36.87 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 81.5 mt -107.14 150.06 26.99 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 124.776 1.23 . . . . 0.0 109.99 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.636 ' HB3' HG13 ' A' ' 63' ' ' VAL . 9.4 t -118.11 106.21 12.63 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.132 0.968 . . . . 0.0 108.553 172.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.662 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 36.2 ttp180 -104.66 127.76 52.51 Favored 'General case' 0 C--N 1.248 -3.823 0 O-C-N 120.811 -1.181 . . . . 0.0 109.954 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.8 -27.55 0.4 Allowed Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.41 141.54 39.54 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.25 160.5 29.44 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.288 2.659 . . . . 0.0 111.643 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 10.3 mt -57.89 142.71 78.71 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 124.081 0.952 . . . . 0.0 112.502 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 8.2 Cg_exo -67.81 -68.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.431 2.087 . . . . 0.0 110.698 173.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.43 133.59 33.0 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-O 122.013 0.911 . . . . 0.0 109.001 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -122.41 93.53 48.42 Favored Pre-proline 0 N--CA 1.388 -3.554 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.637 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -91.62 -61.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.017 1.812 . . . . 0.0 112.737 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.93 -11.3 53.51 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.747 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -88.08 115.58 63.56 Favored Pre-proline 0 CA--C 1.468 -2.181 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.022 -177.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 116' ' ' THR 0.269 53.0 Cg_endo -73.39 -38.2 2.76 Favored 'Trans proline' 0 CA--C 1.481 -2.164 0 C-N-CA 122.32 2.013 . . . . 0.0 112.286 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.785 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 38.6 m-80 -57.4 -13.03 2.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 111.626 -2.534 . . . . 0.0 114.376 -164.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 p -93.11 -21.18 19.85 Favored 'General case' 0 N--CA 1.39 -3.437 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.002 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 115' ' ' VAL . 16.7 m -111.02 160.42 16.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.216 -174.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -72.5 39.78 0.08 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 122.424 1.107 . . . . 0.0 113.678 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 113' ' ' SER . 4.3 p -166.32 86.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.785 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -132.99 -177.49 4.53 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.469 -1.241 . . . . 0.0 112.469 -169.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -51.18 108.48 0.25 Allowed 'General case' 0 N--CA 1.407 -2.576 0 C-N-CA 127.459 2.303 . . . . 0.0 109.392 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 t 61.71 46.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.3 1.048 . . . . 0.0 110.162 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.02 114.99 6.96 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.6 mm 62.01 59.78 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-O 122.164 0.983 . . . . 0.0 108.495 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.63 132.41 41.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.803 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.51 152.64 20.84 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.27 45.85 0.48 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.579 0.704 . . . . 0.0 112.797 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -101.93 136.4 19.51 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 C-N-CA 123.009 2.473 . . . . 0.0 111.872 177.991 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.553 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -99.62 -40.05 7.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.325 0.584 . . . . 0.0 109.775 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.38 75.87 9.73 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.031 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 129.91 -86.65 0.31 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.184 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.5 tptp 56.38 65.13 4.34 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.935 1.294 . . . . 0.0 110.355 -174.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -105.56 -165.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.286 2.658 . . . . 0.0 112.789 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -100.74 111.97 24.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.62 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.7 t80 -106.52 143.06 35.17 Favored 'General case' 0 C--N 1.268 -2.957 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.964 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -147.13 9.68 0.98 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.146 0.974 . . . . 0.0 110.443 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.525 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtm180 53.28 4.71 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 127.241 2.217 . . . . 0.0 114.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.491 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.4 t-20 -130.2 119.91 18.9 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HB3' HG11 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -60.94 -19.1 61.05 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.072 3.182 . . . . 0.0 112.835 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -80.43 -24.57 39.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -98.33 -19.9 17.5 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.847 0.356 . . . . 0.0 111.718 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 42.8 tp -84.99 160.46 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.286 0.565 . . . . 0.0 110.848 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 58.7 mttm -97.56 -171.23 2.14 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.896 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.15 163.95 39.87 Favored Glycine 0 C--N 1.299 -1.506 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 28.2 tttp -93.37 137.97 32.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.607 -1.237 . . . . 0.0 108.828 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 95.9 m-85 -106.05 110.68 23.02 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 122.561 1.172 . . . . 0.0 109.066 -177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 HD13 ' NH2' ' A' ' 99' ' ' ARG . 15.1 mt -114.8 147.33 18.3 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.875 0 CA-C-N 112.36 -2.2 . . . . 0.0 107.94 -173.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -117.35 132.08 56.66 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.917 0.865 . . . . 0.0 111.867 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -140.1 127.58 21.47 Favored 'General case' 0 C--N 1.263 -3.186 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.245 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.796 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttmt -90.15 122.27 32.95 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.843 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.435 HD21 ' CA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -106.79 116.78 32.52 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.596 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.9 ttt180 -76.85 107.83 9.46 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.279 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.731 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.1 tttt -64.08 97.32 0.17 Allowed 'General case' 0 C--O 1.181 -2.512 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 167.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -82.11 -158.24 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -96.58 -0.29 48.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.731 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 83.78 -129.05 8.9 Favored Glycine 0 N--CA 1.406 -3.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.57 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.8 m-85 -90.28 141.98 28.17 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 120.875 0.369 . . . . 0.0 110.207 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.99 86.84 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.143 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.412 ' HB2' HG23 ' A' ' 43' ' ' ILE . 21.3 p90 -111.15 163.3 14.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.475 0.655 . . . . 0.0 110.76 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 69.2 p -115.99 152.27 33.83 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG21 HD23 ' A' ' 41' ' ' LEU . 4.8 p -140.41 143.59 29.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.618 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 33' ' ' GLY . 8.8 p -144.89 167.94 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.453 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.487 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 32' ' ' VAL . . . 111.86 -141.64 16.74 Favored Glycine 1 N--CA 1.388 -4.526 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 -177.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.6 35.66 16.72 Favored Glycine 0 CA--C 1.473 -2.571 0 CA-C-N 117.396 0.598 . . . . 0.0 111.98 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 16.8 t70 -67.0 -29.55 69.42 Favored 'General case' 0 CA--C 1.46 -2.517 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -172.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.41 166.64 13.6 Favored Pre-proline 0 CA--C 1.467 -2.246 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.024 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 20.1 Cg_endo -65.93 58.77 0.42 Allowed 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.561 2.174 . . . . 0.0 109.945 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 11.9 t70 179.24 -16.14 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.233 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 33.9 mm-40 -122.59 123.94 42.35 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 73' ' ' LEU . 6.0 m-30 -76.91 159.28 30.13 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 130.711 3.604 . . . . 0.0 113.762 -169.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 80' ' ' VAL . 8.0 mp -89.03 146.98 24.51 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.8 mt-30 -142.84 157.69 44.36 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.437 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 39.4 mm -74.45 109.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.7 tttp -57.82 -41.05 81.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 60' ' ' THR . 31.2 t 163.04 174.98 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 O-C-N 125.827 1.954 . . . . 0.0 109.808 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.486 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -139.53 150.3 44.94 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.535 0.683 . . . . 0.0 111.826 -175.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 49' ' ' ASP . 60.8 t -75.77 123.87 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 173.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.9 pt? -68.76 -5.21 19.3 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 47' ' ' VAL . 6.3 m-20 -100.0 -6.56 26.31 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.181 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.53 163.76 32.7 Favored Glycine 0 N--CA 1.408 -3.186 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.3 -31.59 30.22 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 124.78 3.654 . . . . 0.0 113.249 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.78 -46.47 84.53 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.425 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.33 -33.95 55.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.058 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.4 mp -70.47 -40.0 73.91 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 124.187 0.995 . . . . 0.0 112.377 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.613 ' OD2' ' HE3' ' A' ' 57' ' ' LYS . 24.4 t70 -66.33 -24.15 66.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.694 1.235 . . . . 0.0 108.326 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.8 19.67 78.24 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.586 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.613 ' HE3' ' OD2' ' A' ' 55' ' ' ASP . 25.6 mtmt -122.02 -18.9 6.81 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -102.19 130.83 48.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.699 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.58 162.91 22.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.403 1.097 . . . . 0.0 111.777 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 45' ' ' SER . 80.7 p -72.57 108.69 5.75 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.657 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.1 -16.14 9.34 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.642 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.678 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 13.5 m-20 -61.13 131.8 51.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.6 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.262 0.2 OUTLIER -85.96 123.58 39.62 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.726 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 15.4 mm -74.06 124.36 31.3 Favored 'Isoleucine or valine' 1 C--O 1.326 5.115 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 8' ' ' PRO . 42.0 t -115.85 -41.06 2.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 110.881 -2.872 . . . . 0.0 111.201 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.579 ' HA ' HG22 ' A' ' 72' ' ' VAL . 68.0 m -144.85 149.27 35.09 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.032 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.775 HG23 HG21 ' A' ' 72' ' ' VAL . 25.1 t -111.7 115.04 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 66.1 -78.83 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.846 1.341 . . . . 0.0 109.634 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -156.22 24.31 0.36 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.36 1.076 . . . . 0.0 110.316 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.538 ' O ' HG13 ' A' ' 72' ' ' VAL . 27.1 m -106.87 117.99 35.51 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 32.3 t -64.9 108.23 1.71 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.775 HG21 HG23 ' A' ' 67' ' ' VAL . 28.2 m -117.53 20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.408 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.62 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 36.3 tp -61.64 112.76 2.37 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 39.54 0.06 OUTLIER Glycine 0 C--N 1.385 3.286 0 O-C-N 125.484 1.74 . . . . 0.0 112.273 -171.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.473 ' O ' HG23 ' A' ' 76' ' ' THR . 4.9 t-160 -42.31 -65.24 0.49 Allowed 'General case' 0 C--N 1.37 1.481 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.1 p -166.36 143.11 4.99 Favored 'General case' 0 C--N 1.257 -3.423 0 N-CA-C 100.812 -3.773 . . . . 0.0 100.812 150.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.615 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.8 -31.37 26.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 121.018 1.735 . . . . 0.0 111.233 173.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.09 -50.26 74.07 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -64.55 -42.01 95.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 41' ' ' LEU . 11.0 m -66.57 -41.85 89.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.05 -38.98 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -37.24 86.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 86' ' ' SER . 2.1 mm -67.56 -35.7 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.56 0.695 . . . . 0.0 112.146 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -73.55 -30.49 63.09 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.74 -26.68 62.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.657 0.783 . . . . 0.0 110.41 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -70.96 -42.5 69.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.768 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 20.6 mt -72.16 130.08 86.85 Favored Pre-proline 0 N--CA 1.408 -2.567 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.017 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.3 Cg_endo -91.86 162.42 3.35 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 123.514 2.809 . . . . 0.0 112.947 -173.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.3 mm -59.43 132.79 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-O 121.296 0.57 . . . . 0.0 111.217 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.65 56.54 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.443 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.9 -169.54 1.69 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 8.1 m -150.6 159.93 44.16 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -142.0 125.01 14.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.766 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.225 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.08 102.16 11.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.76 135.57 40.04 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.221 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 35.5 tt0 -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.805 175.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.0 mt -106.33 144.81 32.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.0 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 10.2 t -112.44 107.78 16.68 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.005 0.907 . . . . 0.0 108.82 172.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.678 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 26.9 ttp180 -101.59 131.74 47.62 Favored 'General case' 0 C--N 1.25 -3.747 0 O-C-N 121.021 -1.049 . . . . 0.0 109.874 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.66 1.41 Allowed Glycine 0 C--N 1.307 -1.061 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.42 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.88 128.73 31.52 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.35 160.3 48.32 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.834 3.022 . . . . 0.0 113.12 -174.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 9.9 mt -59.29 131.19 87.58 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.006 176.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 6.0 Cg_exo -71.29 -39.8 3.6 Favored 'Trans proline' 0 CA--C 1.49 -1.699 0 C-N-CA 122.847 2.364 . . . . 0.0 110.166 176.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.409 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 75.1 t80 -139.17 148.82 43.69 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.597 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' CB ' HG21 ' A' ' 112' ' ' THR . 7.5 p-10 -116.04 88.33 21.63 Favored Pre-proline 0 N--CA 1.395 -3.179 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.31 -173.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 73.7 Cg_endo -93.87 -57.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.028 1.819 . . . . 0.0 112.783 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -91.37 -12.9 33.55 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.321 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -78.38 119.7 78.31 Favored Pre-proline 0 CA--C 1.45 -2.873 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.482 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 89.0 Cg_endo -75.05 -44.66 0.32 Allowed 'Trans proline' 0 N--CA 1.418 -2.919 0 C-N-CA 121.683 1.589 . . . . 0.0 111.306 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.482 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 14.6 m-80 -55.8 1.01 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 129.467 3.107 . . . . 0.0 114.702 -162.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 110' ' ' PRO . 76.1 p -99.51 -20.72 16.26 Favored 'General case' 1 N--CA 1.374 -4.234 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.504 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 11.8 p -165.29 142.82 5.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.734 -170.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 113' ' ' SER 0.33 3.7 pp 64.46 -166.35 0.23 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.954 1.702 . . . . 0.0 111.79 -177.037 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.562 ' N ' ' HB2' ' A' ' 122' ' ' ASP . 3.9 p -63.13 90.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.945 0.879 . . . . 0.0 110.453 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 110' ' ' PRO . 2.7 p -134.0 175.77 9.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 121.901 -0.499 . . . . 0.0 112.253 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.45 ' HB2' ' OD1' ' A' ' 111' ' ' ASN . 15.1 m -63.72 127.42 31.28 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 123.281 0.363 . . . . 0.0 110.997 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.5 p 55.32 20.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.402 1.881 . . . . 0.0 112.791 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.41 94.79 1.63 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.353 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.84 82.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.09 54.76 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.562 ' HB2' ' N ' ' A' ' 115' ' ' VAL . 38.1 t70 -96.22 -84.57 0.35 Allowed 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.851 -172.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -176.15 31.21 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 125.64 1.576 . . . . 0.0 107.762 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.568 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.9 pm0 -73.76 169.82 17.01 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.578 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 6.0 Cg_exo . . . . . 0 C--N 1.376 1.981 1 C-N-CA 126.624 4.883 . . . . 0.0 115.618 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ALA . . . . . 0.8 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -126.63 23.3 6.8 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-O 121.736 0.779 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 58.4 ttm -159.66 35.14 0.19 Allowed 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 133.31 -165.76 23.97 Favored Glycine 0 N--CA 1.406 -3.305 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.349 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.503 ' HA ' ' HE3' ' A' ' 1' ' ' LYS . 0.0 OUTLIER 49.97 55.27 16.8 Favored Pre-proline 0 C--N 1.305 -1.344 0 C-N-CA 124.306 1.042 . . . . 0.0 113.008 -178.118 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 37.2 Cg_endo -106.22 -176.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.636 2.224 . . . . 0.0 111.719 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.412 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 44.0 t80 -86.6 104.47 16.06 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.597 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -106.91 131.07 54.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -140.11 13.53 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.045 0.926 . . . . 0.0 109.912 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 6.2 mtm180 53.07 7.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 54.5 t-20 -132.77 121.27 17.0 Favored Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.001 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -59.21 -22.74 66.28 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 124.262 3.308 . . . . 0.0 113.152 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -79.23 -30.61 43.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.363 0.602 . . . . 0.0 109.478 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -90.41 -24.0 20.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.519 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 38.3 tp -82.26 152.95 26.13 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.35 144.83 42.1 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-O 121.73 0.776 . . . . 0.0 109.767 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.655 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 155.19 -178.13 32.02 Favored Glycine 1 C--N 1.249 -4.292 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -173.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HE2' ' CG1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -98.6 121.73 40.92 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.055 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' A' ' 98' ' ' CYS . 85.9 m-85 -100.1 119.25 38.01 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.131 0.967 . . . . 0.0 109.506 -174.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.602 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 44.7 mt -117.42 141.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.95 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.68 -170.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -107.06 126.44 52.35 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.53 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 9.0 t -137.55 157.54 46.31 Favored 'General case' 0 C--O 1.179 -2.633 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.329 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 35.6 ttpt -130.35 122.99 28.92 Favored 'General case' 0 C--N 1.261 -3.278 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.09 117.07 33.1 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 58.0 ttp180 -73.84 105.43 5.11 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.918 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.727 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.0 tttt -64.16 97.17 0.17 Allowed 'General case' 0 C--O 1.18 -2.602 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -84.53 -154.88 0.18 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -58.99 -38.34 78.93 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.449 0.7 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -90.01 -19.94 23.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.727 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 99.84 -118.9 6.32 Favored Glycine 1 N--CA 1.388 -4.541 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.477 ' HD1' HD12 ' A' ' 20' ' ' LEU . 38.4 m-85 -90.55 136.51 33.02 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 117.674 0.737 . . . . 0.0 110.515 -176.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 9.71 76.79 Favored Glycine 0 C--O 1.212 -1.253 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.613 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 9.3 p90 -121.14 162.67 19.69 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.345 0.572 . . . . 0.0 110.375 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -123.13 147.34 46.9 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.5 m -121.61 146.22 27.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-O 121.284 0.564 . . . . 0.0 111.622 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.85 152.04 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.515 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.89 -129.59 8.33 Favored Glycine 1 N--CA 1.395 -4.08 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 45.06 38.04 5.93 Favored Glycine 0 CA--C 1.472 -2.597 0 C-N-CA 124.935 1.255 . . . . 0.0 114.072 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 6.6 m-20 -67.09 -24.4 65.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.405 -176.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.3 pt-20 -170.82 169.76 3.28 Favored Pre-proline 0 CA--C 1.46 -2.518 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.092 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.9 Cg_endo -65.48 59.05 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.858 2.372 . . . . 0.0 110.709 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 19.4 t70 175.02 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.511 1.525 . . . . 0.0 110.218 -173.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 7.7 mm-40 -123.93 123.96 41.56 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 172.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.525 ' CE1' HD11 ' A' ' 73' ' ' LEU . 5.1 m-30 -76.99 159.63 29.78 Favored 'General case' 1 N--CA 1.55 4.543 0 C-N-CA 131.492 3.917 . . . . 0.0 114.569 -170.119 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.87 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -95.08 140.07 30.53 Favored 'General case' 0 C--O 1.188 -2.141 0 C-N-CA 117.73 -1.588 . . . . 0.0 107.725 172.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 51.0 mt-30 -130.86 158.43 40.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 172.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 62' ' ' ASP . 22.3 mm -81.32 115.48 23.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -66.86 -48.66 68.13 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.656 ' HA ' HG22 ' A' ' 60' ' ' THR . 46.0 t 174.37 173.99 0.19 Allowed 'General case' 0 CA--C 1.497 -1.06 0 O-C-N 123.996 0.81 . . . . 0.0 111.879 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.57 152.28 39.46 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.808 -172.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.41 116.23 9.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -69.56 -10.06 56.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.292 1.044 . . . . 0.0 112.908 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.92 -7.98 38.43 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.025 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.541 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.37 173.41 37.27 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.57 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 15.2 Cg_endo -57.27 -27.93 77.36 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 124.175 3.25 . . . . 0.0 112.872 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.45 -49.75 76.59 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.692 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.44 -32.28 58.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.894 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 50' ' ' GLY . 6.8 mp -65.59 -46.27 80.04 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.714 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 35.4 t70 -62.74 -35.7 80.62 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.41 -17.72 52.75 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 112.878 -1.964 . . . . 0.0 113.267 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 2.9 mptm? -77.27 -27.43 53.14 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 46.7 tpp -94.19 127.08 39.82 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -170.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -136.73 156.55 48.38 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.27 1.033 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -61.97 114.42 3.36 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.71 1.204 . . . . 0.0 110.336 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' HA2' ' HD3' ' A' ' 104' ' ' PRO . . . 112.26 -14.43 25.69 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.192 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.8 m-20 -67.08 141.25 57.54 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.251 0.1 OUTLIER -93.41 123.15 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 113.244 178.34 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.1 mm -73.25 123.62 28.57 Favored 'Isoleucine or valine' 1 C--O 1.337 5.66 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 73' ' ' LEU . 47.1 t -115.87 -36.05 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 O-C-N 127.506 3.004 . . . . 0.0 111.985 -176.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 60.4 m -151.61 162.85 40.28 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.487 -1.383 . . . . 0.0 114.012 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.685 HG23 HG11 ' A' ' 72' ' ' VAL . 48.6 t -134.38 127.16 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.624 0 C-N-CA 125.017 1.327 . . . . 0.0 107.527 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 65.65 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 108.761 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -149.96 31.35 0.7 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.743 0.782 . . . . 0.0 109.165 170.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 m -116.48 126.84 53.94 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.505 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 24.2 t -67.39 115.08 6.62 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.732 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -119.98 15.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.597 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.4 tp -59.34 113.67 2.28 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.2 48.02 0.14 Allowed Glycine 0 C--N 1.379 2.967 0 O-C-N 125.433 1.708 . . . . 0.0 111.846 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.544 ' O ' HG23 ' A' ' 76' ' ' THR . 7.7 t-160 -50.93 -68.35 0.18 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 75' ' ' HIS . 13.9 p -166.55 143.93 5.06 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 152.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.563 ' HA ' HG22 ' A' ' 80' ' ' VAL . 1.3 t60 -50.68 -33.36 22.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 120.088 1.313 . . . . 0.0 110.977 172.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.61 93.19 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.897 -0.502 . . . . 0.0 110.958 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' OE1' ' HD2' ' A' ' 82' ' ' LYS . 10.1 mm-40 -65.2 -43.3 92.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.87 HG21 HD21 ' A' ' 41' ' ' LEU . 17.1 m -62.66 -43.98 99.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.003 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.84 -40.78 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.636 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -62.18 -38.34 88.71 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.636 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 28.1 mt -65.02 -40.39 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.636 0.732 . . . . 0.0 111.329 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.23 -33.59 71.85 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.673 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.38 -20.22 60.8 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.183 0.993 . . . . 0.0 110.96 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.0 m -76.41 -48.75 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.413 HG22 ' HD3' ' A' ' 22' ' ' LYS . 21.4 mt -66.2 135.52 95.02 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -87.98 161.55 7.39 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.258 2.639 . . . . 0.0 113.68 -172.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.559 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.2 mm -63.6 132.49 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.99 11.95 55.89 Favored Glycine 0 C--N 1.288 -2.096 0 C-N-CA 119.783 -1.198 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.35 -171.71 2.13 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.7 m -151.25 156.44 40.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -140.97 125.47 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.867 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.226 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' THR . 10.6 m-20 -79.31 104.2 9.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.39 157.42 16.92 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 125.497 1.519 . . . . 0.0 108.254 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -117.01 121.38 41.21 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 76.1 mt -105.06 164.34 11.87 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 125.107 1.363 . . . . 0.0 109.69 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.655 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 12.4 t -141.05 116.54 10.15 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.843 0.83 . . . . 0.0 109.923 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 31.1 mtm180 -98.6 135.49 40.05 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 121.279 -0.888 . . . . 0.0 113.115 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.62 -25.13 0.84 Allowed Glycine 0 CA--C 1.466 -3.0 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.298 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 22.7 m-85 -81.85 140.64 47.08 Favored Pre-proline 0 N--CA 1.42 -1.954 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.482 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.35 141.57 71.38 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.799 2.999 . . . . 0.0 111.147 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.414 HD23 ' HD2' ' A' ' 104' ' ' PRO . 2.4 tt -66.47 132.52 94.26 Favored Pre-proline 0 N--CA 1.42 -1.948 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.13 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' -2' ' ' ALA . 6.0 Cg_exo -42.27 137.19 3.64 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 125.142 3.895 . . . . 0.0 116.586 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -52.63 149.37 6.07 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.946 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.552 ' HB2' HG21 ' A' ' 112' ' ' THR . 0.3 OUTLIER -117.81 101.82 51.79 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.994 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -99.41 -61.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.249 0 C-N-CA 122.351 2.034 . . . . 0.0 111.128 170.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -121.05 18.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.427 1.108 . . . . 0.0 108.099 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 27.7 t0 -71.61 120.26 78.85 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.63 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.67 ' HB2' ' HA ' ' A' ' 116' ' ' THR 0.281 41.8 Cg_endo -69.35 -35.61 13.51 Favored 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 122.712 2.275 . . . . 0.0 110.458 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.765 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 55.6 m-80 -57.84 -11.88 2.66 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.697 -2.501 . . . . 0.0 114.015 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.552 HG21 ' HB2' ' A' ' 106' ' ' ASP . 68.6 p -104.0 -8.1 19.85 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-O 121.619 0.723 . . . . 0.0 110.666 -173.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -131.17 172.8 11.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.73 155.83 39.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.6 t 69.78 46.22 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 123.217 1.484 . . . . 0.0 107.272 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.765 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -89.55 -175.47 4.7 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.778 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.6 m -70.44 40.54 0.05 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 127.082 2.153 . . . . 0.0 112.674 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p -110.15 3.13 9.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 123.016 1.388 . . . . 0.0 108.141 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.02 83.19 0.14 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.792 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.31 85.73 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.0 111.18 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -80.92 95.48 6.76 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 121.503 0.668 . . . . 0.0 110.395 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -111.78 8.66 20.67 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.808 178.165 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -76.27 142.07 71.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.346 2.698 . . . . 0.0 112.554 177.923 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.636 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.198 0.499 . . . . 0.0 110.692 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.53 175.8 11.73 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 64.67 -116.39 8.94 Favored Glycine 0 C--O 1.245 0.796 0 O-C-N 123.783 0.677 . . . . 0.0 113.831 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt 59.51 66.81 2.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.93 1.292 . . . . 0.0 112.916 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -90.64 -178.84 1.48 Allowed 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.09 2.527 . . . . 0.0 111.424 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -79.63 105.43 10.93 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.592 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 4.8 t80 -108.25 139.55 42.78 Favored 'General case' 0 C--N 1.265 -3.088 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 7' ' ' ASN . 10.2 t -144.48 10.56 1.44 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.522 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 9.5 mtp180 58.01 -19.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.766 2.026 . . . . 0.0 115.466 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -105.84 113.12 64.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 C-N-CA 122.714 0.406 . . . . 0.0 109.973 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' HG11 ' A' ' 65' ' ' VAL . 5.2 Cg_endo -50.87 -27.87 21.89 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 124.077 3.185 . . . . 0.0 113.635 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.5 t -74.03 -25.71 60.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.02 0.438 . . . . 0.0 110.996 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 14.5 mm-40 -91.51 -35.3 14.39 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.435 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 39.0 tp -71.89 155.82 39.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.903 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -106.55 158.57 16.83 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.48 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.768 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 131.31 173.65 13.42 Favored Glycine 0 C--N 1.265 -3.369 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' CE ' HG12 ' A' ' 16' ' ' ILE . 7.6 ttpt -94.4 123.51 37.85 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 95.1 m-85 -101.75 111.55 23.83 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 122.778 1.275 . . . . 0.0 109.85 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG12 ' CE ' ' A' ' 14' ' ' LYS . 34.7 mt -105.87 145.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.739 0 CA-C-N 111.839 -2.437 . . . . 0.0 109.651 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.504 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 4.3 t60 -130.61 115.17 16.37 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 57' ' ' LYS . 2.2 t -139.92 137.73 35.04 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.296 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.6 ttmp? -87.59 125.37 34.31 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.632 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -107.82 121.11 44.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 11.9 ttp180 -81.21 108.87 15.21 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.397 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.646 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 73.7 tttt -62.88 97.47 0.11 Allowed 'General case' 0 C--O 1.182 -2.454 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 169.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -90.93 -154.39 0.35 Allowed 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 124.812 1.245 . . . . 0.0 108.228 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -54.59 -43.94 72.59 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.75 0.82 . . . . 0.0 111.029 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmt_? -85.18 -18.87 32.78 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.15 -114.52 5.0 Favored Glycine 0 N--CA 1.397 -3.955 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -177.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.505 ' HD1' HD12 ' A' ' 20' ' ' LEU . 31.8 m-85 -93.95 141.33 28.64 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.37 -2.92 84.91 Favored Glycine 0 C--O 1.217 -0.959 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.757 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.525 ' HB2' HG23 ' A' ' 43' ' ' ILE . 17.9 p90 -111.97 162.7 15.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 38.8 p -123.59 155.58 37.39 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' CE1' ' A' ' 77' ' ' HIS . 17.1 m -127.4 148.64 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-O 121.631 0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.02 149.93 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.283 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.79 -137.17 12.6 Favored Glycine 0 N--CA 1.398 -3.864 0 N-CA-C 108.236 -1.945 . . . . 0.0 108.236 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 52.34 32.28 36.94 Favored Glycine 0 CA--C 1.47 -2.728 0 N-CA-C 111.786 -0.525 . . . . 0.0 111.786 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -71.62 -19.76 62.07 Favored 'General case' 0 N--CA 1.411 -2.416 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.951 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.1 pt-20 -166.65 166.78 8.66 Favored Pre-proline 0 CA--C 1.468 -2.183 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_endo -66.85 58.18 0.54 Allowed 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.715 2.277 . . . . 0.0 109.737 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 22.1 t70 176.6 -15.06 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.476 -169.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 26.9 mt-10 -123.19 126.12 46.39 Favored 'General case' 0 C--O 1.269 2.116 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 171.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.25 7.3 m-85 -77.85 158.59 29.4 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 131.04 3.736 . . . . 0.0 113.535 -168.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 80' ' ' VAL . 6.0 mp -89.82 143.29 26.92 Favored 'General case' 0 CA--C 1.457 -2.624 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 171.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.12 152.81 49.09 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 29' ' ' PHE . 26.7 mm -69.09 109.09 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 84.1 tttt -55.3 -41.26 72.1 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 124.872 1.357 . . . . 0.0 107.448 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.554 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 162.41 173.52 0.02 OUTLIER 'General case' 0 C--N 1.366 1.326 0 O-C-N 125.395 1.684 . . . . 0.0 109.605 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -138.59 147.27 42.78 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 121.989 0.9 . . . . 0.0 111.976 -173.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ASP . 13.8 t -83.34 130.06 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.972 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 94.7 mt -69.32 -13.52 62.43 Favored 'General case' 0 N--CA 1.38 -3.941 0 CA-C-N 112.799 -2.001 . . . . 0.0 112.849 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . 14.7 t70 -86.0 -24.2 26.54 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.244 173.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -81.09 155.15 36.13 Favored Glycine 0 N--CA 1.401 -3.679 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.556 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 20' ' ' LEU . 9.7 Cg_endo -50.8 -31.48 33.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 125.052 3.834 . . . . 0.0 113.385 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -60.4 -44.53 95.59 Favored 'General case' 0 C--O 1.261 1.701 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.199 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.88 -35.33 50.95 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.496 177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 6.6 mp -65.94 -43.41 88.11 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.981 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.48 -21.85 55.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.909 1.338 . . . . 0.0 107.409 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.9 73.46 Favored Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 113.228 -1.806 . . . . 0.0 112.586 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HB3' HG21 ' A' ' 18' ' ' THR . 72.6 mmtt -98.31 -28.48 13.65 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 120.859 0.362 . . . . 0.0 110.084 -173.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.427 ' HB3' HD22 ' A' ' 46' ' ' LEU . 1.3 mpt? -98.03 149.63 22.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.211 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.71 153.4 47.21 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.5 p -60.09 111.67 1.6 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 113.48 -5.43 24.76 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.215 175.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 43' ' ' ILE . 5.4 m-20 -60.31 126.07 26.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.102 0.951 . . . . 0.0 108.603 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.256 0.2 OUTLIER -80.2 112.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.957 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 97' ' ' LEU . 22.1 mm -66.98 125.3 24.09 Favored 'Isoleucine or valine' 1 C--O 1.332 5.397 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 HD22 ' A' ' 73' ' ' LEU . 48.5 t -115.36 -42.91 3.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 O-C-N 127.585 3.053 . . . . 0.0 112.085 -174.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 69.6 m -147.77 156.78 43.1 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.853 -1.154 . . . . 0.0 112.359 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG11 HG21 ' A' ' 83' ' ' ILE . 6.3 p -135.98 128.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.1 m120 58.53 30.33 19.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.603 0.716 . . . . 0.0 110.65 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 68.06 17.22 9.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.893 1.277 . . . . 0.0 113.28 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.8 m -107.78 125.49 51.49 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.417 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 54.0 t -59.99 110.14 1.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 124.418 1.074 . . . . 0.0 109.783 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -119.8 16.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.592 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 30.6 tp -59.9 113.23 2.18 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.5 43.17 0.07 OUTLIER Glycine 0 N--CA 1.5 2.945 0 O-C-N 125.762 1.914 . . . . 0.0 112.559 -170.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' THR . 6.5 t-160 -46.42 -66.83 0.35 Allowed 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.1 p -166.52 143.85 5.07 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 151.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.589 ' HA ' HG22 ' A' ' 80' ' ' VAL . 2.3 t60 -50.88 -33.59 24.67 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 120.295 1.407 . . . . 0.0 110.876 173.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.17 86.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.967 -0.458 . . . . 0.0 110.866 174.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 41' ' ' LEU . 13.1 m -64.63 -44.5 96.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -66.56 -38.19 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -64.32 -33.93 76.96 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.296 177.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.588 HG21 HG11 ' A' ' 67' ' ' VAL . 3.9 mm -70.8 -36.53 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.732 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.18 -31.42 64.21 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.309 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -70.44 -27.91 64.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.522 1.129 . . . . 0.0 110.634 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -73.17 -34.34 65.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.576 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.0 mt -80.78 134.72 53.13 Favored Pre-proline 0 N--CA 1.412 -2.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.976 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -91.99 162.3 3.27 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 123.585 2.857 . . . . 0.0 113.134 -174.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.533 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.2 mm -62.85 133.01 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.22 0.533 . . . . 0.0 110.885 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.76 12.3 53.44 Favored Glycine 0 C--N 1.293 -1.848 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.674 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.76 -170.82 1.88 Allowed 'General case' 0 C--O 1.207 -1.164 0 O-C-N 122.704 -0.292 . . . . 0.0 110.292 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.9 m -151.21 155.51 38.98 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.657 -0.652 . . . . 0.0 109.358 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.02 127.88 10.67 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.657 0 C-N-CA 118.582 -1.247 . . . . 0.0 113.119 -174.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 22.2 m-20 -80.32 106.88 12.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.533 0.682 . . . . 0.0 109.168 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 71.1 mt -105.59 142.65 34.95 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.806 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' OE2' ' HB3' ' A' ' 15' ' ' PHE . 16.7 tp10 -107.1 127.69 53.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB3' HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -136.2 155.83 49.57 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 124.046 0.938 . . . . 0.0 111.281 -178.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.768 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -119.95 117.13 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.509 1.147 . . . . 0.0 112.936 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 18.8 tpp85 -88.88 111.14 21.71 Favored 'General case' 0 C--N 1.266 -3.058 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.07 -35.63 0.09 OUTLIER Glycine 0 CA--C 1.479 -2.19 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.568 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.62 136.99 24.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.128 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.05 160.89 46.33 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.889 2.392 . . . . 0.0 108.062 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.508 HD11 ' HB ' ' A' ' 60' ' ' THR . 13.3 mt -53.86 129.32 56.25 Favored Pre-proline 0 N--CA 1.432 -1.349 0 O-C-N 123.648 0.592 . . . . 0.0 111.261 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.14 -44.95 0.73 Allowed 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 123.325 2.684 . . . . 0.0 114.317 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 88.7 t80 -138.19 149.74 46.11 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.797 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -110.61 98.68 38.23 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 121.55 0.69 . . . . 0.0 111.338 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 58.7 Cg_endo -96.18 -58.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.284 0 C-N-CA 122.154 1.903 . . . . 0.0 110.403 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.61 7.62 12.66 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 125.798 1.639 . . . . 0.0 108.862 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' OD2' HG23 ' A' ' 112' ' ' THR . 21.0 t0 -72.99 110.26 8.06 Favored Pre-proline 0 CA--C 1.48 -1.741 0 CA-C-O 122.677 1.227 . . . . 0.0 112.39 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 112' ' ' THR . 57.2 Cg_endo -80.12 -32.42 1.4 Allowed 'Trans proline' 0 N--CA 1.433 -2.088 0 C-N-CA 122.038 1.825 . . . . 0.0 109.771 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.456 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 8.6 t-20 -52.68 -5.5 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 1 C-N-CA 132.012 4.125 . . . . 0.0 114.075 -168.404 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 110' ' ' PRO . 27.1 p -93.88 3.58 55.18 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.819 -169.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 m -146.03 104.72 3.86 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.102 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt 52.9 -151.34 0.31 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.612 0.765 . . . . 0.0 110.651 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.0 m -57.18 101.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.816 0.817 . . . . 0.0 111.391 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.61 166.15 25.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.676 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 m 71.81 32.64 1.88 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.211 1.005 . . . . 0.0 109.414 -172.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.27 112.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.481 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.92 70.28 1.1 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.6 mm -82.52 87.12 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.71 0.767 . . . . 0.0 109.081 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -114.06 36.58 3.64 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.603 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.39 156.99 43.2 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.602 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 tpmt? 67.48 18.6 10.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 123.018 1.389 . . . . 0.0 107.896 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.29 145.08 29.37 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 113.276 -1.784 . . . . 0.0 108.577 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.917 2.411 . . . . 0.0 111.847 173.791 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 1' ' ' LYS . . . . . . . . 0 C--O 1.223 -0.539 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.42 64.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.372 1.069 . . . . 0.0 113.884 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -91.68 9.79 30.94 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.991 0.425 . . . . 0.0 111.477 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -130.08 -96.07 0.76 Allowed Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.527 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 28.9 mmmt 52.14 54.75 14.42 Favored Pre-proline 0 N--CA 1.482 1.142 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 97.3 Cg_endo -108.77 170.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.628 0 C-N-CA 122.987 2.458 . . . . 0.0 112.97 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.46 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 23.8 t80 -82.27 105.19 13.14 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.605 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -101.46 133.57 45.9 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -141.15 8.89 2.08 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.903 0.858 . . . . 0.0 110.437 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.489 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 8.3 mtm180 63.9 -27.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.556 1.943 . . . . 0.0 114.964 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -100.54 122.25 50.26 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.1 Cg_endo -55.52 -27.84 61.58 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 124.006 3.137 . . . . 0.0 112.691 175.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 t -75.52 -25.72 57.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.129 0.49 . . . . 0.0 110.314 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -88.9 -24.26 22.54 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.691 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.436 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 41.2 tp -83.33 157.51 22.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 36.6 mtmm -119.69 148.71 43.05 Favored 'General case' 0 N--CA 1.381 -3.908 0 CA-C-O 121.676 0.751 . . . . 0.0 110.524 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.624 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 150.37 178.22 25.06 Favored Glycine 0 C--N 1.257 -3.837 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -171.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -88.41 124.28 33.79 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.6 m-85 -102.8 120.3 40.36 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.103 -1.439 . . . . 0.0 109.949 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.433 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 64.7 mt -120.39 135.97 58.94 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.579 -170.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 t-80 -114.01 115.58 27.84 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.371 -176.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 4.2 t -140.33 131.28 26.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.889 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttpt -92.3 124.95 36.75 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.81 120.62 42.51 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.782 -173.007 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 15.9 tpp180 -76.21 103.47 6.26 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.635 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.723 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 51.2 tttt -59.06 96.97 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.947 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 165.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.565 ' HB2' ' HG3' ' A' ' 21' ' ' ARG . 4.9 t -134.65 139.33 45.2 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.1 p 50.82 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.973 1.709 . . . . 0.0 113.215 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmm_? -76.2 -21.83 56.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.723 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 94.43 24.56 18.37 Favored Glycine 1 N--CA 1.393 -4.213 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.697 174.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.553 ' HD1' HD12 ' A' ' 20' ' ' LEU . 30.8 m-85 155.8 170.39 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 130.393 3.477 . . . . 0.0 105.525 167.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.49 4.0 17.74 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.218 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.517 ' HB2' HG23 ' A' ' 43' ' ' ILE . 8.2 p90 -123.8 163.8 20.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -122.09 147.69 45.8 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.19 147.9 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.988 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 158.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.963 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.984 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.75 -130.12 9.04 Favored Glycine 1 N--CA 1.394 -4.13 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.25 37.11 30.56 Favored Glycine 0 CA--C 1.478 -2.268 0 C-N-CA 123.92 0.772 . . . . 0.0 113.513 175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 42.2 m-20 -67.13 -21.39 65.84 Favored 'General case' 0 CA--C 1.477 -1.845 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.097 -175.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.9 pt-20 -170.78 169.37 3.47 Favored Pre-proline 0 CA--C 1.474 -1.961 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.356 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 21.2 Cg_endo -66.61 51.36 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.923 2.416 . . . . 0.0 111.279 171.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 5.8 m-20 -176.84 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 127.105 2.162 . . . . 0.0 111.352 -170.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 18.6 mm-40 -128.66 123.85 34.24 Favored 'General case' 0 C--O 1.272 2.238 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 73' ' ' LEU . 6.5 m-30 -77.15 159.67 29.57 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 131.14 3.776 . . . . 0.0 114.58 -168.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.832 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -92.87 144.28 25.43 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 172.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.7 mt-30 -138.28 153.19 49.06 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 62' ' ' ASP . 25.0 mm -70.93 111.21 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.402 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 45' ' ' SER . 38.8 ttpt -67.54 -36.5 81.11 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.588 ' HA ' HG22 ' A' ' 60' ' ' THR . 41.1 t 170.53 172.9 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 O-C-N 125.159 1.537 . . . . 0.0 111.221 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -144.76 149.47 35.58 Favored 'General case' 0 N--CA 1.408 -2.562 0 C-N-CA 124.257 1.023 . . . . 0.0 110.879 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 49' ' ' ASP . 15.4 t -78.65 127.64 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.651 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.25 -3.38 10.59 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.571 -2.104 . . . . 0.0 112.264 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.2 t70 -103.13 -18.06 15.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.4 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.98 163.0 32.98 Favored Glycine 0 N--CA 1.41 -3.07 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.729 -170.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -50.27 -32.96 34.86 Favored 'Trans proline' 0 C--O 1.201 -1.372 0 C-N-CA 125.063 3.842 . . . . 0.0 112.617 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -57.51 -47.86 80.82 Favored 'General case' 0 C--O 1.271 2.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.357 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.18 -36.55 54.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.43 -35.45 65.8 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.108 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.69 -22.41 66.08 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.3 24.0 76.17 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.403 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 23.7 mmtp -110.18 -35.69 6.03 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.4 ttm -102.27 143.08 32.49 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.167 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.44 163.93 29.33 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.619 0.723 . . . . 0.0 109.176 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -67.83 114.42 6.4 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 123.709 0.804 . . . . 0.0 108.837 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.443 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 122.62 -22.07 7.43 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.035 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' O ' HG12 ' A' ' 43' ' ' ILE . 8.1 m-20 -62.18 134.69 56.89 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.706 0.753 . . . . 0.0 110.986 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.262 0.2 OUTLIER -82.52 121.51 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.408 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.0 mm -72.58 122.83 25.98 Favored 'Isoleucine or valine' 1 C--O 1.334 5.525 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -115.29 -37.61 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 110.402 -3.09 . . . . 0.0 111.652 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.62 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.0 m -150.76 151.43 32.36 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.302 -1.499 . . . . 0.0 114.424 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.723 HG23 HG21 ' A' ' 72' ' ' VAL . 25.3 t -118.73 114.8 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.629 1.172 . . . . 0.0 109.037 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 52.74 36.69 21.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.312 0.577 . . . . 0.0 112.308 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 72.73 15.41 4.84 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.166 1.786 . . . . 0.0 112.164 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 72' ' ' VAL . 28.6 m -99.1 119.14 37.34 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 169.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.4 t -69.22 110.01 4.37 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.678 0.752 . . . . 0.0 109.491 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.723 HG21 HG23 ' A' ' 67' ' ' VAL . 23.9 m -114.47 18.3 7.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.444 -176.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.605 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 28.5 tp -59.79 113.4 2.25 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.668 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.21 45.72 0.14 Allowed Glycine 0 C--N 1.378 2.9 0 O-C-N 125.661 1.85 . . . . 0.0 111.896 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 76' ' ' THR . 4.8 t-160 -45.15 -66.68 0.37 Allowed 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.8 p -166.9 143.83 4.67 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 150.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 2.4 t60 -51.0 -36.94 42.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 121.008 1.731 . . . . 0.0 110.886 174.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.43 95.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.501 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -69.97 -39.81 75.74 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.832 HG21 HD21 ' A' ' 41' ' ' LEU . 20.9 m -66.54 -41.6 88.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.859 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.63 -40.89 90.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.646 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.4 tmtm? -59.03 -44.58 91.78 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.765 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.646 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.4 mm -66.34 -35.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -70.98 -36.59 72.57 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -68.24 -23.38 64.79 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 124.338 1.055 . . . . 0.0 111.352 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.5 m -75.63 -30.09 59.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.938 176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.529 HG22 ' HD3' ' A' ' 22' ' ' LYS . 51.9 mt -83.24 133.29 47.98 Favored Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.646 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 9.8 Cg_endo -88.08 161.99 7.24 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.552 2.835 . . . . 0.0 112.637 -173.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.536 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 35.5 mm -66.52 133.73 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.87 54.5 Favored Glycine 0 C--N 1.287 -2.173 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.237 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.618 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -101.73 -177.25 3.37 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.565 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 2.9 p -145.54 152.48 39.8 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.78 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.8 t -136.67 125.42 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.34 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.42 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.3 m-20 -78.74 102.85 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 70.0 mt -99.65 139.77 34.82 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.724 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -96.55 118.36 32.89 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 90.4 mt -107.52 164.54 12.12 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 125.283 1.433 . . . . 0.0 109.382 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.645 ' HB3' HG13 ' A' ' 63' ' ' VAL . 19.3 t -142.22 107.77 5.07 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-O 122.387 1.089 . . . . 0.0 110.684 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -85.05 117.75 24.2 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.42 -24.19 0.21 Allowed Glycine 0 CA--C 1.473 -2.558 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.587 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 35.9 m-85 -94.22 133.46 27.27 Favored Pre-proline 0 C--N 1.286 -2.173 0 CA-C-O 121.075 0.464 . . . . 0.0 110.364 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.43 150.6 88.12 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 123.605 2.87 . . . . 0.0 111.969 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 104' ' ' PRO . 3.6 mt -54.06 121.65 31.19 Favored Pre-proline 0 N--CA 1.436 -1.153 0 C-N-CA 124.089 0.956 . . . . 0.0 112.214 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.516 ' HD2' HD23 ' A' ' 103' ' ' LEU . 84.1 Cg_exo -55.68 173.97 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 125.084 3.856 . . . . 0.0 115.9 -177.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.438 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 88.7 t80 -73.34 139.95 46.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 112.69 -2.05 . . . . 0.0 111.021 -178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.84 101.68 50.27 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 124.446 1.098 . . . . 0.0 110.236 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 63.3 Cg_endo -102.46 -60.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.61 2.206 . . . . 0.0 113.306 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -82.83 -16.94 45.77 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.753 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -92.37 141.49 24.93 Favored Pre-proline 0 N--CA 1.385 -3.718 0 CA-C-O 122.004 0.907 . . . . 0.0 112.241 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 93.7 Cg_endo -85.6 -33.59 0.21 Allowed 'Trans proline' 0 N--CA 1.426 -2.49 0 C-N-CA 122.19 1.927 . . . . 0.0 110.961 171.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 1.5 m-20 -32.5 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 131.602 3.961 . . . . 0.0 116.633 -164.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -93.84 2.33 56.22 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -167.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.6 m -93.09 25.33 3.31 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.457 -0.777 . . . . 0.0 113.026 -175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.2 mt 56.59 18.52 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' H ' ' H ' ' A' ' 116' ' ' THR . 10.6 p -156.78 -1.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-O 123.266 1.508 . . . . 0.0 108.44 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.41 ' H ' ' H ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -87.7 157.27 19.11 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 112.901 -1.954 . . . . 0.0 110.065 -175.211 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.2 m 60.77 40.69 15.76 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -167.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.1 114.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 112.075 -2.33 . . . . 0.0 115.611 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.94 20.65 11.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.91 1.338 . . . . 0.0 107.944 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.91 68.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.113 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -107.23 24.02 13.5 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.469 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 53.43 69.1 0.74 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.73 1.212 . . . . 0.0 111.66 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.99 12.73 35.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.588 -176.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.85 135.89 63.12 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.259 1.525 0 C-N-CA 123.774 2.982 . . . . 0.0 113.275 179.473 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.222 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -154.64 -73.14 0.12 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 117.412 0.606 . . . . 0.0 111.125 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.9 ptp -92.85 32.29 1.28 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.496 0.665 . . . . 0.0 111.097 -176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 167.92 -131.55 2.36 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.9 tptt 53.45 73.21 0.96 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 124.379 1.071 . . . . 0.0 112.081 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 36.3 Cg_endo -100.34 -178.42 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.315 2.677 . . . . 0.0 111.896 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -82.58 105.51 13.68 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.5 t80 -105.18 138.42 41.41 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.126 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -154.51 22.97 0.47 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.217 0.532 . . . . 0.0 111.008 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.456 ' HG2' ' HE1' ' A' ' 4' ' ' PHE . 20.2 mtm180 58.11 -30.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 128.446 2.698 . . . . 0.0 116.431 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.4 t-20 -99.88 113.87 65.36 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 65' ' ' VAL . 5.6 Cg_exo -55.22 -32.68 81.54 Favored 'Trans proline' 0 C--O 1.221 -0.329 0 C-N-CA 123.482 2.788 . . . . 0.0 111.46 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -71.34 -11.97 61.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.285 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.493 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 21.4 mm-40 -105.03 -22.35 13.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.474 0.71 . . . . 0.0 111.344 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.4 mm? -79.67 169.48 17.91 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -177.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.87 -170.42 2.04 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.834 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.11 177.76 52.05 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 13.6 ttpt -110.16 132.18 54.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.5 m-85 -99.09 110.79 23.32 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 123.161 1.458 . . . . 0.0 110.8 -174.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.428 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 30.5 mt -107.09 151.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.835 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.28 -174.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.43 121.49 25.99 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.352 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 t -138.51 138.91 38.48 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.58 0.705 . . . . 0.0 110.151 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.784 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 28.6 ttmt -93.8 125.04 38.2 Favored 'General case' 0 C--N 1.259 -3.346 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -105.7 117.05 33.03 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.251 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 37.8 ttt180 -76.7 108.56 9.8 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.909 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.671 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 73.6 tttt -65.05 97.14 0.22 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 89' ' ' ILE . 21.5 t -87.61 -154.83 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -54.4 -41.54 69.39 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.154 0.581 . . . . 0.0 110.767 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -87.15 -20.47 26.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.805 0.812 . . . . 0.0 109.77 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 99.28 -116.33 5.55 Favored Glycine 1 N--CA 1.386 -4.695 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HD1' HD12 ' A' ' 20' ' ' LEU . 31.0 m-85 -93.9 146.79 23.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.14 0.34 66.4 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.642 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.487 ' HB2' HG23 ' A' ' 43' ' ' ILE . 10.0 p90 -111.24 163.14 14.25 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.546 0.689 . . . . 0.0 111.606 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.6 p -116.85 156.4 27.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.583 HG11 HD23 ' A' ' 41' ' ' LEU . 2.6 t -132.35 142.44 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.348 -173.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -152.7 160.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.736 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.91 -1.52 30.19 Favored Glycine 1 CA--C 1.447 -4.189 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 168.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.828 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -116.39 43.98 1.55 Allowed Glycine 1 CA--C 1.408 -6.637 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -170.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.32 -12.41 29.56 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 113.009 -1.595 . . . . 0.0 112.17 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 6.6 pt-20 -165.45 167.25 9.52 Favored Pre-proline 0 CA--C 1.46 -2.512 0 C-N-CA 117.203 -1.799 . . . . 0.0 110.888 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -67.32 57.52 0.64 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 122.463 2.108 . . . . 0.0 110.165 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 26.8 t70 -179.67 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.478 1.911 . . . . 0.0 109.625 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.736 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 26.7 mt-10 -113.47 124.58 52.75 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-O 117.009 -1.472 . . . . 0.0 107.274 171.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.305 6.5 m-30 -79.35 155.38 28.46 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 128.288 3.492 . . . . 0.0 111.733 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.925 HD21 HG21 ' A' ' 80' ' ' VAL . 6.6 mp -87.1 143.34 27.36 Favored 'General case' 0 C--O 1.175 -2.867 0 C-N-CA 116.582 -2.047 . . . . 0.0 108.901 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.5 mt-30 -138.42 157.54 46.01 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 29' ' ' PHE . 25.3 mm -75.48 109.91 9.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.2 tttp -56.8 -37.71 71.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 125.183 1.552 . . . . 0.0 107.07 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.601 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.0 t 159.36 173.13 0.01 OUTLIER 'General case' 0 C--N 1.364 1.239 0 O-C-N 125.769 1.918 . . . . 0.0 109.231 172.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pp -136.74 149.37 47.81 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.44 118.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.263 1.2 pt? -69.59 -5.06 22.01 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -94.64 -3.48 49.44 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.354 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.62 161.78 27.47 Favored Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 8.6 Cg_endo -51.2 -29.9 30.86 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 124.952 3.768 . . . . 0.0 113.38 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.07 -46.71 84.98 Favored 'General case' 0 C--O 1.275 2.41 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.694 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.07 -32.38 56.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.532 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 9.1 mp -68.69 -45.2 72.28 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.996 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.9 -26.93 67.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.12 16.7 79.54 Favored Glycine 0 CA--C 1.487 -1.711 0 CA-C-N 112.933 -1.939 . . . . 0.0 113.842 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -109.53 -24.48 10.96 Favored 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 122.278 0.231 . . . . 0.0 111.573 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.43 140.53 31.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.025 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 41.4 tt0 -149.38 146.89 27.72 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.986 0.898 . . . . 0.0 111.69 -172.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 45' ' ' SER . 5.3 p -49.61 103.52 0.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 126.313 1.845 . . . . 0.0 112.416 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.9 -2.52 31.78 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-O 119.375 -0.68 . . . . 0.0 113.049 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.24 146.95 48.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -98.59 121.22 48.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.503 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 29.7 mm -69.88 123.96 24.81 Favored 'Isoleucine or valine' 0 C--O 1.305 3.975 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 73' ' ' LEU . 43.7 t -115.19 -38.66 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 111.662 -2.517 . . . . 0.0 110.272 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.562 ' HA ' HG22 ' A' ' 72' ' ' VAL . 40.0 m -145.11 142.97 30.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.885 -178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 72' ' ' VAL . 7.1 p -119.57 131.82 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 m120 63.8 23.82 13.56 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.873 0.844 . . . . 0.0 108.958 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.37 -0.66 2.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.408 1.883 . . . . 0.0 112.079 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 72' ' ' VAL . 76.8 m -78.86 119.81 22.58 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.67 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.411 -2.397 0 O-C-N 124.777 1.298 . . . . 0.0 110.29 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.571 HG21 HG12 ' A' ' 67' ' ' VAL . 35.6 m -115.87 26.55 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.535 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.617 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.5 tp -59.71 113.79 2.43 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.26 41.48 0.22 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 125.344 1.653 . . . . 0.0 112.177 -170.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.523 ' O ' HG23 ' A' ' 76' ' ' THR . 6.2 t-160 -45.72 -66.73 0.36 Allowed 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.1 p -167.14 143.5 4.38 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 149.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 1.8 t60 -50.16 -38.61 40.33 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 119.342 0.974 . . . . 0.0 110.658 174.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.53 95.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.082 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -66.37 -43.2 86.6 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.925 HG21 HD21 ' A' ' 41' ' ' LEU . 33.4 m -66.81 -40.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.502 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.94 -39.27 85.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.674 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.92 -40.02 79.4 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.706 176.383 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.674 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 57.9 mt -66.75 -36.78 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.713 0.768 . . . . 0.0 110.802 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -71.49 -30.29 65.8 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.421 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.99 -26.32 59.48 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.487 1.115 . . . . 0.0 110.27 174.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 52.4 m -72.39 -49.29 34.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.995 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.447 HG22 ' HD3' ' A' ' 22' ' ' LYS . 44.3 mt -62.98 134.83 95.92 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.789 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 14.3 Cg_endo -90.51 161.84 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.482 2.788 . . . . 0.0 113.302 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.532 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.4 mm -65.37 132.35 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 121.452 0.644 . . . . 0.0 110.379 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.06 54.13 Favored Glycine 0 C--N 1.288 -2.092 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.793 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -98.66 -170.43 1.94 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -175.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 13.3 m -151.14 158.93 44.62 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.21 126.68 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.772 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.63 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.538 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 15.1 m-20 -78.79 104.14 9.21 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.7 mt -102.42 136.96 41.31 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 124.624 1.169 . . . . 0.0 109.884 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 37.6 tt0 -101.02 121.06 41.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 6.0 mt -107.54 165.04 11.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.048 1.339 . . . . 0.0 108.764 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.584 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 21.1 t -137.97 105.23 5.48 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.103 0.954 . . . . 0.0 110.634 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 59' ' ' GLU . 76.5 mtm180 -96.46 119.98 35.93 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 121.229 -0.92 . . . . 0.0 110.506 174.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.26 -33.95 0.15 Allowed Glycine 0 CA--C 1.474 -2.517 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.62 133.4 23.62 Favored Pre-proline 0 N--CA 1.424 -1.744 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.34 170.39 19.54 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.929 2.419 . . . . 0.0 111.395 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.85 128.42 88.87 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.459 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -76.09 -34.32 3.03 Favored 'Trans proline' 0 CA--C 1.49 -1.72 0 C-N-CA 122.426 2.084 . . . . 0.0 110.864 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.507 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 34.4 t80 -139.0 141.99 38.31 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 113.307 -1.77 . . . . 0.0 106.374 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -113.56 85.9 9.67 Favored Pre-proline 0 N--CA 1.387 -3.618 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.403 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 83.1 Cg_endo -89.9 -55.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.568 2.179 . . . . 0.0 112.257 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.0 -16.36 44.29 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.652 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.488 ' OD2' HG23 ' A' ' 112' ' ' THR . 19.0 t0 -78.01 115.29 49.31 Favored Pre-proline 0 CA--C 1.45 -2.892 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 111' ' ' ASN . 14.6 Cg_endo -87.54 -29.04 0.39 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 121.424 1.416 . . . . 0.0 109.622 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.582 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 9.9 t30 -64.55 4.24 0.41 Allowed 'General case' 0 N--CA 1.386 -3.66 1 C-N-CA 132.566 4.347 . . . . 0.0 114.026 -164.208 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.488 HG23 ' OD2' ' A' ' 109' ' ' ASP . 29.1 p -96.93 4.59 51.51 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.174 -175.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.48 ' HB3' HG21 ' A' ' 116' ' ' THR . 22.5 t -130.7 -177.08 4.2 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 114' ' ' LEU . 2.5 pt? -77.28 142.77 39.31 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.086 0.403 . . . . 0.0 111.028 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p 44.96 53.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.035 1.734 . . . . 0.0 112.775 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 113' ' ' SER . 12.0 p -106.99 -73.67 0.68 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.256 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.406 ' HB2' ' HG2' ' A' ' 110' ' ' PRO . 18.4 t -124.93 159.1 31.96 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 168.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.16 67.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.767 0.794 . . . . 0.0 112.205 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 121' ' ' LEU . . . -170.76 59.79 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.49 100.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.521 -174.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 119' ' ' ALA . 70.8 mt -118.2 131.49 56.38 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 121.713 0.768 . . . . 0.0 111.73 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -135.89 120.06 17.75 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.98 103.21 9.71 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.3 135.96 86.66 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--N 1.355 0.91 0 C-N-CA 123.765 2.977 . . . . 0.0 113.126 -179.395 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.49 -18.54 14.34 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.628 0.728 . . . . 0.0 110.478 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.1 mmt -105.81 41.78 1.34 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 149.62 -143.26 10.58 Favored Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 107.131 -2.387 . . . . 0.0 107.131 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? 53.01 68.54 2.92 Favored Pre-proline 0 CA--C 1.57 1.743 0 O-C-N 124.625 0.838 . . . . 0.0 112.034 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 52.1 Cg_endo -94.52 -163.81 0.1 OUTLIER 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.944 2.43 . . . . 0.0 112.457 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -81.61 103.71 11.52 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -113.7 118.43 34.31 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.385 -176.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -134.7 17.67 3.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.86 0.838 . . . . 0.0 110.267 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.456 ' HA ' HD23 ' A' ' 73' ' ' LEU . 1.7 mtp180 59.59 -20.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.018 2.127 . . . . 0.0 115.762 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.551 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 3.3 t-20 -99.84 112.32 63.58 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-O 121.227 0.537 . . . . 0.0 111.086 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.8 Cg_endo -50.89 -37.1 54.98 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.989 3.126 . . . . 0.0 111.846 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -68.04 -20.31 64.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.763 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 8.3 mm-40 -95.14 -23.54 17.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.573 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 73' ' ' LEU . 19.7 mt -76.3 179.45 5.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.061 0.934 . . . . 0.0 110.421 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -107.65 -177.02 3.23 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.55 166.21 27.41 Favored Glycine 0 C--N 1.283 -2.405 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.074 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 29.2 tttp -93.03 138.96 31.02 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.0 m-85 -113.44 111.57 22.17 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.94 1.352 . . . . 0.0 110.835 -175.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.468 HG12 ' CE ' ' A' ' 14' ' ' LYS . 5.9 mt -109.36 151.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 CA-C-N 112.235 -2.257 . . . . 0.0 108.114 -173.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.515 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 2.8 t60 -130.71 119.77 22.86 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 3.6 t -139.18 129.35 25.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.975 0.893 . . . . 0.0 111.056 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.809 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 36.5 ttpt -90.66 123.65 34.45 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.192 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.479 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.18 119.57 39.74 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.477 -173.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.0 ttm180 -77.43 111.03 12.7 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.863 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.68 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.0 tttt -69.26 97.23 0.92 Allowed 'General case' 0 C--O 1.177 -2.742 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 89' ' ' ILE . 29.4 t -82.05 -155.81 0.15 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -67.45 -31.06 70.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.588 0.709 . . . . 0.0 109.092 174.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.16 -13.33 57.35 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.798 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.68 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 81.29 -125.63 6.98 Favored Glycine 1 N--CA 1.389 -4.485 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 30.3 m-85 -88.52 142.7 27.49 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.699 0.75 . . . . 0.0 110.176 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.81 82.85 Favored Glycine 0 C--N 1.315 -0.61 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.923 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.2 p90 -110.66 162.72 14.46 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.244 0.545 . . . . 0.0 110.341 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 47.3 p -116.76 150.82 37.64 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.67 135.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.863 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.642 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 9.9 p -151.94 165.75 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.954 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 113.15 -0.47 25.39 Favored Glycine 0 CA--C 1.471 -2.687 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 172.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.756 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -120.54 44.55 1.35 Allowed Glycine 1 CA--C 1.395 -7.417 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -171.025 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 7.8 m-20 -59.09 -13.33 6.63 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.606 -1.797 . . . . 0.0 113.04 -174.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 4.2 pt-20 -160.04 166.42 15.89 Favored Pre-proline 0 CA--C 1.455 -2.703 0 C-N-CA 117.177 -1.809 . . . . 0.0 110.631 -174.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 36.8 Cg_endo -67.61 51.62 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.818 2.345 . . . . 0.0 110.585 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 7.7 t70 -179.39 -12.88 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.674 1.19 . . . . 0.0 110.037 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.64 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 30.5 mt-10 -116.48 127.35 54.49 Favored 'General case' 0 C--O 1.276 2.465 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 167.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 73' ' ' LEU . 11.6 m-85 -80.36 155.31 27.24 Favored 'General case' 0 N--CA 1.524 3.254 0 O-C-N 127.942 3.276 . . . . 0.0 111.898 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.756 HD12 ' HA3' ' A' ' 34' ' ' GLY . 4.3 mp -84.33 145.72 28.1 Favored 'General case' 0 C--O 1.177 -2.755 0 C-N-CA 117.391 -1.724 . . . . 0.0 107.929 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.7 mt-30 -142.37 149.25 39.14 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 29' ' ' PHE . 33.1 mm -71.35 112.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 18.5 tptm -65.87 -35.03 79.52 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.516 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.5 t 160.69 172.97 0.01 OUTLIER 'General case' 0 C--N 1.357 0.926 0 O-C-N 125.271 1.607 . . . . 0.0 110.297 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.494 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.6 pp -138.55 148.53 44.32 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.541 0.686 . . . . 0.0 111.705 -173.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.9 119.06 28.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 53' ' ' ALA 0.26 1.1 pt? -69.44 -4.4 18.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.04 -27.13 48.72 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.196 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.437 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.08 171.11 36.82 Favored Glycine 0 N--CA 1.417 -2.62 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.754 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 8.8 Cg_endo -52.54 -32.23 52.55 Favored 'Trans proline' 0 C--O 1.204 -1.179 1 C-N-CA 125.328 4.018 . . . . 0.0 113.871 -173.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.76 -48.65 79.04 Favored 'General case' 0 C--O 1.273 2.333 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.65 -32.94 53.57 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.997 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 6.0 mp -68.21 -40.59 82.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' OD2' ' HD2' ' A' ' 57' ' ' LYS . 33.2 t70 -68.52 -30.02 68.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.75 6.56 87.09 Favored Glycine 0 CA--C 1.493 -1.294 0 CA-C-N 112.423 -2.171 . . . . 0.0 114.113 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 54.0 mttm -98.17 -25.2 14.98 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.6 ttm -96.24 140.63 30.65 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.259 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.54 153.0 50.29 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.771 0.795 . . . . 0.0 110.18 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 45' ' ' SER . 81.6 p -67.03 114.66 5.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.918 1.287 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.26 -20.87 15.88 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 121.961 -0.462 . . . . 0.0 112.41 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 9.2 m-20 -60.45 136.42 58.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -87.32 125.7 41.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.345 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 17.5 mm -73.74 125.15 32.4 Favored 'Isoleucine or valine' 1 C--O 1.307 4.105 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 8' ' ' PRO . 48.4 t -114.42 -34.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.481 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 68.6 m -150.55 153.36 35.64 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.154 -0.966 . . . . 0.0 112.231 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG11 HG21 ' A' ' 83' ' ' ILE . 7.3 p -131.03 127.31 60.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m120 63.25 20.14 12.09 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.647 0.203 . . . . 0.0 110.544 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 79.07 -1.02 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.95 1.7 . . . . 0.0 111.965 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.3 m -85.83 123.17 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.452 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 28.2 t -62.71 109.42 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.782 HG22 HG12 ' A' ' 80' ' ' VAL . 3.6 p -120.54 18.16 6.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.569 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.602 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.7 tp -59.59 113.41 2.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.93 43.71 0.14 Allowed Glycine 0 C--N 1.37 2.471 0 O-C-N 125.355 1.659 . . . . 0.0 112.174 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.495 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t-160 -45.11 -65.94 0.47 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 75' ' ' HIS . 12.8 p -165.79 142.42 5.32 Favored 'General case' 0 C--N 1.264 -3.132 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 152.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.642 ' CE1' ' HA ' ' A' ' 32' ' ' VAL . 1.7 t60 -50.69 -31.52 16.67 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 120.119 1.327 . . . . 0.0 111.351 171.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.19 85.61 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 122.156 -0.34 . . . . 0.0 110.8 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -64.16 -40.99 97.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.782 HG12 HG22 ' A' ' 72' ' ' VAL . 12.6 m -63.44 -45.65 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.825 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.4 t -65.55 -40.07 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.4 -39.18 89.75 Favored 'General case' 0 C--O 1.199 -1.6 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.76 177.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.635 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.3 mm -67.0 -34.63 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.652 0.739 . . . . 0.0 112.026 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -75.1 -29.39 60.58 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.446 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -76.59 -19.91 57.35 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.105 0.962 . . . . 0.0 111.105 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 75.1 m -75.25 -37.72 60.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.018 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.5 mt -78.65 135.58 60.06 Favored Pre-proline 0 N--CA 1.421 -1.923 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.057 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.5 Cg_endo -90.9 161.94 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.455 2.77 . . . . 0.0 112.926 -173.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.538 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 20.8 mm -63.45 132.51 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 121.519 0.676 . . . . 0.0 111.452 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.12 53.21 Favored Glycine 0 C--N 1.294 -1.782 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.918 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.35 -170.27 1.84 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 122.484 0.314 . . . . 0.0 110.242 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 11.1 m -151.22 157.78 43.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.809 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -145.22 125.07 6.51 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.965 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.515 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 11.3 m-20 -77.52 104.18 7.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.77 142.22 33.43 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 124.607 1.163 . . . . 0.0 110.579 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -101.84 125.72 48.57 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 84.8 mt -115.36 152.9 31.98 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.331 1.452 . . . . 0.0 110.957 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.66 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 6.5 t -125.78 107.81 10.88 Favored 'General case' 0 C--O 1.188 -2.168 0 C-N-CA 124.202 1.001 . . . . 0.0 110.016 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.462 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 35.3 ttm180 -93.37 118.95 31.92 Favored 'General case' 0 C--N 1.254 -3.569 0 O-C-N 120.341 -1.474 . . . . 0.0 109.045 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.54 -30.49 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.04 133.0 25.84 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.85 156.38 66.37 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.35 2.7 . . . . 0.0 111.63 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 mt -45.81 135.81 6.29 Favored Pre-proline 0 CA--C 1.51 -0.564 0 C-N-CA 124.729 1.212 . . . . 0.0 112.048 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.47 -170.34 0.72 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.597 2.198 . . . . 0.0 114.022 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -80.55 147.51 30.77 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.98 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.72 88.81 40.3 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.951 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 68.1 Cg_endo -97.39 -60.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.668 2.245 . . . . 0.0 111.857 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.417 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 26.2 t70 -72.71 -23.69 60.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.845 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.51 131.14 42.98 Favored Pre-proline 0 N--CA 1.385 -3.687 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.548 -175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . 0.255 60.4 Cg_endo -82.38 -30.99 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.94 1.76 . . . . 0.0 108.457 163.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 117' ' ' SER . 77.1 m-20 -33.24 -11.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.86 1 C-N-CA 134.308 5.043 . . . . 0.0 119.626 -167.385 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -107.61 15.21 24.94 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -170.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 m -110.65 -167.33 1.17 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.94 129.98 38.68 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t 68.53 46.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.774 1.273 . . . . 0.0 109.388 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -126.19 -177.29 3.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.303 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.563 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 16.3 m 66.26 36.89 5.18 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.5 t 57.74 69.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.346 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.836 0.827 . . . . 0.0 112.088 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.8 mm -98.99 79.2 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.38 54.43 3.15 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.452 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -133.74 144.87 49.35 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.79 65.6 7.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.007 0.908 . . . . 0.0 111.979 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -102.02 134.12 20.28 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 CA--C 1.544 1.02 0 C-N-CA 123.664 2.909 . . . . 0.0 112.965 -178.973 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.382 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 62.18 68.97 0.64 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 123.6 0.76 . . . . 0.0 111.804 176.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 16.9 tpt -178.08 -42.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.376 1.07 . . . . 0.0 109.147 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 176.69 -101.89 0.16 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.09 68.08 2.77 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.459 1.104 . . . . 0.0 112.676 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -104.89 -162.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.311 2.674 . . . . 0.0 111.81 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -98.28 105.88 18.08 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.603 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.9 t80 -95.79 139.79 31.51 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.748 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -148.82 14.61 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.297 0.57 . . . . 0.0 111.416 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.524 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.2 mtm180 55.11 -0.1 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.848 2.059 . . . . 0.0 115.934 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -134.13 123.49 16.84 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.526 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.3 Cg_endo -60.0 -22.7 70.23 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.845 3.03 . . . . 0.0 112.83 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -77.95 -29.8 50.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -87.2 -30.18 21.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.534 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 45.4 tp -81.06 160.4 24.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.684 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 49.5 mtmt -102.84 -179.26 3.91 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.625 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 105.27 168.52 23.9 Favored Glycine 0 C--N 1.281 -2.481 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -175.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -90.57 119.79 31.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 99.2 m-85 -98.5 114.62 27.09 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-O 121.92 0.867 . . . . 0.0 109.849 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.44 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 62.0 mt -117.73 136.01 56.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 CA-C-N 113.87 -1.513 . . . . 0.0 110.284 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.9 t-80 -105.95 113.99 27.86 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.261 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 t -139.96 133.5 30.21 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-O 122.073 0.94 . . . . 0.0 111.65 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.767 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -88.03 127.25 35.39 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.151 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -107.91 118.57 37.09 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 43.0 ttp180 -78.47 107.75 11.35 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.4 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.724 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 72.0 tttt -63.86 97.32 0.16 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 168.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -85.06 -155.41 0.21 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.86 -39.86 90.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -84.96 -13.35 50.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.33 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.724 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 91.2 -121.96 6.53 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.507 ' HD1' HD12 ' A' ' 20' ' ' LEU . 39.7 m-85 -93.39 145.04 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.655 0.727 . . . . 0.0 109.85 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.66 -0.18 72.87 Favored Glycine 0 C--O 1.214 -1.131 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.861 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.548 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.7 p90 -108.28 163.52 13.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.391 0.615 . . . . 0.0 110.646 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.476 ' OG1' ' HE2' ' A' ' 44' ' ' LYS . 46.5 p -121.46 151.02 40.7 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.63 141.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.976 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 33' ' ' GLY . 11.5 p -149.75 167.0 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.474 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 127.19 -64.45 0.59 Allowed Glycine 0 CA--C 1.474 -2.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.402 173.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -71.53 60.52 1.2 Allowed Glycine 1 CA--C 1.41 -6.474 0 C-N-CA 126.951 2.215 . . . . 0.0 116.236 -169.289 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -22.0 66.55 Favored 'General case' 0 C--N 1.245 -3.97 0 O-C-N 124.669 0.864 . . . . 0.0 109.739 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.455 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 10.0 pt-20 -154.27 165.33 18.22 Favored Pre-proline 0 CA--C 1.456 -2.649 0 C-N-CA 116.1 -2.24 . . . . 0.0 111.21 -171.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -68.1 55.65 0.76 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.829 2.352 . . . . 0.0 109.796 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -178.05 -20.71 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.703 -1.589 . . . . 0.0 109.886 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.746 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 13.4 mm-40 -114.79 128.46 56.31 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.477 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.25 7.5 m-30 -79.41 157.23 27.62 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 128.78 3.8 . . . . 0.0 111.773 -179.185 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -88.63 149.51 23.5 Favored 'General case' 0 C--O 1.189 -2.081 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 9.7 mt-30 -145.31 153.32 41.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 29' ' ' PHE . 21.0 mm -69.91 110.51 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HE2' ' OG1' ' A' ' 30' ' ' THR . 3.8 tmmm? -65.01 -33.88 77.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.562 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.1 t 162.03 172.64 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 O-C-N 124.975 1.422 . . . . 0.0 109.775 173.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -136.24 144.55 44.9 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 121.785 0.802 . . . . 0.0 109.947 -174.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 49' ' ' ASP . 11.0 t -78.38 126.3 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mp -68.92 -4.2 15.65 Favored 'General case' 1 N--CA 1.377 -4.112 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.307 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' H ' HG12 ' A' ' 47' ' ' VAL . 20.5 t70 -97.55 -21.4 17.11 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.595 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.19 167.73 34.59 Favored Glycine 0 N--CA 1.404 -3.447 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.494 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.6 Cg_endo -53.65 -31.23 59.27 Favored 'Trans proline' 0 C--O 1.187 -2.046 0 C-N-CA 124.731 3.62 . . . . 0.0 113.037 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.66 76.37 Favored 'General case' 0 C--O 1.264 1.85 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.12 -34.32 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.098 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.23 -38.22 69.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.352 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -73.07 -18.24 61.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 122.273 1.035 . . . . 0.0 108.504 175.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.01 32.59 82.7 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 113.251 -1.795 . . . . 0.0 113.836 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 36.4 mtmt -124.25 -0.72 8.25 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.646 ' HB3' HD22 ' A' ' 46' ' ' LEU . 28.1 mtt -112.71 141.87 45.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.847 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -135.9 149.89 49.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 45' ' ' SER . 32.5 p -63.17 114.64 3.88 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.763 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.82 -14.34 19.7 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.475 176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.1 m-20 -61.73 132.33 52.82 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -81.8 129.47 37.44 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.686 0 CA-C-N 118.607 0.64 . . . . 0.0 112.32 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 38.5 mm -79.53 127.58 39.07 Favored 'Isoleucine or valine' 1 C--O 1.322 4.918 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 173.408 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 73' ' ' LEU . 40.2 t -115.86 -47.44 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 O-C-N 127.085 2.741 . . . . 0.0 111.873 -176.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' A' ' 72' ' ' VAL . 50.1 m -140.88 165.17 28.26 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 117.995 -1.482 . . . . 0.0 113.767 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.668 HG23 HG11 ' A' ' 72' ' ' VAL . 40.0 t -138.07 120.66 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 C-N-CA 124.855 1.262 . . . . 0.0 108.175 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 67.21 -79.34 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.468 1.105 . . . . 0.0 110.154 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -158.15 24.88 0.25 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.336 1.065 . . . . 0.0 109.655 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.8 m -117.19 123.84 47.65 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 t -68.07 108.01 2.94 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 80' ' ' VAL . 1.7 p -111.99 16.82 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 122.13 0.967 . . . . 0.0 108.606 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.603 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.7 tp -60.89 112.84 2.21 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.23 45.51 0.13 Allowed Glycine 0 C--N 1.378 2.874 0 O-C-N 125.754 1.909 . . . . 0.0 111.664 -170.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 76' ' ' THR . 7.0 t-160 -48.41 -66.98 0.31 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' HIS . 8.6 p -166.62 142.64 4.6 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 151.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.594 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.5 -31.61 15.92 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 120.288 1.404 . . . . 0.0 111.516 173.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -48.31 82.24 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 122.116 -0.365 . . . . 0.0 110.723 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.417 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 11.9 mm-40 -61.81 -44.08 97.57 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 122.938 0.495 . . . . 0.0 112.091 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.701 HG21 HD21 ' A' ' 41' ' ' LEU . 9.7 m -64.26 -44.31 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.63 -42.77 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -67.07 -29.15 68.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.383 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 86' ' ' SER . 2.1 mm -68.94 -40.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 123.117 0.567 . . . . 0.0 111.748 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.33 -33.96 67.71 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -73.27 -19.49 61.05 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.368 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 30.1 t -77.44 -43.17 33.4 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 mt -69.06 133.79 89.77 Favored Pre-proline 0 N--CA 1.423 -1.81 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.767 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.8 Cg_endo -89.56 161.84 5.34 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.163 2.576 . . . . 0.0 113.197 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.6 mm -60.83 132.49 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.833 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 12.19 55.96 Favored Glycine 0 C--N 1.288 -2.123 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.834 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.418 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.73 -172.13 2.1 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 19.8 m -151.17 156.87 41.86 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.77 -0.581 . . . . 0.0 109.614 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -143.43 125.49 11.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.672 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.597 -175.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.535 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 17.3 m-20 -78.42 108.26 11.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 67' ' ' VAL . 72.6 mt -108.45 136.03 48.75 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.443 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -91.58 124.65 35.91 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 10.7 mt -107.56 160.06 15.96 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.625 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 14.7 t -131.65 108.0 9.2 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 123.726 0.81 . . . . 0.0 108.993 174.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -96.89 147.12 24.29 Favored 'General case' 0 C--N 1.247 -3.853 0 O-C-N 120.706 -1.246 . . . . 0.0 109.904 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.04 -17.49 4.58 Favored Glycine 0 CA--C 1.482 -1.988 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.91 130.51 28.63 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.94 157.27 60.14 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 123.551 2.834 . . . . 0.0 112.546 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 17.6 mt -53.18 124.12 37.22 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.501 177.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.481 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 67.4 Cg_endo -77.06 -51.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 123.499 2.799 . . . . 0.0 115.698 -168.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.535 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 85.9 t80 -130.37 126.28 36.7 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 120.91 0.386 . . . . 0.0 111.477 -169.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -102.58 105.17 42.68 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.024 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 48.7 Cg_endo -94.7 -61.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.316 0 C-N-CA 122.357 2.038 . . . . 0.0 109.939 169.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.405 -2.681 0 C-N-CA 125.567 1.547 . . . . 0.0 108.421 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 4.6 t0 -76.98 124.09 87.4 Favored Pre-proline 0 CA--C 1.469 -2.152 0 CA-C-O 121.994 0.902 . . . . 0.0 109.786 -172.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.494 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 95.6 Cg_endo -76.58 -38.69 0.9 Allowed 'Trans proline' 0 N--CA 1.42 -2.815 0 C-N-CA 121.538 1.492 . . . . 0.0 111.133 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 44.8 m-80 -60.18 -14.46 17.51 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 127.092 2.157 . . . . 0.0 113.387 -165.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 p -105.2 31.06 5.13 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 114.183 -1.372 . . . . 0.0 113.087 -170.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 57.1 p -148.06 -157.09 0.78 Allowed 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.846 -0.534 . . . . 0.0 110.692 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.89 144.56 29.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.122 -1.806 . . . . 0.0 106.122 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.265 10.3 p 45.54 74.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 123.071 1.415 . . . . 0.0 110.216 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 111' ' ' ASN . 50.5 p -91.53 -137.99 0.16 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.87 -171.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.448 ' N ' ' HB2' ' A' ' 110' ' ' PRO . 1.8 p -50.14 141.08 11.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 124.865 1.266 . . . . 0.0 109.81 173.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.93 83.14 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.26 1.028 . . . . 0.0 110.284 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.22 36.89 0.48 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.32 104.84 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.628 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -109.56 20.19 18.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 t0 72.45 155.71 0.16 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 127.143 2.177 . . . . 0.0 111.404 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -118.33 38.62 3.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.328 1.061 . . . . 0.0 111.707 -173.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 125' ' ' PRO . 7.9 tp10 -98.32 147.55 33.27 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.501 ' HD2' ' OE2' ' A' ' 124' ' ' GLU . 19.2 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.643 2.228 . . . . 0.0 112.027 174.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.659 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 176.53 -50.84 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.8 ttp -148.14 58.62 1.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 104.07 125.36 5.59 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.806 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.572 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 48.2 tptt -104.65 -66.16 0.04 OUTLIER Pre-proline 0 N--CA 1.426 -1.631 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.601 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 1' ' ' LYS . 38.0 Cg_endo -106.34 -175.9 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.377 2.051 . . . . 0.0 111.741 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -73.79 104.25 4.62 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.585 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.4 t80 -105.46 128.61 53.64 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.277 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -144.24 20.35 1.74 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.105 0.955 . . . . 0.0 109.835 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.484 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 15.2 mtm180 57.48 -14.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 127.479 2.312 . . . . 0.0 116.374 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.8 t-20 -112.59 117.03 47.55 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.728 -0.607 . . . . 0.0 110.97 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 6.9 Cg_endo -53.22 -25.51 30.36 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.232 3.288 . . . . 0.0 113.37 174.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -71.61 -27.43 63.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -91.17 -21.24 21.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.512 HD11 HD21 ' A' ' 73' ' ' LEU . 24.5 mt -78.04 175.66 9.89 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.858 0.837 . . . . 0.0 110.641 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -105.11 -167.59 1.36 Allowed 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.72 175.01 45.76 Favored Glycine 0 C--N 1.284 -2.334 0 C-N-CA 119.315 -1.422 . . . . 0.0 112.155 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 4.0 tmmm? -113.62 148.56 36.03 Favored 'General case' 0 C--O 1.194 -1.849 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.2 m-85 -123.6 117.76 25.78 Favored 'General case' 0 CA--C 1.463 -2.387 0 CA-C-O 121.784 0.802 . . . . 0.0 110.807 -165.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.49 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 2.2 mp -111.75 138.1 41.8 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.786 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -102.67 118.67 37.36 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 7.9 t -129.26 157.93 40.49 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.345 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.795 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -129.46 122.05 28.53 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.527 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.69 117.42 34.05 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.085 -176.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 19.2 tpp85 -72.38 106.69 4.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.6 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.72 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 67.9 tttt -66.79 96.97 0.44 Allowed 'General case' 0 C--O 1.171 -3.026 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 166.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 89' ' ' ILE . 21.4 t -85.01 -155.43 0.21 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -56.53 -41.03 76.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.931 0.332 . . . . 0.0 111.371 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -86.09 -20.65 28.42 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.795 0.807 . . . . 0.0 109.82 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.72 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 103.52 -122.35 7.41 Favored Glycine 1 N--CA 1.388 -4.556 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.527 ' HD1' HD12 ' A' ' 20' ' ' LEU . 46.0 m-85 -88.09 142.57 27.67 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 117.214 0.507 . . . . 0.0 110.328 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.47 9.34 74.23 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.139 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.472 ' HB2' HG23 ' A' ' 43' ' ' ILE . 6.3 p90 -122.11 162.98 20.28 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.04 0.447 . . . . 0.0 109.939 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.4 p -116.85 155.19 29.44 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 41' ' ' LEU . 6.1 t -134.48 140.21 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.103 -175.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.8 p -153.15 157.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.03 171.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 116.3 0.11 20.62 Favored Glycine 1 CA--C 1.441 -4.537 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 169.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.831 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -120.73 46.01 1.17 Allowed Glycine 1 CA--C 1.395 -7.438 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.096 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.57 -25.3 64.45 Favored 'General case' 0 C--N 1.264 -3.127 0 CA-C-N 113.228 -1.486 . . . . 0.0 111.498 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt-20 -155.98 167.61 13.95 Favored Pre-proline 0 CA--C 1.463 -2.388 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.843 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -65.28 55.31 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.933 2.422 . . . . 0.0 111.084 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 14.8 t70 178.37 -12.91 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 -175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.713 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 62.7 mt-10 -117.83 123.94 47.15 Favored 'General case' 0 C--O 1.265 1.904 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.301 7.2 m-30 -79.22 156.12 28.29 Favored 'General case' 1 N--CA 1.554 4.755 0 O-C-N 127.687 3.117 . . . . 0.0 112.329 -175.233 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.831 HD12 ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -86.88 142.46 28.02 Favored 'General case' 0 CA--C 1.46 -2.498 0 C-N-CA 115.948 -2.301 . . . . 0.0 107.748 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 48.6 mt-30 -139.88 151.2 45.45 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.487 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 21.5 mm -70.82 112.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.623 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 40.2 ttmt -59.66 -41.69 91.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.591 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.4 t 163.56 173.6 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 O-C-N 125.224 1.577 . . . . 0.0 109.801 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.68 152.38 45.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.95 0.881 . . . . 0.0 113.297 -172.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 49' ' ' ASP . 21.1 t -87.58 129.55 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.028 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.26 -4.2 16.9 Favored 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 112.509 -2.132 . . . . 0.0 112.325 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.576 ' H ' HG12 ' A' ' 47' ' ' VAL . 10.3 t70 -99.32 -20.11 16.7 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.097 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.3 155.9 26.57 Favored Glycine 1 N--CA 1.393 -4.182 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.72 -171.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 11.6 Cg_endo -52.29 -26.66 27.92 Favored 'Trans proline' 0 C--O 1.198 -1.485 0 C-N-CA 125.009 3.806 . . . . 0.0 113.156 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.08 -46.72 85.0 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.114 0.483 . . . . 0.0 111.728 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.17 -36.65 54.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.404 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 8.3 mp -71.56 -36.93 71.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.052 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.51 -15.51 60.39 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.26 41.07 99.73 Favored Glycine 0 CA--C 1.49 -1.507 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.913 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -129.05 -23.88 2.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.281 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.428 ' SD ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -94.95 142.17 27.8 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.172 177.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.01 151.49 52.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -59.0 114.7 2.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.007 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 112.69 -11.83 25.38 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.238 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 9.7 m-20 -59.94 132.85 55.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 117.645 0.723 . . . . 0.0 109.56 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -86.94 119.3 34.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.2 mm -70.9 123.02 24.06 Favored 'Isoleucine or valine' 1 C--O 1.316 4.56 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 73' ' ' LEU . 40.0 t -114.42 -33.83 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-N 111.36 -2.654 . . . . 0.0 110.258 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -150.0 162.05 41.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.52 HG12 ' HB ' ' A' ' 72' ' ' VAL . 6.6 p -145.31 133.43 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 56.56 31.51 19.19 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.915 0.325 . . . . 0.0 111.828 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.66 15.9 10.25 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.592 1.157 . . . . 0.0 112.861 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -108.38 129.71 55.24 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.47 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 20.3 t -68.72 112.72 5.63 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.736 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -117.64 17.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.62 -175.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.585 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 32.1 tp -58.89 113.3 2.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 45.12 0.18 Allowed Glycine 0 N--CA 1.499 2.879 0 O-C-N 125.381 1.676 . . . . 0.0 111.801 -171.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 76' ' ' THR . 7.5 t-160 -47.78 -66.48 0.4 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.3 p -167.1 143.19 4.31 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 151.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.578 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -50.33 -31.77 15.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 119.987 1.267 . . . . 0.0 110.536 171.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.22 77.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.941 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.442 ' HG2' ' OG1' ' A' ' 76' ' ' THR . 71.0 mm-40 -64.67 -40.42 95.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.805 HG21 HD21 ' A' ' 41' ' ' LEU . 13.5 m -65.56 -45.7 91.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.053 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 77' ' ' HIS . 88.0 t -65.69 -37.46 80.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.2 tmtm? -58.26 -45.61 87.5 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.627 175.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.678 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.05 -36.8 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.386 0.613 . . . . 0.0 112.387 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -74.73 -31.36 61.81 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -69.31 -32.12 71.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.163 0.985 . . . . 0.0 110.768 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.2 m -69.58 -37.99 77.17 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.851 1.26 . . . . 0.0 110.122 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.48 HG22 ' HD3' ' A' ' 22' ' ' LYS . 21.8 mt -77.63 133.12 67.26 Favored Pre-proline 0 N--CA 1.411 -2.417 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.182 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.1 Cg_endo -88.66 162.73 6.4 Favored 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 123.611 2.874 . . . . 0.0 112.864 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.531 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.92 135.0 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 121.212 0.529 . . . . 0.0 110.534 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.08 58.83 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.57 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.607 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -100.94 179.61 4.34 Favored 'General case' 0 C--O 1.187 -2.184 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.495 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 6.2 m -140.66 163.71 32.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -150.39 125.52 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.337 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' THR . 4.3 m-20 -82.72 106.46 14.58 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.047 0.927 . . . . 0.0 109.548 174.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.4 mt -108.29 159.06 16.93 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 126.52 1.928 . . . . 0.0 108.852 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -116.89 123.64 47.5 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 81.2 mt -106.87 160.86 15.19 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.825 1.25 . . . . 0.0 109.793 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.634 ' HB3' HG13 ' A' ' 63' ' ' VAL . 16.0 t -135.36 111.0 9.23 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.422 1.106 . . . . 0.0 110.796 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.496 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 19.4 tpp85 -89.99 112.99 24.57 Favored 'General case' 0 C--N 1.266 -3.063 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.4 -26.57 0.31 Allowed Glycine 0 C--N 1.292 -1.879 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.912 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.61 129.69 35.68 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.665 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 141.63 94.19 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.927 3.085 . . . . 0.0 113.785 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 112' ' ' THR . 5.4 mt -50.51 124.11 18.47 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.684 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 27.3 Cg_endo -79.34 -51.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.394 2.729 . . . . 0.0 114.783 -175.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -124.58 138.7 54.3 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.24 108.56 61.65 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.294 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.36 -64.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.669 0 C-N-CA 122.007 1.805 . . . . 0.0 109.653 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.5 30.22 1.38 Allowed 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -116.27 112.32 41.81 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.608 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 112' ' ' THR . 55.7 Cg_endo -78.44 -28.01 4.8 Favored 'Trans proline' 0 CA--C 1.491 -1.667 0 C-N-CA 123.109 2.539 . . . . 0.0 110.458 -174.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.486 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -70.84 8.07 0.99 Allowed 'General case' 0 C--N 1.263 -3.183 0 C-N-CA 129.932 3.293 . . . . 0.0 111.764 -169.159 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 110' ' ' PRO . 25.5 p -91.5 -13.62 31.85 Favored 'General case' 0 N--CA 1.387 -3.619 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.481 -173.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.441 ' HB2' ' OG1' ' A' ' 116' ' ' THR . 15.8 m -112.13 147.55 35.86 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -61.27 128.56 36.95 Favored 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 123.814 0.696 . . . . 0.0 111.088 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.341 9.8 p 58.03 35.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 126.624 1.969 . . . . 0.0 114.89 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 113' ' ' SER . 26.8 m -82.19 -84.29 0.12 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.041 -1.464 . . . . 0.0 107.705 168.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.9 m -116.4 61.24 0.72 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -158.27 130.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.277 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -102.94 47.76 0.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.204 0.526 . . . . 0.0 111.278 -174.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.45 104.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.09 41.76 1.36 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.302 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 t70 71.21 -177.39 0.2 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.186 1.394 . . . . 0.0 110.19 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 63.54 25.71 14.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.898 1.679 . . . . 0.0 111.983 176.124 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.77 135.75 92.39 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.686 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 123.845 3.03 . . . . 0.0 112.995 -179.945 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.443 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.27 131.42 21.89 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 92.0 mtp 65.14 51.14 1.7 Allowed 'General case' 0 C--O 1.248 0.984 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 163.03 -132.47 2.77 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.552 ' HA ' ' HG2' ' A' ' 39' ' ' GLU . 48.7 tptt 47.59 63.26 10.51 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.158 0.983 . . . . 0.0 111.635 177.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 39' ' ' GLU . 6.0 Cg_endo -86.27 173.78 6.48 Favored 'Trans proline' 0 N--CA 1.439 -1.734 0 C-N-CA 122.699 2.266 . . . . 0.0 111.751 -174.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.34 105.12 2.44 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.554 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 5.1 t80 -107.56 135.36 49.14 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -144.17 17.98 1.74 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.111 0.958 . . . . 0.0 110.316 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.501 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 21.4 mtt180 59.4 -27.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.408 2.683 . . . . 0.0 116.57 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 50.3 t-20 -104.65 123.38 40.42 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.2 Cg_exo -54.84 -29.73 64.62 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 C-N-CA 123.737 2.958 . . . . 0.0 112.246 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.75 -26.17 63.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -92.2 -24.32 19.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -86.65 153.74 21.53 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.497 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.508 ' N ' HD13 ' A' ' 11' ' ' LEU . 46.6 mtmt -110.2 133.47 53.2 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 122.066 0.936 . . . . 0.0 110.697 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.515 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 156.83 170.6 22.02 Favored Glycine 1 C--N 1.247 -4.378 0 CA-C-N 113.048 -1.887 . . . . 0.0 108.999 -173.445 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 37.9 tptt -89.54 117.55 28.52 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.877 0.838 . . . . 0.0 109.825 174.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.3 m-85 -101.98 113.98 27.69 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.93 0.872 . . . . 0.0 109.77 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.6 mt -118.74 131.22 72.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.638 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -107.67 108.29 19.47 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -174.006 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -133.77 145.62 49.97 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 122.09 0.947 . . . . 0.0 111.271 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -87.96 130.84 34.82 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.149 177.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -109.66 117.38 33.77 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 40.8 ttt180 -77.12 111.94 13.25 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.087 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.668 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.6 tttt -66.96 96.83 0.45 Allowed 'General case' 0 C--O 1.187 -2.235 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -94.62 -154.26 0.41 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 124.322 1.049 . . . . 0.0 109.107 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -47.84 -41.97 25.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.894 1.278 . . . . 0.0 111.716 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.688 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.5 mmp_? -105.53 10.41 33.14 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.827 -0.546 . . . . 0.0 111.717 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.668 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 82.34 -125.3 6.88 Favored Glycine 1 N--CA 1.384 -4.769 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.0 m-85 -86.02 145.98 26.85 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.765 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.83 -2.93 86.2 Favored Glycine 0 CA--C 1.499 -0.945 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.336 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.543 ' HB2' HG23 ' A' ' 43' ' ' ILE . 20.9 p90 -109.93 162.9 14.06 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.893 0.854 . . . . 0.0 111.488 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.2 p -118.43 145.96 44.82 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG21 HD23 ' A' ' 41' ' ' LEU . 7.2 p -134.67 146.81 30.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.896 -173.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -144.38 165.92 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.873 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.371 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 114.29 -141.39 16.96 Favored Glycine 1 N--CA 1.394 -4.152 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 51.83 33.24 35.1 Favored Glycine 0 CA--C 1.471 -2.689 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.12 -27.95 67.75 Favored 'General case' 0 CA--C 1.455 -2.697 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -170.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 6.6 pt-20 -161.64 166.76 14.13 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.431 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 23.2 Cg_endo -66.63 58.88 0.52 Allowed 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.605 2.204 . . . . 0.0 109.353 169.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 21.7 t70 173.44 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.716 1.606 . . . . 0.0 110.661 -171.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' ' 1' ' ' LYS . 22.6 mt-10 -124.28 127.98 48.46 Favored 'General case' 0 C--O 1.269 2.127 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.447 ' CE1' HD11 ' A' ' 73' ' ' LEU . 8.6 m-30 -77.1 158.49 30.44 Favored 'General case' 0 N--CA 1.518 2.934 0 O-C-N 128.959 3.912 . . . . 0.0 113.258 -167.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 80' ' ' VAL . 7.1 mp -89.2 144.69 25.92 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 172.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.0 mt-30 -143.97 151.76 40.18 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 29' ' ' PHE . 22.2 mm -69.69 112.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.53 -39.18 72.94 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.485 ' HA ' HG22 ' A' ' 60' ' ' THR . 43.0 t 161.23 173.33 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.638 1.836 . . . . 0.0 108.666 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -135.86 148.18 48.53 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-O 121.644 0.735 . . . . 0.0 112.209 -175.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ASP . 43.3 t -83.94 121.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.214 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 6.2 mp -63.44 -3.48 2.1 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.583 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . 12.3 t70 -90.94 -30.7 16.71 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 124.594 1.158 . . . . 0.0 108.889 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -94.64 174.38 33.23 Favored Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 115.354 -168.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -52.35 -34.73 61.86 Favored 'Trans proline' 0 C--O 1.2 -1.389 1 C-N-CA 125.453 4.102 . . . . 0.0 113.815 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -58.03 -48.1 81.1 Favored 'General case' 0 C--O 1.264 1.843 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.78 -37.77 48.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.585 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -69.49 -36.64 76.72 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.198 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.71 -18.52 61.52 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.648 1.213 . . . . 0.0 108.112 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.23 35.23 91.35 Favored Glycine 0 CA--C 1.491 -1.449 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.227 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -115.69 -48.2 2.78 Favored 'General case' 0 N--CA 1.402 -2.867 0 C-N-CA 123.099 0.56 . . . . 0.0 112.479 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.57 151.37 19.38 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -149.68 147.47 28.12 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-O 122.01 0.909 . . . . 0.0 111.673 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 45' ' ' SER . 81.9 p -52.69 105.28 0.11 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.168 1.387 . . . . 0.0 112.346 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.06 -12.89 16.98 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-O 118.629 -1.095 . . . . 0.0 113.187 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.66 143.33 58.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.625 -1.23 . . . . 0.0 107.846 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -90.85 117.42 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 28.0 mm -69.87 125.08 27.27 Favored 'Isoleucine or valine' 1 C--O 1.327 5.163 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 73' ' ' LEU . 46.3 t -115.77 -37.33 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 111.136 -2.756 . . . . 0.0 112.197 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.9 m -149.89 157.28 43.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.381 -1.45 . . . . 0.0 112.617 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.677 HG23 HG11 ' A' ' 72' ' ' VAL . 77.0 t -134.37 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m120 57.89 31.52 20.67 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.808 0.692 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 72.63 1.74 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.621 1.968 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.8 m -89.65 122.2 32.55 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.42 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.2 t -65.5 108.89 2.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.172 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 80' ' ' VAL . 1.4 p -114.68 14.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.605 -175.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.554 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.6 tp -58.67 113.72 2.16 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.04 46.39 0.1 Allowed Glycine 0 C--N 1.378 2.864 0 O-C-N 125.857 1.973 . . . . 0.0 112.228 -170.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.492 ' O ' HG23 ' A' ' 76' ' ' THR . 6.6 t-160 -48.03 -67.35 0.28 Allowed 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 75' ' ' HIS . 14.2 p -165.98 143.22 5.4 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 152.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.562 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.4 t-80 -53.43 -31.26 44.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 120.664 1.574 . . . . 0.0 111.463 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.23 90.58 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.99 -0.444 . . . . 0.0 110.516 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 14.5 mm100 -64.19 -44.0 93.34 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 41' ' ' LEU . 11.2 m -62.19 -41.81 92.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.242 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.07 -38.83 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -63.05 -33.54 75.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.291 176.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 86' ' ' SER . 32.9 mt -67.63 -42.21 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.491 0.662 . . . . 0.0 111.104 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.56 -30.72 67.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.187 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -71.24 -33.16 69.58 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.18 0.992 . . . . 0.0 110.209 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 31.0 t -65.26 -49.07 70.99 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.139 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 12.0 mt -64.88 133.75 95.84 Favored Pre-proline 0 N--CA 1.426 -1.674 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.537 175.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.0 Cg_endo -90.75 162.33 4.15 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 123.563 2.842 . . . . 0.0 113.119 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.547 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.4 mm -62.66 134.76 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-O 121.058 0.456 . . . . 0.0 110.28 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.74 56.68 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.0 -169.14 1.64 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -176.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.618 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 27.1 m -151.34 163.85 38.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.818 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -148.41 124.71 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.085 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.503 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.66 104.99 13.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 63.2 mt -108.27 152.33 24.75 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 125.28 1.432 . . . . 0.0 111.94 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -104.17 119.48 39.04 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.5 mp -111.37 164.49 12.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.305 1.442 . . . . 0.0 108.559 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.564 ' HB3' HG13 ' A' ' 63' ' ' VAL . 38.9 t -145.23 111.69 5.74 Favored 'General case' 0 C--O 1.191 -1.991 0 CA-C-O 122.352 1.072 . . . . 0.0 112.931 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -99.4 120.06 38.99 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 120.957 -1.089 . . . . 0.0 111.202 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.4 -33.43 0.09 OUTLIER Glycine 0 CA--C 1.471 -2.677 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -96.1 141.83 23.71 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.09 -178.56 2.55 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.834 2.356 . . . . 0.0 110.171 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 103' ' ' LEU . 13.7 mt -59.23 120.36 46.97 Favored Pre-proline 0 N--CA 1.412 -2.331 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.71 -44.82 0.89 Allowed 'Trans proline' 0 CA--C 1.493 -1.574 0 C-N-CA 123.195 2.597 . . . . 0.0 114.993 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -129.55 149.8 51.16 Favored 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.493 -170.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 102.58 48.67 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.059 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.4 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 57.7 Cg_endo -96.67 -65.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.691 2.26 . . . . 0.0 110.519 170.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 38.8 t70 -123.35 25.82 8.17 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.449 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.4 114.75 45.65 Favored Pre-proline 0 CA--C 1.476 -1.891 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.95 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.506 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 53.1 Cg_endo -79.7 -38.07 0.41 Allowed 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.747 1.631 . . . . 0.0 111.438 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' A' ' 117' ' ' SER . 17.8 m-80 -55.68 -13.97 1.96 Allowed 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 129.193 2.997 . . . . 0.0 113.046 -165.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.8 p -88.91 -12.2 42.39 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.829 -170.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.1 m -96.61 -165.54 1.29 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.215 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.73 156.29 20.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.26 15.1 m 47.96 33.01 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 126.303 1.841 . . . . 0.0 114.886 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -120.17 -178.7 3.73 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.649 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 37.1 m 77.86 176.21 0.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -168.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -109.93 23.77 3.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.517 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.21 82.39 1.6 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 110.881 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.4 113.08 39.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -130.41 29.48 4.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.78 -18.35 11.37 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 114.273 -1.33 . . . . 0.0 113.388 -170.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -91.01 77.26 6.11 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-O 121.878 0.847 . . . . 0.0 111.031 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.17 141.47 23.01 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.534 2.156 . . . . 0.0 111.198 174.103 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.448 -1.181 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -83.24 105.45 14.21 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 3.1 t80 -103.03 124.61 48.85 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -130.78 11.18 5.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.926 0.869 . . . . 0.0 111.577 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.604 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 40.2 mtt180 55.21 6.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.774 1.63 . . . . 0.0 114.955 173.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -133.91 121.76 16.05 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HB3' HG11 ' A' ' 65' ' ' VAL . 8.5 Cg_exo -59.27 -27.16 84.26 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 123.611 2.874 . . . . 0.0 112.307 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 m -80.02 -24.4 40.82 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.521 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.53 -28.03 15.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 44.2 tp -70.24 155.16 41.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.053 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 24.4 mtmm -90.02 -175.71 4.66 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.571 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 109.02 178.16 21.49 Favored Glycine 0 C--N 1.278 -2.662 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.729 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.7 ' HE2' ' H ' ' A' ' 99' ' ' ARG . 1.6 tmpt? -91.07 134.19 34.71 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 91.8 m-85 -122.84 128.26 50.14 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 119.061 0.846 . . . . 0.0 109.867 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.532 HG13 ' HE3' ' A' ' 14' ' ' LYS . 73.8 mt -137.73 127.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.3 t60 -104.49 104.73 14.63 Favored 'General case' 0 N--CA 1.396 -3.144 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -124.07 143.86 50.2 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.799 0.809 . . . . 0.0 110.853 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.4 ttmp? -88.35 126.38 35.17 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.14 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.572 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -108.18 117.33 33.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 42.3 ttt-85 -77.07 113.89 15.28 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.405 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.715 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.9 tttt -69.64 97.52 1.06 Allowed 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 89' ' ' ILE . 32.2 t -83.59 -155.21 0.17 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.675 1.19 . . . . 0.0 108.514 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -59.4 -40.93 88.21 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.501 0.667 . . . . 0.0 109.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.02 -20.85 34.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.804 0.812 . . . . 0.0 109.521 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.715 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 98.18 -120.53 6.83 Favored Glycine 1 N--CA 1.378 -5.232 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.7 m-85 -91.57 141.72 28.42 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.565 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.21 1.27 87.59 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.107 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.478 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.3 p90 -110.81 163.34 13.88 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.817 0.818 . . . . 0.0 112.161 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 63.0 p -123.2 152.87 40.81 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -127.11 154.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.123 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.83 150.63 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.071 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.75 -138.74 13.89 Favored Glycine 1 N--CA 1.393 -4.175 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.61 28.9 31.03 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.1 -29.39 68.3 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -171.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt-20 -154.49 163.09 25.4 Favored Pre-proline 0 CA--C 1.456 -2.64 0 C-N-CA 118.025 -1.47 . . . . 0.0 109.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.0 Cg_endo -68.3 52.83 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.215 0 C-N-CA 123.076 2.517 . . . . 0.0 109.896 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 171.19 3.28 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.368 -168.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HG3' ' CG ' ' A' ' 36' ' ' GLU . 25.7 mt-10 -132.88 130.21 39.41 Favored 'General case' 0 C--O 1.275 2.44 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 163.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.606 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.256 5.2 m-30 -76.8 158.8 30.61 Favored 'General case' 0 N--CA 1.525 3.305 0 O-C-N 128.898 3.874 . . . . 0.0 114.008 -167.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 80' ' ' VAL . 4.8 mp -93.09 141.69 28.12 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.21 151.44 47.69 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 29' ' ' PHE . 33.1 mm -68.37 109.93 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 41.4 ttmt -58.36 -38.1 76.57 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.9 t 161.77 173.13 0.01 OUTLIER 'General case' 0 C--N 1.362 1.148 0 O-C-N 125.659 1.849 . . . . 0.0 109.825 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.552 HD22 ' HB1' ' A' ' 52' ' ' ALA . 1.5 pp -141.16 149.2 41.18 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.784 -173.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 49' ' ' ASP . 16.9 t -80.1 127.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.81 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.72 -3.69 1.66 Allowed 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 127.423 2.289 . . . . 0.0 113.567 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' H ' HG12 ' A' ' 47' ' ' VAL . 18.5 t70 -102.61 -25.56 13.53 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.492 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.425 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -85.69 162.93 36.41 Favored Glycine 0 N--CA 1.399 -3.822 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.908 -171.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.12 -33.51 35.57 Favored 'Trans proline' 0 C--O 1.188 -2.003 0 C-N-CA 125.006 3.804 . . . . 0.0 113.486 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.552 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.82 -48.7 78.98 Favored 'General case' 0 C--O 1.28 2.702 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HB2' HD13 ' A' ' 46' ' ' LEU . . . -77.33 -34.54 55.27 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.389 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -68.7 -42.5 77.67 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.977 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.717 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 34.7 t70 -64.16 -38.73 92.12 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.903 1.335 . . . . 0.0 107.483 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 -15.75 44.4 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 112.522 -2.126 . . . . 0.0 114.098 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.717 ' HB2' ' OD2' ' A' ' 55' ' ' ASP . 45.8 mtmt -79.14 -17.25 55.37 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.6 ttm -106.93 135.07 49.11 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.111 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.26 164.57 27.78 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.34 0.591 . . . . 0.0 109.903 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 45' ' ' SER . 77.7 p -63.08 118.26 7.62 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.354 1.062 . . . . 0.0 110.083 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 104.67 -5.76 44.0 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.125 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.692 ' OD2' ' HB2' ' A' ' 99' ' ' ARG . 3.0 m-20 -63.19 127.27 30.48 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.644 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -77.46 114.93 18.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 175.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 5.0 mm -67.8 122.11 18.33 Favored 'Isoleucine or valine' 1 C--O 1.331 5.369 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.563 HG13 HD13 ' A' ' 73' ' ' LEU . 61.9 t -114.11 -38.4 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 110.759 -2.928 . . . . 0.0 110.73 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.424 ' HA ' HG12 ' A' ' 72' ' ' VAL . 70.1 m -151.27 160.57 43.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.163 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 83' ' ' ILE . 3.6 p -140.59 127.92 22.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.44 31.98 18.01 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 t70 71.31 1.8 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.179 1.392 . . . . 0.0 111.956 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.2 m -88.84 123.92 33.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.4 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.0 t -67.58 104.76 1.67 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.675 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -113.76 17.14 7.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 40' ' ' PHE . 28.5 tp -59.69 112.95 2.0 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 29.72 45.85 0.09 OUTLIER Glycine 0 N--CA 1.499 2.859 0 O-C-N 125.269 1.606 . . . . 0.0 112.917 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 72' ' ' VAL . 5.0 t60 -47.98 -68.39 0.19 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 79' ' ' GLN . 22.1 p -166.16 143.98 5.48 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 151.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.524 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.61 -31.7 26.02 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 119.948 1.249 . . . . 0.0 110.519 172.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.01 83.12 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 121.971 -0.456 . . . . 0.0 110.72 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HG2' ' OG1' ' A' ' 76' ' ' THR . 55.3 mm-40 -64.91 -43.2 93.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 41' ' ' LEU . 15.8 m -60.16 -43.13 92.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.115 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 71.2 t -64.73 -41.98 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -57.24 -41.93 80.5 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.518 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.665 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 34.1 mt -67.18 -36.15 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 122.038 0.923 . . . . 0.0 111.686 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.87 -25.84 61.24 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.354 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 25.8 mt-30 -76.32 -24.33 54.31 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 67.6 m -73.75 -28.61 61.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.957 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.7 mt -92.78 133.84 28.57 Favored Pre-proline 0 N--CA 1.411 -2.407 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.556 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_endo -92.38 162.13 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.844 3.029 . . . . 0.0 113.393 -174.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.0 mm -62.72 131.86 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 CA-C-O 121.302 0.573 . . . . 0.0 111.072 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.64 12.17 51.45 Favored Glycine 0 C--N 1.294 -1.79 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.806 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.05 -171.24 2.01 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 14.8 m -151.27 157.48 42.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.4 125.54 6.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 C-N-CA 118.393 -1.323 . . . . 0.0 112.972 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 11.0 m-20 -78.7 107.38 11.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 71.1 mt -107.75 144.53 34.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.592 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -97.49 115.75 28.39 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 75.0 mt -113.07 123.76 51.02 Favored 'General case' 0 C--O 1.25 1.119 0 C-N-CA 124.82 1.248 . . . . 0.0 110.55 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -101.68 122.11 43.28 Favored 'General case' 0 C--O 1.154 -3.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.7 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 43.8 ttp180 -116.97 144.07 44.99 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 120.072 -1.642 . . . . 0.0 110.713 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.42 -19.27 3.4 Favored Glycine 0 C--N 1.287 -2.151 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -90.66 132.47 34.91 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo . . . . . 0 CA--C 1.517 -0.345 0 C-N-CA 123.265 2.643 . . . . 0.0 112.396 -176.239 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.433 -2.072 0 CA-C-O 121.332 0.472 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -83.88 104.76 14.23 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -116.67 124.96 51.01 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 t -134.42 19.58 3.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.48 0.657 . . . . 0.0 110.616 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.543 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 30.8 mtm180 54.32 5.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.431 1.892 . . . . 0.0 115.167 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 9' ' ' SER . 23.8 t-20 -133.35 123.77 17.84 Favored Pre-proline 0 C--N 1.298 -1.649 0 CA-C-O 120.963 0.411 . . . . 0.0 111.136 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HB3' HG11 ' A' ' 65' ' ' VAL . 14.8 Cg_endo -64.13 -12.59 33.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.887 3.725 . . . . 0.0 114.425 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.507 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 33.2 t -90.67 -36.75 14.18 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -74.39 -39.07 62.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.569 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 52.5 tp -73.03 158.77 34.77 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -119.31 -174.26 2.68 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.01 -131.55 7.29 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.263 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.746 ' HE2' ' H ' ' A' ' 99' ' ' ARG . 3.2 tmpt? -140.53 127.96 21.33 Favored 'General case' 0 C--N 1.257 -3.432 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.4 m-85 -122.63 123.31 40.87 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 118.666 0.666 . . . . 0.0 110.198 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.545 HG13 ' HE3' ' A' ' 14' ' ' LYS . 70.0 mt -132.05 131.66 61.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.899 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 94' ' ' ASP . 3.7 t60 -103.29 113.31 26.7 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -138.67 142.5 39.01 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.748 0.785 . . . . 0.0 110.55 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.812 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -87.58 133.44 33.8 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.053 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.571 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -108.47 117.57 34.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 21.2 ttt180 -77.43 110.54 12.28 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.695 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 66.2 tttt -65.76 96.78 0.3 Allowed 'General case' 0 C--O 1.19 -2.059 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 170.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -90.0 -154.79 0.34 Allowed 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.674 1.19 . . . . 0.0 108.927 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -57.06 -38.76 73.72 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.782 0.833 . . . . 0.0 110.495 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 mmp_? -90.45 -14.85 32.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 109.785 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 93.7 -115.47 4.97 Favored Glycine 1 N--CA 1.395 -4.058 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.571 ' HD1' HD12 ' A' ' 20' ' ' LEU . 38.6 m-85 -99.88 138.59 36.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 117.907 0.853 . . . . 0.0 109.095 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.08 80.73 Favored Glycine 0 C--O 1.207 -1.591 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.892 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.495 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.2 p90 -106.49 163.35 12.94 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.438 0.637 . . . . 0.0 111.162 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 73.6 p -125.96 146.12 50.0 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG11 HD23 ' A' ' 41' ' ' LEU . 12.3 m -123.03 148.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.933 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.96 154.59 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.689 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.95 -138.3 14.19 Favored Glycine 1 N--CA 1.386 -4.674 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.84 32.18 25.55 Favored Glycine 0 CA--C 1.47 -2.765 0 C-N-CA 123.559 0.6 . . . . 0.0 112.242 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -35.74 81.95 Favored 'General case' 0 CA--C 1.451 -2.855 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.17 165.47 18.51 Favored Pre-proline 0 CA--C 1.462 -2.441 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.293 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.3 Cg_endo -67.27 58.96 0.66 Allowed 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.766 2.311 . . . . 0.0 109.349 170.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.415 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 37.2 t70 174.4 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.393 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.1 mt-10 -128.91 127.42 41.74 Favored 'General case' 0 C--O 1.279 2.631 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CE1' HD11 ' A' ' 73' ' ' LEU . 7.0 m-30 -77.22 158.82 30.09 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 129.023 3.952 . . . . 0.0 113.694 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -92.22 143.0 26.87 Favored 'General case' 0 CA--C 1.46 -2.516 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.724 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.4 mt-30 -136.46 152.78 50.94 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 ' HB2' ' A' ' 29' ' ' PHE . 30.2 mm -71.83 108.93 3.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 39.5 ttpt -60.66 -36.99 80.08 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.507 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.9 t 161.14 173.41 0.01 OUTLIER 'General case' 0 C--N 1.372 1.573 0 O-C-N 125.711 1.882 . . . . 0.0 109.53 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -134.63 152.11 51.54 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.63 113.43 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.9 OUTLIER -69.35 -6.96 33.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.306 1.05 . . . . 0.0 113.101 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.72 -3.86 48.48 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.914 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -97.79 174.81 29.51 Favored Glycine 0 N--CA 1.423 -2.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.595 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.8 Cg_endo -57.54 -29.2 84.11 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 123.973 3.115 . . . . 0.0 113.404 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -59.0 -46.93 86.94 Favored 'General case' 0 C--O 1.268 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 111.95 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.14 -35.66 55.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.043 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 50' ' ' GLY . 9.3 mp -71.54 -34.62 70.17 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.23 -19.97 60.33 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.776 1.275 . . . . 0.0 107.637 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.36 31.74 81.78 Favored Glycine 0 CA--C 1.491 -1.459 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.922 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.28 -29.65 4.78 Favored 'General case' 0 N--CA 1.394 -3.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.3 ttm -101.19 139.76 36.43 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.539 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.14 156.58 46.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.91 0.862 . . . . 0.0 109.477 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 45' ' ' SER . 51.6 p -64.25 115.76 5.34 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 124.861 1.265 . . . . 0.0 109.601 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 117.61 -20.06 11.17 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.588 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.2 m-20 -58.96 135.85 57.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -87.32 117.89 32.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 C-N-CA 122.79 0.436 . . . . 0.0 111.392 175.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 4.3 mm -68.46 123.2 21.32 Favored 'Isoleucine or valine' 1 C--O 1.332 5.432 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 8' ' ' PRO . 46.4 t -115.6 -41.11 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 127.441 2.963 . . . . 0.0 111.793 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 66.4 m -147.04 161.84 40.01 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.17 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.491 HG12 ' HB ' ' A' ' 72' ' ' VAL . 7.2 p -137.49 134.58 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 m120 65.68 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.718 0.636 . . . . 0.0 110.054 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -163.96 33.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.813 1.768 . . . . 0.0 108.008 169.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.8 m -123.74 128.94 50.3 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.787 -1.551 . . . . 0.0 107.762 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.564 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 t -71.29 121.44 18.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 80' ' ' VAL . 4.7 p -121.23 20.15 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.589 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.0 tp -60.24 113.09 2.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.45 44.81 0.09 OUTLIER Glycine 0 N--CA 1.503 3.119 0 O-C-N 125.632 1.832 . . . . 0.0 111.729 -171.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t60 -49.44 -65.62 0.53 Allowed 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.7 p -166.75 143.81 4.82 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 152.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.565 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -50.8 -34.21 26.67 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 119.904 1.229 . . . . 0.0 110.902 172.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.94 96.49 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 122.192 -0.317 . . . . 0.0 110.929 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 8.2 mm-40 -67.51 -41.39 84.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 41' ' ' LEU . 20.2 m -63.45 -45.88 96.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.96 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.96 -39.51 85.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.662 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -56.22 -43.14 78.28 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 123.445 0.465 . . . . 0.0 110.975 175.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.662 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.7 mm -65.16 -36.8 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.432 0.634 . . . . 0.0 112.265 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -75.45 -32.83 60.79 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.192 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -73.05 -21.75 60.74 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.337 1.055 . . . . 0.0 111.305 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.3 m -77.9 -35.19 51.01 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.34 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.6 mt -77.88 133.25 66.08 Favored Pre-proline 0 N--CA 1.417 -2.098 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.238 177.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 13.6 Cg_endo -90.18 161.74 4.73 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.114 2.543 . . . . 0.0 112.972 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.551 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.4 mm -62.76 133.17 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.128 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.98 54.13 Favored Glycine 0 C--N 1.296 -1.649 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.672 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.44 -172.41 2.25 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.7 m -151.1 153.63 35.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.5 125.53 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.127 0 C-N-CA 117.343 -1.743 . . . . 0.0 113.353 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 8.5 m-20 -78.85 105.2 10.0 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.44 146.61 34.22 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 124.279 1.031 . . . . 0.0 109.672 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -107.93 117.01 33.0 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.539 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 68.9 mt -107.48 134.36 50.63 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 125.626 1.57 . . . . 0.0 110.697 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 31.1 t -106.97 123.99 48.98 Favored 'General case' 0 C--O 1.164 -3.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.484 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.746 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 2.9 mtm180 -103.73 123.93 47.95 Favored 'General case' 0 C--N 1.259 -3.331 0 O-C-N 120.641 -1.287 . . . . 0.0 109.525 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.1 -23.5 0.17 Allowed Glycine 0 C--N 1.271 -3.039 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.609 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 38.6 m-85 -96.94 139.21 21.42 Favored Pre-proline 0 N--CA 1.431 -1.382 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.637 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 101' ' ' TYR . 20.6 Cg_exo . . . . . 0 C--O 1.247 0.937 0 C-N-CA 123.341 2.694 . . . . 0.0 112.587 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.451 -1.002 0 N-CA-C 108.737 -1.293 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.01 103.81 4.63 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.5 t80 -111.29 128.98 56.11 Favored 'General case' 0 C--N 1.268 -2.94 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -139.46 13.45 2.56 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.226 0.536 . . . . 0.0 110.846 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.49 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtm180 55.25 6.47 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.139 1.776 . . . . 0.0 114.937 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -133.03 120.41 16.25 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HD3' ' SG ' ' A' ' 71' ' ' CYS . 23.8 Cg_exo -54.2 -32.49 70.82 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 124.472 3.448 . . . . 0.0 112.535 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -72.81 -21.93 60.89 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.59 0.709 . . . . 0.0 111.15 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -94.44 -25.94 16.69 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.571 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.43 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 42.4 tp -81.31 152.39 27.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.741 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -121.16 146.67 46.52 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.608 0.718 . . . . 0.0 110.151 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 158.35 -169.2 34.85 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -173.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.559 ' CE ' HG12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -103.76 108.66 20.07 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 118.401 1.1 . . . . 0.0 109.052 171.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 52.2 m-85 -90.04 120.22 31.05 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.941 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.559 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.7 mt -118.15 138.57 48.43 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.075 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 94' ' ' ASP . 2.2 t-80 -110.0 118.44 36.44 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -140.73 127.86 20.88 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.457 0.646 . . . . 0.0 112.678 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -88.51 126.41 35.24 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.428 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.531 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -107.64 119.75 40.3 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 13.3 ttp180 -79.29 106.35 11.26 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.723 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.724 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.8 tttt -62.71 97.52 0.1 Allowed 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 89' ' ' ILE . 37.3 t -81.69 -157.24 0.18 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 124.335 1.054 . . . . 0.0 108.798 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -63.35 -34.68 78.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.6 tmt_? -81.94 -20.71 38.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.724 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 87.58 -118.4 4.99 Favored Glycine 1 N--CA 1.391 -4.325 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.9 m-85 -94.56 144.14 25.83 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.888 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.23 3.28 63.99 Favored Glycine 0 C--O 1.203 -1.803 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.479 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.43 ' HB2' HG23 ' A' ' 43' ' ' ILE . 8.5 p90 -114.58 163.14 15.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.333 0.587 . . . . 0.0 110.358 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 55.9 p -122.71 148.65 45.06 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.7 m -121.87 143.76 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 CA-C-O 121.608 0.718 . . . . 0.0 111.113 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.66 148.5 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.083 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 118.4 -137.57 13.07 Favored Glycine 2 N--CA 1.381 -5.012 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.8 31.7 16.85 Favored Glycine 0 CA--C 1.467 -2.943 0 O-C-N 124.358 0.681 . . . . 0.0 111.528 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -70.14 -22.98 62.94 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.14 166.03 8.66 Favored Pre-proline 0 CA--C 1.463 -2.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 18.0 Cg_endo -66.56 58.18 0.5 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.389 2.06 . . . . 0.0 109.831 171.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 23.5 t70 177.08 -11.92 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.454 -171.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -124.63 124.98 43.38 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.252 4.9 m-30 -76.78 159.26 30.27 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 131.044 3.738 . . . . 0.0 113.932 -169.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.864 HD21 HG21 ' A' ' 80' ' ' VAL . 8.0 mp -92.56 144.33 25.45 Favored 'General case' 0 C--O 1.183 -2.432 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.3 mt-30 -139.23 156.93 46.74 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG21 HD23 ' A' ' 46' ' ' LEU . 26.3 mm -72.42 111.45 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.261 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.53 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 36.8 ttpt -63.06 -40.97 99.29 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.559 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.8 t 165.15 174.4 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 125.148 1.53 . . . . 0.0 109.81 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 pp -142.64 147.61 36.05 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.94 0.876 . . . . 0.0 112.712 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 49' ' ' ASP . 44.3 t -69.0 116.39 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.984 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.724 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.89 -24.59 62.47 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.403 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.425 ' H ' HG12 ' A' ' 47' ' ' VAL . 9.9 m-20 -94.46 -2.51 51.69 Favored 'General case' 0 C--N 1.258 -3.373 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.656 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.411 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -99.65 170.46 23.12 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.505 -174.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.7 Cg_endo -56.77 -29.25 79.99 Favored 'Trans proline' 0 C--O 1.196 -1.586 0 C-N-CA 124.203 3.269 . . . . 0.0 113.312 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -62.42 -41.49 98.73 Favored 'General case' 0 C--O 1.269 2.112 0 CA-C-O 121.459 0.647 . . . . 0.0 111.479 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.46 47.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.77 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 50' ' ' GLY . 9.4 mp -70.48 -38.96 74.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.581 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.74 -24.91 62.71 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.85 74.03 Favored Glycine 0 CA--C 1.483 -1.923 0 CA-C-N 112.304 -2.225 . . . . 0.0 113.164 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -118.04 -2.04 11.32 Favored 'General case' 0 N--CA 1.385 -3.696 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.98 134.82 52.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.447 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.35 151.83 45.56 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.559 HG22 ' HA ' ' A' ' 45' ' ' SER . 76.2 p -64.91 110.22 2.37 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.378 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 124.31 -19.65 7.16 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-O 119.254 -0.748 . . . . 0.0 113.237 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 13.5 m-20 -61.33 132.23 52.89 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.005 0.902 . . . . 0.0 109.461 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.257 0.1 OUTLIER -82.38 120.54 34.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 177.528 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mm -71.86 123.09 25.53 Favored 'Isoleucine or valine' 1 C--O 1.333 5.488 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.534 HG13 HD13 ' A' ' 73' ' ' LEU . 52.8 t -115.56 -40.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 127.442 2.964 . . . . 0.0 111.28 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -146.25 162.14 38.73 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.319 -0.863 . . . . 0.0 112.906 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG23 HG11 ' A' ' 72' ' ' VAL . 52.7 t -139.82 126.54 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 C-N-CA 125.443 1.497 . . . . 0.0 107.197 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 m120 57.55 30.71 19.17 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.67 0.606 . . . . 0.0 110.947 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.9 t70 77.93 -8.12 1.72 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.043 1.337 . . . . 0.0 111.882 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.1 m -86.51 121.16 28.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.522 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 49.7 t -60.89 112.88 2.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.492 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -119.98 18.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.588 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.5 tp -60.52 112.42 1.97 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.17 39.05 0.06 OUTLIER Glycine 0 N--CA 1.504 3.233 0 O-C-N 125.007 1.442 . . . . 0.0 112.107 -171.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.518 ' O ' HG23 ' A' ' 76' ' ' THR . 5.8 t60 -42.85 -64.34 0.64 Allowed 'General case' 0 C--N 1.373 1.604 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.3 p -166.99 142.99 4.34 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 150.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.573 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -51.57 -32.15 27.25 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 120.951 1.705 . . . . 0.0 110.889 173.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.33 77.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.811 0.338 . . . . 0.0 110.619 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 12.6 mm-40 -65.23 -40.79 94.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.864 HG21 HD21 ' A' ' 41' ' ' LEU . 11.0 m -63.65 -44.47 98.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.94 -40.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.663 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -56.73 -41.64 77.85 Favored 'General case' 0 C--O 1.196 -1.74 0 O-C-N 123.465 0.478 . . . . 0.0 110.835 175.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.663 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.5 mm -65.91 -36.05 76.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 0.0 112.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.39 -26.94 56.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.92 -30.05 61.15 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.179 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -66.29 -42.98 87.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.101 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.498 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.4 mt -76.22 131.88 74.46 Favored Pre-proline 0 N--CA 1.404 -2.769 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.683 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.0 Cg_endo -92.42 161.91 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.175 2.584 . . . . 0.0 112.92 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.562 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 26.8 mm -58.68 132.35 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.36 11.41 54.18 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.98 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.77 -169.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.4 m -151.62 157.44 42.16 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -147.3 124.94 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.601 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.5 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 10.2 m-20 -78.45 103.79 8.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.44 HD22 HG22 ' A' ' 67' ' ' VAL . 52.2 mt -100.01 148.95 23.97 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 125.092 1.357 . . . . 0.0 109.045 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 29.0 tt0 -111.18 119.13 37.91 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.75 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 96.1 mt -106.18 164.6 11.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.646 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 7.9 t -142.09 117.28 10.08 Favored 'General case' 0 C--O 1.18 -2.577 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -100.99 145.25 28.93 Favored 'General case' 0 C--N 1.261 -3.267 0 O-C-N 120.472 -1.393 . . . . 0.0 109.734 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.15 -27.93 1.55 Allowed Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -84.88 130.82 51.13 Favored Pre-proline 0 N--CA 1.427 -1.619 0 CA-C-O 121.051 0.453 . . . . 0.0 110.51 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 C--O 1.244 0.821 0 C-N-CA 123.459 2.772 . . . . 0.0 114.208 -173.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.443 -1.468 0 CA-C-O 121.036 0.348 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.76 103.74 14.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.2 t80 -115.94 126.68 54.19 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.468 ' CG2' HD23 ' A' ' 11' ' ' LEU . 5.8 t -139.4 23.67 2.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.887 0.851 . . . . 0.0 110.884 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 60.0 mtt180 53.03 4.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 127.381 2.272 . . . . 0.0 116.136 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.7 t-20 -134.4 122.98 16.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.7 Cg_exo -54.56 -31.58 70.45 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 123.753 2.969 . . . . 0.0 112.602 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -71.2 -26.81 63.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.397 0.618 . . . . 0.0 110.221 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -93.22 -15.26 26.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.344 0.592 . . . . 0.0 110.85 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . 33.3 mt -76.43 -173.68 2.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.51 1.147 . . . . 0.0 111.767 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -120.5 178.52 4.64 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.568 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.98 164.57 35.27 Favored Glycine 0 C--N 1.281 -2.476 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.204 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 34.0 tptt -88.25 126.83 35.37 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.654 0.782 . . . . 0.0 109.678 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 11' ' ' LEU . 93.4 m-85 -104.79 119.63 39.47 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.016 0.912 . . . . 0.0 110.583 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.521 HD13 ' NH2' ' A' ' 99' ' ' ARG . 8.5 mt -121.67 146.56 26.57 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.116 -172.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -117.29 127.34 53.98 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -139.05 156.86 46.86 Favored 'General case' 0 C--O 1.184 -2.369 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 38.2 ttpt -127.26 123.57 36.79 Favored 'General case' 0 C--N 1.258 -3.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.497 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.81 116.4 31.86 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.75 -170.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 32.8 ttp-105 -79.01 102.38 8.31 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.268 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.692 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.6 tttt -59.54 97.79 0.04 OUTLIER 'General case' 0 C--O 1.179 -2.649 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 t -84.82 -155.3 0.2 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.792 1.237 . . . . 0.0 109.173 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -61.13 -36.36 79.53 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.396 0.617 . . . . 0.0 109.468 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -86.69 -16.78 35.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.736 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.692 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 88.38 -112.17 3.87 Favored Glycine 1 N--CA 1.391 -4.308 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.497 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.1 m-85 -97.09 135.12 39.53 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.172 0.51 . . . . 0.0 109.919 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.93 -3.42 90.6 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.896 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' HB2' HG23 ' A' ' 43' ' ' ILE . 9.7 p90 -113.58 163.68 14.64 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.604 0.716 . . . . 0.0 111.903 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.2 p -124.08 148.06 47.4 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.369 1.468 . . . . 0.0 107.281 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.66 148.23 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.75 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.41 153.48 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.434 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.43 -131.79 9.59 Favored Glycine 0 N--CA 1.398 -3.877 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.65 36.33 24.87 Favored Glycine 0 CA--C 1.466 -2.97 0 O-C-N 124.593 0.82 . . . . 0.0 111.902 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.08 -31.05 70.42 Favored 'General case' 0 CA--C 1.449 -2.932 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -161.4 166.87 14.16 Favored Pre-proline 0 CA--C 1.45 -2.869 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.216 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -66.72 64.04 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.126 1.884 . . . . 0.0 108.468 168.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.46 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 12.9 t70 170.69 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.376 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 21.3 mt-10 -127.58 127.4 43.82 Favored 'General case' 0 C--O 1.276 2.457 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 73' ' ' LEU . 9.7 m-85 -76.92 159.25 30.15 Favored 'General case' 0 N--CA 1.532 3.639 0 O-C-N 128.836 3.835 . . . . 0.0 113.319 -167.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD21 HG21 ' A' ' 80' ' ' VAL . 5.1 mp -92.34 143.2 26.63 Favored 'General case' 0 CA--C 1.469 -2.161 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.8 mt-30 -135.5 154.28 51.46 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 29' ' ' PHE . 20.9 mm -75.35 111.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.39 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 45' ' ' SER . 47.6 tptt -60.83 -47.29 87.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.632 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.9 t 173.2 172.71 0.13 Allowed 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.871 1.357 . . . . 0.0 111.183 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.1 pp -143.1 145.74 33.13 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 123.764 0.826 . . . . 0.0 111.128 -175.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 49' ' ' ASP . 22.0 t -75.18 121.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 1.8 pt? -69.42 -5.24 22.45 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.965 0.888 . . . . 0.0 112.585 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' H ' HG12 ' A' ' 47' ' ' VAL . 19.7 t70 -85.4 -26.65 26.29 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.903 -1.499 . . . . 0.0 108.917 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.44 172.08 37.34 Favored Glycine 0 N--CA 1.402 -3.586 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.676 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HG2' HD11 ' A' ' 20' ' ' LEU . 14.2 Cg_endo -54.87 -26.37 48.06 Favored 'Trans proline' 0 C--O 1.201 -1.375 0 C-N-CA 124.911 3.741 . . . . 0.0 113.325 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -58.26 -52.66 64.64 Favored 'General case' 0 C--O 1.291 3.244 0 C-N-CA 123.377 0.671 . . . . 0.0 112.789 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.36 -33.53 55.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.456 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.3 mp -70.31 -35.59 73.76 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.097 -176.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.34 -21.84 65.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.59 11.83 84.86 Favored Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 112.61 -2.087 . . . . 0.0 113.47 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -107.62 -43.02 4.6 Favored 'General case' 1 N--CA 1.376 -4.132 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.406 ' HB3' HD11 ' A' ' 97' ' ' LEU . 17.0 ptp -95.92 154.7 17.1 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 116.631 -2.028 . . . . 0.0 112.296 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.42 161.19 38.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.749 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 45' ' ' SER . 75.0 p -65.86 113.7 4.56 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.25 -14.18 10.24 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.716 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.4 m-20 -65.95 152.69 43.99 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.44 125.18 55.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.989 -0.444 . . . . 0.0 111.571 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.456 HD13 HD23 ' A' ' 97' ' ' LEU . 10.4 mm -75.52 124.09 32.77 Favored 'Isoleucine or valine' 1 C--O 1.323 4.938 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.594 HG13 HD13 ' A' ' 73' ' ' LEU . 57.7 t -115.11 -36.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 111.037 -2.801 . . . . 0.0 111.247 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 70.3 m -150.8 160.24 44.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.001 -1.062 . . . . 0.0 113.081 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG23 HG11 ' A' ' 72' ' ' VAL . 55.0 t -142.18 129.59 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.5 m120 55.12 41.61 31.47 Favored 'General case' 0 C--O 1.256 1.437 0 O-C-N 123.776 0.673 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 25.26 5.69 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.47 1.108 . . . . 0.0 113.215 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 m -114.72 125.95 54.31 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 27.4 t -67.08 110.82 3.57 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 80' ' ' VAL . 2.2 p -117.35 16.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 65' ' ' VAL . 32.6 tp -57.95 112.85 1.63 Allowed 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.03 40.3 0.05 OUTLIER Glycine 0 N--CA 1.497 2.701 0 O-C-N 125.511 1.757 . . . . 0.0 112.934 -170.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.549 ' O ' HG23 ' A' ' 76' ' ' THR . 4.7 t60 -43.71 -66.48 0.38 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.8 p -166.35 143.51 5.13 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 150.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.555 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -51.47 -31.37 23.2 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 119.699 1.136 . . . . 0.0 110.775 172.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.65 85.51 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.942 -0.474 . . . . 0.0 110.946 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 21.9 mm-40 -65.34 -42.18 93.13 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.784 HG21 HD21 ' A' ' 41' ' ' LEU . 18.4 m -62.11 -43.71 98.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.26 -39.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -61.0 -41.62 96.88 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.02 176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' SER . 37.1 mt -62.01 -40.96 89.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.34 0.59 . . . . 0.0 111.635 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -70.89 -34.97 72.11 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.804 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -72.77 -19.64 61.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.06 0.944 . . . . 0.0 111.676 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 53.4 m -79.79 -27.81 40.35 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.132 0.973 . . . . 0.0 109.372 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.463 HG22 ' HD3' ' A' ' 22' ' ' LYS . 43.2 mt -85.17 134.65 40.47 Favored Pre-proline 0 N--CA 1.416 -2.141 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.607 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 18.5 Cg_endo -92.66 161.68 2.85 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 123.347 2.698 . . . . 0.0 113.039 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.65 133.55 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.63 12.49 53.43 Favored Glycine 0 C--N 1.289 -2.042 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.955 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.3 -170.26 1.85 Allowed 'General case' 0 C--O 1.199 -1.6 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 3.3 t -151.36 159.72 44.13 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.0 t -147.68 126.15 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.507 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.04 112.93 17.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.451 ' CD2' HG22 ' A' ' 67' ' ' VAL . 45.2 mt -109.89 144.55 38.21 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 126.387 1.875 . . . . 0.0 109.962 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.45 118.61 37.14 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 64' ' ' ILE . 23.7 mt -105.6 165.07 11.41 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.903 1.281 . . . . 0.0 108.784 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -142.94 111.05 6.03 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.781 0.801 . . . . 0.0 110.96 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.521 ' NH2' HD13 ' A' ' 16' ' ' ILE . 13.1 mtm180 -97.0 129.69 44.43 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.211 -0.931 . . . . 0.0 112.213 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.07 -17.78 0.82 Allowed Glycine 0 C--N 1.277 -2.702 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.512 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.12 148.85 40.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.862 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.352 0.755 0 C-N-CA 122.889 2.392 . . . . 0.0 111.538 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.554 1.523 0 CA-C-O 121.29 0.454 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.12 107.26 18.95 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 2.1 t80 -99.11 129.8 45.39 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 7' ' ' ASN . 14.6 t -138.1 10.82 2.82 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.873 0.845 . . . . 0.0 110.628 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 31.3 mtt180 58.25 -22.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.557 2.343 . . . . 0.0 115.738 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.479 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 56.1 t-20 -104.6 117.74 58.25 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HB3' HG11 ' A' ' 65' ' ' VAL . 9.3 Cg_endo -57.39 -26.05 68.99 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.965 3.11 . . . . 0.0 112.956 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -74.11 -30.29 62.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.124 0.487 . . . . 0.0 110.002 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -89.36 -29.61 18.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 41.2 tp -72.07 155.85 39.84 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.548 0.689 . . . . 0.0 111.619 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 9.2 mtmp? -90.18 -167.17 1.77 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.614 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 91.13 173.58 43.65 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.183 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -97.44 129.6 44.63 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.5 m-85 -103.16 113.74 27.47 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-O 122.538 1.161 . . . . 0.0 110.04 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -116.55 143.7 26.06 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.908 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.56 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.7 t60 -110.62 131.02 55.41 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 8.8 t -139.29 156.76 46.82 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.2 ttmp? -125.24 122.83 38.08 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -108.35 116.68 32.43 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.393 -174.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.0 ttp180 -75.09 107.77 7.38 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.021 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.626 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.7 tttt -66.71 95.68 0.36 Allowed 'General case' 0 C--O 1.171 -3.07 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 167.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t -89.55 -155.26 0.35 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 m -60.95 -32.81 72.33 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 122.56 0.344 . . . . 0.0 110.397 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -83.11 -21.02 33.78 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.368 0.604 . . . . 0.0 109.55 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 73.12 80.16 0.45 Allowed Glycine 0 N--CA 1.417 -2.584 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 20' ' ' LEU . 24.3 m-85 80.49 168.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.736 2.014 . . . . 0.0 110.07 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.18 10.99 5.6 Favored Glycine 0 CA--C 1.497 -1.077 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.018 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' HG23 ' A' ' 43' ' ' ILE . 19.4 p90 -119.49 162.93 18.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.235 0.54 . . . . 0.0 109.758 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.4 p -119.41 153.83 34.61 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -144.85 141.41 23.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.117 -174.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.6 p -151.83 166.12 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.353 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.6 3.06 30.74 Favored Glycine 0 CA--C 1.454 -3.766 0 N-CA-C 116.521 1.368 . . . . 0.0 116.521 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.802 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -117.06 48.89 0.9 Allowed Glycine 1 CA--C 1.41 -6.516 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -168.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.26 -29.16 60.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 112.841 -1.679 . . . . 0.0 110.239 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.6 pt-20 -163.81 171.96 5.46 Favored Pre-proline 0 CA--C 1.465 -2.293 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.093 -172.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 36' ' ' GLU . 21.9 Cg_endo -64.73 54.9 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.011 2.474 . . . . 0.0 110.898 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -177.53 -19.62 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.305 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.72 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 2.8 mt-10 -119.53 122.73 42.31 Favored 'General case' 0 C--O 1.265 1.885 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 171.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.296 5.4 m-30 -78.92 155.99 28.78 Favored 'General case' 0 N--CA 1.533 3.703 0 O-C-N 127.78 3.175 . . . . 0.0 112.722 -176.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.802 HD12 ' HA3' ' A' ' 34' ' ' GLY . 7.4 mp -85.75 143.08 28.54 Favored 'General case' 0 C--O 1.179 -2.607 0 C-N-CA 117.153 -1.819 . . . . 0.0 108.112 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.0 mt-30 -139.31 151.24 46.25 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.9 mm -72.38 110.95 5.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 58.3 tttm -59.39 -38.99 81.96 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.598 ' HA ' HG22 ' A' ' 60' ' ' THR . 30.7 t 163.78 172.34 0.02 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.637 1.836 . . . . 0.0 110.646 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -141.58 152.14 43.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.866 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 49' ' ' ASP . 56.9 t -81.61 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.6 pt? -68.63 -11.12 59.67 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.452 ' H ' HG12 ' A' ' 47' ' ' VAL . 6.3 m-20 -95.15 -7.29 39.69 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.073 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.26 163.0 37.18 Favored Glycine 0 N--CA 1.404 -3.461 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.765 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.83 -30.37 38.14 Favored 'Trans proline' 0 C--O 1.211 -0.873 0 C-N-CA 124.718 3.612 . . . . 0.0 112.897 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.87 -45.82 85.78 Favored 'General case' 0 C--O 1.271 2.223 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.798 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.9 -31.94 57.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.645 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.32 -40.62 64.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.069 0.547 . . . . 0.0 112.419 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.76 -25.62 67.35 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.02 5.33 65.08 Favored Glycine 0 CA--C 1.483 -1.935 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.939 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.89 -28.78 14.53 Favored 'General case' 1 N--CA 1.378 -4.061 0 C-N-CA 122.782 0.433 . . . . 0.0 111.551 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.8 ttm -97.04 140.49 31.48 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.064 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -137.97 161.9 35.5 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -71.01 107.53 4.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.825 0.85 . . . . 0.0 111.264 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.83 -16.6 9.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.207 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 2.9 m-20 -61.9 134.45 56.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -84.62 124.89 40.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.276 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.75 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 14.4 mm -73.8 124.58 31.36 Favored 'Isoleucine or valine' 1 C--O 1.32 4.78 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 170.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 8' ' ' PRO . 47.9 t -115.09 -40.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 111.481 -2.6 . . . . 0.0 110.939 -176.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.2 m -146.27 166.29 26.71 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.193 -1.003 . . . . 0.0 113.345 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG23 HG11 ' A' ' 72' ' ' VAL . 39.8 t -139.7 120.69 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 125.313 1.445 . . . . 0.0 107.493 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.7 m120 67.53 -75.75 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.471 1.107 . . . . 0.0 109.809 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.07 4.14 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.322 0.649 . . . . 0.0 110.862 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -96.94 121.82 39.23 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 72.1 m -70.71 88.2 0.71 Allowed 'General case' 0 N--CA 1.398 -3.045 0 O-C-N 124.639 1.212 . . . . 0.0 108.366 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 80' ' ' VAL . 3.8 p -97.73 19.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.43 -171.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.581 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.3 tp -58.82 113.19 1.94 Allowed 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.84 44.92 0.1 OUTLIER Glycine 0 C--N 1.384 3.246 0 O-C-N 125.996 2.06 . . . . 0.0 111.661 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.563 ' O ' HG23 ' A' ' 76' ' ' THR . 3.5 t60 -48.42 -64.26 0.85 Allowed 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 75' ' ' HIS . 12.0 p -166.42 142.79 4.83 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 151.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.35 -31.58 22.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 120.498 1.499 . . . . 0.0 111.373 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.56 77.0 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 122.029 -0.419 . . . . 0.0 110.438 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 11.9 mm-40 -64.46 -39.01 93.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 41' ' ' LEU . 11.6 m -64.16 -43.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.2 -37.8 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.1 tmtm? -57.78 -42.84 84.94 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.298 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.649 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.3 mm -66.21 -33.72 65.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.642 0.734 . . . . 0.0 112.628 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -76.09 -28.92 57.74 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.297 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -72.89 -28.26 62.38 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.373 1.069 . . . . 0.0 110.663 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.8 m -65.57 -38.66 90.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.455 175.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.513 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 22.1 mt -82.89 133.76 48.08 Favored Pre-proline 0 N--CA 1.405 -2.681 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.03 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.1 Cg_endo -90.71 161.98 4.2 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.086 2.524 . . . . 0.0 113.234 -173.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.565 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.1 mm -60.77 133.84 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.457 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 11.62 56.63 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.133 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.92 -169.72 1.72 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -151.34 165.73 33.16 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.2 t -150.35 126.21 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.887 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.56 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -78.65 107.02 11.03 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.194 -1.002 . . . . 0.0 108.743 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.464 ' CD2' HG22 ' A' ' 67' ' ' VAL . 56.7 mt -103.84 152.45 21.9 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.801 1.64 . . . . 0.0 108.391 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 30.1 tt0 -111.11 123.42 50.17 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 76.6 mt -105.65 153.87 21.23 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.759 1.223 . . . . 0.0 110.247 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.641 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 9.6 t -124.26 107.12 10.85 Favored 'General case' 0 C--O 1.186 -2.241 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.476 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 40.4 ttp180 -101.39 138.62 38.15 Favored 'General case' 1 C--N 1.243 -4.052 0 O-C-N 120.59 -1.319 . . . . 0.0 110.494 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.51 -32.84 0.84 Allowed Glycine 0 CA--C 1.464 -3.123 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.45 137.59 45.03 Favored Pre-proline 0 N--CA 1.412 -2.34 0 CA-C-N 113.871 -1.165 . . . . 0.0 108.434 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 C--N 1.317 -1.106 0 C-N-CA 122.964 2.443 . . . . 0.0 112.242 -177.256 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.438 -1.774 0 CA-C-O 121.35 0.479 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -94.5 111.15 22.9 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.594 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -107.81 123.17 48.17 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -133.3 12.41 4.19 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.339 0.59 . . . . 0.0 110.279 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.529 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtp180 60.47 -29.7 0.05 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.446 2.298 . . . . 0.0 115.381 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 55.6 t-20 -95.92 117.38 66.39 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.4 Cg_endo -59.36 -22.79 67.27 Favored 'Trans proline' 0 C--O 1.21 -0.924 0 C-N-CA 123.772 2.982 . . . . 0.0 113.134 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -76.92 -25.37 52.85 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.804 -0.56 . . . . 0.0 109.562 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -93.82 -19.32 21.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.574 0.702 . . . . 0.0 110.22 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.4 tm? -88.14 145.78 25.74 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.369 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' N ' HD13 ' A' ' 11' ' ' LEU . 57.3 mttm -103.32 137.74 41.03 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-O 121.873 0.844 . . . . 0.0 110.581 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 152.82 169.52 18.15 Favored Glycine 1 C--N 1.246 -4.417 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.237 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.47 122.3 40.37 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.908 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.2 m-85 -96.53 111.34 23.5 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.784 1.278 . . . . 0.0 112.157 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.477 HD11 ' HG3' ' A' ' 99' ' ' ARG . 5.9 mm -92.55 152.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 CA-C-N 112.779 -2.009 . . . . 0.0 108.436 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 113.05 14.47 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 t -139.37 132.88 30.3 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.918 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.9 ttpt -92.95 125.92 37.78 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.509 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.28 117.3 33.69 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -175.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.444 ' HD3' ' OG ' ' A' ' 92' ' ' SER . 18.6 tpp180 -74.59 103.83 5.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.954 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.653 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 69.9 tttt -62.17 97.29 0.08 Allowed 'General case' 0 C--O 1.177 -2.733 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.0 t -129.71 125.87 36.94 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t 62.18 -77.73 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.127 1.371 . . . . 0.0 110.534 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -85.48 -20.63 29.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.653 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 107.83 -110.43 3.16 Favored Glycine 1 N--CA 1.385 -4.73 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.509 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.1 m-85 -92.45 135.7 33.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.268 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.56 3.55 84.71 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.812 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE2' HG22 ' A' ' 31' ' ' VAL . 10.0 p90 -119.07 162.92 17.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.194 0.521 . . . . 0.0 110.434 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 21.5 p -113.15 145.81 40.3 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.665 HG11 HD23 ' A' ' 41' ' ' LEU . 1.6 t -119.19 143.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.505 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.33 149.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.785 0 CA-C-O 121.336 0.588 . . . . 0.0 109.428 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.25 -138.52 11.02 Favored Glycine 1 N--CA 1.391 -4.317 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.63 36.97 19.46 Favored Glycine 0 CA--C 1.456 -3.598 0 O-C-N 124.517 0.775 . . . . 0.0 111.346 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 3.1 t70 -69.93 -27.71 65.0 Favored 'General case' 0 CA--C 1.463 -2.394 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -170.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.9 pt-20 -164.28 167.69 10.19 Favored Pre-proline 0 CA--C 1.464 -2.354 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.057 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.4 Cg_endo -67.21 56.03 0.55 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.394 2.063 . . . . 0.0 110.277 172.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 177.97 -7.86 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.338 -169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 22.9 mm-40 -129.29 125.34 36.58 Favored 'General case' 0 C--O 1.276 2.493 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.253 6.0 m-30 -76.44 158.93 30.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 129.871 3.268 . . . . 0.0 112.514 -169.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 80' ' ' VAL . 6.7 mp -88.97 147.77 24.13 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.5 mt-30 -144.18 155.6 43.97 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 62' ' ' ASP . 20.4 mm -72.98 115.91 14.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 38.4 ttmt -58.95 -44.65 91.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.59 ' HA ' HG22 ' A' ' 60' ' ' THR . 21.0 t 169.62 173.65 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 125.144 1.527 . . . . 0.0 110.453 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -144.27 144.91 31.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-O 121.647 0.737 . . . . 0.0 111.899 -175.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 49' ' ' ASP . 14.5 t -73.26 122.92 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.769 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.2 mt -61.31 -15.01 31.19 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 112.489 -2.141 . . . . 0.0 113.121 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.1 t70 -92.72 -13.66 29.04 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.767 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.53 163.62 28.74 Favored Glycine 0 N--CA 1.415 -2.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.425 -172.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.44 -28.73 45.71 Favored 'Trans proline' 0 C--O 1.205 -1.136 0 C-N-CA 124.72 3.613 . . . . 0.0 112.798 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.85 -50.77 72.17 Favored 'General case' 0 C--O 1.264 1.853 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.052 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.26 -33.49 55.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.8 mp -72.57 -33.72 66.96 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.049 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.43 -27.79 66.5 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' HE3' ' A' ' 57' ' ' LYS . . . 78.61 3.59 86.91 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 112.51 -2.132 . . . . 0.0 113.352 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HE3' ' C ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -96.18 -31.8 12.79 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.0 ttm -97.97 142.0 30.24 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.616 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -139.25 159.16 42.8 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 122.226 1.012 . . . . 0.0 110.061 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.7 p -63.85 115.65 5.03 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.564 1.146 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 111.74 -15.96 26.28 Favored Glycine 0 N--CA 1.435 -1.425 0 O-C-N 121.767 -0.583 . . . . 0.0 112.799 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 43' ' ' ILE . 17.4 m-20 -61.08 134.28 56.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -83.38 126.47 40.13 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 CA-C-N 118.905 0.775 . . . . 0.0 113.035 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 12.7 mm -76.78 125.27 36.43 Favored 'Isoleucine or valine' 1 C--O 1.321 4.866 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 8' ' ' PRO . 25.9 t -115.68 -37.6 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 111.435 -2.62 . . . . 0.0 111.035 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.696 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.9 m -144.51 149.75 36.43 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.227 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.625 HG12 HG21 ' A' ' 72' ' ' VAL . 12.4 p -134.58 133.43 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.487 ' OD1' HG22 ' A' ' 67' ' ' VAL . 21.7 m120 60.13 27.84 17.35 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.02 0.914 . . . . 0.0 110.398 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 72.97 2.48 4.39 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.668 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.7 m -90.56 126.88 36.08 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 31.7 t -66.49 108.0 2.25 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.696 HG22 ' HA ' ' A' ' 66' ' ' SER . 29.6 m -123.18 27.87 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.841 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.594 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.0 tp -59.88 113.54 2.34 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.7 41.57 0.26 Allowed Glycine 0 C--N 1.376 2.767 0 O-C-N 125.191 1.557 . . . . 0.0 112.205 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 76' ' ' THR . 8.8 t60 -44.01 -67.86 0.24 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 75' ' ' HIS . 18.2 p -166.1 143.46 5.36 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 149.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -50.77 -37.15 40.49 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 120.098 1.317 . . . . 0.0 110.711 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.409 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.499 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 9.0 mm-40 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 41' ' ' LEU . 34.0 m -69.17 -39.88 79.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.591 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 71.1 t -65.45 -37.43 80.04 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.28 -38.55 83.93 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 122.887 0.117 . . . . 0.0 111.277 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' SER . 63.1 mt -65.58 -35.73 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.612 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.6 -31.52 65.25 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.356 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 71.1 mm-40 -72.82 -26.56 61.53 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 122.084 0.945 . . . . 0.0 109.901 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.2 m -73.66 -47.06 42.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.602 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.506 HG22 ' HD3' ' A' ' 22' ' ' LYS . 20.9 mt -66.68 136.58 94.74 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.302 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 30.5 Cg_endo -91.64 162.49 3.49 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.185 3.257 . . . . 0.0 113.125 -174.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 28.8 mm -62.29 135.25 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 121.07 0.462 . . . . 0.0 110.63 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.85 57.14 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.554 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.14 -172.42 2.16 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.444 ' OG ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -149.01 158.87 44.52 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -142.49 125.27 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.211 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -79.33 104.17 9.77 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.44 143.84 32.47 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 125.357 1.463 . . . . 0.0 111.514 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 38.0 tt0 -104.41 127.04 52.01 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.336 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 67.1 mt -115.11 157.83 23.03 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.573 1.171 . . . . 0.0 110.027 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.6 t -129.83 111.17 12.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.548 1.166 . . . . 0.0 110.157 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HG3' HD11 ' A' ' 16' ' ' ILE . 3.7 mmm180 -88.54 120.9 30.35 Favored 'General case' 0 C--N 1.245 -3.958 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 157.32 -22.06 0.43 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.7 138.56 21.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 C--N 1.365 1.421 0 C-N-CA 124.756 3.638 . . . . 0.0 112.936 -179.318 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 74.4 Cg_endo . . . . . 0 CA--C 1.55 1.283 0 CA-C-O 121.153 0.397 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -84.53 104.22 14.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.606 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -111.27 130.04 55.79 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 t -143.43 16.39 1.85 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.628 0.728 . . . . 0.0 110.063 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HG2' ' HE1' ' A' ' 4' ' ' PHE . 16.0 mtm180 58.06 -21.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 127.993 2.517 . . . . 0.0 115.683 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.537 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -99.89 113.37 65.11 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-O 120.894 0.378 . . . . 0.0 111.5 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 1.3 Cg_endo -48.14 -36.1 27.91 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.582 3.522 . . . . 0.0 112.705 174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -73.97 -17.04 61.05 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.063 0.459 . . . . 0.0 111.61 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 20.8 mm-40 -94.93 -17.28 22.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.228 0.537 . . . . 0.0 110.201 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 73' ' ' LEU . 20.5 mt -80.15 178.36 8.31 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 122.109 0.957 . . . . 0.0 109.697 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -114.48 -161.33 0.77 Allowed 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.665 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.87 176.69 38.14 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.081 -1.533 . . . . 0.0 112.799 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.1 OUTLIER -103.29 132.09 49.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.4 m-85 -108.07 111.77 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.486 1.136 . . . . 0.0 111.535 -175.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.534 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 21.3 mt -112.46 149.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.03 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.896 -174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -130.45 104.64 7.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -123.58 129.48 51.24 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 122.318 1.056 . . . . 0.0 111.581 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.4 ttmt -88.77 122.07 31.8 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.572 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.464 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.01 117.35 33.81 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 27.3 ttp-105 -79.27 107.36 11.97 Favored 'General case' 0 N--CA 1.394 -3.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.754 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.75 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 64.6 tttt -64.08 97.88 0.19 Allowed 'General case' 0 C--O 1.176 -2.781 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 169.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' ILE . 22.9 t -80.46 -155.81 0.12 Allowed 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 124.54 1.136 . . . . 0.0 109.16 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 m -58.55 -41.47 85.66 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -85.86 -21.46 28.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.75 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 102.27 -124.8 8.31 Favored Glycine 1 N--CA 1.392 -4.266 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 35.9 m-85 -86.74 145.7 26.55 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.729 0.764 . . . . 0.0 110.48 -176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.63 1.63 64.03 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.908 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 31' ' ' VAL . 6.7 p90 -114.27 163.06 15.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.453 0.644 . . . . 0.0 111.813 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -116.13 148.53 40.22 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.586 HG11 HD23 ' A' ' 41' ' ' LEU . 4.0 t -127.23 143.68 39.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.125 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -152.23 163.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.956 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.76 -65.04 0.55 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -76.11 58.81 3.16 Favored Glycine 2 CA--C 1.408 -6.64 0 C-N-CA 125.621 1.581 . . . . 0.0 116.971 -166.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -66.21 -9.07 28.51 Favored 'General case' 0 C--N 1.253 -3.629 0 O-C-N 124.32 0.659 . . . . 0.0 111.75 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt-20 -160.62 166.36 15.69 Favored Pre-proline 0 CA--C 1.452 -2.799 0 C-N-CA 116.078 -2.249 . . . . 0.0 111.849 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.4 Cg_endo -67.62 53.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.807 2.338 . . . . 0.0 110.287 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 29.6 t70 -177.61 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.498 1.519 . . . . 0.0 109.872 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.655 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 34.3 mt-10 -117.72 129.75 55.9 Favored 'General case' 0 C--O 1.272 2.256 0 CA-C-O 116.649 -1.643 . . . . 0.0 106.75 169.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.263 6.8 m-30 -79.33 156.4 28.03 Favored 'General case' 0 N--CA 1.523 3.18 0 O-C-N 128.675 3.735 . . . . 0.0 111.927 -177.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.901 HD21 HG21 ' A' ' 80' ' ' VAL . 6.3 mp -91.68 143.17 26.83 Favored 'General case' 0 CA--C 1.455 -2.689 0 C-N-CA 117.153 -1.819 . . . . 0.0 107.437 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 14.1 mt-30 -139.36 154.74 47.92 Favored 'General case' 0 C--N 1.266 -3.04 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 29' ' ' PHE . 19.7 mm -75.11 109.48 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.431 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.22 -37.01 79.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.5 t 161.87 173.66 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 125.388 1.68 . . . . 0.0 109.344 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.495 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.3 pp -137.33 151.87 49.09 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 123.257 0.623 . . . . 0.0 111.469 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.08 116.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.264 0.8 OUTLIER -69.38 -4.17 17.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -174.389 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.49 -2.67 54.14 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.406 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.42 167.11 24.56 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.818 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 20' ' ' LEU . 9.2 Cg_endo -53.32 -31.78 58.3 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 124.624 3.549 . . . . 0.0 113.411 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.84 -44.55 86.57 Favored 'General case' 0 C--O 1.273 2.293 0 CA-C-O 121.753 0.787 . . . . 0.0 111.522 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.74 -35.21 57.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.328 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.21 -28.21 53.75 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.36 -20.86 62.11 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.27 63.58 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.962 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -29.76 7.39 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.637 -172.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 51.2 ttm -96.96 132.84 42.35 Favored 'General case' 0 N--CA 1.407 -2.593 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.187 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -124.29 156.94 36.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 122.193 0.997 . . . . 0.0 109.336 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 45' ' ' SER . 82.7 p -71.48 107.76 4.55 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.297 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 122.08 -11.96 9.24 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.755 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 8.6 m-20 -64.44 151.46 44.16 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.401 1.101 . . . . 0.0 108.654 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -99.94 123.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 175.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 10.8 mm -71.29 122.31 23.1 Favored 'Isoleucine or valine' 1 C--O 1.322 4.883 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 171.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG13 HD13 ' A' ' 73' ' ' LEU . 44.4 t -114.69 -34.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 O-C-N 127.122 2.764 . . . . 0.0 109.905 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.571 ' HA ' HG22 ' A' ' 72' ' ' VAL . 39.4 m -147.66 148.84 31.49 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.457 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.641 HG12 HG11 ' A' ' 72' ' ' VAL . 8.4 p -125.28 133.11 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.57 27.24 16.39 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.519 0.676 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.35 26.13 14.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 123.484 1.612 . . . . 0.0 111.466 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.9 m -109.16 124.54 50.99 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.24 105.57 0.93 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.101 0.876 . . . . 0.0 109.927 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.641 HG11 HG12 ' A' ' 67' ' ' VAL . 35.7 m -121.18 27.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.406 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.606 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 43.8 tp -60.9 113.28 2.43 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.18 45.88 0.3 Allowed Glycine 0 N--CA 1.492 2.397 0 O-C-N 125.557 1.786 . . . . 0.0 111.606 -170.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t60 -46.83 -69.14 0.14 Allowed 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 175.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 75' ' ' HIS . 21.5 p -164.86 144.0 6.89 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 148.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -49.84 -36.14 25.69 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 119.718 1.145 . . . . 0.0 110.437 173.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.01 91.89 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.481 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.524 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 2.1 mp0 -64.05 -44.08 93.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.901 HG21 HD21 ' A' ' 41' ' ' LEU . 28.8 m -70.34 -43.5 78.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.808 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.1 -36.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.58 -43.27 99.17 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.328 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.658 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.7 -36.54 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.24 0.543 . . . . 0.0 112.435 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.33 -32.64 68.81 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.316 0.579 . . . . 0.0 110.173 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.565 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 7.8 mm-40 -75.55 -26.3 57.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.749 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.8 m -72.02 -40.36 68.5 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.765 1.226 . . . . 0.0 109.275 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 22' ' ' LYS . 23.5 mt -69.81 135.45 87.8 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.994 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 16.3 Cg_endo -90.39 162.53 4.51 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 123.679 2.919 . . . . 0.0 113.208 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.7 mm -59.92 135.1 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.031 175.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.71 10.26 63.42 Favored Glycine 0 C--N 1.291 -1.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.843 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.53 133.57 49.16 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 6.7 m -100.79 159.42 15.2 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.538 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -144.74 125.5 8.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.648 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.623 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 23.4 m-20 -79.11 109.42 13.4 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.5 mt -104.63 136.91 43.28 Favored 'General case' 0 C--N 1.277 -2.557 0 C-N-CA 124.842 1.257 . . . . 0.0 109.836 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 40.8 tt0 -97.6 122.99 41.32 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 95.9 mt -112.65 148.84 33.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 125.154 1.382 . . . . 0.0 109.713 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.665 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 8.1 t -124.56 115.18 20.43 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.915 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -102.01 141.98 34.0 Favored 'General case' 0 C--N 1.256 -3.489 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.067 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.71 -17.06 3.98 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.354 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -92.01 139.97 24.59 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 C--N 1.361 1.204 0 C-N-CA 124.712 3.608 . . . . 0.0 113.935 -175.145 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.448 -1.184 0 N-CA-C 111.094 -0.387 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.19 104.83 3.2 Favored 'General case' 0 N--CA 1.411 -2.377 0 C-N-CA 124.349 1.06 . . . . 0.0 108.562 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.606 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.7 t80 -98.94 139.12 35.07 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -147.51 10.28 0.96 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.963 0.887 . . . . 0.0 110.79 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.544 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 14.1 mtp180 52.9 6.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.803 2.041 . . . . 0.0 115.092 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -134.09 122.1 16.05 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HB3' HG11 ' A' ' 65' ' ' VAL . 3.4 Cg_exo -54.98 -34.93 88.6 Favored 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 124.135 3.223 . . . . 0.0 112.345 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -71.81 -21.99 61.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.563 0.697 . . . . 0.0 111.21 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -92.45 -24.27 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 42.5 tp -85.91 159.2 19.73 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.829 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.4 mttp -99.13 -171.23 2.05 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.96 177.93 27.94 Favored Glycine 0 C--N 1.292 -1.865 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.911 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -99.81 122.67 43.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.5 m-85 -103.87 117.97 35.59 Favored 'General case' 0 C--N 1.253 -3.628 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.41 HG13 ' HE3' ' A' ' 14' ' ' LYS . 66.4 mt -127.25 126.74 68.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.463 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -99.95 111.95 24.24 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.507 ' OG1' ' HD2' ' A' ' 57' ' ' LYS . 14.8 t -133.1 147.59 52.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.018 0.913 . . . . 0.0 110.73 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.808 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 22.0 ttpp -90.17 132.31 35.54 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.608 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -109.68 119.27 38.88 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 72.5 ttt180 -81.48 109.47 15.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.965 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.5 tttt -63.95 96.51 0.14 Allowed 'General case' 0 C--O 1.184 -2.377 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -90.03 -154.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 124.457 1.103 . . . . 0.0 109.061 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 m -52.35 -40.63 62.2 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.878 0.871 . . . . 0.0 111.695 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -95.6 -9.41 32.27 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.012 0.434 . . . . 0.0 110.065 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.734 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.01 -119.08 6.25 Favored Glycine 1 N--CA 1.392 -4.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.589 ' HD1' HD12 ' A' ' 20' ' ' LEU . 46.2 m-85 -91.46 139.88 30.29 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 117.763 0.782 . . . . 0.0 108.935 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.94 3.01 87.28 Favored Glycine 0 C--N 1.315 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.897 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.523 ' HB2' HG23 ' A' ' 43' ' ' ILE . 12.1 p90 -116.33 162.69 17.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.353 0.597 . . . . 0.0 111.324 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 26.3 p -116.19 152.91 32.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG11 HD23 ' A' ' 41' ' ' LEU . 4.6 t -126.53 143.86 38.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.464 -174.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.66 155.61 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.25 -72.94 0.45 Allowed Glycine 0 CA--C 1.459 -3.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.0 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.858 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -62.11 58.51 0.03 OUTLIER Glycine 1 CA--C 1.442 -4.505 0 C-N-CA 127.454 2.454 . . . . 0.0 117.459 -169.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.638 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 17.3 t70 -63.09 -27.98 69.77 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -154.82 166.31 16.32 Favored Pre-proline 0 CA--C 1.454 -2.727 0 C-N-CA 116.192 -2.203 . . . . 0.0 110.941 -170.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.7 Cg_endo -68.42 55.79 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.308 2.005 . . . . 0.0 109.718 171.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -178.63 -17.15 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.008 1.723 . . . . 0.0 110.06 -171.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.858 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 19.1 mm-40 -115.89 127.03 54.68 Favored 'General case' 0 C--O 1.273 2.301 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.269 6.0 m-30 -79.02 157.68 28.04 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 128.77 3.794 . . . . 0.0 111.628 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 80' ' ' VAL . 5.3 mp -88.25 143.53 26.98 Favored 'General case' 0 C--O 1.185 -2.319 0 C-N-CA 117.149 -1.821 . . . . 0.0 107.105 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.2 mt-30 -140.25 154.68 46.94 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.523 HG23 ' HB2' ' A' ' 29' ' ' PHE . 18.9 mm -73.96 113.24 11.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 19.2 ttmm -57.14 -38.04 72.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 125.13 1.519 . . . . 0.0 107.16 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.512 ' HA ' HG22 ' A' ' 60' ' ' THR . 34.8 t 159.86 173.35 0.01 OUTLIER 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.428 1.891 . . . . 0.0 109.114 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -139.4 147.82 41.98 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.414 0.626 . . . . 0.0 111.671 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 49' ' ' ASP . 44.3 t -76.53 128.06 37.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.51 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -64.53 -15.45 60.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.47 ' H ' HG12 ' A' ' 47' ' ' VAL . 2.3 m-20 -99.12 6.83 46.32 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.957 176.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.25 158.81 21.79 Favored Glycine 0 N--CA 1.398 -3.847 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HG2' HD11 ' A' ' 20' ' ' LEU . 10.1 Cg_endo -52.21 -30.52 42.12 Favored 'Trans proline' 0 C--O 1.202 -1.318 0 C-N-CA 124.429 3.42 . . . . 0.0 112.884 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -60.1 -44.59 94.73 Favored 'General case' 0 C--O 1.278 2.565 0 CA-C-O 121.551 0.691 . . . . 0.0 111.982 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.55 -35.02 53.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.811 -1.541 . . . . 0.0 111.022 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.1 -46.02 72.1 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.313 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 38.3 t70 -63.67 -34.58 78.17 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -8.77 58.25 Favored Glycine 0 CA--C 1.492 -1.393 0 CA-C-N 112.484 -2.144 . . . . 0.0 114.082 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 46.1 mttp -86.7 -14.53 42.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 123.117 0.567 . . . . 0.0 112.081 -176.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 ttm -104.02 144.96 30.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -143.67 155.52 44.25 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 121.447 0.642 . . . . 0.0 110.103 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 45' ' ' SER . 77.8 p -63.21 108.45 1.28 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.86 -0.31 31.92 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.121 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.606 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.0 p30 -73.43 146.94 44.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.425 -1.71 . . . . 0.0 107.292 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -94.65 120.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 26.6 mm -71.08 125.16 28.93 Favored 'Isoleucine or valine' 1 C--O 1.319 4.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 73' ' ' LEU . 48.6 t -115.27 -41.36 3.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.614 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.632 ' HA ' HG22 ' A' ' 72' ' ' VAL . 66.5 m -145.34 147.42 32.29 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.281 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 72' ' ' VAL . 6.4 p -125.1 132.0 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.03 29.57 14.67 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.452 0.644 . . . . 0.0 111.101 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 67.58 11.51 8.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.7 m -93.47 122.85 36.33 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.2 t -66.04 103.6 0.98 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.632 HG22 ' HA ' ' A' ' 66' ' ' SER . 33.6 m -117.84 25.67 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.884 0.849 . . . . 0.0 110.501 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.606 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.2 tp -61.43 113.28 2.57 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 35.46 40.72 0.3 Allowed Glycine 0 N--CA 1.497 2.725 0 O-C-N 125.188 1.555 . . . . 0.0 111.785 -170.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 76' ' ' THR . 7.0 t60 -43.98 -67.22 0.3 Allowed 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.4 p -167.35 143.57 4.25 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 150.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.522 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -49.8 -36.55 26.7 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 120.194 1.361 . . . . 0.0 110.119 172.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.2 81.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.448 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.53 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 7.3 mm-40 -66.8 -44.26 81.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 41' ' ' LEU . 34.0 m -65.58 -40.06 86.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.471 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.5 -39.04 84.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -59.62 -38.43 81.31 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.676 177.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.599 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 72.4 mt -68.09 -38.41 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.574 0.702 . . . . 0.0 110.853 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.07 -30.83 65.52 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.89 -32.55 73.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.313 1.045 . . . . 0.0 109.994 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 59.5 m -71.84 -43.17 66.0 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.474 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.5 mt -71.8 133.06 84.55 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.574 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 36.0 Cg_endo -91.44 161.84 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.507 2.804 . . . . 0.0 113.549 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.0 mm -61.63 129.98 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 121.156 0.503 . . . . 0.0 111.019 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.72 11.94 51.95 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.707 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.4 -170.48 1.81 Allowed 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -147.79 166.78 26.52 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -150.45 125.2 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.463 -2.371 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.772 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.58 105.53 16.23 Favored 'General case' 0 C--N 1.268 -2.969 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -111.83 151.61 28.87 Favored 'General case' 0 C--O 1.208 -1.083 0 C-N-CA 125.593 1.557 . . . . 0.0 110.777 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 22.8 tt0 -111.01 121.73 46.1 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.748 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.7 mp -108.62 164.42 12.38 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 126.654 1.982 . . . . 0.0 109.272 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.5 t -140.69 112.46 7.57 Favored 'General case' 0 C--O 1.19 -2.026 0 CA-C-O 122.339 1.066 . . . . 0.0 111.992 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.606 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 7.7 tpp180 -95.3 129.99 42.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.78 -17.52 0.96 Allowed Glycine 0 C--N 1.294 -1.769 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.053 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -107.23 126.94 28.9 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 C--O 1.246 0.917 0 C-N-CA 124.126 3.217 . . . . 0.0 112.573 -174.599 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.446 -1.308 0 CA-C-O 121.154 0.398 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -76.31 107.14 8.35 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 124.97 1.308 . . . . 0.0 107.659 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.587 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.1 t80 -101.73 129.87 48.0 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -138.17 11.8 2.82 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.284 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtt180 52.59 8.43 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.804 2.042 . . . . 0.0 114.789 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.407 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 7.9 m120 -131.96 116.75 15.83 Favored Pre-proline 0 N--CA 1.415 -2.176 0 C-N-CA 122.458 0.303 . . . . 0.0 110.974 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -63.56 -18.05 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 110.785 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 7' ' ' ASN . 7.8 p -76.15 -29.72 57.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.851 177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -107.38 -10.96 15.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.051 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -93.5 149.82 20.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.466 ' N ' HD13 ' A' ' 11' ' ' LEU . 45.9 mtmt -105.79 135.54 47.04 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.731 0.776 . . . . 0.0 110.998 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.569 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 151.17 170.15 17.75 Favored Glycine 1 C--N 1.244 -4.583 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -172.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -92.32 122.35 34.7 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.397 1.098 . . . . 0.0 108.443 175.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.6 m-85 -98.66 117.45 33.14 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 122.611 1.196 . . . . 0.0 110.027 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.469 HG12 ' HE3' ' A' ' 14' ' ' LYS . 34.1 mt -114.35 152.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.065 0 CA-C-N 112.755 -2.021 . . . . 0.0 109.357 -172.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 94' ' ' ASP . 2.8 t-160 -129.31 108.47 10.33 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.415 ' CG2' HD11 ' A' ' 97' ' ' LEU . 7.7 t -131.54 135.08 46.75 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.872 0.844 . . . . 0.0 109.81 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.8 ttmt -89.45 126.65 35.65 Favored 'General case' 0 C--N 1.257 -3.436 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.782 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.498 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.47 116.94 32.8 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 56.5 ttt180 -77.89 107.44 10.42 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.931 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.735 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 64.7 tttt -61.85 97.34 0.08 Allowed 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -86.23 -155.36 0.25 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 124.758 1.223 . . . . 0.0 108.818 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 m -54.21 -41.3 68.5 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.991 0.916 . . . . 0.0 110.816 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -96.16 -8.85 32.06 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.189 0.519 . . . . 0.0 109.958 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.735 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 96.32 -120.67 6.7 Favored Glycine 1 N--CA 1.391 -4.315 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.514 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 34.2 m-85 -89.58 141.74 28.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.401 0.6 . . . . 0.0 109.576 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.22 1.11 84.31 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.966 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' HB2' HG23 ' A' ' 43' ' ' ILE . 19.4 p90 -114.58 162.37 16.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.725 0.774 . . . . 0.0 111.099 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 40.6 p -115.18 154.34 29.18 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 41' ' ' LEU . 3.3 p -143.81 144.24 23.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.664 -174.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.33 170.02 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.26 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.05 -68.83 0.48 Allowed Glycine 0 CA--C 1.452 -3.906 0 CA-C-N 115.124 -0.943 . . . . 0.0 113.796 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -75.39 58.02 2.86 Favored Glycine 2 CA--C 1.406 -6.73 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' HIS . 13.4 m-20 -64.45 -12.78 47.08 Favored 'General case' 0 C--N 1.261 -3.251 0 O-C-N 124.449 0.735 . . . . 0.0 110.797 176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 38' ' ' ASP . 6.1 pt-20 -158.23 165.14 19.22 Favored Pre-proline 0 CA--C 1.452 -2.812 0 C-N-CA 116.519 -2.072 . . . . 0.0 111.205 -173.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.5 Cg_endo -68.37 47.01 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.764 2.309 . . . . 0.0 111.529 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 36' ' ' GLU . 27.2 m-20 -165.44 -22.69 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.356 2.262 . . . . 0.0 109.248 -172.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.716 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 37.9 mt-10 -112.83 126.25 55.23 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.259 5.2 m-30 -78.78 157.43 28.44 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 128.076 3.36 . . . . 0.0 111.365 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 80' ' ' VAL . 6.9 mp -90.08 144.71 25.65 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 117.506 -1.678 . . . . 0.0 107.093 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.8 mt-30 -143.54 151.01 39.72 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 29' ' ' PHE . 19.3 mm -68.39 117.8 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.625 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 20.8 tptm -63.05 -43.37 98.81 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.534 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.2 t 166.14 174.97 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 125.596 1.81 . . . . 0.0 109.993 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.3 152.41 45.85 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.704 0.764 . . . . 0.0 112.923 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 49' ' ' ASP . 49.4 t -85.35 128.61 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.51 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 89.1 mt -68.88 -15.9 63.62 Favored 'General case' 0 N--CA 1.387 -3.612 0 CA-C-N 112.733 -2.03 . . . . 0.0 113.59 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.49 ' H ' HG12 ' A' ' 47' ' ' VAL . 3.9 m-20 -96.26 -5.36 40.44 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 114.154 -1.385 . . . . 0.0 111.245 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.71 162.96 28.11 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.6 Cg_endo -53.99 -31.79 65.43 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 124.541 3.494 . . . . 0.0 113.576 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -59.3 -42.67 91.87 Favored 'General case' 0 C--O 1.279 2.641 0 CA-C-O 121.706 0.765 . . . . 0.0 111.42 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.74 -37.35 49.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.899 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 8.6 mp -68.82 -40.28 79.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.74 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.55 -26.1 61.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.72 2.78 77.42 Favored Glycine 0 CA--C 1.495 -1.181 0 CA-C-N 112.888 -1.96 . . . . 0.0 113.826 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -91.46 -21.28 21.01 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.21 149.28 23.25 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.575 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.37 154.73 40.34 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.395 0.617 . . . . 0.0 110.625 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 45' ' ' SER . 67.8 p -61.37 106.04 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.761 0.824 . . . . 0.0 111.493 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 110.79 -2.27 28.88 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 119.311 -0.716 . . . . 0.0 113.563 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.55 ' CB ' ' HG3' ' A' ' 99' ' ' ARG . 2.8 p30 -69.71 138.67 53.09 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.5 OUTLIER -87.76 120.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.486 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 31.3 mm -71.62 124.37 27.96 Favored 'Isoleucine or valine' 1 C--O 1.324 4.978 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 172.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 73' ' ' LEU . 37.0 t -115.63 -40.9 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.064 -2.789 . . . . 0.0 111.036 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.55 ' HA ' HG22 ' A' ' 72' ' ' VAL . 24.7 m -149.82 150.38 31.89 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.7 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.722 HG13 HG21 ' A' ' 72' ' ' VAL . 2.9 m -121.99 142.11 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 169.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.8 m120 54.61 28.11 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.548 0.689 . . . . 0.0 111.379 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 54.9 42.32 31.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.668 1.699 . . . . 0.0 111.832 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 72' ' ' VAL . 88.8 m -122.12 122.82 40.1 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.898 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.54 100.17 0.49 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.926 0.869 . . . . 0.0 111.055 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.722 HG21 HG13 ' A' ' 67' ' ' VAL . 17.4 m -105.04 17.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.587 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.1 tp -60.61 112.96 2.2 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.44 44.98 0.3 Allowed Glycine 0 N--CA 1.496 2.645 0 O-C-N 125.649 1.843 . . . . 0.0 111.272 -170.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 76' ' ' THR . 8.4 t60 -45.37 -67.62 0.27 Allowed 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' HIS . 3.1 p -166.9 142.78 4.36 Favored 'General case' 0 C--N 1.262 -3.219 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 148.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.653 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.04 -35.21 33.19 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 120.695 1.588 . . . . 0.0 111.205 173.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.14 96.39 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.654 0.264 . . . . 0.0 110.929 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.431 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 16.9 mm-40 -69.65 -41.57 75.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.876 HG21 HD21 ' A' ' 41' ' ' LEU . 21.1 m -63.66 -39.82 86.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.154 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.62 -40.77 90.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -61.06 -36.81 80.59 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.556 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.9 mm -70.45 -37.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 123.683 0.793 . . . . 0.0 112.057 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.33 -29.01 62.39 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -76.34 -20.18 57.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.407 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 37.6 t -78.04 -26.39 48.35 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.501 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.6 mt -90.07 130.11 43.53 Favored Pre-proline 0 N--CA 1.398 -3.032 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.134 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.0 Cg_endo -89.49 162.44 5.41 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 123.697 2.932 . . . . 0.0 112.954 -173.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.557 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.3 mm -60.12 133.6 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 CA-C-O 121.538 0.685 . . . . 0.0 110.902 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.76 60.33 Favored Glycine 0 C--N 1.289 -2.078 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.019 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.38 -167.92 1.46 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.9 m -151.52 163.39 39.13 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 121.929 -0.482 . . . . 0.0 109.919 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -145.83 125.26 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 C-N-CA 119.569 -0.853 . . . . 0.0 111.76 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 9.5 m-20 -80.08 107.16 12.65 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' SER . 63.6 mt -104.96 135.59 46.01 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 124.433 1.093 . . . . 0.0 111.75 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 38.8 mt-10 -90.52 120.47 31.64 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 7.9 mt -105.65 164.63 11.76 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.569 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.8 t -141.37 109.16 5.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 122.254 1.026 . . . . 0.0 110.906 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.55 ' HG3' ' CB ' ' A' ' 62' ' ' ASP 0.33 23.7 mtm180 -96.18 117.97 31.81 Favored 'General case' 0 C--N 1.257 -3.422 0 O-C-N 121.331 -0.856 . . . . 0.0 113.133 174.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.55 -29.73 0.1 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.287 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -101.64 135.46 19.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.547 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.242 0.701 0 C-N-CA 123.257 2.638 . . . . 0.0 111.231 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.444 -1.423 0 N-CA-C 110.228 -0.72 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -89.93 104.8 17.34 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.552 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.9 t80 -105.15 131.15 53.0 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 HD23 ' A' ' 11' ' ' LEU . 8.8 t -140.38 19.05 2.4 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.246 1.022 . . . . 0.0 110.704 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 57.6 mtt180 58.41 -13.13 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.96 2.104 . . . . 0.0 115.961 172.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.533 ' OD1' ' HB2' ' A' ' 9' ' ' SER . 23.7 t-20 -113.57 119.48 41.52 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 110.927 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.1 Cg_exo -54.4 -32.82 74.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.179 3.252 . . . . 0.0 112.814 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.533 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 26.4 m -75.69 -22.48 56.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.408 0.683 . . . . 0.0 110.954 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 22.3 mm-40 -90.29 -19.56 23.96 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.898 0.879 . . . . 0.0 111.033 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD11 HD21 ' A' ' 73' ' ' LEU . 51.0 mt -74.48 172.37 12.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.092 0.948 . . . . 0.0 111.485 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -108.39 -170.39 1.67 Allowed 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 90.16 165.71 40.81 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.09 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 22.2 ttpt -95.86 137.7 34.55 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.464 ' HZ ' ' HB2' ' A' ' 11' ' ' LEU . 30.8 m-85 -104.88 111.89 24.81 Favored 'General case' 0 CA--C 1.458 -2.592 0 CA-C-O 122.687 1.232 . . . . 0.0 110.226 -173.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.461 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.4 mt -108.46 113.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.9 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.007 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.87 128.42 34.41 Favored 'General case' 0 C--N 1.252 -3.631 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.915 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 95' ' ' LEU . 7.4 t -133.62 157.01 46.83 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.399 -173.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -130.58 119.02 21.89 Favored 'General case' 0 C--N 1.247 -3.865 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 172.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' HG ' ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -106.67 117.47 34.14 Favored 'General case' 0 C--N 1.277 -2.576 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.837 -174.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 23.4 tpp180 -70.66 105.66 3.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.51 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.744 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 62.6 tttt -69.34 97.76 1.0 Allowed 'General case' 0 C--O 1.161 -3.603 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 165.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -86.66 -155.27 0.26 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.6 m -63.31 -33.12 74.82 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.541 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 1.3 tmt_? -83.53 -20.97 32.93 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.744 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 94.14 -129.19 9.79 Favored Glycine 0 N--CA 1.401 -3.649 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.8 m-85 -86.98 146.97 25.94 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 118.134 0.967 . . . . 0.0 110.212 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 20' ' ' LEU . . . -94.38 0.74 66.15 Favored Glycine 0 C--O 1.22 -0.775 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.533 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 5.8 p90 -115.67 163.48 15.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.514 . . . . 0.0 110.642 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 61.6 p -123.71 147.53 47.38 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.84 150.14 26.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.391 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.49 152.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.523 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.84 -132.12 9.7 Favored Glycine 1 N--CA 1.395 -4.06 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 47.58 37.46 13.42 Favored Glycine 0 CA--C 1.476 -2.363 0 C-N-CA 124.212 0.911 . . . . 0.0 113.55 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 29.3 t70 -69.03 -29.4 67.54 Favored 'General case' 0 CA--C 1.459 -2.547 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -174.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -162.38 166.74 13.46 Favored Pre-proline 0 CA--C 1.455 -2.702 0 C-N-CA 118.352 -1.339 . . . . 0.0 109.243 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.7 Cg_endo -66.19 58.72 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.005 2.47 . . . . 0.0 109.583 170.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 174.54 -9.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.746 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.5 mm-40 -128.34 124.53 36.68 Favored 'General case' 0 C--O 1.281 2.744 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.521 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.276 5.9 m-30 -76.66 158.81 30.75 Favored 'General case' 1 N--CA 1.549 4.52 0 C-N-CA 130.914 3.685 . . . . 0.0 113.609 -168.246 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 80' ' ' VAL . 6.2 mp -92.4 138.86 31.15 Favored 'General case' 0 C--O 1.178 -2.659 0 C-N-CA 117.068 -1.853 . . . . 0.0 106.951 170.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.592 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 18.1 mt-30 -136.16 154.18 51.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 20.7 mm -71.34 115.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' SER . 31.0 ttpt -65.01 -41.63 95.18 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 166.72 173.72 0.03 OUTLIER 'General case' 0 C--N 1.371 1.503 0 O-C-N 125.186 1.554 . . . . 0.0 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 58' ' ' MET . 1.4 pp -141.6 152.2 43.8 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 123.816 0.846 . . . . 0.0 111.819 -172.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 49' ' ' ASP . 14.0 t -82.85 124.41 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.793 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.88 -3.75 13.83 Favored 'General case' 0 N--CA 1.379 -3.975 0 CA-C-N 112.836 -1.984 . . . . 0.0 112.937 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' H ' HG12 ' A' ' 47' ' ' VAL . 17.0 t70 -95.79 -22.97 17.17 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.658 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.35 162.77 36.83 Favored Glycine 0 N--CA 1.398 -3.892 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.586 -170.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -51.39 -30.32 33.98 Favored 'Trans proline' 0 C--O 1.197 -1.553 0 C-N-CA 125.178 3.919 . . . . 0.0 112.952 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.06 -47.97 81.52 Favored 'General case' 0 C--O 1.258 1.524 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.34 -36.2 54.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.644 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.31 -40.6 70.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.733 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.37 -21.6 62.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.81 39.88 75.84 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -111.26 -37.62 5.25 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.677 0.275 . . . . 0.0 111.463 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.429 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 1.1 mpt? -95.93 153.14 17.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.403 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.78 158.38 43.69 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 45' ' ' SER . 49.0 p -64.22 108.67 1.64 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.007 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.486 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.56 -11.64 9.61 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.709 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 2.9 m-20 -62.86 136.69 57.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.547 1.173 . . . . 0.0 108.803 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -88.25 123.36 40.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 177.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.59 123.52 30.28 Favored 'Isoleucine or valine' 1 C--O 1.34 5.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 HD13 ' A' ' 73' ' ' LEU . 46.0 t -115.53 -36.14 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 127.444 2.965 . . . . 0.0 111.375 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 65.6 m -148.57 159.62 43.9 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.515 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG12 ' HB ' ' A' ' 72' ' ' VAL . 4.3 p -141.45 130.18 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 108.016 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.23 31.48 20.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.461 0.648 . . . . 0.0 110.728 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 71.2 1.4 3.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.495 1.518 . . . . 0.0 112.593 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.3 m -90.95 121.97 33.23 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.8 t -58.86 114.8 2.72 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -124.23 19.39 4.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.57 HD13 HG13 ' A' ' 65' ' ' VAL . 27.8 tp -59.15 112.85 1.86 Allowed 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.11 39.76 0.06 OUTLIER Glycine 0 C--O 1.186 -2.879 0 O-C-N 125.737 1.898 . . . . 0.0 112.792 -170.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 76' ' ' THR . 4.6 t60 -43.38 -65.75 0.46 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.9 p -167.33 143.84 4.35 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 151.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.581 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.85 -35.13 30.99 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 120.099 1.318 . . . . 0.0 109.702 171.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -46.95 87.17 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.436 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 13.3 mm-40 -66.35 -43.08 87.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 41' ' ' LEU . 15.3 m -64.44 -44.89 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 84.5 t -64.51 -42.12 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.74 -37.89 83.3 Favored 'General case' 0 C--O 1.212 -0.887 0 O-C-N 123.151 0.282 . . . . 0.0 111.47 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.57 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.9 mm -67.48 -38.28 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.307 0.575 . . . . 0.0 112.148 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.54 -32.19 65.88 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.523 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 25.6 mt-30 -67.78 -32.07 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.211 1.005 . . . . 0.0 109.691 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.2 m -72.33 -40.6 67.31 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.886 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.478 HG22 ' HD3' ' A' ' 22' ' ' LYS . 30.8 mt -70.34 133.05 87.47 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.475 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 15.0 Cg_endo -87.21 162.65 8.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.57 2.847 . . . . 0.0 113.433 -172.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.526 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.9 mm -60.22 134.8 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.609 0.719 . . . . 0.0 111.074 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.37 8.26 66.4 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.365 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.536 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.24 128.08 51.94 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.415 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 1.9 p -89.79 159.14 17.18 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.13 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -141.78 125.6 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.183 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.913 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.3 104.5 15.2 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.492 ' HB2' HG23 ' A' ' 18' ' ' THR . 27.9 mt -109.68 159.72 16.9 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 126.138 1.775 . . . . 0.0 109.305 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.44 122.71 48.5 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 75.7 mt -109.14 163.14 13.61 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.21 1.004 . . . . 0.0 108.766 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -142.91 116.58 9.22 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.412 175.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.493 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 ttm180 -104.73 125.57 50.95 Favored 'General case' 0 C--N 1.258 -3.374 0 O-C-N 120.729 -1.232 . . . . 0.0 108.764 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.9 -22.03 0.23 Allowed Glycine 0 CA--C 1.472 -2.639 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -90.89 134.62 29.99 Favored Pre-proline 0 N--CA 1.422 -1.835 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.475 0.426 0 C-N-CA 123.803 3.002 . . . . 0.0 112.939 -175.109 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.443 ' HG3' ' H ' ' A' ' 40' ' ' PHE . 40.2 Cg_endo . . . . . 0 N--CA 1.443 -1.46 0 CA-C-O 121.98 0.742 . . . . 0.0 113.57 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -88.83 105.3 17.64 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.8 t80 -108.76 135.24 50.31 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -143.3 12.7 1.78 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.313 1.054 . . . . 0.0 110.239 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.566 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 7.1 mtm180 59.76 -11.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.008 2.123 . . . . 0.0 114.88 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.495 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 51.2 t-20 -111.35 115.98 51.48 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.1 0.476 . . . . 0.0 110.626 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 4.2 Cg_endo -56.46 -28.19 72.13 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.649 2.9 . . . . 0.0 112.84 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.61 -27.19 63.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -91.42 -22.45 20.45 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.843 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.595 HD11 HD21 ' A' ' 73' ' ' LEU . 44.3 mt -72.09 179.48 3.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.108 0.956 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -108.87 -166.37 1.11 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.069 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.588 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.17 167.56 41.66 Favored Glycine 0 C--N 1.304 -1.23 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.751 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 33.4 tttp -97.53 143.39 28.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.7 m-85 -106.95 112.04 24.81 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.415 1.103 . . . . 0.0 109.419 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' HE3' ' A' ' 14' ' ' LYS . 14.4 mt -112.3 148.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.442 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.09 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.592 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.9 t60 -124.76 120.02 30.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -140.34 131.5 26.45 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.741 0.781 . . . . 0.0 111.294 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 31.7 ttmt -88.16 125.95 34.88 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.327 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.38 117.4 33.95 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.912 -176.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 41.3 ttm180 -77.44 107.42 9.87 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.699 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.644 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 76.3 tttt -64.54 97.39 0.2 Allowed 'General case' 0 C--O 1.178 -2.699 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 t -91.86 -153.53 0.34 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 125.347 1.459 . . . . 0.0 108.216 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 p -52.68 -46.8 67.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.982 0.513 . . . . 0.0 111.564 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 31.2 mmt180 -84.07 -17.23 40.97 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.514 0.674 . . . . 0.0 109.904 173.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.644 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 95.68 -105.61 3.27 Favored Glycine 1 N--CA 1.377 -5.295 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.507 ' HD1' HD12 ' A' ' 20' ' ' LEU . 40.5 m-85 -97.1 140.22 31.93 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.687 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.87 4.83 84.94 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.638 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' HB2' HG23 ' A' ' 43' ' ' ILE . 27.4 p90 -111.99 163.04 14.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.454 0.645 . . . . 0.0 110.499 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HE3' ' A' ' 44' ' ' LYS . 43.7 p -117.6 149.15 41.15 Favored 'General case' 0 N--CA 1.401 -2.891 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.51 HG21 HD23 ' A' ' 41' ' ' LEU . 3.3 p -141.24 139.16 33.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 C-N-CA 119.246 -0.981 . . . . 0.0 112.06 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 33' ' ' GLY . 13.1 p -149.24 167.24 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.942 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 128.55 -65.11 0.59 Allowed Glycine 0 CA--C 1.453 -3.795 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.175 173.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -74.9 57.64 2.66 Favored Glycine 2 CA--C 1.42 -5.897 0 C-N-CA 125.649 1.595 . . . . 0.0 116.284 -167.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.88 -11.95 50.79 Favored 'General case' 0 C--N 1.257 -3.438 0 O-C-N 124.123 0.543 . . . . 0.0 111.571 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.551 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 6.9 pt-20 -160.92 167.35 13.69 Favored Pre-proline 0 CA--C 1.451 -2.859 0 C-N-CA 116.11 -2.236 . . . . 0.0 110.615 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.1 Cg_endo -68.23 54.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.351 2.034 . . . . 0.0 110.198 172.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -176.41 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.685 1.594 . . . . 0.0 109.93 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.708 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 51.3 mm-40 -114.36 128.42 56.34 Favored 'General case' 0 C--O 1.276 2.45 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.443 ' H ' ' HG3' ' A' ' 2' ' ' PRO 0.267 8.5 m-30 -79.56 156.4 27.74 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 128.101 3.375 . . . . 0.0 111.19 -178.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -87.33 142.21 28.06 Favored 'General case' 0 C--O 1.178 -2.692 0 C-N-CA 117.103 -1.839 . . . . 0.0 107.684 174.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.505 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 49.6 mt-30 -138.97 154.61 48.31 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG23 ' HB2' ' A' ' 29' ' ' PHE . 31.2 mm -76.41 111.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HE3' ' OG1' ' A' ' 30' ' ' THR . 0.5 OUTLIER -61.98 -37.54 85.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.59 ' HA ' HG22 ' A' ' 60' ' ' THR . 48.5 t 164.68 173.22 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 125.37 1.669 . . . . 0.0 109.479 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -137.2 151.58 48.93 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-O 122.044 0.926 . . . . 0.0 113.063 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 49' ' ' ASP . 40.7 t -73.54 117.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 113.454 -1.703 . . . . 0.0 106.748 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.66 -23.08 49.49 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 112.976 -1.92 . . . . 0.0 112.896 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.455 ' H ' HG12 ' A' ' 47' ' ' VAL . 31.8 m-20 -96.68 -2.04 45.38 Favored 'General case' 0 C--N 1.267 -3.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.219 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.33 167.64 26.35 Favored Glycine 0 N--CA 1.422 -2.256 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.366 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.1 Cg_endo -55.25 -31.03 74.57 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 124.187 3.258 . . . . 0.0 112.979 -176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.36 -44.94 89.01 Favored 'General case' 0 C--O 1.274 2.371 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.36 55.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.294 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.81 -35.43 64.87 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.82 -24.47 65.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.96 22.02 78.34 Favored Glycine 0 CA--C 1.49 -1.524 0 CA-C-N 112.515 -2.13 . . . . 0.0 113.79 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -109.44 -32.71 7.05 Favored 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.5 ttm -96.07 142.22 28.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.47 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.01 166.2 23.27 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.076 0.941 . . . . 0.0 111.082 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.9 p -70.74 111.77 6.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.081 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.7 -11.64 15.66 Favored Glycine 0 C--N 1.309 -0.929 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.903 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.662 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.8 m-20 -63.54 134.62 55.86 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -91.66 124.73 44.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 13.1 mm -73.17 123.9 29.03 Favored 'Isoleucine or valine' 1 C--O 1.32 4.764 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 HD13 ' A' ' 73' ' ' LEU . 42.9 t -115.53 -34.49 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 O-C-N 126.979 2.674 . . . . 0.0 110.447 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.583 ' HA ' HG22 ' A' ' 72' ' ' VAL . 36.5 m -148.98 146.71 27.93 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.954 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.591 HG12 HG11 ' A' ' 72' ' ' VAL . 7.1 p -124.75 132.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.0 m120 61.11 23.75 13.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 110.978 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.7 t70 66.66 21.46 10.62 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.743 1.617 . . . . 0.0 112.015 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' HG13 ' A' ' 72' ' ' VAL . 56.2 m -102.91 120.43 40.61 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 171.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.7 t -66.7 110.33 3.19 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG11 HG12 ' A' ' 67' ' ' VAL . 35.7 m -122.67 28.88 2.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.563 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.595 HD21 HD11 ' A' ' 11' ' ' LEU . 39.0 tp -60.98 112.92 2.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.82 42.29 0.23 Allowed Glycine 0 C--N 1.376 2.763 0 O-C-N 125.339 1.649 . . . . 0.0 111.374 -170.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' HG23 ' A' ' 76' ' ' THR . 5.3 t60 -43.31 -66.11 0.41 Allowed 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' HIS . 7.2 p -167.31 143.31 4.21 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 151.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -49.69 -35.69 22.59 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 120.31 1.414 . . . . 0.0 110.572 173.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.13 71.37 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.934 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 8.5 mm100 -60.27 -44.5 95.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 41' ' ' LEU . 35.8 m -71.23 -43.31 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.606 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 91.6 t -64.92 -41.29 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -60.91 -38.58 86.22 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.692 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.591 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.8 mm -68.58 -33.21 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.313 0.577 . . . . 0.0 112.478 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -73.25 -30.12 63.23 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 87.5 mt-30 -76.64 -19.9 57.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.824 1.25 . . . . 0.0 110.821 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.7 m -79.68 -44.33 21.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.923 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.491 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.6 mt -67.24 136.46 93.74 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.199 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -90.99 161.18 3.93 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 123.081 2.52 . . . . 0.0 112.969 -173.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.566 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.0 mm -63.88 134.76 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-O 120.912 0.386 . . . . 0.0 110.705 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.04 54.16 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.312 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.03 -170.0 1.82 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -175.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 20.8 m -151.06 157.38 42.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.46 125.66 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.807 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.592 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 14.4 m-20 -76.44 105.3 7.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.7 mt -103.86 138.41 40.48 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 124.139 0.976 . . . . 0.0 110.484 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.3 tt0 -101.05 118.38 36.87 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 81.5 mt -107.14 150.06 26.99 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 124.776 1.23 . . . . 0.0 109.99 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.636 ' HB3' HG13 ' A' ' 63' ' ' VAL . 9.4 t -118.11 106.21 12.63 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.132 0.968 . . . . 0.0 108.553 172.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.662 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 36.2 ttp180 -104.66 127.76 52.51 Favored 'General case' 0 C--N 1.248 -3.823 0 O-C-N 120.811 -1.181 . . . . 0.0 109.954 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.8 -27.55 0.4 Allowed Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.41 141.54 39.54 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 C--O 1.238 0.494 0 C-N-CA 123.288 2.659 . . . . 0.0 111.643 -179.008 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.443 -1.478 0 CA-C-O 121.589 0.579 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -100.74 111.97 24.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.62 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.7 t80 -106.52 143.06 35.17 Favored 'General case' 0 C--N 1.268 -2.957 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.964 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -147.13 9.68 0.98 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.146 0.974 . . . . 0.0 110.443 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.525 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtm180 53.28 4.71 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 127.241 2.217 . . . . 0.0 114.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.491 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.4 t-20 -130.2 119.91 18.9 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HB3' HG11 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -60.94 -19.1 61.05 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.072 3.182 . . . . 0.0 112.835 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -80.43 -24.57 39.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -98.33 -19.9 17.5 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.847 0.356 . . . . 0.0 111.718 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 42.8 tp -84.99 160.46 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.286 0.565 . . . . 0.0 110.848 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.487 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 58.7 mttm -97.56 -171.23 2.14 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.896 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.15 163.95 39.87 Favored Glycine 0 C--N 1.299 -1.506 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 28.2 tttp -93.37 137.97 32.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.607 -1.237 . . . . 0.0 108.828 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 95.9 m-85 -106.05 110.68 23.02 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 122.561 1.172 . . . . 0.0 109.066 -177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 HD13 ' NH2' ' A' ' 99' ' ' ARG . 15.1 mt -114.8 147.33 18.3 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.875 0 CA-C-N 112.36 -2.2 . . . . 0.0 107.94 -173.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -117.35 132.08 56.66 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.917 0.865 . . . . 0.0 111.867 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -140.1 127.58 21.47 Favored 'General case' 0 C--N 1.263 -3.186 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.245 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.796 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttmt -90.15 122.27 32.95 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.843 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.435 HD21 ' CA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -106.79 116.78 32.52 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.9 ttt180 -76.85 107.83 9.46 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.279 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.731 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.1 tttt -64.08 97.32 0.17 Allowed 'General case' 0 C--O 1.181 -2.512 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 167.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -82.11 -158.24 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -96.58 -0.29 48.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.731 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 83.78 -129.05 8.9 Favored Glycine 0 N--CA 1.406 -3.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.57 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.8 m-85 -90.28 141.98 28.17 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 120.875 0.369 . . . . 0.0 110.207 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.99 86.84 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.143 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.412 ' HB2' HG23 ' A' ' 43' ' ' ILE . 21.3 p90 -111.15 163.3 14.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.475 0.655 . . . . 0.0 110.76 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 69.2 p -115.99 152.27 33.83 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG21 HD23 ' A' ' 41' ' ' LEU . 4.8 p -140.41 143.59 29.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.618 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 33' ' ' GLY . 8.8 p -144.89 167.94 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.453 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.487 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 32' ' ' VAL . . . 111.86 -141.64 16.74 Favored Glycine 1 N--CA 1.388 -4.526 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 -177.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.6 35.66 16.72 Favored Glycine 0 CA--C 1.473 -2.571 0 CA-C-N 117.396 0.598 . . . . 0.0 111.98 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 16.8 t70 -67.0 -29.55 69.42 Favored 'General case' 0 CA--C 1.46 -2.517 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -172.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.41 166.64 13.6 Favored Pre-proline 0 CA--C 1.467 -2.246 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.024 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 20.1 Cg_endo -65.93 58.77 0.42 Allowed 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.561 2.174 . . . . 0.0 109.945 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 11.9 t70 179.24 -16.14 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.233 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 33.9 mm-40 -122.59 123.94 42.35 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 73' ' ' LEU . 6.0 m-30 -76.91 159.28 30.13 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 130.711 3.604 . . . . 0.0 113.762 -169.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 80' ' ' VAL . 8.0 mp -89.03 146.98 24.51 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.8 mt-30 -142.84 157.69 44.36 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.437 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 39.4 mm -74.45 109.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.7 tttp -57.82 -41.05 81.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 60' ' ' THR . 31.2 t 163.04 174.98 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 O-C-N 125.827 1.954 . . . . 0.0 109.808 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.486 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -139.53 150.3 44.94 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.535 0.683 . . . . 0.0 111.826 -175.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 49' ' ' ASP . 60.8 t -75.77 123.87 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 173.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.9 pt? -68.76 -5.21 19.3 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 47' ' ' VAL . 6.3 m-20 -100.0 -6.56 26.31 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.181 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.53 163.76 32.7 Favored Glycine 0 N--CA 1.408 -3.186 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.3 -31.59 30.22 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 124.78 3.654 . . . . 0.0 113.249 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.78 -46.47 84.53 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.425 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.33 -33.95 55.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.058 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.4 mp -70.47 -40.0 73.91 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 124.187 0.995 . . . . 0.0 112.377 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.613 ' OD2' ' HE3' ' A' ' 57' ' ' LYS . 24.4 t70 -66.33 -24.15 66.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.694 1.235 . . . . 0.0 108.326 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.8 19.67 78.24 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.586 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.613 ' HE3' ' OD2' ' A' ' 55' ' ' ASP . 25.6 mtmt -122.02 -18.9 6.81 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -102.19 130.83 48.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.699 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.58 162.91 22.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.403 1.097 . . . . 0.0 111.777 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 45' ' ' SER . 80.7 p -72.57 108.69 5.75 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.657 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.1 -16.14 9.34 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.642 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.678 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 13.5 m-20 -61.13 131.8 51.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.6 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.262 0.2 OUTLIER -85.96 123.58 39.62 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.726 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 15.4 mm -74.06 124.36 31.3 Favored 'Isoleucine or valine' 1 C--O 1.326 5.115 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 8' ' ' PRO . 42.0 t -115.85 -41.06 2.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 110.881 -2.872 . . . . 0.0 111.201 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.579 ' HA ' HG22 ' A' ' 72' ' ' VAL . 68.0 m -144.85 149.27 35.09 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.032 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.775 HG23 HG21 ' A' ' 72' ' ' VAL . 25.1 t -111.7 115.04 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 66.1 -78.83 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.846 1.341 . . . . 0.0 109.634 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -156.22 24.31 0.36 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.36 1.076 . . . . 0.0 110.316 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.538 ' O ' HG13 ' A' ' 72' ' ' VAL . 27.1 m -106.87 117.99 35.51 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 32.3 t -64.9 108.23 1.71 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.775 HG21 HG23 ' A' ' 67' ' ' VAL . 28.2 m -117.53 20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.408 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.62 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 36.3 tp -61.64 112.76 2.37 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 39.54 0.06 OUTLIER Glycine 0 C--N 1.385 3.286 0 O-C-N 125.484 1.74 . . . . 0.0 112.273 -171.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.473 ' O ' HG23 ' A' ' 76' ' ' THR . 3.0 t60 -42.31 -65.24 0.49 Allowed 'General case' 0 C--N 1.37 1.481 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.1 p -166.36 143.11 4.99 Favored 'General case' 0 C--N 1.257 -3.423 0 N-CA-C 100.812 -3.773 . . . . 0.0 100.812 150.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.615 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.8 -31.37 26.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 121.018 1.735 . . . . 0.0 111.233 173.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.09 -50.26 74.07 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 13.3 mm100 -64.55 -42.01 95.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 41' ' ' LEU . 11.0 m -66.57 -41.85 89.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.05 -38.98 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -37.24 86.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 86' ' ' SER . 2.1 mm -67.56 -35.7 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.56 0.695 . . . . 0.0 112.146 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -73.55 -30.49 63.09 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.74 -26.68 62.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.657 0.783 . . . . 0.0 110.41 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -70.96 -42.5 69.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.768 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 20.6 mt -72.16 130.08 86.85 Favored Pre-proline 0 N--CA 1.408 -2.567 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.017 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.3 Cg_endo -91.86 162.42 3.35 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 123.514 2.809 . . . . 0.0 112.947 -173.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.3 mm -59.43 132.79 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-O 121.296 0.57 . . . . 0.0 111.217 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.65 56.54 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.443 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.9 -169.54 1.69 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 8.1 m -150.6 159.93 44.16 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -142.0 125.01 14.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.766 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.225 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.08 102.16 11.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.76 135.57 40.04 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.221 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 35.5 tt0 -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.805 175.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.0 mt -106.33 144.81 32.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.0 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 10.2 t -112.44 107.78 16.68 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.005 0.907 . . . . 0.0 108.82 172.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.678 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 26.9 ttp180 -101.59 131.74 47.62 Favored 'General case' 0 C--N 1.25 -3.747 0 O-C-N 121.021 -1.049 . . . . 0.0 109.874 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.66 1.41 Allowed Glycine 0 C--N 1.307 -1.061 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.42 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.88 128.73 31.52 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.245 0.849 0 C-N-CA 123.834 3.022 . . . . 0.0 113.12 -174.458 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.448 -1.194 0 CA-C-O 121.092 0.371 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.412 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 44.0 t80 -86.6 104.47 16.06 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.597 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -106.91 131.07 54.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -140.11 13.53 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.045 0.926 . . . . 0.0 109.912 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 6.2 mtm180 53.07 7.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 54.5 t-20 -132.77 121.27 17.0 Favored Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.001 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -59.21 -22.74 66.28 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 124.262 3.308 . . . . 0.0 113.152 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -79.23 -30.61 43.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.363 0.602 . . . . 0.0 109.478 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -90.41 -24.0 20.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.519 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 38.3 tp -82.26 152.95 26.13 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.35 144.83 42.1 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-O 121.73 0.776 . . . . 0.0 109.767 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.655 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 155.19 -178.13 32.02 Favored Glycine 1 C--N 1.249 -4.292 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -173.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HE2' ' CG1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -98.6 121.73 40.92 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' A' ' 98' ' ' CYS . 85.9 m-85 -100.1 119.25 38.01 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.131 0.967 . . . . 0.0 109.506 -174.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.602 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 44.7 mt -117.42 141.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.95 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.68 -170.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -107.06 126.44 52.35 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.53 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 9.0 t -137.55 157.54 46.31 Favored 'General case' 0 C--O 1.179 -2.633 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.329 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 35.6 ttpt -130.35 122.99 28.92 Favored 'General case' 0 C--N 1.261 -3.278 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.09 117.07 33.1 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 58.0 ttp180 -73.84 105.43 5.11 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.918 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.727 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.0 tttt -64.16 97.17 0.17 Allowed 'General case' 0 C--O 1.18 -2.602 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -84.53 -154.88 0.18 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -58.99 -38.34 78.93 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.449 0.7 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -90.01 -19.94 23.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.727 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 99.84 -118.9 6.32 Favored Glycine 1 N--CA 1.388 -4.541 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.477 ' HD1' HD12 ' A' ' 20' ' ' LEU . 38.4 m-85 -90.55 136.51 33.02 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 117.674 0.737 . . . . 0.0 110.515 -176.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 9.71 76.79 Favored Glycine 0 C--O 1.212 -1.253 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.613 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 9.3 p90 -121.14 162.67 19.69 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.345 0.572 . . . . 0.0 110.375 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -123.13 147.34 46.9 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.413 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.5 m -121.61 146.22 27.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-O 121.284 0.564 . . . . 0.0 111.622 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.85 152.04 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.515 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.89 -129.59 8.33 Favored Glycine 1 N--CA 1.395 -4.08 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 45.06 38.04 5.93 Favored Glycine 0 CA--C 1.472 -2.597 0 C-N-CA 124.935 1.255 . . . . 0.0 114.072 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 6.6 m-20 -67.09 -24.4 65.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.405 -176.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.3 pt-20 -170.82 169.76 3.28 Favored Pre-proline 0 CA--C 1.46 -2.518 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.092 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.9 Cg_endo -65.48 59.05 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.858 2.372 . . . . 0.0 110.709 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 19.4 t70 175.02 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.511 1.525 . . . . 0.0 110.218 -173.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 7.7 mm-40 -123.93 123.96 41.56 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 172.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.525 ' CE1' HD11 ' A' ' 73' ' ' LEU . 5.1 m-30 -76.99 159.63 29.78 Favored 'General case' 1 N--CA 1.55 4.543 0 C-N-CA 131.492 3.917 . . . . 0.0 114.569 -170.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.87 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -95.08 140.07 30.53 Favored 'General case' 0 C--O 1.188 -2.141 0 C-N-CA 117.73 -1.588 . . . . 0.0 107.725 172.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 51.0 mt-30 -130.86 158.43 40.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 172.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 62' ' ' ASP . 22.3 mm -81.32 115.48 23.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -66.86 -48.66 68.13 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.656 ' HA ' HG22 ' A' ' 60' ' ' THR . 46.0 t 174.37 173.99 0.19 Allowed 'General case' 0 CA--C 1.497 -1.06 0 O-C-N 123.996 0.81 . . . . 0.0 111.879 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.57 152.28 39.46 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.808 -172.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.41 116.23 9.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -69.56 -10.06 56.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.292 1.044 . . . . 0.0 112.908 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.92 -7.98 38.43 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.025 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.541 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.37 173.41 37.27 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.57 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 15.2 Cg_endo -57.27 -27.93 77.36 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 124.175 3.25 . . . . 0.0 112.872 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.45 -49.75 76.59 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.692 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.44 -32.28 58.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.894 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 50' ' ' GLY . 6.8 mp -65.59 -46.27 80.04 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.714 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 35.4 t70 -62.74 -35.7 80.62 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.41 -17.72 52.75 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 112.878 -1.964 . . . . 0.0 113.267 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 2.9 mptm? -77.27 -27.43 53.14 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 46.7 tpp -94.19 127.08 39.82 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -170.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -136.73 156.55 48.38 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.27 1.033 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -61.97 114.42 3.36 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.71 1.204 . . . . 0.0 110.336 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.26 -14.43 25.69 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.192 174.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.8 m-20 -67.08 141.25 57.54 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.251 0.1 OUTLIER -93.41 123.15 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 113.244 178.34 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.1 mm -73.25 123.62 28.57 Favored 'Isoleucine or valine' 1 C--O 1.337 5.66 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 73' ' ' LEU . 47.1 t -115.87 -36.05 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 O-C-N 127.506 3.004 . . . . 0.0 111.985 -176.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 60.4 m -151.61 162.85 40.28 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.487 -1.383 . . . . 0.0 114.012 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.685 HG23 HG11 ' A' ' 72' ' ' VAL . 48.6 t -134.38 127.16 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.624 0 C-N-CA 125.017 1.327 . . . . 0.0 107.527 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.2 m120 65.65 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 108.761 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -149.96 31.35 0.7 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.743 0.782 . . . . 0.0 109.165 170.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 m -116.48 126.84 53.94 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.505 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 24.2 t -67.39 115.08 6.62 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.732 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -119.98 15.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.597 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.4 tp -59.34 113.67 2.28 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.2 48.02 0.14 Allowed Glycine 0 C--N 1.379 2.967 0 O-C-N 125.433 1.708 . . . . 0.0 111.846 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.544 ' O ' HG23 ' A' ' 76' ' ' THR . 3.0 t60 -50.93 -68.35 0.18 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 75' ' ' HIS . 13.9 p -166.55 143.93 5.06 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 152.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.563 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.68 -33.36 22.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 120.088 1.313 . . . . 0.0 110.977 172.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.61 93.19 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.897 -0.502 . . . . 0.0 110.958 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 10.1 mm-40 -65.2 -43.3 92.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.87 HG21 HD21 ' A' ' 41' ' ' LEU . 17.1 m -62.66 -43.98 99.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.003 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.84 -40.78 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.636 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -62.18 -38.34 88.71 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.636 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 28.1 mt -65.02 -40.39 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.636 0.732 . . . . 0.0 111.329 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.23 -33.59 71.85 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.673 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.38 -20.22 60.8 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.183 0.993 . . . . 0.0 110.96 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.0 m -76.41 -48.75 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.413 HG22 ' HD3' ' A' ' 22' ' ' LYS . 21.4 mt -66.2 135.52 95.02 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -87.98 161.55 7.39 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.258 2.639 . . . . 0.0 113.68 -172.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.559 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.2 mm -63.6 132.49 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.99 11.95 55.89 Favored Glycine 0 C--N 1.288 -2.096 0 C-N-CA 119.783 -1.198 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.35 -171.71 2.13 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.7 m -151.25 156.44 40.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -140.97 125.47 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.867 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.226 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' THR . 10.6 m-20 -79.31 104.2 9.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.39 157.42 16.92 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 125.497 1.519 . . . . 0.0 108.254 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -117.01 121.38 41.21 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 76.1 mt -105.06 164.34 11.87 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 125.107 1.363 . . . . 0.0 109.69 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.655 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 12.4 t -141.05 116.54 10.15 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.843 0.83 . . . . 0.0 109.923 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 31.1 mtm180 -98.6 135.49 40.05 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 121.279 -0.888 . . . . 0.0 113.115 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.62 -25.13 0.84 Allowed Glycine 0 CA--C 1.466 -3.0 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.298 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 22.7 m-85 -81.85 140.64 47.08 Favored Pre-proline 0 N--CA 1.42 -1.954 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.482 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--N 1.359 1.122 0 C-N-CA 123.799 2.999 . . . . 0.0 111.147 179.356 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--O 1.247 0.929 0 N-CA-C 111.424 -0.26 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -79.63 105.43 10.93 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.592 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 4.8 t80 -108.25 139.55 42.78 Favored 'General case' 0 C--N 1.265 -3.088 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 7' ' ' ASN . 10.2 t -144.48 10.56 1.44 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.522 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 9.5 mtp180 58.01 -19.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.766 2.026 . . . . 0.0 115.466 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -105.84 113.12 64.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 C-N-CA 122.714 0.406 . . . . 0.0 109.973 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' HG11 ' A' ' 65' ' ' VAL . 5.2 Cg_endo -50.87 -27.87 21.89 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 124.077 3.185 . . . . 0.0 113.635 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.5 t -74.03 -25.71 60.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.02 0.438 . . . . 0.0 110.996 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 14.5 mm-40 -91.51 -35.3 14.39 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.435 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 39.0 tp -71.89 155.82 39.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.903 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -106.55 158.57 16.83 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.48 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.768 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 131.31 173.65 13.42 Favored Glycine 0 C--N 1.265 -3.369 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' CE ' HG12 ' A' ' 16' ' ' ILE . 7.6 ttpt -94.4 123.51 37.85 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 95.1 m-85 -101.75 111.55 23.83 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 122.778 1.275 . . . . 0.0 109.85 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG12 ' CE ' ' A' ' 14' ' ' LYS . 34.7 mt -105.87 145.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.739 0 CA-C-N 111.839 -2.437 . . . . 0.0 109.651 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.504 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 4.3 t60 -130.61 115.17 16.37 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 57' ' ' LYS . 2.2 t -139.92 137.73 35.04 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.296 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.6 ttmp? -87.59 125.37 34.31 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.632 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -107.82 121.11 44.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 11.9 ttp180 -81.21 108.87 15.21 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.397 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.646 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 73.7 tttt -62.88 97.47 0.11 Allowed 'General case' 0 C--O 1.182 -2.454 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 169.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -90.93 -154.39 0.35 Allowed 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 124.812 1.245 . . . . 0.0 108.228 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -54.59 -43.94 72.59 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.75 0.82 . . . . 0.0 111.029 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmt_? -85.18 -18.87 32.78 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.15 -114.52 5.0 Favored Glycine 0 N--CA 1.397 -3.955 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -177.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.505 ' HD1' HD12 ' A' ' 20' ' ' LEU . 31.8 m-85 -93.95 141.33 28.64 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.37 -2.92 84.91 Favored Glycine 0 C--O 1.217 -0.959 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.757 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.525 ' HB2' HG23 ' A' ' 43' ' ' ILE . 17.9 p90 -111.97 162.7 15.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 38.8 p -123.59 155.58 37.39 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.4 148.64 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-O 121.631 0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.02 149.93 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.283 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.79 -137.17 12.6 Favored Glycine 0 N--CA 1.398 -3.864 0 N-CA-C 108.236 -1.945 . . . . 0.0 108.236 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 52.34 32.28 36.94 Favored Glycine 0 CA--C 1.47 -2.728 0 N-CA-C 111.786 -0.525 . . . . 0.0 111.786 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -71.62 -19.76 62.07 Favored 'General case' 0 N--CA 1.411 -2.416 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.951 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.1 pt-20 -166.65 166.78 8.66 Favored Pre-proline 0 CA--C 1.468 -2.183 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_endo -66.85 58.18 0.54 Allowed 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.715 2.277 . . . . 0.0 109.737 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 22.1 t70 176.6 -15.06 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.476 -169.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 26.9 mt-10 -123.19 126.12 46.39 Favored 'General case' 0 C--O 1.269 2.116 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 171.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.25 7.3 m-85 -77.85 158.59 29.4 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 131.04 3.736 . . . . 0.0 113.535 -168.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 80' ' ' VAL . 6.0 mp -89.82 143.29 26.92 Favored 'General case' 0 CA--C 1.457 -2.624 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 171.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.12 152.81 49.09 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 29' ' ' PHE . 26.7 mm -69.09 109.09 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 84.1 tttt -55.3 -41.26 72.1 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 124.872 1.357 . . . . 0.0 107.448 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.554 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 162.41 173.52 0.02 OUTLIER 'General case' 0 C--N 1.366 1.326 0 O-C-N 125.395 1.684 . . . . 0.0 109.605 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -138.59 147.27 42.78 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 121.989 0.9 . . . . 0.0 111.976 -173.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ASP . 13.8 t -83.34 130.06 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.972 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 94.7 mt -69.32 -13.52 62.43 Favored 'General case' 0 N--CA 1.38 -3.941 0 CA-C-N 112.799 -2.001 . . . . 0.0 112.849 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . 14.7 t70 -86.0 -24.2 26.54 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.244 173.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -81.09 155.15 36.13 Favored Glycine 0 N--CA 1.401 -3.679 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.556 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 20' ' ' LEU . 9.7 Cg_endo -50.8 -31.48 33.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 125.052 3.834 . . . . 0.0 113.385 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -60.4 -44.53 95.59 Favored 'General case' 0 C--O 1.261 1.701 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.199 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.88 -35.33 50.95 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.496 177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 6.6 mp -65.94 -43.41 88.11 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.981 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.48 -21.85 55.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.909 1.338 . . . . 0.0 107.409 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.9 73.46 Favored Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 113.228 -1.806 . . . . 0.0 112.586 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HB3' HG21 ' A' ' 18' ' ' THR . 72.6 mmtt -98.31 -28.48 13.65 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 120.859 0.362 . . . . 0.0 110.084 -173.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.427 ' HB3' HD22 ' A' ' 46' ' ' LEU . 1.3 mpt? -98.03 149.63 22.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.211 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.71 153.4 47.21 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.5 p -60.09 111.67 1.6 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 113.48 -5.43 24.76 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.215 175.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 43' ' ' ILE . 5.4 m-20 -60.31 126.07 26.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.102 0.951 . . . . 0.0 108.603 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.256 0.2 OUTLIER -80.2 112.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.957 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 97' ' ' LEU . 22.1 mm -66.98 125.3 24.09 Favored 'Isoleucine or valine' 1 C--O 1.332 5.397 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 HD22 ' A' ' 73' ' ' LEU . 48.5 t -115.36 -42.91 3.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 O-C-N 127.585 3.053 . . . . 0.0 112.085 -174.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 69.6 m -147.77 156.78 43.1 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.853 -1.154 . . . . 0.0 112.359 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG11 HG21 ' A' ' 83' ' ' ILE . 6.3 p -135.98 128.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.1 m120 58.53 30.33 19.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.603 0.716 . . . . 0.0 110.65 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 68.06 17.22 9.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.893 1.277 . . . . 0.0 113.28 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.8 m -107.78 125.49 51.49 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.417 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 54.0 t -59.99 110.14 1.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 124.418 1.074 . . . . 0.0 109.783 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -119.8 16.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.592 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 30.6 tp -59.9 113.23 2.18 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.5 43.17 0.07 OUTLIER Glycine 0 N--CA 1.5 2.945 0 O-C-N 125.762 1.914 . . . . 0.0 112.559 -170.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' THR . 3.2 t60 -46.42 -66.83 0.35 Allowed 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.1 p -166.52 143.85 5.07 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 151.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.589 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -50.88 -33.59 24.67 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 120.295 1.407 . . . . 0.0 110.876 173.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.17 86.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.967 -0.458 . . . . 0.0 110.866 174.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.509 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 14.3 mm-40 -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 41' ' ' LEU . 13.1 m -64.63 -44.5 96.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -66.56 -38.19 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -64.32 -33.93 76.96 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.296 177.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.588 HG21 HG11 ' A' ' 67' ' ' VAL . 3.9 mm -70.8 -36.53 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.732 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.18 -31.42 64.21 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.309 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -70.44 -27.91 64.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.522 1.129 . . . . 0.0 110.634 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -73.17 -34.34 65.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.576 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.0 mt -80.78 134.72 53.13 Favored Pre-proline 0 N--CA 1.412 -2.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.976 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -91.99 162.3 3.27 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 123.585 2.857 . . . . 0.0 113.134 -174.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.533 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.2 mm -62.85 133.01 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.22 0.533 . . . . 0.0 110.885 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.76 12.3 53.44 Favored Glycine 0 C--N 1.293 -1.848 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.674 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.76 -170.82 1.88 Allowed 'General case' 0 C--O 1.207 -1.164 0 O-C-N 122.704 -0.292 . . . . 0.0 110.292 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.9 m -151.21 155.51 38.98 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.657 -0.652 . . . . 0.0 109.358 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.02 127.88 10.67 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.657 0 C-N-CA 118.582 -1.247 . . . . 0.0 113.119 -174.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 22.2 m-20 -80.32 106.88 12.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.533 0.682 . . . . 0.0 109.168 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 71.1 mt -105.59 142.65 34.95 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.806 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' OE2' ' HB3' ' A' ' 15' ' ' PHE . 16.7 tp10 -107.1 127.69 53.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB3' HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -136.2 155.83 49.57 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 124.046 0.938 . . . . 0.0 111.281 -178.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.768 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -119.95 117.13 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.509 1.147 . . . . 0.0 112.936 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 18.8 tpp85 -88.88 111.14 21.71 Favored 'General case' 0 C--N 1.266 -3.058 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.07 -35.63 0.09 OUTLIER Glycine 0 CA--C 1.479 -2.19 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.568 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.62 136.99 24.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.128 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.889 2.392 . . . . 0.0 108.062 173.644 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HG3' ' H ' ' A' ' 40' ' ' PHE . 97.3 Cg_endo . . . . . 0 N--CA 1.44 -1.628 0 CA-C-O 121.379 0.491 . . . . 0.0 112.97 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.46 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 23.8 t80 -82.27 105.19 13.14 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.605 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -101.46 133.57 45.9 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -141.15 8.89 2.08 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.903 0.858 . . . . 0.0 110.437 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.489 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 8.3 mtm180 63.9 -27.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.556 1.943 . . . . 0.0 114.964 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -100.54 122.25 50.26 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.1 Cg_endo -55.52 -27.84 61.58 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 124.006 3.137 . . . . 0.0 112.691 175.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 t -75.52 -25.72 57.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.129 0.49 . . . . 0.0 110.314 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -88.9 -24.26 22.54 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.691 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.436 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 41.2 tp -83.33 157.51 22.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.415 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 36.6 mtmm -119.69 148.71 43.05 Favored 'General case' 0 N--CA 1.381 -3.908 0 CA-C-O 121.676 0.751 . . . . 0.0 110.524 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.624 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 150.37 178.22 25.06 Favored Glycine 0 C--N 1.257 -3.837 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -171.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -88.41 124.28 33.79 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.6 m-85 -102.8 120.3 40.36 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.103 -1.439 . . . . 0.0 109.949 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.433 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 64.7 mt -120.39 135.97 58.94 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.579 -170.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 t-80 -114.01 115.58 27.84 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.371 -176.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 4.2 t -140.33 131.28 26.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.889 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttpt -92.3 124.95 36.75 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.81 120.62 42.51 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.782 -173.007 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 15.9 tpp180 -76.21 103.47 6.26 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.635 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.723 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 51.2 tttt -59.06 96.97 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.947 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 165.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.565 ' HB2' ' HG3' ' A' ' 21' ' ' ARG . 4.9 t -134.65 139.33 45.2 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.1 p 50.82 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.973 1.709 . . . . 0.0 113.215 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmm_? -76.2 -21.83 56.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.723 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 94.43 24.56 18.37 Favored Glycine 1 N--CA 1.393 -4.213 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.697 174.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.553 ' HD1' HD12 ' A' ' 20' ' ' LEU . 30.8 m-85 155.8 170.39 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 130.393 3.477 . . . . 0.0 105.525 167.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.49 4.0 17.74 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.218 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.517 ' HB2' HG23 ' A' ' 43' ' ' ILE . 8.2 p90 -123.8 163.8 20.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -122.09 147.69 45.8 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.19 147.9 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.988 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 158.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.963 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.984 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.75 -130.12 9.04 Favored Glycine 1 N--CA 1.394 -4.13 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.25 37.11 30.56 Favored Glycine 0 CA--C 1.478 -2.268 0 C-N-CA 123.92 0.772 . . . . 0.0 113.513 175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 42.2 m-20 -67.13 -21.39 65.84 Favored 'General case' 0 CA--C 1.477 -1.845 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.097 -175.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.9 pt-20 -170.78 169.37 3.47 Favored Pre-proline 0 CA--C 1.474 -1.961 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.356 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 21.2 Cg_endo -66.61 51.36 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.923 2.416 . . . . 0.0 111.279 171.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 5.8 m-20 -176.84 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 127.105 2.162 . . . . 0.0 111.352 -170.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 18.6 mm-40 -128.66 123.85 34.24 Favored 'General case' 0 C--O 1.272 2.238 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 73' ' ' LEU . 6.5 m-30 -77.15 159.67 29.57 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 131.14 3.776 . . . . 0.0 114.58 -168.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.832 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -92.87 144.28 25.43 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 172.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.7 mt-30 -138.28 153.19 49.06 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 62' ' ' ASP . 25.0 mm -70.93 111.21 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.402 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 45' ' ' SER . 38.8 ttpt -67.54 -36.5 81.11 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.588 ' HA ' HG22 ' A' ' 60' ' ' THR . 41.1 t 170.53 172.9 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 O-C-N 125.159 1.537 . . . . 0.0 111.221 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -144.76 149.47 35.58 Favored 'General case' 0 N--CA 1.408 -2.562 0 C-N-CA 124.257 1.023 . . . . 0.0 110.879 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 49' ' ' ASP . 15.4 t -78.65 127.64 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.651 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.25 -3.38 10.59 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.571 -2.104 . . . . 0.0 112.264 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.2 t70 -103.13 -18.06 15.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.4 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.98 163.0 32.98 Favored Glycine 0 N--CA 1.41 -3.07 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.729 -170.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -50.27 -32.96 34.86 Favored 'Trans proline' 0 C--O 1.201 -1.372 0 C-N-CA 125.063 3.842 . . . . 0.0 112.617 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.469 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -57.51 -47.86 80.82 Favored 'General case' 0 C--O 1.271 2.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.357 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.18 -36.55 54.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.43 -35.45 65.8 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.108 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.69 -22.41 66.08 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.3 24.0 76.17 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.403 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 23.7 mmtp -110.18 -35.69 6.03 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.4 ttm -102.27 143.08 32.49 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.167 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.44 163.93 29.33 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.619 0.723 . . . . 0.0 109.176 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -67.83 114.42 6.4 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 123.709 0.804 . . . . 0.0 108.837 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.443 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 122.62 -22.07 7.43 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.035 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' O ' HG12 ' A' ' 43' ' ' ILE . 8.1 m-20 -62.18 134.69 56.89 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.706 0.753 . . . . 0.0 110.986 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.262 0.2 OUTLIER -82.52 121.51 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.408 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.0 mm -72.58 122.83 25.98 Favored 'Isoleucine or valine' 1 C--O 1.334 5.525 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -115.29 -37.61 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 110.402 -3.09 . . . . 0.0 111.652 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.62 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.0 m -150.76 151.43 32.36 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.302 -1.499 . . . . 0.0 114.424 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.723 HG23 HG21 ' A' ' 72' ' ' VAL . 25.3 t -118.73 114.8 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.629 1.172 . . . . 0.0 109.037 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 52.74 36.69 21.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.312 0.577 . . . . 0.0 112.308 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 72.73 15.41 4.84 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.166 1.786 . . . . 0.0 112.164 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 72' ' ' VAL . 28.6 m -99.1 119.14 37.34 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 169.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.4 t -69.22 110.01 4.37 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.678 0.752 . . . . 0.0 109.491 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.723 HG21 HG23 ' A' ' 67' ' ' VAL . 23.9 m -114.47 18.3 7.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.444 -176.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.605 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 28.5 tp -59.79 113.4 2.25 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.668 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.21 45.72 0.14 Allowed Glycine 0 C--N 1.378 2.9 0 O-C-N 125.661 1.85 . . . . 0.0 111.896 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 76' ' ' THR . 8.9 t60 -45.15 -66.68 0.37 Allowed 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.8 p -166.9 143.83 4.67 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 150.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -51.0 -36.94 42.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 121.008 1.731 . . . . 0.0 110.886 174.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.43 95.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.501 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 18.6 mm-40 -69.97 -39.81 75.74 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.832 HG21 HD21 ' A' ' 41' ' ' LEU . 20.9 m -66.54 -41.6 88.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.859 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.63 -40.89 90.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.646 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.4 tmtm? -59.03 -44.58 91.78 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.765 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.646 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.4 mm -66.34 -35.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -70.98 -36.59 72.57 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -68.24 -23.38 64.79 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 124.338 1.055 . . . . 0.0 111.352 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.5 m -75.63 -30.09 59.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.938 176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.529 HG22 ' HD3' ' A' ' 22' ' ' LYS . 51.9 mt -83.24 133.29 47.98 Favored Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.646 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 9.8 Cg_endo -88.08 161.99 7.24 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.552 2.835 . . . . 0.0 112.637 -173.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.536 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 35.5 mm -66.52 133.73 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.87 54.5 Favored Glycine 0 C--N 1.287 -2.173 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.237 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.618 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -101.73 -177.25 3.37 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.565 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 2.9 p -145.54 152.48 39.8 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.78 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.8 t -136.67 125.42 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.34 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.42 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.3 m-20 -78.74 102.85 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 70.0 mt -99.65 139.77 34.82 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.724 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -96.55 118.36 32.89 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 90.4 mt -107.52 164.54 12.12 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 125.283 1.433 . . . . 0.0 109.382 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.645 ' HB3' HG13 ' A' ' 63' ' ' VAL . 19.3 t -142.22 107.77 5.07 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-O 122.387 1.089 . . . . 0.0 110.684 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -85.05 117.75 24.2 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.42 -24.19 0.21 Allowed Glycine 0 CA--C 1.473 -2.558 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.587 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 35.9 m-85 -94.22 133.46 27.27 Favored Pre-proline 0 C--N 1.286 -2.173 0 CA-C-O 121.075 0.464 . . . . 0.0 110.364 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.246 0.914 0 C-N-CA 123.605 2.87 . . . . 0.0 111.969 -177.219 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 36.3 Cg_endo . . . . . 0 N--CA 1.449 -1.111 0 CA-C-O 121.21 0.421 . . . . 0.0 111.896 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -82.58 105.51 13.68 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.617 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.5 t80 -105.18 138.42 41.41 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.126 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -154.51 22.97 0.47 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.217 0.532 . . . . 0.0 111.008 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.456 ' HG2' ' HE1' ' A' ' 4' ' ' PHE . 20.2 mtm180 58.11 -30.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 128.446 2.698 . . . . 0.0 116.431 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.4 t-20 -99.88 113.87 65.36 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 65' ' ' VAL . 5.6 Cg_exo -55.22 -32.68 81.54 Favored 'Trans proline' 0 C--O 1.221 -0.329 0 C-N-CA 123.482 2.788 . . . . 0.0 111.46 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -71.34 -11.97 61.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.285 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.493 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 21.4 mm-40 -105.03 -22.35 13.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.474 0.71 . . . . 0.0 111.344 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.4 mm? -79.67 169.48 17.91 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -177.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.87 -170.42 2.04 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.834 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.11 177.76 52.05 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 13.6 ttpt -110.16 132.18 54.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.5 m-85 -99.09 110.79 23.32 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 123.161 1.458 . . . . 0.0 110.8 -174.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.428 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 30.5 mt -107.09 151.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.835 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.28 -174.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.43 121.49 25.99 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.352 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 t -138.51 138.91 38.48 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.58 0.705 . . . . 0.0 110.151 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.784 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 28.6 ttmt -93.8 125.04 38.2 Favored 'General case' 0 C--N 1.259 -3.346 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -105.7 117.05 33.03 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 37.8 ttt180 -76.7 108.56 9.8 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.909 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.671 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 73.6 tttt -65.05 97.14 0.22 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 89' ' ' ILE . 21.5 t -87.61 -154.83 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -54.4 -41.54 69.39 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.154 0.581 . . . . 0.0 110.767 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -87.15 -20.47 26.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.805 0.812 . . . . 0.0 109.77 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 99.28 -116.33 5.55 Favored Glycine 1 N--CA 1.386 -4.695 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HD1' HD12 ' A' ' 20' ' ' LEU . 31.0 m-85 -93.9 146.79 23.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.14 0.34 66.4 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.642 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.487 ' HB2' HG23 ' A' ' 43' ' ' ILE . 10.0 p90 -111.24 163.14 14.25 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.546 0.689 . . . . 0.0 111.606 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.6 p -116.85 156.4 27.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.583 HG11 HD23 ' A' ' 41' ' ' LEU . 2.6 t -132.35 142.44 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.348 -173.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -152.7 160.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.736 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.91 -1.52 30.19 Favored Glycine 1 CA--C 1.447 -4.189 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 168.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.828 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -116.39 43.98 1.55 Allowed Glycine 1 CA--C 1.408 -6.637 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -170.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.32 -12.41 29.56 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 113.009 -1.595 . . . . 0.0 112.17 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 6.6 pt-20 -165.45 167.25 9.52 Favored Pre-proline 0 CA--C 1.46 -2.512 0 C-N-CA 117.203 -1.799 . . . . 0.0 110.888 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -67.32 57.52 0.64 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 122.463 2.108 . . . . 0.0 110.165 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 26.8 t70 -179.67 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.478 1.911 . . . . 0.0 109.625 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.736 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 26.7 mt-10 -113.47 124.58 52.75 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-O 117.009 -1.472 . . . . 0.0 107.274 171.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.305 6.5 m-30 -79.35 155.38 28.46 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 128.288 3.492 . . . . 0.0 111.733 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.925 HD21 HG21 ' A' ' 80' ' ' VAL . 6.6 mp -87.1 143.34 27.36 Favored 'General case' 0 C--O 1.175 -2.867 0 C-N-CA 116.582 -2.047 . . . . 0.0 108.901 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.5 mt-30 -138.42 157.54 46.01 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 29' ' ' PHE . 25.3 mm -75.48 109.91 9.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.2 tttp -56.8 -37.71 71.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 125.183 1.552 . . . . 0.0 107.07 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.601 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.0 t 159.36 173.13 0.01 OUTLIER 'General case' 0 C--N 1.364 1.239 0 O-C-N 125.769 1.918 . . . . 0.0 109.231 172.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pp -136.74 149.37 47.81 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.44 118.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.263 1.2 pt? -69.59 -5.06 22.01 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -94.64 -3.48 49.44 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.354 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.62 161.78 27.47 Favored Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 8.6 Cg_endo -51.2 -29.9 30.86 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 124.952 3.768 . . . . 0.0 113.38 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.07 -46.71 84.98 Favored 'General case' 0 C--O 1.275 2.41 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.694 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.07 -32.38 56.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.532 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 9.1 mp -68.69 -45.2 72.28 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.996 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.9 -26.93 67.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.12 16.7 79.54 Favored Glycine 0 CA--C 1.487 -1.711 0 CA-C-N 112.933 -1.939 . . . . 0.0 113.842 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -109.53 -24.48 10.96 Favored 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 122.278 0.231 . . . . 0.0 111.573 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.43 140.53 31.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.025 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 41.4 tt0 -149.38 146.89 27.72 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.986 0.898 . . . . 0.0 111.69 -172.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 45' ' ' SER . 5.3 p -49.61 103.52 0.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 126.313 1.845 . . . . 0.0 112.416 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.9 -2.52 31.78 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-O 119.375 -0.68 . . . . 0.0 113.049 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.24 146.95 48.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -98.59 121.22 48.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.503 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 29.7 mm -69.88 123.96 24.81 Favored 'Isoleucine or valine' 0 C--O 1.305 3.975 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 73' ' ' LEU . 43.7 t -115.19 -38.66 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 111.662 -2.517 . . . . 0.0 110.272 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.562 ' HA ' HG22 ' A' ' 72' ' ' VAL . 40.0 m -145.11 142.97 30.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.885 -178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 72' ' ' VAL . 7.1 p -119.57 131.82 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 m120 63.8 23.82 13.56 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.873 0.844 . . . . 0.0 108.958 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.37 -0.66 2.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.408 1.883 . . . . 0.0 112.079 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 72' ' ' VAL . 76.8 m -78.86 119.81 22.58 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.67 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.411 -2.397 0 O-C-N 124.777 1.298 . . . . 0.0 110.29 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.571 HG21 HG12 ' A' ' 67' ' ' VAL . 35.6 m -115.87 26.55 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.535 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.617 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.5 tp -59.71 113.79 2.43 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.26 41.48 0.22 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 125.344 1.653 . . . . 0.0 112.177 -170.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.523 ' O ' HG23 ' A' ' 76' ' ' THR . 14.5 t60 -45.72 -66.73 0.36 Allowed 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.1 p -167.14 143.5 4.38 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 149.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -50.16 -38.61 40.33 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 119.342 0.974 . . . . 0.0 110.658 174.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.53 95.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.082 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.471 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 68.3 mm-40 -66.37 -43.2 86.6 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.925 HG21 HD21 ' A' ' 41' ' ' LEU . 33.4 m -66.81 -40.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.502 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.94 -39.27 85.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.674 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.92 -40.02 79.4 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.706 176.383 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.674 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 57.9 mt -66.75 -36.78 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.713 0.768 . . . . 0.0 110.802 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -71.49 -30.29 65.8 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.421 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.99 -26.32 59.48 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.487 1.115 . . . . 0.0 110.27 174.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 52.4 m -72.39 -49.29 34.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.995 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.447 HG22 ' HD3' ' A' ' 22' ' ' LYS . 44.3 mt -62.98 134.83 95.92 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.789 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 14.3 Cg_endo -90.51 161.84 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.482 2.788 . . . . 0.0 113.302 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.532 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.4 mm -65.37 132.35 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 121.452 0.644 . . . . 0.0 110.379 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.06 54.13 Favored Glycine 0 C--N 1.288 -2.092 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.793 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -98.66 -170.43 1.94 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -175.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 13.3 m -151.14 158.93 44.62 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.21 126.68 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.772 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.63 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.538 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 15.1 m-20 -78.79 104.14 9.21 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.7 mt -102.42 136.96 41.31 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 124.624 1.169 . . . . 0.0 109.884 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 37.6 tt0 -101.02 121.06 41.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 6.0 mt -107.54 165.04 11.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.048 1.339 . . . . 0.0 108.764 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.584 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 21.1 t -137.97 105.23 5.48 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.103 0.954 . . . . 0.0 110.634 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 59' ' ' GLU . 76.5 mtm180 -96.46 119.98 35.93 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 121.229 -0.92 . . . . 0.0 110.506 174.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.26 -33.95 0.15 Allowed Glycine 0 CA--C 1.474 -2.517 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.62 133.4 23.62 Favored Pre-proline 0 N--CA 1.424 -1.744 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 122.929 2.419 . . . . 0.0 111.395 -178.27 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 52.1 Cg_endo . . . . . 0 CA--C 1.545 1.063 0 CA-C-O 121.359 0.483 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -81.61 103.71 11.52 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.602 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -113.7 118.43 34.31 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.385 -176.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -134.7 17.67 3.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.86 0.838 . . . . 0.0 110.267 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.456 ' HA ' HD23 ' A' ' 73' ' ' LEU . 1.7 mtp180 59.59 -20.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.018 2.127 . . . . 0.0 115.762 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.551 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 3.3 t-20 -99.84 112.32 63.58 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-O 121.227 0.537 . . . . 0.0 111.086 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.8 Cg_endo -50.89 -37.1 54.98 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.989 3.126 . . . . 0.0 111.846 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -68.04 -20.31 64.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.763 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 8.3 mm-40 -95.14 -23.54 17.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.573 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 73' ' ' LEU . 19.7 mt -76.3 179.45 5.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.061 0.934 . . . . 0.0 110.421 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -107.65 -177.02 3.23 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.55 166.21 27.41 Favored Glycine 0 C--N 1.283 -2.405 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.074 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 29.2 tttp -93.03 138.96 31.02 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.0 m-85 -113.44 111.57 22.17 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.94 1.352 . . . . 0.0 110.835 -175.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.468 HG12 ' CE ' ' A' ' 14' ' ' LYS . 5.9 mt -109.36 151.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 CA-C-N 112.235 -2.257 . . . . 0.0 108.114 -173.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.515 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 2.8 t60 -130.71 119.77 22.86 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 3.6 t -139.18 129.35 25.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.975 0.893 . . . . 0.0 111.056 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.809 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 36.5 ttpt -90.66 123.65 34.45 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.192 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.479 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.18 119.57 39.74 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.477 -173.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.0 ttm180 -77.43 111.03 12.7 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.863 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.68 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.0 tttt -69.26 97.23 0.92 Allowed 'General case' 0 C--O 1.177 -2.742 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 89' ' ' ILE . 29.4 t -82.05 -155.81 0.15 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -67.45 -31.06 70.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.588 0.709 . . . . 0.0 109.092 174.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.16 -13.33 57.35 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.798 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.68 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 81.29 -125.63 6.98 Favored Glycine 1 N--CA 1.389 -4.485 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 30.3 m-85 -88.52 142.7 27.49 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.699 0.75 . . . . 0.0 110.176 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.81 82.85 Favored Glycine 0 C--N 1.315 -0.61 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.923 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.2 p90 -110.66 162.72 14.46 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.244 0.545 . . . . 0.0 110.341 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 47.3 p -116.76 150.82 37.64 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.67 135.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.863 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.541 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 9.9 p -151.94 165.75 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.954 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 113.15 -0.47 25.39 Favored Glycine 0 CA--C 1.471 -2.687 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 172.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.756 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -120.54 44.55 1.35 Allowed Glycine 1 CA--C 1.395 -7.417 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -171.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 7.8 m-20 -59.09 -13.33 6.63 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.606 -1.797 . . . . 0.0 113.04 -174.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 4.2 pt-20 -160.04 166.42 15.89 Favored Pre-proline 0 CA--C 1.455 -2.703 0 C-N-CA 117.177 -1.809 . . . . 0.0 110.631 -174.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 36.8 Cg_endo -67.61 51.62 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.818 2.345 . . . . 0.0 110.585 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 7.7 t70 -179.39 -12.88 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.674 1.19 . . . . 0.0 110.037 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.64 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 30.5 mt-10 -116.48 127.35 54.49 Favored 'General case' 0 C--O 1.276 2.465 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 167.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 73' ' ' LEU . 11.6 m-85 -80.36 155.31 27.24 Favored 'General case' 0 N--CA 1.524 3.254 0 O-C-N 127.942 3.276 . . . . 0.0 111.898 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.756 HD12 ' HA3' ' A' ' 34' ' ' GLY . 4.3 mp -84.33 145.72 28.1 Favored 'General case' 0 C--O 1.177 -2.755 0 C-N-CA 117.391 -1.724 . . . . 0.0 107.929 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.7 mt-30 -142.37 149.25 39.14 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 29' ' ' PHE . 33.1 mm -71.35 112.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 18.5 tptm -65.87 -35.03 79.52 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.516 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.5 t 160.69 172.97 0.01 OUTLIER 'General case' 0 C--N 1.357 0.926 0 O-C-N 125.271 1.607 . . . . 0.0 110.297 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.494 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.6 pp -138.55 148.53 44.32 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.541 0.686 . . . . 0.0 111.705 -173.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.9 119.06 28.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 53' ' ' ALA 0.26 1.1 pt? -69.44 -4.4 18.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.04 -27.13 48.72 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.196 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.437 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.08 171.11 36.82 Favored Glycine 0 N--CA 1.417 -2.62 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.754 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 8.8 Cg_endo -52.54 -32.23 52.55 Favored 'Trans proline' 0 C--O 1.204 -1.179 1 C-N-CA 125.328 4.018 . . . . 0.0 113.871 -173.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.76 -48.65 79.04 Favored 'General case' 0 C--O 1.273 2.333 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.65 -32.94 53.57 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.997 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 6.0 mp -68.21 -40.59 82.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' OD2' ' HD2' ' A' ' 57' ' ' LYS . 33.2 t70 -68.52 -30.02 68.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.75 6.56 87.09 Favored Glycine 0 CA--C 1.493 -1.294 0 CA-C-N 112.423 -2.171 . . . . 0.0 114.113 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 54.0 mttm -98.17 -25.2 14.98 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.6 ttm -96.24 140.63 30.65 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.259 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.54 153.0 50.29 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.771 0.795 . . . . 0.0 110.18 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 45' ' ' SER . 81.6 p -67.03 114.66 5.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.918 1.287 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.26 -20.87 15.88 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 121.961 -0.462 . . . . 0.0 112.41 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 9.2 m-20 -60.45 136.42 58.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -87.32 125.7 41.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.345 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 17.5 mm -73.74 125.15 32.4 Favored 'Isoleucine or valine' 1 C--O 1.307 4.105 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 8' ' ' PRO . 48.4 t -114.42 -34.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.481 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 68.6 m -150.55 153.36 35.64 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.154 -0.966 . . . . 0.0 112.231 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG11 HG21 ' A' ' 83' ' ' ILE . 7.3 p -131.03 127.31 60.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m120 63.25 20.14 12.09 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.647 0.203 . . . . 0.0 110.544 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 79.07 -1.02 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.95 1.7 . . . . 0.0 111.965 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.3 m -85.83 123.17 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.452 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 28.2 t -62.71 109.42 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.782 HG22 HG12 ' A' ' 80' ' ' VAL . 3.6 p -120.54 18.16 6.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.569 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.602 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.7 tp -59.59 113.41 2.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.93 43.71 0.14 Allowed Glycine 0 C--N 1.37 2.471 0 O-C-N 125.355 1.659 . . . . 0.0 112.174 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.519 ' CD2' HG23 ' A' ' 72' ' ' VAL . 3.9 t60 -45.11 -65.94 0.47 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 75' ' ' HIS . 12.8 p -165.79 142.42 5.32 Favored 'General case' 0 C--N 1.264 -3.132 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 152.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -50.69 -31.52 16.67 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 120.119 1.327 . . . . 0.0 111.351 171.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.19 85.61 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 122.156 -0.34 . . . . 0.0 110.8 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 47.7 mm-40 -64.16 -40.99 97.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.782 HG12 HG22 ' A' ' 72' ' ' VAL . 12.6 m -63.44 -45.65 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.825 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.4 t -65.55 -40.07 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.4 -39.18 89.75 Favored 'General case' 0 C--O 1.199 -1.6 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.76 177.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.635 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.3 mm -67.0 -34.63 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.652 0.739 . . . . 0.0 112.026 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -75.1 -29.39 60.58 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.446 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -76.59 -19.91 57.35 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.105 0.962 . . . . 0.0 111.105 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 75.1 m -75.25 -37.72 60.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.018 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.5 mt -78.65 135.58 60.06 Favored Pre-proline 0 N--CA 1.421 -1.923 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.057 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.5 Cg_endo -90.9 161.94 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.455 2.77 . . . . 0.0 112.926 -173.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.538 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 20.8 mm -63.45 132.51 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 121.519 0.676 . . . . 0.0 111.452 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.12 53.21 Favored Glycine 0 C--N 1.294 -1.782 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.918 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.35 -170.27 1.84 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 122.484 0.314 . . . . 0.0 110.242 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 11.1 m -151.22 157.78 43.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.809 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -145.22 125.07 6.51 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.965 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.515 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 11.3 m-20 -77.52 104.18 7.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.77 142.22 33.43 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 124.607 1.163 . . . . 0.0 110.579 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -101.84 125.72 48.57 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 84.8 mt -115.36 152.9 31.98 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.331 1.452 . . . . 0.0 110.957 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.66 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 6.5 t -125.78 107.81 10.88 Favored 'General case' 0 C--O 1.188 -2.168 0 C-N-CA 124.202 1.001 . . . . 0.0 110.016 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.462 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 35.3 ttm180 -93.37 118.95 31.92 Favored 'General case' 0 C--N 1.254 -3.569 0 O-C-N 120.341 -1.474 . . . . 0.0 109.045 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.54 -30.49 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.04 133.0 25.84 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 C--O 1.244 0.799 0 C-N-CA 123.35 2.7 . . . . 0.0 111.63 -178.704 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 CA-C-O 121.372 0.488 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -98.28 105.88 18.08 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.603 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.9 t80 -95.79 139.79 31.51 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.748 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -148.82 14.61 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.297 0.57 . . . . 0.0 111.416 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.524 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.2 mtm180 55.11 -0.1 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.848 2.059 . . . . 0.0 115.934 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -134.13 123.49 16.84 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.526 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.3 Cg_endo -60.0 -22.7 70.23 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.845 3.03 . . . . 0.0 112.83 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -77.95 -29.8 50.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -87.2 -30.18 21.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.534 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 45.4 tp -81.06 160.4 24.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.684 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 49.5 mtmt -102.84 -179.26 3.91 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.625 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 105.27 168.52 23.9 Favored Glycine 0 C--N 1.281 -2.481 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -175.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -90.57 119.79 31.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 99.2 m-85 -98.5 114.62 27.09 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-O 121.92 0.867 . . . . 0.0 109.849 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.44 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 62.0 mt -117.73 136.01 56.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 CA-C-N 113.87 -1.513 . . . . 0.0 110.284 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.9 t-80 -105.95 113.99 27.86 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.261 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 t -139.96 133.5 30.21 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-O 122.073 0.94 . . . . 0.0 111.65 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.767 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -88.03 127.25 35.39 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.151 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -107.91 118.57 37.09 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 43.0 ttp180 -78.47 107.75 11.35 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.4 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.724 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 72.0 tttt -63.86 97.32 0.16 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 168.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -85.06 -155.41 0.21 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.86 -39.86 90.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -84.96 -13.35 50.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.33 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.724 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 91.2 -121.96 6.53 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.507 ' HD1' HD12 ' A' ' 20' ' ' LEU . 39.7 m-85 -93.39 145.04 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.655 0.727 . . . . 0.0 109.85 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.66 -0.18 72.87 Favored Glycine 0 C--O 1.214 -1.131 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.861 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.548 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.7 p90 -108.28 163.52 13.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.391 0.615 . . . . 0.0 110.646 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.476 ' OG1' ' HE2' ' A' ' 44' ' ' LYS . 46.5 p -121.46 151.02 40.7 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.63 141.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.976 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 33' ' ' GLY . 11.5 p -149.75 167.0 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.474 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 127.19 -64.45 0.59 Allowed Glycine 0 CA--C 1.474 -2.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.402 173.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -71.53 60.52 1.2 Allowed Glycine 1 CA--C 1.41 -6.474 0 C-N-CA 126.951 2.215 . . . . 0.0 116.236 -169.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -22.0 66.55 Favored 'General case' 0 C--N 1.245 -3.97 0 O-C-N 124.669 0.864 . . . . 0.0 109.739 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.455 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 10.0 pt-20 -154.27 165.33 18.22 Favored Pre-proline 0 CA--C 1.456 -2.649 0 C-N-CA 116.1 -2.24 . . . . 0.0 111.21 -171.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -68.1 55.65 0.76 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.829 2.352 . . . . 0.0 109.796 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -178.05 -20.71 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.703 -1.589 . . . . 0.0 109.886 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.746 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 13.4 mm-40 -114.79 128.46 56.31 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.477 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.25 7.5 m-30 -79.41 157.23 27.62 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 128.78 3.8 . . . . 0.0 111.773 -179.185 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -88.63 149.51 23.5 Favored 'General case' 0 C--O 1.189 -2.081 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 9.7 mt-30 -145.31 153.32 41.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 29' ' ' PHE . 21.0 mm -69.91 110.51 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HE2' ' OG1' ' A' ' 30' ' ' THR . 3.8 tmmm? -65.01 -33.88 77.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.562 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.1 t 162.03 172.64 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 O-C-N 124.975 1.422 . . . . 0.0 109.775 173.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -136.24 144.55 44.9 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 121.785 0.802 . . . . 0.0 109.947 -174.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 49' ' ' ASP . 11.0 t -78.38 126.3 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mp -68.92 -4.2 15.65 Favored 'General case' 1 N--CA 1.377 -4.112 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.307 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.506 ' H ' HG12 ' A' ' 47' ' ' VAL . 20.5 t70 -97.55 -21.4 17.11 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.595 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.19 167.73 34.59 Favored Glycine 0 N--CA 1.404 -3.447 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.494 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.6 Cg_endo -53.65 -31.23 59.27 Favored 'Trans proline' 0 C--O 1.187 -2.046 0 C-N-CA 124.731 3.62 . . . . 0.0 113.037 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.66 76.37 Favored 'General case' 0 C--O 1.264 1.85 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.12 -34.32 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.098 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.23 -38.22 69.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.352 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -73.07 -18.24 61.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 122.273 1.035 . . . . 0.0 108.504 175.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.01 32.59 82.7 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 113.251 -1.795 . . . . 0.0 113.836 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 36.4 mtmt -124.25 -0.72 8.25 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.646 ' HB3' HD22 ' A' ' 46' ' ' LEU . 28.1 mtt -112.71 141.87 45.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.847 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -135.9 149.89 49.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 45' ' ' SER . 32.5 p -63.17 114.64 3.88 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.763 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.82 -14.34 19.7 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.475 176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.1 m-20 -61.73 132.33 52.82 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -81.8 129.47 37.44 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.686 0 CA-C-N 118.607 0.64 . . . . 0.0 112.32 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 38.5 mm -79.53 127.58 39.07 Favored 'Isoleucine or valine' 1 C--O 1.322 4.918 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 173.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 73' ' ' LEU . 40.2 t -115.86 -47.44 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 O-C-N 127.085 2.741 . . . . 0.0 111.873 -176.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' A' ' 72' ' ' VAL . 50.1 m -140.88 165.17 28.26 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 117.995 -1.482 . . . . 0.0 113.767 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.668 HG23 HG11 ' A' ' 72' ' ' VAL . 40.0 t -138.07 120.66 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 C-N-CA 124.855 1.262 . . . . 0.0 108.175 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.9 m120 67.21 -79.34 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.468 1.105 . . . . 0.0 110.154 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -158.15 24.88 0.25 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.336 1.065 . . . . 0.0 109.655 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.8 m -117.19 123.84 47.65 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 t -68.07 108.01 2.94 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 80' ' ' VAL . 1.7 p -111.99 16.82 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 122.13 0.967 . . . . 0.0 108.606 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.603 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.7 tp -60.89 112.84 2.21 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.23 45.51 0.13 Allowed Glycine 0 C--N 1.378 2.874 0 O-C-N 125.754 1.909 . . . . 0.0 111.664 -170.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 76' ' ' THR . 2.5 t60 -48.41 -66.98 0.31 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' HIS . 8.6 p -166.62 142.64 4.6 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 151.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.594 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.5 -31.61 15.92 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 120.288 1.404 . . . . 0.0 111.516 173.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -48.31 82.24 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 122.116 -0.365 . . . . 0.0 110.723 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 11.9 mm-40 -61.81 -44.08 97.57 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 122.938 0.495 . . . . 0.0 112.091 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.701 HG21 HD21 ' A' ' 41' ' ' LEU . 9.7 m -64.26 -44.31 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.63 -42.77 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -67.07 -29.15 68.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.383 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 86' ' ' SER . 2.1 mm -68.94 -40.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 123.117 0.567 . . . . 0.0 111.748 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.33 -33.96 67.71 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -73.27 -19.49 61.05 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.368 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 30.1 t -77.44 -43.17 33.4 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 mt -69.06 133.79 89.77 Favored Pre-proline 0 N--CA 1.423 -1.81 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.767 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.8 Cg_endo -89.56 161.84 5.34 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.163 2.576 . . . . 0.0 113.197 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.6 mm -60.83 132.49 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.833 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 12.19 55.96 Favored Glycine 0 C--N 1.288 -2.123 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.834 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.418 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.73 -172.13 2.1 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 19.8 m -151.17 156.87 41.86 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.77 -0.581 . . . . 0.0 109.614 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -143.43 125.49 11.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.672 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.597 -175.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.535 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 17.3 m-20 -78.42 108.26 11.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 67' ' ' VAL . 72.6 mt -108.45 136.03 48.75 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.443 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -91.58 124.65 35.91 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 10.7 mt -107.56 160.06 15.96 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.625 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 14.7 t -131.65 108.0 9.2 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 123.726 0.81 . . . . 0.0 108.993 174.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -96.89 147.12 24.29 Favored 'General case' 0 C--N 1.247 -3.853 0 O-C-N 120.706 -1.246 . . . . 0.0 109.904 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.04 -17.49 4.58 Favored Glycine 0 CA--C 1.482 -1.988 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.91 130.51 28.63 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 C--O 1.243 0.745 0 C-N-CA 123.551 2.834 . . . . 0.0 112.546 -174.032 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 CA--C 1.545 1.039 0 CA-C-O 121.071 0.363 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -73.79 104.25 4.62 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.585 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.4 t80 -105.46 128.61 53.64 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.277 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -144.24 20.35 1.74 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.105 0.955 . . . . 0.0 109.835 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.484 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 15.2 mtm180 57.48 -14.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 127.479 2.312 . . . . 0.0 116.374 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.8 t-20 -112.59 117.03 47.55 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.728 -0.607 . . . . 0.0 110.97 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 6.9 Cg_endo -53.22 -25.51 30.36 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.232 3.288 . . . . 0.0 113.37 174.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -71.61 -27.43 63.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -91.17 -21.24 21.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.512 HD11 HD21 ' A' ' 73' ' ' LEU . 24.5 mt -78.04 175.66 9.89 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.858 0.837 . . . . 0.0 110.641 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -105.11 -167.59 1.36 Allowed 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.72 175.01 45.76 Favored Glycine 0 C--N 1.284 -2.334 0 C-N-CA 119.315 -1.422 . . . . 0.0 112.155 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 4.0 tmmm? -113.62 148.56 36.03 Favored 'General case' 0 C--O 1.194 -1.849 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.2 m-85 -123.6 117.76 25.78 Favored 'General case' 0 CA--C 1.463 -2.387 0 CA-C-O 121.784 0.802 . . . . 0.0 110.807 -165.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.49 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 2.2 mp -111.75 138.1 41.8 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.786 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -102.67 118.67 37.36 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 7.9 t -129.26 157.93 40.49 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.345 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.795 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -129.46 122.05 28.53 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.527 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.69 117.42 34.05 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.085 -176.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 19.2 tpp85 -72.38 106.69 4.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.6 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.72 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 67.9 tttt -66.79 96.97 0.44 Allowed 'General case' 0 C--O 1.171 -3.026 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 166.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 89' ' ' ILE . 21.4 t -85.01 -155.43 0.21 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -56.53 -41.03 76.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.931 0.332 . . . . 0.0 111.371 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -86.09 -20.65 28.42 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.795 0.807 . . . . 0.0 109.82 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.72 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 103.52 -122.35 7.41 Favored Glycine 1 N--CA 1.388 -4.556 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.527 ' HD1' HD12 ' A' ' 20' ' ' LEU . 46.0 m-85 -88.09 142.57 27.67 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 117.214 0.507 . . . . 0.0 110.328 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.47 9.34 74.23 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.139 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.472 ' HB2' HG23 ' A' ' 43' ' ' ILE . 6.3 p90 -122.11 162.98 20.28 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.04 0.447 . . . . 0.0 109.939 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.4 p -116.85 155.19 29.44 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 41' ' ' LEU . 6.1 t -134.48 140.21 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.103 -175.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.8 p -153.15 157.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.03 171.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 116.3 0.11 20.62 Favored Glycine 1 CA--C 1.441 -4.537 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 169.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.831 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -120.73 46.01 1.17 Allowed Glycine 1 CA--C 1.395 -7.438 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.57 -25.3 64.45 Favored 'General case' 0 C--N 1.264 -3.127 0 CA-C-N 113.228 -1.486 . . . . 0.0 111.498 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt-20 -155.98 167.61 13.95 Favored Pre-proline 0 CA--C 1.463 -2.388 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.843 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -65.28 55.31 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.933 2.422 . . . . 0.0 111.084 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 14.8 t70 178.37 -12.91 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 -175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.713 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 62.7 mt-10 -117.83 123.94 47.15 Favored 'General case' 0 C--O 1.265 1.904 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.301 7.2 m-30 -79.22 156.12 28.29 Favored 'General case' 1 N--CA 1.554 4.755 0 O-C-N 127.687 3.117 . . . . 0.0 112.329 -175.233 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.831 HD12 ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -86.88 142.46 28.02 Favored 'General case' 0 CA--C 1.46 -2.498 0 C-N-CA 115.948 -2.301 . . . . 0.0 107.748 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.2 mt-30 -139.88 151.2 45.45 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.487 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 21.5 mm -70.82 112.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.623 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 40.2 ttmt -59.66 -41.69 91.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.591 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.4 t 163.56 173.6 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 O-C-N 125.224 1.577 . . . . 0.0 109.801 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.68 152.38 45.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.95 0.881 . . . . 0.0 113.297 -172.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 49' ' ' ASP . 21.1 t -87.58 129.55 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.028 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.26 -4.2 16.9 Favored 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 112.509 -2.132 . . . . 0.0 112.325 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.576 ' H ' HG12 ' A' ' 47' ' ' VAL . 10.3 t70 -99.32 -20.11 16.7 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.097 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.3 155.9 26.57 Favored Glycine 1 N--CA 1.393 -4.182 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.72 -171.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 11.6 Cg_endo -52.29 -26.66 27.92 Favored 'Trans proline' 0 C--O 1.198 -1.485 0 C-N-CA 125.009 3.806 . . . . 0.0 113.156 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.08 -46.72 85.0 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.114 0.483 . . . . 0.0 111.728 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.17 -36.65 54.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.404 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 8.3 mp -71.56 -36.93 71.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.052 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.51 -15.51 60.39 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.26 41.07 99.73 Favored Glycine 0 CA--C 1.49 -1.507 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.913 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -129.05 -23.88 2.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.281 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.428 ' SD ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -94.95 142.17 27.8 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.172 177.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.01 151.49 52.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -59.0 114.7 2.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.007 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 112.69 -11.83 25.38 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.238 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 9.7 m-20 -59.94 132.85 55.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 117.645 0.723 . . . . 0.0 109.56 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -86.94 119.3 34.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.2 mm -70.9 123.02 24.06 Favored 'Isoleucine or valine' 1 C--O 1.316 4.56 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 73' ' ' LEU . 40.0 t -114.42 -33.83 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-N 111.36 -2.654 . . . . 0.0 110.258 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -150.0 162.05 41.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.52 HG12 ' HB ' ' A' ' 72' ' ' VAL . 6.6 p -145.31 133.43 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 56.56 31.51 19.19 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.915 0.325 . . . . 0.0 111.828 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.66 15.9 10.25 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.592 1.157 . . . . 0.0 112.861 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -108.38 129.71 55.24 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.47 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 20.3 t -68.72 112.72 5.63 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.736 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -117.64 17.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.62 -175.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.585 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 32.1 tp -58.89 113.3 2.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 45.12 0.18 Allowed Glycine 0 N--CA 1.499 2.879 0 O-C-N 125.381 1.676 . . . . 0.0 111.801 -171.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.541 ' CD2' HG23 ' A' ' 72' ' ' VAL . 3.9 t60 -47.78 -66.48 0.4 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.3 p -167.1 143.19 4.31 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 151.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.578 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.33 -31.77 15.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 119.987 1.267 . . . . 0.0 110.536 171.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.22 77.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.941 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 71.0 mm-40 -64.67 -40.42 95.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.805 HG21 HD21 ' A' ' 41' ' ' LEU . 13.5 m -65.56 -45.7 91.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.053 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 77' ' ' HIS . 88.0 t -65.69 -37.46 80.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.2 tmtm? -58.26 -45.61 87.5 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.627 175.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.678 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.05 -36.8 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.386 0.613 . . . . 0.0 112.387 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -74.73 -31.36 61.81 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -69.31 -32.12 71.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.163 0.985 . . . . 0.0 110.768 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.2 m -69.58 -37.99 77.17 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.851 1.26 . . . . 0.0 110.122 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.48 HG22 ' HD3' ' A' ' 22' ' ' LYS . 21.8 mt -77.63 133.12 67.26 Favored Pre-proline 0 N--CA 1.411 -2.417 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.182 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.1 Cg_endo -88.66 162.73 6.4 Favored 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 123.611 2.874 . . . . 0.0 112.864 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.531 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.92 135.0 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 121.212 0.529 . . . . 0.0 110.534 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.08 58.83 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.57 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.607 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -100.94 179.61 4.34 Favored 'General case' 0 C--O 1.187 -2.184 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.495 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 6.2 m -140.66 163.71 32.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -150.39 125.52 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.337 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' THR . 4.3 m-20 -82.72 106.46 14.58 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.047 0.927 . . . . 0.0 109.548 174.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.4 mt -108.29 159.06 16.93 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 126.52 1.928 . . . . 0.0 108.852 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -116.89 123.64 47.5 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 81.2 mt -106.87 160.86 15.19 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.825 1.25 . . . . 0.0 109.793 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.634 ' HB3' HG13 ' A' ' 63' ' ' VAL . 16.0 t -135.36 111.0 9.23 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.422 1.106 . . . . 0.0 110.796 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.496 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 19.4 tpp85 -89.99 112.99 24.57 Favored 'General case' 0 C--N 1.266 -3.063 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.4 -26.57 0.31 Allowed Glycine 0 C--N 1.292 -1.879 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.912 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.61 129.69 35.68 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.665 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo . . . . . 0 C--O 1.241 0.632 0 C-N-CA 123.927 3.085 . . . . 0.0 113.785 -173.919 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 39' ' ' GLU . 6.0 Cg_endo . . . . . 0 N--CA 1.439 -1.734 0 CA-C-O 121.005 0.336 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.34 105.12 2.44 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.554 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 5.1 t80 -107.56 135.36 49.14 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -144.17 17.98 1.74 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.111 0.958 . . . . 0.0 110.316 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.501 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 21.4 mtt180 59.4 -27.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.408 2.683 . . . . 0.0 116.57 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 50.3 t-20 -104.65 123.38 40.42 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.2 Cg_exo -54.84 -29.73 64.62 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 C-N-CA 123.737 2.958 . . . . 0.0 112.246 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.75 -26.17 63.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -92.2 -24.32 19.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -86.65 153.74 21.53 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.497 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.508 ' N ' HD13 ' A' ' 11' ' ' LEU . 46.6 mtmt -110.2 133.47 53.2 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 122.066 0.936 . . . . 0.0 110.697 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.515 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 156.83 170.6 22.02 Favored Glycine 1 C--N 1.247 -4.378 0 CA-C-N 113.048 -1.887 . . . . 0.0 108.999 -173.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 37.9 tptt -89.54 117.55 28.52 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.877 0.838 . . . . 0.0 109.825 174.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.3 m-85 -101.98 113.98 27.69 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.93 0.872 . . . . 0.0 109.77 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.6 mt -118.74 131.22 72.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.638 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -107.67 108.29 19.47 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -174.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -133.77 145.62 49.97 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 122.09 0.947 . . . . 0.0 111.271 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -87.96 130.84 34.82 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.149 177.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -109.66 117.38 33.77 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 40.8 ttt180 -77.12 111.94 13.25 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.087 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.668 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.6 tttt -66.96 96.83 0.45 Allowed 'General case' 0 C--O 1.187 -2.235 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -94.62 -154.26 0.41 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 124.322 1.049 . . . . 0.0 109.107 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -47.84 -41.97 25.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.894 1.278 . . . . 0.0 111.716 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.688 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.5 mmp_? -105.53 10.41 33.14 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.827 -0.546 . . . . 0.0 111.717 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.668 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 82.34 -125.3 6.88 Favored Glycine 1 N--CA 1.384 -4.769 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.0 m-85 -86.02 145.98 26.85 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.765 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.83 -2.93 86.2 Favored Glycine 0 CA--C 1.499 -0.945 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.336 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.543 ' HB2' HG23 ' A' ' 43' ' ' ILE . 20.9 p90 -109.93 162.9 14.06 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.893 0.854 . . . . 0.0 111.488 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.2 p -118.43 145.96 44.82 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG21 HD23 ' A' ' 41' ' ' LEU . 7.2 p -134.67 146.81 30.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.896 -173.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -144.38 165.92 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.873 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.371 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 114.29 -141.39 16.96 Favored Glycine 1 N--CA 1.394 -4.152 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 51.83 33.24 35.1 Favored Glycine 0 CA--C 1.471 -2.689 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.12 -27.95 67.75 Favored 'General case' 0 CA--C 1.455 -2.697 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -170.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 6.6 pt-20 -161.64 166.76 14.13 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.431 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 23.2 Cg_endo -66.63 58.88 0.52 Allowed 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.605 2.204 . . . . 0.0 109.353 169.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 21.7 t70 173.44 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.716 1.606 . . . . 0.0 110.661 -171.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 22.6 mt-10 -124.28 127.98 48.46 Favored 'General case' 0 C--O 1.269 2.127 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.447 ' CE1' HD11 ' A' ' 73' ' ' LEU . 8.6 m-30 -77.1 158.49 30.44 Favored 'General case' 0 N--CA 1.518 2.934 0 O-C-N 128.959 3.912 . . . . 0.0 113.258 -167.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 80' ' ' VAL . 7.1 mp -89.2 144.69 25.92 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 172.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.0 mt-30 -143.97 151.76 40.18 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 29' ' ' PHE . 22.2 mm -69.69 112.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.53 -39.18 72.94 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.485 ' HA ' HG22 ' A' ' 60' ' ' THR . 43.0 t 161.23 173.33 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.638 1.836 . . . . 0.0 108.666 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -135.86 148.18 48.53 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-O 121.644 0.735 . . . . 0.0 112.209 -175.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ASP . 43.3 t -83.94 121.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.214 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 6.2 mp -63.44 -3.48 2.1 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.583 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . 12.3 t70 -90.94 -30.7 16.71 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 124.594 1.158 . . . . 0.0 108.889 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -94.64 174.38 33.23 Favored Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 115.354 -168.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -52.35 -34.73 61.86 Favored 'Trans proline' 0 C--O 1.2 -1.389 1 C-N-CA 125.453 4.102 . . . . 0.0 113.815 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -58.03 -48.1 81.1 Favored 'General case' 0 C--O 1.264 1.843 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.78 -37.77 48.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.585 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -69.49 -36.64 76.72 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.198 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.71 -18.52 61.52 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.648 1.213 . . . . 0.0 108.112 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.23 35.23 91.35 Favored Glycine 0 CA--C 1.491 -1.449 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.227 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -115.69 -48.2 2.78 Favored 'General case' 0 N--CA 1.402 -2.867 0 C-N-CA 123.099 0.56 . . . . 0.0 112.479 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.57 151.37 19.38 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -149.68 147.47 28.12 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-O 122.01 0.909 . . . . 0.0 111.673 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 45' ' ' SER . 81.9 p -52.69 105.28 0.11 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.168 1.387 . . . . 0.0 112.346 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.06 -12.89 16.98 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-O 118.629 -1.095 . . . . 0.0 113.187 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.66 143.33 58.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.625 -1.23 . . . . 0.0 107.846 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -90.85 117.42 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 28.0 mm -69.87 125.08 27.27 Favored 'Isoleucine or valine' 1 C--O 1.327 5.163 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 73' ' ' LEU . 46.3 t -115.77 -37.33 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 111.136 -2.756 . . . . 0.0 112.197 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.9 m -149.89 157.28 43.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.381 -1.45 . . . . 0.0 112.617 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.677 HG23 HG11 ' A' ' 72' ' ' VAL . 77.0 t -134.37 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m120 57.89 31.52 20.67 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.808 0.692 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 72.63 1.74 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.621 1.968 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.8 m -89.65 122.2 32.55 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.42 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.2 t -65.5 108.89 2.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.172 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 80' ' ' VAL . 1.4 p -114.68 14.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.605 -175.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.554 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.6 tp -58.67 113.72 2.16 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.04 46.39 0.1 Allowed Glycine 0 C--N 1.378 2.864 0 O-C-N 125.857 1.973 . . . . 0.0 112.228 -170.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.492 ' O ' HG23 ' A' ' 76' ' ' THR . 2.8 t60 -48.03 -67.35 0.28 Allowed 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 75' ' ' HIS . 14.2 p -165.98 143.22 5.4 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 152.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.562 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.4 t-80 -53.43 -31.26 44.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 120.664 1.574 . . . . 0.0 111.463 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.23 90.58 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.99 -0.444 . . . . 0.0 110.516 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.5 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 23.2 mm-40 -64.19 -44.0 93.34 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 41' ' ' LEU . 11.2 m -62.19 -41.81 92.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.242 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.07 -38.83 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -63.05 -33.54 75.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.291 176.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 86' ' ' SER . 32.9 mt -67.63 -42.21 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.491 0.662 . . . . 0.0 111.104 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.56 -30.72 67.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.187 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -71.24 -33.16 69.58 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.18 0.992 . . . . 0.0 110.209 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 31.0 t -65.26 -49.07 70.99 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.139 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 12.0 mt -64.88 133.75 95.84 Favored Pre-proline 0 N--CA 1.426 -1.674 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.537 175.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.0 Cg_endo -90.75 162.33 4.15 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 123.563 2.842 . . . . 0.0 113.119 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.547 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.4 mm -62.66 134.76 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-O 121.058 0.456 . . . . 0.0 110.28 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.74 56.68 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.0 -169.14 1.64 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -176.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.618 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 27.1 m -151.34 163.85 38.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.818 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -148.41 124.71 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.085 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.503 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.66 104.99 13.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 63.2 mt -108.27 152.33 24.75 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 125.28 1.432 . . . . 0.0 111.94 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -104.17 119.48 39.04 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.5 mp -111.37 164.49 12.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.305 1.442 . . . . 0.0 108.559 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.564 ' HB3' HG13 ' A' ' 63' ' ' VAL . 38.9 t -145.23 111.69 5.74 Favored 'General case' 0 C--O 1.191 -1.991 0 CA-C-O 122.352 1.072 . . . . 0.0 112.931 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -99.4 120.06 38.99 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 120.957 -1.089 . . . . 0.0 111.202 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.4 -33.43 0.09 OUTLIER Glycine 0 CA--C 1.471 -2.677 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -96.1 141.83 23.71 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 CA--C 1.503 -1.066 0 C-N-CA 122.834 2.356 . . . . 0.0 110.171 179.292 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.724 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.95 -50.4 10.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.19 0.519 . . . . 0.0 110.495 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.0 mtt -110.15 57.51 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.315 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 152.53 -136.15 5.26 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.282 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? 47.94 71.57 1.55 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.934 1.294 . . . . 0.0 113.422 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.81 -164.49 0.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.606 2.204 . . . . 0.0 109.261 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -83.24 105.45 14.21 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 3.1 t80 -103.03 124.61 48.85 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -130.78 11.18 5.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.926 0.869 . . . . 0.0 111.577 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.604 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 40.2 mtt180 55.21 6.23 0.14 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.774 1.63 . . . . 0.0 114.955 173.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -133.91 121.76 16.05 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HB3' HG11 ' A' ' 65' ' ' VAL . 8.5 Cg_exo -59.27 -27.16 84.26 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 123.611 2.874 . . . . 0.0 112.307 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 m -80.02 -24.4 40.82 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.521 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -94.53 -28.03 15.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 44.2 tp -70.24 155.16 41.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.053 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 24.4 mtmm -90.02 -175.71 4.66 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.571 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 109.02 178.16 21.49 Favored Glycine 0 C--N 1.278 -2.662 0 C-N-CA 119.424 -1.369 . . . . 0.0 112.729 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.7 ' HE2' ' H ' ' A' ' 99' ' ' ARG . 1.6 tmpt? -91.07 134.19 34.71 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 91.8 m-85 -122.84 128.26 50.14 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 119.061 0.846 . . . . 0.0 109.867 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.532 HG13 ' HE3' ' A' ' 14' ' ' LYS . 73.8 mt -137.73 127.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.3 t60 -104.49 104.73 14.63 Favored 'General case' 0 N--CA 1.396 -3.144 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -124.07 143.86 50.2 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.799 0.809 . . . . 0.0 110.853 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.4 ttmp? -88.35 126.38 35.17 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.14 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.572 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -108.18 117.33 33.85 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 42.3 ttt-85 -77.07 113.89 15.28 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.405 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.715 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.9 tttt -69.64 97.52 1.06 Allowed 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 169.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 89' ' ' ILE . 32.2 t -83.59 -155.21 0.17 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.675 1.19 . . . . 0.0 108.514 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -59.4 -40.93 88.21 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.501 0.667 . . . . 0.0 109.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.02 -20.85 34.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.804 0.812 . . . . 0.0 109.521 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.715 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 98.18 -120.53 6.83 Favored Glycine 1 N--CA 1.378 -5.232 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.7 m-85 -91.57 141.72 28.42 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.565 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.21 1.27 87.59 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.107 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.478 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.3 p90 -110.81 163.34 13.88 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.817 0.818 . . . . 0.0 112.161 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 63.0 p -123.2 152.87 40.81 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -127.11 154.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.123 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.83 150.63 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.071 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.75 -138.74 13.89 Favored Glycine 1 N--CA 1.393 -4.175 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.61 28.9 31.03 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.1 -29.39 68.3 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -171.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt-20 -154.49 163.09 25.4 Favored Pre-proline 0 CA--C 1.456 -2.64 0 C-N-CA 118.025 -1.47 . . . . 0.0 109.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.0 Cg_endo -68.3 52.83 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.215 0 C-N-CA 123.076 2.517 . . . . 0.0 109.896 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t70 171.19 3.28 0.0 OUTLIER 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.368 -168.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HG3' ' CG ' ' A' ' 36' ' ' GLU . 25.7 mt-10 -132.88 130.21 39.41 Favored 'General case' 0 C--O 1.275 2.44 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 163.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.606 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.256 5.2 m-30 -76.8 158.8 30.61 Favored 'General case' 0 N--CA 1.525 3.305 0 O-C-N 128.898 3.874 . . . . 0.0 114.008 -167.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 80' ' ' VAL . 4.8 mp -93.09 141.69 28.12 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.21 151.44 47.69 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 29' ' ' PHE . 33.1 mm -68.37 109.93 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 41.4 ttmt -58.36 -38.1 76.57 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.9 t 161.77 173.13 0.01 OUTLIER 'General case' 0 C--N 1.362 1.148 0 O-C-N 125.659 1.849 . . . . 0.0 109.825 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.552 HD22 ' HB1' ' A' ' 52' ' ' ALA . 1.5 pp -141.16 149.2 41.18 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.784 -173.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 49' ' ' ASP . 16.9 t -80.1 127.21 39.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.81 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.72 -3.69 1.66 Allowed 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 127.423 2.289 . . . . 0.0 113.567 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' H ' HG12 ' A' ' 47' ' ' VAL . 18.5 t70 -102.61 -25.56 13.53 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.492 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.425 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -85.69 162.93 36.41 Favored Glycine 0 N--CA 1.399 -3.822 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.908 -171.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.12 -33.51 35.57 Favored 'Trans proline' 0 C--O 1.188 -2.003 0 C-N-CA 125.006 3.804 . . . . 0.0 113.486 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.552 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.82 -48.7 78.98 Favored 'General case' 0 C--O 1.28 2.702 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HB2' HD13 ' A' ' 46' ' ' LEU . . . -77.33 -34.54 55.27 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.389 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -68.7 -42.5 77.67 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.977 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.717 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 34.7 t70 -64.16 -38.73 92.12 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.903 1.335 . . . . 0.0 107.483 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 -15.75 44.4 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 112.522 -2.126 . . . . 0.0 114.098 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.717 ' HB2' ' OD2' ' A' ' 55' ' ' ASP . 45.8 mtmt -79.14 -17.25 55.37 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.6 ttm -106.93 135.07 49.11 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.111 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.26 164.57 27.78 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.34 0.591 . . . . 0.0 109.903 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 45' ' ' SER . 77.7 p -63.08 118.26 7.62 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.354 1.062 . . . . 0.0 110.083 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 104.67 -5.76 44.0 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.125 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.692 ' OD2' ' HB2' ' A' ' 99' ' ' ARG . 3.0 m-20 -63.19 127.27 30.48 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.644 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -77.46 114.93 18.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 175.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 5.0 mm -67.8 122.11 18.33 Favored 'Isoleucine or valine' 1 C--O 1.331 5.369 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 169.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.563 HG13 HD13 ' A' ' 73' ' ' LEU . 61.9 t -114.11 -38.4 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 110.759 -2.928 . . . . 0.0 110.73 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.424 ' HA ' HG12 ' A' ' 72' ' ' VAL . 70.1 m -151.27 160.57 43.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.163 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 83' ' ' ILE . 3.6 p -140.59 127.92 22.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.44 31.98 18.01 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 t70 71.31 1.8 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.179 1.392 . . . . 0.0 111.956 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.2 m -88.84 123.92 33.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.4 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.0 t -67.58 104.76 1.67 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.675 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -113.76 17.14 7.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 40' ' ' PHE . 28.5 tp -59.69 112.95 2.0 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 29.72 45.85 0.09 OUTLIER Glycine 0 N--CA 1.499 2.859 0 O-C-N 125.269 1.606 . . . . 0.0 112.917 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 72' ' ' VAL . 5.0 t60 -47.98 -68.39 0.19 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 79' ' ' GLN . 22.1 p -166.16 143.98 5.48 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 151.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.524 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.61 -31.7 26.02 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 119.948 1.249 . . . . 0.0 110.519 172.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.01 83.12 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 121.971 -0.456 . . . . 0.0 110.72 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HG2' ' OG1' ' A' ' 76' ' ' THR . 55.3 mm-40 -64.91 -43.2 93.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 41' ' ' LEU . 15.8 m -60.16 -43.13 92.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.115 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 71.2 t -64.73 -41.98 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -57.24 -41.93 80.5 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.518 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.665 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 34.1 mt -67.18 -36.15 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 122.038 0.923 . . . . 0.0 111.686 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.87 -25.84 61.24 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.354 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 25.8 mt-30 -76.32 -24.33 54.31 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 109.677 171.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 67.6 m -73.75 -28.61 61.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.957 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.7 mt -92.78 133.84 28.57 Favored Pre-proline 0 N--CA 1.411 -2.407 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.556 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_endo -92.38 162.13 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.844 3.029 . . . . 0.0 113.393 -174.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.0 mm -62.72 131.86 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 CA-C-O 121.302 0.573 . . . . 0.0 111.072 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.64 12.17 51.45 Favored Glycine 0 C--N 1.294 -1.79 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.806 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.05 -171.24 2.01 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 14.8 m -151.27 157.48 42.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.4 125.54 6.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 C-N-CA 118.393 -1.323 . . . . 0.0 112.972 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 11.0 m-20 -78.7 107.38 11.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 71.1 mt -107.75 144.53 34.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.592 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -97.49 115.75 28.39 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 75.0 mt -113.07 123.76 51.02 Favored 'General case' 0 C--O 1.25 1.119 0 C-N-CA 124.82 1.248 . . . . 0.0 110.55 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -101.68 122.11 43.28 Favored 'General case' 0 C--O 1.154 -3.932 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.7 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 43.8 ttp180 -116.97 144.07 44.99 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 120.072 -1.642 . . . . 0.0 110.713 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.42 -19.27 3.4 Favored Glycine 0 C--N 1.287 -2.151 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -90.66 132.47 34.91 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.97 147.19 95.67 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 123.265 2.643 . . . . 0.0 112.396 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 9.8 mt -53.11 127.03 45.77 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.692 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 6.3 Cg_exo -69.56 -42.79 3.29 Favored 'Trans proline' 0 CA--C 1.485 -1.94 0 C-N-CA 123.497 2.798 . . . . 0.0 110.444 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.56 141.04 39.27 Favored 'General case' 0 N--CA 1.39 -3.429 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -127.36 85.82 60.06 Favored Pre-proline 0 N--CA 1.393 -3.275 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.335 -168.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -92.99 -54.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.265 1.977 . . . . 0.0 112.632 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.26 -5.9 59.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.973 0.892 . . . . 0.0 110.078 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 6.5 t70 -97.01 110.68 55.02 Favored Pre-proline 0 CA--C 1.469 -2.144 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.753 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 65.7 Cg_endo -75.31 -38.64 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.554 2.169 . . . . 0.0 111.008 -174.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 17.9 t30 -54.75 -7.62 0.18 Allowed 'General case' 0 C--N 1.264 -3.109 1 C-N-CA 133.146 4.578 . . . . 0.0 114.737 -167.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.3 p -92.79 -29.18 16.13 Favored 'General case' 0 N--CA 1.397 -3.116 0 CA-C-O 121.274 0.559 . . . . 0.0 112.094 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 p -152.41 -164.15 1.89 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.2 -171.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.08 157.02 0.93 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 110.634 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.326 12.2 p 53.35 66.73 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 123.448 1.594 . . . . 0.0 111.725 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.753 ' HA ' ' HB2' ' A' ' 110' ' ' PRO . 2.6 t -120.59 -176.65 3.28 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.38 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.491 ' HB2' HG12 ' A' ' 120' ' ' ILE . 69.7 m -56.38 145.6 26.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.29 1.436 . . . . 0.0 109.06 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.0 9.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 123.02 1.391 . . . . 0.0 110.683 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.18 5.65 35.08 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.049 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 117' ' ' SER . 49.7 mm -119.71 90.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 CA-C-N 112.988 -1.914 . . . . 0.0 106.823 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.0 mt -121.76 133.78 54.92 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.52 141.42 33.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -58.8 -22.04 57.56 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.148 0.979 . . . . 0.0 111.723 177.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.85 135.37 48.81 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 C--O 1.261 1.665 0 C-N-CA 123.774 2.982 . . . . 0.0 112.834 179.568 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.579 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -152.4 23.29 0.62 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.483 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 50.8 ttm -95.38 -46.54 6.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -98.9 -71.25 1.0 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 50.1 68.42 3.46 Favored Pre-proline 0 C--O 1.242 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 112.143 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -96.7 -168.83 0.13 Allowed 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 123.035 2.49 . . . . 0.0 111.25 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -83.88 104.76 14.23 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -116.67 124.96 51.01 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 t -134.42 19.58 3.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.48 0.657 . . . . 0.0 110.616 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.543 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 30.8 mtm180 54.32 5.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.431 1.892 . . . . 0.0 115.167 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 9' ' ' SER . 23.8 t-20 -133.35 123.77 17.84 Favored Pre-proline 0 C--N 1.298 -1.649 0 CA-C-O 120.963 0.411 . . . . 0.0 111.136 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HB3' HG11 ' A' ' 65' ' ' VAL . 14.8 Cg_endo -64.13 -12.59 33.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.887 3.725 . . . . 0.0 114.425 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.507 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 33.2 t -90.67 -36.75 14.18 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -74.39 -39.07 62.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.569 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 52.5 tp -73.03 158.77 34.77 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -119.31 -174.26 2.68 Favored 'General case' 0 N--CA 1.392 -3.352 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.01 -131.55 7.29 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.263 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.746 ' HE2' ' H ' ' A' ' 99' ' ' ARG . 3.2 tmpt? -140.53 127.96 21.33 Favored 'General case' 0 C--N 1.257 -3.432 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.4 m-85 -122.63 123.31 40.87 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 118.666 0.666 . . . . 0.0 110.198 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.545 HG13 ' HE3' ' A' ' 14' ' ' LYS . 70.0 mt -132.05 131.66 61.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.899 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 94' ' ' ASP . 3.7 t60 -103.29 113.31 26.7 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -138.67 142.5 39.01 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.748 0.785 . . . . 0.0 110.55 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.812 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -87.58 133.44 33.8 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.053 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.571 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -108.47 117.57 34.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 21.2 ttt180 -77.43 110.54 12.28 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.695 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 66.2 tttt -65.76 96.78 0.3 Allowed 'General case' 0 C--O 1.19 -2.059 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 170.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -90.0 -154.79 0.34 Allowed 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.674 1.19 . . . . 0.0 108.927 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -57.06 -38.76 73.72 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.782 0.833 . . . . 0.0 110.495 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 mmp_? -90.45 -14.85 32.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 109.785 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 93.7 -115.47 4.97 Favored Glycine 1 N--CA 1.395 -4.058 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.571 ' HD1' HD12 ' A' ' 20' ' ' LEU . 38.6 m-85 -99.88 138.59 36.74 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 117.907 0.853 . . . . 0.0 109.095 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.22 -0.08 80.73 Favored Glycine 0 C--O 1.207 -1.591 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.892 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.495 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.2 p90 -106.49 163.35 12.94 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.438 0.637 . . . . 0.0 111.162 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 73.6 p -125.96 146.12 50.0 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG11 HD23 ' A' ' 41' ' ' LEU . 12.3 m -123.03 148.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.933 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.96 154.59 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.689 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.95 -138.3 14.19 Favored Glycine 1 N--CA 1.386 -4.674 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.84 32.18 25.55 Favored Glycine 0 CA--C 1.47 -2.765 0 C-N-CA 123.559 0.6 . . . . 0.0 112.242 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -35.74 81.95 Favored 'General case' 0 CA--C 1.451 -2.855 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.17 165.47 18.51 Favored Pre-proline 0 CA--C 1.462 -2.441 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.293 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.3 Cg_endo -67.27 58.96 0.66 Allowed 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.766 2.311 . . . . 0.0 109.349 170.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.415 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 37.2 t70 174.4 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.393 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.1 mt-10 -128.91 127.42 41.74 Favored 'General case' 0 C--O 1.279 2.631 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CE1' HD11 ' A' ' 73' ' ' LEU . 7.0 m-30 -77.22 158.82 30.09 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 129.023 3.952 . . . . 0.0 113.694 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -92.22 143.0 26.87 Favored 'General case' 0 CA--C 1.46 -2.516 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.724 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.4 mt-30 -136.46 152.78 50.94 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 ' HB2' ' A' ' 29' ' ' PHE . 30.2 mm -71.83 108.93 3.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 39.5 ttpt -60.66 -36.99 80.08 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.507 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.9 t 161.14 173.41 0.01 OUTLIER 'General case' 0 C--N 1.372 1.573 0 O-C-N 125.711 1.882 . . . . 0.0 109.53 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -134.63 152.11 51.54 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.63 113.43 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.9 OUTLIER -69.35 -6.96 33.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.306 1.05 . . . . 0.0 113.101 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.72 -3.86 48.48 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.914 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -97.79 174.81 29.51 Favored Glycine 0 N--CA 1.423 -2.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.595 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.8 Cg_endo -57.54 -29.2 84.11 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 123.973 3.115 . . . . 0.0 113.404 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -59.0 -46.93 86.94 Favored 'General case' 0 C--O 1.268 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 111.95 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.14 -35.66 55.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.043 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 50' ' ' GLY . 9.3 mp -71.54 -34.62 70.17 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.23 -19.97 60.33 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.776 1.275 . . . . 0.0 107.637 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.36 31.74 81.78 Favored Glycine 0 CA--C 1.491 -1.459 0 CA-C-N 112.712 -2.04 . . . . 0.0 112.922 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.28 -29.65 4.78 Favored 'General case' 0 N--CA 1.394 -3.228 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.3 ttm -101.19 139.76 36.43 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.539 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.14 156.58 46.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.91 0.862 . . . . 0.0 109.477 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 45' ' ' SER . 51.6 p -64.25 115.76 5.34 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 124.861 1.265 . . . . 0.0 109.601 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 117.61 -20.06 11.17 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.588 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.2 m-20 -58.96 135.85 57.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -87.32 117.89 32.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 C-N-CA 122.79 0.436 . . . . 0.0 111.392 175.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 4.3 mm -68.46 123.2 21.32 Favored 'Isoleucine or valine' 1 C--O 1.332 5.432 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 8' ' ' PRO . 46.4 t -115.6 -41.11 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 127.441 2.963 . . . . 0.0 111.793 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 66.4 m -147.04 161.84 40.01 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.17 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.491 HG12 ' HB ' ' A' ' 72' ' ' VAL . 7.2 p -137.49 134.58 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 m120 65.68 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.718 0.636 . . . . 0.0 110.054 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -163.96 33.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.813 1.768 . . . . 0.0 108.008 169.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.8 m -123.74 128.94 50.3 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 113.787 -1.551 . . . . 0.0 107.762 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.564 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 23.2 t -71.29 121.44 18.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 80' ' ' VAL . 4.7 p -121.23 20.15 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.589 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.0 tp -60.24 113.09 2.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.45 44.81 0.09 OUTLIER Glycine 0 N--CA 1.503 3.119 0 O-C-N 125.632 1.832 . . . . 0.0 111.729 -171.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t60 -49.44 -65.62 0.53 Allowed 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.7 p -166.75 143.81 4.82 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 152.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.565 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -50.8 -34.21 26.67 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 119.904 1.229 . . . . 0.0 110.902 172.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.94 96.49 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 122.192 -0.317 . . . . 0.0 110.929 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 8.2 mm-40 -67.51 -41.39 84.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 41' ' ' LEU . 20.2 m -63.45 -45.88 96.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.96 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.96 -39.51 85.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.662 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -56.22 -43.14 78.28 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 123.445 0.465 . . . . 0.0 110.975 175.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.662 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.7 mm -65.16 -36.8 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.432 0.634 . . . . 0.0 112.265 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -75.45 -32.83 60.79 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.192 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -73.05 -21.75 60.74 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.337 1.055 . . . . 0.0 111.305 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.3 m -77.9 -35.19 51.01 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.34 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.6 mt -77.88 133.25 66.08 Favored Pre-proline 0 N--CA 1.417 -2.098 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.238 177.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 13.6 Cg_endo -90.18 161.74 4.73 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.114 2.543 . . . . 0.0 112.972 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.551 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.4 mm -62.76 133.17 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.128 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.98 54.13 Favored Glycine 0 C--N 1.296 -1.649 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.672 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.44 -172.41 2.25 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.7 m -151.1 153.63 35.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.5 125.53 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.127 0 C-N-CA 117.343 -1.743 . . . . 0.0 113.353 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 8.5 m-20 -78.85 105.2 10.0 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.4 mt -109.44 146.61 34.22 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 124.279 1.031 . . . . 0.0 109.672 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -107.93 117.01 33.0 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.539 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 68.9 mt -107.48 134.36 50.63 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 125.626 1.57 . . . . 0.0 110.697 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 31.1 t -106.97 123.99 48.98 Favored 'General case' 0 C--O 1.164 -3.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.484 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.746 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 2.9 mtm180 -103.73 123.93 47.95 Favored 'General case' 0 C--N 1.259 -3.331 0 O-C-N 120.641 -1.287 . . . . 0.0 109.525 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.1 -23.5 0.17 Allowed Glycine 0 C--N 1.271 -3.039 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.609 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 38.6 m-85 -96.94 139.21 21.42 Favored Pre-proline 0 N--CA 1.431 -1.382 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.637 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 101' ' ' TYR . 20.6 Cg_exo -64.89 143.96 81.35 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 123.341 2.694 . . . . 0.0 112.587 -174.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.5 mt -51.63 123.57 23.83 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 124.466 1.106 . . . . 0.0 110.452 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 12.4 Cg_exo -70.52 -150.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.854 3.036 . . . . 0.0 113.144 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.415 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 54.4 t80 -68.15 131.43 45.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.549 1.166 . . . . 0.0 110.74 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -115.75 85.74 14.75 Favored Pre-proline 0 N--CA 1.395 -3.203 0 CA-C-N 112.287 -2.233 . . . . 0.0 109.595 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 72.9 Cg_endo -86.41 -58.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 122.298 1.999 . . . . 0.0 113.581 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.1 -7.05 27.28 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.516 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.54 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 6.3 t70 -75.86 121.34 84.86 Favored Pre-proline 0 CA--C 1.457 -2.62 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 117' ' ' SER . 20.7 Cg_endo -86.34 -28.63 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.282 1.988 . . . . 0.0 111.308 -173.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.54 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 21.2 t-20 -59.51 -8.81 2.05 Favored 'General case' 0 N--CA 1.4 -2.935 0 C-N-CA 130.139 3.375 . . . . 0.0 113.281 -169.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 79.1 p -93.07 -19.32 21.65 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.591 -171.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -85.18 153.84 22.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.26 120.3 16.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.522 0.201 . . . . 0.0 111.153 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.5 t 65.04 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.967 1.307 . . . . 0.0 109.985 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 110' ' ' PRO . 1.1 m -139.2 -168.51 2.46 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 110' ' ' PRO 0.303 42.6 p 69.46 115.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 125.891 1.676 . . . . 0.0 112.736 -176.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.3 t 61.65 27.03 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -171.69 111.96 0.32 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.055 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.1 mt -112.41 90.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.6 mt -91.47 124.52 35.7 Favored 'General case' 0 C--N 1.266 -3.026 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.3 t70 78.6 134.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 O-C-N 125.463 1.727 . . . . 0.0 111.749 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.16 42.81 1.79 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.581 0.705 . . . . 0.0 109.929 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -77.19 145.72 73.49 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.356 0.95 0 C-N-CA 123.09 2.526 . . . . 0.0 111.5 174.731 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 63.2 -92.13 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.369 1.068 . . . . 0.0 109.911 -174.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 64.7 mtt -133.48 20.35 3.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.429 0.633 . . . . 0.0 109.9 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 113.07 90.66 1.88 Allowed Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.436 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.416 ' HG3' ' HG2' ' A' ' 39' ' ' GLU . 3.8 mppt? 61.56 96.84 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.574 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.56 -169.31 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.572 2.181 . . . . 0.0 108.737 170.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -74.01 103.81 4.63 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.5 t80 -111.29 128.98 56.11 Favored 'General case' 0 C--N 1.268 -2.94 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -139.46 13.45 2.56 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.226 0.536 . . . . 0.0 110.846 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.49 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtm180 55.25 6.47 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.139 1.776 . . . . 0.0 114.937 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -133.03 120.41 16.25 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HD3' ' SG ' ' A' ' 71' ' ' CYS . 23.8 Cg_exo -54.2 -32.49 70.82 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 124.472 3.448 . . . . 0.0 112.535 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -72.81 -21.93 60.89 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.59 0.709 . . . . 0.0 111.15 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -94.44 -25.94 16.69 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.571 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.43 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 42.4 tp -81.31 152.39 27.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.741 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -121.16 146.67 46.52 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-O 121.608 0.718 . . . . 0.0 110.151 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 158.35 -169.2 34.85 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -173.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.559 ' CE ' HG12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -103.76 108.66 20.07 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 118.401 1.1 . . . . 0.0 109.052 171.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 52.2 m-85 -90.04 120.22 31.05 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.941 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.559 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.7 mt -118.15 138.57 48.43 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.075 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 94' ' ' ASP . 2.2 t-80 -110.0 118.44 36.44 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -140.73 127.86 20.88 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.457 0.646 . . . . 0.0 112.678 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -88.51 126.41 35.24 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.428 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.531 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -107.64 119.75 40.3 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 13.3 ttp180 -79.29 106.35 11.26 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.723 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.724 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.8 tttt -62.71 97.52 0.1 Allowed 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 89' ' ' ILE . 37.3 t -81.69 -157.24 0.18 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 124.335 1.054 . . . . 0.0 108.798 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -63.35 -34.68 78.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.6 tmt_? -81.94 -20.71 38.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.724 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 87.58 -118.4 4.99 Favored Glycine 1 N--CA 1.391 -4.325 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.9 m-85 -94.56 144.14 25.83 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.888 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.23 3.28 63.99 Favored Glycine 0 C--O 1.203 -1.803 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.479 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.43 ' HB2' HG23 ' A' ' 43' ' ' ILE . 8.5 p90 -114.58 163.14 15.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.333 0.587 . . . . 0.0 110.358 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 55.9 p -122.71 148.65 45.06 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.7 m -121.87 143.76 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 CA-C-O 121.608 0.718 . . . . 0.0 111.113 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.66 148.5 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.083 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 118.4 -137.57 13.07 Favored Glycine 2 N--CA 1.381 -5.012 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -178.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.8 31.7 16.85 Favored Glycine 0 CA--C 1.467 -2.943 0 O-C-N 124.358 0.681 . . . . 0.0 111.528 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -70.14 -22.98 62.94 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.14 166.03 8.66 Favored Pre-proline 0 CA--C 1.463 -2.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 18.0 Cg_endo -66.56 58.18 0.5 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.389 2.06 . . . . 0.0 109.831 171.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 23.5 t70 177.08 -11.92 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.454 -171.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HG2' ' HG3' ' A' ' 1' ' ' LYS . 17.7 mt-10 -124.63 124.98 43.38 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 169.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.252 4.9 m-30 -76.78 159.26 30.27 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 131.044 3.738 . . . . 0.0 113.932 -169.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.864 HD21 HG21 ' A' ' 80' ' ' VAL . 8.0 mp -92.56 144.33 25.45 Favored 'General case' 0 C--O 1.183 -2.432 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.3 mt-30 -139.23 156.93 46.74 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG21 HD23 ' A' ' 46' ' ' LEU . 26.3 mm -72.42 111.45 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.261 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 36.8 ttpt -63.06 -40.97 99.29 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.559 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.8 t 165.15 174.4 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 125.148 1.53 . . . . 0.0 109.81 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 pp -142.64 147.61 36.05 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.94 0.876 . . . . 0.0 112.712 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 49' ' ' ASP . 44.3 t -69.0 116.39 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.984 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.724 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mt -58.89 -24.59 62.47 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.403 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.425 ' H ' HG12 ' A' ' 47' ' ' VAL . 9.9 m-20 -94.46 -2.51 51.69 Favored 'General case' 0 C--N 1.258 -3.373 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.656 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.411 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -99.65 170.46 23.12 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.505 -174.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 20' ' ' LEU . 18.7 Cg_endo -56.77 -29.25 79.99 Favored 'Trans proline' 0 C--O 1.196 -1.586 0 C-N-CA 124.203 3.269 . . . . 0.0 113.312 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -62.42 -41.49 98.73 Favored 'General case' 0 C--O 1.269 2.112 0 CA-C-O 121.459 0.647 . . . . 0.0 111.479 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.33 -39.46 47.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.77 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 50' ' ' GLY . 9.4 mp -70.48 -38.96 74.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.581 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.74 -24.91 62.71 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.85 74.03 Favored Glycine 0 CA--C 1.483 -1.923 0 CA-C-N 112.304 -2.225 . . . . 0.0 113.164 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -118.04 -2.04 11.32 Favored 'General case' 0 N--CA 1.385 -3.696 0 CA-C-O 120.613 0.244 . . . . 0.0 111.287 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.98 134.82 52.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.447 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.35 151.83 45.56 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.559 HG22 ' HA ' ' A' ' 45' ' ' SER . 76.2 p -64.91 110.22 2.37 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.378 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 124.31 -19.65 7.16 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-O 119.254 -0.748 . . . . 0.0 113.237 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 13.5 m-20 -61.33 132.23 52.89 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.005 0.902 . . . . 0.0 109.461 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.257 0.1 OUTLIER -82.38 120.54 34.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 177.528 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mm -71.86 123.09 25.53 Favored 'Isoleucine or valine' 1 C--O 1.333 5.488 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.534 HG13 HD13 ' A' ' 73' ' ' LEU . 52.8 t -115.56 -40.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 127.442 2.964 . . . . 0.0 111.28 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -146.25 162.14 38.73 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 121.319 -0.863 . . . . 0.0 112.906 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG23 HG11 ' A' ' 72' ' ' VAL . 52.7 t -139.82 126.54 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 C-N-CA 125.443 1.497 . . . . 0.0 107.197 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 m120 57.55 30.71 19.17 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.67 0.606 . . . . 0.0 110.947 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.9 t70 77.93 -8.12 1.72 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.043 1.337 . . . . 0.0 111.882 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.1 m -86.51 121.16 28.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.522 ' SG ' ' HD3' ' A' ' 8' ' ' PRO . 49.7 t -60.89 112.88 2.23 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.492 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -119.98 18.83 6.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.588 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.5 tp -60.52 112.42 1.97 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.17 39.05 0.06 OUTLIER Glycine 0 N--CA 1.504 3.233 0 O-C-N 125.007 1.442 . . . . 0.0 112.107 -171.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.518 ' O ' HG23 ' A' ' 76' ' ' THR . 5.8 t60 -42.85 -64.34 0.64 Allowed 'General case' 0 C--N 1.373 1.604 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 75' ' ' HIS . 5.3 p -166.99 142.99 4.34 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 150.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.573 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -51.57 -32.15 27.25 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 120.951 1.705 . . . . 0.0 110.889 173.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.33 77.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.811 0.338 . . . . 0.0 110.619 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 12.6 mm-40 -65.23 -40.79 94.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.864 HG21 HD21 ' A' ' 41' ' ' LEU . 11.0 m -63.65 -44.47 98.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.671 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.94 -40.62 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.663 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -56.73 -41.64 77.85 Favored 'General case' 0 C--O 1.196 -1.74 0 O-C-N 123.465 0.478 . . . . 0.0 110.835 175.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.663 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.5 mm -65.91 -36.05 76.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 0.0 112.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.39 -26.94 56.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.92 -30.05 61.15 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.383 1.073 . . . . 0.0 110.179 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -66.29 -42.98 87.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.101 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.498 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.4 mt -76.22 131.88 74.46 Favored Pre-proline 0 N--CA 1.404 -2.769 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.683 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.0 Cg_endo -92.42 161.91 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.175 2.584 . . . . 0.0 112.92 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.562 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 26.8 mm -58.68 132.35 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.36 11.41 54.18 Favored Glycine 0 C--N 1.295 -1.745 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.98 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.77 -169.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 17.4 m -151.62 157.44 42.16 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -147.3 124.94 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.601 0 C-N-CA 118.444 -1.303 . . . . 0.0 112.5 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 19' ' ' LYS . 10.2 m-20 -78.45 103.79 8.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 173.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.44 HD22 HG22 ' A' ' 67' ' ' VAL . 52.2 mt -100.01 148.95 23.97 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 125.092 1.357 . . . . 0.0 109.045 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 29.0 tt0 -111.18 119.13 37.91 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.75 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 96.1 mt -106.18 164.6 11.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 125.627 1.571 . . . . 0.0 109.646 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 7.9 t -142.09 117.28 10.08 Favored 'General case' 0 C--O 1.18 -2.577 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -100.99 145.25 28.93 Favored 'General case' 0 C--N 1.261 -3.267 0 O-C-N 120.472 -1.393 . . . . 0.0 109.734 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.15 -27.93 1.55 Allowed Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -84.88 130.82 51.13 Favored Pre-proline 0 N--CA 1.427 -1.619 0 CA-C-O 121.051 0.453 . . . . 0.0 110.51 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.51 140.76 83.52 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 123.459 2.772 . . . . 0.0 114.208 -173.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.483 HD23 ' HD2' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -54.04 124.59 45.71 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 113.452 -1.704 . . . . 0.0 111.401 175.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.483 ' HD2' HD23 ' A' ' 103' ' ' LEU . 7.7 Cg_exo -72.64 -74.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.179 2.586 . . . . 0.0 110.825 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.5 134.24 33.69 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' A' ' 109' ' ' ASP . 65.9 t0 -128.18 100.01 24.01 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-O 122.06 0.933 . . . . 0.0 109.217 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -92.8 -31.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.259 2.64 . . . . 0.0 112.379 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -26.96 61.27 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.907 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.499 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 6.9 t70 -113.4 124.03 32.14 Favored Pre-proline 0 CA--C 1.448 -2.966 0 C-N-CA 118.167 -1.413 . . . . 0.0 107.323 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.539 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 67.0 Cg_endo -71.47 -35.64 7.86 Favored 'Trans proline' 0 N--CA 1.424 -2.581 0 C-N-CA 122.364 2.043 . . . . 0.0 112.327 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.539 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 46.6 m-80 -62.99 6.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 126.644 1.978 . . . . 0.0 114.592 -165.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 110' ' ' PRO . 57.6 p -101.93 20.92 15.55 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-O 121.14 0.495 . . . . 0.0 111.961 -170.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 37.8 t -151.22 -175.3 5.11 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 116' ' ' THR . 57.2 tp -82.17 156.67 24.33 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p 57.53 38.21 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.394 1.478 . . . . 0.0 111.509 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 114' ' ' LEU . 44.0 p -106.53 -158.02 0.64 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.74 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -74.14 0.82 12.73 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.624 1.102 . . . . 0.0 113.878 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -74.82 129.34 36.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.46 43.09 1.11 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.581 0.705 . . . . 0.0 110.484 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.3 mm -125.06 113.07 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -113.71 24.95 11.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.283 1.04 . . . . 0.0 108.726 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -116.09 160.62 20.08 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 113.999 -1.455 . . . . 0.0 108.299 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.84 32.18 0.68 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.588 0.709 . . . . 0.0 110.997 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -88.53 139.49 29.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.88 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 C--O 1.255 1.35 0 C-N-CA 123.35 2.7 . . . . 0.0 112.788 178.347 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.88 57.31 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.152 0.501 . . . . 0.0 110.387 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 39.2 ttm -116.09 -69.44 0.85 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -75.97 154.07 44.44 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 55.66 70.85 1.39 Allowed Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -93.96 -166.29 0.13 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.375 2.717 . . . . 0.0 111.505 -174.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.76 103.74 14.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.2 t80 -115.94 126.68 54.19 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.468 ' CG2' HD23 ' A' ' 11' ' ' LEU . 5.8 t -139.4 23.67 2.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.887 0.851 . . . . 0.0 110.884 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 60.0 mtt180 53.03 4.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 127.381 2.272 . . . . 0.0 116.136 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.7 t-20 -134.4 122.98 16.21 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.7 Cg_exo -54.56 -31.58 70.45 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 123.753 2.969 . . . . 0.0 112.602 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -71.2 -26.81 63.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.397 0.618 . . . . 0.0 110.221 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -93.22 -15.26 26.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.344 0.592 . . . . 0.0 110.85 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . 33.3 mt -76.43 -173.68 2.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.51 1.147 . . . . 0.0 111.767 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -120.5 178.52 4.64 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.568 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.98 164.57 35.27 Favored Glycine 0 C--N 1.281 -2.476 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.204 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 34.0 tptt -88.25 126.83 35.37 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.654 0.782 . . . . 0.0 109.678 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 11' ' ' LEU . 93.4 m-85 -104.79 119.63 39.47 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.016 0.912 . . . . 0.0 110.583 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.521 HD13 ' NH2' ' A' ' 99' ' ' ARG . 8.5 mt -121.67 146.56 26.57 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.116 -172.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -117.29 127.34 53.98 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -139.05 156.86 46.86 Favored 'General case' 0 C--O 1.184 -2.369 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 38.2 ttpt -127.26 123.57 36.79 Favored 'General case' 0 C--N 1.258 -3.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.497 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.81 116.4 31.86 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.75 -170.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 32.8 ttp-105 -79.01 102.38 8.31 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.268 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.692 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.6 tttt -59.54 97.79 0.04 OUTLIER 'General case' 0 C--O 1.179 -2.649 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 t -84.82 -155.3 0.2 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 124.792 1.237 . . . . 0.0 109.173 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -61.13 -36.36 79.53 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.396 0.617 . . . . 0.0 109.468 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -86.69 -16.78 35.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.736 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.692 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 88.38 -112.17 3.87 Favored Glycine 1 N--CA 1.391 -4.308 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.497 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.1 m-85 -97.09 135.12 39.53 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.172 0.51 . . . . 0.0 109.919 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.93 -3.42 90.6 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.896 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' HB2' HG23 ' A' ' 43' ' ' ILE . 9.7 p90 -113.58 163.68 14.64 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.604 0.716 . . . . 0.0 111.903 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.2 p -124.08 148.06 47.4 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.369 1.468 . . . . 0.0 107.281 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.66 148.23 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.75 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.41 153.48 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.434 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.43 -131.79 9.59 Favored Glycine 0 N--CA 1.398 -3.877 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 49.65 36.33 24.87 Favored Glycine 0 CA--C 1.466 -2.97 0 O-C-N 124.593 0.82 . . . . 0.0 111.902 175.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.08 -31.05 70.42 Favored 'General case' 0 CA--C 1.449 -2.932 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -161.4 166.87 14.16 Favored Pre-proline 0 CA--C 1.45 -2.869 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.216 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -66.72 64.04 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.126 1.884 . . . . 0.0 108.468 168.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.46 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 12.9 t70 170.69 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.376 -172.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 21.3 mt-10 -127.58 127.4 43.82 Favored 'General case' 0 C--O 1.276 2.457 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 73' ' ' LEU . 9.7 m-85 -76.92 159.25 30.15 Favored 'General case' 0 N--CA 1.532 3.639 0 O-C-N 128.836 3.835 . . . . 0.0 113.319 -167.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD21 HG21 ' A' ' 80' ' ' VAL . 5.1 mp -92.34 143.2 26.63 Favored 'General case' 0 CA--C 1.469 -2.161 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.8 mt-30 -135.5 154.28 51.46 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 29' ' ' PHE . 20.9 mm -75.35 111.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.39 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 45' ' ' SER . 47.6 tptt -60.83 -47.29 87.02 Favored 'General case' 0 N--CA 1.409 -2.495 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.632 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.9 t 173.2 172.71 0.13 Allowed 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.871 1.357 . . . . 0.0 111.183 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.1 pp -143.1 145.74 33.13 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 123.764 0.826 . . . . 0.0 111.128 -175.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 49' ' ' ASP . 22.0 t -75.18 121.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 1.8 pt? -69.42 -5.24 22.45 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.965 0.888 . . . . 0.0 112.585 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' H ' HG12 ' A' ' 47' ' ' VAL . 19.7 t70 -85.4 -26.65 26.29 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.903 -1.499 . . . . 0.0 108.917 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.44 172.08 37.34 Favored Glycine 0 N--CA 1.402 -3.586 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.676 -171.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HG2' HD11 ' A' ' 20' ' ' LEU . 14.2 Cg_endo -54.87 -26.37 48.06 Favored 'Trans proline' 0 C--O 1.201 -1.375 0 C-N-CA 124.911 3.741 . . . . 0.0 113.325 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -58.26 -52.66 64.64 Favored 'General case' 0 C--O 1.291 3.244 0 C-N-CA 123.377 0.671 . . . . 0.0 112.789 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.36 -33.53 55.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.456 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.3 mp -70.31 -35.59 73.76 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.097 -176.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.34 -21.84 65.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.59 11.83 84.86 Favored Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 112.61 -2.087 . . . . 0.0 113.47 172.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -107.62 -43.02 4.6 Favored 'General case' 1 N--CA 1.376 -4.132 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.406 ' HB3' HD11 ' A' ' 97' ' ' LEU . 17.0 ptp -95.92 154.7 17.1 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 116.631 -2.028 . . . . 0.0 112.296 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.42 161.19 38.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.749 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 45' ' ' SER . 75.0 p -65.86 113.7 4.56 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.25 -14.18 10.24 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.716 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' CG ' ' HG3' ' A' ' 99' ' ' ARG . 2.4 m-20 -65.95 152.69 43.99 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.44 125.18 55.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.989 -0.444 . . . . 0.0 111.571 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.456 HD13 HD23 ' A' ' 97' ' ' LEU . 10.4 mm -75.52 124.09 32.77 Favored 'Isoleucine or valine' 1 C--O 1.323 4.938 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.594 HG13 HD13 ' A' ' 73' ' ' LEU . 57.7 t -115.11 -36.7 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 111.037 -2.801 . . . . 0.0 111.247 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 70.3 m -150.8 160.24 44.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.001 -1.062 . . . . 0.0 113.081 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG23 HG11 ' A' ' 72' ' ' VAL . 55.0 t -142.18 129.59 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.5 m120 55.12 41.61 31.47 Favored 'General case' 0 C--O 1.256 1.437 0 O-C-N 123.776 0.673 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 25.26 5.69 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.47 1.108 . . . . 0.0 113.215 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 m -114.72 125.95 54.31 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 27.4 t -67.08 110.82 3.57 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 80' ' ' VAL . 2.2 p -117.35 16.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 65' ' ' VAL . 32.6 tp -57.95 112.85 1.63 Allowed 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.03 40.3 0.05 OUTLIER Glycine 0 N--CA 1.497 2.701 0 O-C-N 125.511 1.757 . . . . 0.0 112.934 -170.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.549 ' O ' HG23 ' A' ' 76' ' ' THR . 4.7 t60 -43.71 -66.48 0.38 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.8 p -166.35 143.51 5.13 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 150.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.555 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -51.47 -31.37 23.2 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 119.699 1.136 . . . . 0.0 110.775 172.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.65 85.51 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.942 -0.474 . . . . 0.0 110.946 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 21.9 mm-40 -65.34 -42.18 93.13 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.784 HG21 HD21 ' A' ' 41' ' ' LEU . 18.4 m -62.11 -43.71 98.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.26 -39.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -61.0 -41.62 96.88 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.02 176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 86' ' ' SER . 37.1 mt -62.01 -40.96 89.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.34 0.59 . . . . 0.0 111.635 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -70.89 -34.97 72.11 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.804 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -72.77 -19.64 61.32 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.06 0.944 . . . . 0.0 111.676 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 53.4 m -79.79 -27.81 40.35 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.132 0.973 . . . . 0.0 109.372 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.463 HG22 ' HD3' ' A' ' 22' ' ' LYS . 43.2 mt -85.17 134.65 40.47 Favored Pre-proline 0 N--CA 1.416 -2.141 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.607 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 18.5 Cg_endo -92.66 161.68 2.85 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 123.347 2.698 . . . . 0.0 113.039 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.65 133.55 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.63 12.49 53.43 Favored Glycine 0 C--N 1.289 -2.042 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.955 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.3 -170.26 1.85 Allowed 'General case' 0 C--O 1.199 -1.6 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 3.3 t -151.36 159.72 44.13 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.0 t -147.68 126.15 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.507 -175.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.04 112.93 17.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.451 ' CD2' HG22 ' A' ' 67' ' ' VAL . 45.2 mt -109.89 144.55 38.21 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 126.387 1.875 . . . . 0.0 109.962 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.45 118.61 37.14 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 64' ' ' ILE . 23.7 mt -105.6 165.07 11.41 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 124.903 1.281 . . . . 0.0 108.784 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 16.2 t -142.94 111.05 6.03 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.781 0.801 . . . . 0.0 110.96 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.521 ' NH2' HD13 ' A' ' 16' ' ' ILE . 13.1 mtm180 -97.0 129.69 44.43 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.211 -0.931 . . . . 0.0 112.213 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.07 -17.78 0.82 Allowed Glycine 0 C--N 1.277 -2.702 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.512 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.12 148.85 40.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.862 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 131.76 47.94 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.889 2.392 . . . . 0.0 111.538 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' A' ' 104' ' ' PRO . 2.0 tt -58.54 135.6 85.87 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.498 ' HD2' HD23 ' A' ' 103' ' ' LEU . 3.8 Cg_exo -42.05 158.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 125.672 4.248 . . . . 0.0 116.102 -178.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.547 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 70.6 t80 -44.44 134.2 5.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.916 -1.947 . . . . 0.0 113.081 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -104.14 99.77 18.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.766 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 73.2 Cg_endo -97.18 -57.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.095 0 C-N-CA 122.187 1.925 . . . . 0.0 110.179 168.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -138.77 31.44 2.26 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -76.22 128.15 83.35 Favored Pre-proline 0 CA--C 1.489 -1.404 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.541 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.708 ' HB2' ' H ' ' A' ' 117' ' ' SER 0.386 7.5 Cg_endo -62.93 -48.08 7.36 Favored 'Trans proline' 0 CA--C 1.459 -3.275 0 C-N-CA 122.041 1.827 . . . . 0.0 112.648 174.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.653 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 48.1 m-80 -59.57 -25.6 64.7 Favored 'General case' 0 N--CA 1.414 -2.255 0 O-C-N 125.921 2.013 . . . . 0.0 113.508 -159.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -92.96 -27.31 17.12 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.765 -175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 m -94.22 173.19 7.77 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 125.478 1.511 . . . . 0.0 110.378 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.62 36.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.045 0.938 . . . . 0.0 111.074 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.0 p -155.42 40.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.653 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -77.39 132.48 38.55 Favored 'General case' 0 CA--C 1.475 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 115.053 -172.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.708 ' H ' ' HB2' ' A' ' 110' ' ' PRO . 78.1 p 45.59 63.61 1.73 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 125.058 1.474 . . . . 0.0 108.836 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -37.34 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.103 2.161 . . . . 0.0 115.385 -167.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.0 32.39 4.8 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.64 116.53 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.03 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.42 31.23 6.4 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.227 0.537 . . . . 0.0 109.904 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -149.58 131.37 15.07 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 75.29 -43.67 0.51 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.878 1.671 . . . . 0.0 112.254 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.463 ' OE2' ' HD2' ' A' ' 125' ' ' PRO . 10.4 tp10 -66.31 144.71 98.83 Favored Pre-proline 0 C--N 1.291 -1.938 0 C-N-CA 125.221 1.409 . . . . 0.0 108.332 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.463 ' HD2' ' OE2' ' A' ' 124' ' ' GLU . 6.3 Cg_exo . . . . . 0 C--N 1.371 1.759 1 C-N-CA 125.377 4.051 . . . . 0.0 114.571 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 55.16 37.73 29.36 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.243 1.02 . . . . 0.0 110.268 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 40.0 tpp 165.83 90.36 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.458 ' HA2' ' HG2' ' A' ' 39' ' ' GLU . . . -50.6 126.35 24.6 Favored Glycine 0 CA--C 1.476 -2.401 0 O-C-N 124.653 1.221 . . . . 0.0 112.686 -174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -62.07 -47.63 90.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -98.17 -178.0 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 C-N-CA 122.395 2.063 . . . . 0.0 112.371 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.12 107.26 18.95 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 6' ' ' ARG . 2.1 t80 -99.11 129.8 45.39 Favored 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 7' ' ' ASN . 14.6 t -138.1 10.82 2.82 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.873 0.845 . . . . 0.0 110.628 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 31.3 mtt180 58.25 -22.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 127.557 2.343 . . . . 0.0 115.738 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.479 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 56.1 t-20 -104.6 117.74 58.25 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HB3' HG11 ' A' ' 65' ' ' VAL . 9.3 Cg_endo -57.39 -26.05 68.99 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.965 3.11 . . . . 0.0 112.956 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -74.11 -30.29 62.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.124 0.487 . . . . 0.0 110.002 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -89.36 -29.61 18.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 41.2 tp -72.07 155.85 39.84 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.548 0.689 . . . . 0.0 111.619 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 9.2 mtmp? -90.18 -167.17 1.77 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.614 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 91.13 173.58 43.65 Favored Glycine 0 C--N 1.291 -1.961 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.183 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -97.44 129.6 44.63 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.5 m-85 -103.16 113.74 27.47 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-O 122.538 1.161 . . . . 0.0 110.04 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -116.55 143.7 26.06 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.083 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.908 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.56 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.7 t60 -110.62 131.02 55.41 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 8.8 t -139.29 156.76 46.82 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.2 ttmp? -125.24 122.83 38.08 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -108.35 116.68 32.43 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.393 -174.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.0 ttp180 -75.09 107.77 7.38 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.021 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.626 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.7 tttt -66.71 95.68 0.36 Allowed 'General case' 0 C--O 1.171 -3.07 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 167.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t -89.55 -155.26 0.35 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 m -60.95 -32.81 72.33 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 122.56 0.344 . . . . 0.0 110.397 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -83.11 -21.02 33.78 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.368 0.604 . . . . 0.0 109.55 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 73.12 80.16 0.45 Allowed Glycine 0 N--CA 1.417 -2.584 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 20' ' ' LEU . 24.3 m-85 80.49 168.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.736 2.014 . . . . 0.0 110.07 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.18 10.99 5.6 Favored Glycine 0 CA--C 1.497 -1.077 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.018 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' HG23 ' A' ' 43' ' ' ILE . 19.4 p90 -119.49 162.93 18.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.235 0.54 . . . . 0.0 109.758 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 41.4 p -119.41 153.83 34.61 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 p -144.85 141.41 23.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.117 -174.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.6 p -151.83 166.12 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.353 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.6 3.06 30.74 Favored Glycine 0 CA--C 1.454 -3.766 0 N-CA-C 116.521 1.368 . . . . 0.0 116.521 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.802 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -117.06 48.89 0.9 Allowed Glycine 1 CA--C 1.41 -6.516 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -168.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.26 -29.16 60.73 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 112.841 -1.679 . . . . 0.0 110.239 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.6 pt-20 -163.81 171.96 5.46 Favored Pre-proline 0 CA--C 1.465 -2.293 0 C-N-CA 117.846 -1.542 . . . . 0.0 111.093 -172.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 36' ' ' GLU . 21.9 Cg_endo -64.73 54.9 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.011 2.474 . . . . 0.0 110.898 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -177.53 -19.62 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.305 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.72 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 2.8 mt-10 -119.53 122.73 42.31 Favored 'General case' 0 C--O 1.265 1.885 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 171.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.296 5.4 m-30 -78.92 155.99 28.78 Favored 'General case' 0 N--CA 1.533 3.703 0 O-C-N 127.78 3.175 . . . . 0.0 112.722 -176.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.802 HD12 ' HA3' ' A' ' 34' ' ' GLY . 7.4 mp -85.75 143.08 28.54 Favored 'General case' 0 C--O 1.179 -2.607 0 C-N-CA 117.153 -1.819 . . . . 0.0 108.112 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.0 mt-30 -139.31 151.24 46.25 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 62' ' ' ASP . 33.9 mm -72.38 110.95 5.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 58.3 tttm -59.39 -38.99 81.96 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.598 ' HA ' HG22 ' A' ' 60' ' ' THR . 30.7 t 163.78 172.34 0.02 OUTLIER 'General case' 0 C--N 1.363 1.16 0 O-C-N 125.637 1.836 . . . . 0.0 110.646 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -141.58 152.14 43.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.866 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 49' ' ' ASP . 56.9 t -81.61 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.6 pt? -68.63 -11.12 59.67 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' H ' HG12 ' A' ' 47' ' ' VAL . 6.3 m-20 -95.15 -7.29 39.69 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.073 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.26 163.0 37.18 Favored Glycine 0 N--CA 1.404 -3.461 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.765 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.83 -30.37 38.14 Favored 'Trans proline' 0 C--O 1.211 -0.873 0 C-N-CA 124.718 3.612 . . . . 0.0 112.897 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.87 -45.82 85.78 Favored 'General case' 0 C--O 1.271 2.223 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.798 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.9 -31.94 57.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.645 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.32 -40.62 64.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.069 0.547 . . . . 0.0 112.419 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.76 -25.62 67.35 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.02 5.33 65.08 Favored Glycine 0 CA--C 1.483 -1.935 0 CA-C-N 112.465 -2.152 . . . . 0.0 113.939 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.89 -28.78 14.53 Favored 'General case' 1 N--CA 1.378 -4.061 0 C-N-CA 122.782 0.433 . . . . 0.0 111.551 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.8 ttm -97.04 140.49 31.48 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.064 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -137.97 161.9 35.5 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -71.01 107.53 4.14 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.825 0.85 . . . . 0.0 111.264 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 120.83 -16.6 9.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.207 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 2.9 m-20 -61.9 134.45 56.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.262 0.2 OUTLIER -84.62 124.89 40.22 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.276 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.75 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 14.4 mm -73.8 124.58 31.36 Favored 'Isoleucine or valine' 1 C--O 1.32 4.78 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 170.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 8' ' ' PRO . 47.9 t -115.09 -40.9 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 111.481 -2.6 . . . . 0.0 110.939 -176.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.2 m -146.27 166.29 26.71 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.193 -1.003 . . . . 0.0 113.345 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG23 HG11 ' A' ' 72' ' ' VAL . 39.8 t -139.7 120.69 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 125.313 1.445 . . . . 0.0 107.493 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.7 m120 67.53 -75.75 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.471 1.107 . . . . 0.0 109.809 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.07 4.14 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.322 0.649 . . . . 0.0 110.862 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -96.94 121.82 39.23 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 72.1 m -70.71 88.2 0.71 Allowed 'General case' 0 N--CA 1.398 -3.045 0 O-C-N 124.639 1.212 . . . . 0.0 108.366 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 80' ' ' VAL . 3.8 p -97.73 19.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.43 -171.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.581 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 34.3 tp -58.82 113.19 1.94 Allowed 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.84 44.92 0.1 OUTLIER Glycine 0 C--N 1.384 3.246 0 O-C-N 125.996 2.06 . . . . 0.0 111.661 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.563 ' O ' HG23 ' A' ' 76' ' ' THR . 3.5 t60 -48.42 -64.26 0.85 Allowed 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 75' ' ' HIS . 12.0 p -166.42 142.79 4.83 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 151.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.35 -31.58 22.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 120.498 1.499 . . . . 0.0 111.373 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.56 77.0 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 122.029 -0.419 . . . . 0.0 110.438 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 11.9 mm-40 -64.46 -39.01 93.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 41' ' ' LEU . 11.6 m -64.16 -43.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.2 -37.8 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.1 tmtm? -57.78 -42.84 84.94 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.298 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.649 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.3 mm -66.21 -33.72 65.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.642 0.734 . . . . 0.0 112.628 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -76.09 -28.92 57.74 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.297 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -72.89 -28.26 62.38 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.373 1.069 . . . . 0.0 110.663 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.8 m -65.57 -38.66 90.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.455 175.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.513 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 22.1 mt -82.89 133.76 48.08 Favored Pre-proline 0 N--CA 1.405 -2.681 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.03 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.1 Cg_endo -90.71 161.98 4.2 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.086 2.524 . . . . 0.0 113.234 -173.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.565 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.1 mm -60.77 133.84 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.457 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 11.62 56.63 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.133 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.92 -169.72 1.72 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -151.34 165.73 33.16 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.2 t -150.35 126.21 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.687 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.887 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.56 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -78.65 107.02 11.03 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.194 -1.002 . . . . 0.0 108.743 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' CD2' HG22 ' A' ' 67' ' ' VAL . 56.7 mt -103.84 152.45 21.9 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 125.801 1.64 . . . . 0.0 108.391 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 30.1 tt0 -111.11 123.42 50.17 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 76.6 mt -105.65 153.87 21.23 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.759 1.223 . . . . 0.0 110.247 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.641 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 9.6 t -124.26 107.12 10.85 Favored 'General case' 0 C--O 1.186 -2.241 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.476 172.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 40.4 ttp180 -101.39 138.62 38.15 Favored 'General case' 1 C--N 1.243 -4.052 0 O-C-N 120.59 -1.319 . . . . 0.0 110.494 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.51 -32.84 0.84 Allowed Glycine 0 CA--C 1.464 -3.123 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -82.45 137.59 45.03 Favored Pre-proline 0 N--CA 1.412 -2.34 0 CA-C-N 113.871 -1.165 . . . . 0.0 108.434 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -85.62 164.41 10.7 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.964 2.443 . . . . 0.0 112.242 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 13.3 mt -57.09 121.22 44.93 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.244 173.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 30.7 Cg_endo -76.52 -79.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.154 2.569 . . . . 0.0 114.763 -170.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -138.78 143.61 39.02 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-O 121.837 0.827 . . . . 0.0 109.835 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -116.4 85.51 16.27 Favored Pre-proline 0 N--CA 1.392 -3.334 0 CA-C-N 113.003 -1.908 . . . . 0.0 110.529 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.77 -59.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.78 1.654 . . . . 0.0 110.787 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -112.58 32.96 5.24 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.922 1.82 . . . . 0.0 108.663 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 111' ' ' ASN . 5.9 t70 -104.53 109.53 62.95 Favored Pre-proline 0 CA--C 1.435 -3.445 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 170.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.459 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 97.5 Cg_endo -75.09 -35.04 3.31 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 121.664 1.576 . . . . 0.0 110.683 -175.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.591 ' OD1' ' HA ' ' A' ' 117' ' ' SER . 74.3 m-20 -51.19 -10.15 0.08 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 130.251 3.42 . . . . 0.0 114.704 -167.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 110' ' ' PRO . 76.2 p -97.65 -10.34 25.24 Favored 'General case' 0 N--CA 1.384 -3.747 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.632 -169.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.4 p -148.76 128.79 13.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 115' ' ' VAL . 6.3 tp 63.58 -154.28 0.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.179 1.392 . . . . 0.0 110.854 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' H ' ' HG ' ' A' ' 114' ' ' LEU . 13.2 m -66.06 78.15 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 122.491 1.139 . . . . 0.0 112.573 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 p -134.57 -169.25 2.3 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.338 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.591 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 78.3 p 64.86 21.93 12.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.127 1.371 . . . . 0.0 112.119 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.3 p -91.42 125.69 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.91 74.03 5.65 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.1 0.476 . . . . 0.0 111.961 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.7 mm -99.13 89.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.41 138.16 47.16 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.155 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -148.08 154.18 39.87 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -77.98 -28.34 49.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.018 0.437 . . . . 0.0 111.809 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -102.58 133.01 20.73 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.577 2.851 . . . . 0.0 112.117 179.234 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.803 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -133.81 -46.74 0.8 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 62.6 mtt -86.25 93.78 9.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 144.87 -94.17 0.17 Allowed Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.463 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 29.6 mmmt 50.46 61.2 13.85 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 40.5 Cg_endo -107.44 -172.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 123.15 2.567 . . . . 0.0 111.79 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -94.5 111.15 22.9 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.594 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -107.81 123.17 48.17 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -133.3 12.41 4.19 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.339 0.59 . . . . 0.0 110.279 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.529 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtp180 60.47 -29.7 0.05 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.446 2.298 . . . . 0.0 115.381 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 55.6 t-20 -95.92 117.38 66.39 Favored Pre-proline 0 C--N 1.288 -2.068 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.4 Cg_endo -59.36 -22.79 67.27 Favored 'Trans proline' 0 C--O 1.21 -0.924 0 C-N-CA 123.772 2.982 . . . . 0.0 113.134 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -76.92 -25.37 52.85 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.804 -0.56 . . . . 0.0 109.562 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -93.82 -19.32 21.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.574 0.702 . . . . 0.0 110.22 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.4 tm? -88.14 145.78 25.74 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.369 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' N ' HD13 ' A' ' 11' ' ' LEU . 57.3 mttm -103.32 137.74 41.03 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-O 121.873 0.844 . . . . 0.0 110.581 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 152.82 169.52 18.15 Favored Glycine 1 C--N 1.246 -4.417 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.237 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.47 122.3 40.37 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.908 174.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.2 m-85 -96.53 111.34 23.5 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.784 1.278 . . . . 0.0 112.157 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.477 HD11 ' HG3' ' A' ' 99' ' ' ARG . 5.9 mm -92.55 152.15 3.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 CA-C-N 112.779 -2.009 . . . . 0.0 108.436 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 113.05 14.47 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 t -139.37 132.88 30.3 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.918 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.9 ttpt -92.95 125.92 37.78 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.509 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.28 117.3 33.69 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -175.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.444 ' HD3' ' OG ' ' A' ' 92' ' ' SER . 18.6 tpp180 -74.59 103.83 5.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.954 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.653 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 69.9 tttt -62.17 97.29 0.08 Allowed 'General case' 0 C--O 1.177 -2.733 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.0 t -129.71 125.87 36.94 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t 62.18 -77.73 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.127 1.371 . . . . 0.0 110.534 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -85.48 -20.63 29.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.653 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 107.83 -110.43 3.16 Favored Glycine 1 N--CA 1.385 -4.73 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.509 ' HD1' HD12 ' A' ' 20' ' ' LEU . 44.1 m-85 -92.45 135.7 33.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.268 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.56 3.55 84.71 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.812 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE2' HG22 ' A' ' 31' ' ' VAL . 10.0 p90 -119.07 162.92 17.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.194 0.521 . . . . 0.0 110.434 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 21.5 p -113.15 145.81 40.3 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.665 HG11 HD23 ' A' ' 41' ' ' LEU . 1.6 t -119.19 143.51 30.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.505 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.33 149.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.785 0 CA-C-O 121.336 0.588 . . . . 0.0 109.428 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.25 -138.52 11.02 Favored Glycine 1 N--CA 1.391 -4.317 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.63 36.97 19.46 Favored Glycine 0 CA--C 1.456 -3.598 0 O-C-N 124.517 0.775 . . . . 0.0 111.346 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 3.1 t70 -69.93 -27.71 65.0 Favored 'General case' 0 CA--C 1.463 -2.394 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -170.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.9 pt-20 -164.28 167.69 10.19 Favored Pre-proline 0 CA--C 1.464 -2.354 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.057 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.4 Cg_endo -67.21 56.03 0.55 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.394 2.063 . . . . 0.0 110.277 172.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 177.97 -7.86 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.338 -169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 22.9 mm-40 -129.29 125.34 36.58 Favored 'General case' 0 C--O 1.276 2.493 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.253 6.0 m-30 -76.44 158.93 30.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 129.871 3.268 . . . . 0.0 112.514 -169.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 80' ' ' VAL . 6.7 mp -88.97 147.77 24.13 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.5 mt-30 -144.18 155.6 43.97 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 62' ' ' ASP . 20.4 mm -72.98 115.91 14.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 38.4 ttmt -58.95 -44.65 91.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.59 ' HA ' HG22 ' A' ' 60' ' ' THR . 21.0 t 169.62 173.65 0.05 OUTLIER 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 125.144 1.527 . . . . 0.0 110.453 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.5 pp -144.27 144.91 31.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-O 121.647 0.737 . . . . 0.0 111.899 -175.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 49' ' ' ASP . 14.5 t -73.26 122.92 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.769 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.2 mt -61.31 -15.01 31.19 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 112.489 -2.141 . . . . 0.0 113.121 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.1 t70 -92.72 -13.66 29.04 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.767 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.53 163.62 28.74 Favored Glycine 0 N--CA 1.415 -2.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.425 -172.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.44 -28.73 45.71 Favored 'Trans proline' 0 C--O 1.205 -1.136 0 C-N-CA 124.72 3.613 . . . . 0.0 112.798 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.85 -50.77 72.17 Favored 'General case' 0 C--O 1.264 1.853 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.052 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.26 -33.49 55.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.8 mp -72.57 -33.72 66.96 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.049 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.43 -27.79 66.5 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' HE3' ' A' ' 57' ' ' LYS . . . 78.61 3.59 86.91 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 112.51 -2.132 . . . . 0.0 113.352 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HE3' ' C ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -96.18 -31.8 12.79 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 53.0 ttm -97.97 142.0 30.24 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.616 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -139.25 159.16 42.8 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 122.226 1.012 . . . . 0.0 110.061 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.7 p -63.85 115.65 5.03 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.564 1.146 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 111.74 -15.96 26.28 Favored Glycine 0 N--CA 1.435 -1.425 0 O-C-N 121.767 -0.583 . . . . 0.0 112.799 175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 43' ' ' ILE . 17.4 m-20 -61.08 134.28 56.91 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -83.38 126.47 40.13 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 CA-C-N 118.905 0.775 . . . . 0.0 113.035 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 12.7 mm -76.78 125.27 36.43 Favored 'Isoleucine or valine' 1 C--O 1.321 4.866 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 8' ' ' PRO . 25.9 t -115.68 -37.6 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 111.435 -2.62 . . . . 0.0 111.035 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.696 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.9 m -144.51 149.75 36.43 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.227 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.625 HG12 HG21 ' A' ' 72' ' ' VAL . 12.4 p -134.58 133.43 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.487 ' OD1' HG22 ' A' ' 67' ' ' VAL . 21.7 m120 60.13 27.84 17.35 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.02 0.914 . . . . 0.0 110.398 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 72.97 2.48 4.39 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.578 -1.646 . . . . 0.0 112.668 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.7 m -90.56 126.88 36.08 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 31.7 t -66.49 108.0 2.25 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.696 HG22 ' HA ' ' A' ' 66' ' ' SER . 29.6 m -123.18 27.87 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.841 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.594 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.0 tp -59.88 113.54 2.34 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.7 41.57 0.26 Allowed Glycine 0 C--N 1.376 2.767 0 O-C-N 125.191 1.557 . . . . 0.0 112.205 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 76' ' ' THR . 8.8 t60 -44.01 -67.86 0.24 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 75' ' ' HIS . 18.2 p -166.1 143.46 5.36 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 102.585 -3.117 . . . . 0.0 102.585 149.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -50.77 -37.15 40.49 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 120.098 1.317 . . . . 0.0 110.711 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.409 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.499 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 9.0 mm-40 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 41' ' ' LEU . 34.0 m -69.17 -39.88 79.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.591 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 71.1 t -65.45 -37.43 80.04 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.28 -38.55 83.93 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 122.887 0.117 . . . . 0.0 111.277 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' SER . 63.1 mt -65.58 -35.73 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.812 0.815 . . . . 0.0 110.612 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.6 -31.52 65.25 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.356 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 71.1 mm-40 -72.82 -26.56 61.53 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 122.084 0.945 . . . . 0.0 109.901 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.2 m -73.66 -47.06 42.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.602 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.506 HG22 ' HD3' ' A' ' 22' ' ' LYS . 20.9 mt -66.68 136.58 94.74 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.302 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 30.5 Cg_endo -91.64 162.49 3.49 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.185 3.257 . . . . 0.0 113.125 -174.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 28.8 mm -62.29 135.25 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 CA-C-O 121.07 0.462 . . . . 0.0 110.63 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.85 57.14 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.554 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.14 -172.42 2.16 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.444 ' OG ' ' HD3' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -149.01 158.87 44.52 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -142.49 125.27 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.211 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -79.33 104.17 9.77 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.44 143.84 32.47 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 125.357 1.463 . . . . 0.0 111.514 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 38.0 tt0 -104.41 127.04 52.01 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.336 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 67.1 mt -115.11 157.83 23.03 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 124.573 1.171 . . . . 0.0 110.027 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.6 t -129.83 111.17 12.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.548 1.166 . . . . 0.0 110.157 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HG3' HD11 ' A' ' 16' ' ' ILE . 3.7 mmm180 -88.54 120.9 30.35 Favored 'General case' 0 C--N 1.245 -3.958 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 157.32 -22.06 0.43 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.7 138.56 21.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.21 146.98 21.9 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 124.756 3.638 . . . . 0.0 112.936 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.472 HD23 ' HD2' ' A' ' 104' ' ' PRO . 1.2 tt -70.33 125.26 91.93 Favored Pre-proline 0 N--CA 1.413 -2.319 0 C-N-CA 124.422 1.089 . . . . 0.0 109.195 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.472 ' HD2' HD23 ' A' ' 103' ' ' LEU . 45.0 Cg_exo -64.64 -173.25 0.23 Allowed 'Trans proline' 0 CA--C 1.509 -0.735 0 C-N-CA 124.322 3.348 . . . . 0.0 113.302 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -82.37 128.61 34.4 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.774 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -117.69 85.16 21.15 Favored Pre-proline 0 N--CA 1.39 -3.428 0 CA-C-N 111.846 -2.434 . . . . 0.0 110.542 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -87.51 -54.99 0.02 OUTLIER 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.004 1.802 . . . . 0.0 111.994 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.12 -9.84 59.39 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.647 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.41 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -89.47 121.57 69.14 Favored Pre-proline 0 CA--C 1.478 -1.809 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.108 -176.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.735 ' HB2' ' HA ' ' A' ' 116' ' ' THR 0.348 18.3 Cg_endo -69.44 -42.77 3.42 Favored 'Trans proline' 0 CA--C 1.469 -2.77 0 C-N-CA 123.071 2.514 . . . . 0.0 113.174 177.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.689 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 42.6 m-80 -58.27 -14.13 6.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 111.95 -2.386 . . . . 0.0 114.295 -161.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 44.2 p -99.76 -20.45 16.23 Favored 'General case' 0 N--CA 1.395 -3.186 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.473 -172.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -132.27 -157.98 0.86 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.64 -169.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -65.05 162.76 16.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 123.614 0.571 . . . . 0.0 109.944 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p 49.0 45.07 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 123.083 1.42 . . . . 0.0 111.344 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.735 ' HA ' ' HB2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -75.53 158.96 31.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.605 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.4 t -82.12 53.57 2.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.883 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.2 m -96.18 155.68 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.492 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.37 75.65 3.9 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.209 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.66 58.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.86 29.46 2.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.124 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.61 140.1 17.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.57 113.16 10.81 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.15 134.5 80.48 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 C--O 1.262 1.717 0 C-N-CA 123.384 2.723 . . . . 0.0 112.123 178.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 64.65 -79.23 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.467 1.107 . . . . 0.0 112.204 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . 0.457 ' HB3' ' HB3' ' A' ' 105' ' ' PHE . 21.2 ptp -142.67 153.96 43.89 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.463 ' HA3' ' OE1' ' A' ' 39' ' ' GLU . . . 78.46 -148.35 32.35 Favored Glycine 0 N--CA 1.425 -2.069 0 O-C-N 123.986 0.804 . . . . 0.0 112.347 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 38.73 65.33 3.19 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.688 1.595 . . . . 0.0 114.952 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 74.4 Cg_endo -101.54 -162.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.283 0 C-N-CA 123.769 2.979 . . . . 0.0 111.326 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -84.53 104.22 14.34 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.606 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -111.27 130.04 55.79 Favored 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 t -143.43 16.39 1.85 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.628 0.728 . . . . 0.0 110.063 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HG2' ' HE1' ' A' ' 4' ' ' PHE . 16.0 mtm180 58.06 -21.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 127.993 2.517 . . . . 0.0 115.683 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.537 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -99.89 113.37 65.11 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-O 120.894 0.378 . . . . 0.0 111.5 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 1.3 Cg_endo -48.14 -36.1 27.91 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.582 3.522 . . . . 0.0 112.705 174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -73.97 -17.04 61.05 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.063 0.459 . . . . 0.0 111.61 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 20.8 mm-40 -94.93 -17.28 22.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.228 0.537 . . . . 0.0 110.201 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 73' ' ' LEU . 20.5 mt -80.15 178.36 8.31 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 122.109 0.957 . . . . 0.0 109.697 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -114.48 -161.33 0.77 Allowed 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.665 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 94.87 176.69 38.14 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.081 -1.533 . . . . 0.0 112.799 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.1 OUTLIER -103.29 132.09 49.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.4 m-85 -108.07 111.77 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.486 1.136 . . . . 0.0 111.535 -175.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.534 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 21.3 mt -112.46 149.63 14.94 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.03 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.896 -174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -130.45 104.64 7.36 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -123.58 129.48 51.24 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 122.318 1.056 . . . . 0.0 111.581 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.4 ttmt -88.77 122.07 31.8 Favored 'General case' 0 C--N 1.262 -3.235 0 CA-C-N 113.998 -1.456 . . . . 0.0 108.572 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.464 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.01 117.35 33.81 Favored 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 27.3 ttp-105 -79.27 107.36 11.97 Favored 'General case' 0 N--CA 1.394 -3.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.754 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.75 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 64.6 tttt -64.08 97.88 0.19 Allowed 'General case' 0 C--O 1.176 -2.781 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 169.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' ILE . 22.9 t -80.46 -155.81 0.12 Allowed 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 124.54 1.136 . . . . 0.0 109.16 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 m -58.55 -41.47 85.66 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -85.86 -21.46 28.03 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.75 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 102.27 -124.8 8.31 Favored Glycine 1 N--CA 1.392 -4.266 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 35.9 m-85 -86.74 145.7 26.55 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.729 0.764 . . . . 0.0 110.48 -176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.63 1.63 64.03 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.908 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 31' ' ' VAL . 6.7 p90 -114.27 163.06 15.78 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.453 0.644 . . . . 0.0 111.813 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -116.13 148.53 40.22 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.586 HG11 HD23 ' A' ' 41' ' ' LEU . 4.0 t -127.23 143.68 39.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.125 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 104' ' ' PRO . 9.0 p -152.23 163.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.956 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 173.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.76 -65.04 0.55 Allowed Glycine 0 CA--C 1.467 -2.93 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -76.11 58.81 3.16 Favored Glycine 2 CA--C 1.408 -6.64 0 C-N-CA 125.621 1.581 . . . . 0.0 116.971 -166.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -66.21 -9.07 28.51 Favored 'General case' 0 C--N 1.253 -3.629 0 O-C-N 124.32 0.659 . . . . 0.0 111.75 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt-20 -160.62 166.36 15.69 Favored Pre-proline 0 CA--C 1.452 -2.799 0 C-N-CA 116.078 -2.249 . . . . 0.0 111.849 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.4 Cg_endo -67.62 53.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.807 2.338 . . . . 0.0 110.287 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 29.6 t70 -177.61 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.498 1.519 . . . . 0.0 109.872 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.655 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 34.3 mt-10 -117.72 129.75 55.9 Favored 'General case' 0 C--O 1.272 2.256 0 CA-C-O 116.649 -1.643 . . . . 0.0 106.75 169.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.263 6.8 m-30 -79.33 156.4 28.03 Favored 'General case' 0 N--CA 1.523 3.18 0 O-C-N 128.675 3.735 . . . . 0.0 111.927 -177.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.901 HD21 HG21 ' A' ' 80' ' ' VAL . 6.3 mp -91.68 143.17 26.83 Favored 'General case' 0 CA--C 1.455 -2.689 0 C-N-CA 117.153 -1.819 . . . . 0.0 107.437 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 14.1 mt-30 -139.36 154.74 47.92 Favored 'General case' 0 C--N 1.266 -3.04 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 29' ' ' PHE . 19.7 mm -75.11 109.48 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.431 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.22 -37.01 79.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.5 t 161.87 173.66 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 125.388 1.68 . . . . 0.0 109.344 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.495 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.3 pp -137.33 151.87 49.09 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 123.257 0.623 . . . . 0.0 111.469 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.08 116.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.264 0.8 OUTLIER -69.38 -4.17 17.25 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -174.389 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.49 -2.67 54.14 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.406 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.42 167.11 24.56 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.818 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 20' ' ' LEU . 9.2 Cg_endo -53.32 -31.78 58.3 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 124.624 3.549 . . . . 0.0 113.411 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.84 -44.55 86.57 Favored 'General case' 0 C--O 1.273 2.293 0 CA-C-O 121.753 0.787 . . . . 0.0 111.522 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.74 -35.21 57.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.328 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.21 -28.21 53.75 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.36 -20.86 62.11 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.27 63.58 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 112.699 -2.046 . . . . 0.0 112.962 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -29.76 7.39 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.637 -172.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 51.2 ttm -96.96 132.84 42.35 Favored 'General case' 0 N--CA 1.407 -2.593 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.187 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -124.29 156.94 36.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 122.193 0.997 . . . . 0.0 109.336 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 45' ' ' SER . 82.7 p -71.48 107.76 4.55 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.297 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 122.08 -11.96 9.24 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.755 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 8.6 m-20 -64.44 151.46 44.16 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.401 1.101 . . . . 0.0 108.654 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -99.94 123.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 175.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 10.8 mm -71.29 122.31 23.1 Favored 'Isoleucine or valine' 1 C--O 1.322 4.883 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 171.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG13 HD13 ' A' ' 73' ' ' LEU . 44.4 t -114.69 -34.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 O-C-N 127.122 2.764 . . . . 0.0 109.905 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.571 ' HA ' HG22 ' A' ' 72' ' ' VAL . 39.4 m -147.66 148.84 31.49 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.457 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.641 HG12 HG11 ' A' ' 72' ' ' VAL . 8.4 p -125.28 133.11 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.57 27.24 16.39 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.519 0.676 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.35 26.13 14.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 123.484 1.612 . . . . 0.0 111.466 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.9 m -109.16 124.54 50.99 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.24 105.57 0.93 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.101 0.876 . . . . 0.0 109.927 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.641 HG11 HG12 ' A' ' 67' ' ' VAL . 35.7 m -121.18 27.34 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.406 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.606 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 43.8 tp -60.9 113.28 2.43 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.18 45.88 0.3 Allowed Glycine 0 N--CA 1.492 2.397 0 O-C-N 125.557 1.786 . . . . 0.0 111.606 -170.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 76' ' ' THR . 5.9 t60 -46.83 -69.14 0.14 Allowed 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 175.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 75' ' ' HIS . 21.5 p -164.86 144.0 6.89 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 148.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -49.84 -36.14 25.69 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 119.718 1.145 . . . . 0.0 110.437 173.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.01 91.89 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.481 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.524 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 2.1 mp0 -64.05 -44.08 93.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.901 HG21 HD21 ' A' ' 41' ' ' LEU . 28.8 m -70.34 -43.5 78.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.808 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.1 -36.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.58 -43.27 99.17 Favored 'General case' 0 C--O 1.19 -2.029 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.328 176.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.658 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.7 -36.54 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.24 0.543 . . . . 0.0 112.435 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.33 -32.64 68.81 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.316 0.579 . . . . 0.0 110.173 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.565 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 7.8 mm-40 -75.55 -26.3 57.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.749 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.8 m -72.02 -40.36 68.5 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.765 1.226 . . . . 0.0 109.275 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 22' ' ' LYS . 23.5 mt -69.81 135.45 87.8 Favored Pre-proline 0 N--CA 1.42 -1.943 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.994 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 16.3 Cg_endo -90.39 162.53 4.51 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 123.679 2.919 . . . . 0.0 113.208 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.7 mm -59.92 135.1 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.031 175.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.71 10.26 63.42 Favored Glycine 0 C--N 1.291 -1.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.843 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.53 133.57 49.16 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 6.7 m -100.79 159.42 15.2 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.538 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.7 t -144.74 125.5 8.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.648 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.623 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 23.4 m-20 -79.11 109.42 13.4 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.5 mt -104.63 136.91 43.28 Favored 'General case' 0 C--N 1.277 -2.557 0 C-N-CA 124.842 1.257 . . . . 0.0 109.836 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 40.8 tt0 -97.6 122.99 41.32 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 95.9 mt -112.65 148.84 33.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 125.154 1.382 . . . . 0.0 109.713 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.665 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 8.1 t -124.56 115.18 20.43 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.915 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -102.01 141.98 34.0 Favored 'General case' 0 C--N 1.256 -3.489 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.067 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.71 -17.06 3.98 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.354 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -92.01 139.97 24.59 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.16 134.26 24.54 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 124.712 3.608 . . . . 0.0 113.935 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.468 HD23 ' HD2' ' A' ' 104' ' ' PRO . 1.5 tt -62.24 137.06 95.8 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 125.102 1.361 . . . . 0.0 109.611 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' HD2' HD23 ' A' ' 103' ' ' LEU . 18.2 Cg_exo -49.88 156.52 3.28 Favored 'Trans proline' 0 CA--C 1.504 -0.977 0 C-N-CA 124.951 3.767 . . . . 0.0 115.367 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.492 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 t80 -80.1 138.1 36.88 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-N 112.876 -1.965 . . . . 0.0 110.034 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 109' ' ' ASP . 0.3 OUTLIER -111.82 100.84 49.9 Favored Pre-proline 1 N--CA 1.375 -4.208 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.16 -175.512 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 59.3 Cg_endo -97.9 -56.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.293 1.995 . . . . 0.0 111.862 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -111.11 11.46 21.95 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 0.0 109.733 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 106' ' ' ASP . 8.6 t70 -68.69 126.06 92.39 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.627 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.541 ' O ' ' HB ' ' A' ' 116' ' ' THR 0.292 35.9 Cg_endo -74.7 -44.57 0.36 Allowed 'Trans proline' 0 CA--C 1.484 -2.002 0 C-N-CA 122.398 2.065 . . . . 0.0 111.804 178.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.831 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 0.0 OUTLIER -58.39 -21.26 49.77 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 110.993 -2.821 . . . . 0.0 113.019 -164.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.5 p -93.68 -20.36 20.24 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.225 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.0 m -115.21 172.71 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.814 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.8 tp -85.09 65.85 9.44 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.962 0.887 . . . . 0.0 110.527 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.6 p -173.3 40.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.831 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 1.2 t -95.48 129.8 42.52 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -168.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m 45.13 77.42 0.08 Allowed 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 112.61 -2.087 . . . . 0.0 114.118 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 120' ' ' ILE . 89.8 t -66.51 129.7 31.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.595 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.97 16.53 4.85 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.001 0.905 . . . . 0.0 112.251 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.542 ' H ' HG12 ' A' ' 118' ' ' VAL . 53.7 mt -143.37 71.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.4 mt -83.35 119.96 25.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.789 0.804 . . . . 0.0 110.296 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -99.16 113.84 26.29 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.693 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -142.7 52.2 1.42 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.91 136.97 73.15 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.559 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 C--O 1.254 1.28 0 C-N-CA 122.882 2.388 . . . . 0.0 110.93 173.72 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.875 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 65.52 -80.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.282 1.433 . . . . 0.0 112.455 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -119.84 90.78 3.4 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 135.08 -124.16 3.31 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.449 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 1.1 tppp? 48.35 67.54 4.39 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 125.191 1.396 . . . . 0.0 112.424 -174.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 1.8 Cg_endo -87.27 -175.77 1.65 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.128 2.552 . . . . 0.0 111.094 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.19 104.83 3.2 Favored 'General case' 0 N--CA 1.411 -2.377 0 C-N-CA 124.349 1.06 . . . . 0.0 108.562 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.606 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.7 t80 -98.94 139.12 35.07 Favored 'General case' 0 C--N 1.268 -2.976 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -147.51 10.28 0.96 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.963 0.887 . . . . 0.0 110.79 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.544 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 14.1 mtp180 52.9 6.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.803 2.041 . . . . 0.0 115.092 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -134.09 122.1 16.05 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HB3' HG11 ' A' ' 65' ' ' VAL . 3.4 Cg_exo -54.98 -34.93 88.6 Favored 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 124.135 3.223 . . . . 0.0 112.345 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -71.81 -21.99 61.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.563 0.697 . . . . 0.0 111.21 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -92.45 -24.27 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 42.5 tp -85.91 159.2 19.73 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.829 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 53.4 mttp -99.13 -171.23 2.05 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.96 177.93 27.94 Favored Glycine 0 C--N 1.292 -1.865 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.911 -176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -99.81 122.67 43.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.5 m-85 -103.87 117.97 35.59 Favored 'General case' 0 C--N 1.253 -3.628 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.41 HG13 ' HE3' ' A' ' 14' ' ' LYS . 66.4 mt -127.25 126.74 68.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.463 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -99.95 111.95 24.24 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.507 ' OG1' ' HD2' ' A' ' 57' ' ' LYS . 14.8 t -133.1 147.59 52.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.018 0.913 . . . . 0.0 110.73 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.808 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 22.0 ttpp -90.17 132.31 35.54 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.608 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -109.68 119.27 38.88 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 72.5 ttt180 -81.48 109.47 15.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.965 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.5 tttt -63.95 96.51 0.14 Allowed 'General case' 0 C--O 1.184 -2.377 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -90.03 -154.73 0.34 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 124.457 1.103 . . . . 0.0 109.061 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 m -52.35 -40.63 62.2 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.878 0.871 . . . . 0.0 111.695 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -95.6 -9.41 32.27 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.012 0.434 . . . . 0.0 110.065 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.734 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.01 -119.08 6.25 Favored Glycine 1 N--CA 1.392 -4.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.589 ' HD1' HD12 ' A' ' 20' ' ' LEU . 46.2 m-85 -91.46 139.88 30.29 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 117.763 0.782 . . . . 0.0 108.935 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.94 3.01 87.28 Favored Glycine 0 C--N 1.315 -0.638 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.897 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.523 ' HB2' HG23 ' A' ' 43' ' ' ILE . 12.1 p90 -116.33 162.69 17.13 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.353 0.597 . . . . 0.0 111.324 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 26.3 p -116.19 152.91 32.8 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG11 HD23 ' A' ' 41' ' ' LEU . 4.6 t -126.53 143.86 38.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.464 -174.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.66 155.61 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.25 -72.94 0.45 Allowed Glycine 0 CA--C 1.459 -3.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.0 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.858 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -62.11 58.51 0.03 OUTLIER Glycine 1 CA--C 1.442 -4.505 0 C-N-CA 127.454 2.454 . . . . 0.0 117.459 -169.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.638 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 17.3 t70 -63.09 -27.98 69.77 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -154.82 166.31 16.32 Favored Pre-proline 0 CA--C 1.454 -2.727 0 C-N-CA 116.192 -2.203 . . . . 0.0 110.941 -170.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 34.7 Cg_endo -68.42 55.79 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.308 2.005 . . . . 0.0 109.718 171.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -178.63 -17.15 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.008 1.723 . . . . 0.0 110.06 -171.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.858 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 19.1 mm-40 -115.89 127.03 54.68 Favored 'General case' 0 C--O 1.273 2.301 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.269 6.0 m-30 -79.02 157.68 28.04 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 128.77 3.794 . . . . 0.0 111.628 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 80' ' ' VAL . 5.3 mp -88.25 143.53 26.98 Favored 'General case' 0 C--O 1.185 -2.319 0 C-N-CA 117.149 -1.821 . . . . 0.0 107.105 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.2 mt-30 -140.25 154.68 46.94 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.523 HG23 ' HB2' ' A' ' 29' ' ' PHE . 18.9 mm -73.96 113.24 11.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 19.2 ttmm -57.14 -38.04 72.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 125.13 1.519 . . . . 0.0 107.16 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.512 ' HA ' HG22 ' A' ' 60' ' ' THR . 34.8 t 159.86 173.35 0.01 OUTLIER 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.428 1.891 . . . . 0.0 109.114 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -139.4 147.82 41.98 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.414 0.626 . . . . 0.0 111.671 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 49' ' ' ASP . 44.3 t -76.53 128.06 37.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.51 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -64.53 -15.45 60.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.47 ' H ' HG12 ' A' ' 47' ' ' VAL . 2.3 m-20 -99.12 6.83 46.32 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.957 176.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.25 158.81 21.79 Favored Glycine 0 N--CA 1.398 -3.847 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HG2' HD11 ' A' ' 20' ' ' LEU . 10.1 Cg_endo -52.21 -30.52 42.12 Favored 'Trans proline' 0 C--O 1.202 -1.318 0 C-N-CA 124.429 3.42 . . . . 0.0 112.884 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -60.1 -44.59 94.73 Favored 'General case' 0 C--O 1.278 2.565 0 CA-C-O 121.551 0.691 . . . . 0.0 111.982 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.55 -35.02 53.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.811 -1.541 . . . . 0.0 111.022 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.1 -46.02 72.1 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.313 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 38.3 t70 -63.67 -34.58 78.17 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.62 -8.77 58.25 Favored Glycine 0 CA--C 1.492 -1.393 0 CA-C-N 112.484 -2.144 . . . . 0.0 114.082 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HD2' ' OG1' ' A' ' 18' ' ' THR . 46.1 mttp -86.7 -14.53 42.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 123.117 0.567 . . . . 0.0 112.081 -176.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 ttm -104.02 144.96 30.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -143.67 155.52 44.25 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 121.447 0.642 . . . . 0.0 110.103 -173.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 45' ' ' SER . 77.8 p -63.21 108.45 1.28 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.909 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.86 -0.31 31.92 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.121 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.606 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.0 p30 -73.43 146.94 44.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.425 -1.71 . . . . 0.0 107.292 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -94.65 120.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 26.6 mm -71.08 125.16 28.93 Favored 'Isoleucine or valine' 1 C--O 1.319 4.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 73' ' ' LEU . 48.6 t -115.27 -41.36 3.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.614 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.632 ' HA ' HG22 ' A' ' 72' ' ' VAL . 66.5 m -145.34 147.42 32.29 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.281 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 72' ' ' VAL . 6.4 p -125.1 132.0 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.03 29.57 14.67 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.452 0.644 . . . . 0.0 111.101 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 67.58 11.51 8.41 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.7 m -93.47 122.85 36.33 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 37.2 t -66.04 103.6 0.98 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.632 HG22 ' HA ' ' A' ' 66' ' ' SER . 33.6 m -117.84 25.67 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.884 0.849 . . . . 0.0 110.501 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.606 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.2 tp -61.43 113.28 2.57 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 35.46 40.72 0.3 Allowed Glycine 0 N--CA 1.497 2.725 0 O-C-N 125.188 1.555 . . . . 0.0 111.785 -170.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 76' ' ' THR . 7.0 t60 -43.98 -67.22 0.3 Allowed 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.4 p -167.35 143.57 4.25 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 150.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.522 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -49.8 -36.55 26.7 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 120.194 1.361 . . . . 0.0 110.119 172.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.2 81.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.448 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' OE1' ' HA ' ' A' ' 79' ' ' GLN . 7.3 mm-40 -66.8 -44.26 81.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 41' ' ' LEU . 34.0 m -65.58 -40.06 86.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.471 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.5 -39.04 84.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -59.62 -38.43 81.31 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.676 177.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.599 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 72.4 mt -68.09 -38.41 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.574 0.702 . . . . 0.0 110.853 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.07 -30.83 65.52 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.89 -32.55 73.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.313 1.045 . . . . 0.0 109.994 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 59.5 m -71.84 -43.17 66.0 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.474 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 17.5 mt -71.8 133.06 84.55 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.574 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 36.0 Cg_endo -91.44 161.84 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.507 2.804 . . . . 0.0 113.549 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.0 mm -61.63 129.98 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 121.156 0.503 . . . . 0.0 111.019 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.72 11.94 51.95 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.707 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.4 -170.48 1.81 Allowed 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.2 m -147.79 166.78 26.52 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -150.45 125.2 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.463 -2.371 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.772 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.58 105.53 16.23 Favored 'General case' 0 C--N 1.268 -2.969 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -111.83 151.61 28.87 Favored 'General case' 0 C--O 1.208 -1.083 0 C-N-CA 125.593 1.557 . . . . 0.0 110.777 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 17' ' ' HIS . 22.8 tt0 -111.01 121.73 46.1 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.748 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.7 mp -108.62 164.42 12.38 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 126.654 1.982 . . . . 0.0 109.272 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.5 t -140.69 112.46 7.57 Favored 'General case' 0 C--O 1.19 -2.026 0 CA-C-O 122.339 1.066 . . . . 0.0 111.992 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.606 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 7.7 tpp180 -95.3 129.99 42.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.78 -17.52 0.96 Allowed Glycine 0 C--N 1.294 -1.769 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.053 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -107.23 126.94 28.9 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 121.022 0.439 . . . . 0.0 109.892 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.14 150.69 71.96 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 124.126 3.217 . . . . 0.0 112.573 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 6.4 mt -57.34 124.48 67.01 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.239 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 7.4 Cg_exo -66.75 -46.76 3.24 Favored 'Trans proline' 0 CA--C 1.49 -1.684 0 C-N-CA 123.339 2.693 . . . . 0.0 110.787 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 86.0 t80 -138.66 141.67 39.04 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.291 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.43 100.69 42.76 Favored Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 124.286 0.991 . . . . 0.0 111.813 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.468 ' HG3' ' HG2' ' A' ' 44' ' ' LYS . 59.9 Cg_endo -99.45 -64.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.643 0 C-N-CA 122.588 2.192 . . . . 0.0 111.621 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -119.68 31.72 6.42 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.989 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 34.8 t70 -86.48 108.73 19.03 Favored Pre-proline 0 CA--C 1.457 -2.633 0 C-N-CA 117.466 -1.694 . . . . 0.0 106.573 168.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.592 ' HG2' ' HB3' ' A' ' 117' ' ' SER . 73.2 Cg_endo -73.4 -30.84 9.73 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 122.161 1.908 . . . . 0.0 110.309 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.547 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 26.6 t30 -65.27 -2.31 2.96 Favored 'General case' 0 N--CA 1.389 -3.523 0 C-N-CA 131.358 3.863 . . . . 0.0 112.683 -168.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.467 HG23 ' OD2' ' A' ' 109' ' ' ASP . 23.7 p -92.36 -22.37 19.72 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.366 -175.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.9 m -92.17 162.17 14.43 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.31 -1.313 . . . . 0.0 107.994 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.98 141.52 47.75 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.35 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.26 21.8 m 49.26 38.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.774 1.63 . . . . 0.0 114.247 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 110' ' ' PRO . 1.1 m -110.56 -172.88 2.12 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.592 ' HB3' ' HG2' ' A' ' 110' ' ' PRO . 10.9 p 59.56 96.1 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.075 0.95 . . . . 0.0 112.376 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -69.07 74.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.589 1.185 . . . . 0.0 112.688 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.71 33.2 2.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.544 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.0 mt 60.73 58.24 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.27 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.0 mt -127.27 117.43 22.26 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.835 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -125.28 51.14 1.71 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -92.55 80.36 4.84 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.728 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -101.88 136.65 19.48 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--O 1.262 1.724 0 C-N-CA 123.024 2.483 . . . . 0.0 112.225 176.79 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.785 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -64.37 -64.34 0.91 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 117.558 0.679 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -111.9 19.0 18.34 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 98.88 -146.76 18.27 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.594 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 46.8 mmtm -108.6 -61.31 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 CA-C-N 118.69 1.245 . . . . 0.0 110.242 168.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 1' ' ' LYS . 44.2 Cg_endo -104.34 -164.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.814 1.676 . . . . 0.0 111.594 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -76.31 107.14 8.35 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 124.97 1.308 . . . . 0.0 107.659 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.587 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.1 t80 -101.73 129.87 48.0 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -138.17 11.8 2.82 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.284 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 32.6 mtt180 52.59 8.43 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.804 2.042 . . . . 0.0 114.789 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.407 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 7.9 m120 -131.96 116.75 15.83 Favored Pre-proline 0 N--CA 1.415 -2.176 0 C-N-CA 122.458 0.303 . . . . 0.0 110.974 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -63.56 -18.05 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 110.785 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 7' ' ' ASN . 7.8 p -76.15 -29.72 57.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.851 177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -107.38 -10.96 15.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.051 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -93.5 149.82 20.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.466 ' N ' HD13 ' A' ' 11' ' ' LEU . 45.9 mtmt -105.79 135.54 47.04 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.731 0.776 . . . . 0.0 110.998 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.569 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 151.17 170.15 17.75 Favored Glycine 1 C--N 1.244 -4.583 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -172.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -92.32 122.35 34.7 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.397 1.098 . . . . 0.0 108.443 175.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 95.6 m-85 -98.66 117.45 33.14 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 122.611 1.196 . . . . 0.0 110.027 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.469 HG12 ' HE3' ' A' ' 14' ' ' LYS . 34.1 mt -114.35 152.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.065 0 CA-C-N 112.755 -2.021 . . . . 0.0 109.357 -172.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 94' ' ' ASP . 2.8 t-160 -129.31 108.47 10.33 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.415 ' CG2' HD11 ' A' ' 97' ' ' LEU . 7.7 t -131.54 135.08 46.75 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 121.872 0.844 . . . . 0.0 109.81 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 33.8 ttmt -89.45 126.65 35.65 Favored 'General case' 0 C--N 1.257 -3.436 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.782 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.498 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.47 116.94 32.8 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 56.5 ttt180 -77.89 107.44 10.42 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.931 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.735 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 64.7 tttt -61.85 97.34 0.08 Allowed 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t -86.23 -155.36 0.25 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 124.758 1.223 . . . . 0.0 108.818 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 m -54.21 -41.3 68.5 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.991 0.916 . . . . 0.0 110.816 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 mmp_? -96.16 -8.85 32.06 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.189 0.519 . . . . 0.0 109.958 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.735 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 96.32 -120.67 6.7 Favored Glycine 1 N--CA 1.391 -4.315 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.514 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 34.2 m-85 -89.58 141.74 28.31 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.401 0.6 . . . . 0.0 109.576 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.22 1.11 84.31 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.966 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' HB2' HG23 ' A' ' 43' ' ' ILE . 19.4 p90 -114.58 162.37 16.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.725 0.774 . . . . 0.0 111.099 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 40.6 p -115.18 154.34 29.18 Favored 'General case' 0 N--CA 1.399 -3.013 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 41' ' ' LEU . 3.3 p -143.81 144.24 23.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.664 -174.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.33 170.02 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.26 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.05 -68.83 0.48 Allowed Glycine 0 CA--C 1.452 -3.906 0 CA-C-N 115.124 -0.943 . . . . 0.0 113.796 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -75.39 58.02 2.86 Favored Glycine 2 CA--C 1.406 -6.73 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' HIS . 13.4 m-20 -64.45 -12.78 47.08 Favored 'General case' 0 C--N 1.261 -3.251 0 O-C-N 124.449 0.735 . . . . 0.0 110.797 176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 38' ' ' ASP . 6.1 pt-20 -158.23 165.14 19.22 Favored Pre-proline 0 CA--C 1.452 -2.812 0 C-N-CA 116.519 -2.072 . . . . 0.0 111.205 -173.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.5 Cg_endo -68.37 47.01 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.764 2.309 . . . . 0.0 111.529 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 36' ' ' GLU . 27.2 m-20 -165.44 -22.69 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.356 2.262 . . . . 0.0 109.248 -172.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.716 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 37.9 mt-10 -112.83 126.25 55.23 Favored 'General case' 0 C--O 1.268 2.055 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.259 5.2 m-30 -78.78 157.43 28.44 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 128.076 3.36 . . . . 0.0 111.365 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 80' ' ' VAL . 6.9 mp -90.08 144.71 25.65 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 117.506 -1.678 . . . . 0.0 107.093 175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.8 mt-30 -143.54 151.01 39.72 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 29' ' ' PHE . 19.3 mm -68.39 117.8 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.987 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.625 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 20.8 tptm -63.05 -43.37 98.81 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.534 ' HA ' HG22 ' A' ' 60' ' ' THR . 40.2 t 166.14 174.97 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 125.596 1.81 . . . . 0.0 109.993 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.3 152.41 45.85 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.704 0.764 . . . . 0.0 112.923 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 49' ' ' ASP . 49.4 t -85.35 128.61 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.51 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 89.1 mt -68.88 -15.9 63.62 Favored 'General case' 0 N--CA 1.387 -3.612 0 CA-C-N 112.733 -2.03 . . . . 0.0 113.59 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.49 ' H ' HG12 ' A' ' 47' ' ' VAL . 3.9 m-20 -96.26 -5.36 40.44 Favored 'General case' 0 C--N 1.26 -3.303 0 CA-C-N 114.154 -1.385 . . . . 0.0 111.245 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.71 162.96 28.11 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.6 Cg_endo -53.99 -31.79 65.43 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 124.541 3.494 . . . . 0.0 113.576 -174.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -59.3 -42.67 91.87 Favored 'General case' 0 C--O 1.279 2.641 0 CA-C-O 121.706 0.765 . . . . 0.0 111.42 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.74 -37.35 49.46 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.899 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 8.6 mp -68.82 -40.28 79.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.74 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.55 -26.1 61.61 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.72 2.78 77.42 Favored Glycine 0 CA--C 1.495 -1.181 0 CA-C-N 112.888 -1.96 . . . . 0.0 113.826 172.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -91.46 -21.28 21.01 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.21 149.28 23.25 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.575 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.37 154.73 40.34 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.395 0.617 . . . . 0.0 110.625 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 45' ' ' SER . 67.8 p -61.37 106.04 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.761 0.824 . . . . 0.0 111.493 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 110.79 -2.27 28.88 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 119.311 -0.716 . . . . 0.0 113.563 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.55 ' CB ' ' HG3' ' A' ' 99' ' ' ARG . 2.8 p30 -69.71 138.67 53.09 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.5 OUTLIER -87.76 120.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.486 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 31.3 mm -71.62 124.37 27.96 Favored 'Isoleucine or valine' 1 C--O 1.324 4.978 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 172.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 73' ' ' LEU . 37.0 t -115.63 -40.9 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.064 -2.789 . . . . 0.0 111.036 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.55 ' HA ' HG22 ' A' ' 72' ' ' VAL . 24.7 m -149.82 150.38 31.89 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.7 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.722 HG13 HG21 ' A' ' 72' ' ' VAL . 2.9 m -121.99 142.11 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 169.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.8 m120 54.61 28.11 9.46 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.548 0.689 . . . . 0.0 111.379 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 54.9 42.32 31.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.668 1.699 . . . . 0.0 111.832 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 72' ' ' VAL . 88.8 m -122.12 122.82 40.1 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.898 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.54 100.17 0.49 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.926 0.869 . . . . 0.0 111.055 -175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.722 HG21 HG13 ' A' ' 67' ' ' VAL . 17.4 m -105.04 17.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.587 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.1 tp -60.61 112.96 2.2 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.44 44.98 0.3 Allowed Glycine 0 N--CA 1.496 2.645 0 O-C-N 125.649 1.843 . . . . 0.0 111.272 -170.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 76' ' ' THR . 8.4 t60 -45.37 -67.62 0.27 Allowed 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 176.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' HIS . 3.1 p -166.9 142.78 4.36 Favored 'General case' 0 C--N 1.262 -3.219 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 148.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.653 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -51.04 -35.21 33.19 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 120.695 1.588 . . . . 0.0 111.205 173.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.14 96.39 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.654 0.264 . . . . 0.0 110.929 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.431 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 16.9 mm-40 -69.65 -41.57 75.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.876 HG21 HD21 ' A' ' 41' ' ' LEU . 21.1 m -63.66 -39.82 86.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.154 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.62 -40.77 90.22 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -61.06 -36.81 80.59 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.704 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.556 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.9 mm -70.45 -37.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 123.683 0.793 . . . . 0.0 112.057 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -73.33 -29.01 62.39 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -76.34 -20.18 57.49 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.407 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 37.6 t -78.04 -26.39 48.35 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.501 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.6 mt -90.07 130.11 43.53 Favored Pre-proline 0 N--CA 1.398 -3.032 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.134 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.0 Cg_endo -89.49 162.44 5.41 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 123.697 2.932 . . . . 0.0 112.954 -173.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.557 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 27.3 mm -60.12 133.6 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 CA-C-O 121.538 0.685 . . . . 0.0 110.902 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.58 11.76 60.33 Favored Glycine 0 C--N 1.289 -2.078 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.019 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.38 -167.92 1.46 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 15.9 m -151.52 163.39 39.13 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 121.929 -0.482 . . . . 0.0 109.919 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -145.83 125.26 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 C-N-CA 119.569 -0.853 . . . . 0.0 111.76 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 9.5 m-20 -80.08 107.16 12.65 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' SER . 63.6 mt -104.96 135.59 46.01 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 124.433 1.093 . . . . 0.0 111.75 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 38.8 mt-10 -90.52 120.47 31.64 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 7.9 mt -105.65 164.63 11.76 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.569 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 34.8 t -141.37 109.16 5.68 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 122.254 1.026 . . . . 0.0 110.906 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.55 ' HG3' ' CB ' ' A' ' 62' ' ' ASP 0.33 23.7 mtm180 -96.18 117.97 31.81 Favored 'General case' 0 C--N 1.257 -3.422 0 O-C-N 121.331 -0.856 . . . . 0.0 113.133 174.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.55 -29.73 0.1 Allowed Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.287 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -101.64 135.46 19.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.547 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.72 161.77 44.64 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.257 2.638 . . . . 0.0 111.231 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 14.4 mt -50.41 127.06 23.17 Favored Pre-proline 0 N--CA 1.44 -0.96 0 C-N-CA 124.452 1.101 . . . . 0.0 111.195 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 66.4 Cg_endo -78.94 -81.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.048 3.165 . . . . 0.0 117.045 -170.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -128.22 146.56 50.7 Favored 'General case' 0 N--CA 1.424 -1.725 0 O-C-N 121.861 -0.524 . . . . 0.0 111.041 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' HB2' HG21 ' A' ' 112' ' ' THR . 0.7 OUTLIER -132.96 104.84 12.63 Favored Pre-proline 0 C--N 1.302 -1.498 0 C-N-CA 124.689 1.196 . . . . 0.0 110.621 -178.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -99.76 -64.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.282 1.988 . . . . 0.0 112.698 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -88.22 -11.58 46.26 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.47 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -91.97 142.67 26.68 Favored Pre-proline 0 CA--C 1.463 -2.375 0 C-N-CA 118.427 -1.309 . . . . 0.0 113.392 -167.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.541 ' HB3' ' O ' ' A' ' 119' ' ' ALA 0.285 50.2 Cg_endo -81.56 -40.93 0.14 Allowed 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.798 1.666 . . . . 0.0 111.699 167.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.718 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 55.5 m-80 -48.68 -17.12 0.15 Allowed 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -163.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.457 HG21 ' HB2' ' A' ' 106' ' ' ASP . 46.9 p -82.64 -38.93 22.8 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -170.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.2 m -158.79 125.82 4.81 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.0 mt 50.57 111.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.76 2.024 . . . . 0.0 114.765 173.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.0 t 60.68 77.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 111' ' ' ASN . 1.6 p -124.66 166.79 15.51 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.058 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 110' ' ' PRO . 32.7 t 63.71 114.67 0.02 OUTLIER 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.444 1.097 . . . . 0.0 111.309 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.6 t 59.36 46.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.79 1.281 . . . . 0.0 108.256 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 110' ' ' PRO . . . -159.93 69.13 0.4 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.879 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.97 91.12 3.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.31 12.19 23.34 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.772 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -85.02 -7.79 58.98 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.015 -1.902 . . . . 0.0 107.158 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 75.89 71.27 0.08 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.193 2.197 . . . . 0.0 113.742 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -101.94 142.87 25.47 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--O 1.254 1.308 0 C-N-CA 123.033 2.488 . . . . 0.0 112.703 177.1 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -150.81 -163.5 1.79 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . 0.582 ' HA ' ' HB3' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -68.03 -31.92 71.93 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.231 175.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -136.17 -93.06 0.36 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.477 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.1 OUTLIER 58.51 71.75 0.96 Allowed Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 124.781 1.233 . . . . 0.0 113.695 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -104.07 -172.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 123.42 2.747 . . . . 0.0 110.228 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -89.93 104.8 17.34 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.552 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.9 t80 -105.15 131.15 53.0 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 HD23 ' A' ' 11' ' ' LEU . 8.8 t -140.38 19.05 2.4 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.246 1.022 . . . . 0.0 110.704 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 57.6 mtt180 58.41 -13.13 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.96 2.104 . . . . 0.0 115.961 172.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.533 ' OD1' ' HB2' ' A' ' 9' ' ' SER . 23.7 t-20 -113.57 119.48 41.52 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 110.927 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.1 Cg_exo -54.4 -32.82 74.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.179 3.252 . . . . 0.0 112.814 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.533 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 26.4 m -75.69 -22.48 56.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.408 0.683 . . . . 0.0 110.954 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 22.3 mm-40 -90.29 -19.56 23.96 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.898 0.879 . . . . 0.0 111.033 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD11 HD21 ' A' ' 73' ' ' LEU . 51.0 mt -74.48 172.37 12.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.092 0.948 . . . . 0.0 111.485 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -108.39 -170.39 1.67 Allowed 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 90.16 165.71 40.81 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.09 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 22.2 ttpt -95.86 137.7 34.55 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.464 ' HZ ' ' HB2' ' A' ' 11' ' ' LEU . 30.8 m-85 -104.88 111.89 24.81 Favored 'General case' 0 CA--C 1.458 -2.592 0 CA-C-O 122.687 1.232 . . . . 0.0 110.226 -173.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.461 HG12 ' CE ' ' A' ' 14' ' ' LYS . 9.4 mt -108.46 113.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.9 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.007 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.87 128.42 34.41 Favored 'General case' 0 C--N 1.252 -3.631 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.915 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 95' ' ' LEU . 7.4 t -133.62 157.01 46.83 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.399 -173.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -130.58 119.02 21.89 Favored 'General case' 0 C--N 1.247 -3.865 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 172.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' HG ' ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -106.67 117.47 34.14 Favored 'General case' 0 C--N 1.277 -2.576 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.837 -174.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 23.4 tpp180 -70.66 105.66 3.24 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.51 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.744 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 62.6 tttt -69.34 97.76 1.0 Allowed 'General case' 0 C--O 1.161 -3.603 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 165.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -86.66 -155.27 0.26 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.6 m -63.31 -33.12 74.82 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.541 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 1.3 tmt_? -83.53 -20.97 32.93 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.744 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 94.14 -129.19 9.79 Favored Glycine 0 N--CA 1.401 -3.649 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.8 m-85 -86.98 146.97 25.94 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 118.134 0.967 . . . . 0.0 110.212 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 20' ' ' LEU . . . -94.38 0.74 66.15 Favored Glycine 0 C--O 1.22 -0.775 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.533 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 5.8 p90 -115.67 163.48 15.74 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.178 0.514 . . . . 0.0 110.642 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 61.6 p -123.71 147.53 47.38 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.84 150.14 26.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.391 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.49 152.89 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.523 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.84 -132.12 9.7 Favored Glycine 1 N--CA 1.395 -4.06 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 47.58 37.46 13.42 Favored Glycine 0 CA--C 1.476 -2.363 0 C-N-CA 124.212 0.911 . . . . 0.0 113.55 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 29.3 t70 -69.03 -29.4 67.54 Favored 'General case' 0 CA--C 1.459 -2.547 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -174.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -162.38 166.74 13.46 Favored Pre-proline 0 CA--C 1.455 -2.702 0 C-N-CA 118.352 -1.339 . . . . 0.0 109.243 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 30.7 Cg_endo -66.19 58.72 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.005 2.47 . . . . 0.0 109.583 170.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 174.54 -9.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.746 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.5 mm-40 -128.34 124.53 36.68 Favored 'General case' 0 C--O 1.281 2.744 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.521 ' CE1' HD11 ' A' ' 73' ' ' LEU 0.276 5.9 m-30 -76.66 158.81 30.75 Favored 'General case' 1 N--CA 1.549 4.52 0 C-N-CA 130.914 3.685 . . . . 0.0 113.609 -168.246 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 80' ' ' VAL . 6.2 mp -92.4 138.86 31.15 Favored 'General case' 0 C--O 1.178 -2.659 0 C-N-CA 117.068 -1.853 . . . . 0.0 106.951 170.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.592 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 18.1 mt-30 -136.16 154.18 51.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 20.7 mm -71.34 115.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' SER . 31.0 ttpt -65.01 -41.63 95.18 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 166.72 173.72 0.03 OUTLIER 'General case' 0 C--N 1.371 1.503 0 O-C-N 125.186 1.554 . . . . 0.0 110.724 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 58' ' ' MET . 1.4 pp -141.6 152.2 43.8 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 123.816 0.846 . . . . 0.0 111.819 -172.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 49' ' ' ASP . 14.0 t -82.85 124.41 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.793 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.88 -3.75 13.83 Favored 'General case' 0 N--CA 1.379 -3.975 0 CA-C-N 112.836 -1.984 . . . . 0.0 112.937 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' H ' HG12 ' A' ' 47' ' ' VAL . 17.0 t70 -95.79 -22.97 17.17 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.658 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.35 162.77 36.83 Favored Glycine 0 N--CA 1.398 -3.892 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.586 -170.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -51.39 -30.32 33.98 Favored 'Trans proline' 0 C--O 1.197 -1.553 0 C-N-CA 125.178 3.919 . . . . 0.0 112.952 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.06 -47.97 81.52 Favored 'General case' 0 C--O 1.258 1.524 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.34 -36.2 54.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.644 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.31 -40.6 70.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.733 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.37 -21.6 62.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.81 39.88 75.84 Favored Glycine 0 CA--C 1.492 -1.372 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.29 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -111.26 -37.62 5.25 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.677 0.275 . . . . 0.0 111.463 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.429 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 1.1 mpt? -95.93 153.14 17.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.403 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.78 158.38 43.69 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 45' ' ' SER . 49.0 p -64.22 108.67 1.64 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.007 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.486 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.56 -11.64 9.61 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.709 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 2.9 m-20 -62.86 136.69 57.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.547 1.173 . . . . 0.0 108.803 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -88.25 123.36 40.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 177.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.5 mm -74.59 123.52 30.28 Favored 'Isoleucine or valine' 1 C--O 1.34 5.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 HD13 ' A' ' 73' ' ' LEU . 46.0 t -115.53 -36.14 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 127.444 2.965 . . . . 0.0 111.375 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 65.6 m -148.57 159.62 43.9 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.515 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG12 ' HB ' ' A' ' 72' ' ' VAL . 4.3 p -141.45 130.18 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 124.72 1.208 . . . . 0.0 108.016 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.23 31.48 20.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.461 0.648 . . . . 0.0 110.728 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t70 71.2 1.4 3.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.495 1.518 . . . . 0.0 112.593 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.3 m -90.95 121.97 33.23 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.8 t -58.86 114.8 2.72 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -124.23 19.39 4.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.57 HD13 HG13 ' A' ' 65' ' ' VAL . 27.8 tp -59.15 112.85 1.86 Allowed 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.11 39.76 0.06 OUTLIER Glycine 0 C--O 1.186 -2.879 0 O-C-N 125.737 1.898 . . . . 0.0 112.792 -170.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 76' ' ' THR . 4.6 t60 -43.38 -65.75 0.46 Allowed 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.9 p -167.33 143.84 4.35 Favored 'General case' 0 C--N 1.266 -3.052 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 151.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.581 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.85 -35.13 30.99 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 120.099 1.318 . . . . 0.0 109.702 171.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.29 -46.95 87.17 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.436 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 13.3 mm-40 -66.35 -43.08 87.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 41' ' ' LEU . 15.3 m -64.44 -44.89 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 84.5 t -64.51 -42.12 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -60.74 -37.89 83.3 Favored 'General case' 0 C--O 1.212 -0.887 0 O-C-N 123.151 0.282 . . . . 0.0 111.47 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.57 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.9 mm -67.48 -38.28 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.307 0.575 . . . . 0.0 112.148 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.54 -32.19 65.88 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.523 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 25.6 mt-30 -67.78 -32.07 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.211 1.005 . . . . 0.0 109.691 173.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.2 m -72.33 -40.6 67.31 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.886 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.478 HG22 ' HD3' ' A' ' 22' ' ' LYS . 30.8 mt -70.34 133.05 87.47 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.475 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 91' ' ' ALA . 15.0 Cg_endo -87.21 162.65 8.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.57 2.847 . . . . 0.0 113.433 -172.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.526 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.9 mm -60.22 134.8 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.609 0.719 . . . . 0.0 111.074 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.37 8.26 66.4 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.365 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.536 ' O ' ' HB3' ' A' ' 22' ' ' LYS . . . -104.24 128.08 51.94 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.415 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 1.9 p -89.79 159.14 17.18 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.13 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -141.78 125.6 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.183 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.913 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.3 104.5 15.2 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.492 ' HB2' HG23 ' A' ' 18' ' ' THR . 27.9 mt -109.68 159.72 16.9 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 126.138 1.775 . . . . 0.0 109.305 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -112.44 122.71 48.5 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 75.7 mt -109.14 163.14 13.61 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.21 1.004 . . . . 0.0 108.766 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -142.91 116.58 9.22 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.412 175.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.493 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 ttm180 -104.73 125.57 50.95 Favored 'General case' 0 C--N 1.258 -3.374 0 O-C-N 120.729 -1.232 . . . . 0.0 108.764 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.9 -22.03 0.23 Allowed Glycine 0 CA--C 1.472 -2.639 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -90.89 134.62 29.99 Favored Pre-proline 0 N--CA 1.422 -1.835 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.58 152.57 81.28 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.803 3.002 . . . . 0.0 112.939 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 6.1 mt -59.9 128.41 86.84 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 123.477 0.711 . . . . 0.0 110.654 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 90.6 Cg_endo -83.9 -158.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.054 2.503 . . . . 0.0 113.389 -177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.582 ' HB3' ' HA ' ' A' ' -1' ' ' MET . 66.9 t80 -79.96 150.63 30.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 123.153 1.454 . . . . 0.0 111.293 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -115.41 86.32 14.67 Favored Pre-proline 0 N--CA 1.388 -3.574 0 CA-C-N 111.726 -2.488 . . . . 0.0 110.887 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -88.3 -49.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.516 2.144 . . . . 0.0 111.378 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -59.38 -22.99 62.19 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 125.183 1.393 . . . . 0.0 110.832 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.499 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -108.53 102.98 49.69 Favored Pre-proline 0 CA--C 1.473 -2.009 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.879 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.499 ' HD2' ' HA ' ' A' ' 109' ' ' ASP 0.285 54.7 Cg_endo -76.65 -29.41 5.75 Favored 'Trans proline' 0 CA--C 1.501 -1.128 0 C-N-CA 122.371 2.047 . . . . 0.0 108.89 170.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 110' ' ' PRO . 57.2 m-20 -47.58 -2.81 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 1 C-N-CA 132.67 4.388 . . . . 0.0 116.014 -168.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 110' ' ' PRO . 26.4 p -107.04 6.38 28.94 Favored 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -168.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.0 m -146.19 110.26 4.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.773 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.8 mt 55.66 -154.22 0.31 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.279 0.631 . . . . 0.0 110.374 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.6 m -56.46 84.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 122.04 0.924 . . . . 0.0 112.745 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.436 ' HB ' ' HA ' ' A' ' 111' ' ' ASN . 2.0 p -134.67 167.16 21.34 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.431 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . 61.8 p 61.9 101.53 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.406 1.082 . . . . 0.0 109.411 -168.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.9 m -52.23 96.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -175.02 114.98 0.15 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.3 mm -122.04 103.5 13.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 122.049 0.928 . . . . 0.0 112.399 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.3 mt -116.37 22.59 12.72 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.94 146.05 26.4 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.605 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -86.79 -10.68 52.99 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.098 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.05 139.62 96.69 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.495 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 C--O 1.256 1.382 0 C-N-CA 123.818 3.012 . . . . 0.0 112.463 174.558 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 1' ' ' LYS . . . . . . . . 0 CA--C 1.494 -1.273 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.23 -85.27 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 7.5 mmt -101.75 0.03 35.18 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 173.51 -97.26 0.11 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.416 ' HB2' ' HA2' ' A' ' -3' ' ' GLY . 24.9 mmmt 59.16 69.69 1.29 Allowed Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.417 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' HG3' ' H ' ' A' ' 40' ' ' PHE . 40.2 Cg_endo -108.61 -175.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.931 2.42 . . . . 0.0 113.57 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -88.83 105.3 17.64 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.576 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.8 t80 -108.76 135.24 50.31 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -143.3 12.7 1.78 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.313 1.054 . . . . 0.0 110.239 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.566 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 7.1 mtm180 59.76 -11.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.008 2.123 . . . . 0.0 114.88 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.495 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 51.2 t-20 -111.35 115.98 51.48 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.1 0.476 . . . . 0.0 110.626 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 4.2 Cg_endo -56.46 -28.19 72.13 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.649 2.9 . . . . 0.0 112.84 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.61 -27.19 63.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -91.42 -22.45 20.45 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.843 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.595 HD11 HD21 ' A' ' 73' ' ' LEU . 44.3 mt -72.09 179.48 3.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.108 0.956 . . . . 0.0 112.208 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -108.87 -166.37 1.11 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.069 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.588 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.17 167.56 41.66 Favored Glycine 0 C--N 1.304 -1.23 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.751 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 33.4 tttp -97.53 143.39 28.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.7 m-85 -106.95 112.04 24.81 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.415 1.103 . . . . 0.0 109.419 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' HE3' ' A' ' 14' ' ' LYS . 14.4 mt -112.3 148.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.442 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.09 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.592 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 1.9 t60 -124.76 120.02 30.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -140.34 131.5 26.45 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.741 0.781 . . . . 0.0 111.294 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 31.7 ttmt -88.16 125.95 34.88 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.327 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -106.38 117.4 33.95 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.677 -1.147 . . . . 0.0 107.912 -176.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 41.3 ttm180 -77.44 107.42 9.87 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.699 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.644 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 76.3 tttt -64.54 97.39 0.2 Allowed 'General case' 0 C--O 1.178 -2.699 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 t -91.86 -153.53 0.34 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 125.347 1.459 . . . . 0.0 108.216 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 p -52.68 -46.8 67.41 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.982 0.513 . . . . 0.0 111.564 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 31.2 mmt180 -84.07 -17.23 40.97 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.514 0.674 . . . . 0.0 109.904 173.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.644 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 95.68 -105.61 3.27 Favored Glycine 1 N--CA 1.377 -5.295 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.507 ' HD1' HD12 ' A' ' 20' ' ' LEU . 40.5 m-85 -97.1 140.22 31.93 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.687 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.87 4.83 84.94 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.638 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' HB2' HG23 ' A' ' 43' ' ' ILE . 27.4 p90 -111.99 163.04 14.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.454 0.645 . . . . 0.0 110.499 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HE3' ' A' ' 44' ' ' LYS . 43.7 p -117.6 149.15 41.15 Favored 'General case' 0 N--CA 1.401 -2.891 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.51 HG21 HD23 ' A' ' 41' ' ' LEU . 3.3 p -141.24 139.16 33.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 C-N-CA 119.246 -0.981 . . . . 0.0 112.06 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 33' ' ' GLY . 13.1 p -149.24 167.24 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.942 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 128.55 -65.11 0.59 Allowed Glycine 0 CA--C 1.453 -3.795 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.175 173.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -74.9 57.64 2.66 Favored Glycine 2 CA--C 1.42 -5.897 0 C-N-CA 125.649 1.595 . . . . 0.0 116.284 -167.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.88 -11.95 50.79 Favored 'General case' 0 C--N 1.257 -3.438 0 O-C-N 124.123 0.543 . . . . 0.0 111.571 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.551 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 6.9 pt-20 -160.92 167.35 13.69 Favored Pre-proline 0 CA--C 1.451 -2.859 0 C-N-CA 116.11 -2.236 . . . . 0.0 110.615 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.1 Cg_endo -68.23 54.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.351 2.034 . . . . 0.0 110.198 172.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -176.41 -19.89 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.685 1.594 . . . . 0.0 109.93 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.708 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 51.3 mm-40 -114.36 128.42 56.34 Favored 'General case' 0 C--O 1.276 2.45 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.443 ' H ' ' HG3' ' A' ' 2' ' ' PRO 0.267 8.5 m-30 -79.56 156.4 27.74 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 128.101 3.375 . . . . 0.0 111.19 -178.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 80' ' ' VAL . 5.2 mp -87.33 142.21 28.06 Favored 'General case' 0 C--O 1.178 -2.692 0 C-N-CA 117.103 -1.839 . . . . 0.0 107.684 174.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.505 ' HG2' ' HB ' ' A' ' 63' ' ' VAL . 49.6 mt-30 -138.97 154.61 48.31 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG23 ' HB2' ' A' ' 29' ' ' PHE . 31.2 mm -76.41 111.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HE3' ' OG1' ' A' ' 30' ' ' THR . 0.5 OUTLIER -61.98 -37.54 85.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.59 ' HA ' HG22 ' A' ' 60' ' ' THR . 48.5 t 164.68 173.22 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 125.37 1.669 . . . . 0.0 109.479 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pp -137.2 151.58 48.93 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-O 122.044 0.926 . . . . 0.0 113.063 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 49' ' ' ASP . 40.7 t -73.54 117.78 17.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 113.454 -1.703 . . . . 0.0 106.748 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mt -57.66 -23.08 49.49 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 112.976 -1.92 . . . . 0.0 112.896 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' H ' HG12 ' A' ' 47' ' ' VAL . 31.8 m-20 -96.68 -2.04 45.38 Favored 'General case' 0 C--N 1.267 -3.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.219 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.33 167.64 26.35 Favored Glycine 0 N--CA 1.422 -2.256 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.366 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 20' ' ' LEU . 11.1 Cg_endo -55.25 -31.03 74.57 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 124.187 3.258 . . . . 0.0 112.979 -176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.36 -44.94 89.01 Favored 'General case' 0 C--O 1.274 2.371 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.36 55.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.294 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.81 -35.43 64.87 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.82 -24.47 65.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.96 22.02 78.34 Favored Glycine 0 CA--C 1.49 -1.524 0 CA-C-N 112.515 -2.13 . . . . 0.0 113.79 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -109.44 -32.71 7.05 Favored 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.5 ttm -96.07 142.22 28.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.47 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.01 166.2 23.27 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.076 0.941 . . . . 0.0 111.082 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.9 p -70.74 111.77 6.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.081 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.7 -11.64 15.66 Favored Glycine 0 C--N 1.309 -0.929 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.903 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.662 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.8 m-20 -63.54 134.62 55.86 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -91.66 124.73 44.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 13.1 mm -73.17 123.9 29.03 Favored 'Isoleucine or valine' 1 C--O 1.32 4.764 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 HD13 ' A' ' 73' ' ' LEU . 42.9 t -115.53 -34.49 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 O-C-N 126.979 2.674 . . . . 0.0 110.447 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.583 ' HA ' HG22 ' A' ' 72' ' ' VAL . 36.5 m -148.98 146.71 27.93 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.954 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.591 HG12 HG11 ' A' ' 72' ' ' VAL . 7.1 p -124.75 132.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.0 m120 61.11 23.75 13.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 110.978 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.7 t70 66.66 21.46 10.62 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.743 1.617 . . . . 0.0 112.015 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' HG13 ' A' ' 72' ' ' VAL . 56.2 m -102.91 120.43 40.61 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 171.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.7 t -66.7 110.33 3.19 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG11 HG12 ' A' ' 67' ' ' VAL . 35.7 m -122.67 28.88 2.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.563 -176.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.595 HD21 HD11 ' A' ' 11' ' ' LEU . 39.0 tp -60.98 112.92 2.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 33.82 42.29 0.23 Allowed Glycine 0 C--N 1.376 2.763 0 O-C-N 125.339 1.649 . . . . 0.0 111.374 -170.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' HG23 ' A' ' 76' ' ' THR . 5.3 t60 -43.31 -66.11 0.41 Allowed 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' HIS . 7.2 p -167.31 143.31 4.21 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 151.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -49.69 -35.69 22.59 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 120.31 1.414 . . . . 0.0 110.572 173.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.13 71.37 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.934 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 8.5 mm100 -60.27 -44.5 95.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 41' ' ' LEU . 35.8 m -71.23 -43.31 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.606 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 91.6 t -64.92 -41.29 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -60.91 -38.58 86.22 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.692 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.591 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.8 mm -68.58 -33.21 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.313 0.577 . . . . 0.0 112.478 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -73.25 -30.12 63.23 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 81' ' ' VAL . 87.5 mt-30 -76.64 -19.9 57.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.824 1.25 . . . . 0.0 110.821 174.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.7 m -79.68 -44.33 21.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.923 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.491 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.6 mt -67.24 136.46 93.74 Favored Pre-proline 0 N--CA 1.422 -1.873 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.199 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -90.99 161.18 3.93 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 123.081 2.52 . . . . 0.0 112.969 -173.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.566 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 22.0 mm -63.88 134.76 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-O 120.912 0.386 . . . . 0.0 110.705 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.04 54.16 Favored Glycine 0 C--N 1.288 -2.084 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.312 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -100.03 -170.0 1.82 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -175.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 20.8 m -151.06 157.38 42.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.46 125.66 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.807 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.592 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 14.4 m-20 -76.44 105.3 7.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.7 mt -103.86 138.41 40.48 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 124.139 0.976 . . . . 0.0 110.484 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.3 tt0 -101.05 118.38 36.87 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 81.5 mt -107.14 150.06 26.99 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 124.776 1.23 . . . . 0.0 109.99 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.636 ' HB3' HG13 ' A' ' 63' ' ' VAL . 9.4 t -118.11 106.21 12.63 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.132 0.968 . . . . 0.0 108.553 172.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.662 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 36.2 ttp180 -104.66 127.76 52.51 Favored 'General case' 0 C--N 1.248 -3.823 0 O-C-N 120.811 -1.181 . . . . 0.0 109.954 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.8 -27.55 0.4 Allowed Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.41 141.54 39.54 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.25 160.5 29.44 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.288 2.659 . . . . 0.0 111.643 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 10.3 mt -57.89 142.71 78.71 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 124.081 0.952 . . . . 0.0 112.502 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 8.2 Cg_exo -67.81 -68.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.431 2.087 . . . . 0.0 110.698 173.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.43 133.59 33.0 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-O 122.013 0.911 . . . . 0.0 109.001 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -122.41 93.53 48.42 Favored Pre-proline 0 N--CA 1.388 -3.554 0 CA-C-N 112.89 -1.959 . . . . 0.0 110.637 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -91.62 -61.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.017 1.812 . . . . 0.0 112.737 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.93 -11.3 53.51 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.747 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -88.08 115.58 63.56 Favored Pre-proline 0 CA--C 1.468 -2.181 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.022 -177.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 116' ' ' THR 0.269 53.0 Cg_endo -73.39 -38.2 2.76 Favored 'Trans proline' 0 CA--C 1.481 -2.164 0 C-N-CA 122.32 2.013 . . . . 0.0 112.286 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.785 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 38.6 m-80 -57.4 -13.03 2.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 111.626 -2.534 . . . . 0.0 114.376 -164.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 p -93.11 -21.18 19.85 Favored 'General case' 0 N--CA 1.39 -3.437 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.002 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 115' ' ' VAL . 16.7 m -111.02 160.42 16.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.216 -174.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -72.5 39.78 0.08 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 122.424 1.107 . . . . 0.0 113.678 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 113' ' ' SER . 4.3 p -166.32 86.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.785 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -132.99 -177.49 4.53 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.469 -1.241 . . . . 0.0 112.469 -169.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.6 t -51.18 108.48 0.25 Allowed 'General case' 0 N--CA 1.407 -2.576 0 C-N-CA 127.459 2.303 . . . . 0.0 109.392 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 t 61.71 46.83 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.3 1.048 . . . . 0.0 110.162 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.02 114.99 6.96 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.6 mm 62.01 59.78 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-O 122.164 0.983 . . . . 0.0 108.495 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.63 132.41 41.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.803 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.51 152.64 20.84 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.27 45.85 0.48 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.579 0.704 . . . . 0.0 112.797 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -101.93 136.4 19.51 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 C-N-CA 123.009 2.473 . . . . 0.0 111.872 177.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.553 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -99.62 -40.05 7.99 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.325 0.584 . . . . 0.0 109.775 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.38 75.87 9.73 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.031 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 129.91 -86.65 0.31 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.184 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.5 tptp 56.38 65.13 4.34 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.935 1.294 . . . . 0.0 110.355 -174.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -105.56 -165.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.286 2.658 . . . . 0.0 112.789 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -100.74 111.97 24.3 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.62 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.7 t80 -106.52 143.06 35.17 Favored 'General case' 0 C--N 1.268 -2.957 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.964 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -147.13 9.68 0.98 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 122.146 0.974 . . . . 0.0 110.443 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.525 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.6 mtm180 53.28 4.71 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 127.241 2.217 . . . . 0.0 114.87 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.491 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.4 t-20 -130.2 119.91 18.9 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HB3' HG11 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -60.94 -19.1 61.05 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.072 3.182 . . . . 0.0 112.835 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -80.43 -24.57 39.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -98.33 -19.9 17.5 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.847 0.356 . . . . 0.0 111.718 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 42.8 tp -84.99 160.46 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.286 0.565 . . . . 0.0 110.848 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 58.7 mttm -97.56 -171.23 2.14 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.896 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.649 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.15 163.95 39.87 Favored Glycine 0 C--N 1.299 -1.506 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 28.2 tttp -93.37 137.97 32.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.607 -1.237 . . . . 0.0 108.828 175.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 95.9 m-85 -106.05 110.68 23.02 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 122.561 1.172 . . . . 0.0 109.066 -177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 HD13 ' NH2' ' A' ' 99' ' ' ARG . 15.1 mt -114.8 147.33 18.3 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.875 0 CA-C-N 112.36 -2.2 . . . . 0.0 107.94 -173.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -117.35 132.08 56.66 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.917 0.865 . . . . 0.0 111.867 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -140.1 127.58 21.47 Favored 'General case' 0 C--N 1.263 -3.186 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.245 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.796 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttmt -90.15 122.27 32.95 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.843 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.435 HD21 ' CA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -106.79 116.78 32.52 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 61.9 ttt180 -76.85 107.83 9.46 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.279 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.731 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 68.1 tttt -64.08 97.32 0.17 Allowed 'General case' 0 C--O 1.181 -2.512 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 167.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -82.11 -158.24 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -96.58 -0.29 48.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.642 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.731 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 83.78 -129.05 8.9 Favored Glycine 0 N--CA 1.406 -3.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.57 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 29.8 m-85 -90.28 141.98 28.17 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 120.875 0.369 . . . . 0.0 110.207 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.99 86.84 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.143 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.412 ' HB2' HG23 ' A' ' 43' ' ' ILE . 21.3 p90 -111.15 163.3 14.04 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.475 0.655 . . . . 0.0 110.76 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 69.2 p -115.99 152.27 33.83 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG21 HD23 ' A' ' 41' ' ' LEU . 4.8 p -140.41 143.59 29.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.618 -174.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 33' ' ' GLY . 8.8 p -144.89 167.94 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.453 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.487 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 32' ' ' VAL . . . 111.86 -141.64 16.74 Favored Glycine 1 N--CA 1.388 -4.526 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 -177.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 48.6 35.66 16.72 Favored Glycine 0 CA--C 1.473 -2.571 0 CA-C-N 117.396 0.598 . . . . 0.0 111.98 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 16.8 t70 -67.0 -29.55 69.42 Favored 'General case' 0 CA--C 1.46 -2.517 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -172.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.41 166.64 13.6 Favored Pre-proline 0 CA--C 1.467 -2.246 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.024 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 20.1 Cg_endo -65.93 58.77 0.42 Allowed 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.561 2.174 . . . . 0.0 109.945 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 11.9 t70 179.24 -16.14 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.233 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 35' ' ' ASP . 33.9 mm-40 -122.59 123.94 42.35 Favored 'General case' 0 C--O 1.275 2.404 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 173.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 73' ' ' LEU . 6.0 m-30 -76.91 159.28 30.13 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 130.711 3.604 . . . . 0.0 113.762 -169.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 80' ' ' VAL . 8.0 mp -89.03 146.98 24.51 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.8 mt-30 -142.84 157.69 44.36 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.437 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 39.4 mm -74.45 109.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.7 tttp -57.82 -41.05 81.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 60' ' ' THR . 31.2 t 163.04 174.98 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 O-C-N 125.827 1.954 . . . . 0.0 109.808 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.486 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -139.53 150.3 44.94 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.535 0.683 . . . . 0.0 111.826 -175.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 49' ' ' ASP . 60.8 t -75.77 123.87 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 173.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.9 pt? -68.76 -5.21 19.3 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 47' ' ' VAL . 6.3 m-20 -100.0 -6.56 26.31 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.181 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.53 163.76 32.7 Favored Glycine 0 N--CA 1.408 -3.186 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -50.3 -31.59 30.22 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 124.78 3.654 . . . . 0.0 113.249 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.78 -46.47 84.53 Favored 'General case' 0 C--O 1.267 2.004 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.425 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.33 -33.95 55.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.058 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.4 mp -70.47 -40.0 73.91 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 124.187 0.995 . . . . 0.0 112.377 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.613 ' OD2' ' HE3' ' A' ' 57' ' ' LYS . 24.4 t70 -66.33 -24.15 66.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.694 1.235 . . . . 0.0 108.326 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.8 19.67 78.24 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.586 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.613 ' HE3' ' OD2' ' A' ' 55' ' ' ASP . 25.6 mtmt -122.02 -18.9 6.81 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -102.19 130.83 48.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.699 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.58 162.91 22.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.403 1.097 . . . . 0.0 111.777 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 45' ' ' SER . 80.7 p -72.57 108.69 5.75 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.657 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 121.1 -16.14 9.34 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.642 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.678 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 13.5 m-20 -61.13 131.8 51.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.6 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.262 0.2 OUTLIER -85.96 123.58 39.62 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.726 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 15.4 mm -74.06 124.36 31.3 Favored 'Isoleucine or valine' 1 C--O 1.326 5.115 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 8' ' ' PRO . 42.0 t -115.85 -41.06 2.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 110.881 -2.872 . . . . 0.0 111.201 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.579 ' HA ' HG22 ' A' ' 72' ' ' VAL . 68.0 m -144.85 149.27 35.09 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.032 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.775 HG23 HG21 ' A' ' 72' ' ' VAL . 25.1 t -111.7 115.04 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 66.1 -78.83 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.846 1.341 . . . . 0.0 109.634 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -156.22 24.31 0.36 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.36 1.076 . . . . 0.0 110.316 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.538 ' O ' HG13 ' A' ' 72' ' ' VAL . 27.1 m -106.87 117.99 35.51 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 32.3 t -64.9 108.23 1.71 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.775 HG21 HG23 ' A' ' 67' ' ' VAL . 28.2 m -117.53 20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.408 -174.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.62 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 36.3 tp -61.64 112.76 2.37 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 39.54 0.06 OUTLIER Glycine 0 C--N 1.385 3.286 0 O-C-N 125.484 1.74 . . . . 0.0 112.273 -171.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.473 ' O ' HG23 ' A' ' 76' ' ' THR . 3.0 t60 -42.31 -65.24 0.49 Allowed 'General case' 0 C--N 1.37 1.481 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 75' ' ' HIS . 6.1 p -166.36 143.11 4.99 Favored 'General case' 0 C--N 1.257 -3.423 0 N-CA-C 100.812 -3.773 . . . . 0.0 100.812 150.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.615 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -51.8 -31.37 26.9 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 121.018 1.735 . . . . 0.0 111.233 173.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.09 -50.26 74.07 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 13.3 mm100 -64.55 -42.01 95.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 41' ' ' LEU . 11.0 m -66.57 -41.85 89.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.05 -38.98 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -37.24 86.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 86' ' ' SER . 2.1 mm -67.56 -35.7 73.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.56 0.695 . . . . 0.0 112.146 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -73.55 -30.49 63.09 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.74 -26.68 62.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.657 0.783 . . . . 0.0 110.41 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 68.5 m -70.96 -42.5 69.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.768 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 20.6 mt -72.16 130.08 86.85 Favored Pre-proline 0 N--CA 1.408 -2.567 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.017 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.3 Cg_endo -91.86 162.42 3.35 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 123.514 2.809 . . . . 0.0 112.947 -173.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 23.3 mm -59.43 132.79 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-O 121.296 0.57 . . . . 0.0 111.217 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.65 56.54 Favored Glycine 0 C--N 1.298 -1.568 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.443 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.9 -169.54 1.69 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 8.1 m -150.6 159.93 44.16 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -142.0 125.01 14.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.766 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.225 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.08 102.16 11.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.76 135.57 40.04 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.221 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 35.5 tt0 -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.805 175.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 83.0 mt -106.33 144.81 32.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.0 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.649 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 10.2 t -112.44 107.78 16.68 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-O 122.005 0.907 . . . . 0.0 108.82 172.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.678 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 26.9 ttp180 -101.59 131.74 47.62 Favored 'General case' 0 C--N 1.25 -3.747 0 O-C-N 121.021 -1.049 . . . . 0.0 109.874 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.66 1.41 Allowed Glycine 0 C--N 1.307 -1.061 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.42 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.88 128.73 31.52 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.35 160.3 48.32 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.834 3.022 . . . . 0.0 113.12 -174.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 9.9 mt -59.29 131.19 87.58 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.006 176.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 6.0 Cg_exo -71.29 -39.8 3.6 Favored 'Trans proline' 0 CA--C 1.49 -1.699 0 C-N-CA 122.847 2.364 . . . . 0.0 110.166 176.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.409 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 75.1 t80 -139.17 148.82 43.69 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.597 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' CB ' HG21 ' A' ' 112' ' ' THR . 7.5 p-10 -116.04 88.33 21.63 Favored Pre-proline 0 N--CA 1.395 -3.179 0 CA-C-N 113.074 -1.876 . . . . 0.0 111.31 -173.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 73.7 Cg_endo -93.87 -57.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.028 1.819 . . . . 0.0 112.783 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -91.37 -12.9 33.55 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.321 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -78.38 119.7 78.31 Favored Pre-proline 0 CA--C 1.45 -2.873 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.482 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 89.0 Cg_endo -75.05 -44.66 0.32 Allowed 'Trans proline' 0 N--CA 1.418 -2.919 0 C-N-CA 121.683 1.589 . . . . 0.0 111.306 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.482 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 14.6 m-80 -55.8 1.01 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 129.467 3.107 . . . . 0.0 114.702 -162.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 110' ' ' PRO . 76.1 p -99.51 -20.72 16.26 Favored 'General case' 1 N--CA 1.374 -4.234 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.504 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 11.8 p -165.29 142.82 5.92 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.734 -170.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 113' ' ' SER 0.33 3.7 pp 64.46 -166.35 0.23 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.954 1.702 . . . . 0.0 111.79 -177.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.562 ' N ' ' HB2' ' A' ' 122' ' ' ASP . 3.9 p -63.13 90.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.945 0.879 . . . . 0.0 110.453 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 110' ' ' PRO . 2.7 p -134.0 175.77 9.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 121.901 -0.499 . . . . 0.0 112.253 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.45 ' HB2' ' OD1' ' A' ' 111' ' ' ASN . 15.1 m -63.72 127.42 31.28 Favored 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 123.281 0.363 . . . . 0.0 110.997 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.5 p 55.32 20.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.402 1.881 . . . . 0.0 112.791 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.41 94.79 1.63 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.353 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.84 82.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.09 54.76 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.562 ' HB2' ' N ' ' A' ' 115' ' ' VAL . 38.1 t70 -96.22 -84.57 0.35 Allowed 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.851 -172.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -176.15 31.21 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 125.64 1.576 . . . . 0.0 107.762 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.568 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 1.9 pm0 -73.76 169.82 17.01 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.578 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 6.0 Cg_exo . . . . . 0 C--N 1.376 1.981 1 C-N-CA 126.624 4.883 . . . . 0.0 115.618 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . 0.8 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -126.63 23.3 6.8 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-O 121.736 0.779 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 58.4 ttm -159.66 35.14 0.19 Allowed 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 133.31 -165.76 23.97 Favored Glycine 0 N--CA 1.406 -3.305 0 CA-C-N 112.904 -1.953 . . . . 0.0 108.349 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.503 ' HA ' ' HE3' ' A' ' 1' ' ' LYS . 0.0 OUTLIER 49.97 55.27 16.8 Favored Pre-proline 0 C--N 1.305 -1.344 0 C-N-CA 124.306 1.042 . . . . 0.0 113.008 -178.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 37.2 Cg_endo -106.22 -176.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.636 2.224 . . . . 0.0 111.719 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.412 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 44.0 t80 -86.6 104.47 16.06 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.597 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.6 t80 -106.91 131.07 54.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -140.11 13.53 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.045 0.926 . . . . 0.0 109.912 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 6.2 mtm180 53.07 7.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 54.5 t-20 -132.77 121.27 17.0 Favored Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.001 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -59.21 -22.74 66.28 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 124.262 3.308 . . . . 0.0 113.152 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -79.23 -30.61 43.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.363 0.602 . . . . 0.0 109.478 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -90.41 -24.0 20.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.519 -176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 38.3 tp -82.26 152.95 26.13 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.35 144.83 42.1 Favored 'General case' 0 N--CA 1.392 -3.338 0 CA-C-O 121.73 0.776 . . . . 0.0 109.767 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.655 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 155.19 -178.13 32.02 Favored Glycine 1 C--N 1.249 -4.292 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -173.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HE2' ' CG1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -98.6 121.73 40.92 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 173.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' A' ' 98' ' ' CYS . 85.9 m-85 -100.1 119.25 38.01 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.131 0.967 . . . . 0.0 109.506 -174.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.602 ' CG1' ' HE2' ' A' ' 14' ' ' LYS . 44.7 mt -117.42 141.47 35.88 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.95 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.68 -170.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -107.06 126.44 52.35 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.53 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 9.0 t -137.55 157.54 46.31 Favored 'General case' 0 C--O 1.179 -2.633 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.329 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 35.6 ttpt -130.35 122.99 28.92 Favored 'General case' 0 C--N 1.261 -3.278 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.09 117.07 33.1 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 58.0 ttp180 -73.84 105.43 5.11 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.918 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.727 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 70.0 tttt -64.16 97.17 0.17 Allowed 'General case' 0 C--O 1.18 -2.602 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -84.53 -154.88 0.18 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.516 1.126 . . . . 0.0 108.952 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -58.99 -38.34 78.93 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.449 0.7 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -90.01 -19.94 23.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.727 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 99.84 -118.9 6.32 Favored Glycine 1 N--CA 1.388 -4.541 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.477 ' HD1' HD12 ' A' ' 20' ' ' LEU . 38.4 m-85 -90.55 136.51 33.02 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 117.674 0.737 . . . . 0.0 110.515 -176.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 9.71 76.79 Favored Glycine 0 C--O 1.212 -1.253 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.613 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' CE1' ' HG ' ' A' ' 20' ' ' LEU . 9.3 p90 -121.14 162.67 19.69 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.345 0.572 . . . . 0.0 110.375 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -123.13 147.34 46.9 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.413 HG23 ' CE1' ' A' ' 77' ' ' HIS . 15.5 m -121.61 146.22 27.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-O 121.284 0.564 . . . . 0.0 111.622 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.85 152.04 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.515 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.89 -129.59 8.33 Favored Glycine 1 N--CA 1.395 -4.08 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 45.06 38.04 5.93 Favored Glycine 0 CA--C 1.472 -2.597 0 C-N-CA 124.935 1.255 . . . . 0.0 114.072 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 6.6 m-20 -67.09 -24.4 65.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.405 -176.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.3 pt-20 -170.82 169.76 3.28 Favored Pre-proline 0 CA--C 1.46 -2.518 0 C-N-CA 118.804 -1.159 . . . . 0.0 110.092 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.9 Cg_endo -65.48 59.05 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.858 2.372 . . . . 0.0 110.709 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 19.4 t70 175.02 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.511 1.525 . . . . 0.0 110.218 -173.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 7.7 mm-40 -123.93 123.96 41.56 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 172.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.525 ' CE1' HD11 ' A' ' 73' ' ' LEU . 5.1 m-30 -76.99 159.63 29.78 Favored 'General case' 1 N--CA 1.55 4.543 0 C-N-CA 131.492 3.917 . . . . 0.0 114.569 -170.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.87 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -95.08 140.07 30.53 Favored 'General case' 0 C--O 1.188 -2.141 0 C-N-CA 117.73 -1.588 . . . . 0.0 107.725 172.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 51.0 mt-30 -130.86 158.43 40.22 Favored 'General case' 0 C--N 1.26 -3.311 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 172.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 62' ' ' ASP . 22.3 mm -81.32 115.48 23.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -66.86 -48.66 68.13 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.656 ' HA ' HG22 ' A' ' 60' ' ' THR . 46.0 t 174.37 173.99 0.19 Allowed 'General case' 0 CA--C 1.497 -1.06 0 O-C-N 123.996 0.81 . . . . 0.0 111.879 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.57 152.28 39.46 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.808 -172.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.41 116.23 9.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -69.56 -10.06 56.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.292 1.044 . . . . 0.0 112.908 -177.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.92 -7.98 38.43 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.025 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.541 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.37 173.41 37.27 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.57 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 15.2 Cg_endo -57.27 -27.93 77.36 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 124.175 3.25 . . . . 0.0 112.872 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -59.45 -49.75 76.59 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.692 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -76.44 -32.28 58.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.894 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 50' ' ' GLY . 6.8 mp -65.59 -46.27 80.04 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.714 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 57' ' ' LYS . 35.4 t70 -62.74 -35.7 80.62 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.41 -17.72 52.75 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 112.878 -1.964 . . . . 0.0 113.267 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 2.9 mptm? -77.27 -27.43 53.14 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 46.7 tpp -94.19 127.08 39.82 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -170.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -136.73 156.55 48.38 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.27 1.033 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -61.97 114.42 3.36 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.71 1.204 . . . . 0.0 110.336 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' HA2' ' HD3' ' A' ' 104' ' ' PRO . . . 112.26 -14.43 25.69 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.192 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.8 m-20 -67.08 141.25 57.54 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.251 0.1 OUTLIER -93.41 123.15 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 113.244 178.34 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.1 mm -73.25 123.62 28.57 Favored 'Isoleucine or valine' 1 C--O 1.337 5.66 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 73' ' ' LEU . 47.1 t -115.87 -36.05 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 O-C-N 127.506 3.004 . . . . 0.0 111.985 -176.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 60.4 m -151.61 162.85 40.28 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.487 -1.383 . . . . 0.0 114.012 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.685 HG23 HG11 ' A' ' 72' ' ' VAL . 48.6 t -134.38 127.16 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.624 0 C-N-CA 125.017 1.327 . . . . 0.0 107.527 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.2 m120 65.65 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 108.761 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -149.96 31.35 0.7 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.743 0.782 . . . . 0.0 109.165 170.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.0 m -116.48 126.84 53.94 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.505 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 24.2 t -67.39 115.08 6.62 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.732 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -119.98 15.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.597 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.4 tp -59.34 113.67 2.28 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.2 48.02 0.14 Allowed Glycine 0 C--N 1.379 2.967 0 O-C-N 125.433 1.708 . . . . 0.0 111.846 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.544 ' O ' HG23 ' A' ' 76' ' ' THR . 3.0 t60 -50.93 -68.35 0.18 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 75' ' ' HIS . 13.9 p -166.55 143.93 5.06 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 152.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.563 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.68 -33.36 22.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 120.088 1.313 . . . . 0.0 110.977 172.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.61 93.19 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.897 -0.502 . . . . 0.0 110.958 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 10.1 mm-40 -65.2 -43.3 92.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.87 HG21 HD21 ' A' ' 41' ' ' LEU . 17.1 m -62.66 -43.98 99.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.003 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.84 -40.78 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.636 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -62.18 -38.34 88.71 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.636 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 28.1 mt -65.02 -40.39 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.636 0.732 . . . . 0.0 111.329 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.23 -33.59 71.85 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.673 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.38 -20.22 60.8 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 124.183 0.993 . . . . 0.0 110.96 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 58.0 m -76.41 -48.75 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.413 HG22 ' HD3' ' A' ' 22' ' ' LYS . 21.4 mt -66.2 135.52 95.02 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.191 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.3 Cg_endo -87.98 161.55 7.39 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.258 2.639 . . . . 0.0 113.68 -172.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.559 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.2 mm -63.6 132.49 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.99 11.95 55.89 Favored Glycine 0 C--N 1.288 -2.096 0 C-N-CA 119.783 -1.198 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.35 -171.71 2.13 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.7 m -151.25 156.44 40.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -140.97 125.47 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.867 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.226 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' THR . 10.6 m-20 -79.31 104.2 9.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.39 157.42 16.92 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 125.497 1.519 . . . . 0.0 108.254 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -117.01 121.38 41.21 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 76.1 mt -105.06 164.34 11.87 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 125.107 1.363 . . . . 0.0 109.69 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.655 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 12.4 t -141.05 116.54 10.15 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.843 0.83 . . . . 0.0 109.923 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 31.1 mtm180 -98.6 135.49 40.05 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 121.279 -0.888 . . . . 0.0 113.115 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.62 -25.13 0.84 Allowed Glycine 0 CA--C 1.466 -3.0 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.298 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 22.7 m-85 -81.85 140.64 47.08 Favored Pre-proline 0 N--CA 1.42 -1.954 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.482 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.35 141.57 71.38 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 123.799 2.999 . . . . 0.0 111.147 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.414 HD23 ' HD2' ' A' ' 104' ' ' PRO . 2.4 tt -66.47 132.52 94.26 Favored Pre-proline 0 N--CA 1.42 -1.948 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.13 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' -2' ' ' ALA . 6.0 Cg_exo -42.27 137.19 3.64 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 125.142 3.895 . . . . 0.0 116.586 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -52.63 149.37 6.07 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.946 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.552 ' HB2' HG21 ' A' ' 112' ' ' THR . 0.3 OUTLIER -117.81 101.82 51.79 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.994 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -99.41 -61.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.249 0 C-N-CA 122.351 2.034 . . . . 0.0 111.128 170.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -121.05 18.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.427 1.108 . . . . 0.0 108.099 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 27.7 t0 -71.61 120.26 78.85 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.63 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.67 ' HB2' ' HA ' ' A' ' 116' ' ' THR 0.281 41.8 Cg_endo -69.35 -35.61 13.51 Favored 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 122.712 2.275 . . . . 0.0 110.458 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.765 ' HA ' ' OG1' ' A' ' 116' ' ' THR . 55.6 m-80 -57.84 -11.88 2.66 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.697 -2.501 . . . . 0.0 114.015 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.552 HG21 ' HB2' ' A' ' 106' ' ' ASP . 68.6 p -104.0 -8.1 19.85 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-O 121.619 0.723 . . . . 0.0 110.666 -173.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -131.17 172.8 11.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -173.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.73 155.83 39.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.6 t 69.78 46.22 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 123.217 1.484 . . . . 0.0 107.272 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.765 ' OG1' ' HA ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -89.55 -175.47 4.7 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.778 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.6 m -70.44 40.54 0.05 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 127.082 2.153 . . . . 0.0 112.674 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p -110.15 3.13 9.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 123.016 1.388 . . . . 0.0 108.141 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.02 83.19 0.14 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.792 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.31 85.73 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.0 111.18 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -80.92 95.48 6.76 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 121.503 0.668 . . . . 0.0 110.395 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -111.78 8.66 20.67 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.808 178.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -76.27 142.07 71.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.346 2.698 . . . . 0.0 112.554 177.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.636 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.198 0.499 . . . . 0.0 110.692 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.53 175.8 11.73 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 64.67 -116.39 8.94 Favored Glycine 0 C--O 1.245 0.796 0 O-C-N 123.783 0.677 . . . . 0.0 113.831 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt 59.51 66.81 2.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.93 1.292 . . . . 0.0 112.916 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -90.64 -178.84 1.48 Allowed 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.09 2.527 . . . . 0.0 111.424 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -79.63 105.43 10.93 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.592 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 4.8 t80 -108.25 139.55 42.78 Favored 'General case' 0 C--N 1.265 -3.088 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 7' ' ' ASN . 10.2 t -144.48 10.56 1.44 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.522 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 9.5 mtp180 58.01 -19.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.766 2.026 . . . . 0.0 115.466 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.2 t-20 -105.84 113.12 64.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 C-N-CA 122.714 0.406 . . . . 0.0 109.973 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' HG11 ' A' ' 65' ' ' VAL . 5.2 Cg_endo -50.87 -27.87 21.89 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 124.077 3.185 . . . . 0.0 113.635 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.5 t -74.03 -25.71 60.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.02 0.438 . . . . 0.0 110.996 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 14.5 mm-40 -91.51 -35.3 14.39 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.435 -176.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 39.0 tp -71.89 155.82 39.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.903 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -106.55 158.57 16.83 Favored 'General case' 0 N--CA 1.399 -2.999 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.48 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.768 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 131.31 173.65 13.42 Favored Glycine 0 C--N 1.265 -3.369 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' CE ' HG12 ' A' ' 16' ' ' ILE . 7.6 ttpt -94.4 123.51 37.85 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 98' ' ' CYS . 95.1 m-85 -101.75 111.55 23.83 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 122.778 1.275 . . . . 0.0 109.85 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG12 ' CE ' ' A' ' 14' ' ' LYS . 34.7 mt -105.87 145.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.739 0 CA-C-N 111.839 -2.437 . . . . 0.0 109.651 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.504 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 4.3 t60 -130.61 115.17 16.37 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 57' ' ' LYS . 2.2 t -139.92 137.73 35.04 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.296 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.6 ttmp? -87.59 125.37 34.31 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.632 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.505 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -107.82 121.11 44.06 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 11.9 ttp180 -81.21 108.87 15.21 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.397 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.646 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 73.7 tttt -62.88 97.47 0.11 Allowed 'General case' 0 C--O 1.182 -2.454 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 169.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -90.93 -154.39 0.35 Allowed 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 124.812 1.245 . . . . 0.0 108.228 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -54.59 -43.94 72.59 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.75 0.82 . . . . 0.0 111.029 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmt_? -85.18 -18.87 32.78 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 97.15 -114.52 5.0 Favored Glycine 0 N--CA 1.397 -3.955 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -177.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.505 ' HD1' HD12 ' A' ' 20' ' ' LEU . 31.8 m-85 -93.95 141.33 28.64 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.37 -2.92 84.91 Favored Glycine 0 C--O 1.217 -0.959 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.757 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.525 ' HB2' HG23 ' A' ' 43' ' ' ILE . 17.9 p90 -111.97 162.7 15.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 38.8 p -123.59 155.58 37.39 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.4 148.64 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-O 121.631 0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.02 149.93 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.283 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.79 -137.17 12.6 Favored Glycine 0 N--CA 1.398 -3.864 0 N-CA-C 108.236 -1.945 . . . . 0.0 108.236 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . 52.34 32.28 36.94 Favored Glycine 0 CA--C 1.47 -2.728 0 N-CA-C 111.786 -0.525 . . . . 0.0 111.786 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -71.62 -19.76 62.07 Favored 'General case' 0 N--CA 1.411 -2.416 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.951 -170.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.1 pt-20 -166.65 166.78 8.66 Favored Pre-proline 0 CA--C 1.468 -2.183 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_endo -66.85 58.18 0.54 Allowed 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.715 2.277 . . . . 0.0 109.737 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 22.1 t70 176.6 -15.06 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.476 -169.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 26.9 mt-10 -123.19 126.12 46.39 Favored 'General case' 0 C--O 1.269 2.116 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 171.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.25 7.3 m-85 -77.85 158.59 29.4 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 131.04 3.736 . . . . 0.0 113.535 -168.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 80' ' ' VAL . 6.0 mp -89.82 143.29 26.92 Favored 'General case' 0 CA--C 1.457 -2.624 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 171.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.5 mt-30 -138.12 152.81 49.09 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 29' ' ' PHE . 26.7 mm -69.09 109.09 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 84.1 tttt -55.3 -41.26 72.1 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 124.872 1.357 . . . . 0.0 107.448 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.554 ' HA ' HG22 ' A' ' 60' ' ' THR . 47.0 t 162.41 173.52 0.02 OUTLIER 'General case' 0 C--N 1.366 1.326 0 O-C-N 125.395 1.684 . . . . 0.0 109.605 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -138.59 147.27 42.78 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 121.989 0.9 . . . . 0.0 111.976 -173.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ASP . 13.8 t -83.34 130.06 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.972 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 94.7 mt -69.32 -13.52 62.43 Favored 'General case' 0 N--CA 1.38 -3.941 0 CA-C-N 112.799 -2.001 . . . . 0.0 112.849 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . 14.7 t70 -86.0 -24.2 26.54 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.244 173.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -81.09 155.15 36.13 Favored Glycine 0 N--CA 1.401 -3.679 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.556 -172.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 20' ' ' LEU . 9.7 Cg_endo -50.8 -31.48 33.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 125.052 3.834 . . . . 0.0 113.385 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -60.4 -44.53 95.59 Favored 'General case' 0 C--O 1.261 1.701 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.199 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.88 -35.33 50.95 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.496 177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 6.6 mp -65.94 -43.41 88.11 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.981 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.48 -21.85 55.31 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.909 1.338 . . . . 0.0 107.409 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.9 73.46 Favored Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 113.228 -1.806 . . . . 0.0 112.586 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HB3' HG21 ' A' ' 18' ' ' THR . 72.6 mmtt -98.31 -28.48 13.65 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 120.859 0.362 . . . . 0.0 110.084 -173.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.427 ' HB3' HD22 ' A' ' 46' ' ' LEU . 1.3 mpt? -98.03 149.63 22.25 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.211 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.71 153.4 47.21 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 45' ' ' SER . 65.5 p -60.09 111.67 1.6 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 113.48 -5.43 24.76 Favored Glycine 0 N--CA 1.432 -1.624 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.215 175.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 43' ' ' ILE . 5.4 m-20 -60.31 126.07 26.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.102 0.951 . . . . 0.0 108.603 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.256 0.2 OUTLIER -80.2 112.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.957 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 97' ' ' LEU . 22.1 mm -66.98 125.3 24.09 Favored 'Isoleucine or valine' 1 C--O 1.332 5.397 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 HD22 ' A' ' 73' ' ' LEU . 48.5 t -115.36 -42.91 3.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 O-C-N 127.585 3.053 . . . . 0.0 112.085 -174.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 69.6 m -147.77 156.78 43.1 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.853 -1.154 . . . . 0.0 112.359 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG11 HG21 ' A' ' 83' ' ' ILE . 6.3 p -135.98 128.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.1 m120 58.53 30.33 19.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.603 0.716 . . . . 0.0 110.65 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 68.06 17.22 9.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.893 1.277 . . . . 0.0 113.28 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.8 m -107.78 125.49 51.49 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.417 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 54.0 t -59.99 110.14 1.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 124.418 1.074 . . . . 0.0 109.783 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 80' ' ' VAL . 2.0 p -119.8 16.36 6.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.592 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 30.6 tp -59.9 113.23 2.18 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.5 43.17 0.07 OUTLIER Glycine 0 N--CA 1.5 2.945 0 O-C-N 125.762 1.914 . . . . 0.0 112.559 -170.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' THR . 3.2 t60 -46.42 -66.83 0.35 Allowed 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 75' ' ' HIS . 20.1 p -166.52 143.85 5.07 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 151.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.589 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -50.88 -33.59 24.67 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 120.295 1.407 . . . . 0.0 110.876 173.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.17 86.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.967 -0.458 . . . . 0.0 110.866 174.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.509 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 14.3 mm-40 -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 41' ' ' LEU . 13.1 m -64.63 -44.5 96.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -66.56 -38.19 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -64.32 -33.93 76.96 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.296 177.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.588 HG21 HG11 ' A' ' 67' ' ' VAL . 3.9 mm -70.8 -36.53 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.732 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.18 -31.42 64.21 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.309 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -70.44 -27.91 64.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.522 1.129 . . . . 0.0 110.634 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -73.17 -34.34 65.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.576 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.0 mt -80.78 134.72 53.13 Favored Pre-proline 0 N--CA 1.412 -2.352 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.976 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -91.99 162.3 3.27 Favored 'Trans proline' 0 C--N 1.322 -0.867 0 C-N-CA 123.585 2.857 . . . . 0.0 113.134 -174.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.533 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.2 mm -62.85 133.01 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.22 0.533 . . . . 0.0 110.885 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.76 12.3 53.44 Favored Glycine 0 C--N 1.293 -1.848 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.674 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.76 -170.82 1.88 Allowed 'General case' 0 C--O 1.207 -1.164 0 O-C-N 122.704 -0.292 . . . . 0.0 110.292 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 12.9 m -151.21 155.51 38.98 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.657 -0.652 . . . . 0.0 109.358 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.4 t -145.02 127.88 10.67 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.657 0 C-N-CA 118.582 -1.247 . . . . 0.0 113.119 -174.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.504 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 22.2 m-20 -80.32 106.88 12.67 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.533 0.682 . . . . 0.0 109.168 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 71.1 mt -105.59 142.65 34.95 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.806 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' OE2' ' HB3' ' A' ' 15' ' ' PHE . 16.7 tp10 -107.1 127.69 53.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB3' HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -136.2 155.83 49.57 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 124.046 0.938 . . . . 0.0 111.281 -178.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.768 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -119.95 117.13 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.509 1.147 . . . . 0.0 112.936 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 18.8 tpp85 -88.88 111.14 21.71 Favored 'General case' 0 C--N 1.266 -3.058 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.07 -35.63 0.09 OUTLIER Glycine 0 CA--C 1.479 -2.19 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.568 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.62 136.99 24.53 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.128 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.05 160.89 46.33 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.889 2.392 . . . . 0.0 108.062 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.508 HD11 ' HB ' ' A' ' 60' ' ' THR . 13.3 mt -53.86 129.32 56.25 Favored Pre-proline 0 N--CA 1.432 -1.349 0 O-C-N 123.648 0.592 . . . . 0.0 111.261 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.14 -44.95 0.73 Allowed 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 123.325 2.684 . . . . 0.0 114.317 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 88.7 t80 -138.19 149.74 46.11 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.797 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -110.61 98.68 38.23 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 121.55 0.69 . . . . 0.0 111.338 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 58.7 Cg_endo -96.18 -58.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.284 0 C-N-CA 122.154 1.903 . . . . 0.0 110.403 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.61 7.62 12.66 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 125.798 1.639 . . . . 0.0 108.862 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' OD2' HG23 ' A' ' 112' ' ' THR . 21.0 t0 -72.99 110.26 8.06 Favored Pre-proline 0 CA--C 1.48 -1.741 0 CA-C-O 122.677 1.227 . . . . 0.0 112.39 -171.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 112' ' ' THR . 57.2 Cg_endo -80.12 -32.42 1.4 Allowed 'Trans proline' 0 N--CA 1.433 -2.088 0 C-N-CA 122.038 1.825 . . . . 0.0 109.771 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.456 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 8.6 t-20 -52.68 -5.5 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.218 1 C-N-CA 132.012 4.125 . . . . 0.0 114.075 -168.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 110' ' ' PRO . 27.1 p -93.88 3.58 55.18 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.819 -169.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 m -146.03 104.72 3.86 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.102 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt 52.9 -151.34 0.31 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.612 0.765 . . . . 0.0 110.651 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.0 m -57.18 101.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.816 0.817 . . . . 0.0 111.391 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.61 166.15 25.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.676 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 m 71.81 32.64 1.88 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.211 1.005 . . . . 0.0 109.414 -172.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.27 112.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.481 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.92 70.28 1.1 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.6 mm -82.52 87.12 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.71 0.767 . . . . 0.0 109.081 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -114.06 36.58 3.64 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.603 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.39 156.99 43.2 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.602 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 tpmt? 67.48 18.6 10.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 123.018 1.389 . . . . 0.0 107.896 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.29 145.08 29.37 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 113.276 -1.784 . . . . 0.0 108.577 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.917 2.411 . . . . 0.0 111.847 173.791 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 1' ' ' LYS . . . . . . . . 0 C--O 1.223 -0.539 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.42 64.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.372 1.069 . . . . 0.0 113.884 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -91.68 9.79 30.94 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.991 0.425 . . . . 0.0 111.477 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -130.08 -96.07 0.76 Allowed Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.527 ' N ' ' HD3' ' A' ' 2' ' ' PRO . 28.9 mmmt 52.14 54.75 14.42 Favored Pre-proline 0 N--CA 1.482 1.142 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 1' ' ' LYS . 97.3 Cg_endo -108.77 170.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.628 0 C-N-CA 122.987 2.458 . . . . 0.0 112.97 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.46 ' HB3' ' OH ' ' A' ' 101' ' ' TYR . 23.8 t80 -82.27 105.19 13.14 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.605 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.2 t80 -101.46 133.57 45.9 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -141.15 8.89 2.08 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.903 0.858 . . . . 0.0 110.437 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.489 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 8.3 mtm180 63.9 -27.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.556 1.943 . . . . 0.0 114.964 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -100.54 122.25 50.26 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB3' HG11 ' A' ' 65' ' ' VAL . 6.1 Cg_endo -55.52 -27.84 61.58 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 124.006 3.137 . . . . 0.0 112.691 175.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 t -75.52 -25.72 57.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.129 0.49 . . . . 0.0 110.314 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -88.9 -24.26 22.54 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.691 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.436 HD22 ' CZ ' ' A' ' 40' ' ' PHE . 41.2 tp -83.33 157.51 22.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 36.6 mtmm -119.69 148.71 43.05 Favored 'General case' 0 N--CA 1.381 -3.908 0 CA-C-O 121.676 0.751 . . . . 0.0 110.524 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.624 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 150.37 178.22 25.06 Favored Glycine 0 C--N 1.257 -3.837 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -171.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -88.41 124.28 33.79 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.6 m-85 -102.8 120.3 40.36 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 118.103 -1.439 . . . . 0.0 109.949 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.433 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 64.7 mt -120.39 135.97 58.94 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.579 -170.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.8 t-80 -114.01 115.58 27.84 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.371 -176.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 4.2 t -140.33 131.28 26.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.889 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 39.5 ttpt -92.3 124.95 36.75 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -106.81 120.62 42.51 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.782 -173.007 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 15.9 tpp180 -76.21 103.47 6.26 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.635 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.723 ' HG3' ' CA ' ' A' ' 26' ' ' GLY . 51.2 tttt -59.06 96.97 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.947 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 165.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.565 ' HB2' ' HG3' ' A' ' 21' ' ' ARG . 4.9 t -134.65 139.33 45.2 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.1 p 50.82 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.973 1.709 . . . . 0.0 113.215 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 25' ' ' ARG . 2.8 tmm_? -76.2 -21.83 56.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.723 ' CA ' ' HG3' ' A' ' 22' ' ' LYS . . . 94.43 24.56 18.37 Favored Glycine 1 N--CA 1.393 -4.213 0 CA-C-O 118.11 -1.383 . . . . 0.0 112.697 174.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.553 ' HD1' HD12 ' A' ' 20' ' ' LEU . 30.8 m-85 155.8 170.39 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 130.393 3.477 . . . . 0.0 105.525 167.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.49 4.0 17.74 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.218 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.517 ' HB2' HG23 ' A' ' 43' ' ' ILE . 8.2 p90 -123.8 163.8 20.46 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -122.09 147.69 45.8 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.19 147.9 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.988 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 158.67 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.963 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.984 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.75 -130.12 9.04 Favored Glycine 1 N--CA 1.394 -4.13 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 50.25 37.11 30.56 Favored Glycine 0 CA--C 1.478 -2.268 0 C-N-CA 123.92 0.772 . . . . 0.0 113.513 175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 42.2 m-20 -67.13 -21.39 65.84 Favored 'General case' 0 CA--C 1.477 -1.845 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.097 -175.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 7.9 pt-20 -170.78 169.37 3.47 Favored Pre-proline 0 CA--C 1.474 -1.961 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.356 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 21.2 Cg_endo -66.61 51.36 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.923 2.416 . . . . 0.0 111.279 171.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 5.8 m-20 -176.84 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 127.105 2.162 . . . . 0.0 111.352 -170.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 18.6 mm-40 -128.66 123.85 34.24 Favored 'General case' 0 C--O 1.272 2.238 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 171.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 73' ' ' LEU . 6.5 m-30 -77.15 159.67 29.57 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 131.14 3.776 . . . . 0.0 114.58 -168.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.832 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -92.87 144.28 25.43 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 172.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 13.7 mt-30 -138.28 153.19 49.06 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 62' ' ' ASP . 25.0 mm -70.93 111.21 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.402 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 45' ' ' SER . 38.8 ttpt -67.54 -36.5 81.11 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.588 ' HA ' HG22 ' A' ' 60' ' ' THR . 41.1 t 170.53 172.9 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 O-C-N 125.159 1.537 . . . . 0.0 111.221 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -144.76 149.47 35.58 Favored 'General case' 0 N--CA 1.408 -2.562 0 C-N-CA 124.257 1.023 . . . . 0.0 110.879 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 49' ' ' ASP . 15.4 t -78.65 127.64 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.651 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.25 -3.38 10.59 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.571 -2.104 . . . . 0.0 112.264 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.2 t70 -103.13 -18.06 15.11 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.4 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.98 163.0 32.98 Favored Glycine 0 N--CA 1.41 -3.07 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.729 -170.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -50.27 -32.96 34.86 Favored 'Trans proline' 0 C--O 1.201 -1.372 0 C-N-CA 125.063 3.842 . . . . 0.0 112.617 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -57.51 -47.86 80.82 Favored 'General case' 0 C--O 1.271 2.229 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.357 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.18 -36.55 54.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.43 -35.45 65.8 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.108 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.69 -22.41 66.08 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.3 24.0 76.17 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.403 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 23.7 mmtp -110.18 -35.69 6.03 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.4 ttm -102.27 143.08 32.49 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.167 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.44 163.93 29.33 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.619 0.723 . . . . 0.0 109.176 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 45' ' ' SER . 60.2 p -67.83 114.42 6.4 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 123.709 0.804 . . . . 0.0 108.837 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.443 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 122.62 -22.07 7.43 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.035 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' O ' HG12 ' A' ' 43' ' ' ILE . 8.1 m-20 -62.18 134.69 56.89 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.706 0.753 . . . . 0.0 110.986 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 98' ' ' CYS 0.262 0.2 OUTLIER -82.52 121.51 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 178.408 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.0 mm -72.58 122.83 25.98 Favored 'Isoleucine or valine' 1 C--O 1.334 5.525 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -115.29 -37.61 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 110.402 -3.09 . . . . 0.0 111.652 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.62 ' HA ' HG22 ' A' ' 72' ' ' VAL . 51.0 m -150.76 151.43 32.36 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.302 -1.499 . . . . 0.0 114.424 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.723 HG23 HG21 ' A' ' 72' ' ' VAL . 25.3 t -118.73 114.8 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.629 1.172 . . . . 0.0 109.037 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 52.74 36.69 21.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.312 0.577 . . . . 0.0 112.308 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 72.73 15.41 4.84 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.166 1.786 . . . . 0.0 112.164 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 72' ' ' VAL . 28.6 m -99.1 119.14 37.34 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 169.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.4 t -69.22 110.01 4.37 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 121.678 0.752 . . . . 0.0 109.491 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.723 HG21 HG23 ' A' ' 67' ' ' VAL . 23.9 m -114.47 18.3 7.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.444 -176.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.605 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 28.5 tp -59.79 113.4 2.25 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.668 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.21 45.72 0.14 Allowed Glycine 0 C--N 1.378 2.9 0 O-C-N 125.661 1.85 . . . . 0.0 111.896 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 76' ' ' THR . 8.9 t60 -45.15 -66.68 0.37 Allowed 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 103.606 -2.739 . . . . 0.0 103.606 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.8 p -166.9 143.83 4.67 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 150.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -51.0 -36.94 42.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 121.008 1.731 . . . . 0.0 110.886 174.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.43 95.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.501 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 18.6 mm-40 -69.97 -39.81 75.74 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.832 HG21 HD21 ' A' ' 41' ' ' LEU . 20.9 m -66.54 -41.6 88.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.859 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.63 -40.89 90.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.646 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.4 tmtm? -59.03 -44.58 91.78 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.765 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.646 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 1.4 mm -66.34 -35.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -70.98 -36.59 72.57 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -68.24 -23.38 64.79 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 124.338 1.055 . . . . 0.0 111.352 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 74.5 m -75.63 -30.09 59.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.938 176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.529 HG22 ' HD3' ' A' ' 22' ' ' LYS . 51.9 mt -83.24 133.29 47.98 Favored Pre-proline 0 N--CA 1.407 -2.585 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.646 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 9.8 Cg_endo -88.08 161.99 7.24 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.552 2.835 . . . . 0.0 112.637 -173.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.536 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 35.5 mm -66.52 133.73 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.87 54.5 Favored Glycine 0 C--N 1.287 -2.173 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.237 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.618 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -101.73 -177.25 3.37 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.565 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 2.9 p -145.54 152.48 39.8 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.78 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.8 t -136.67 125.42 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.34 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.42 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.3 m-20 -78.74 102.85 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 70.0 mt -99.65 139.77 34.82 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.724 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -96.55 118.36 32.89 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 90.4 mt -107.52 164.54 12.12 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 125.283 1.433 . . . . 0.0 109.382 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.645 ' HB3' HG13 ' A' ' 63' ' ' VAL . 19.3 t -142.22 107.77 5.07 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-O 122.387 1.089 . . . . 0.0 110.684 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -85.05 117.75 24.2 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.42 -24.19 0.21 Allowed Glycine 0 CA--C 1.473 -2.558 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.587 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' A' ' 3' ' ' PHE . 35.9 m-85 -94.22 133.46 27.27 Favored Pre-proline 0 C--N 1.286 -2.173 0 CA-C-O 121.075 0.464 . . . . 0.0 110.364 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.43 150.6 88.12 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 123.605 2.87 . . . . 0.0 111.969 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 104' ' ' PRO . 3.6 mt -54.06 121.65 31.19 Favored Pre-proline 0 N--CA 1.436 -1.153 0 C-N-CA 124.089 0.956 . . . . 0.0 112.214 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.516 ' HD2' HD23 ' A' ' 103' ' ' LEU . 84.1 Cg_exo -55.68 173.97 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 125.084 3.856 . . . . 0.0 115.9 -177.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.438 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 88.7 t80 -73.34 139.95 46.38 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 112.69 -2.05 . . . . 0.0 111.021 -178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.84 101.68 50.27 Favored Pre-proline 0 C--N 1.309 -1.189 0 C-N-CA 124.446 1.098 . . . . 0.0 110.236 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 63.3 Cg_endo -102.46 -60.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.61 2.206 . . . . 0.0 113.306 175.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -82.83 -16.94 45.77 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.753 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -92.37 141.49 24.93 Favored Pre-proline 0 N--CA 1.385 -3.718 0 CA-C-O 122.004 0.907 . . . . 0.0 112.241 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 93.7 Cg_endo -85.6 -33.59 0.21 Allowed 'Trans proline' 0 N--CA 1.426 -2.49 0 C-N-CA 122.19 1.927 . . . . 0.0 110.961 171.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 1.5 m-20 -32.5 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 131.602 3.961 . . . . 0.0 116.633 -164.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.6 p -93.84 2.33 56.22 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -167.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.6 m -93.09 25.33 3.31 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.457 -0.777 . . . . 0.0 113.026 -175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.2 mt 56.59 18.52 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' H ' ' H ' ' A' ' 116' ' ' THR . 10.6 p -156.78 -1.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-O 123.266 1.508 . . . . 0.0 108.44 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.41 ' H ' ' H ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -87.7 157.27 19.11 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 112.901 -1.954 . . . . 0.0 110.065 -175.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.2 m 60.77 40.69 15.76 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -167.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.1 114.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 112.075 -2.33 . . . . 0.0 115.611 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.94 20.65 11.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.91 1.338 . . . . 0.0 107.944 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.91 68.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.113 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -107.23 24.02 13.5 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.469 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 53.43 69.1 0.74 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.73 1.212 . . . . 0.0 111.66 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.99 12.73 35.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.588 -176.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.85 135.89 63.12 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.259 1.525 0 C-N-CA 123.774 2.982 . . . . 0.0 113.275 179.473 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.222 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -154.64 -73.14 0.12 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 117.412 0.606 . . . . 0.0 111.125 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.9 ptp -92.85 32.29 1.28 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.496 0.665 . . . . 0.0 111.097 -176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 167.92 -131.55 2.36 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 54.9 tptt 53.45 73.21 0.96 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 124.379 1.071 . . . . 0.0 112.081 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 36.3 Cg_endo -100.34 -178.42 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.315 2.677 . . . . 0.0 111.896 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -82.58 105.51 13.68 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.5 t80 -105.18 138.42 41.41 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.126 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -154.51 22.97 0.47 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.217 0.532 . . . . 0.0 111.008 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.456 ' HG2' ' HE1' ' A' ' 4' ' ' PHE . 20.2 mtm180 58.11 -30.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 128.446 2.698 . . . . 0.0 116.431 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 4.4 t-20 -99.88 113.87 65.36 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 65' ' ' VAL . 5.6 Cg_exo -55.22 -32.68 81.54 Favored 'Trans proline' 0 C--O 1.221 -0.329 0 C-N-CA 123.482 2.788 . . . . 0.0 111.46 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -71.34 -11.97 61.19 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.285 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.493 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 21.4 mm-40 -105.03 -22.35 13.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.474 0.71 . . . . 0.0 111.344 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.4 mm? -79.67 169.48 17.91 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -177.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.87 -170.42 2.04 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.834 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 83.11 177.76 52.05 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -177.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 13.6 ttpt -110.16 132.18 54.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 96.5 m-85 -99.09 110.79 23.32 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 123.161 1.458 . . . . 0.0 110.8 -174.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.428 ' CD1' ' HE ' ' A' ' 99' ' ' ARG . 30.5 mt -107.09 151.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.835 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.28 -174.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -130.43 121.49 25.99 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.352 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.8 t -138.51 138.91 38.48 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.58 0.705 . . . . 0.0 110.151 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.784 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 28.6 ttmt -93.8 125.04 38.2 Favored 'General case' 0 C--N 1.259 -3.346 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -105.7 117.05 33.03 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 37.8 ttt180 -76.7 108.56 9.8 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.909 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.671 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 73.6 tttt -65.05 97.14 0.22 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 89' ' ' ILE . 21.5 t -87.61 -154.83 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -54.4 -41.54 69.39 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.154 0.581 . . . . 0.0 110.767 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -87.15 -20.47 26.99 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.805 0.812 . . . . 0.0 109.77 174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 99.28 -116.33 5.55 Favored Glycine 1 N--CA 1.386 -4.695 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HD1' HD12 ' A' ' 20' ' ' LEU . 31.0 m-85 -93.9 146.79 23.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.14 0.34 66.4 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.642 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.487 ' HB2' HG23 ' A' ' 43' ' ' ILE . 10.0 p90 -111.24 163.14 14.25 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.546 0.689 . . . . 0.0 111.606 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.6 p -116.85 156.4 27.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.583 HG11 HD23 ' A' ' 41' ' ' LEU . 2.6 t -132.35 142.44 42.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.348 -173.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -152.7 160.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.736 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 109.91 -1.52 30.19 Favored Glycine 1 CA--C 1.447 -4.189 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 168.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.828 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -116.39 43.98 1.55 Allowed Glycine 1 CA--C 1.408 -6.637 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -170.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.32 -12.41 29.56 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 113.009 -1.595 . . . . 0.0 112.17 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 6.6 pt-20 -165.45 167.25 9.52 Favored Pre-proline 0 CA--C 1.46 -2.512 0 C-N-CA 117.203 -1.799 . . . . 0.0 110.888 -176.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -67.32 57.52 0.64 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 122.463 2.108 . . . . 0.0 110.165 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 26.8 t70 -179.67 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.478 1.911 . . . . 0.0 109.625 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.736 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 26.7 mt-10 -113.47 124.58 52.75 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-O 117.009 -1.472 . . . . 0.0 107.274 171.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.305 6.5 m-30 -79.35 155.38 28.46 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 128.288 3.492 . . . . 0.0 111.733 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.925 HD21 HG21 ' A' ' 80' ' ' VAL . 6.6 mp -87.1 143.34 27.36 Favored 'General case' 0 C--O 1.175 -2.867 0 C-N-CA 116.582 -2.047 . . . . 0.0 108.901 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 53.5 mt-30 -138.42 157.54 46.01 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 29' ' ' PHE . 25.3 mm -75.48 109.91 9.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 55.2 tttp -56.8 -37.71 71.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 125.183 1.552 . . . . 0.0 107.07 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.601 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.0 t 159.36 173.13 0.01 OUTLIER 'General case' 0 C--N 1.364 1.239 0 O-C-N 125.769 1.918 . . . . 0.0 109.231 172.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pp -136.74 149.37 47.81 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.44 118.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 53' ' ' ALA 0.263 1.2 pt? -69.59 -5.06 22.01 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -94.64 -3.48 49.44 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.354 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -91.62 161.78 27.47 Favored Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 8.6 Cg_endo -51.2 -29.9 30.86 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 124.952 3.768 . . . . 0.0 113.38 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.07 -46.71 84.98 Favored 'General case' 0 C--O 1.275 2.41 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.694 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . . . -77.07 -32.38 56.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.532 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 9.1 mp -68.69 -45.2 72.28 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.996 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.9 -26.93 67.11 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.12 16.7 79.54 Favored Glycine 0 CA--C 1.487 -1.711 0 CA-C-N 112.933 -1.939 . . . . 0.0 113.842 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -109.53 -24.48 10.96 Favored 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 122.278 0.231 . . . . 0.0 111.573 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.43 140.53 31.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.025 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 41.4 tt0 -149.38 146.89 27.72 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.986 0.898 . . . . 0.0 111.69 -172.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 45' ' ' SER . 5.3 p -49.61 103.52 0.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 126.313 1.845 . . . . 0.0 112.416 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 108.9 -2.52 31.78 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-O 119.375 -0.68 . . . . 0.0 113.049 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -71.24 146.95 48.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.4 OUTLIER -98.59 121.22 48.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -177.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.503 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 29.7 mm -69.88 123.96 24.81 Favored 'Isoleucine or valine' 0 C--O 1.305 3.975 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 73' ' ' LEU . 43.7 t -115.19 -38.66 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 111.662 -2.517 . . . . 0.0 110.272 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.562 ' HA ' HG22 ' A' ' 72' ' ' VAL . 40.0 m -145.11 142.97 30.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.885 -178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.571 HG12 HG21 ' A' ' 72' ' ' VAL . 7.1 p -119.57 131.82 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 m120 63.8 23.82 13.56 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.873 0.844 . . . . 0.0 108.958 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.37 -0.66 2.47 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.408 1.883 . . . . 0.0 112.079 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 72' ' ' VAL . 76.8 m -78.86 119.81 22.58 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.67 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.411 -2.397 0 O-C-N 124.777 1.298 . . . . 0.0 110.29 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.571 HG21 HG12 ' A' ' 67' ' ' VAL . 35.6 m -115.87 26.55 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.535 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.617 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 33.5 tp -59.71 113.79 2.43 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 34.26 41.48 0.22 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 125.344 1.653 . . . . 0.0 112.177 -170.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.523 ' O ' HG23 ' A' ' 76' ' ' THR . 14.5 t60 -45.72 -66.73 0.36 Allowed 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 75' ' ' HIS . 2.1 p -167.14 143.5 4.38 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 149.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -50.16 -38.61 40.33 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 119.342 0.974 . . . . 0.0 110.658 174.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.53 95.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.082 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.471 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 68.3 mm-40 -66.37 -43.2 86.6 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.925 HG21 HD21 ' A' ' 41' ' ' LEU . 33.4 m -66.81 -40.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.502 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.94 -39.27 85.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.674 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.92 -40.02 79.4 Favored 'General case' 0 C--O 1.206 -1.208 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.706 176.383 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.674 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 57.9 mt -66.75 -36.78 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.713 0.768 . . . . 0.0 110.802 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -71.49 -30.29 65.8 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.421 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -74.99 -26.32 59.48 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.487 1.115 . . . . 0.0 110.27 174.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 52.4 m -72.39 -49.29 34.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.995 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.447 HG22 ' HD3' ' A' ' 22' ' ' LYS . 44.3 mt -62.98 134.83 95.92 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.789 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 91' ' ' ALA . 14.3 Cg_endo -90.51 161.84 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.482 2.788 . . . . 0.0 113.302 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.532 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 25.4 mm -65.37 132.35 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 121.452 0.644 . . . . 0.0 110.379 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.67 12.06 54.13 Favored Glycine 0 C--N 1.288 -2.092 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.793 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -98.66 -170.43 1.94 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -175.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 13.3 m -151.14 158.93 44.62 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.5 t -146.21 126.68 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.772 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.63 -174.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.538 ' OD1' ' HE3' ' A' ' 19' ' ' LYS . 15.1 m-20 -78.79 104.14 9.21 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.7 mt -102.42 136.96 41.31 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 124.624 1.169 . . . . 0.0 109.884 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 37.6 tt0 -101.02 121.06 41.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 6.0 mt -107.54 165.04 11.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.048 1.339 . . . . 0.0 108.764 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.584 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 21.1 t -137.97 105.23 5.48 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.103 0.954 . . . . 0.0 110.634 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 59' ' ' GLU . 76.5 mtm180 -96.46 119.98 35.93 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 121.229 -0.92 . . . . 0.0 110.506 174.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.26 -33.95 0.15 Allowed Glycine 0 CA--C 1.474 -2.517 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.62 133.4 23.62 Favored Pre-proline 0 N--CA 1.424 -1.744 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.34 170.39 19.54 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.929 2.419 . . . . 0.0 111.395 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.85 128.42 88.87 Favored Pre-proline 0 N--CA 1.42 -1.968 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.459 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -76.09 -34.32 3.03 Favored 'Trans proline' 0 CA--C 1.49 -1.72 0 C-N-CA 122.426 2.084 . . . . 0.0 110.864 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.507 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 34.4 t80 -139.0 141.99 38.31 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 113.307 -1.77 . . . . 0.0 106.374 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -113.56 85.9 9.67 Favored Pre-proline 0 N--CA 1.387 -3.618 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.403 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 83.1 Cg_endo -89.9 -55.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.568 2.179 . . . . 0.0 112.257 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.0 -16.36 44.29 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.652 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.488 ' OD2' HG23 ' A' ' 112' ' ' THR . 19.0 t0 -78.01 115.29 49.31 Favored Pre-proline 0 CA--C 1.45 -2.892 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 111' ' ' ASN . 14.6 Cg_endo -87.54 -29.04 0.39 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 121.424 1.416 . . . . 0.0 109.622 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.582 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 9.9 t30 -64.55 4.24 0.41 Allowed 'General case' 0 N--CA 1.386 -3.66 1 C-N-CA 132.566 4.347 . . . . 0.0 114.026 -164.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.488 HG23 ' OD2' ' A' ' 109' ' ' ASP . 29.1 p -96.93 4.59 51.51 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.174 -175.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.48 ' HB3' HG21 ' A' ' 116' ' ' THR . 22.5 t -130.7 -177.08 4.2 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 114' ' ' LEU . 2.5 pt? -77.28 142.77 39.31 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.086 0.403 . . . . 0.0 111.028 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p 44.96 53.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.035 1.734 . . . . 0.0 112.775 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 113' ' ' SER . 12.0 p -106.99 -73.67 0.68 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.256 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.406 ' HB2' ' HG2' ' A' ' 110' ' ' PRO . 18.4 t -124.93 159.1 31.96 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 168.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.16 67.06 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.767 0.794 . . . . 0.0 112.205 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 121' ' ' LEU . . . -170.76 59.79 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.49 100.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.521 -174.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 119' ' ' ALA . 70.8 mt -118.2 131.49 56.38 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-O 121.713 0.768 . . . . 0.0 111.73 -174.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -135.89 120.06 17.75 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.98 103.21 9.71 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.3 135.96 86.66 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--N 1.355 0.91 0 C-N-CA 123.765 2.977 . . . . 0.0 113.126 -179.395 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.49 -18.54 14.34 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.628 0.728 . . . . 0.0 110.478 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.1 mmt -105.81 41.78 1.34 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 149.62 -143.26 10.58 Favored Glycine 0 CA--C 1.477 -2.321 0 N-CA-C 107.131 -2.387 . . . . 0.0 107.131 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? 53.01 68.54 2.92 Favored Pre-proline 0 CA--C 1.57 1.743 0 O-C-N 124.625 0.838 . . . . 0.0 112.034 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 38' ' ' ASP . 52.1 Cg_endo -94.52 -163.81 0.1 OUTLIER 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.944 2.43 . . . . 0.0 112.457 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -81.61 103.71 11.52 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.3 t80 -113.7 118.43 34.31 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.385 -176.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -134.7 17.67 3.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.86 0.838 . . . . 0.0 110.267 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.456 ' HA ' HD23 ' A' ' 73' ' ' LEU . 1.7 mtp180 59.59 -20.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.018 2.127 . . . . 0.0 115.762 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.551 ' OD1' ' HG2' ' A' ' 10' ' ' GLU . 3.3 t-20 -99.84 112.32 63.58 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-O 121.227 0.537 . . . . 0.0 111.086 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.8 Cg_endo -50.89 -37.1 54.98 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.989 3.126 . . . . 0.0 111.846 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -68.04 -20.31 64.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.763 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' HG2' ' OD1' ' A' ' 7' ' ' ASN . 8.3 mm-40 -95.14 -23.54 17.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.573 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 73' ' ' LEU . 19.7 mt -76.3 179.45 5.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.061 0.934 . . . . 0.0 110.421 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -107.65 -177.02 3.23 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 101.55 166.21 27.41 Favored Glycine 0 C--N 1.283 -2.405 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.074 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 29.2 tttp -93.03 138.96 31.02 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 98.0 m-85 -113.44 111.57 22.17 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.94 1.352 . . . . 0.0 110.835 -175.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.468 HG12 ' CE ' ' A' ' 14' ' ' LYS . 5.9 mt -109.36 151.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 CA-C-N 112.235 -2.257 . . . . 0.0 108.114 -173.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.515 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 2.8 t60 -130.71 119.77 22.86 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 57' ' ' LYS . 3.6 t -139.18 129.35 25.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.975 0.893 . . . . 0.0 111.056 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.809 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 36.5 ttpt -90.66 123.65 34.45 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.192 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.479 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.18 119.57 39.74 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.477 -173.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 39.0 ttm180 -77.43 111.03 12.7 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.863 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.68 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.0 tttt -69.26 97.23 0.92 Allowed 'General case' 0 C--O 1.177 -2.742 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 89' ' ' ILE . 29.4 t -82.05 -155.81 0.15 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -67.45 -31.06 70.97 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.588 0.709 . . . . 0.0 109.092 174.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.16 -13.33 57.35 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.798 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.68 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 81.29 -125.63 6.98 Favored Glycine 1 N--CA 1.389 -4.485 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 30.3 m-85 -88.52 142.7 27.49 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.699 0.75 . . . . 0.0 110.176 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.81 82.85 Favored Glycine 0 C--N 1.315 -0.61 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.923 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' HB2' HG23 ' A' ' 43' ' ' ILE . 28.2 p90 -110.66 162.72 14.46 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.244 0.545 . . . . 0.0 110.341 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 47.3 p -116.76 150.82 37.64 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.67 135.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.863 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.541 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 9.9 p -151.94 165.75 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.954 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 113.15 -0.47 25.39 Favored Glycine 0 CA--C 1.471 -2.687 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 172.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.756 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -120.54 44.55 1.35 Allowed Glycine 1 CA--C 1.395 -7.417 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -171.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 7.8 m-20 -59.09 -13.33 6.63 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.606 -1.797 . . . . 0.0 113.04 -174.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 4.2 pt-20 -160.04 166.42 15.89 Favored Pre-proline 0 CA--C 1.455 -2.703 0 C-N-CA 117.177 -1.809 . . . . 0.0 110.631 -174.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 36.8 Cg_endo -67.61 51.62 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.818 2.345 . . . . 0.0 110.585 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 2' ' ' PRO . 7.7 t70 -179.39 -12.88 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.674 1.19 . . . . 0.0 110.037 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.64 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 30.5 mt-10 -116.48 127.35 54.49 Favored 'General case' 0 C--O 1.276 2.465 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 167.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 73' ' ' LEU . 11.6 m-85 -80.36 155.31 27.24 Favored 'General case' 0 N--CA 1.524 3.254 0 O-C-N 127.942 3.276 . . . . 0.0 111.898 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.756 HD12 ' HA3' ' A' ' 34' ' ' GLY . 4.3 mp -84.33 145.72 28.1 Favored 'General case' 0 C--O 1.177 -2.755 0 C-N-CA 117.391 -1.724 . . . . 0.0 107.929 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.7 mt-30 -142.37 149.25 39.14 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 29' ' ' PHE . 33.1 mm -71.35 112.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 18.5 tptm -65.87 -35.03 79.52 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.516 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.5 t 160.69 172.97 0.01 OUTLIER 'General case' 0 C--N 1.357 0.926 0 O-C-N 125.271 1.607 . . . . 0.0 110.297 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.494 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.6 pp -138.55 148.53 44.32 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.541 0.686 . . . . 0.0 111.705 -173.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.9 119.06 28.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 53' ' ' ALA 0.26 1.1 pt? -69.44 -4.4 18.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.04 -27.13 48.72 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.196 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.437 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -90.08 171.11 36.82 Favored Glycine 0 N--CA 1.417 -2.62 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.754 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 8.8 Cg_endo -52.54 -32.23 52.55 Favored 'Trans proline' 0 C--O 1.204 -1.179 1 C-N-CA 125.328 4.018 . . . . 0.0 113.871 -173.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -57.76 -48.65 79.04 Favored 'General case' 0 C--O 1.273 2.333 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.65 -32.94 53.57 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.997 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 6.0 mp -68.21 -40.59 82.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' OD2' ' HD2' ' A' ' 57' ' ' LYS . 33.2 t70 -68.52 -30.02 68.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.75 6.56 87.09 Favored Glycine 0 CA--C 1.493 -1.294 0 CA-C-N 112.423 -2.171 . . . . 0.0 114.113 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 54.0 mttm -98.17 -25.2 14.98 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.6 ttm -96.24 140.63 30.65 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.259 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -131.54 153.0 50.29 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.771 0.795 . . . . 0.0 110.18 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 45' ' ' SER . 81.6 p -67.03 114.66 5.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.918 1.287 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.26 -20.87 15.88 Favored Glycine 0 CA--C 1.495 -1.209 0 O-C-N 121.961 -0.462 . . . . 0.0 112.41 177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 9.2 m-20 -60.45 136.42 58.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -87.32 125.7 41.07 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.345 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 17.5 mm -73.74 125.15 32.4 Favored 'Isoleucine or valine' 1 C--O 1.307 4.105 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 8' ' ' PRO . 48.4 t -114.42 -34.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-N 111.728 -2.487 . . . . 0.0 110.481 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 68.6 m -150.55 153.36 35.64 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.154 -0.966 . . . . 0.0 112.231 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG11 HG21 ' A' ' 83' ' ' ILE . 7.3 p -131.03 127.31 60.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m120 63.25 20.14 12.09 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.647 0.203 . . . . 0.0 110.544 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 t70 79.07 -1.02 2.33 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.95 1.7 . . . . 0.0 111.965 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.3 m -85.83 123.17 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.452 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 28.2 t -62.71 109.42 1.41 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.794 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.782 HG22 HG12 ' A' ' 80' ' ' VAL . 3.6 p -120.54 18.16 6.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.569 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.602 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 38.7 tp -59.59 113.41 2.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.93 43.71 0.14 Allowed Glycine 0 C--N 1.37 2.471 0 O-C-N 125.355 1.659 . . . . 0.0 112.174 -171.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.519 ' CD2' HG23 ' A' ' 72' ' ' VAL . 3.9 t60 -45.11 -65.94 0.47 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 75' ' ' HIS . 12.8 p -165.79 142.42 5.32 Favored 'General case' 0 C--N 1.264 -3.132 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 152.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -50.69 -31.52 16.67 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 120.119 1.327 . . . . 0.0 111.351 171.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.19 85.61 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 122.156 -0.34 . . . . 0.0 110.8 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 47.7 mm-40 -64.16 -40.99 97.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.782 HG12 HG22 ' A' ' 72' ' ' VAL . 12.6 m -63.44 -45.65 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.825 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.4 t -65.55 -40.07 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.4 -39.18 89.75 Favored 'General case' 0 C--O 1.199 -1.6 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.76 177.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.635 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.3 mm -67.0 -34.63 71.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.652 0.739 . . . . 0.0 112.026 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -75.1 -29.39 60.58 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.446 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -76.59 -19.91 57.35 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.105 0.962 . . . . 0.0 111.105 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 75.1 m -75.25 -37.72 60.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.018 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 24.5 mt -78.65 135.58 60.06 Favored Pre-proline 0 N--CA 1.421 -1.923 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.057 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.5 Cg_endo -90.9 161.94 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.455 2.77 . . . . 0.0 112.926 -173.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.538 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 20.8 mm -63.45 132.51 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-O 121.519 0.676 . . . . 0.0 111.452 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.99 12.12 53.21 Favored Glycine 0 C--N 1.294 -1.782 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.918 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.35 -170.27 1.84 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 122.484 0.314 . . . . 0.0 110.242 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 11.1 m -151.22 157.78 43.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.809 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -145.22 125.07 6.51 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.965 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.515 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 11.3 m-20 -77.52 104.18 7.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.77 142.22 33.43 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 124.607 1.163 . . . . 0.0 110.579 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -101.84 125.72 48.57 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 84.8 mt -115.36 152.9 31.98 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.331 1.452 . . . . 0.0 110.957 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.66 ' HB2' ' CE1' ' A' ' 15' ' ' PHE . 6.5 t -125.78 107.81 10.88 Favored 'General case' 0 C--O 1.188 -2.168 0 C-N-CA 124.202 1.001 . . . . 0.0 110.016 175.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.462 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 35.3 ttm180 -93.37 118.95 31.92 Favored 'General case' 0 C--N 1.254 -3.569 0 O-C-N 120.341 -1.474 . . . . 0.0 109.045 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.54 -30.49 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.04 133.0 25.84 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.85 156.38 66.37 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.35 2.7 . . . . 0.0 111.63 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 mt -45.81 135.81 6.29 Favored Pre-proline 0 CA--C 1.51 -0.564 0 C-N-CA 124.729 1.212 . . . . 0.0 112.048 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.47 -170.34 0.72 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.597 2.198 . . . . 0.0 114.022 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -80.55 147.51 30.77 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.98 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.72 88.81 40.3 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.951 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 68.1 Cg_endo -97.39 -60.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.668 2.245 . . . . 0.0 111.857 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.417 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 26.2 t70 -72.71 -23.69 60.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.845 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.51 131.14 42.98 Favored Pre-proline 0 N--CA 1.385 -3.687 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.548 -175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . 0.255 60.4 Cg_endo -82.38 -30.99 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.94 1.76 . . . . 0.0 108.457 163.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 117' ' ' SER . 77.1 m-20 -33.24 -11.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.86 1 C-N-CA 134.308 5.043 . . . . 0.0 119.626 -167.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.7 p -107.61 15.21 24.94 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -170.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 m -110.65 -167.33 1.17 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 85.1 mt -92.94 129.98 38.68 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t 68.53 46.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.774 1.273 . . . . 0.0 109.388 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.5 p -126.19 -177.29 3.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.303 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.563 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 16.3 m 66.26 36.89 5.18 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.5 t 57.74 69.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.346 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.25 23.44 5.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.836 0.827 . . . . 0.0 112.088 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.8 mm -98.99 79.2 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.38 54.43 3.15 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.452 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -133.74 144.87 49.35 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.79 65.6 7.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.007 0.908 . . . . 0.0 111.979 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -102.02 134.12 20.28 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 CA--C 1.544 1.02 0 C-N-CA 123.664 2.909 . . . . 0.0 112.965 -178.973 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.382 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 62.18 68.97 0.64 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 123.6 0.76 . . . . 0.0 111.804 176.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 16.9 tpt -178.08 -42.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.376 1.07 . . . . 0.0 109.147 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 176.69 -101.89 0.16 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.09 68.08 2.77 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 124.459 1.104 . . . . 0.0 112.676 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -104.89 -162.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.311 2.674 . . . . 0.0 111.81 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -98.28 105.88 18.08 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.603 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 3.9 t80 -95.79 139.79 31.51 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.748 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -148.82 14.61 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.297 0.57 . . . . 0.0 111.416 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.524 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 12.2 mtm180 55.11 -0.1 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.848 2.059 . . . . 0.0 115.934 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -134.13 123.49 16.84 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.526 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.3 Cg_endo -60.0 -22.7 70.23 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 123.845 3.03 . . . . 0.0 112.83 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -77.95 -29.8 50.05 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -87.2 -30.18 21.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.534 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 45.4 tp -81.06 160.4 24.52 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.684 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 49.5 mtmt -102.84 -179.26 3.91 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.625 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 105.27 168.52 23.9 Favored Glycine 0 C--N 1.281 -2.481 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -175.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -90.57 119.79 31.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 99.2 m-85 -98.5 114.62 27.09 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-O 121.92 0.867 . . . . 0.0 109.849 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.44 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 62.0 mt -117.73 136.01 56.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 CA-C-N 113.87 -1.513 . . . . 0.0 110.284 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.9 t-80 -105.95 113.99 27.86 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.261 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 t -139.96 133.5 30.21 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-O 122.073 0.94 . . . . 0.0 111.65 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.767 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -88.03 127.25 35.39 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.151 175.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -107.91 118.57 37.09 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 43.0 ttp180 -78.47 107.75 11.35 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.4 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.724 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 72.0 tttt -63.86 97.32 0.16 Allowed 'General case' 0 C--O 1.177 -2.723 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 168.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -85.06 -155.41 0.21 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.86 -39.86 90.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -84.96 -13.35 50.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.33 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.724 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 91.2 -121.96 6.53 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.507 ' HD1' HD12 ' A' ' 20' ' ' LEU . 39.7 m-85 -93.39 145.04 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.655 0.727 . . . . 0.0 109.85 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.66 -0.18 72.87 Favored Glycine 0 C--O 1.214 -1.131 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.861 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.548 ' HB2' HG23 ' A' ' 43' ' ' ILE . 18.7 p90 -108.28 163.52 13.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.391 0.615 . . . . 0.0 110.646 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.476 ' OG1' ' HE2' ' A' ' 44' ' ' LYS . 46.5 p -121.46 151.02 40.7 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.63 141.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.976 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 33' ' ' GLY . 11.5 p -149.75 167.0 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.474 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 127.19 -64.45 0.59 Allowed Glycine 0 CA--C 1.474 -2.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.402 173.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 39' ' ' GLU . . . -71.53 60.52 1.2 Allowed Glycine 1 CA--C 1.41 -6.474 0 C-N-CA 126.951 2.215 . . . . 0.0 116.236 -169.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -22.0 66.55 Favored 'General case' 0 C--N 1.245 -3.97 0 O-C-N 124.669 0.864 . . . . 0.0 109.739 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.455 ' CG ' ' HG2' ' A' ' 39' ' ' GLU . 10.0 pt-20 -154.27 165.33 18.22 Favored Pre-proline 0 CA--C 1.456 -2.649 0 C-N-CA 116.1 -2.24 . . . . 0.0 111.21 -171.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 35.4 Cg_endo -68.1 55.65 0.76 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.829 2.352 . . . . 0.0 109.796 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -178.05 -20.71 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.703 -1.589 . . . . 0.0 109.886 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.746 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 13.4 mm-40 -114.79 128.46 56.31 Favored 'General case' 0 C--O 1.274 2.384 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.477 ' CZ ' HD22 ' A' ' 11' ' ' LEU 0.25 7.5 m-30 -79.41 157.23 27.62 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 128.78 3.8 . . . . 0.0 111.773 -179.185 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 80' ' ' VAL . 6.5 mp -88.63 149.51 23.5 Favored 'General case' 0 C--O 1.189 -2.081 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 9.7 mt-30 -145.31 153.32 41.13 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 29' ' ' PHE . 21.0 mm -69.91 110.51 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HE2' ' OG1' ' A' ' 30' ' ' THR . 3.8 tmmm? -65.01 -33.88 77.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.562 ' HA ' HG22 ' A' ' 60' ' ' THR . 37.1 t 162.03 172.64 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 O-C-N 124.975 1.422 . . . . 0.0 109.775 173.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 58' ' ' MET . 0.6 OUTLIER -136.24 144.55 44.9 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-O 121.785 0.802 . . . . 0.0 109.947 -174.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 49' ' ' ASP . 11.0 t -78.38 126.3 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.85 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 5.9 mp -68.92 -4.2 15.65 Favored 'General case' 1 N--CA 1.377 -4.112 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.307 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' H ' HG12 ' A' ' 47' ' ' VAL . 20.5 t70 -97.55 -21.4 17.11 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.595 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.19 167.73 34.59 Favored Glycine 0 N--CA 1.404 -3.447 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.494 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.6 Cg_endo -53.65 -31.23 59.27 Favored 'Trans proline' 0 C--O 1.187 -2.046 0 C-N-CA 124.731 3.62 . . . . 0.0 113.037 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.66 76.37 Favored 'General case' 0 C--O 1.264 1.85 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.12 -34.32 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.098 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.23 -38.22 69.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.352 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -73.07 -18.24 61.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 122.273 1.035 . . . . 0.0 108.504 175.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.01 32.59 82.7 Favored Glycine 0 CA--C 1.498 -1.013 0 CA-C-N 113.251 -1.795 . . . . 0.0 113.836 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 36.4 mtmt -124.25 -0.72 8.25 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.646 ' HB3' HD22 ' A' ' 46' ' ' LEU . 28.1 mtt -112.71 141.87 45.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.847 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -135.9 149.89 49.14 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 45' ' ' SER . 32.5 p -63.17 114.64 3.88 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.763 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 114.82 -14.34 19.7 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.475 176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 43' ' ' ILE . 1.1 m-20 -61.73 132.33 52.82 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -81.8 129.47 37.44 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.686 0 CA-C-N 118.607 0.64 . . . . 0.0 112.32 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 41' ' ' LEU . 38.5 mm -79.53 127.58 39.07 Favored 'Isoleucine or valine' 1 C--O 1.322 4.918 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 173.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 73' ' ' LEU . 40.2 t -115.86 -47.44 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 O-C-N 127.085 2.741 . . . . 0.0 111.873 -176.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' A' ' 72' ' ' VAL . 50.1 m -140.88 165.17 28.26 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 117.995 -1.482 . . . . 0.0 113.767 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.668 HG23 HG11 ' A' ' 72' ' ' VAL . 40.0 t -138.07 120.66 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 C-N-CA 124.855 1.262 . . . . 0.0 108.175 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.9 m120 67.21 -79.34 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.468 1.105 . . . . 0.0 110.154 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -158.15 24.88 0.25 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.336 1.065 . . . . 0.0 109.655 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.8 m -117.19 123.84 47.65 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 t -68.07 108.01 2.94 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 80' ' ' VAL . 1.7 p -111.99 16.82 7.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 122.13 0.967 . . . . 0.0 108.606 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.603 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 37.7 tp -60.89 112.84 2.21 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 31.23 45.51 0.13 Allowed Glycine 0 C--N 1.378 2.874 0 O-C-N 125.754 1.909 . . . . 0.0 111.664 -170.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 76' ' ' THR . 2.5 t60 -48.41 -66.98 0.31 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' HIS . 8.6 p -166.62 142.64 4.6 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 151.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.594 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.5 -31.61 15.92 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 120.288 1.404 . . . . 0.0 111.516 173.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -48.31 82.24 Favored 'General case' 0 C--O 1.243 0.752 0 O-C-N 122.116 -0.365 . . . . 0.0 110.723 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 11.9 mm-40 -61.81 -44.08 97.57 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 122.938 0.495 . . . . 0.0 112.091 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.701 HG21 HD21 ' A' ' 41' ' ' LEU . 9.7 m -64.26 -44.31 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.63 -42.77 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -67.07 -29.15 68.84 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.383 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 86' ' ' SER . 2.1 mm -68.94 -40.45 81.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 123.117 0.567 . . . . 0.0 111.748 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.33 -33.96 67.71 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -73.27 -19.49 61.05 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.368 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 30.1 t -77.44 -43.17 33.4 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 mt -69.06 133.79 89.77 Favored Pre-proline 0 N--CA 1.423 -1.81 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.767 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.8 Cg_endo -89.56 161.84 5.34 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.163 2.576 . . . . 0.0 113.197 -173.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.548 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.6 mm -60.83 132.49 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.833 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.69 12.19 55.96 Favored Glycine 0 C--N 1.288 -2.123 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.834 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.418 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -101.73 -172.13 2.1 Favored 'General case' 0 C--O 1.205 -1.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' ARG . 19.8 m -151.17 156.87 41.86 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.77 -0.581 . . . . 0.0 109.614 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.6 t -143.43 125.49 11.84 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.672 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.597 -175.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.535 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 17.3 m-20 -78.42 108.26 11.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 67' ' ' VAL . 72.6 mt -108.45 136.03 48.75 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.443 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -91.58 124.65 35.91 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 10.7 mt -107.56 160.06 15.96 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.625 ' SG ' ' HA3' ' A' ' 13' ' ' GLY . 14.7 t -131.65 108.0 9.2 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 123.726 0.81 . . . . 0.0 108.993 174.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -96.89 147.12 24.29 Favored 'General case' 0 C--N 1.247 -3.853 0 O-C-N 120.706 -1.246 . . . . 0.0 109.904 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.04 -17.49 4.58 Favored Glycine 0 CA--C 1.482 -1.988 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.91 130.51 28.63 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.94 157.27 60.14 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 123.551 2.834 . . . . 0.0 112.546 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 17.6 mt -53.18 124.12 37.22 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.501 177.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.481 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 67.4 Cg_endo -77.06 -51.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 123.499 2.799 . . . . 0.0 115.698 -168.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.535 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 85.9 t80 -130.37 126.28 36.7 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 120.91 0.386 . . . . 0.0 111.477 -169.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -102.58 105.17 42.68 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.024 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 105' ' ' PHE . 48.7 Cg_endo -94.7 -61.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.316 0 C-N-CA 122.357 2.038 . . . . 0.0 109.939 169.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.405 -2.681 0 C-N-CA 125.567 1.547 . . . . 0.0 108.421 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 4.6 t0 -76.98 124.09 87.4 Favored Pre-proline 0 CA--C 1.469 -2.152 0 CA-C-O 121.994 0.902 . . . . 0.0 109.786 -172.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.494 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 95.6 Cg_endo -76.58 -38.69 0.9 Allowed 'Trans proline' 0 N--CA 1.42 -2.815 0 C-N-CA 121.538 1.492 . . . . 0.0 111.133 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 44.8 m-80 -60.18 -14.46 17.51 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 127.092 2.157 . . . . 0.0 113.387 -165.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.4 p -105.2 31.06 5.13 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 114.183 -1.372 . . . . 0.0 113.087 -170.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 57.1 p -148.06 -157.09 0.78 Allowed 'General case' 0 C--N 1.318 -0.769 0 O-C-N 121.846 -0.534 . . . . 0.0 110.692 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.89 144.56 29.7 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.122 -1.806 . . . . 0.0 106.122 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.265 10.3 p 45.54 74.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 123.071 1.415 . . . . 0.0 110.216 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 111' ' ' ASN . 50.5 p -91.53 -137.99 0.16 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.87 -171.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.448 ' N ' ' HB2' ' A' ' 110' ' ' PRO . 1.8 p -50.14 141.08 11.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 124.865 1.266 . . . . 0.0 109.81 173.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.93 83.14 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.26 1.028 . . . . 0.0 110.284 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.22 36.89 0.48 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.32 104.84 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.628 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -109.56 20.19 18.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 t0 72.45 155.71 0.16 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 127.143 2.177 . . . . 0.0 111.404 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -118.33 38.62 3.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.328 1.061 . . . . 0.0 111.707 -173.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 125' ' ' PRO . 7.9 tp10 -98.32 147.55 33.27 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.501 ' HD2' ' OE2' ' A' ' 124' ' ' GLU . 19.2 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.643 2.228 . . . . 0.0 112.027 174.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.659 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 176.53 -50.84 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.8 ttp -148.14 58.62 1.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 104.07 125.36 5.59 Favored Glycine 0 N--CA 1.422 -2.299 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.806 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.572 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 48.2 tptt -104.65 -66.16 0.04 OUTLIER Pre-proline 0 N--CA 1.426 -1.631 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.601 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 1' ' ' LYS . 38.0 Cg_endo -106.34 -175.9 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.377 2.051 . . . . 0.0 111.741 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -73.79 104.25 4.62 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.585 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 2.4 t80 -105.46 128.61 53.64 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.277 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -144.24 20.35 1.74 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.105 0.955 . . . . 0.0 109.835 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.484 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 15.2 mtm180 57.48 -14.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 127.479 2.312 . . . . 0.0 116.374 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 47.8 t-20 -112.59 117.03 47.55 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.728 -0.607 . . . . 0.0 110.97 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 7' ' ' ASN . 6.9 Cg_endo -53.22 -25.51 30.36 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.232 3.288 . . . . 0.0 113.37 174.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -71.61 -27.43 63.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -91.17 -21.24 21.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.512 HD11 HD21 ' A' ' 73' ' ' LEU . 24.5 mt -78.04 175.66 9.89 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.858 0.837 . . . . 0.0 110.641 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -105.11 -167.59 1.36 Allowed 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 89.72 175.01 45.76 Favored Glycine 0 C--N 1.284 -2.334 0 C-N-CA 119.315 -1.422 . . . . 0.0 112.155 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 4.0 tmmm? -113.62 148.56 36.03 Favored 'General case' 0 C--O 1.194 -1.849 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.48 ' CE1' ' HB2' ' A' ' 98' ' ' CYS . 97.2 m-85 -123.6 117.76 25.78 Favored 'General case' 0 CA--C 1.463 -2.387 0 CA-C-O 121.784 0.802 . . . . 0.0 110.807 -165.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.49 ' CG1' ' HE3' ' A' ' 14' ' ' LYS . 2.2 mp -111.75 138.1 41.8 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.786 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -102.67 118.67 37.36 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 94' ' ' ASP . 7.9 t -129.26 157.93 40.49 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.345 -171.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.795 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -129.46 122.05 28.53 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.527 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -107.69 117.42 34.05 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.085 -176.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' HD3' ' O ' ' A' ' 91' ' ' ALA . 19.2 tpp85 -72.38 106.69 4.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.6 175.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.72 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 67.9 tttt -66.79 96.97 0.44 Allowed 'General case' 0 C--O 1.171 -3.026 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 166.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 89' ' ' ILE . 21.4 t -85.01 -155.43 0.21 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -56.53 -41.03 76.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.931 0.332 . . . . 0.0 111.371 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -86.09 -20.65 28.42 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.795 0.807 . . . . 0.0 109.82 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.72 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 103.52 -122.35 7.41 Favored Glycine 1 N--CA 1.388 -4.556 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.527 ' HD1' HD12 ' A' ' 20' ' ' LEU . 46.0 m-85 -88.09 142.57 27.67 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 117.214 0.507 . . . . 0.0 110.328 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.47 9.34 74.23 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.139 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.472 ' HB2' HG23 ' A' ' 43' ' ' ILE . 6.3 p90 -122.11 162.98 20.28 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.04 0.447 . . . . 0.0 109.939 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 44' ' ' LYS . 39.4 p -116.85 155.19 29.44 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 41' ' ' LEU . 6.1 t -134.48 140.21 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.103 -175.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.8 p -153.15 157.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.03 171.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 39' ' ' GLU . . . 116.3 0.11 20.62 Favored Glycine 1 CA--C 1.441 -4.537 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 169.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.831 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -120.73 46.01 1.17 Allowed Glycine 1 CA--C 1.395 -7.438 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -59.57 -25.3 64.45 Favored 'General case' 0 C--N 1.264 -3.127 0 CA-C-N 113.228 -1.486 . . . . 0.0 111.498 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt-20 -155.98 167.61 13.95 Favored Pre-proline 0 CA--C 1.463 -2.388 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.843 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 24.9 Cg_endo -65.28 55.31 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.933 2.422 . . . . 0.0 111.084 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.424 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 14.8 t70 178.37 -12.91 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 -175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.713 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 62.7 mt-10 -117.83 123.94 47.15 Favored 'General case' 0 C--O 1.265 1.904 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . 0.301 7.2 m-30 -79.22 156.12 28.29 Favored 'General case' 1 N--CA 1.554 4.755 0 O-C-N 127.687 3.117 . . . . 0.0 112.329 -175.233 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.831 HD12 ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -86.88 142.46 28.02 Favored 'General case' 0 CA--C 1.46 -2.498 0 C-N-CA 115.948 -2.301 . . . . 0.0 107.748 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.2 mt-30 -139.88 151.2 45.45 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.487 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 21.5 mm -70.82 112.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.623 ' HB3' ' OG1' ' A' ' 30' ' ' THR . 40.2 ttmt -59.66 -41.69 91.14 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.591 ' HA ' HG22 ' A' ' 60' ' ' THR . 42.4 t 163.56 173.6 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 O-C-N 125.224 1.577 . . . . 0.0 109.801 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.68 152.38 45.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.95 0.881 . . . . 0.0 113.297 -172.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 49' ' ' ASP . 21.1 t -87.58 129.55 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.028 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.26 -4.2 16.9 Favored 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 112.509 -2.132 . . . . 0.0 112.325 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.576 ' H ' HG12 ' A' ' 47' ' ' VAL . 10.3 t70 -99.32 -20.11 16.7 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.097 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -88.3 155.9 26.57 Favored Glycine 1 N--CA 1.393 -4.182 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.72 -171.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 54' ' ' LEU . 11.6 Cg_endo -52.29 -26.66 27.92 Favored 'Trans proline' 0 C--O 1.198 -1.485 0 C-N-CA 125.009 3.806 . . . . 0.0 113.156 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' CA ' HD21 ' A' ' 20' ' ' LEU . . . -58.08 -46.72 85.0 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.114 0.483 . . . . 0.0 111.728 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.17 -36.65 54.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.404 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 51' ' ' PRO . 8.3 mp -71.56 -36.93 71.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.052 -174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.51 -15.51 60.39 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.26 41.07 99.73 Favored Glycine 0 CA--C 1.49 -1.507 0 CA-C-N 112.632 -2.076 . . . . 0.0 112.913 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -129.05 -23.88 2.97 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.281 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.428 ' SD ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -94.95 142.17 27.8 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.172 177.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.01 151.49 52.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 171.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 45' ' ' SER . 38.6 p -59.0 114.7 2.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.007 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 112.69 -11.83 25.38 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.238 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 9.7 m-20 -59.94 132.85 55.22 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 117.645 0.723 . . . . 0.0 109.56 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 98' ' ' CYS . 0.2 OUTLIER -86.94 119.3 34.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 9.2 mm -70.9 123.02 24.06 Favored 'Isoleucine or valine' 1 C--O 1.316 4.56 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 171.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 73' ' ' LEU . 40.0 t -114.42 -33.83 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-N 111.36 -2.654 . . . . 0.0 110.258 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 69.3 m -150.0 162.05 41.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.52 HG12 ' HB ' ' A' ' 72' ' ' VAL . 6.6 p -145.31 133.43 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 56.56 31.51 19.19 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.915 0.325 . . . . 0.0 111.828 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.66 15.9 10.25 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.592 1.157 . . . . 0.0 112.861 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -108.38 129.71 55.24 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.47 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 20.3 t -68.72 112.72 5.63 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.736 HG22 HG12 ' A' ' 80' ' ' VAL . 3.2 p -117.64 17.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.62 -175.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.585 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 32.1 tp -58.89 113.3 2.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 32.1 45.12 0.18 Allowed Glycine 0 N--CA 1.499 2.879 0 O-C-N 125.381 1.676 . . . . 0.0 111.801 -171.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.541 ' CD2' HG23 ' A' ' 72' ' ' VAL . 3.9 t60 -47.78 -66.48 0.4 Allowed 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' HIS . 10.3 p -167.1 143.19 4.31 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 151.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.578 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -50.33 -31.77 15.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 119.987 1.267 . . . . 0.0 110.536 171.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.22 77.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.941 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 71.0 mm-40 -64.67 -40.42 95.39 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.805 HG21 HD21 ' A' ' 41' ' ' LEU . 13.5 m -65.56 -45.7 91.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.053 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 77' ' ' HIS . 88.0 t -65.69 -37.46 80.0 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 83' ' ' ILE . 1.2 tmtm? -58.26 -45.61 87.5 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.627 175.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.678 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 2.2 mm -64.05 -36.8 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.386 0.613 . . . . 0.0 112.387 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -74.73 -31.36 61.81 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.175 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -69.31 -32.12 71.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.163 0.985 . . . . 0.0 110.768 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 66.2 m -69.58 -37.99 77.17 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.851 1.26 . . . . 0.0 110.122 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.48 HG22 ' HD3' ' A' ' 22' ' ' LYS . 21.8 mt -77.63 133.12 67.26 Favored Pre-proline 0 N--CA 1.411 -2.417 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.182 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.1 Cg_endo -88.66 162.73 6.4 Favored 'Trans proline' 0 C--N 1.327 -0.585 0 C-N-CA 123.611 2.874 . . . . 0.0 112.864 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.531 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.9 mm -61.92 135.0 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 CA-C-O 121.212 0.529 . . . . 0.0 110.534 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.44 12.08 58.83 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.57 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.607 ' O ' ' HD3' ' A' ' 21' ' ' ARG . . . -100.94 179.61 4.34 Favored 'General case' 0 C--O 1.187 -2.184 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.495 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 6.2 m -140.66 163.71 32.16 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -150.39 125.52 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 C-N-CA 117.8 -1.56 . . . . 0.0 113.337 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' THR . 4.3 m-20 -82.72 106.46 14.58 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.047 0.927 . . . . 0.0 109.548 174.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.4 mt -108.29 159.06 16.93 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 126.52 1.928 . . . . 0.0 108.852 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -116.89 123.64 47.5 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 62' ' ' ASP . 81.2 mt -106.87 160.86 15.19 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.825 1.25 . . . . 0.0 109.793 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.634 ' HB3' HG13 ' A' ' 63' ' ' VAL . 16.0 t -135.36 111.0 9.23 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.422 1.106 . . . . 0.0 110.796 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.496 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 19.4 tpp85 -89.99 112.99 24.57 Favored 'General case' 0 C--N 1.266 -3.063 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.4 -26.57 0.31 Allowed Glycine 0 C--N 1.292 -1.879 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.912 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.61 129.69 35.68 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.665 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 141.63 94.19 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.927 3.085 . . . . 0.0 113.785 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 112' ' ' THR . 5.4 mt -50.51 124.11 18.47 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.684 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 27.3 Cg_endo -79.34 -51.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.394 2.729 . . . . 0.0 114.783 -175.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -124.58 138.7 54.3 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.24 108.56 61.65 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.294 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.36 -64.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.669 0 C-N-CA 122.007 1.805 . . . . 0.0 109.653 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -143.5 30.22 1.38 Allowed 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -116.27 112.32 41.81 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.608 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 112' ' ' THR . 55.7 Cg_endo -78.44 -28.01 4.8 Favored 'Trans proline' 0 CA--C 1.491 -1.667 0 C-N-CA 123.109 2.539 . . . . 0.0 110.458 -174.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.486 ' N ' ' HG2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -70.84 8.07 0.99 Allowed 'General case' 0 C--N 1.263 -3.183 0 C-N-CA 129.932 3.293 . . . . 0.0 111.764 -169.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 110' ' ' PRO . 25.5 p -91.5 -13.62 31.85 Favored 'General case' 0 N--CA 1.387 -3.619 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.481 -173.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.441 ' HB2' ' OG1' ' A' ' 116' ' ' THR . 15.8 m -112.13 147.55 35.86 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -61.27 128.56 36.95 Favored 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 123.814 0.696 . . . . 0.0 111.088 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.341 9.8 p 58.03 35.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 126.624 1.969 . . . . 0.0 114.89 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 113' ' ' SER . 26.8 m -82.19 -84.29 0.12 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 118.041 -1.464 . . . . 0.0 107.705 168.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.9 m -116.4 61.24 0.72 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -158.27 130.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.277 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -102.94 47.76 0.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.204 0.526 . . . . 0.0 111.278 -174.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.45 104.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -106.09 41.76 1.36 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.302 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 t70 71.21 -177.39 0.2 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.186 1.394 . . . . 0.0 110.19 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 63.54 25.71 14.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.898 1.679 . . . . 0.0 111.983 176.124 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.77 135.75 92.39 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.686 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 123.845 3.03 . . . . 0.0 112.995 -179.945 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.443 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.27 131.42 21.89 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 92.0 mtp 65.14 51.14 1.7 Allowed 'General case' 0 C--O 1.248 0.984 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 163.03 -132.47 2.77 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.552 ' HA ' ' HG2' ' A' ' 39' ' ' GLU . 48.7 tptt 47.59 63.26 10.51 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.158 0.983 . . . . 0.0 111.635 177.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 39' ' ' GLU . 6.0 Cg_endo -86.27 173.78 6.48 Favored 'Trans proline' 0 N--CA 1.439 -1.734 0 C-N-CA 122.699 2.266 . . . . 0.0 111.751 -174.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.34 105.12 2.44 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.554 ' HZ ' ' O ' ' A' ' 73' ' ' LEU . 5.1 t80 -107.56 135.36 49.14 Favored 'General case' 0 C--N 1.267 -3.011 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -144.17 17.98 1.74 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.111 0.958 . . . . 0.0 110.316 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.501 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 21.4 mtt180 59.4 -27.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.408 2.683 . . . . 0.0 116.57 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 50.3 t-20 -104.65 123.38 40.42 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB3' HG11 ' A' ' 65' ' ' VAL . 4.2 Cg_exo -54.84 -29.73 64.62 Favored 'Trans proline' 0 C--O 1.206 -1.102 0 C-N-CA 123.737 2.958 . . . . 0.0 112.246 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -70.75 -26.17 63.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -92.2 -24.32 19.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 12' ' ' LYS . 3.5 tm? -86.65 153.74 21.53 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.497 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.508 ' N ' HD13 ' A' ' 11' ' ' LEU . 46.6 mtmt -110.2 133.47 53.2 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 122.066 0.936 . . . . 0.0 110.697 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.515 ' HA3' ' SG ' ' A' ' 98' ' ' CYS . . . 156.83 170.6 22.02 Favored Glycine 1 C--N 1.247 -4.378 0 CA-C-N 113.048 -1.887 . . . . 0.0 108.999 -173.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 37.9 tptt -89.54 117.55 28.52 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.877 0.838 . . . . 0.0 109.825 174.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 98.3 m-85 -101.98 113.98 27.69 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.93 0.872 . . . . 0.0 109.77 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.6 mt -118.74 131.22 72.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.638 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -107.67 108.29 19.47 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -174.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -133.77 145.62 49.97 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 122.09 0.947 . . . . 0.0 111.271 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -87.96 130.84 34.82 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.149 177.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD12 ' HD1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -109.66 117.38 33.77 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 40.8 ttt180 -77.12 111.94 13.25 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.087 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.668 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 74.6 tttt -66.96 96.83 0.45 Allowed 'General case' 0 C--O 1.187 -2.235 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -94.62 -154.26 0.41 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 124.322 1.049 . . . . 0.0 109.107 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -47.84 -41.97 25.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.894 1.278 . . . . 0.0 111.716 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.688 ' HA ' ' NE ' ' A' ' 25' ' ' ARG . 2.5 mmp_? -105.53 10.41 33.14 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.827 -0.546 . . . . 0.0 111.717 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.668 ' HA2' ' HG3' ' A' ' 22' ' ' LYS . . . 82.34 -125.3 6.88 Favored Glycine 1 N--CA 1.384 -4.769 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 34.0 m-85 -86.02 145.98 26.85 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.765 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.83 -2.93 86.2 Favored Glycine 0 CA--C 1.499 -0.945 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.336 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.543 ' HB2' HG23 ' A' ' 43' ' ' ILE . 20.9 p90 -109.93 162.9 14.06 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.893 0.854 . . . . 0.0 111.488 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.2 p -118.43 145.96 44.82 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG21 HD23 ' A' ' 41' ' ' LEU . 7.2 p -134.67 146.81 30.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.896 -173.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 33' ' ' GLY . 14.9 p -144.38 165.92 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.873 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.371 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' N ' HG22 ' A' ' 32' ' ' VAL . . . 114.29 -141.39 16.96 Favored Glycine 1 N--CA 1.394 -4.152 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 77' ' ' HIS . . . 51.83 33.24 35.1 Favored Glycine 0 CA--C 1.471 -2.689 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.12 -27.95 67.75 Favored 'General case' 0 CA--C 1.455 -2.697 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -170.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 6.6 pt-20 -161.64 166.76 14.13 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.431 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 23.2 Cg_endo -66.63 58.88 0.52 Allowed 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 122.605 2.204 . . . . 0.0 109.353 169.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 21.7 t70 173.44 -9.53 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.716 1.606 . . . . 0.0 110.661 -171.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' ' 1' ' ' LYS . 22.6 mt-10 -124.28 127.98 48.46 Favored 'General case' 0 C--O 1.269 2.127 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.447 ' CE1' HD11 ' A' ' 73' ' ' LEU . 8.6 m-30 -77.1 158.49 30.44 Favored 'General case' 0 N--CA 1.518 2.934 0 O-C-N 128.959 3.912 . . . . 0.0 113.258 -167.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 80' ' ' VAL . 7.1 mp -89.2 144.69 25.92 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 172.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 11.0 mt-30 -143.97 151.76 40.18 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 29' ' ' PHE . 22.2 mm -69.69 112.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.53 -39.18 72.94 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.485 ' HA ' HG22 ' A' ' 60' ' ' THR . 43.0 t 161.23 173.33 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.638 1.836 . . . . 0.0 108.666 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 52' ' ' ALA . 2.0 pp -135.86 148.18 48.53 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-O 121.644 0.735 . . . . 0.0 112.209 -175.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 49' ' ' ASP . 43.3 t -83.94 121.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.214 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 6.2 mp -63.44 -3.48 2.1 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 112.053 -2.339 . . . . 0.0 113.583 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' HG12 ' A' ' 47' ' ' VAL . 12.3 t70 -90.94 -30.7 16.71 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 124.594 1.158 . . . . 0.0 108.889 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 54' ' ' LEU . . . -94.64 174.38 33.23 Favored Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 115.354 -168.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -52.35 -34.73 61.86 Favored 'Trans proline' 0 C--O 1.2 -1.389 1 C-N-CA 125.453 4.102 . . . . 0.0 113.815 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -58.03 -48.1 81.1 Favored 'General case' 0 C--O 1.264 1.843 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 48' ' ' LEU . . . -77.78 -37.77 48.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.585 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 50' ' ' GLY . 7.7 mp -69.49 -36.64 76.72 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.198 -175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.71 -18.52 61.52 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.648 1.213 . . . . 0.0 108.112 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.23 35.23 91.35 Favored Glycine 0 CA--C 1.491 -1.449 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.227 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -115.69 -48.2 2.78 Favored 'General case' 0 N--CA 1.402 -2.867 0 C-N-CA 123.099 0.56 . . . . 0.0 112.479 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.3 ttm -95.57 151.37 19.38 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -149.68 147.47 28.12 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-O 122.01 0.909 . . . . 0.0 111.673 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 45' ' ' SER . 81.9 p -52.69 105.28 0.11 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.168 1.387 . . . . 0.0 112.346 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 116.06 -12.89 16.98 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-O 118.629 -1.095 . . . . 0.0 113.187 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.66 143.33 58.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.625 -1.23 . . . . 0.0 107.846 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -90.85 117.42 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 41' ' ' LEU . 28.0 mm -69.87 125.08 27.27 Favored 'Isoleucine or valine' 1 C--O 1.327 5.163 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 73' ' ' LEU . 46.3 t -115.77 -37.33 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 111.136 -2.756 . . . . 0.0 112.197 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 71' ' ' CYS . 63.9 m -149.89 157.28 43.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.381 -1.45 . . . . 0.0 112.617 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.677 HG23 HG11 ' A' ' 72' ' ' VAL . 77.0 t -134.37 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m120 57.89 31.52 20.67 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.808 0.692 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 72.63 1.74 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.621 1.968 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.8 m -89.65 122.2 32.55 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.42 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 49.2 t -65.5 108.89 2.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.172 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 80' ' ' VAL . 1.4 p -114.68 14.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.605 -175.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.554 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 27.6 tp -58.67 113.72 2.16 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 30.04 46.39 0.1 Allowed Glycine 0 C--N 1.378 2.864 0 O-C-N 125.857 1.973 . . . . 0.0 112.228 -170.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.492 ' O ' HG23 ' A' ' 76' ' ' THR . 2.8 t60 -48.03 -67.35 0.28 Allowed 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 75' ' ' HIS . 14.2 p -165.98 143.22 5.4 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 152.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.562 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.4 t-80 -53.43 -31.26 44.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 120.664 1.574 . . . . 0.0 111.463 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.23 90.58 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.99 -0.444 . . . . 0.0 110.516 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 23.2 mm-40 -64.19 -44.0 93.34 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 41' ' ' LEU . 11.2 m -62.19 -41.81 92.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.242 -178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.07 -38.83 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -63.05 -33.54 75.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.291 176.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 86' ' ' SER . 32.9 mt -67.63 -42.21 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.491 0.662 . . . . 0.0 111.104 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.56 -30.72 67.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.187 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -71.24 -33.16 69.58 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.18 0.992 . . . . 0.0 110.209 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 31.0 t -65.26 -49.07 70.99 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.139 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 12.0 mt -64.88 133.75 95.84 Favored Pre-proline 0 N--CA 1.426 -1.674 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.537 175.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.0 Cg_endo -90.75 162.33 4.15 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 123.563 2.842 . . . . 0.0 113.119 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.547 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 24.4 mm -62.66 134.76 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-O 121.058 0.456 . . . . 0.0 110.28 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.52 11.74 56.68 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . . . -102.0 -169.14 1.64 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -176.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.618 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 27.1 m -151.34 163.85 38.0 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.818 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 1.3 t -148.41 124.71 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.085 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.503 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.66 104.99 13.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 63.2 mt -108.27 152.33 24.75 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 125.28 1.432 . . . . 0.0 111.94 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -104.17 119.48 39.04 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 1.5 mp -111.37 164.49 12.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.305 1.442 . . . . 0.0 108.559 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.564 ' HB3' HG13 ' A' ' 63' ' ' VAL . 38.9 t -145.23 111.69 5.74 Favored 'General case' 0 C--O 1.191 -1.991 0 CA-C-O 122.352 1.072 . . . . 0.0 112.931 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -99.4 120.06 38.99 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 120.957 -1.089 . . . . 0.0 111.202 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.4 -33.43 0.09 OUTLIER Glycine 0 CA--C 1.471 -2.677 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -96.1 141.83 23.71 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.09 -178.56 2.55 Favored 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 122.834 2.356 . . . . 0.0 110.171 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 103' ' ' LEU . 13.7 mt -59.23 120.36 46.97 Favored Pre-proline 0 N--CA 1.412 -2.331 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.71 -44.82 0.89 Allowed 'Trans proline' 0 CA--C 1.493 -1.574 0 C-N-CA 123.195 2.597 . . . . 0.0 114.993 -167.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -129.55 149.8 51.16 Favored 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.493 -170.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.11 102.58 48.67 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.059 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.4 ' CG ' ' H ' ' A' ' 108' ' ' ASP . 57.7 Cg_endo -96.67 -65.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.691 2.26 . . . . 0.0 110.519 170.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 107' ' ' PRO . 38.8 t70 -123.35 25.82 8.17 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.449 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.4 114.75 45.65 Favored Pre-proline 0 CA--C 1.476 -1.891 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.95 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.506 ' HG2' ' N ' ' A' ' 111' ' ' ASN . 53.1 Cg_endo -79.7 -38.07 0.41 Allowed 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.747 1.631 . . . . 0.0 111.438 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' A' ' 117' ' ' SER . 17.8 m-80 -55.68 -13.97 1.96 Allowed 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 129.193 2.997 . . . . 0.0 113.046 -165.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.8 p -88.91 -12.2 42.39 Favored 'General case' 0 N--CA 1.395 -3.211 0 CA-C-N 113.774 -1.557 . . . . 0.0 111.829 -170.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.1 m -96.61 -165.54 1.29 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.215 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.73 156.29 20.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.26 15.1 m 47.96 33.01 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 126.303 1.841 . . . . 0.0 114.886 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -120.17 -178.7 3.73 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.649 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 37.1 m 77.86 176.21 0.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -168.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -109.93 23.77 3.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.517 -177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.21 82.39 1.6 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 110.881 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.4 113.08 39.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -130.41 29.48 4.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.78 -18.35 11.37 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 114.273 -1.33 . . . . 0.0 113.388 -170.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -91.01 77.26 6.11 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-O 121.878 0.847 . . . . 0.0 111.031 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.17 141.47 23.01 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.534 2.156 . . . . 0.0 111.198 174.103 . . . . . . . . 0 0 . 1 stop_ save_